PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Francis, M; Ahmad, A; Bodgi, L; Azzam, P; Youssef, T; Abou Daher, A; Eid, AA; Fornoni, A; Pollack, A; Marples, B; Zeidan, YH				Francis, Marina; Ahmad, Anis; Bodgi, Larry; Azzam, Patrick; Youssef, Tarek; Abou Daher, Alaa; Eid, Assaad A.; Fornoni, Alessia; Pollack, Alan; Marples, Brian; Zeidan, Youssef H.			SMPDL3b modulates radiation-induced DNA damage response in renal podocytes	FASEB JOURNAL			English	Article						nuclear sphingolipids; ATM nuclear shuttling; DNA damage response; double-strand breaks; radiation nephropathy; radiation podocytopathy; SMPDL3b; sphingolipids	DOUBLE-STRAND BREAKS; HISTONE H2AX; ATM KINASE; PROTEIN; P53; SPHINGOLIPIDS; IMPACT; REPAIR; PHOSPHORYLATION; THERAPY	The kidneys are radiosensitive and dose-limiting organs for radiotherapy (RT) targeting abdominal and paraspinal tumors. Excessive radiation doses to the kidneys ultimately lead to radiation nephropathy. Our prior work unmasked a novel role for the lipid-modifying enzyme, sphingomyelin phosphodiesterase acid-like 3b (SMPDL3b), in regulating the response of renal podocytes to radiation injury. In this study, we investigated the role of SMPDL3b in DNA double-strand breaks (DSBs) repair in vitro and in vivo. We assessed the kinetics of DSBs recognition and repair along with the ATM pathway and nuclear sphingolipid metabolism in wild-type (WT) and SMPDL3b overexpressing (OE) human podocytes. We also assessed the extent of DNA damage repair in SMPDL3b knock-down (KD) human podocytes, and C57BL6 WT and podocyte-specific SMPDL3b-knock out (KO) mice after radiation injury. We found that SMPDL3b overexpression enhanced DSBs recognition and repair through modulating ATM nuclear shuttling. OE podocytes were protected against radiation-induced apoptosis by increasing the phosphorylation of p53 at serine 15 and attenuating subsequent caspase-3 cleavage. SMPDL3b overexpression prevented radiation-induced alterations in nuclear ceramide-1-phosphate (C1P) and ceramide levels. Interestingly, exogenous C1P pretreatment radiosensitized OE podocytes by delaying ATM nuclear foci formation and DSBs repair. On the other hand, SMPDL3b knock-down, in vitro and in vivo, induced a significant delay in DSBs repair. Additionally, increased activation of apoptosis was induced in podocytes of SMPDL3b-KO mice compared to WT mice at 24h post-irradiation. Together, our results unravel a novel role for SMPDL3b in radiation-induced DNA damage response. The current work suggests that SMPDL3b modulates nuclear sphingolipid metabolism, ATM nuclear shuttling, and DSBs repair.	[Francis, Marina; Azzam, Patrick; Youssef, Tarek; Abou Daher, Alaa; Eid, Assaad A.; Zeidan, Youssef H.] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol, Beirut, Lebanon; [Ahmad, Anis; Pollack, Alan] Univ Miami, Miller Sch Med, Sylvester Canc Ctr, Dept Radiat Oncol, Miami, FL 33136 USA; [Bodgi, Larry; Zeidan, Youssef H.] Amer Univ Beirut, Dept Radiat Oncol, Beirut, Lebanon; [Fornoni, Alessia] Univ Miami, Peggy & Harold Katz Family Drug Discovery Ctr, Miami, FL USA; [Fornoni, Alessia] Univ Miami, Dept Med, Katz Family Div Nephrol & Hypertens, Miami, FL USA; [Marples, Brian] Univ Rochester, Dept Radiat Oncol, Rochester, NY USA	American University of Beirut; University of Miami; American University of Beirut; University of Miami; University of Miami; University of Rochester	Zeidan, YH (corresponding author), Amer Univ Beirut, Dept Radiat Oncol, Med Ctr, POB 11-0236, Beirut 11072020, Lebanon.	yz09@aub.edu.lb		Eid, Assaad/0000-0002-3603-0960; Francis, Marina/0000-0001-7264-8111; Bodgi, Larry/0000-0003-1067-9435	National Institutes of Health [1R01CA227493]; Live Like Bella, Florida Department of Health [9LA08]; Medical Practice Plan; American University of Beirut; Sylvester Cancer Center Award [PG011608, PG014020]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Live Like Bella, Florida Department of Health; Medical Practice Plan; American University of Beirut; Sylvester Cancer Center Award	National Institutes of Health, Grant/Award Number: 1R01CA227493; Live Like Bella, Florida Department of Health, Grant/Award Number: 9LA08; Medical Practice Plan, American University of Beirut; Sylvester Cancer Center Award, Grant/Award Number: PG011608 and PG014020	Abou Daher A, 2020, FASEB J, V34, P7915, DOI 10.1096/fj.201902179R; Ahmad A, 2017, FASEB J, V31, P771, DOI 10.1096/fj.201600618R; Albi E., 2006, RECENT RES DEV BIOPH, V37, P211; Azzam P, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.732528; BALDWIN JN, 1962, CALIF MED, V97, P359; Barnett GC, 2009, NAT REV CANCER, V9, P134, DOI 10.1038/nrc2587; Basic-Jukic N, 2013, CURR PHARM DESIGN, V19, P6046; Baskar R, 2012, INT J MED SCI, V9, P193, DOI 10.7150/ijms.3635; Bauer NC, 2015, NUCLEIC ACIDS RES, V43, P10083, DOI 10.1093/nar/gkv1136; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Bodgi L, 2016, INT J RADIAT BIOL, V92, P117, DOI 10.3109/09553002.2016.1135260; Bodgi L, 2013, J THEOR BIOL, V333, P135, DOI 10.1016/j.jtbi.2013.05.020; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carroll Brittany, 2015, Advances in Biological Regulation, V58, P38, DOI 10.1016/j.jbior.2014.11.001; CASSADY JR, 1995, INT J RADIAT ONCOL, V31, P1249, DOI 10.1016/0360-3016(94)00428-N; Cheng JC, 2008, INT J RADIAT ONCOL, V71, P1436, DOI 10.1016/j.ijrobp.2007.12.009; Combemale P, 2022, MOL NEUROBIOL, V59, P556, DOI 10.1007/s12035-021-02615-3; Dawson LA, 2010, INT J RADIAT ONCOL, V76, pS108, DOI 10.1016/j.ijrobp.2009.02.089; Edeani A., 2016, AM SOC NEPHROLOGY; Edsall DL, 1906, J AMER MED ASSOC, V47, P1425; Eriksson D, 2010, TUMOR BIOL, V31, P363, DOI 10.1007/s13277-010-0042-8; Ferlazzo ML, 2018, MOL NEUROBIOL, V55, P4973, DOI 10.1007/s12035-017-0648-6; Ferlazzo ML, 2014, MOL NEUROBIOL, V49, P1200, DOI 10.1007/s12035-013-8591-7; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Francis M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124481; Hankins JL, 2013, J BIOL CHEM, V288, P19726, DOI 10.1074/jbc.M113.481622; Heinz LX, 2015, CELL REP, V11, P1919, DOI 10.1016/j.celrep.2015.05.006; Hofmann LP, 2008, BIOL CHEM, V389, P1399, DOI 10.1515/BC.2008.160; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; KASTAN MB, 1991, CANCER RES, V51, P6304; Klaus R, 2021, RADIAT ONCOL, V16, DOI 10.1186/s13014-021-01764-y; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Ledeen RW, 2008, J LIPID RES, V49, P1176, DOI 10.1194/jlr.R800009-JLR200; Lennon R, 2009, NEPHROL DIAL TRANSPL, V24, P3288, DOI 10.1093/ndt/gfp302; Loughery J, 2014, NUCLEIC ACIDS RES, V42, P7664, DOI 10.1093/nar/gku501; Mallela SK, 2019, BBA-MOL CELL BIOL L, V1864, DOI 10.1016/j.bbalip.2019.158517; Merscher S, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00127; Mitrofanova A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10584-4; Negritto M, 2010, NAT ED, V3, P26; Okada T, 2005, J BIOL CHEM, V280, P36318, DOI 10.1074/jbc.M504507200; Ouenzar F, 2016, TRANSL CANCER RES, V5, pS742, DOI 10.21037/tcr.2016.10.61; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Pereira S, 2018, INT J RADIAT ONCOL, V100, P353, DOI 10.1016/j.ijrobp.2017.10.029; Rappold I, 2001, J CELL BIOL, V153, P613, DOI 10.1083/jcb.153.3.613; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Saha GB, 2012, PHYS RADIOBIOLOGY NU; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider G, 2013, MOL CANCER RES, V11, P793, DOI 10.1158/1541-7786.MCR-12-0600; Schnitzer SE, 2009, MOL CANCER RES, V7, P393, DOI 10.1158/1541-7786.MCR-08-0156; Sera N, 2013, RADIAT RES, V179, P46, DOI 10.1667/RR2863.1; STEPHENS LC, 1995, INT J RADIAT ONCOL, V31, P865, DOI 10.1016/0360-3016(94)00437-4; Suzuki K, 2001, RADIAT RES, V155, P248, DOI 10.1667/0033-7587(2001)155[0248:RISLGA]2.0.CO;2; Tomassoni ML, 1999, BIOCHEM BIOPH RES CO, V258, P476, DOI 10.1006/bbrc.1999.0659; Van Brocklyn JR, 2005, J NEUROPATH EXP NEUR, V64, P695, DOI 10.1097/01.jnen.0000175329.59092.2c; Varela I, 2008, NAT MED, V14, P767, DOI 10.1038/nm1786; Wijesinghe DS, 2010, J LIPID RES, V51, P641, DOI 10.1194/jlr.D000430; Yoo TH, 2015, J AM SOC NEPHROL, V26, P133, DOI 10.1681/ASN.2013111213; Zhao H, 2008, CELL CYCLE, V7, P3048, DOI 10.4161/cc.7.19.6750	64	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22545	10.1096/fj.202100186RR	http://dx.doi.org/10.1096/fj.202100186RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4M1XJ	36094323				2022-12-26	WOS:000853121100001
J	Wang, X; Simon, SM; Coffino, P				Wang, Xiao; Simon, Sanford M.; Coffino, Philip			Single molecule microscopy reveals diverse actions of substrate sequences that impair ClpX AAA plus ATPase function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DEGRADATION; PORE LOOPS; TRANSLOCATION; RECOGNITION; REPEAT; ENGAGEMENT; DEPENDENCE; UNFOLD; DOMAIN	AAA+ (ATPases Associated with diverse cellular Activities) proteases unfold substrate proteins by pulling the substrate polypeptide through a narrow pore. To overcome the barrier to unfolding, substrates may require extended association with the ATPase. Failed unfolding attempts can lead to a slip of grip, which may result in substrate dissociation, but how substrate sequence affects slippage is unresolved. Here, we measured single molecule dwell time using total internal reflection fluo-rescence microscopy, scoring time-dependent dissociation of engaged substrates from bacterial AAA+ ATPase unfoldase/ translocase ClpX. Substrates comprising a stable domain resistant to unfolding and a C-terminal unstructured tail, tag-ged with a degron for initiating translocase insertion, were used to determine dwell time in relation to tail length and compo-sition. We found greater tail length promoted substrate retention during futile unfolding. Additionally, we tested two tail compositions known to frustrate unfolding. A poly-glycine tract (polyG) promoted release, but only when adjacent to the folded domain, whereas glycine-alanine repeats (GAr) did not promote release. A high complexity motif containing polar and charged residues also promoted release. We further investi-gated the impact of these and related motifs on substrate degradation rates and ATP consumption, using the unfoldase??? protease complex ClpXP. Here, substrate domain stability modulates the effects of substrate tail sequences. polyG and GAr are both inhibitory for unfolding, but act in different ways. GAr motifs only negatively affected degradation of highly sta-ble substrates, which is accompanied by reduced ClpXP ATPase activity. Together, our results specify substrate char-acteristics that affect unfolding and degradation by ClpXP.	[Wang, Xiao; Simon, Sanford M.; Coffino, Philip] Rockefeller Univ, Lab Cellular Biophys, 1230 York Ave, New York, NY 10021 USA	Rockefeller University	Coffino, P (corresponding author), Rockefeller Univ, Lab Cellular Biophys, 1230 York Ave, New York, NY 10021 USA.	pcoffino@rockefeller.edu		Simon, Sanford/0000-0002-8615-4224; Wang, Xiao/0000-0001-7406-0346				Antony PMA, 2013, FEBS J, V280, P5981, DOI 10.1111/febs.12335; Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Bard JAM, 2019, CELL, V177, P286, DOI 10.1016/j.cell.2019.02.031; Bell TA, 2019, ELIFE, V8, DOI 10.7554/eLife.46808; Chang YJ, 2016, J BIOL CHEM, V291, P4903, DOI 10.1074/jbc.M115.694273; Cordova JC, 2014, CELL, V158, P647, DOI 10.1016/j.cell.2014.05.043; FALK K, 1995, J GEN VIROL, V76, P779, DOI 10.1099/0022-1317-76-4-779; Fei X, 2020, ELIFE, V9, DOI 10.7554/eLife.52774; Freibaum BD, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00035; Glynn SE, 2009, CELL, V139, P744, DOI 10.1016/j.cell.2009.09.034; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Guo Q, 2018, CELL, V172, P696, DOI 10.1016/j.cell.2017.12.030; Henderson A, 2011, J BIOL CHEM, V286, P17495, DOI 10.1074/jbc.M110.212027; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Hua BY, 2014, NAT METHODS, V11, P1233, DOI [10.1038/NMETH.3143, 10.1038/nmeth.3143]; Iosefson O, 2015, CELL REP, V12, P1032, DOI 10.1016/j.celrep.2015.07.007; Iosefson O, 2015, NAT CHEM BIOL, V11, P201, DOI 10.1038/nchembio.1732; Johnson Daniel S, 2012, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1229s61; Jonsson E., 2021, BIORXIV, DOI [10.1101/2021.08.18.456915, DOI 10.1101/2021.08.18.456915]; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Koodathingal P, 2009, J BIOL CHEM, V284, P18674, DOI 10.1074/jbc.M900783200; Kraut DA, 2013, J BIOL CHEM, V288, P34729, DOI 10.1074/jbc.M113.512533; Kraut DA, 2012, ACS CHEM BIOL, V7, P1444, DOI 10.1021/cb3001155; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Levitskaya J, 1997, P NATL ACAD SCI USA, V94, P12616, DOI 10.1073/pnas.94.23.12616; Li HB, 2000, NAT STRUCT BIOL, V7, P1117; Lin L, 1996, MOL CELL BIOL, V16, P2248; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Nassif ND, 2014, IUBMB LIFE, V66, P309, DOI 10.1002/iub.1271; Olivares AO, 2017, P NATL ACAD SCI USA, V114, pE6306, DOI 10.1073/pnas.1707794114; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Pohl C, 2019, SCIENCE, V366, P818, DOI 10.1126/science.aax3769; Ripstein ZA, 2020, ELIFE, V9, DOI 10.7554/eLife.52158; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Rodriguez-Aliaga P, 2016, NAT STRUCT MOL BIOL, V23, P974, DOI 10.1038/nsmb.3298; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Saudou F, 2016, NEURON, V89, P910, DOI 10.1016/j.neuron.2016.02.003; Saunders RA, 2020, P NATL ACAD SCI USA, V117, P28005, DOI 10.1073/pnas.2010804117; Schrader EK, 2011, J BIOL CHEM, V286, P39051, DOI 10.1074/jbc.M111.274993; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Shin Y, 2009, P NATL ACAD SCI USA, V106, P19340, DOI 10.1073/pnas.0910484106; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Too PHM, 2013, J BIOL CHEM, V288, P13243, DOI 10.1074/jbc.M113.452524; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; Wootton JC, 1996, METHOD ENZYMOL, V266, P554; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Yu HQ, 2016, J BIOL CHEM, V291, P14526, DOI 10.1074/jbc.M116.727578; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200	57	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102457	10.1016/j.jbc.2022.102457	http://dx.doi.org/10.1016/j.jbc.2022.102457			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5H2JF	36064000	Green Published, gold			2022-12-26	WOS:000867509200008
J	Chong, YM; Chan, YF; Jamaluddin, MFH; Hasan, MS; Pang, YK; Ponnampalavanar, S; Syed Omar, SF; Sam, IC				Chong, Yoong Min; Chan, Yoke Fun; Jamaluddin, Mohamad Fadhil Hadi; Hasan, M. Shahnaz; Pang, Yong Kek; Ponnampalavanar, Sasheela; Syed Omar, Sharifah Faridah; Sam, I-Ching			Rhinovirus/enterovirus was the most common respiratory virus detected in adults with severe acute respiratory infections pre-COVID-19 in Kuala Lumpur, Malaysiae	PLOS ONE			English	Article							HUMAN RHINOVIRUS; PCR ASSAY; IDENTIFICATION; AMPLIFICATION; EPIDEMIOLOGY	Background Severe acute respiratory infections (SARI) pose a great global burden. The contribution of respiratory viruses to adult SARI is relatively understudied in Asia. We aimed to determine viral aetiology of adult SARI patients in Kuala Lumpur, Malaysia. Methods The prevalence of 20 common (mainly viral) respiratory pathogens, and MERS-CoV, SARS-CoV and 5 bacterial select agents was investigated from May 2017 to October 2019 in 489 SARI adult patients in Kuala Lumpur, Malaysia, using molecular assays (Luminex NxTAG-RPP kit and qPCR assays). Viral metagenomics analysis was performed on 105 negative samples. Results Viral respiratory pathogens were detected by PCR in 279 cases (57.1%), including 10 (2.0%) additional detections by metagenomics analysis. The most detected viruses were rhinovirus/enterovirus (RV/EV) (49.1%) and influenza virus (7.4%). Three melioidosis cases were detected but no SARS-CoV, MERS-CoV or other bacterial select agents. Bacterial/ viral co-detections and viral co-detections were found in 44 (9.0%) and 27 (5.5%) cases respectively, mostly involving RV/EV. Independent predictors of critical disease were male gender, chronic lung disease, lack of runny nose and positive blood culture with a significant bacterial pathogen. Asthma and sore throat were associated with increased risk of RV/EV detection, while among RV/EV cases, males and those with neurological disease were at increased risk of critical disease. Conclusions Prior to the COVID-19 pandemic, the high prevalence of respiratory viruses in adults with SARI was mainly attributed to RV/EV. Continued surveillance of respiratory virus trends contributes to effective diagnostic, prevention, and treatment strategies.	[Chong, Yoong Min; Chan, Yoke Fun; Sam, I-Ching] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia; [Jamaluddin, Mohamad Fadhil Hadi; Hasan, M. Shahnaz] Univ Malaya, Dept Anesthesiol, Fac Med, Kuala Lumpur, Malaysia; [Pang, Yong Kek; Ponnampalavanar, Sasheela; Syed Omar, Sharifah Faridah] Univ Malaya, Dept Med, Fac Med, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya	Chan, YF; Sam, IC (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia.	chanyf@um.edu.my; jicsam@ummc.edu.my	Sam, I-Ching/B-8688-2010	Sam, I-Ching/0000-0002-1296-7898	Ministry of Education, Malaysia [FRGS/1/2020/SKK0/UM/02/5]; Defense Threat Reduction Agency, USA [HDTRA1-17-1-0027]	Ministry of Education, Malaysia(Ministry of Education, Malaysia); Defense Threat Reduction Agency, USA(United States Department of DefenseDefense Threat Reduction Agency)	This study was funded by the Ministry of Education, Malaysia (grant number: FRGS/1/2020/SKK0/UM/02/5; recipients: YFC, ICS); and the Defense Threat Reduction Agency, USA, under Broad Agency Announcement HDTRA1-6 (grant number HDTRA1-17-1-0027; recipients: YFC, MFHJ, MSH, YKP, SP, SFSO, ICS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camargo CN, 2012, BRAZ J MICROBIOL, V43, P1641, DOI 10.1590/S1517-838220120004000049; Ching NS, 2018, J PAEDIATR CHILD H, V54, P1321, DOI 10.1111/jpc.14076; Chong YM, 2021, J CLIN VIROL, V145, DOI 10.1016/j.jcv.2021.105000; Chrzastek K, 2017, VIROLOGY, V509, P159, DOI 10.1016/j.virol.2017.06.019; Corman VM, 2012, EUROSURVEILLANCE, V17, P3; Department of Statistics Malaysia, 2020, STAT CAUS DEATH; Dolores A, 2022, J CLIN VIROL, V149, DOI 10.1016/j.jcv.2022.105126; Fall A, 2016, AM J TROP MED HYG, V95, P339, DOI 10.4269/ajtmh.15-0799; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Kalantar KL, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa111; Khor CS, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-32; Klee SR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-2; Legand A, 2013, FUTURE VIROL, V8, P953, DOI 10.2217/fvl.13.85; Liu Y, 2020, J INFECTION, V81, pE62, DOI 10.1016/j.jinf.2020.04.032; Ljubin-Sternak S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02737; Miller S, 2019, GENOME RES, V29, P831, DOI 10.1101/gr.238170.118; Anh NT, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00386-19; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Novak RT, 2006, J CLIN MICROBIOL, V44, P85, DOI 10.1128/JCM.44.1.85-90.2006; Pang YK, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06360-9; Parsons TM., 2013, J BIOTERR BIODEF, VS3, P009, DOI [10.4172/2157-2526.S3-009, DOI 10.4172/2157-2526.S3-009]; Partridge E, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35281; Poon LLM, 2004, CLIN CHEM, V50, P67, DOI 10.1373/clinchem.2003.023663; Prasetyo AA, 2015, INTERVIROLOGY, V58, P57, DOI 10.1159/000369211; Principi N, 2015, J CLIN VIROL, V66, P83, DOI 10.1016/j.jcv.2015.03.013; Rambaut A, 2020, FIGTREE V1 4 2 GRAPH; Rhedin S, 2014, PEDIATRICS, V133, pE538, DOI 10.1542/peds.2013-3042; Riehm JM, 2011, MOL CELL PROBE, V25, P8, DOI 10.1016/j.mcp.2010.09.002; Roslani ADRM, 2014, AM J TROP MED HYG, V91, P1176, DOI 10.4269/ajtmh.14-0354; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sam IC, 2019, J MED VIROL, V91, P498, DOI 10.1002/jmv.25313; Self WH, 2016, J INFECT DIS, V213, P584, DOI 10.1093/infdis/jiv323; Sharp Colin, 2018, BMC Res Notes, V11, P120, DOI 10.1186/s13104-018-3234-8; Shi T, 2020, J INFECT DIS, V222, pS563, DOI 10.1093/infdis/jiy662; Stone CA, 2016, CLIN VACCINE IMMUNOL, V23, P6, DOI 10.1128/CVI.00414-15; Subakir H, 2020, J MED MICROBIOL, V69, P49, DOI 10.1099/jmm.0.001108; Sundell N, 2016, J CLIN VIROL, V84, P59, DOI 10.1016/j.jcv.2016.10.005; Toh TH, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz074; Troeger CE, 2019, LANCET RESP MED, V7, P69, DOI [10.1016/S2213-2600(18)30496-X, 10.1016/s2213-2600(18)30496-x]; Versage JL, 2003, J CLIN MICROBIOL, V41, P5492, DOI 10.1128/JCM.41.12.5492-5499.2003; Wai-san Ko F, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1181-0; WHO, 2013, GLOB EP SURV STAND I; Zhao YJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01836	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273697	10.1371/journal.pone.0273697	http://dx.doi.org/10.1371/journal.pone.0273697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054088	gold, Green Published			2022-12-26	WOS:000892641400030
J	Donovan, E; Tanson, K; Martin, SR; Weston, G; Griffin, A; Zeltzer, LK				Donovan, Elizabeth; Tanson, Katherina; Martin, Sarah R.; Weston, Georgia; Griffin, Anya; Zeltzer, Lonnie K.			The acceptability of photovoice as a method for incorporating resilience-enhancing factors into pediatric pain research	PLOS ONE			English	Article							ADOLESCENTS; ACCEPTANCE; HEALTH; YOUTH	Recurrent or chronic pain affects 11-38% of children and adolescents. Pediatric pain research typically focuses on risk factors, such as anxiety and parent functional disability, but resilience-building, protective factors also play an important role in the pain experience. New methods to incorporate resilience-enhancing factors into pain research are needed. Photovoice is a highly participatory research method, where participants take photos to address a common question, caption their photos, and discuss the meaning of the photos in a group. The main objective of this study was to determine whether photovoice is an acceptable method to young people living with chronic pain for identifying and sharing sources of joy. Another objective was to explore sources of joy. Sixteen adolescents and young adults participated, which involved meeting in a group to discuss the goal of the study, taking photographs of self-identified sources of joy over a two-week period, and meeting as a group again to discuss the photographs and participate in a focus group about the experience. Results suggest that photovoice is an acceptable method, as all participants took photographs and attended both meetings, and three themes from the focus group data suggested the participants considered photovoice to be appropriate: 1.) Relief associated with meeting peers, 2.) Potential to benefit young people living with pain, and 3.) Potential to raise awareness. Three themes emerged from the discussion of the photographs to describe sources of joy: 1.) Gratitude for everyday pleasures and accomplishments, 2.) Support from pets, and 3.) Journey of acceptance. Results add to the strengths-based literature on pediatric pain by identifying an acceptable method that could be further explored for use as an intervention to enhance protective factors such as positive affect, gratitude, and social support and to compare the experiences of different populations of youth living with pain.	[Donovan, Elizabeth] Simmons Univ, Dept Psychol, Boston, MA 02115 USA; [Tanson, Katherina] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA; [Tanson, Katherina] Charles R Drew Univ Med & Sci, Los Angeles, CA USA; [Martin, Sarah R.] Univ Calif Irvine, Sch Med, Dept Anesthesiol & Perioperat Care, Orange, CA USA; [Weston, Georgia; Zeltzer, Lonnie K.] Creat Healing Youth Pain, Los Angeles, CA USA; [Griffin, Anya] Stanford Univ, Sch Med, Palo Alto, CA USA; [Zeltzer, Lonnie K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA USA; [Zeltzer, Lonnie K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Anesthesiol, Los Angeles, CA USA; [Zeltzer, Lonnie K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA USA	Simmons University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Charles R. Drew University of Medicine & Science; University of California System; University of California Irvine; Stanford University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Donovan, E (corresponding author), Simmons Univ, Dept Psychol, Boston, MA 02115 USA.	donoe@simmons.edu			Simmons University	Simmons University	ED received a Fund For Research internal grant from Simmons University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baig AA, 2019, TRANSL BEHAV MED, V9, P1151, DOI 10.1093/tbm/ibz082; Baum F, 2006, J EPIDEMIOL COMMUN H, V60, P854, DOI 10.1136/jech.2004.028662; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bugos Eva, 2014, Prev Chronic Dis, V11, pE189, DOI 10.5888/pcd11.140216; Bundurraga A., 2013, RES TRAINING CTR PAT, P1; Catalani C, 2010, HEALTH EDUC BEHAV, V37, P424, DOI 10.1177/1090198109342084; Cheng TL, 2015, PEDIATRICS, V135, pE225, DOI 10.1542/peds.2014-3109; Cousins LA, 2015, J PEDIATR PSYCHOL, V40, P840, DOI 10.1093/jpepsy/jsv037; Cousins LA, 2015, J PEDIATR PSYCHOL, V40, P934, DOI 10.1093/jpepsy/jsu094; Crabtree BF., 1999, DOING QUALITATIVE RE, V2nd ed; Dassah E, 2017, QUAL HEALTH RES, V27, P1412, DOI 10.1177/1049732316687731; Drainoni ML, 2019, HARM REDUCT J, V16, DOI 10.1186/s12954-019-0334-2; Emerson ND, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7100184; Foster-Fishman P, 2005, AM J COMMUN PSYCHOL, V36, P275, DOI 10.1007/s10464-005-8626-y; Gleeson K., 2020, HDB VISUAL METHODS P, P536; Hardin AP, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2151; Jones A, 2021, J PEDIATR PSYCHOL, V46, P219, DOI 10.1093/jpepsy/jsaa101; Kalapurakkel S, 2015, J PEDIATR PSYCHOL, V40, P926, DOI 10.1093/jpepsy/jsu091; King S, 2011, PAIN, V152, P2729, DOI 10.1016/j.pain.2011.07.016; Lechuga-Pena S., 2021, ADV SOCIAL WORK, V21, P1124, DOI [10.18060/24385, DOI 10.18060/24385]; Mizock L, 2015, PSYCHIATR REHABIL J, V38, P279, DOI 10.1037/prj0000111; Peters ML, 2017, CLIN J PAIN, V33, P962, DOI 10.1097/AJP.0000000000000494; Sawyer SM, 2018, LANCET CHILD ADOLESC, V2, P223, DOI 10.1016/S2352-4642(18)30022-1; Sekhon M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2031-8; Short RV, 2006, PHILOS T R SOC B, V361, P811, DOI 10.1098/rstb.2005.1781; Simons LE, 2010, CLIN J PAIN, V26, P16, DOI 10.1097/AJP.0b013e3181b511c2; Stewart D., 2007, FOCUS GROUPS; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tornbom K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222099; Valenzuela JM, 2013, FAM COMMUNITY HEALTH, V36, P97, DOI 10.1097/FCH.0b013e318282b2f2; Veehof MM, 2016, COGN BEHAV THERAPY, V45, P5, DOI 10.1080/16506073.2015.1098724; Vetter TR, 2013, PAIN RES TREAT, V2013, DOI 10.1155/2013/143292; WALLERSTEIN N, 1988, HEALTH EDUC QUART, V15, P379, DOI 10.1177/109019818801500402; Wang C, 1997, HEALTH EDUC BEHAV, V24, P369, DOI 10.1177/109019819702400309; Werremeyer Amy, 2020, Ment Health Clin, V10, P237, DOI 10.9740/mhc.2020.07.237; Yvonna S., 1985, NATURALISTIC INQUIRY	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0272504	10.1371/journal.pone.0272504	http://dx.doi.org/10.1371/journal.pone.0272504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054195	gold, Green Published			2022-12-26	WOS:000892641400010
J	Houlton, TMR; Jooste, N; Steyn, M; Hemingway, J				Houlton, Tobias M. R.; Jooste, Nicolene; Steyn, Maryna; Hemingway, Jason			Visualising trends in dentition to lip mouth morphology using geometric morphometrics	PLOS ONE			English	Article							FACIAL SHAPE; WIDTH	Linear measurements taken from bony landmarks are often utilised in facial approximation (FA) to estimate and plan the placement of overlying soft tissue features. This process similarly guides craniofacial superimposition (CFS) practices. Knowledge of how hard and soft tissue features spatially relate around the mouth region is, however, limited. Geometric morphometric techniques have thus been used to investigate size and shape variation in dentition-to-lip mouth morphology in a South African population. Twenty landmarks (twelve dentition, eight lips) were digitised, using cone-beam CT images of the anterior craniofacial complex in a Frankfurt/Frankfort position, for 147 individuals aged between 20 and 75 years. Principal Component Analysis and Canonical Variate Analysis established that much shape variation exists. A two-way ANOVA identified significant (p < 0.0001) population and sex variation with mouth shape. Black individuals presented with thicker lips, with the oral fissure aligning closely to the dental occlusion. Oral fissure position for white individuals corresponded to the inferior one-quarter (females) or one-sixth (males) of the maxillary central incisor crowns. Males presented larger dimensions than females, but females had a greater lip-to-teeth height ratio than their male counterparts. A pooled within-group regression analysis assessed the effect of age on the dentition and lips and found that it had a significant (p < 0.0001) impact on mouth shape. Ageing was associated with a reduced lip and teeth height, increased mouth width, and a lowered oral fissure and cheilion placement. The generated mean shape data, with metric guides, offer a visual and numerical guide that builds on existing FA and CFS standards, enhancing our understanding of hard and soft tissue relationships.	[Houlton, Tobias M. R.] Univ Dundee, Sch Sci & Engn, Ctr Anat & Human Identificat, Dundee, Scotland; [Jooste, Nicolene] Univ Johannesburg, Dept Human Anat & Physiol, Johannesburg, South Africa; [Steyn, Maryna; Hemingway, Jason] Univ Witwatersrand, Sch Anat Sci, Human Variat & Identificat Res Unit HVIRU, Johannesburg, South Africa	University of Dundee; University of Johannesburg; University of Witwatersrand	Houlton, TMR (corresponding author), Univ Dundee, Sch Sci & Engn, Ctr Anat & Human Identificat, Dundee, Scotland.	thoulton001@dundee.ac.uk			Leverhulme Trust (UK) [SAS-2017-005]	Leverhulme Trust (UK)(Leverhulme Trust)	TMRH was awarded the Study Abroad Studentship by the Leverhulme Trust (UK), grant number: SAS-2017-005 (URL: https://www.leverhulme.ac.uk/study-abroad-studentships).	Akgul AA, 2002, AM J ORTHOD DENTOFAC, V122, P512, DOI 10.1067/mod.2002.128861; Allam E, 2018, J FORENSIC SCI, V63, P1652, DOI 10.1111/1556-4029.13801; Angel JL., 1978, P M AM AC FOR SCI ST; Djordjevic J, 2013, ORTHOD CRANIOFAC RES, V16, P146, DOI 10.1111/ocr.12012; Dryden IL, 1998, STAT SHAPE ANAL; FERRARIO VF, 1993, AM J ORTHOD DENTOFAC, V103, P327, DOI 10.1016/0889-5406(93)70013-E; Ferrario VF, 2000, CLEFT PALATE-CRAN J, V37, P48, DOI 10.1597/1545-1569(2000)037<0048:ATDQAO>2.3.CO;2; Gatliff B P, 1979, J Biocommun, V6, P27; George RM., 1993, FORENSIC ANAL SKULL, P215; Gerasimov M., 1971, THE FACE FINDER; Goldman Alberto, 2010, J Cutan Aesthet Surg, V3, P145, DOI 10.4103/0974-2077.74490; Good P, 2000, PERMUTATION TESTS PR; GOODALL C, 1991, J ROY STAT SOC B MET, V53, P285, DOI 10.1111/j.2517-6161.1991.tb01825.x; Grauer D, 2010, ANGLE ORTHOD, V80, P286, DOI 10.2319/030909-135.1; Hajnis Karle, 1994, P201; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Houlton TMR, 2020, J FORENSIC SCI, V65, P372, DOI 10.1111/1556-4029.14207; Houlton Tobias MR, 2020, S. Afr. dent. j., V75, P415, DOI 10.17159/2519-0105/2020/v75no8a1; Ito T, 2015, PRIMATES, V56, P11, DOI 10.1007/s10329-014-0440-4; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Krogman WM., 1986, HUMAN SKELETON FOREN; LATTA GH, 1991, J PROSTHET DENT, V65, P250, DOI 10.1016/0022-3913(91)90170-2; Manthey L., 2020, STAT PROBABILITY FOR, P289; Molelekwa T., 2021, SPOTLIGHT; Munn L, 2018, FORENSIC SCI INT, V289, P40, DOI 10.1016/j.forsciint.2018.05.016; Ramphoma KJ, 2016, S. Afr. dent. j., V71, P402; Schmidlin EJ, 2018, FORENSIC SCI INT, V289, P277, DOI 10.1016/j.forsciint.2018.05.006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sforza C, 2013, J ANTHROPOL SCI, V91, P159, DOI [10.4436/jass.91007, 10.4436/JASS.91007]; Sforza C, 2010, FORENSIC SCI INT, V200, DOI 10.1016/j.forsciint.2010.04.050; Stephan C N, 2008, J Forensic Odontostomatol, V26, P2; Stephan CN, 2003, J FORENSIC SCI, V48, P725; Stephan CN, 2003, AM J PHYS ANTHROPOL, V121, P48, DOI 10.1002/ajpa.10166; Stephan CN., 2014, ENCY GLOBAL ARCHAEOL, P2721, DOI DOI 10.1007/978-1-4419-0465-2_149; Stephan CN., 2009, HDB FORENSIC ANTHR A, P304; Steyn M, 2016, WAC RES H ARCHAEOL, P151; Toma AM, 2012, EUR J ORTHODONT, V34, P655, DOI 10.1093/ejo/cjr106; Wen YF, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218542; Wilder HH, 1912, AM ANTHROPOL, V14, P415, DOI 10.1525/aa.1912.14.3.02a00010; Wilkinson C., 2004, FORENSIC FACIAL RECO; Wilkinson CM, 2003, J FORENSIC SCI, V48, P12; Wilkinson CM., 2006, FORENSIC HUMAN IDENT, P231; Windhager S, 2011, AM J HUM BIOL, V23, P805, DOI 10.1002/ajhb.21219	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274127	10.1371/journal.pone.0274127	http://dx.doi.org/10.1371/journal.pone.0274127			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054122	gold, Green Published			2022-12-26	WOS:000892641400064
J	Haider, P; Kral-Pointner, JB; Salzmann, M; Moik, F; Bleichert, S; Schrottmaier, WC; Kaun, C; Brekalo, M; Fischer, MB; Speidl, WS; Hengstenberg, C; Podesser, BK; Huber, K; Pabinger, I; Knapp, S; Brombacher, F; Brostjan, C; Ay, C; Wojta, J; Hohensinner, PJ				Haider, Patrick; Kral-Pointner, Julia B.; Salzmann, Manuel; Moik, Florian; Bleichert, Sonja; Schrottmaier, Waltraud C.; Kaun, Christoph; Brekalo, Mira; Fischer, Michael B.; Speidl, Walter S.; Hengstenberg, Christian; Podesser, Bruno K.; Huber, Kurt; Pabinger, Ingrid; Knapp, Sylvia; Brombacher, Frank; Brostjan, Christine; Ay, Cihan; Wojta, Johann; Hohensinner, Philipp J.			Interleukin-4 receptor alpha signaling regulates monocyte homeostasis	FASEB JOURNAL			English	Article						homeostasis; immunity; innate; interleukin-4; monocytes; receptors; signal transduction	VENOUS THROMBOEMBOLISM; UNIQUE FUNCTIONS; MACROPHAGES; ACTIVATION; IL-4; CANCER; MICE; SURVIVAL	Interleukin-4 (IL-4) and its receptors (IL-4R) promote the proliferation and polarization of macrophages. However, it is unknown if IL-4R also influences monocyte homeostasis and if steady state IL-4 levels are sufficient to affect monocytes. Employing full IL-4 receptor alpha knockout mice (IL-4R alpha(-/-)) and mice with a myeloid-specific deletion of IL-4R alpha (IL-4R alpha(f/f) LysM(cre)), we show that IL-4 acts as a homeostatic factor regulating circulating monocyte numbers. In the absence of IL-4R alpha, murine monocytes in blood were reduced by 50% without altering monocytopoiesis in the bone marrow. This reduction was accompanied by a decrease in monocyte-derived inflammatory cytokines in the plasma. RNA sequencing analysis and immunohistochemical staining of splenic monocytes revealed changes in mRNA and protein levels of anti-apoptotic factors including BIRC6 in IL-4R alpha(-/-) knockout animals. Furthermore, assessment of monocyte lifespan in vivo measuring BrdU(+) cells revealed that the lifespan of circulating monocytes was reduced by 55% in IL-4R alpha(-/-) mice, whereas subcutaneously applied IL-4 prolonged it by 75%. Treatment of human monocytes with IL-4 reduced the amount of dying monocytes in vitro. Furthermore, IL-4 stimulation reduced the phosphorylation of proteins involved in the apoptosis pathway, including the phosphorylation of the NF kappa Bp65 protein. In a cohort of human patients, serum IL-4 levels were significantly associated with monocyte counts. In a sterile peritonitis model, reduced monocyte counts resulted in an attenuated recruitment of monocytes upon inflammatory stimulation in IL-4R alpha(f/f) LysM(cre) mice without changes in overall migratory function. Thus, we identified a homeostatic role of IL-4R alpha in regulating the lifespan of monocytes in vivo.	[Haider, Patrick; Kral-Pointner, Julia B.; Salzmann, Manuel; Kaun, Christoph; Brekalo, Mira; Speidl, Walter S.; Hengstenberg, Christian; Wojta, Johann; Hohensinner, Philipp J.] Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Kral-Pointner, Julia B.; Podesser, Bruno K.; Wojta, Johann; Hohensinner, Philipp J.] Ludwig Boltzmann Inst Cardiovasc Res, Vienna, Austria; [Moik, Florian; Pabinger, Ingrid; Ay, Cihan] Med Univ Vienna, Comprehens Canc Ctr, Dept Internal Med 1, Div Haematol & Haemostaseol, Vienna, Austria; [Bleichert, Sonja; Brostjan, Christine] Med Univ Vienna, Dept Gen Surg, Vis Vasc Surg, Vienna, Austria; [Schrottmaier, Waltraud C.] Med Univ Vienna, Inst Vasc Biol & Thrombosis Res, Vienna, Austria; [Fischer, Michael B.] Med Univ Vienna, Dept Blood Grp Serol & Transfus Med, Vienna, Austria; [Fischer, Michael B.] Danube Univ Krems, Dept Biomed Res, Krems, Austria; [Podesser, Bruno K.; Hohensinner, Philipp J.] Med Univ Vienna, Ctr Biomed Res, Vienna, Austria; [Huber, Kurt] Wilhelminenhosp, Dept Med Cardiol & Intens Care Med 3, Vienna, Austria; [Huber, Kurt] Sigmund Freud Univ, Med Fac, Vienna, Austria; [Knapp, Sylvia] Med Univ Vienna, Dept Internal Med 1, Lab Infect Biol, Vienna, Austria; [Brombacher, Frank] Int Ctr Genet & Biotechnol Cape Town Component, Inst Infect Dis & Mol Med, Cape Town, South Africa; [Brombacher, Frank] Univ Cape Town, Cape Town, South Africa; [Wojta, Johann] Med Univ Vienna, Core Facil, Vienna, Austria	Medical University of Vienna; Ludwig Boltzmann Institute; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Danube University Krems; Medical University of Vienna; Wilhelminenspital; Medical University of Vienna; University of Cape Town; University of Cape Town; Medical University of Vienna	Wojta, J (corresponding author), Med Univ Vienna, Dept Internal Med 2, Div Cardiol, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	johann.wojta@meduniwien.ac.at	Schrottmaier, Waltraud Cornelia/ADY-2164-2022	Schrottmaier, Waltraud Cornelia/0000-0003-0550-4120; Brostjan, Christine/0000-0003-1462-5397	Austrian Science Fund (FWF) [SFB54]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Austrian Science Fund (FWF), Grant/Award Number: SFB54	Ay C, 2010, BLOOD, V116, P5377, DOI 10.1182/blood-2010-02-270116; Bitton A, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaw2938; Celik MO, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133093; Chong SZ, 2016, J EXP MED, V213, P2293, DOI 10.1084/jem.20160800; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Dalmasso AP, 2014, J BIOL CHEM, V289, P838, DOI 10.1074/jbc.M113.455766; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ensembl, 2018, MM10 MUR REF GEN DOW; Fettelschoss A, 2011, P NATL ACAD SCI USA, V108, P18055, DOI 10.1073/pnas.1109176108; Gencode, 2019, MUR GEN ANN DOWNL GE; Genome Aggregation Database (gnomAD), 2021, MORPHEUS; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Haider P, 2020, ARTERIOSCL THROM VAS, V40, P2265, DOI 10.1161/ATVBAHA.120.314883; Harris NL, 2017, IMMUNITY, V47, P1024, DOI 10.1016/j.immuni.2017.11.015; Heller NM, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164795; Herbert DR, 2004, IMMUNITY, V20, P623, DOI 10.1016/S1074-7613(04)00107-4; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hohensinner PJ, 2021, BIOCHEM PHARMACOL, V190, DOI 10.1016/j.bcp.2021.114634; Hohensinner PJ, 2021, HAEMATOLOGICA, V106, P454, DOI 10.3324/haematol.2019.220210; Huber S, 2010, BLOOD, V116, P3311, DOI 10.1182/blood-2010-02-271981; Irvine KM, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86914; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lewis SM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6085; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maguire O, 2011, CYTOM PART A, V79A, P461, DOI 10.1002/cyto.a.21068; Mohrs M, 1999, J IMMUNOL, V162, P7302; PRENDIVILLE J, 1993, EUR J CANCER, V29A, P1700, DOI 10.1016/0959-8049(93)90108-R; Punnonen J, 1997, J ALLERGY CLIN IMMUN, V100, P792, DOI 10.1016/S0091-6749(97)70276-8; Ramalingam TR, 2008, NAT IMMUNOL, V9, P25, DOI 10.1038/ni1544; Ranasinghe C., 2018, ENCY SIGNALING MOL, P2549; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reinhart R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0754-z; Reitter EM, 2014, CLIN EXP IMMUNOL, V177, P253, DOI 10.1111/cei.12308; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Thaler B, 2019, BLOOD, V134, P561, DOI 10.1182/blood.2018850420; Uzonna JE, 1998, J IMMUNOL, V161, P5507; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; YOSHIMURA T, 1989, J IMMUNOL, V142, P1956	41	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22532	10.1096/fj.202101672RR	http://dx.doi.org/10.1096/fj.202101672RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H4LR	36063138	Green Published, hybrid			2022-12-26	WOS:000849852400001
J	Tantengco, OAG; Richardson, LS; Radnaa, E; Kammala, AK; Kim, S; Medina, PMB; Han, A; Menon, R				Tantengco, Ourlad Alzeus G.; Richardson, Lauren S.; Radnaa, Enkhtuya; Kammala, Ananth Kumar; Kim, Sungjin; Medina, Paul Mark B.; Han, Arum; Menon, Ramkumar			Modeling ascending Ureaplasma parvum infection through the female reproductive tract using vagina-cervix-decidua-organ-on-a-chip and feto-maternal interface-organ-on-a-chip	FASEB JOURNAL			English	Article						microfluidics; mycoplasma; organ-on-a-chip; pregnancy; preterm birth; Ureaplasma parvum infection of the maternal uterine tract	PRETERM PREMATURE RUPTURE; INTRAUTERINE INFECTION; MEMBRANES; PREGNANCY; BIRTH; TERM; CHORIOAMNIONITIS; INFLAMMATION; ASSOCIATION; PARTURITION	Genital mycoplasmas can break the cervical barrier and cause intraamniotic infection and preterm birth. This study developed a six-chamber vagina-cervix-decidua-organ-on-a-chip (VCD-OOC) that recapitulates the female reproductive tract during pregnancy with culture chambers populated by vaginal epithelial cells, cervical epithelial and stromal cells, and decidual cells. Cells cultured in VCD-OOC were characterized by morphology and immunostaining for cell-specific markers. We transferred the media from the decidual cell chamber of the VCD-OOC to decidual cell chamber in feto-maternal interface organ-on-a-chip (FMi-OOC), which contains the fetal membrane layers. An ascending Ureaplasma parvum infection was created in VCD-OOC. U. parvum was monitored for 48 h post-infection with their cytotoxicity (LDH assay) and inflammatory effects (multiplex cytokine assay) in the cells tested. An ascending U. parvum infection model of PTB was developed using CD-1 mice. The cell morphology and expression of cell-specific markers in the VCD-OOC mimicked those seen in lower genital tract tissues. U. parvum reached the cervical epithelial cells and decidua within 48 h and did not cause cell death in VCD-OOC or FMi-OOC cells. U. parvum infection promoted minimal inflammation, while the combination of U. parvum and LPS promoted massive inflammation in the VCD-OOC and FMi-OOC cells. In the animal model, U. parvum vaginal inoculation of low-dose U. parvum did not result in PTB, and even a high dose had only some effects on PTB (20%). However, intra-amniotic injection of U. parvum resulted in 67% PTB. We report the colonization of U. parvum in various cell types; however, inconsistent, and low-grade inflammation across multiple cell types suggests poor immunogenicity induced by U. parvum.	[Tantengco, Ourlad Alzeus G.; Richardson, Lauren S.; Radnaa, Enkhtuya; Kammala, Ananth Kumar; Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Basic Sci & Translat Res, Galveston, TX 77555 USA; [Tantengco, Ourlad Alzeus G.; Medina, Paul Mark B.] Univ Philippines Manila, Coll Med, Dept Biochem & Mol Biol, Biol Models Lab, Manila, Philippines; [Kim, Sungjin; Han, Arum] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA; [Han, Arum] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA; [Han, Arum] Texas A&M Univ, Dept Chem Engn, College Stn, TX 77843 USA	University of Texas System; University of Texas Medical Branch Galveston; University of the Philippines System; University of the Philippines Manila; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Han, A (corresponding author), Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA.; Menon, R (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, 301 Univ Blvd, Galveston, TX 77555 USA.	arum.han@ece.tamu.edu; ra2menon@utmb.edu	; Han, Arum/C-7078-2013	Radnaa, Enkhtuya/0000-0001-8142-8137; Richardson, Lauren/0000-0001-8392-2833; Tantengco, Ourlad Alzeus/0000-0002-4535-8837; Menon, Ramkumar/0000-0001-9213-6105; Medina, Paul Mark/0000-0001-6116-1818; Han, Arum/0000-0002-9223-8301	HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [1R01HD100729]	HHS \ NIH \ Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HHS vertical bar NIH vertical bar Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: 1R01HD100729	AVERBUCH B, 1995, EUR J OBSTET GYN R B, V62, P25, DOI 10.1016/0301-2115(95)02176-8; De Tomasi JB, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7693183; Bosquet EG, 2006, GYNECOL OBSTET INVES, V61, P119, DOI 10.1159/000089457; Caballero A, 2019, J WOMENS HEALTH, V28, P606, DOI 10.1089/jwh.2018.7043; Cappelletti M, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001385; CHAMBERS S, 1991, EUR J OBSTET GYN R B, V38, P103, DOI 10.1016/0028-2243(91)90185-N; Chen X., 2021, FRONT ONCOL, V11, P2258; Cunha GKP, 2022, BJOG-INT J OBSTET GY, V129, P1174, DOI [10.1111/1471-0528.17076, 10.1111/1471-0528.16949]; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; Dolgushin I I, 2004, Zh Mikrobiol Epidemiol Immunobiol, P43; Dubicke A, 2016, REPROD SCI, V23, P595, DOI 10.1177/1933719115616497; Dubicke A, 2010, J REPROD IMMUNOL, V84, P176, DOI 10.1016/j.jri.2009.12.004; Edwards VL., 2021, BIORXIV; Frew L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103434; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gonzalez JM, 2009, BIOL REPROD, V81, P1226, DOI 10.1095/biolreprod.108.075309; Gordon J, 2019, CELL TISSUE RES, V376, P443, DOI 10.1007/s00441-018-02983-8; Gravina FS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111307; Hein M, 2002, AM J OBSTET GYNECOL, V187, P137, DOI 10.1067/mob.2002.123034; Hein M, 2001, AM J OBSTET GYNECOL, V185, P586, DOI 10.1067/mob.2001.116685; Herbst-Kralovetz MM, 2008, AM J REPROD IMMUNOL, V59, P212, DOI 10.1111/j.1600-0897.2007.00566.x; HIRSCH E, 1995, AM J OBSTET GYNECOL, V172, P1598, DOI 10.1016/0002-9378(95)90503-0; Iwahashi M, 2003, J CLIN ENDOCR METAB, V88, P2231, DOI 10.1210/jc.2002-021213; Kacerovsky M, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.01.004; Kacerovsky Marian, 2009, Acta Medica (Hradec Kralove), V52, P117; Khorsandi D, 2019, INT J GYNECOL CANCER, V29, pA154, DOI 10.1136/ijgc-2019-ESGO.220; Lee SM, 2011, PLACENTA, V32, P516, DOI 10.1016/j.placenta.2011.03.012; Lee SE, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.047; Lohmussaar K, 2021, CELL STEM CELL, V28, P1380, DOI 10.1016/j.stem.2021.03.012; Mahendroo M, 2012, REPRODUCTION, V143, P429, DOI 10.1530/REP-11-0466; MITCHELL BF, 1984, AM J OBSTET GYNECOL, V148, P303, DOI 10.1016/S0002-9378(84)80073-3; Motomura K, 2020, MBIO, V11, DOI 10.1128/mBio.00797-20; Myers DA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.105049; Myers KM, 2015, J BIOMECH, V48, P1511, DOI 10.1016/j.jbiomech.2015.02.065; Nallasamy S, 2017, SEMIN REPROD MED, V35, P190, DOI 10.1055/s-0037-1599091; Namba F, 2010, PEDIATR RES, V67, P166, DOI 10.1203/PDR.0b013e3181c6e58e; Noda-Nicolau NM, 2022, FRONT MICROBIOL, V13, DOI 10.3389/fmicb.2022.859732; Noda-Nicolau NM, 2018, J REPROD IMMUNOL, V126, P60, DOI 10.1016/j.jri.2018.02.007; Nott J.P., 2016, T RES ANAT, V2, P1, DOI [10.1016/j.tria.2016.02.001, DOI 10.1016/j.tria.2016.02.001]; Oh KJ, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.035; Pavlidis I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14089-y; Perni SC, 2004, AM J OBSTET GYNECOL, V191, P1382, DOI 10.1016/j.ajog.2004.05.070; Radnaa E, 2022, BIOL REPROD, V106, P568, DOI 10.1093/biolre/ioab231; Radnaa E, 2021, LAB CHIP, V21, P1956, DOI 10.1039/d0lc01323d; Read CP, 2007, REPRODUCTION, V134, P327, DOI 10.1530/REP-07-0032; Richardson L, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00715; Richardson LS, 2020, LAB CHIP, V20, P4486, DOI 10.1039/d0lc00875c; Richardson LS, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aay1486; ROMERO R, 1992, AM J OBSTET GYNECOL, V167, P1086, DOI 10.1016/S0002-9378(12)80043-3; Sheller-Miller S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd3865; Spencer NR, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0260370; Stygar D, 2002, BIOL REPROD, V67, P889, DOI 10.1095/biolreprod.102.005116; Suff N, 2018, AM J PATHOL, V188, P2164, DOI 10.1016/j.ajpath.2018.06.016; Tantengco OAG, 2021, BIOL REPROD, V105, P1562, DOI 10.1093/biolre/ioab181; Tantengco Ourlad Alzeus G, 2021, Front Glob Womens Health, V2, P777643, DOI 10.3389/fgwh.2021.777643; Tantengco OAG, 2022, REPRODUCTION, V163, P1, DOI 10.1530/REP-21-0308; Tantengco OAG, 2021, BIOL REPROD, V105, P204, DOI 10.1093/biolre/ioab058; Tantengco OAG, 2021, FASEB J, V35, DOI 10.1096/fj.202002590RRR; Tantengco OAG, 2021, AM J REPROD IMMUNOL, V85, DOI 10.1111/aji.13370; Tantengco OAG, 2020, MED HYPOTHESES, V145, DOI 10.1016/j.mehy.2020.110336; Vink J, 2018, BEST PRACT RES CL OB, V52, P88, DOI 10.1016/j.bpobgyn.2018.03.007; Vink J, 2017, SEMIN PERINATOL, V41, P427, DOI 10.1053/j.semperi.2017.07.014; Vink J, 2016, SEMIN FETAL NEONAT M, V21, P106, DOI 10.1016/j.siny.2015.12.009; Wittmaack A, 2019, J WOMENS HEALTH, V28, P1538, DOI 10.1089/jwh.2018.7457; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777; Xiao S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14584; Yellon SM, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03156; Yoshida K, 2019, INTERFACE FOCUS, V9, DOI 10.1098/rsfs.2019.0026; Yu SX, 2022, BIOSENS BIOELECTRON, V204, DOI 10.1016/j.bios.2022.114040	69	0	0	2	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22551	10.1096/fj.202200872R	http://dx.doi.org/10.1096/fj.202200872R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4O3AR	36106554				2022-12-26	WOS:000854575800001
J	van Beurden, AW; Schoonderwoerd, RA; Tersteeg, MMH; Gutierrez, PD; Michel, S; Blommers, R; Rohling, JHT; Meijer, JH				van Beurden, Anouk W.; Schoonderwoerd, Robin A.; Tersteeg, Mayke M. H.; Gutierrez, Pablo de Torres; Michel, Stephan; Blommers, Ruben; Rohling, Jos H. T.; Meijer, Johanna H.			Single cell model for re-entrainment to a shifted light cycle	FASEB JOURNAL			English	Article						entrainment; PER2; phase shift; retinohypothalamic tract; suprachiasmatic nucleus	SUPRACHIASMATIC NUCLEUS; MOUSE; EXPRESSION; CLOCK; TIME; RAT; OSCILLATIONS; ORGANIZATION; MECHANISM; MPER2	Our daily 24-h rhythm is synchronized to the external light-dark cycle resulting from the Earth's daily rotation. In the mammalian brain, the suprachiasmatic nucleus (SCN) serves as the master clock and receives light-mediated input via the retinohypothalamic tract. Abrupt changes in the timing of the light-dark cycle (e.g., due to jet lag) cause a phase shift in the circadian rhythms in the SCN. Here, we investigated the effects of a 6-h delay in the light-dark cycle on PERIOD2::LUCIFERASE expression at the single-cell level in mouse SCN organotypic explants. The ensemble pattern in phase shift response obtained from individual neurons in the anterior and central SCN revealed a bimodal distribution; specifically, neurons in the ventrolateral SCN responded with a rapid phase shift, while neurons in the dorsal SCN generally did not respond to the shift in the light-dark cycle. We also stimulated the hypothalamic tract in acute SCN slices to simulate light-mediated input to the SCN; interestingly, we found similarities between the distribution and fraction of rapid shifting neurons (in response to the delay) and neurons that were excited in response to electrical stimulation. These results suggest that a subpopulation of neurons in the ventral SCN that have an excitatory response to light input, shift their clock more readily than dorsal located neurons, and initiate the SCN's entrainment to the new light-dark cycle. Thus, we propose that light-excited neurons in the anterior and central SCN play an important role in the organism's ability to adjust to changes in the external light-dark cycle.	[van Beurden, Anouk W.; Schoonderwoerd, Robin A.; Tersteeg, Mayke M. H.; Gutierrez, Pablo de Torres; Michel, Stephan; Blommers, Ruben; Rohling, Jos H. T.; Meijer, Johanna H.] Leiden Univ Med Ctr, Dept Cell & Chem Biol, POB 9600, NL-2300 RC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC)	Meijer, JH (corresponding author), Leiden Univ Med Ctr, Dept Cell & Chem Biol, POB 9600, NL-2300 RC Leiden, Netherlands.	j.h.meijerk@lumc.nl		de Torres Gutierrez, Pablo/0000-0002-8387-1885; van Beurden, Anouk/0000-0002-0551-0347	EC | European Research Council (ERC) [834513]	EC | European Research Council (ERC)	EC | European Research Council (ERC), Grant/Award Number: 834513	Abrahamson EE, 2001, BRAIN RES, V916, P172, DOI 10.1016/S0006-8993(01)02890-6; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Brenna A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-01178-6; Buijink MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168954; Cassone VM, 1988, J BIOL RHYTHM, V3, P71, DOI 10.1177/074873048800300106; Colwell CS, 2011, NAT REV NEUROSCI, V12, P553, DOI 10.1038/nrn3086; Colwell CS, 2001, EUR J NEUROSCI, V13, P1420, DOI 10.1046/j.0953-816x.2001.01517.x; Davidson AJ, 2009, EUR J NEUROSCI, V29, P171, DOI 10.1111/j.1460-9568.2008.06534.x; Evans JA, 2013, PROG MOL BIOL TRANSL, V119, P283, DOI 10.1016/B978-0-12-396971-2.00010-5; Foley NC, 2011, EUR J NEUROSCI, V33, P1851, DOI 10.1111/j.1460-9568.2011.07682.x; GROOS GA, 1980, J COMP PHYSIOL, V135, P349, DOI 10.1007/BF00657651; Hamada T, 2001, J NEUROSCI, V21, P7742, DOI 10.1523/JNEUROSCI.21-19-07742.2001; Hastings MH, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010013; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Irwin RP, 2009, EUR J NEUROSCI, V30, P1462, DOI 10.1111/j.1460-9568.2009.06944.x; Lokshin M, 2015, J BIOL RHYTHM, V30, P251, DOI 10.1177/0748730415584058; MEIJER JH, 1986, BRAIN RES, V382, P109, DOI 10.1016/0006-8993(86)90117-4; Michel S, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-15; Michel S, 2013, EUR J NEUROSCI, V37, P964, DOI 10.1111/ejn.12109; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Morin LP, 2006, NEUROSCIENCE, V137, P1285, DOI 10.1016/j.neuroscience.2005.10.030; Nagano M, 2003, J NEUROSCI, V23, P6141; Nakamura W, 2005, J NEUROSCI, V25, P5481, DOI 10.1523/JNEUROSCI.0889-05.2005; Plano SA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00558; Quintero JE, 2003, J NEUROSCI, V23, P8070; Rohling JHT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025437; Schoonderwoerd RA, 2022, FASEB J, V36, DOI 10.1096/fj.202200477R; SHIBATA S, 1993, BRAIN RES, V615, P95, DOI 10.1016/0006-8993(93)91118-C; Sonoda T, 2020, SCIENCE, V368, P527, DOI 10.1126/science.aay3152; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yan LL, 2004, EUR J NEUROSCI, V19, P1105, DOI 10.1111/j.1460-9568.2004.03189.x; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775	37	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22518	10.1096/fj.202200478R	http://dx.doi.org/10.1096/fj.202200478R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4G6YV	36057093	Green Published			2022-12-26	WOS:000849340200001
J	Chen, XJ; Lee, KM; Villar, SS; Robertson, DS				Chen, Xijin; Lee, Kim May; Villar, Sofia S.; Robertson, David S.			Some performance considerations when using multi-armed bandit algorithms in the presence of missing data	PLOS ONE			English	Article							RESPONSE-ADAPTIVE RANDOMIZATION; CLINICAL-TRIALS; GITTINS INDEX; ALLOCATION; DESIGN; MODELS; CANCER	When comparing the performance of multi-armed bandit algorithms, the potential impact of missing data is often overlooked. In practice, it also affects their implementation where the simplest approach to overcome this is to continue to sample according to the original bandit algorithm, ignoring missing outcomes. We investigate the impact on performance of this approach to deal with missing data for several bandit algorithms through an extensive simulation study assuming the rewards are missing at random. We focus on two-armed bandit algorithms with binary outcomes in the context of patient allocation for clinical trials with relatively small sample sizes. However, our results apply to other applications of bandit algorithms where missing data is expected to occur. We assess the resulting operating characteristics, including the expected reward. Different probabilities of missingness in both arms are considered. The key finding of our work is that when using the simplest strategy of ignoring missing data, the impact on the expected performance of multi-armed bandit strategies varies according to the way these strategies balance the exploration-exploitation tradeoff. Algorithms that are geared towards exploration continue to assign samples to the arm with more missing responses (which being perceived as the arm with less observed information is deemed more appealing by the algorithm than it would otherwise be). In contrast, algorithms that are geared towards exploitation would rapidly assign a high value to samples from the arms with a current high mean irrespective of the level observations per arm. Furthermore, for algorithms focusing more on exploration, we illustrate that the problem of missing responses can be alleviated using a simple mean imputation approach.	[Chen, Xijin; Villar, Sofia S.; Robertson, David S.] Univ Cambridge, MRC Biostat Unit, Cambridge, England; [Lee, Kim May] Kings Coll London, Inst Psychiat Psychol & Neurosci, London, England	MRC Biostatistics Unit; University of Cambridge; University of London; King's College London	Chen, XJ (corresponding author), Univ Cambridge, MRC Biostat Unit, Cambridge, England.	xijin.chen@mrc-bsu.cam.ac.uk		Chen, Xijin/0000-0001-5591-4828; Lee, Kim May/0000-0002-0553-973X	NIHR Cambridge Biomedical Research Centre [BRC1215-20014]; NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; UK Medical Research Council [MC_UU_00002/15, MC_UU_00002/14]; Biometrika Trust; National Institute for Health Research (NIHR) [NIHR300051]	NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biometrika Trust; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	This research was supported by the NIHR Cambridge Biomedical Research Centre (BRC1215-20014), the NIHR Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care (DHCS). SSV received funding from the UK Medical Research Council (MC_UU_00002/15). DSR received funding from the Biometrika Trust and the UK Medical Research Council (MC_UU_00002/14). KML received funding from the National Institute for Health Research (NIHR Research Professorship, Professor Richard Emsley, NIHR300051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Mehrabian, 2020, Arxiv, DOI arXiv:1910.04928; Abbasi-Yadkori Y., 2011, ADV NEURAL INFORM PR, P2312; Abernethy J, 2014, C LEARNING THEORY, P807; Agarwal A, 2012, IEEE DECIS CONTR P, P5451, DOI 10.1109/CDC.2012.6426626; Slivkins A, 2019, Arxiv, DOI arXiv:1904.07272; Atkinson AC., 2013, RANDOMISED RESPONSE; Auer P, 2002, MACH LEARN, V47, P235, DOI 10.1023/A:1013689704352; Aziz M, 2021, J MACH LEARN RES, V22; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Barocas Solon, 2017, NIPS TUTORIAL, V1; BARTLETT RH, 1985, PEDIATRICS, V76, P479; Bartok G, 2014, MATH OPER RES, V39, P967, DOI 10.1287/moor.2014.0663; Bastani H, 2020, OPER RES, V68, P276, DOI 10.1287/opre.2019.1902; BATHER JA, 1981, J R STAT SOC B, V43, P265; Bell ML, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8668; Biswas A, 2004, STAT PROBABIL LETT, V70, P59, DOI 10.1016/j.spl.2004.08.008; Bouneffouf D, 2021, 2021 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP 2021), P3145, DOI 10.1109/ICASSP39728.2021.9414300; Branislav Kveton, 2019, Arxiv, DOI arXiv:1903.09132; Burton PR., 1997, SEMINARS NEONATOLOGY, V2, P69; Chen IY., 2020, ANN REV BIOMEDICAL D, V4; Chien Isabel, 2022, FAccT '22: 2022 ACM Conference on Fairness, Accountability, and Transparency, P906, DOI 10.1145/3531146.3533154; Chow SC, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-11; Daniel Hsu, 2011, Arxiv, DOI arXiv:1106.2369; Robertson DS, 2022, Arxiv, DOI arXiv:2005.00564; Desautels T, 2014, J MACH LEARN RES, V15, P3873; Deshpande Y, 2018, PR MACH LEARN RES, V80; Dimakopoulou M., 2021, ADV NEURAL INFORM PR, V34; Djallel Bouneffouf, 2020, Arxiv, DOI arXiv:2007.06368; Dziura James D., 2013, Yale Journal of Biology and Medicine, V86, P343; GITTINS J, 1992, ANN STAT, V20, P1625, DOI 10.1214/aos/1176348788; Gittins J., 1974, PROGR STAT, P241; GLAZEBROOK KD, 1980, J R STAT SOC B, V42, P342; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Grover A, 2018, PR MACH LEARN RES, V80; Demirel I, 2021, Arxiv, DOI arXiv:2111.13415; Jin IH, 2014, J AM STAT ASSOC, V109, P525, DOI 10.1080/01621459.2014.881740; Joulani P, 2013, INT C MACH LEARN, P1453; Kalvit A., 2021, ADV NEURAL INFORM PR, V34; Kaufmann E, 2018, ANN STAT, V46, P842, DOI 10.1214/17-AOS1569; Kim B, 2019, ARXIV; Kim MO, 2014, STAT MED, V33, P4029, DOI 10.1002/sim.6222; Lee KM, 2016, OPTIMAL DESIGNS PRES; Ma Z, 2013, MISSING DATA ADAPTIV; Newman DA, 2014, ORGAN RES METHODS, V17, P372, DOI 10.1177/1094428114548590; Nino-Mora J, 2007, TOP, V15, P161, DOI 10.1007/s11750-007-0025-0; Peter Jacko, 2019, Arxiv, DOI arXiv:1906.10173; Pilarski S., 2021, IEEE T ARTIFICIAL IN; Press WH, 2009, P NATL ACAD SCI USA, V106, P22387, DOI 10.1073/pnas.0912378106; Richards S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4811; ROSENBERGER WF, 1993, CONTROL CLIN TRIALS, V14, P471, DOI 10.1016/0197-2456(93)90028-C; Rosenberger WF, 2001, BIOMETRICS, V57, P909, DOI 10.1111/j.0006-341X.2001.00909.x; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Scott I, 2021, BMJ HEALTH CARE INFO, V28, DOI 10.1136/bmjhci-2020-100251; Shin J, 2019, ADV NEUR IN, V32; Shrestha S, 2021, STAT MED, V40, P1825, DOI 10.1002/sim.8873; Smith AL, 2018, J APPL STAT, V45, P1052, DOI 10.1080/02664763.2017.1342780; Suggala A., 2020, ADV NEURAL INFORM PR, V33, P22316; Sverdlov O, 2015, MODERN ADAPTIVE RAND, V81; Lancewicki T, 2021, Arxiv, DOI arXiv:2106.02436; Team R. R, 2020, R LANG ENV STAT COMP; Thall PF, 2007, EUR J CANCER, V43, P859, DOI 10.1016/j.ejca.2007.01.006; Thompson WR, 1933, BIOMETRIKA, V25, P285, DOI 10.2307/2332286; Tomson CRV, 2013, CLIN MED, V13, P19, DOI 10.7861/clinmedicine.13-1-19; Villar SS, 2015, BIOMETRICS, V71, P969, DOI 10.1111/biom.12337; Villar SS, 2015, STAT SCI, V30, P199, DOI 10.1214/14-STS504; WEI LJ, 1978, J AM STAT ASSOC, V73, P840; Williamson SF, 2022, COMPUT STAT DATA AN, V174, DOI 10.1016/j.csda.2021.107407; Williamson SF, 2020, BIOMETRICS, V76, P197, DOI 10.1111/biom.13119; Zhang Kelly W, 2020, Adv Neural Inf Process Syst, V33, P9818; Zhang LJ, 2007, J R STAT SOC C-APPL, V56, P153, DOI 10.1111/j.1467-9876.2007.00571.x; Zhang LJ, 2006, BIOMETRICS, V62, P562, DOI 10.1111/j.1541-0420.2005.00496.x; Zhang YF, 2021, BIOMETRICS, V77, P796, DOI 10.1111/biom.13347; Zhou X, 2008, CLIN TRIALS, V5, P181, DOI 10.1177/1740774508091815; Zhou ZY, 2019, ADV NEUR IN, V32	77	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274272	10.1371/journal.pone.0274272	http://dx.doi.org/10.1371/journal.pone.0274272			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094920	Green Submitted, Green Published, gold			2022-12-26	WOS:000892376500033
J	Winkler, R; Magdefrau, AS; Piskor, EM; Kleemann, M; Beyer, M; Linke, K; Hansen, L; Schaffer, AM; Hoffmann, ME; Poepsel, S; Heyd, F; Beli, P; Moroy, T; Mahboobi, S; Kramer, OH; Kosan, C				Winkler, Rene; Magdefrau, Ann-Sophie; Piskor, Eva-Maria; Kleemann, Markus; Beyer, Mandy; Linke, Kevin; Hansen, Lisa; Schaffer, Anna-Maria; Hoffmann, Marina E.; Poepsel, Simon; Heyd, Florian; Beli, Petra; Moroy, Tarik; Mahboobi, Siavosh; Kramer, Oliver H.; Kosan, Christian			Targeting the MYC interaction network in B-cell lymphoma via histone deacetylase 6 inhibition	ONCOGENE			English	Article							UBIQUITIN-MEDIATED PROTEOLYSIS; C-MYC; DOWN-REGULATION; HDAC6; CANCER; TUBULIN; ACETYLATION; EXPRESSION; LINES; NOXA	Overexpression of MYC is a genuine cancer driver in lymphomas and related to poor prognosis. However, therapeutic targeting of the transcription factor MYC remains challenging. Here, we show that inhibition of the histone deacetylase 6 (HDAC6) using the HDAC6 inhibitor Marbostat-100 (M-100) reduces oncogenic MYC levels and prevents lymphomagenesis in a mouse model of MYC-induced aggressive B-cell lymphoma. M-100 specifically alters protein-protein interactions by switching the acetylation state of HDAC6 substrates, such as tubulin. Tubulin facilitates nuclear import of MYC, and MYC-dependent B-cell lymphoma cells rely on continuous import of MYC due to its high turn-over. Acetylation of tubulin impairs this mechanism and enables proteasomal degradation of MYC. M-100 targets almost exclusively B-cell lymphoma cells with high levels of MYC whereas non-tumor cells are not affected. M-100 induces massive apoptosis in human and murine MYC-overexpressing B-cell lymphoma cells. We identified the heat-shock protein DNAJA3 as an interactor of tubulin in an acetylation-dependent manner and overexpression of DNAJA3 resulted in a pronounced degradation of MYC. We propose a mechanism by which DNAJA3 associates with hyperacetylated tubulin in the cytoplasm to control MYC turnover. Taken together, our data demonstrate a beneficial role of HDAC6 inhibition in MYC-dependent B-cell lymphoma.	[Winkler, Rene; Magdefrau, Ann-Sophie; Piskor, Eva-Maria; Kleemann, Markus; Linke, Kevin; Hansen, Lisa; Schaffer, Anna-Maria; Kosan, Christian] Friedrich Schiller Univ, Ctr Mol Biomed CMB, Dept Biochem, D-07745 Jena, Germany; [Beyer, Mandy; Kramer, Oliver H.] Univ Med Ctr Mainz, Inst Toxicol, D-55131 Mainz, Germany; [Hoffmann, Marina E.; Beli, Petra] Inst Mol Biol IMB, D-55128 Mainz, Germany; [Poepsel, Simon] Univ Cologne, Fac Med, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany; [Poepsel, Simon] Univ Cologne, Univ Hosp, D-50931 Cologne, Germany; [Poepsel, Simon] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Heyd, Florian] Free Univ Berlin, Inst Chem & Biochem, Lab RNA Biochem, D-14195 Berlin, Germany; [Moroy, Tarik] Inst Rech Clin Montreal IRCM, Montreal, PQ H2W 1R7, Canada; [Mahboobi, Siavosh] Univ Regensburg, Inst Pharm, Dept Pharmaceut Med Chem 1, D-93040 Regensburg, Germany; [Winkler, Rene] Josep Carreras Leukaemia Res Inst IJC, Campus ICO Germans Trias & Pujol, Badalona 08916, Spain	Friedrich Schiller University of Jena; Johannes Gutenberg University of Mainz; Institute of Molecular Biology (IMB); University of Cologne; University of Cologne; University of Cologne; Free University of Berlin; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Regensburg; Catalan Institute of Oncology; Institut de Recerca Contra la Leucemia Josep Carreras (IJC)	Kosan, C (corresponding author), Friedrich Schiller Univ, Ctr Mol Biomed CMB, Dept Biochem, D-07745 Jena, Germany.	christian.kosan@uni-jena.de	Winkler, René/ABB-4629-2020	Winkler, René/0000-0002-7570-0242	Carl Zeiss Foundation; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [GRK 1715]; Landesgraduiertenstipendium (Friedrich Schiller University Jena); DFG [393547839-SFB 1361, GRK 2291/9-1, 427404172]; Projekt DEAL	Carl Zeiss Foundation; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Landesgraduiertenstipendium (Friedrich Schiller University Jena); DFG(German Research Foundation (DFG)); Projekt DEAL	RW was supported by a scholarship from the Carl Zeiss Foundation. CK received funding from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), GRK 1715. E-MP was supported by a Landesgraduiertenstipendium (Friedrich Schiller University Jena). Work done in the group of OHK was done by MB and is funded by DFG, Project-ID 393547839-SFB 1361 and DFG, GRK 2291/9-1, project number 427404172. Open Access funding enabled and organized by Projekt DEAL.	ALEXANDROVA N, 1995, MOL CELL BIOL, V15, P5188; Amengual JE, 2021, ONCOLOGIST, V26, DOI 10.1002/onco.13673; Amengual JE, 2017, CLIN CANCER RES, V23, P3084, DOI 10.1158/1078-0432.CCR-16-2022; Amengual JE, 2015, CLIN CANCER RES, V21, P4663, DOI 10.1158/1078-0432.CCR-14-3068; Aukema SM, 2014, HAEMATOLOGICA, V99, P726, DOI 10.3324/haematol.2013.091827; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Bemark M, 2000, ONCOGENE, V19, P3404, DOI 10.1038/sj.onc.1203686; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Beyer M, 2019, CANCERS, V11, DOI 10.3390/cancers11101436; Chen CY, 2013, CANCER RES, V73, P4009, DOI 10.1158/0008-5472.CAN-12-4066; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croxford JL, 2013, BLOOD, V121, P2512, DOI 10.1182/blood-2012-08-449025; Deng WH, 2018, TRANSL ONCOL, V11, P1147, DOI 10.1016/j.tranon.2018.07.007; Depetter Y, 2019, INT J CANCER, V145, P735, DOI 10.1002/ijc.32169; Fernandez-Serrano M, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23010253; Gupta M, 2012, BLOOD, V120, P4400, DOI 10.1182/blood-2012-05-428466; Heidelberger JB, 2018, EMBO REP, V19, DOI 10.15252/embr.201744754; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Inoue S, 2013, GENE DEV, V27, P1101, DOI 10.1101/gad.214577.113; Joshi G, 2020, CANCERS, V12, DOI 10.3390/cancers12103009; Karpova MB, 2005, LEUKEMIA, V19, P159, DOI 10.1038/sj.leu.2403534; Kleo K, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5537-0; Koh CM, 2015, NATURE, V523, P96, DOI 10.1038/nature14351; Lechner S, 2022, NAT CHEM BIOL; Leonhardt M, 2018, EUR J MED CHEM, V152, P329, DOI 10.1016/j.ejmech.2018.04.046; Lorenzin F, 2016, ELIFE, V5, DOI 10.7554/eLife.15161; Lu B, 2006, J BIOL CHEM, V281, P13150, DOI 10.1074/jbc.M509179200; Maclean KH, 2003, MOL CELL BIOL, V23, P7256, DOI 10.1128/MCB.23.20.7256-7270.2003; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Miyake Y, 2016, NAT CHEM BIOL, V12, P748, DOI 10.1038/nchembio.2140; Nakamura M, 1996, INT IMMUNOL, V8, P193, DOI 10.1093/intimm/8.2.193; Nebbioso A, 2017, CLIN CANCER RES, V23, P2542, DOI 10.1158/1078-0432.CCR-15-2388; New M, 2012, MOL ONCOL, V6, P637, DOI 10.1016/j.molonc.2012.09.003; Niklinski J, 2000, MOL CELL BIOL, V20, P5276, DOI 10.1128/MCB.20.14.5276-5284.2000; PHILIP I, 1984, J NATL CANCER I, V73, P835; Poole CJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8050142; Popov N, 2010, NAT CELL BIOL, V12, P973, DOI 10.1038/ncb2104; Rempel RE, 2014, MOL CANCER THER, V13, P3219, DOI 10.1158/1535-7163.MCT-13-0044; Ross J, 2021, EUR J MED CHEM, V213, DOI 10.1016/j.ejmech.2020.113137; Ross J, 2019, CANCER RES, V79, P4184, DOI 10.1158/0008-5472.CAN-18-3038; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Schafer C, 2017, CELL SIGNAL, V29, P218, DOI 10.1016/j.cellsig.2016.11.002; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schuster C, 2011, BLOOD, V118, P4635, DOI 10.1182/blood-2010-10-313098; Sellmer A, 2018, J MED CHEM, V61, P3454, DOI 10.1021/acs.jmedchem.7b01593; Shin DY, 2015, CANCER LETT, V364, P89, DOI 10.1016/j.canlet.2015.03.016; Sterrenberg JN, 2011, CANCER LETT, V312, P129, DOI 10.1016/j.canlet.2011.08.019; Stojanovic N, 2017, ONCOGENE, V36, P1804, DOI 10.1038/onc.2016.344; Stubbs MC, 2015, CLIN CANCER RES, V21, P2348, DOI 10.1158/1078-0432.CCR-14-1290; Swerdlow SH, 2016, BLOOD, V127, P2375, DOI 10.1182/blood-2016-01-643569; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Thompson JW, 2014, J BIOL CHEM, V289, P28942, DOI 10.1074/jbc.M114.573352; Trabucco SE, 2015, CLIN CANCER RES, V21, P113, DOI 10.1158/1078-0432.CCR-13-3346; Wachholz V, 2022, ARCH TOXICOL, V96, P177, DOI 10.1007/s00204-021-03174-1; Winkler R, 2017, METHODS MOL BIOL, V1510, P93, DOI 10.1007/978-1-4939-6527-4_7; Wirth M, 2014, NUCLEIC ACIDS RES, V42, P10433, DOI 10.1093/nar/gku763	60	0	0	0	0	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 30	2022	41	40					4560	4572		10.1038/s41388-022-02450-3	http://dx.doi.org/10.1038/s41388-022-02450-3		SEP 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4Z8CT	36068335	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000850425100003
J	Deng, ZH; Zhong, J; Jiang, HL; Jeong, HW; Chen, JW; Shu, YH; Tan, M; Adams, RH; Xie, KP; Chen, Q; Liu, Y				Deng, Zhao-hua; Zhong, Jing; Jiang, Hai-lin; Jeong, Hyun-Woo; Chen, Jian-wei; Shu, Ya-hai; Tan, Ming; Adams, Ralf H.; Xie, Ke-ping; Chen, Qi; Liu, Yang			Antipsychotic drugs induce vascular defects in hematopoietic organs	FASEB JOURNAL			English	Article						antipsychotic agents; bone marrow; haloperidol; hematopoietic stem cell; stem cell microenvironment; vascular endothelial cell; VEGF	ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; VEGF; NICHE; LIVER; RECONSTITUTION; ANGIOGENESIS; HALOPERIDOL; EFFICACY; SAFETY	Antipsychotic agents are clinically utilized to treat schizophrenia and other mental disorders. These drugs induce neurological and metabolic side effects, but their influence on blood vessels remains largely unknown. Here, we show that haloperidol, one of the most frequently prescribed antipsychotic agents, induces vascular defects in bone marrow. Acute haloperidol treatment results in vascular dilation that is specific to hematopoietic organs. This vessel dilation is associated with disruption of hematopoiesis and hematopoietic stem/progenitor cells (HSPCs), both of which are reversible after haloperidol withdrawal. Mechanistically, haloperidol treatment blocked the secretion of vascular endothelial growth factor A (VEGF-A) from HSPCs. Genetic blockade of VEGF-A secretion from hematopoietic cells or inhibition of VEGFR2 in endothelial cells result in similar vessel dilation in bone marrow during regeneration after irradiation and transplantation. Conversely, VEGF-A gain of function rescues the bone marrow vascular defects induced by haloperidol treatment and irradiation. Our work reveals an unknown effect of antipsychotic agents on the vasculature and hematopoiesis with potential implications for drug application in clinic.	[Deng, Zhao-hua; Zhong, Jing; Chen, Jian-wei; Shu, Ya-hai; Tan, Ming; Chen, Qi] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangdong Prov Key Lab Stem Cell & Regenerat Med, CAS Key Lab Regenerat Biol,Ctr Cell Lineage & Dev, Guangzhou, Peoples R China; [Deng, Zhao-hua; Zhong, Jing; Chen, Jian-wei; Shu, Ya-hai; Tan, Ming; Chen, Qi] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, GIBH HKU Guangdong Hong Kong Stem Cell & Regenera, Guangzhou, Peoples R China; [Deng, Zhao-hua; Zhong, Jing; Chen, Jian-wei; Shu, Ya-hai; Tan, Ming; Chen, Qi] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, GIBH CUHK Joint Res Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China; [Deng, Zhao-hua; Zhong, Jing; Chen, Jian-wei; Shu, Ya-hai; Tan, Ming; Chen, Qi] China New Zealand Joint Lab Biomed & Hlth, Guangzhou, Peoples R China; [Zhong, Jing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Jiang, Hai-lin; Xie, Ke-ping; Liu, Yang] South China Univ Technol, Sch Med, Dept Pathol, Guangzhou 510006, Peoples R China; [Jiang, Hai-lin; Xie, Ke-ping; Liu, Yang] South China Univ Technol, Sch Med, Ctr Pancreat Canc Res, Guangzhou 510006, Peoples R China; [Jeong, Hyun-Woo; Adams, Ralf H.; Chen, Qi; Liu, Yang] Univ Munster, Fac Med, Max Planck Inst Mol Biomed, Dept Tissue Morphogenesis, Munster, Germany; [Chen, Jian-wei] Anhui Univ, Inst Phys Sci & Informat Technol, Hefei, Peoples R China; [Chen, Qi] Shandong First Med Univ, Shandong Acad Med Sci, Biomed Sci Coll, Jinan, Peoples R China; [Chen, Qi] Shandong First Med Univ, Shandong Acad Med Sci, Shandong Med Biotechnol Ctr, Jinan, Peoples R China; [Chen, Qi] Shandong First Med Univ, Shandong Acad Med Sci, NHC Key Lab Biotechnol Drugs, Jinan, Peoples R China; [Chen, Qi] Shandong First Med Univ, Shandong Acad Med Sci, Key Lab Rare & Uncommon Dis Shandong Prov, Jinan, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; South China University of Technology; South China University of Technology; Max Planck Society; University of Munster; Anhui University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Liu, Y (corresponding author), South China Univ Technol, Sch Med, Dept Pathol, Guangzhou 510006, Peoples R China.; Liu, Y (corresponding author), South China Univ Technol, Sch Med, Ctr Pancreat Canc Res, Guangzhou 510006, Peoples R China.; Chen, Q (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Ctr Cell Lineage & Dev, Guangzhou 510530, Peoples R China.	chen_qi@gibh.ac.cn; yangl005@scut.edu.cn		Jeong, Hyun-Woo/0000-0002-6976-6739; Chen, Qi/0000-0001-8485-6540	CAS|Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences [1103792101]; European Research Council [AdG 786672]; Leducq Foundation; Max Planck Society, Germany; Science and Techonology Planning Project of Guangdong Province, China [2020B1212060052]; South China University of Technology (SCUT); University of Muenster, Germany; Christiane Nuesslein-Volhard Foundation, Germany	CAS|Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences; European Research Council(European Research Council (ERC)European Commission); Leducq Foundation(Leducq Foundation); Max Planck Society, Germany(Max Planck Society); Science and Techonology Planning Project of Guangdong Province, China; South China University of Technology (SCUT); University of Muenster, Germany; Christiane Nuesslein-Volhard Foundation, Germany	CAS|Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Sciences, Grant/Award Number: 1103792101; Christiane Nuesslein-Volhard Foundation, Germany; European Research Council, Grant/Award Number: AdG 786672, PROVEC; Leducq Foundation; Max Planck Society, Germany; Science and Techonology Planning Project of Guangdong Province, China, Grant/Award Number: 2020B1212060052; South China University of Technology (SCUT); University of Muenster, Germany	ALVIR JMJ, 1993, NEW ENGL J MED, V329, P162, DOI 10.1056/NEJM199307153290303; [Anonymous], 2012, CLIN RES INFORM DRUG; Augustin HG, 2017, SCIENCE, V357, DOI 10.1126/science.aal2379; Ban Thomas A, 2007, Neuropsychiatr Dis Treat, V3, P495; Batsivari A, 2020, NAT CELL BIOL, V22, P7, DOI 10.1038/s41556-019-0444-9; Beach SR, 2020, GEN HOSP PSYCHIAT, V67, P42, DOI 10.1016/j.genhosppsych.2020.08.008; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Bourne JA, 2001, CNS DRUG REV, V7, P399; Casey DE, 1996, J CLIN PSYCHIAT, V57, P40; Chen Q, 2019, CELL STEM CELL, V25, P768, DOI 10.1016/j.stem.2019.10.006; COLLINS RH, 1993, NEW ENGL J MED, V328, P762, DOI 10.1056/NEJM199303183281104; Comazzetto S, 2021, DEV CELL, V56, P1848, DOI 10.1016/j.devcel.2021.05.018; Copley MR, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.98; Crane GM, 2017, NAT REV IMMUNOL, V17, P573, DOI 10.1038/nri.2017.53; CREESE I, 1976, SCIENCE, V192, P481, DOI 10.1126/science.3854; Cristina C, 2005, ENDOCRINOLOGY, V146, P2952, DOI 10.1210/en.2004-1445; de Araujo AN, 2012, DRUG HEALTHC PATIENT, V4, P173, DOI 10.2147/DHPS.S37429; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dold M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009831.pub2; Duarte D, 2018, CELL STEM CELL, V22, P64, DOI 10.1016/j.stem.2017.11.006; Fang ST, 2020, BLOOD, V136, P1871, DOI 10.1182/blood.2020005699; Fielding C, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28175-1; Gao X, 2021, NATURE, V589, P591, DOI 10.1038/s41586-020-03057-y; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Haigh JJ, 2003, DEV BIOL, V262, P225, DOI 10.1016/S0012-1606(03)00356-7; Hall R L, 2003, Expert Opin Drug Saf, V2, P395, DOI 10.1517/eods.2.4.395.21419; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hoyer FF, 2020, CIRCULATION, V142, P244, DOI 10.1161/CIRCULATIONAHA.120.046038; Inra CN, 2015, NATURE, V527, P466, DOI 10.1038/nature15530; Jozwiak-Bebenista M, 2018, PHARMACOL REP, V70, P1032, DOI 10.1016/j.pharep.2018.05.005; Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015; Khan JA, 2016, SCIENCE, V351, P176, DOI 10.1126/science.aad0084; King DJ, 1998, J PSYCHOPHARMACOL, V12, P283, DOI 10.1177/026988119801200309; Kotton DN, 2005, BLOOD, V106, P1574, DOI 10.1182/blood-2005-03-1017; Lee YJ, 2021, J EXP MED, V218, DOI 10.1084/jem.20200882; Liu Y, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28775-x; Liu Y, 2021, BLOOD, V138, P2051, DOI 10.1182/blood.2020010419; MALHOTRA AK, 1993, DRUG SAFETY, V9, P429, DOI 10.2165/00002018-199309060-00005; Maryanovich M, 2018, NAT MED, V24, P782, DOI 10.1038/s41591-018-0030-x; Maryanovich M, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031344; Paik DT, 2020, CIRCULATION, V142, P1848, DOI 10.1161/CIRCULATIONAHA.119.041433; Pani L, 2007, EUR PSYCHIAT, V22, P267, DOI 10.1016/j.eurpsy.2007.02.005; Pillai A, 2006, SCHIZOPHR RES, V87, P48, DOI 10.1016/j.schres.2006.06.017; Pimkin M, 2014, GENOME RES, V24, P1932, DOI 10.1101/gr.164178.113; Pinho S, 2019, NAT REV MOL CELL BIO, V20, P303, DOI 10.1038/s41580-019-0103-9; Poller WC, 2020, CIRC RES, V126, P1061, DOI 10.1161/CIRCRESAHA.120.315895; Rohde David, 2022, Nat Cardiovasc Res, V1, P28, DOI 10.1038/s44161-021-00002-8; Schloss MJ, 2022, NAT IMMUNOL, V23, P605, DOI 10.1038/s41590-022-01165-7; Shao Lijian, 2021, Blood, V137, P775, DOI 10.1182/blood.2019004415; Stroup TS, 2018, WORLD PSYCHIATRY, V17, P341, DOI 10.1002/wps.20567; Taniguchi H, 1996, NAT MED, V2, P198, DOI 10.1038/nm0296-198; Wang L, 2013, EMBO J, V32, P219, DOI 10.1038/emboj.2012.308; Wang XQ, 2012, HEPATOLOGY, V56, P1557, DOI 10.1002/hep.25820; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Zhou BO, 2015, ELIFE, V4, DOI 10.7554/eLife.05521; Zhu FF, 2019, P NATL ACAD SCI USA, V116, P18416, DOI 10.1073/pnas.1906251116	56	1	1	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22538	10.1096/fj.202200862R	http://dx.doi.org/10.1096/fj.202200862R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H7GU	36065631	hybrid			2022-12-26	WOS:000850045500001
J	Doustmohammadian, A; Mohammadi-Nasrabadi, F; Fadavi, G				Doustmohammadian, Azam; Mohammadi-Nasrabadi, Fatemeh; Fadavi, Ghasem			COVID-19 pandemic and food security in different contexts: A systematic review protocol	PLOS ONE			English	Review							INSECURITY	Background Given the unprecedented nature of the COVID-19 crisis and the importance of early implementation of prevention programs, it is essential to understand better its potential impacts on various food security dimensions and indicators. Methods Research databases, including Cochrane Central Register of Controlled Trials (CENTRAL), Cochrane Public Health Register, PubMed/MEDLINE, SCOPUS, EMBASE, CINAHL, Web of science, and Google Scholar, will be searched using a search strategy and keywords developed in collaboration with librarians. The review will include all field and community trials and observational studies in all population groups. Searching electronic databases, study selection, and data extraction will be conducted by two researchers independently. Four critical appraisal tools will be used to assess the quality of included studies according to the study design: The Joanna Briggs Institute (JBI) Prevalence Critical Appraisal tool, the JBI critical appraisal checklist for randomized control/pseudo-randomized trial, descriptive/ case series, and comparable cohort/case-control. These tools were initially designed for use in systematic reviews. A narrative synthesis will be implemented to summarize findings if meta-analyses are not appropriate. Discussion The current systematic review results can be used to predict the effect of COVID-19 on the individuals' and households' food security, especially in vulnerable populations, and develop effective interventions. This review can provide information for policymakers to better understand the factors influencing the implementation of these interventions and inform decision-making to improve food security.	[Doustmohammadian, Azam] Iran Univ Med Sci, Gastrointestinal & Liver Dis Res Ctr GILDRC, Tehran, Iran; [Mohammadi-Nasrabadi, Fatemeh] Standard Res Inst, Food Halal & Agr Prod Res Grp, Res Ctr Food Technol & Agr Prod, Karaj, Alborz, Iran; [Fadavi, Ghasem] Shahid Beheshti Univ Med Sci, Fac Nutr Sci & Food Technol, Food & Nutr Policy & Planning Res Dept, Natl Nutr & Food Technol Res Inst NNFTRI, Tehran, Iran	Iran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Mohammadi-Nasrabadi, F (corresponding author), Standard Res Inst, Food Halal & Agr Prod Res Grp, Res Ctr Food Technol & Agr Prod, Karaj, Alborz, Iran.	f.mohammadinasrabadi@sbmu.ac.ir	Mohammadi-Nasrabadi, Fatemeh/R-7600-2016	Mohammadi-Nasrabadi, Fatemeh/0000-0001-5861-6420	National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences [99-23953]	National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences	This systematic review is funded by National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences (Grant No. 99-23953). The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript except for reviewing the proposal.	AlTarrah D, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13168987; [Anonymous], THESAURUS TERMS 1083; Ben Hassen T, 2022, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.779654; Ben Hassen T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176973; Bodamaev S., 2020, INDONESIA COVID 19 E; Breisinger C., 2020, IMPACT COVID 19 EGYP; Carletto C, 2013, GLOB FOOD SECUR-AGR, V2, P30, DOI 10.1016/j.gfs.2012.11.006; Deaton BJ, 2020, CAN J AGR ECON, V68, P143, DOI 10.1111/cjag.12227; Deeks JJ., 2019, COCHRANE HDB SYSTEMA, P241, DOI [DOI 10.1002/9780470712184.CH9, 10.1002/9781119536604.ch10, DOI 10.1002/9781119536604.CH10]; Dodson S., 2015, HLTH LITERACY OTHER; ElHajjhassan S., 2020, FOOD SECURITY IRAQ I; ElKadhi Z., 2020, IMPACT COVID 19 TUNI; FAO, 2021, SOMALIA AGR LIVELIHO; FAO, 2021, AFGHANISTAN AGR LIVE; FAO, 2020, COVID 19 ITS IMPACT; FAO CELAC, 2020, FOOD SECURITY COVID; FAO IFAD WFP, 2013, STATE FOOD INSECURIT; Haghshomar M, 2022, J EAT DISORD, V10, DOI 10.1186/s40337-022-00550-9; Jones AD, 2017, AM J PREV MED, V53, P264, DOI 10.1016/j.amepre.2017.04.008; Khan K., 2011, SYSTEMATIC REV SUPPO; McGowan J, 2016, J CLIN EPIDEMIOL, V75, P40, DOI 10.1016/j.jclinepi.2016.01.021; Moher D., 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, DOI 10.1371/JOURNAL.PMED.1000097]; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; Munn Z, 2014, INT J HEALTH POLICY, V3, P123, DOI 10.15171/ijhpm.2014.71; Niles MT, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072096; Pakravan-Charvadeh MR, 2021, PUBLIC HEALTH NUTR, V24, P1619, DOI 10.1017/S1368980021000318; Pakravan-Charvadeh Mohammad Reza, 2021, J Clean Prod, V281, P124537, DOI 10.1016/j.jclepro.2020.124537; Partridge A, 2020, IMPLICATIONS COVID 1; Rathbone J, 2015, SYST REV, V4, DOI 10.1186/2046-4053-4-6; Swinnen J., 2020, COVID 19 GLOBAL FOOD, DOI 10.2499/p15738coll2.133762; Troskie D, 2020, IMPACT COVID 19 AGR; United Nations, 2020, POLICY BRIEF IMPACT; Zurayk R, 2020, J AGRIC FOOD SYST CO, V9, P17, DOI 10.5304/jafscd.2020.093.014	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0273046	10.1371/journal.pone.0273046	http://dx.doi.org/10.1371/journal.pone.0273046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095016	gold, Green Published			2022-12-26	WOS:000892376500014
J	Schneider, M; Vedder, L; Oyiga, BC; Mathew, B; Schoof, H; Leon, J; Naz, AA				Schneider, Michael; Vedder, Lucia; Oyiga, Benedict Chijioke; Mathew, Boby; Schoof, Heiko; Leon, Jens; Naz, Ali Ahmad			Transcriptome profiling of barley and tomato shoot and root meristems unravels physiological variations underlying photoperiodic sensitivity	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; CIRCULAR VISUALIZATION; NADPH DEHYDROGENASE; LEAF APPEARANCE; LIGHT; CALCIUM; IDENTIFICATION; ALIGNMENT; PACKAGE; GROWTH	The average sowing date of crops in temperate climate zones has been shifted forwards by several days, resulting in a changed photoperiod regime at the emergence stage. In the present study, we performed a global transcriptome profiling of plant development genes in the seedling stage of root and shoot apical meristems of a photoperiod-sensitive species (barley) and a photoperiod insensitive species (tomato) in short-day conditions (8h). Variant expression indicated differences in physiological development under this short day-length regime between species and tissues. The barley tissue transcriptome revealed reduced differentiation compared to tomato. In addition, decreased photosynthetic activity was observed in barley transcriptome and leaf chlorophyll content under 8h conditions, indicating a slower physiological development of shoot meristems than in tomatoes. The photomorphogenesis controlling cryptochrome gene cry1, with an effect on physiological differentiation, showed an underexpression in barley compared to tomato shoot meristems. This might lead to a cascade of suspended sink-source activities, which ultimately delay organ development and differentiation in barley shoot meristems under short photoperiods.	[Schneider, Michael; Oyiga, Benedict Chijioke; Mathew, Boby; Leon, Jens; Naz, Ali Ahmad] Univ Bonn, Inst Crop Sci & Resource Conservat, Plant Breeding, Bonn, Germany; [Vedder, Lucia; Schoof, Heiko] Univ Bonn, Inst Crop Sci & Resource Conservat, Crop Bioinformat, Bonn, Germany; [Schneider, Michael] Heinrich Heine Univ, Inst Quantitat Genet & Genom Plants, Dusseldorf, Germany; [Naz, Ali Ahmad] Plant Breeding Univ Osnabruck, Fac Agr & Landscape Architecture, Osnabruck, Germany	University of Bonn; University of Bonn; Heinrich Heine University Dusseldorf	Naz, AA (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat, Plant Breeding, Bonn, Germany.; Naz, AA (corresponding author), Plant Breeding Univ Osnabruck, Fac Agr & Landscape Architecture, Osnabruck, Germany.	a.naz@hs-osnabrueck.de	Schoof, Heiko/Y-7073-2018	Schoof, Heiko/0000-0002-1527-3752; Schneider, Michael/0000-0002-6491-8852				Alqudah AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113120; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barber J, 2009, CHEM SOC REV, V38, P185, DOI 10.1039/b802262n; Barrero JM, 2014, PLANT CELL, V26, P1094, DOI 10.1105/tpc.113.121830; Bauerle WL, 2012, P NATL ACAD SCI USA, V109, P8612, DOI 10.1073/pnas.1119131109; Berisio R, 2003, NAT STRUCT BIOL, V10, P366, DOI 10.1038/nsb915; Bezanson J, 2017, SIAM REV, V59, P65, DOI 10.1137/141000671; Bhavsar Rital B., 2010, Human Genomics, V4, P327; Blighe K., 2019, PCATOOLS PCATOOLS EV; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borras-Gelonch G, 2010, FIELD CROP RES, V119, P36, DOI 10.1016/j.fcr.2010.06.013; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Cunningham F, 2019, NUCLEIC ACIDS RES, V47, pD745, DOI 10.1093/nar/gky1113; D'Amico-Damiao V, 2019, THEOR EXP PLANT PHYS, V31, P295, DOI 10.1007/s40626-019-00141-1; Duarte-Delgado D, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02616-9; Fantini E, 2019, PLANT PHYSIOL, V179, P732, DOI 10.1104/pp.18.00793; Glanz-Idan N, 2020, J EXP BOT, V71, P247, DOI 10.1093/jxb/erz399; Graifer D, 2014, BIOCHIMIE, V99, P8, DOI 10.1016/j.biochi.2013.11.001; Gu ZG, 2016, BIOINFORMATICS, V32, P2847, DOI 10.1093/bioinformatics/btw313; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hanumappa M, 1999, PLANT PHYSIOL, V119, P1033, DOI 10.1104/pp.119.3.1033; HAY RKM, 1990, NEW PHYTOL, V116, P233, DOI 10.1111/j.1469-8137.1990.tb04711.x; HEPLER PK, 1985, ANNU REV PLANT PHYS, V36, P397, DOI 10.1146/annurev.pp.36.060185.002145; HILLMAN WS, 1956, AM J BOT, V43, P89, DOI 10.2307/2438816; Hotsonyame GK, 1997, CAN J PLANT SCI, V77, P23, DOI 10.4141/P96-030; Hu Y, 2014, CANCER INFORM, V13, P13, DOI 10.4137/CIN.S13495; HUNTER RB, 1977, CAN J PLANT SCI, V57, P1127, DOI 10.4141/cjps77-167; Ifuku K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00084; Kassambara Alboukadel, 2020, CRAN; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Ko D, 2017, CURR BIOL, V27, pR973, DOI 10.1016/j.cub.2017.06.054; Korner C, 2010, SCIENCE, V327, P1461, DOI 10.1126/science.1186473; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Linderholm HW, 2006, AGR FOREST METEOROL, V137, P1, DOI 10.1016/j.agrformet.2006.03.006; Liu HR, 2020, CROP J, V8, P71, DOI 10.1016/j.cj.2019.04.005; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Melo AMP, 2001, J BIOL CHEM, V276, P3947, DOI 10.1074/jbc.M008199200; Michalecka AM, 2004, PLANT J, V37, P415, DOI 10.1046/j.1365-313X.2003.01970.x; Mizoguchi T, 2007, PLANT BIOTECHNOL-NAR, V24, P83, DOI 10.5511/plantbiotechnology.24.83; Musseau C, 2020, PLANT CELL, V32, P3188, DOI 10.1105/tpc.20.00245; Naz AA, 2013, P NATL ACAD SCI USA, V110, P2401, DOI 10.1073/pnas.1214300110; Nori H, 2016, EUR J AGRON, V72, P99, DOI 10.1016/j.eja.2015.10.004; Parekh S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25533; Perrotta G, 2001, PLANT CELL ENVIRON, V24, P991, DOI 10.1046/j.0016-8025.2001.00736.x; R Core Team, 2021, R LANGUAGE ENV STAT; RASMUSSON AG, 1991, EUR J BIOCHEM, V202, P617, DOI 10.1111/j.1432-1033.1991.tb16415.x; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scholthof K-BG., 2014, Q REV BIOL, V89, P185, DOI [10.1086/676086, DOI 10.1086/676086]; Slafer GA, 2001, EUPHYTICA, V119, P191, DOI 10.1023/A:1017535632171; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Struk S, 2019, PLANT CELL ENVIRON, V42, P387, DOI 10.1111/pce.13433; Tian T, 2017, NUCLEIC ACIDS RES, V45, pW122, DOI 10.1093/nar/gkx382; Wang X, 2014, ENZYMES, V35, P167, DOI 10.1016/B978-0-12-801922-1.00007-5; Wei T., 2011, CORRPLOT VISUALIZATI; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Zawada AM, 2014, EPIGENETICS-US, V9, P161, DOI 10.4161/epi.26931	60	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0265981	10.1371/journal.pone.0265981	http://dx.doi.org/10.1371/journal.pone.0265981			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095002	gold, Green Submitted, Green Published			2022-12-26	WOS:000892376500002
J	Zahedi, F; Mehrizi, AA; Sardari, S; Alemzadeh, I				Zahedi, Farhad; Mehrizi, Akram Abouie; Sardari, Soroush; Alemzadeh, Iran			Design and development of a self-assembling protein nanoparticle displaying PfHAP2 antigenic determinants recognized by natural acquired antibodies	PLOS ONE			English	Article							COILED-COIL; MALARIA TRANSMISSION; PLASMODIUM-BERGHEI; HELPER EPITOPES; IN-VIVO; VACCINE; HAP2; CHLAMYDOMONAS; REPRODUCTION; PROTECTION	Backgrounds In order to move towards the elimination and eradication of malaria in the world, the development of vaccines is inevitable. Many modern vaccines are based on recombinant technology; however, they may not provide a fully protective, long-lasting immune response. One of the strategies to improve recombinant vaccines is designing the nanovaccines such as self-assembling protein nanoparticles (SAPNs). Hence, the presentation of epitopes in a repeat array and correct conformation should be considered. P. falciparum generative cellspecific 1 (PfGCS1) is a main transmission-blocking vaccine candidate with two highly conserved fragments, HAP2-GCS1 and cd loop, inducing partial malaria transmission inhibitory antibodies. Therefore, to design an effective malaria vaccine, we used cd loop and HAP2GCS1 fragments at the amino and carboxy terminuses of the SAPN-forming amino acid sequence, respectively. Methodology/Principal findings The SAPN monomer (PfGCS1-SAPN) sequence was designed, and the three-dimensional (3D) structure was predicted. The result of this prediction ensured the presence of antigens on the SAPN surface. Then the accuracy of the predicted 3D structure and its stability were confirmed by 100 ns molecular dynamics (MD) simulation. The designed SAPN substructure sequence was synthesized, cloned, and expressed in Escherichia coll. With a gradual decrease in urea concentration in dialysis solutions, the purified proteins progressed to the final desired structure of the SAPN, which then was confirmed by Dynamic Light Scattering (DLS) and Field Emission Scanning Electron Microscopy (FESEM) tests. According to the Enzyme-Linked Immunosorbent Assay (ELISA), antigenic determinants were presented on the SAPN surface and interacted with antibodies in the serum of malaria patients. Conclusions/Significance Our results show that the SAPN formed by PfGCS1-SAPN has produced the correct shape and size, and the antigenic determinants are presented on the surface of the SAPN, which indicates that the designed SAPN has great potential to be used in the future as a malaria vaccine.	[Zahedi, Farhad; Mehrizi, Akram Abouie] Pasteur Inst Iran, Malaria & Vector Res Grp, Biotechnol Res Ctr, Tehran, Iran; [Zahedi, Farhad; Alemzadeh, Iran] Sharif Univ Technol, Chem & Petr Engn Dept BBRC, Tehran, Iran; [Sardari, Soroush] Pasteur Inst Iran, Drug Design & Bioinformat Unit, Med Biotechnol Dept, Biotechnol Res Ctr, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Sharif University of Technology; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Mehrizi, AA (corresponding author), Pasteur Inst Iran, Malaria & Vector Res Grp, Biotechnol Res Ctr, Tehran, Iran.; Sardari, S (corresponding author), Pasteur Inst Iran, Drug Design & Bioinformat Unit, Med Biotechnol Dept, Biotechnol Res Ctr, Tehran, Iran.	abouei@pasteur.ac.ir; ssardari@hotmail.com						ALEXANDER J, 1994, IMMUNITY, V1, P751, DOI 10.1016/S1074-7613(94)80017-0; Angrisano F, 2017, CELL REP, V21, P2868, DOI 10.1016/j.celrep.2017.11.024; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Blagborough AM, 2009, VACCINE, V27, P5187, DOI 10.1016/j.vaccine.2009.06.069; Burkhard P, 2002, J MOL BIOL, V318, P901, DOI 10.1016/S0022-2836(02)00114-6; Burkhard P, 2015, EXPERT REV VACCINES, V14, P1525, DOI 10.1586/14760584.2015.1096781; Chandrudu S, 2016, THER DELIV, V7, P601, DOI 10.4155/tde-2016-0037; Churcher TS, 2012, INT J PARASITOL, V42, P1037, DOI 10.1016/j.ijpara.2012.09.002; Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055; delGuercio MF, 1997, VACCINE, V15, P441, DOI 10.1016/S0264-410X(97)00186-2; Doll TAPF, 2015, J NANOBIOTECHNOL, V13, DOI 10.1186/s12951-015-0119-z; El Bissati K, 2014, VACCINE, V32, P3243, DOI 10.1016/j.vaccine.2014.03.092; Fedry J, 2017, CELL, V168, P904, DOI 10.1016/j.cell.2017.01.024; Heppner DG, 2005, VACCINE, V23, P2243, DOI 10.1016/j.vaccine.2005.01.042; Hirai M, 2008, CURR BIOL, V18, P607, DOI 10.1016/j.cub.2008.03.045; Horikoshi S., 2013, MICROWAVES NANOPARTI, P1, DOI DOI 10.1002/9783527648122; IKAI A, 1980, J BIOCHEM-TOKYO, V88, P1895; Indelicato G, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.161092; Indelicato G, 2016, BIOPHYS J, V110, P646, DOI 10.1016/j.bpj.2015.10.057; Kaba SA, 2018, VACCINE, V36, P906, DOI 10.1016/j.vaccine.2017.12.001; Kaba SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048304; Kaba SA, 2009, J IMMUNOL, V183, P7268, DOI 10.4049/jimmunol.0901957; Karch CP, 2019, JOVE-J VIS EXP, DOI 10.3791/60103; Karch CP, 2017, NANOMED-NANOTECHNOL, V13, P241, DOI 10.1016/j.nano.2016.08.030; Karch CP, 2016, BIOCHEM PHARMACOL, V120, P1, DOI 10.1016/j.bcp.2016.05.001; Kaslow DC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002455; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Malashkevich VN, 1996, SCIENCE, V274, P761, DOI 10.1126/science.274.5288.761; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; Meigouni MA, 2022, PROTEIN EXPRES PURIF, V198, DOI 10.1016/j.pep.2022.106126; Miura K, 2013, INFECT IMMUN, V81, P4377, DOI 10.1128/IAI.01056-13; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Moyer TJ, 2016, J CLIN INVEST, V126, P799, DOI 10.1172/JCI81083; Naing C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003071; Ning J, 2013, GENE DEV, V27, P1198, DOI 10.1101/gad.212746.112; Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257; Penny MA, 2016, LANCET, V387, P367, DOI 10.1016/S0140-6736(15)00725-4; Phillips MA, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.50; Pimentel TAPF, 2009, CHEM BIOL DRUG DES, V73, P53, DOI 10.1111/j.1747-0285.2008.00746.x; Pirahmadi S, 2021, INT J PARASITOL, V51, P699, DOI 10.1016/j.ijpara.2021.01.006; Punt J., 2019, KUBY IMMUNOLOGY; Ralay-Ranaivo B, 2014, J CONTROL RELEASE, V194, P323, DOI 10.1016/j.jconrel.2014.07.060; Raman S., 2009, OPEN NANOMED J, V2, P15, DOI DOI 10.2174/1875933500902010015; Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007; Seth L, 2017, VACCINE, V35, P5448, DOI 10.1016/j.vaccine.2017.02.040; Skwarczynski M, 2011, CURR DRUG DELIV, V8, P282, DOI 10.2174/156720111795256192; Snapper CM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00598; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Srirajaskanthan R., 2012, NANOMEDICINE CANC, V1st; Wahome N, 2012, CHEM BIOL DRUG DES, V80, P349, DOI 10.1111/j.1747-0285.2012.01423.x; WHO, 2021, WORD MAL REP 2021; Yang YK, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-42; Zhao GZ, 2017, EUR POLYM J, V93, P670, DOI 10.1016/j.eurpolymj.2017.02.014	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274275	10.1371/journal.pone.0274275	http://dx.doi.org/10.1371/journal.pone.0274275			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094917	gold, Green Published			2022-12-26	WOS:000892376500034
J	Go, MT; George, AM; Tahsin, B; Fogelfeld, L				Go, Muriel Tania; George, Amrutha Mary; Tahsin, Bettina; Fogelfeld, Leon			Tachycardia in hyperthyroidism: Not so common	PLOS ONE			English	Article							THYROID-HORMONE; PULSE PRESSURE; GRAVES-DISEASE; HEART-FAILURE; OLDER; SIGNS; THYROTOXICOSIS; SYMPTOMS; RISK; AGE	Objective The commonly held association of hyperthyroidism with sinus tachycardia and widened pulse pressure (PP) has not been reassessed in decades despite patients with hyperthyroidism in current practice not always present with these signs. The study objective was to assess prevalence and variability of sinus tachycardia and widened PP in present day among individuals with different degrees of hyperthyroidism. Methods Data was collected retrospectively from 248 adult patients in an outpatient setting with biochemical evidence of hyperthyroidism, recorded heart rate (HR) and blood pressure (BP) who were not treated with medications that can influence these parameters. Results Mean age was 42.0 +/- 14.2 years with 66.9% being female. Median free thyroxine (fT4) level was 3.49 (IQR 2.42-4.58) ng/dL and thyroid stimulating hormone (TSH) 0.02 (IQR 0.01-0.03) mIU/L. Tachycardia, defined as HR >100 bpm, was present in 28.2%. In the lowest and highest fT4 quartiles, tachycardia was present in 16.4% and 38.7% respectively. Using logistic regression, tachycardia was associated with higher fT4 and diastolic BP. More lenient outcome of tachycardia with HR >90 bpm was seen in 47.2%. Widened PP, defined as >50 mmHg, was observed in 64.1% of patients and correlated with higher fT4 and BP. Conclusions Tachycardia is not a common feature of hyperthyroidism today. The relatively infrequent finding of tachycardia in this study compared to older studies may reflect differences in the way medicine is practiced today. The increased ordering of thyroid function tests most likely unmasked cases of mild or asymptomatic thyrotoxicosis. A widened PP was a more prevalent clinical finding in this study.	[Go, Muriel Tania; George, Amrutha Mary; Tahsin, Bettina; Fogelfeld, Leon] John H Stroger Jr Hosp Cook Cty, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Fogelfeld, L (corresponding author), John H Stroger Jr Hosp Cook Cty, Chicago, IL 60612 USA.	lfogelfeld@cookcountyhhs.org		Fogelfeld, Leon/0000-0002-1303-7879				ARONOW WS, 1995, CLIN GERIATR MED, V11, P219, DOI 10.1016/S0749-0690(18)30292-1; Asmar R, 2001, AM J HYPERTENS, V14, P415, DOI 10.1016/S0895-7061(01)01284-5; BILEZIKIAN JP, 1983, ENDOCR REV, V4, P378, DOI 10.1210/edrv-4-4-378; BISCHOFF S, 1988, DEUT MED WOCHENSCHR, V113, P579, DOI 10.1055/s-2008-1067686; Bohm M, 2018, EUR HEART J, V39, P3105, DOI 10.1093/eurheartj/ehy287; Boelaert K, 2010, J CLIN ENDOCR METAB, V95, P2715, DOI 10.1210/jc.2009-2495; Burch H., 2013, WERNER INGBARS THYRO, V10th, P444; Chae CU, 1999, JAMA-J AM MED ASSOC, V281, P634, DOI 10.1001/jama.281.7.634; Dahl Peter, 2008, Curr Heart Fail Rep, V5, P170, DOI 10.1007/s11897-008-0026-9; DAVIS PJ, 1974, MEDICINE, V53, P161, DOI 10.1097/00005792-197405000-00001; DAVIS PJ, 1993, ANN THORAC SURG, V56, pS16, DOI 10.1016/0003-4975(93)90550-2; Fazio S, 2004, RECENT PROG HORM RES, V59, P31, DOI 10.1210/rp.59.1.31; Fitzgerald SP, 2020, THYROID, V30, P1695, DOI 10.1089/thy.2019.0535; Gibbons V, 2009, NEW ZEAL MED J, V122, P25; GRAETTINGER JS, 1959, J CLIN INVEST, V38, P1316, DOI 10.1172/JCI103906; Kahaly GJ, 1999, J CLIN ENDOCR METAB, V84, P2308, DOI 10.1210/jc.84.7.2308; Kahaly GJ, 2005, ENDOCR REV, V26, P704, DOI 10.1210/er.2003-0033; Kahaly GJ, 2002, THYROID, V12, P473, DOI 10.1089/105072502760143845; Kahaly GJ., 1998, THYROID INT, V4, P1; Klein I, 1998, ENDOCRIN METAB CLIN, V27, P51, DOI 10.1016/S0889-8529(05)70297-8; KLEIN I, 1984, AM J MED, V76, P167, DOI 10.1016/0002-9343(84)90768-X; Konrady Andras, 2000, Orvosi Hetilap, V141, P337; LARSEN PR, 1982, NEW ENGL J MED, V306, P23; Marschall K., 2017, STOELTINGS ANESTHESI, V7th; MCDONOUGH KH, 1987, AM J PHYSIOL, V252, pH788, DOI 10.1152/ajpheart.1987.252.4.H788; NORDYKE RA, 1988, ARCH INTERN MED, V148, P626, DOI 10.1001/archinte.148.3.626; ROTI E, 1988, ARCH INTERN MED, V148, P1919, DOI 10.1001/archinte.148.9.1919; SCOTT J, 1976, GUT, V17, P390; Shahangian S, 2014, ARCH PATHOL LAB MED, V138, P189, DOI 10.5858/arpa.2013-0149-OA; Trivalle C, 1996, J AM GERIATR SOC, V44, P50, DOI 10.1111/j.1532-5415.1996.tb05637.x; TRZEPACZ PT, 1989, AM J MED, V87, P558; USALA SJ, 1988, MOL ENDOCRINOL, V2, P1217, DOI 10.1210/mend-2-12-1217; Vaccarino V, 2000, J AM COLL CARDIOL, V36, P130, DOI 10.1016/S0735-1097(00)00687-2; Vargas-Uricoechea H, 2014, HORM MOL BIOL CLIN I, V18, P15, DOI 10.1515/hmbci-2013-0059; Vinyoles E, 2017, J HYPERTENS, V35, P1011, DOI 10.1097/HJH.0000000000001268; Wagner S, 1996, Z KARDIOL, V85, P588; WHEATLEY AM, 1988, BASIC RES CARDIOL, V83, P634, DOI 10.1007/BF01906958; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; WILLIAMS RH, 1946, J CLIN ENDOCR METAB, V6, P1	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273724	10.1371/journal.pone.0273724	http://dx.doi.org/10.1371/journal.pone.0273724			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054093	Green Published, gold			2022-12-26	WOS:000892641400032
J	Lepping, K; Adams-Campbell, LL; Hicks, J; Mills, M; Dash, C				Lepping, Krista; Adams-Campbell, Lucile L.; Hicks, Jennifer; Mills, Mary; Dash, Chiranjeev			Dietary fiber intake and metabolic syndrome in postmenopausal African American women with obesity	PLOS ONE			English	Article							BREAST-CANCER; RISK; EXERCISE; HEALTH; QUESTIONNAIRE; NUTRITION; HISTORY	Fiber intake may be associated with lower risk of metabolic syndrome (MetS) but data from metabolically unhealthy African American women is sparse. We examined the association of dietary fiber intake and MetS among postmenopausal African American women with obesity. Baseline cross-sectional data from the Focused Intervention on Exercise to Reduce CancEr (FIERCE) trial of 213 women (mean age 58.3 years) were used. Dietary intake was assessed by Food Frequency Questionnaires (FFQs). Multivariate linear and logistic regressions were performed to estimate associations of MetS with fiber intake and adherence to dietary fiber intake guidelines, respectively. Mean daily fiber intake was (10.33 g/1000kcal) in women with impaired metabolic health. We observed an inverse association of total fiber intake with MetS. One unit increase in energy-adjusted fiber intake was associated with a 0.10 unit decrease in the MetS z-score (p = 0.02). Similar results were obtained for both soluble and insoluble fiber. In multivariate-adjusted analyses, participants not adherent to fiber intake recommendations were more likely to have MetS as compared to those reporting intakes in the recommended range (adjusted odds ratio 4.24, 95% CI: 1.75, 10.30). Of the MetS components, high fasting glucose and high triglycerides were all associated with lower intake of fiber. Study participants who consumed a higher amount of fiber had a better overall metabolic profile and were less likely to have MetS in our cross-sectional analysis of postmenopausal African American women with obesity and unhealthy metabolic profiles.	[Lepping, Krista; Adams-Campbell, Lucile L.; Hicks, Jennifer; Mills, Mary; Dash, Chiranjeev] Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC 20057 USA	Georgetown University	Dash, C (corresponding author), Georgetown Univ, Georgetown Lombardi Comprehens Canc Ctr, Med Ctr, Washington, DC 20057 USA.	cd422@georgetown.edu		Dash, Chiranjeev/0000-0002-3314-8461	National Institute on Minority Health and Health Disparities [1P60MD006920-01]; National Cancer Institute [P30 CA051008]; National Center for Advancing Translational Science [UL1TR001409]; National Cancer Institute training grant [K07 CA197112-02]	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Science; National Cancer Institute training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the National Institute on Minority Health and Health Disparities (1P60MD006920-01). https://www.nimhd.nih.gov The Georgetown Lombardi Comprehensive Cancer Center Biostatistics and Bioinformatics Shared Resource is partially supported by the National Cancer Institute (grant P30 CA051008) https://www.cancer.gov and the National Center for Advancing Translational Science (grant UL1TR001409). http://www.georgetownhowardctsa.org CD is supported by a National Cancer Institute training grant (K07 CA197112-02). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health. https://www.nih.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOCK G, 1990, J CLIN EPIDEMIOL, V43, P1327, DOI 10.1016/0895-4356(90)90099-B; Burton-Freeman Britt, 2017, Nutr Healthy Aging, V4, P157, DOI 10.3233/NHA-160018; Buscemi J, 2018, EAT BEHAV, V29, P48, DOI 10.1016/j.eatbeh.2018.02.005; Camhi SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138548; Carson JAS, 2012, J ACAD NUTR DIET, V112, P1852, DOI 10.1016/j.jand.2012.06.357; Chen JP, 2018, NUTRIENTS, V10, DOI 10.3390/nu10010024; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dahl WJ, 2015, J ACAD NUTR DIET, V115, P1861, DOI 10.1016/j.jand.2015.09.003; Dash C, 2018, CANCER-AM CANCER SOC, V124, P3355, DOI 10.1002/cncr.31569; Dash C, 2015, CONTEMP CLIN TRIALS, V43, P33, DOI 10.1016/j.cct.2015.04.015; Dreher ML., 2015, ADV OBES WEIGHT MANA, V3, P244; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Julibert A, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081901; Kim K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91312-1; Liu Ying, 2017, Prev Med Rep, V7, P193, DOI 10.1016/j.pmedr.2017.06.010; Lutsey PL, 2008, CIRCULATION, V117, P754, DOI 10.1161/CIRCULATIONAHA.107.716159; McCracken E, 2018, CLIN DERMATOL, V36, P14, DOI 10.1016/j.clindermatol.2017.09.004; Moore JX, 2017, PREV CHRONIC DIS, V14, DOI 10.5888/pcd14.160287; Franco BM, 2014, NUTR HOSP, V30, P1279, DOI 10.3305/nh.2014.30.6.7778; Quagliani D, 2017, AM J LIFESTYLE MED, V11, P80, DOI 10.1177/1559827615588079; Reynolds A, 2019, LANCET, V393, P434, DOI 10.1016/S0140-6736(18)31809-9; Slavin J, 2013, NUTRIENTS, V5, P1417, DOI 10.3390/nu5041417; Soliman GA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051155; U.S. Department of Agriculture Agricultural Research Service, 2018, NHANES 2015 2016; Vykoukal D, 2011, J VASC SURG, V54, P819, DOI 10.1016/j.jvs.2011.01.003; Yoo S, COMP DIETARY INTAKES, P1; Zhou Q, 2015, INT J ENV RES PUB HE, V12, P4726, DOI 10.3390/ijerph120504726	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273911	10.1371/journal.pone.0273911	http://dx.doi.org/10.1371/journal.pone.0273911			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054124	Green Published, gold			2022-12-26	WOS:000892641400042
J	Yoshikawa, N; Yoshihara, M; Tamauchi, S; Ikeda, Y; Yokoi, A; Kajiyama, H				Yoshikawa, Nobuhisa; Yoshihara, Masato; Tamauchi, Satoshi; Ikeda, Yoshiki; Yokoi, Akira; Kajiyama, Hiroaki			Hypoalbuminemia for the prediction of survival in patients with stage IVB cervical cancer	PLOS ONE			English	Article							QUALITY-OF-LIFE; GYNECOLOGIC-ONCOLOGY; PERFORMANCE STATUS; JAPAN SOCIETY; CHEMOTHERAPY; OBSTETRICS; COMMITTEE; IMPACT	We evaluated the prognostic significance of malnutrition in patients with metastatic cervical cancer. In this study, we retrospectively analyzed the cases of 43 patients with stage IVB (FIGO2018) cervical cancer treated at our institute from December 2004 to December 2017. We determined the correlation between clinicopathological characteristics and survival by performing univariate and multivariate analyses. The serum albumin value at diagnosis was used as an index of malnutrition. The median follow-up period was 16.4 months (range, 0.9-91.4 months). On Kaplan-Meier analysis, the 1- and 2-year overall survival (OS) rates for all patients were 61.6% and 48.6%, respectively. The optimal serum albumin for predicting 1-year survival was 3.3 g/dL, as determined by the receiver operating characteristic curve to maximize the area under the curve. The OS of the patients with albumin >3.3 g/dL (n = 28) was significantly better than that of the patients with albumin <= 3.3 g/dL (n = 15) (p = 0.004). The univariate and multivariate analyses revealed that pretreatment serum albumin and mode of primary treatment were significantly associated with survival in patients with stage IVB cervical cancer. Hypoalbuminemia was an unfavorable prognostic factor for patients with metastatic cervical cancer.	[Yoshikawa, Nobuhisa; Yoshihara, Masato; Tamauchi, Satoshi; Ikeda, Yoshiki; Yokoi, Akira; Kajiyama, Hiroaki] Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi, Japan	Nagoya University	Yoshikawa, N (corresponding author), Nagoya Univ, Dept Obstet & Gynecol, Grad Sch Med, Nagoya, Aichi, Japan.	n-yoshikawa@med.nagoya-u.ac.jp						Aust S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140403; Bhatla N, 2018, INT J GYNECOL OBSTET, V143, P22, DOI 10.1002/ijgo.12611; Bromwich E, 2004, BRIT J CANCER, V91, P1236, DOI 10.1038/sj.bjc.6602152; Cella D, 2010, GYNECOL ONCOL, V119, P531, DOI 10.1016/j.ygyno.2010.08.020; Grigsby PW, 2020, GYNECOL ONCOL, V157, P639, DOI 10.1016/j.ygyno.2020.03.027; Guner A, 2018, ANN SURG ONCOL, V25, P3239, DOI 10.1245/s10434-018-6684-2; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; International Agency for Research on Cancer, 2018, GLOBOCAN2018; Ishikawa M, 2018, JPN J CLIN ONCOL, V48, P1096, DOI 10.1093/jjco/hyy137; Kim MA, 2018, J KOREAN MED SCI, V33, DOI 10.3346/jkms.2018.33.e331; Koh WJ, 2019, J NATL COMPR CANC NE, V17, P64, DOI 10.6004/jnccn.2019.0001; Li ZL, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.651975; Maccio A, 2012, GYNECOL ONCOL, V124, P417, DOI 10.1016/j.ygyno.2011.12.435; Mirili C, 2019, INT J CLIN ONCOL, V24, P1301, DOI 10.1007/s10147-019-01461-7; Mol L, 2016, EUR J CANCER, V66, P138, DOI 10.1016/j.ejca.2016.07.013; Nagase S, 2019, J OBSTET GYNAECOL RE, V45, P289, DOI 10.1111/jog.13863; Saito T, 2016, J OBSTET GYNAECOL RE, V42, P1069, DOI 10.1111/jog.13043; Sasahara M, 2020, DIGEST SURG, V37, P135, DOI 10.1159/000497454; Seo SH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2934-5; Shimizu T, 2019, ANTICANCER RES, V39, P2169, DOI 10.21873/anticanres.13331; Yamagami W, 2015, J OBSTET GYNAECOL RE, V41, P1861, DOI 10.1111/jog.12833; Yoshida K, 2019, J GYNECOL ONCOL, V30, DOI 10.3802/jgo.2019.30.e85; Yoshikawa N, 2020, NUTR CLIN PRACT, V35, P1041, DOI 10.1002/ncp.10482	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273876	10.1371/journal.pone.0273876	http://dx.doi.org/10.1371/journal.pone.0273876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054114	Green Published, gold			2022-12-26	WOS:000892641400039
J	Hirata, T; Yang, J; Tomida, S; Tokoro, Y; Kinoshita, T; Fujita, M; Kizuka, Y				Hirata, Tetsuya; Yang, Jing; Tomida, Seita; Tokoro, Yuko; Kinoshita, Taroh; Fujita, Morihisa; Kizuka, Yasuhiko			ER entry pathway and glycosylation of GPI-anchored proteins are determined by N-terminal signal sequence and C-terminal GPI-attachment sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM MEMBRANE; TARGETING FACTOR; INSERTION; COMPLEX; TRANSLOCATION; TRANSPORT; OLIGOMERIZATION; POLYPEPTIDE; BIOGENESIS; REQUIRES	Newly synthesized proteins in the secretory pathway, including glycosylphosphatidylinositol (GPI)-anchored pro-teins (GPI-APs), need to be correctly targeted and imported into the endoplasmic reticulum (ER) lumen. GPI-APs are synthesized in the cytosol as preproproteins, which contain an N-terminal signal sequence (SS), mature protein part, and C-terminal GPI-attachment sequence (GPI-AS), and trans -located into the ER lumen where SS and GPI-AS are removed, generating mature GPI-APs. However, how various GPI-APs are translocated into the ER lumen in mammalian cells is un-clear. Here, we investigated the ER entry pathways of GPI-APs using a panel of KO cells defective in each signal recognition particle-independent ER entry pathway-namely, Sec62, GET, or SND pathway. We found GPI-AP CD59 largely depends on the SND pathway for ER entry, whereas prion protein (Prion) and LY6K depend on both Sec62 and GET pathways. Using chimeric Prion and LY6K constructs in which the N-terminal SS or C-terminal GPI-AS was replaced with that of CD59, we revealed that the hydrophobicity of the SSs and GPI-ASs contributes to the dependence on Sec62 and GET pathways, respectively. Moreover, the ER entry route of chimeric Prion constructs with the C-terminal GPI-ASs replaced with that of CD59 was changed to the SND pathway. Simultaneously, their GPI structures and which oligosaccharyltransferase isoforms modify the constructs were altered without any amino acid change in the mature protein part. Taking these findings together, this study revealed N-and C-terminal sequences of GPI-APs determine the selective ER entry route, which in turn regulates subsequent maturation processes of GPI-APs.	[Hirata, Tetsuya; Tomida, Seita; Tokoro, Yuko; Fujita, Morihisa; Kizuka, Yasuhiko] Gifu Univ, Inst Glycocore Res iGCORE, Gifu, Japan; [Yang, Jing; Fujita, Morihisa] Jiangnan Univ, Sch Biotechnol, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Wuxi, Peoples R China; [Tomida, Seita] Gifu Univ, Grad Sch Nat Sci & Technol, Gifu, Japan; [Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Suita, Japan; [Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Japan; [Kinoshita, Taroh] Osaka Univ, Ctr Infect Dis Educ & Res, Suita, Japan	Gifu University; Jiangnan University; Gifu University; Osaka University; Osaka University; Osaka University	Kizuka, Y (corresponding author), Gifu Univ, Inst Glycocore Res iGCORE, Gifu, Japan.	kizuka@gifu-u.ac.jp			Japan Science and Technology (JST) [20K15746, JPMJAX201B]; Japan Society for the Promotion of Science (JSPS) [20H03207]; JST [18070267]; Takeda Science Foundation; Naito Foundation	Japan Science and Technology (JST)(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation)	This work was supported by a Grant-in-Aid for Early-Career Scientists to T. H. (20K15746), an ACT-X grant ((JPMJAX201B) to T. H.) from Japan Science and Technology (JST), a Grant-in-Aid for Scientific Research (B) to Y. K. (20H03207), Leading Initiative for Excellent Young Researchers (LEADER) project (Y. K.) from the Japan Society for the Promotion of Science (JSPS), a CREST grant ((18070267) to Y. K.) from JST, a grant from the Takeda Science Foundation to Y. K., and a grant from the Naito Foundation to Y. K..	Almeida AM, 2006, NAT MED, V12, P846, DOI 10.1038/nm1410; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Aviram N, 2017, J CELL SCI, V130, P4079, DOI 10.1242/jcs.204396; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Bellai-Dussault K, 2019, CLIN GENET, V95, P112, DOI 10.1111/cge.13425; BLOBEL G, 1975, J CELL BIOL, V67, P835, DOI 10.1083/jcb.67.3.835; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; Casson J, 2017, J CELL SCI, V130, P3851, DOI 10.1242/jcs.207829; Chen YJ, 2005, NUCLEIC ACIDS RES, V33, pD169; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Davis EM, 2015, CELL REP, V11, P1727, DOI 10.1016/j.celrep.2015.05.026; Egea PF, 2005, CURR OPIN STRUC BIOL, V15, P213, DOI 10.1016/j.sbi.2005.03.007; EVANS EA, 1986, P NATL ACAD SCI USA, V83, P581, DOI 10.1073/pnas.83.3.581; Favaloro V, 2010, J CELL SCI, V123, P1522, DOI 10.1242/jcs.055970; Ferguson M. A. J., 2015, ESSENTIALS GLYCOBIOL, P137; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Galian C, 2012, J BIOL CHEM, V287, P16399, DOI 10.1074/jbc.M112.350009; Gemmer M, 2020, J CELL SCI, V133, DOI 10.1242/jcs.231340; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; HAMBURGER D, 1995, J CELL BIOL, V129, P629, DOI 10.1083/jcb.129.3.629; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; Hassdenteufel S, 2018, CELL REP, V23, P1373, DOI 10.1016/j.celrep.2018.03.122; Hassdenteufel S, 2017, FEBS LETT, V591, P3211, DOI 10.1002/1873-3468.12831; Hegde RS, 2011, NAT REV MOL CELL BIO, V12, P787, DOI 10.1038/nrm3226; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Hirata T, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101720; Hirata T, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129726; Hirata T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02799-0; Hirata T, 2015, MOL BIOL CELL, V26, P3071, DOI 10.1091/mbc.E14-11-1568; Kinoshita T, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.190290; Kitajima T, 2018, FEBS J, V285, P915, DOI 10.1111/febs.14375; KURZCHALIA TV, 1986, NATURE, V320, P634, DOI 10.1038/320634a0; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Lee GH, 2020, J BIOL CHEM, V295, P14501, DOI 10.1074/jbc.RA120.014643; Liaci AM, 2021, MOL CELL, V81, P3934, DOI 10.1016/j.molcel.2021.07.031; Liu YS, 2020, BIOCHEM SOC T, V48, P1129, DOI 10.1042/BST20191142; Liu YS, 2018, J CELL BIOL, V217, P585, DOI 10.1083/jcb.201706135; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; Mateja A, 2015, SCIENCE, V347, P1152, DOI 10.1126/science.1261671; Matlack KES, 1997, SCIENCE, V277, P938, DOI 10.1126/science.277.5328.938; MENON AK, 1994, METHOD ENZYMOL, V230, P418; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Miyagawa-Yamaguchi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093054; Narimatsu Y, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100448; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; O'Keefe S, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02363-z; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Puig B, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007520; Puig B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024624; Schjoldager KT, 2020, NAT REV MOL CELL BIO, V21, P729, DOI 10.1038/s41580-020-00294-x; Schorr S, 2020, FEBS J, V287, P4612, DOI 10.1111/febs.15274; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shrimal S, 2015, SEMIN CELL DEV BIOL, V41, P71, DOI 10.1016/j.semcdb.2014.11.005; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Sun S, 2020, J BIOL CHEM, V295, P15498, DOI 10.1074/jbc.RA120.012992; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Talbot BE, 2019, J BIOL CHEM, V294, P12655, DOI 10.1074/jbc.RA119.008299; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; Tyedmers J, 2003, EMBO REP, V4, P505, DOI 10.1038/sj.embor.embor826; Vilardi F, 2011, J CELL SCI, V124, P1301, DOI 10.1242/jcs.084277; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Walmsley AR, 2009, MOL CELL NEUROSCI, V40, P242, DOI 10.1016/j.mcn.2008.10.012; Wang F, 2014, NATURE, V512, P441, DOI 10.1038/nature13471; Wang YC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14678-2; Yamamoto Y, 2012, MOL CELL, V48, P387, DOI 10.1016/j.molcel.2012.08.028; Yang J, 2021, FEBS LETT, V595, P1542, DOI 10.1002/1873-3468.14083; Yu JL, 1997, P NATL ACAD SCI USA, V94, P12580, DOI 10.1073/pnas.94.23.12580	71	0	0	4	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102444	10.1016/j.jbc.2022.102444	http://dx.doi.org/10.1016/j.jbc.2022.102444			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5J0EG	36055406	gold, Green Published			2022-12-26	WOS:000868720100011
J	Katagiri, W; Yokomizo, S; Ishizuka, T; Yamashita, K; Kopp, T; Roessing, M; Sato, A; Iwasaki, T; Sato, H; Fukuda, T; Monaco, H; Manganiello, S; Nomura, S; Ng, MR; Feil, S; Ogawa, E; Fukumura, D; Atochin, DN; Choi, HS; Kashiwagi, S				Katagiri, Wataru; Yokomizo, Shinya; Ishizuka, Takanobu; Yamashita, Keiko; Kopp, Timo; Roessing, Malte; Sato, Akiko; Iwasaki, Taizo; Sato, Hideki; Fukuda, Takeshi; Monaco, Hailey; Manganiello, Sophia; Nomura, Shinsuke; Ng, Mei Rosa; Feil, Susanne; Ogawa, Emiyu; Fukumura, Dai; Atochin, Dmitriy N.; Choi, Hak Soo; Kashiwagi, Satoshi			Dual near-infrared II laser modulates the cellular redox state of T cells and augments the efficacy of cancer immunotherapy	FASEB JOURNAL			English	Article						immunotherapy; multispectral near-infrared II laser; photobiomodulation; T cell exhaustion; tumor microenvironment	TUMOR-INFILTRATING LYMPHOCYTES; CYTOCHROME-C-OXIDASE; BIPHASIC DOSE-RESPONSE; NITRIC-OXIDE; STANDARDIZED METHOD; MULTIPLE ROLES; SOLID TUMORS; ACTIVATION; THERAPY; MECHANISMS	Immunotherapy, including immune checkpoint inhibitors, has revolutionized cancer treatment, but only a minor fraction of patients shows durable responses. A new approach to overcome this limitation is yet to be identified. Recently, we have shown that photobiomodulation (PBM) with near-infrared (NIR) light in the NIR-II window reduces oxidative stress and supports the proliferation of CD8(+) T cells, suggesting that PBM with NIR-II light could augment anti-cancer immunity. Here, we report a novel approach to support tumor-infiltrating CD8(+) T cells upon PBM with NIR-II laser with high tissue penetration depth. Brief treatments of a murine model of breast cancer with dual 1064 and 1270 nm lasers reduced the expression of the programmed cell death protein 1 (PD-1) in CD8(+) T cells in a syngeneic mouse model of breast cancer. The direct effect of the NIR-II laser treatment on T cells was confirmed by the enhanced tumor growth delay by the adoptive transfer of laser-treated CD8(+) T cells ex vivo against a model tumor antigen. We further demonstrated that specific NIR-II laser parameters augmented the effect of the immune checkpoint inhibitor on tumor growth. PBM with NIR-II light augments the efficacy of cancer immunotherapy by supporting CD8(+) T cells. Unlike the current immunotherapy with risks of undesirable drug-drug interactions and severe adverse events, the laser is safe and low-cost. It can be broadly combined with other therapy without modification to achieve clinical significance. In addition, our study established a path to develop a novel laser-based therapy to treat cancer effectively.	[Katagiri, Wataru; Yokomizo, Shinya; Fukuda, Takeshi; Monaco, Hailey; Manganiello, Sophia; Nomura, Shinsuke; Choi, Hak Soo; Kashiwagi, Satoshi] Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Dept Radiol, 149 13th St, Charlestown, MA 02129 USA; [Katagiri, Wataru] Keio Univ, Grad Sch Sci & Technol, Yokohama, Kanagawa, Japan; [Yokomizo, Shinya] Tokyo Metropolitan Univ, Dept Radiol Sci, Arakawa, Japan; [Ishizuka, Takanobu; Sato, Akiko; Iwasaki, Taizo; Sato, Hideki] Terumo Co Ltd, Biores Ctr, Tokyo, Japan; [Ishizuka, Takanobu; Yamashita, Keiko; Sato, Akiko; Iwasaki, Taizo; Sato, Hideki] Terumo Co Ltd, Corp R&D Ctr, Tokyo, Japan; [Kopp, Timo; Roessing, Malte; Feil, Susanne] Univ Tubingen, Interfac Inst Biochem IFIB, Tubingen, Germany; [Nomura, Shinsuke] Univ Miyazaki Hosp, Fac Med, Dept Surg, Miyazaki, Japan; [Ng, Mei Rosa; Fukumura, Dai] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab Tumor Biol, Charlestown, MA 02129 USA; [Ogawa, Emiyu] Kitasato Univ, Sch Allied Hlth Sci, Sagamihara, Kanagawa, Japan; [Atochin, Dmitriy N.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dept Med, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Keio University; Tokyo Metropolitan University; Terumo Corporation; Terumo Corporation; Eberhard Karls University of Tubingen; University of Miyazaki; Harvard University; Massachusetts General Hospital; Kitasato University; Harvard University; Massachusetts General Hospital	Kashiwagi, S (corresponding author), Massachusetts Gen Hosp, Gordon Ctr Med Imaging, Dept Radiol, 149 13th St, Charlestown, MA 02129 USA.	skashiwagi@mgh.harvard.edu	Kashiwagi, Satoshi/T-2420-2019		CMI, Inc.; Deutsche Forschungsgemeinschaft (DFG) [335549539 - GRK 2381]; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [R01AI105131, R21AI144103]; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) [R01NS096237]; Japan Business Federation; Massachusetts General Hospital (MGH); MEXT | Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Reinhard Frank-Stiftung; Terumo Corporation; Keio University (Keio)	CMI, Inc.; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID); HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS); Japan Business Federation; Massachusetts General Hospital (MGH); MEXT | Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Reinhard Frank-Stiftung; Terumo Corporation; Keio University (Keio)	CMI, Inc., Grant/Award Number: Study abroad scholarship; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: 335549539 - GRK 2381; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: R01AI105131 and R21AI144103; HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS096237; Japan Business Federation; Keio University (Keio); Massachusetts General Hospital (MGH); MEXT | Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology (MEXT); Reinhard Frank-Stiftung; Terumo Corporation	Ager EI, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv017; BOELENS R, 1983, BIOCHIM BIOPHYS ACTA, V724, P176, DOI 10.1016/0005-2728(83)90136-6; Borutaite V, 2000, BBA-BIOENERGETICS, V1459, P405, DOI 10.1016/S0005-2728(00)00178-X; Brown CE, 2016, NEW ENGL J MED, V375, P2561, DOI 10.1056/NEJMoa1610497; Feske S, 2015, ANNU REV IMMUNOL, V33, P291, DOI 10.1146/annurev-immunol-032414-112212; Frossi B, 2008, MOL IMMUNOL, V45, P58, DOI 10.1016/j.molimm.2007.05.008; Fu GT, 2017, J EXP MED, V214, P1453, DOI 10.1084/jem.20161120; Goff SL, 2016, J CLIN ONCOL, V34, P2389, DOI 10.1200/JCO.2016.66.7220; Gomes-Santos IL, 2021, CANCER IMMUNOL RES, V9, P765, DOI 10.1158/2326-6066.CIR-20-0499; Halle S, 2017, TRENDS IMMUNOL, V38, P432, DOI 10.1016/j.it.2017.04.002; Halle S, 2016, IMMUNITY, V44, P233, DOI 10.1016/j.immuni.2016.01.010; Hendry S, 2017, ADV ANAT PATHOL, V24, P311, DOI 10.1097/PAP.0000000000000161; Hendry S, 2017, ADV ANAT PATHOL, V24, P235, DOI 10.1097/PAP.0000000000000162; Hu S, 2018, ADV HEALTHC MATER, V7, DOI 10.1002/adhm.201800066; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Incio J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aag0945; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Kaminski MM, 2012, CELL REP, V2, P1300, DOI 10.1016/j.celrep.2012.10.009; Kaminski MM, 2010, J IMMUNOL, V184, P4827, DOI 10.4049/jimmunol.0901662; Karu T, 2013, PHOTOMED LASER SURG, V31, P189, DOI 10.1089/pho.2013.3510; Karu T, 2010, PHOTOMED LASER SURG, V28, P159, DOI 10.1089/pho.2010.2789; Karu TI, 2010, IUBMB LIFE, V62, P607, DOI 10.1002/iub.359; Kashiwagi S, 2020, FASEB J, V34, P3485, DOI 10.1096/fj.201902164R; Kashiwagi Satoshi, 2016, J Vaccines Vaccin, V7; Kashiwagi S, 2014, HUM VACC IMMUNOTHER, V10, P1892, DOI 10.4161/hv.28840; Kashiwagi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082899; Katagiri W, 2020, J BIOMED OPT, V25, DOI 10.1117/1.JBO.25.3.036003; Khan I, 2015, SCI REP-UK, V5, DOI 10.1038/srep10581; Kimizuka Y, 2018, J IMMUNOL, V201, P3587, DOI 10.4049/jimmunol.1701687; Kimizuka Y, 2017, VACCINE, V35, P2404, DOI 10.1016/j.vaccine.2017.03.036; Lee JH, 2012, QUANT IMAGING MED SU, V2, P266, DOI 10.3978/j.issn.2223-4292.2012.12.04; Mellman I, 2016, CANCER IMMUNOL RES, V4, P279, DOI 10.1158/2326-6066.CIR-16-0045; Moncada S, 2006, J NEUROCHEM, V97, P1676, DOI 10.1111/j.1471-4159.2006.03988.x; Morse K, 2017, J IMMUNOL, V199, P1319, DOI 10.4049/jimmunol.1601873; Murray T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00573; O'Donnell JS, 2019, NAT REV CLIN ONCOL, V16, P151, DOI 10.1038/s41571-018-0142-8; Owens EA, 2016, ACCOUNTS CHEM RES, V49, P1731, DOI 10.1021/acs.accounts.6b00239; Park JH, 2018, NEW ENGL J MED, V378, P449, DOI 10.1056/NEJMoa1709919; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Sanderson TH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25184-3; Sanderson TH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21869-x; Sarti P., 2012, INT J CELL BIOL, V2012; Sarti P, 2012, BBA-BIOENERGETICS, V1817, P610, DOI 10.1016/j.bbabio.2011.09.002; Sawada J, 2021, AM J PATHOL, V191, P396, DOI 10.1016/j.ajpath.2020.10.009; Scheffel MJ, 2016, CANCER RES, V76, P6006, DOI 10.1158/0008-5472.CAN-16-0587; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Stael Simon, 2022, Methods Mol Biol, V2447, P127, DOI 10.1007/978-1-0716-2079-3_11; Stevanovic S, 2017, SCIENCE, V356, P200, DOI 10.1126/science.aak9510; Taube JM, 2014, CLIN CANCER RES, V20, P5064, DOI 10.1158/1078-0432.CCR-13-3271; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Tran E, 2017, NAT IMMUNOL, V18, P255, DOI 10.1038/ni.3682; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Tran E, 2015, SCIENCE, V350, P1387, DOI 10.1126/science.aad1253; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; Trebak M, 2019, NAT REV IMMUNOL, V19, P154, DOI 10.1038/s41577-018-0110-7; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Wang HY, 2016, IMMUNITY, V44, P782, DOI 10.1016/j.immuni.2016.01.015; Wang XL, 2016, SCI REP-UK, V6, DOI 10.1038/srep30540; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Weinberg F, 2019, CANCERS, V11, DOI 10.3390/cancers11081191; Wilkinson RW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01082; Yang J, 2010, P NATL ACAD SCI USA, V107, P4716, DOI 10.1073/pnas.0911587107; Yu P, 2004, NAT IMMUNOL, V5, P141, DOI 10.1038/ni1029; Zacharakis N, 2018, NAT MED, V24, P724, DOI 10.1038/s41591-018-0040-8; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com	66	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22521	10.1096/fj.202200033R	http://dx.doi.org/10.1096/fj.202200033R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4F6SB	36052742				2022-12-26	WOS:000848638600001
J	Yoo, JH; Kahne, SC; Darwin, KH				Yoo, Jin Hee; Kahne, Shoshanna C.; Darwin, K. Heran			A conserved loop sequence of the proteasome system depupylase Dop regulates substrate selectivity in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PUP; PATHWAY; RESISTANCE; PHOSPHATE	Mycobacteria use a proteasome system that is similar to a eukaryotic proteasome but do not use ubiquitin to target proteins for degradation. Instead, mycobacteria encode a pro-karyotic ubiquitin-like protein (Pup) that posttranslationally modifies proteins to mark them for proteolysis. Pupylation occurs on lysines of targeted proteins and is catalyzed by the ligase PafA. Like ubiquitylation, pupylation can be reversed by the depupylase Dop, which shares high structural similarity with PafA. Unique to Dop near its active site is a disordered loop of approximately 40 amino acids that is highly conserved among diverse dop-containing bacterial genera. To understand the function of this domain, we deleted discrete sequences from the Dop loop and assessed pupylation in mutant strains of Mycobacterium tuberculosis. We determined that various Dop loop mutations resulted in altered pupylome profiles, in particular when mutant dop alleles were overexpressed. Taken together, our data suggest these conserved amino acids play a role in substrate selectivity for Dop.	[Yoo, Jin Hee; Kahne, Shoshanna C.; Darwin, K. Heran] NYU, Dept Microbiol, Sch Med, New York, NY 10012 USA	New York University	Darwin, KH (corresponding author), NYU, Dept Microbiol, Sch Med, New York, NY 10012 USA.	heran.darwin@med.nyu.edu		Kahne, Shoshanna/0000-0002-4483-4707	NIH [AI088075]; Public Health Service Institutional Research Training Award [T32 AI007180]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Public Health Service Institutional Research Training Award	This work was supported by NIH grant AI088075 awarded to K. H. D. S. C. K. was supported in part by a Public Health Service Institutional Research Training Award T32 AI007180. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bolten M, 2017, J BIOL CHEM, V292, P4044, DOI 10.1074/jbc.M116.755645; Burns KE, 2012, J BIOL CHEM, V287, P37522, DOI 10.1074/jbc.M112.384784; Burns KE, 2010, MOL CELL, V39, P821, DOI 10.1016/j.molcel.2010.07.019; Cerda-Maira FA, 2011, EMBO REP, V12, P863, DOI 10.1038/embor.2011.109; Cerda-Maira FA, 2010, MOL MICROBIOL, V77, P1123, DOI 10.1111/j.1365-2958.2010.07276.x; Chakrabarti P, 2022, BIOPHYS CHEM, V283, DOI 10.1016/j.bpc.2022.106769; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Cox J, 2011, J AM SOC MASS SPECTR, V22, P1373, DOI 10.1007/s13361-011-0142-8; Cui HJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26848-x; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; Festa RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008589; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Guth E, 2011, J BIOL CHEM, V286, P4412, DOI 10.1074/jbc.M110.189282; Hatfull GF, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P37; Hecht N, 2021, MOL BIOL EVOL, V38, P761, DOI 10.1093/molbev/msaa215; Hecht N, 2020, FEBS J, V287, P4389, DOI 10.1111/febs.15245; Horton R M, 1993, Methods Mol Biol, V15, P251, DOI 10.1385/0-89603-244-2:251; Howland J., 1996, SHORT PROTOCOLS MOL, VThird; Imkamp F, 2010, EMBO REP, V11, P791, DOI 10.1038/embor.2010.119; Iyer LM, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-45; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Ozcelik D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2009; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Samanovic MI, 2015, MOL CELL, V57, P984, DOI 10.1016/j.molcel.2015.01.024; Schimpf J, 2022, STRUCTURE, V30, P80, DOI 10.1016/j.str.2021.09.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Sutter M, 2009, FEBS LETT, V583, P3151, DOI 10.1016/j.febslet.2009.09.020; Vilcheze C, 2018, P NATL ACAD SCI USA, V115, P1599, DOI 10.1073/pnas.1721545115; Wang T, 2010, NAT STRUCT MOL BIOL, V17, P1352, DOI 10.1038/nsmb.1918; Watrous J, 2010, MOL BIOSYST, V6, P376, DOI 10.1039/b916104j; Zhang SS, 2017, MBIO, V8, DOI 10.1128/mBio.00122-17	37	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102478	10.1016/j.jbc.2022.102478	http://dx.doi.org/10.1016/j.jbc.2022.102478			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5S8ED	36100038	gold, Green Published			2022-12-26	WOS:000875415100005
J	Levenstein, MA; Gysbers, DJ; Marhaver, KL; Kattom, S; Tichy, L; Quinlan, Z; Tholen, HM; Kelly, LW; Vermeij, MJA; Johnson, AJW; Juarez, G				Levenstein, Mark A.; Gysbers, Daniel J.; Marhaver, Kristen L.; Kattom, Sameh; Tichy, Lucas; Quinlan, Zachary; Tholen, Haley M.; Kelly, Linda Wegley; Vermeij, Mark J. A.; Johnson, Amy J. Wagoner; Juarez, Gabriel			Millimeter-scale topography facilitates coral larval settlement in wave-driven oscillatory flow	PLOS ONE			English	Article							RECRUITMENT FAILURE; TURBULENT; REEFS; METAMORPHOSIS; BEHAVIOR; WATER; ATTACHMENT; ROUGHNESS; SURVIVAL	Larval settlement in wave-dominated, nearshore environments is the most critical life stage for a vast array of marine invertebrates, yet it is poorly understood and virtually impossible to observe in situ. Using a custom-built flume tank that mimics the oscillatory fluid flow over a shallow coral reef, we isolated the effect of millimeter-scale benthic topography and showed that it increases the settlement of slow-swimming coral larvae by an order of magnitude relative to flat substrates. Particle tracking velocimetry of flow fields revealed that millimeter-scale ridges introduced regions of flow recirculation that redirected larvae toward the substrate surface and decreased the local fluid speed, effectively increasing the window of time for larvae to settle. Regions of recirculation were quantified using the Q-criterion method of vortex identification and correlated with the settlement locations of larvae for the first time. In agreement with experiments, computational fluid dynamics modeling and agent-based larval simulations also showed significantly higher settlement onto ridged substrates. Additionally, in contrast to previous reports on the effect of micro-scale substrate topography, we found that these topographies did not produce key hydrodynamic features linked to increased settlement. These findings highlight how physics-based substrate design can create new opportunities to increase larval recruitment for ecosystem restoration.	[Levenstein, Mark A.; Kattom, Sameh; Tholen, Haley M.; Johnson, Amy J. Wagoner; Juarez, Gabriel] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA; [Levenstein, Mark A.; Johnson, Amy J. Wagoner] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Gysbers, Daniel J.] Univ Illinois, Dept Phys, Urbana, IL USA; [Marhaver, Kristen L.; Tichy, Lucas; Vermeij, Mark J. A.] CARMABI Fdn, Piscaderabaai Z-N, Willemstad, Cw, Neth Antilles; [Tichy, Lucas] Raboud Univ, Dept Microbiol, Nijmegen, Netherlands; [Quinlan, Zachary; Kelly, Linda Wegley] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Vermeij, Mark J. A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Freshwater & Marine Ecol, Amsterdam, Netherlands; [Johnson, Amy J. Wagoner] Univ Illinois, Carle Illinois Coll Med, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Radboud University Nijmegen; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of Amsterdam; University of Illinois System; University of Illinois Urbana-Champaign	Johnson, AJW; Juarez, G (corresponding author), Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA.; Johnson, AJW (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.; Marhaver, KL (corresponding author), CARMABI Fdn, Piscaderabaai Z-N, Willemstad, Cw, Neth Antilles.; Johnson, AJW (corresponding author), Univ Illinois, Carle Illinois Coll Med, Urbana, IL 61801 USA.	kristen@marhaverlab.com; ajwj@illinois.edu; gjuarez@illinois.edu	Levenstein, Mark/L-8719-2015; Wagoner Johnson, Amy/C-3472-2008; Juarez, Gabriel/C-1974-2016	Levenstein, Mark/0000-0002-2309-3743; Wagoner Johnson, Amy/0000-0001-8396-3803; Vermeij, Mark/0000-0001-9612-9527; Tichy, Lucas/0000-0002-6596-0403; Juarez, Gabriel/0000-0002-5854-6925	National Science Foundation (US) under the Convergence RAISE program [IOS-1848671]; Paul G. Allen Family Foundation; NSF Graduate Research Fellowship Program [DGE-1842470]	National Science Foundation (US) under the Convergence RAISE program(National Science Foundation (NSF)); Paul G. Allen Family Foundation; NSF Graduate Research Fellowship Program(National Science Foundation (NSF))	KLM, LWK, AJWJ, and GJ received funding from the National Science Foundation (US) under the Convergence RAISE program, grant number (#IOS-1848671). KLM received support from the Paul G. Allen Family Foundation for coral spawning research at CARMABI in 2019. ZAQ received support from the NSF Graduate Research Fellowship Program (Award #DGE-1842470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Anthony E., 2008, ELSEVIER SCI; Bostrom-Einarsson L, 2020, PLOS ONE, V15, P1, DOI DOI 10.1371/JOURNAL.PONE.0226631; Callow ME, 2002, BIOFOULING, V18, P237, DOI 10.1080/08927010290014917; Carl C, 2012, BIOFOULING, V28, P175, DOI 10.1080/08927014.2012.662676; Chamberland VF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17555-z; Chamberland VF, 2017, CORAL REEFS, V36, P83, DOI 10.1007/s00338-016-1504-2; Chan NCS, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00010; Chong-Seng KM, 2014, CORAL REEFS, V33, P449, DOI 10.1007/s00338-014-1137-2; Cowen Robert K., 2002, P149, DOI 10.1016/B978-012615185-5/50010-4; Crimaldi JP, 2002, LIMNOL OCEANOGR, V47, P1137, DOI 10.4319/lo.2002.47.4.1137; Davis K.A., 2021, ANNU REV MAR SCI, V13, P1; De Gregorio F., 2020, Journal of Physics: Conference Series, V1589, DOI 10.1088/1742-6596/1589/1/012001; dela Cruz Dexter W., 2017, Scientific Reports, V7, P13985, DOI 10.1038/s41598-017-14546-y; DENNISON WC, 1988, J EXP MAR BIOL ECOL, V115, P67, DOI 10.1016/0022-0981(88)90190-6; Dustan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057386; Figueiredo J, 2022, NAT CLIM CHANGE, V12, P83, DOI 10.1038/s41558-021-01248-7; Fuchs HL, 2015, J EXP BIOL, V218, P1419, DOI 10.1242/jeb.118562; Gaylord B, 2013, P NATL ACAD SCI USA, V110, P6901, DOI 10.1073/pnas.1220680110; Gleason DF, 2006, MAR BIOL, V148, P503, DOI 10.1007/s00227-005-0098-y; Gomez-Lemos L.A., 2018, SCI REP-UK, V8, P1; Graham NAJ, 2013, CORAL REEFS, V32, P315, DOI 10.1007/s00338-012-0984-y; Haller G, 2005, J FLUID MECH, V525, P1, DOI 10.1017/S0022112004002526; Hata T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02402-y; Heyward AJ, 1999, CORAL REEFS, V18, P273, DOI 10.1007/s003380050193; Hodin J., 2018, FEEL THAT FLUID DYNA, V1; Hodin J, 2018, BMC ZOOL, V3, DOI 10.1186/s40850-018-0034-5; Huang SY, 2003, MAR ECOL PROG SER, V260, P161, DOI 10.3354/meps260161; Hughes TP, 2019, NATURE, V568, P387, DOI 10.1038/s41586-019-1081-y; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Hunt J.C.R., 1988, EDDIES STREAM CONVER, P193; Jaramillo S, 2011, CORAL REEFS, V30, P11, DOI 10.1007/s00338-011-0731-9; Koehl MAR, 2015, INTEGR COMP BIOL, V55, P683, DOI 10.1093/icb/icv092; Koehl MAR, 2013, MAR ECOL PROG SER, V479, P47, DOI 10.3354/meps10193; Koehl MAR, 2004, J MARINE SYST, V49, P75, DOI 10.1016/j.jmarsys.2003.06.003; Larsson AI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158957; Levenstein M.A, 2022, CHEM ENG-NEW YORK; Marhaver KL, 2013, ECOLOGY, V94, P146, DOI 10.1890/12-0985.1; Marhaver KL, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0039-7; Mason B, 2011, CORAL REEFS, V30, P667, DOI 10.1007/s00338-011-0739-1; McCave I.N., 1976, BENTHIC BOUNDARY LAY; Miller MW, 2022, RESTOR ECOL, V30, DOI 10.1111/rec.13512; MORSE DE, 1988, J EXP MAR BIOL ECOL, V116, P193, DOI 10.1016/0022-0981(88)90027-5; Myan FWY, 2013, BIOINTERPHASES, V8, DOI 10.1186/1559-4106-8-30; Negri AP, 2001, MAR ECOL PROG SER, V223, P121, DOI 10.3354/meps223121; Nunes V, 2008, J COASTAL RES, V24, P39, DOI 10.2112/05-0616.1; PATTERSON MR, 1989, P NATL ACAD SCI USA, V86, P8833, DOI 10.1073/pnas.86.22.8833; Perkol-Finkel S, 2018, ECOL ENG, V120, P645, DOI 10.1016/j.ecoleng.2017.06.051; Petersen D, 2005, MAR BIOL, V146, P937, DOI 10.1007/s00227-004-1503-7; Pineda J, 2007, OCEANOGRAPHY, V20, P22, DOI 10.5670/oceanog.2007.27; Randall CJ, 2020, MAR ECOL PROG SER, V635, P203, DOI 10.3354/meps13206; Reidenbach MA, 2006, LIMNOL OCEANOGR, V51, P1956, DOI 10.4319/lo.2006.51.5.1956; Reidenbach MA, 2009, LIMNOL OCEANOGR, V54, P318, DOI 10.4319/lo.2009.54.1.0318; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Ritson-Williams Raphael, 2009, Smithsonian Contributions to the Marine Sciences, P437; ROBINSON SK, 1991, ANNU REV FLUID MECH, V23, P601, DOI 10.1146/annurev.fl.23.010191.003125; Rogers A, 2014, CURR BIOL, V24, P1000, DOI 10.1016/j.cub.2014.03.026; Scardino AJ, 2006, BIOFOULING, V22, P55, DOI 10.1080/08927010500506094; Sneed JM, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3086; Sokal R.R., 1995, BIOMETRY PRINCIPLES, Vthird; Stocking JB, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0448; Stocking JB, 2016, CORAL REEFS, V35, P1047, DOI 10.1007/s00338-016-1446-8; Storlazzi CD, 2011, CORAL REEFS, V30, P83, DOI 10.1007/s00338-011-0723-9; Suzuki G, 2020, RESTOR ECOL, V28, P1172, DOI 10.1111/rec.13178; Tebben J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10803; Tebben J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019082; Thomas FIM, 1997, LIMNOL OCEANOGR, V42, P81, DOI 10.4319/lo.1997.42.1.0081; Vardi T, 2021, RESTOR ECOL, V29, DOI 10.1111/rec.13498; Vermeij MJA, 2006, MAR ECOL PROG SER, V310, P119, DOI 10.3354/meps310119; Vermeij M.J.A., 2010, PLOS ONE, V5, P3; Vermeij Mark J.A., 2011, Diversity, V3, P296, DOI 10.3390/d3030296; Vucko MJ, 2014, BIOFOULING, V30, P1, DOI 10.1080/08927014.2013.836507; Webster NS, 2004, APPL ENVIRON MICROB, V70, P1213, DOI 10.1128/AEM.70.2.1213-1221.2004; Whalan S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117675; Wheeler JD, 2019, ANNU REV CELL DEV BI, V35, P213, DOI 10.1146/annurev-cellbio-100818-125119; Williams DE, 2008, CORAL REEFS, V27, P697, DOI 10.1007/s00338-008-0386-3	76	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274088	10.1371/journal.pone.0274088	http://dx.doi.org/10.1371/journal.pone.0274088			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095015	gold, Green Published, Green Submitted			2022-12-26	WOS:000892376500026
J	Pereira, ICF; Wyss, HM; Pinchuk, L; Beckers, HJM; den Toonder, JMJ				Pereira, Ines C. F.; Wyss, Hans M.; Pinchuk, Leonard; Beckers, Henny J. M.; den Toonder, Jaap M. J.			A model for designing intraocular pressure-regulating glaucoma implants	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; FILTERING BLEB; DRUG-DELIVERY; AQUEOUS-HUMOR; NUMERICAL-SIMULATION; DRAINAGE IMPLANT; FLUID; CONJUNCTIVA; RABBIT; TRABECULECTOMY	Glaucoma is a group of eye conditions that damage the optic nerve, the health of which is vital for vision. The key risk factor for the development and progression of this disease is increased intraocular pressure (IOP). Implantable glaucoma drainage devices have been developed to divert aqueous humor from the glaucomatous eye as a means of reducing IOP. The artificial drainage pathway created by these devices drives the fluid into a filtering bleb. The long-term success of filtration surgery is dictated by the proper functioning of the bleb and overlying Tenon's and conjunctival tissue. To better understand the influence of the health condition of these tissues on IOP, we have developed a mathematical model of fluid production in the eye, its removal from the anterior chamber by a particular glaucoma implant-the PRESERFLO (R) MicroShunt-, drainage into the bleb and absorption by the subconjunctival vasculature. The mathematical model was numerically solved by commercial FEM package COMSOL. Our numerical results of IOP for different postoperative conditions are consistent with the available evidence on IOP outcomes after the implantation of this device. To obtain insight into the adjustments in the implant's hydrodynamic resistance that are required for IOP control when hypotony or bleb scarring due to tissue fibrosis take place, we have simulated the flow through a microshunt with an adjustable lumen diameter. Our findings show that increasing the hydrodynamic resistance of the microshunt by reducing the lumen diameter, can effectively help to prevent hypotony. However, decreasing the hydrodynamic resistance of the implant will not sufficiently decrease the IOP to acceptable levels when the bleb is encapsulated due to tissue fibrosis. Therefore, to effectively reduce IOP, the adjustable glaucoma implant should be combined with a means of reducing fibrosis. The results reported herein may provide guidelines to support the design of future glaucoma implants with adjustable hydrodynamic resistances.	[Pereira, Ines C. F.; Wyss, Hans M.; den Toonder, Jaap M. J.] Eindhoven Univ Technol, Dept Mech Engn, Microsystems, Eindhoven, Netherlands; [Pereira, Ines C. F.; Wyss, Hans M.; den Toonder, Jaap M. J.] Eindhoven Univ Technol, Inst Complex Mol Syst ICMS, Eindhoven, Netherlands; [Pinchuk, Leonard] InnFocus Inc, Miami, FL USA; [Pinchuk, Leonard] Univ Miami, Miller Sch Med, Bascom Palmer Eye Inst, Ophthalm Biophys Ctr, Miami, FL USA; [Beckers, Henny J. M.] Maastricht Univ Med Ctr MUMC, Univ Eye Clin Maastricht, Maastricht, Netherlands	Eindhoven University of Technology; Eindhoven University of Technology; Bascom Palmer Eye Institute; University of Miami; Maastricht University; Maastricht University Medical Centre (MUMC)	den Toonder, JMJ (corresponding author), Eindhoven Univ Technol, Dept Mech Engn, Microsystems, Eindhoven, Netherlands.; den Toonder, JMJ (corresponding author), Eindhoven Univ Technol, Inst Complex Mol Syst ICMS, Eindhoven, Netherlands.	j.m.j.d.toonder@tue.nl		Beckers, Henny/0000-0001-9406-1426; den Toonder, Jaap/0000-0002-5923-4456; Pereira, Ines/0000-0003-0291-9785	Chemelot Institute for Science & Technology (InSciTe) [BM3.03 SEAMS]	Chemelot Institute for Science & Technology (InSciTe)	This research was financially supported by Chemelot Institute for Science & Technology (InSciTe) under grant agreement BM3.03 SEAMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta AC, 2006, ARCH OPHTHALMOL-CHIC, V124, P1742, DOI 10.1001/archopht.124.12.1742; Amar N, 2008, OPHTHALMOLOGY, V115, P1154, DOI 10.1016/j.ophtha.2007.10.024; Batlle JF, 2021, J GLAUCOMA, V30, P281, DOI 10.1097/IJG.0000000000001734; Bouhenni RA, 2016, J GLAUCOMA, V25, pE35, DOI 10.1097/IJG.0000000000000199; Budenz DL, 2015, OPHTHALMOLOGY, V122, P308, DOI 10.1016/j.ophtha.2014.08.043; Christakis PG, 2016, OPHTHALMOLOGY, V123, P2093, DOI 10.1016/j.ophtha.2016.06.035; Ciancaglini M, 2008, J GLAUCOMA, V17, P308, DOI 10.1097/IJG.0b013e31815c3a19; Ferreira JA, 2014, APPL MATH COMPUT, V226, P777, DOI 10.1016/j.amc.2013.10.070; Gardiner BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013178; Gedde SJ, 2011, EXP EYE RES, V93, P284, DOI 10.1016/j.exer.2011.03.013; Goel M, 2010, OPEN OPHTHALMOL J, V4, P52, DOI 10.2174/1874364101004010052; Guthoff R, 2006, ESSENT OPHTHALMOL, P157; Barbera MI, 2021, TRANSL VIS SCI TECHN, V10, DOI 10.1167/tvst.10.13.26; Johnson RW, 2016, HANDBOOK OF FLUID DYNAMICS, 2ND EDITION, P1, DOI 10.1201/b19031; Jung KI, 2013, INVEST OPHTH VIS SCI, V54, P3957, DOI 10.1167/iovs.12-11310; Kasaragod D, 2016, INVEST OPHTH VIS SCI, V57, P2305, DOI 10.1167/iovs.15-18178; Kotliar KE, 2009, BIOMED TECH, V54, P14, DOI 10.1515/BMT.2009.003; Lee JY, 2021, EYE, V35, P202, DOI 10.1038/s41433-020-01215-0; Lee JY., 2021, OPHTHALMOL SCI, V1; Lim KS, 2018, EYE, V32, P230, DOI 10.1038/eye.2017.316; Loch C, 2012, EUR J PHARM SCI, V47, P131, DOI 10.1016/j.ejps.2012.05.007; Sanchez GJM, 2019, MED ENG PHYS, V65, P24, DOI 10.1016/j.medengphy.2018.12.022; Mastropasqua R, 2017, INVEST OPHTH VIS SCI, V58, pBIO114, DOI 10.1167/iovs.17-21795; Matsuo H, 2002, AM J OPHTHALMOL, V133, P456, DOI 10.1016/S0002-9394(01)01432-5; Moghadam MC, 2015, MICROVASC RES, V101, P62, DOI 10.1016/j.mvr.2015.06.007; Mohammadi M, 2015, MICROVASC RES, V101, P26, DOI 10.1016/j.mvr.2015.06.001; Narita A, 2017, JPN J OPHTHALMOL, V61, P253, DOI 10.1007/s10384-017-0504-2; Nguyen DQ, 2012, INVEST OPHTH VIS SCI, V53, P6914, DOI 10.1167/iovs.12-10438; Pandav Surinder S, 2016, J Curr Glaucoma Pract, V10, P91; Pereira ICF, 2021, EYE, V35, P3202, DOI 10.1038/s41433-021-01595-x; Pinchuk L, 2017, J BIOMED MATER RES B, V105, P211, DOI 10.1002/jbm.b.33525; Pollmann Andre S, 2020, Am J Ophthalmol Case Rep, V19, P100752, DOI 10.1016/j.ajoc.2020.100752; Prausnitz MR, 1998, J PHARM SCI, V87, P1479, DOI 10.1021/js9802594; Richter GM, 2016, CLIN OPHTHALMOL, V10, P189, DOI 10.2147/OPTH.S80490; Sadruddin O, 2019, EYE VISION, V6, DOI 10.1186/s40662-019-0162-1; Samples JR., 2014, SURG INNOVATIONS GLA; Schlunck G, 2016, EXP EYE RES, V142, P76, DOI 10.1016/j.exer.2015.03.021; Schuff MM, 2013, J MATH BIOL, V67, P1307, DOI 10.1007/s00285-012-0544-7; Sefidgar M, 2015, MICROVASC RES, V99, P43, DOI 10.1016/j.mvr.2015.02.007; Sefidgar M, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/673426; Seibold LK, 2012, SURV OPHTHALMOL, V57, P530, DOI 10.1016/j.survophthal.2012.01.008; Shah M, 2019, EYE VISION, V6, DOI 10.1186/s40662-019-0154-1; Shojaee P, 2019, BIOMED PHYS ENG EXPR, V5, DOI 10.1088/2057-1976/ab1283; Soltani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067025; Sousa DC., 2018, EUR OPHTHALMIC REV, V12, P98, DOI [10.17925/EOR.2018.12.2.98, DOI 10.17925/EOR.2018.12.2.98]; Steimle A., 2018, LASER TECH J, V15, P32, DOI [10.1002/latj.201800003, DOI 10.1002/LATJ.201800003]; Sugimoto K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72056-w; Suthisomboon T, 2020, 2020 S DESIGN TEST I, P1; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Thygesen J., 2015, GLAUCOMA, V2nd, P863; Tovar M, 2018, BIOMICROFLUIDICS, V12, DOI 10.1063/1.5013325; van Zijderveld R, 2014, GRAEF ARCH CLIN EXP, V252, P773, DOI 10.1007/s00417-014-2603-9; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Yilmaz SG, 2015, TURK OFTALMOL DERG, V45, P132, DOI 10.4274/tjo.29052; Yu DY, 2009, PROG RETIN EYE RES, V28, P303, DOI 10.1016/j.preteyeres.2009.06.004; Yu-Wai-Man C, 2015, EXPERT REV OPHTHALMO, V10, P65, DOI 10.1586/17469899.2015.983475	56	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273672	10.1371/journal.pone.0273672	http://dx.doi.org/10.1371/journal.pone.0273672			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054120	gold, Green Published			2022-12-26	WOS:000892641400028
J	Zong, BB; Wang, YJ; Wang, JY; Zhang, P; Kan, GH; Li, MY; Feng, J; Wang, YF; Chen, XP; Jin, R; Ge, Q				Zong, Beibei; Wang, Yujia; Wang, Jingyi; Zhang, Peng; Kan, Guanghan; Li, Mingyang; Feng, Juan; Wang, Yifan; Chen, Xiaoping; Jin, Rong; Ge, Qing			Effects of long-term simulated microgravity on liver metabolism in rhesus macaques	FASEB JOURNAL			English	Article						dysbiosis; head-down bed rest; lipid metabolism; liver; rhesus macaques	BED-REST; PHYSICAL INACTIVITY; INSULIN-RESISTANCE; NONHUMAN-PRIMATES; ACID; SPACEFLIGHT; MICROBIOTA; SPACE; IRON; PROMOTES	The liver is an essential multifunctional organ and constantly communicates with nearly all the tissues in the body. Spaceflight or simulated microgravity has a significant impact on the livers of rodent models, including lipid accumulation and inflammatory cell infiltration. Whether similar liver lipotoxicity could occur in humans is not known, even though altered circulating cholesterol profile has been reported in astronauts. Using a 42-day head-down bed rest (HDBR) model in rhesus macaques, the present study investigated whether simulated microgravity alters the liver of non-human primates at the transcriptome and metabolome levels. Its association with stress and intestinal changes was also explored. Compared to the controls, the HDBR monkeys showed mild liver injury, elevated ANGPTL3 level in the plasma, and accumulation of fat vacuoles and inflammatory cells in the liver. Altered transcriptome signatures with up-regulation of genes in lipid metabolisms and down-regulation of genes in innate immune defense were also found in HDBR group-derived liver samples. The metabolic profiling of the liver revealed mildly disturbed fatty acid metabolism in the liver of HDBR monkeys. The intestinal dysbiosis, its associated endotoxemia and changes in the composition of bile acids, and elevated stress hormone in HDBR monkeys may contribute to the altered lipid metabolisms in the liver. These data indicate that liver metabolic functions and gut-liver axis should be closely monitored in prolonged spaceflight to facilitate strategy design to improve and maintain metabolic homeostasis.	[Zong, Beibei; Ge, Qing] Peking Univ, Sch Basic Med Sci, Dept Integrat Chinese & Western Med, Beijing, Peoples R China; [Wang, Yujia; Wang, Jingyi; Wang, Yifan; Jin, Rong; Ge, Qing] Peking Univ, Sch Basic Med Sci, Dept Immunol, NHC Key Lab Med Immunol, Beijing, Peoples R China; [Zhang, Peng; Kan, Guanghan; Chen, Xiaoping] Chinese Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Beijing, Peoples R China; [Li, Mingyang] Capital Med Univ, Beijing Friendship Hosp, Immunol Res Ctr, Beijing Clin Res Inst, Beijing, Peoples R China; [Feng, Juan] Peking Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Key Lab Mol Cardiovasc Sci,Minist Educ, Beijing, Peoples R China; [Chen, Xiaoping] China Astronauts Res & Training Ctr, Natl Key Lab Human Factors Engn, Beijing, Peoples R China; [Zong, Beibei; Ge, Qing] Peking Univ, Sch Basic Med Sci, Dept Immunol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China	Peking University; Peking University; Capital Medical University; Peking University; Peking University	Jin, R; Ge, Q (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Immunol, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	jinrong@bjmu.edu.cn; qingge@bjmu.edu.cn	Wang, Jin/GYA-2019-2022; wang, jing/GVT-8700-2022; Li, Mingyang/HGF-2294-2022; WANG, JINGYI/GSJ-1241-2022	Li, Mingyang/0000-0003-1446-6381; 	Beijing Natural Science Foundation [7202079]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81621001]; National Natural Science Foundation of China [32070897, 31872734, 31671244, 31872733, 32071178]; Open Funding Project of National Key Laboratory of Human Factors Engineering [6142222200105]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Funding Project of National Key Laboratory of Human Factors Engineering	Beijing Natural Science Foundation, Grant/Award Number: 7202079; Foundation for Innovative Research Groups of the National Natural Science Foundation of China, Grant/Award Number: 81621001; National Natural Science Foundation of China, Grant/Award Number: 32070897, 31872734, 31671244, 31872733 and 32071178; the Open Funding Project of National Key Laboratory of Human Factors Engineering, Grant/Award Number: 6142222200105	Afarideh M, 2015, ENDOCR PRACT, V21, P711, DOI 10.4158/EP14442.OR; Anselm V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081763; Austermann K, 2021, J NUTR, V151, P1527, DOI 10.1093/jn/nxab036; Baqai FP, 2009, J APPL PHYSIOL, V106, P1935, DOI 10.1152/japplphysiol.91361.2008; Barcelos RP, 2016, MINI-REV MED CHEM, V16, P12, DOI 10.2174/1389557515666150722102613; Beheshti A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55869-2; Belozerova I N, 2003, Neurosci Behav Physiol, V33, P735, DOI 10.1023/A:1024429311622; Bergouignan A, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010027; Bergouignan A, 2011, J APPL PHYSIOL, V111, P1201, DOI 10.1152/japplphysiol.00698.2011; Bergouignan A, 2009, DIABETES, V58, P367, DOI 10.2337/db08-0263; Blaber EA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102062; Bonnefoy J, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.830662; Brooks NE, 2014, INT J MED SCI, V11, P1248, DOI 10.7150/ijms.9694; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Cavey T, 2017, EXP PHYSIOL, V102, P291, DOI 10.1113/EP086188; Chen Y, 2017, INFLAMMATION, V40, P589, DOI 10.1007/s10753-016-0506-0; Choi SY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58898-4; CHUNG KT, 1975, J BACTERIOL, V124, P573, DOI 10.1128/JB.124.1.573-575.1975; Coker RH, 2014, J GERONTOL A-BIOL, V69, P363, DOI [10.1093/gerona/glt100, 10.1093/gerona/glu123]; Cox LA, 2017, ILAR J, V58, P235, DOI 10.1093/ilar/ilx025; Da Silva MS, 2002, NUTRITION, V18, P805, DOI 10.1016/S0899-9007(02)00915-2; da Silveira WA, 2020, CELL, V183, P1185, DOI 10.1016/j.cell.2020.11.002; Davies KAB, 2019, THER ADV ENDOCRINOL, V10, DOI 10.1177/2042018819888824; Desai RI, 2021, LIFE SCI SPACE RES, V30, P9, DOI 10.1016/j.lssr.2021.03.008; Dirks ML, 2016, DIABETES, V65, P2862, DOI 10.2337/db15-1661; Fianchi F, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22126485; Foley MH, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017709118; Garrett-Bakelman FE, 2019, SCIENCE, V364, P144, DOI 10.1126/science.aau8650; Hamburg NM, 2007, ARTERIOSCL THROM VAS, V27, P2650, DOI 10.1161/ATVBAHA.107.153288; Havel PJ, 2017, ILAR J, V58, P251, DOI 10.1093/ilar/ilx031; Hess AL, 2018, GENES NUTR, V13, DOI 10.1186/s12263-018-0597-3; Jiang P, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0724-4; Jiang S, 2019, J DRUG TARGET, V27, P876, DOI 10.1080/1061186X.2019.1566342; Jin ML, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00729; Jomura R, 2022, BBA-BIOMEMBRANES, V1864, DOI 10.1016/j.bbamem.2021.183840; Jonscher KR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152877; Kalra S., 2021, MED SCI BASEL, V9, P39; Kersten S, 2019, CURR OPIN LIPIDOL, V30, P205, DOI 10.1097/MOL.0000000000000600; Kim YK, 2021, J CLIN MED, V10, DOI 10.3390/jcm10173819; Koenig SC, 2004, AVIAT SPACE ENVIR MD, V75, P7; Kuehnast T, 2022, MICROBIOME, V10, DOI 10.1186/s40168-021-01222-7; Le Roux E, 2022, J PHYSIOL-LONDON, V600, P1037, DOI 10.1113/JP281064; Li BG, 2019, CELL REP, V26, P2720, DOI 10.1016/j.celrep.2019.02.015; Li R, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00343-5; Liu C, 2021, FASEB J, V35, DOI 10.1096/fj.202100939R; Liu ZZ, 2020, GUT MICROBES, V11, DOI 10.1080/19490976.2019.1710091; Lu Y, 2020, J CLIN INVEST, V130, P3791, DOI 10.1172/JCI134485; Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Markin A, 1998, ACTA ASTRONAUT, V42, P247, DOI 10.1016/S0094-5765(98)00121-0; Mazzucco S, 2010, J CLIN ENDOCR METAB, V95, P2508, DOI 10.1210/jc.2009-2561; Momken I, 2011, FASEB J, V25, P3646, DOI 10.1096/fj.10-177295; Moore ST, 2003, J VESTIBUL RES-EQUIL, V13, P377; Morton NM, 2008, FRONT HORM RES, V36, P146, DOI 10.1159/000115363; Nay K, 2020, FASEB J, V34, P14920, DOI 10.1096/fj.202001199RR; Pecaut MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174174; Rada P, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03003-w; Rahimi L, 2020, DIABET METAB SYND OB, V13, P1133, DOI 10.2147/DMSO.S247379; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Ridola Lorenzo, 2022, J Hepatol, V77, P262, DOI 10.1016/j.jhep.2022.01.003; Rivera CA, 2003, J APPL PHYSIOL, V95, P1656, DOI 10.1152/japplphysiol.00302.2003; Rojas IY, 2021, OBESITY, V29, P337, DOI 10.1002/oby.23065; Rudwill F, 2015, LIVER INT, V35, P1700, DOI 10.1111/liv.12743; Saxena R, 1999, HEPATOLOGY, V30, P1339, DOI 10.1002/hep.510300607; Sayin SI, 2013, CELL METAB, V17, P225, DOI 10.1016/j.cmet.2013.01.003; Song JW, 2020, CELL METAB, V32, P188, DOI 10.1016/j.cmet.2020.06.016; STUART CA, 1988, METABOLISM, V37, P802, DOI 10.1016/0026-0495(88)90018-2; Vacca M, 2020, NAT METAB, V2, P514, DOI 10.1038/s42255-020-0214-9; Vacca M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040573; Visekruna A, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.703218; Voorhies AA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46303-8; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wang K, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-019-2214-9; Wang XP, 2020, FASEB J, V34, P15180, DOI 10.1096/fj.202001246RR; Wang XC, 2021, INT J ENDOCRINOL, V2021, DOI 10.1155/2021/6620289; Wang YF, 2019, FASEB J, V33, P10140, DOI 10.1096/fj.201900238RR; Ward K, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.573581; Xu X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077401; Xu Z, 2017, BONE, V94, P152, DOI 10.1016/j.bone.2016.09.023; Yang JC, 2018, BONE, V114, P235, DOI 10.1016/j.bone.2018.06.012; Zhang P., 2022, JCSM RAPID COMMUNICA, V5, P212; Zhang X, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0459-y; Zhang Y, 2021, BIOL PHARM BULL, V44, P162, DOI 10.1248/bpb.b20-00299; Zhou KJ, 2015, J PROTEOME RES, V14, P4844, DOI 10.1021/acs.jproteome.5b00676; Zwart SR, 2013, AM J CLIN NUTR, V98, P217, DOI 10.3945/ajcn.112.056465	85	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22536	10.1096/fj.202200544RR	http://dx.doi.org/10.1096/fj.202200544RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4I5BN	36070186				2022-12-26	WOS:000850592300001
J	Hu, XQ; Xi, YF; Bai, WQ; Zhang, ZJ; Qi, JH; Dong, L; Liang, HT; Sun, ZY; Lei, LJ; Fan, GQ; Sun, CM; Huo, C; Huang, JJ; Wang, T				Hu, Xiaoqin; Xi, Yanfeng; Bai, Wenqi; Zhang, Zhenjun; Qi, Jiahao; Dong, Liang; Liang, Huiting; Sun, Zeyu; Lei, Lijian; Fan, Guoquan; Sun, Chenming; Huo, Cheng; Huang, Jianjun; Wang, Tong			Polymorphisms of adiponectin gene and gene-lipid interaction with hypertension risk in Chinese coal miners: A matched case-control study	PLOS ONE			English	Article							INSULIN-RESISTANCE; INCIDENT HYPERTENSION; BLOOD-LIPIDS; SERUM-LIPIDS; ADIPOQ; DYSLIPIDEMIA; ASSOCIATIONS; METABOLISM; PREDICTOR; GLUCOSE	Objective Low serum adiponectin level can predict hypertension development, and adiponectin gene (ADIPOQ) polymorphisms have been reported to be linked with hypertension risk. Whereas, the interaction between ADIPOQ polymorphisms and environmental factors on the susceptibility of hypertension remained unclear. The purpose of this study was to explore the relationship of ADIPOQ polymorphisms with hypertension risk and their interaction with lipid levels in coal miners. Methods A matched case-control study with 296 case-control pairs was performed in a large coal mining group located in North China. The participants were questioned by trained interviewers, and their ADIPOQ genotype and lipid levels were determined. Logistic regression, stratified analysis, and crossover analysis were applied to evaluate the effects of rs2241766, rs1501299, and rs266729 genotypes and gene-lipid interaction on hypertension risk. Results In this matched case-control study, the genotypes of rs2241766 TG+GG, rs1501299 GT +TT, and rs266729 CG+GG were marginally related to hypertension risk. Individuals with high total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and high-density lipoprotein cholesterol (HDL-C) level were susceptible to hypertension (TC: odds ratio [OR] = 1.807, 95% confidence intervals [95%CI] = 1.266-2.581; LDL-C: OR = 1.981, 95%CI = 1.400-2.803; HDL-C: OR = 1.559, 95%CI = 1.093-2.223). Antagonistic interactions were detected between rs2241766 and TC, rs1501299 and TC, rs2241766 and LDL-C, and rs1501299 and HDL-C (rs2241766 and TC: OR = 0.393, 95%CI= 0.191-0.806; rs1501299 and TC: OR = 0.445, 95%CI= 0.216-0.918; rs2241766 and LDL-C: OR = 0.440, 95%CI= 0.221-0.877; rs1501299 and HDL-C: OR = 0.479, 95%CI= 0.237-0.967). Stratified analysis showed that hypertension risk was high for the subjects with rs2241766 TG+GG or rs1501299 GG under the low lipid level but low for those under the high lipid level. In the case group, the TC and LDL-C levels for rs2241766 TG+GG were lower than those for rs2241766 GG, and the TC and HDL-C levels for rs1501299 GT+TT were higher than those for rs1501299 GG. Conclusions Although the effects of ADIPOQ polymorphisms alone were not remarkable, an antagonistic interaction was observed between ADIPOQ polymorphisms and lipid levels.	[Hu, Xiaoqin] Shanxi Med Univ, Chinese Acad Med Sci, Shanxi Prov Canc Hosp, Canc Hosp,Shanxi Hosp,Sch Publ Hlth, Taiyuan, Peoples R China; [Xi, Yanfeng; Bai, Wenqi; Zhang, Zhenjun] Shanxi Med Univ, Chinese Acad Med Sci, Canc Hosp, Shanxi Hosp,Shanxi Prov Canc Hosp, Taiyuan, Peoples R China; [Qi, Jiahao; Dong, Liang; Liang, Huiting; Sun, Zeyu; Lei, Lijian; Fan, Guoquan; Wang, Tong] Shanxi Med Univ, Sch Publ Hlth, Taiyuan, Peoples R China; [Sun, Chenming; Huo, Cheng; Huang, Jianjun] Sinopharm Tongmei Gen Hosp, Datong, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Shanxi Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Shanxi Medical University; Shanxi Medical University	Hu, XQ (corresponding author), Shanxi Med Univ, Chinese Acad Med Sci, Shanxi Prov Canc Hosp, Canc Hosp,Shanxi Hosp,Sch Publ Hlth, Taiyuan, Peoples R China.; Wang, T (corresponding author), Shanxi Med Univ, Sch Publ Hlth, Taiyuan, Peoples R China.	huxiaoqin.love@163.com; tongwang@sxmu.edu.cn	wang, tong/I-6454-2018	wang, tong/0000-0002-9403-7167	National Natural Science Foundation of China [81803326, 81872701]; Research Project of Public Health Graduate Education Innovation Center of Shanxi Coal Mine [KY2015005]; Applied Basic Research Program of Shanxi [201801D221265]; Research Project of Postgraduate Education Reform in Shanxi Province [2020YJJG134]; Medical Education Research Project of Medical Education Branch of Chinese Medical Association and Medical Education Professional Committee of Chinese Higher Education Association [2020A-N02036]; Doctoral Startup Research Fund of Shanxi Medical University [03201415]; Youth Research Fund of Shanxi Medical University [02201509]; Teaching Reform and Innovation Project of Shanxi Medical University [GXJ202011]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Project of Public Health Graduate Education Innovation Center of Shanxi Coal Mine; Applied Basic Research Program of Shanxi; Research Project of Postgraduate Education Reform in Shanxi Province; Medical Education Research Project of Medical Education Branch of Chinese Medical Association and Medical Education Professional Committee of Chinese Higher Education Association; Doctoral Startup Research Fund of Shanxi Medical University; Youth Research Fund of Shanxi Medical University; Teaching Reform and Innovation Project of Shanxi Medical University	The study was supported by a grant from the National Natural Science Foundation of China (No: 81803326, 81872701), Research Project of Public Health Graduate Education Innovation Center of Shanxi Coal Mine (No: KY2015005), Applied Basic Research Program of Shanxi (No: 201801D221265), Research Project of Postgraduate Education Reform in Shanxi Province No: 2020YJJG134), Medical Education Research Project of Medical Education Branch of Chinese Medical Association and Medical Education Professional Committee of Chinese Higher Education Association (No: 2020A-N02036), Doctoral Startup Research Fund of Shanxi Medical University (No: 03201415), Youth Research Fund of Shanxi Medical University (No: 02201509), and Teaching Reform and Innovation Project of Shanxi Medical University (No: GXJ202011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no salary from the funders.	Alif SM., 2022, EUR RESPIR J, V79, P347, DOI [10.1136/oemed-2021-107498, DOI 10.1183/13993003.congress-2021.PA3361]; Aller R, 2019, NUTRITION, V65, P44, DOI 10.1016/j.nut.2019.02.012; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; [Anonymous], GLOB HLTH OBS DAT; de Luis DA, 2019, DIABETES RES CLIN PR, V148, P262, DOI 10.1016/j.diabres.2017.11.007; de Luis DA, 2018, SURG OBES RELAT DIS, V14, P1402, DOI 10.1016/j.soard.2018.06.006; Chen J, 2015, J ATHEROSCLER THROMB, V22, P126, DOI 10.5551/jat.26401; Chow WS, 2007, HYPERTENSION, V49, P1455, DOI 10.1161/HYPERTENSIONAHA.107.086835; Chung HK, 2009, DIABETES CARE, V32, P552, DOI 10.2337/dc08-1605; da Silveira CG, 2018, INHAL TOXICOL, V30, P370, DOI 10.1080/08958378.2018.1530317; Daimon Makoto, 2012, Nihon Rinsho, V70 Suppl 3, P256; de Souza SR, 2016, NUTR HOSP, V33, P123, DOI 10.20960/nh.40; Ding YM, 2016, MOL CELL ENDOCRINOL, V433, P12, DOI 10.1016/j.mce.2016.05.021; Drivsholm A, 2019, J PEDIATR ENDOCR MET, V32, P1351, DOI 10.1515/jpem-2019-0359; Drzikova B, 2005, BRIT J NUTR, V94, P1012, DOI 10.1079/bjn20051577; Fan WN, 2017, SCI REP-UK, V7, DOI 10.1038/srep41683; Fomenko D. V, 2011, Meditsina Truda i Promyshlennaya Ekologiya, P13; Guo LN, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-182; Guo Zhi-Rong, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P554; Joint committee for guideline revision, 2018, J Geriatr Cardiol, V15, P1, DOI 10.11909/j.issn.1671-5411.2018.01.011; Kim DH, 2013, HYPERTENSION, V62, P27, DOI 10.1161/HYPERTENSIONAHA.113.01453; Kitajima K, 2011, BIOCHEM BIOPH RES CO, V411, P305, DOI 10.1016/j.bbrc.2011.06.131; Laaksonen DE, 2008, EUR HEART J, V29, P2561, DOI 10.1093/eurheartj/ehn061; Li YP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019686; Li Y, 2014, LIFE SCI, V118, P27, DOI 10.1016/j.lfs.2014.10.003; Liu Li-Sheng, 2011, Zhonghua Xin Xue Guan Bing Za Zhi, V39, P579; Liu W, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019052; Ma J, 2019, CLIN EXP HYPERTENS, V41, P702, DOI 10.1080/10641963.2018.1545845; Manrique C, 2009, MED CLIN N AM, V93, P569, DOI 10.1016/j.mcna.2009.02.014; Otsuka T, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003053; Paynter NP, 2011, CLIN CHEM, V57, P1178, DOI 10.1373/clinchem.2011.167544; Pineda-Tenor D, 2014, EUR J CLIN INVEST, V44, P453, DOI 10.1111/eci.12250; Rojas E, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0463-7; Romero FD, 1998, REV ESP CARDIOL, V51, P24; Schindler M, 2017, HUM REPROD, V32, P1382, DOI 10.1093/humrep/dex087; Su M, 2021, HORM METAB RES, V53, P541, DOI 10.1055/a-1543-6362; Tanida M, 2007, EXP BIOL MED, V232, P390; Taverne Femke, 2013, PharmaNutrition, V1, P130, DOI 10.1016/j.phanu.2013.07.003; Tohidi M, 2012, J HUM HYPERTENS, V26, P525, DOI 10.1038/jhh.2011.70; Ustinova OIu., 2013, MED TR PROM EKOL, P27; Wildman RP, 2008, INT J OBESITY, V32, P740, DOI 10.1038/sj.ijo.0803782; Xi B, 2012, MOL BIOL REP, V39, P8771, DOI 10.1007/s11033-012-1739-0; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904; Zhang J, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-54; Zhang M, 2021, Zhonghua Liu Xing Bing Xue Za Zhi, V42, P1780, DOI 10.3760/cma.j.cn112338-20210508-00379; Zhang Y, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001912; Zhao TF, 2011, CLIN ENDOCRINOL, V74, P214, DOI 10.1111/j.1365-2265.2010.03902.x	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0268984	10.1371/journal.pone.0268984	http://dx.doi.org/10.1371/journal.pone.0268984			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094942	Green Published, gold			2022-12-26	WOS:000892376500005
J	Janakiraman, H; Becker, SA; Bradshaw, A; Rubinstein, MP; Camp, ER				Janakiraman, Harinarayanan; Becker, Scott A.; Bradshaw, Alexandra; Rubinstein, Mark P.; Camp, Ernest Ramsay			Critical evaluation of an autologous peripheral blood mononuclear cell-based humanized cancer model	PLOS ONE			English	Article							VERSUS-HOST-DISEASE; T-CELLS; ANTITUMOR-ACTIVITY; IN-VIVO; MICE; IMMUNOTHERAPY; GENERATION; ANTIBODY; IMMUNITY	The use of humanized mouse models for oncology is rapidly expanding. Autologous patient-derived systems are particularly attractive as they can model the human cancer's heterogeneity and immune microenvironment. In this study, we developed an autologous humanized mouse cancer model by engrafting NSG mice with patient-derived xenografts and infused matched peripheral blood mononuclear cells (PBMCs). We first defined the time course of xenogeneic graft-versus-host-disease (xGVHD) and determined that only minimal xGVHD was observed for up to 8 weeks. Next, colorectal and pancreatic cancer patient-derived xenograft bearing NSG mice were infused with 5x10(6) human PBMCS for development of the humanized cancer models (iPDX). Early after infusion of human PBMCs, iPDX mice demonstrated engraftment of human CD4+ and CD8+ T cells in the blood of both colorectal and pancreatic cancer patient-derived models that persisted for up to 8 weeks. At the end of the experiment, iPDX xenografts maintained the features of the primary human tumor including tumor grade and cell type. The iPDX tumors demonstrated infiltration of human CD3+ cells with high PD-1 expression although we observed significant intra and intermodel variability. In summary, the iPDX models reproduced key features of the corresponding human tumor. The observed variability and high PD-1 expression are important considerations that need to be addressed in order to develop a reproducible model system.	[Janakiraman, Harinarayanan; Camp, Ernest Ramsay] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Becker, Scott A.] Emory Univ, Mol & Syst Pharmacol, Atlanta, GA 30322 USA; [Bradshaw, Alexandra] Med Univ South Carolina, Dept Surg, Charleston, SC 29425 USA; [Rubinstein, Mark P.] Ohio State Univ, Pelotonia Inst Immunooncol, Comprehens Canc Ctr James, Columbus, OH 43210 USA; [Camp, Ernest Ramsay] Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA; [Camp, Ernest Ramsay] Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Emory University; Medical University of South Carolina; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Baylor College of Medicine	Camp, ER (corresponding author), Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA.; Camp, ER (corresponding author), Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA.; Camp, ER (corresponding author), Michael E DeBakey VA Med Ctr, Houston, TX 77030 USA.	ramsay.camp@bcm.edu			MERIT REVIEW AWARD; Department of Veteran Affairs and Clinical Science Research and Development [1l01CX001880-01A1]; Translational Science Shared Resource, Hollings Cancer Center, Medical University of South Carolina [P30 CA138313]; Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center, Medical University of South Carolina	MERIT REVIEW AWARD(US Department of Veterans Affairs); Department of Veteran Affairs and Clinical Science Research and Development; Translational Science Shared Resource, Hollings Cancer Center, Medical University of South Carolina; Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center, Medical University of South Carolina	This work was supported in part by funding from MERIT REVIEW AWARD (Issue date: 1/15/2019) Department of Veteran Affairs and Clinical Science Research and Development (1l01CX001880-01A1) for the research project titled "Targeting Sphingosine-1-phosphate to overcome SNAI1-mediated therapy" issued to C.E. R. Supported in part by the Translational Science Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313). Supported in part by the Biorepository & Tissue Analysis Shared Resource, Hollings Cancer Center, Medical University of South Carolina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashizawa T, 2017, CLIN CANCER RES, V23, P149, DOI 10.1158/1078-0432.CCR-16-0122; Bertotti A, 2011, CANCER DISCOV, V1, P508, DOI 10.1158/2159-8290.CD-11-0109; Bird GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105525; Bryson JS, 1997, BONE MARROW TRANSPL, V19, P721, DOI 10.1038/sj.bmt.1700719; Chang DK, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0384-3; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Covassin L, 2013, CLIN EXP IMMUNOL, V174, P372, DOI 10.1111/cei.12180; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Fischer MR, 2019, EXP DERMATOL, V28, P1087, DOI 10.1111/exd.13999; Fisher TS, 2012, CANCER IMMUNOL IMMUN, V61, P1721, DOI 10.1007/s00262-012-1237-1; Gadgeel S, 2020, J CLIN ONCOL, V38, P1505, DOI 10.1200/JCO.19.03136; Gitto SB, 2020, GYNECOL ONCOL, V156, P222, DOI 10.1016/j.ygyno.2019.10.011; Hall M, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0164-7; Hidalgo M, 2011, MOL CANCER THER, V10, P1311, DOI 10.1158/1535-7163.MCT-11-0233; Hu Z, 2016, ONCOTARGET, V7, P6448, DOI 10.18632/oncotarget.7044; Janakiraman H, 2020, INT J CANCER, V147, P1405, DOI 10.1002/ijc.32876; Jespersen H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00786-z; Jimeno A, 2009, MOL CANCER THER, V8, P310, DOI 10.1158/1535-7163.MCT-08-0924; Jin KT, 2021, CANCER SCI, V112, P2592, DOI 10.1111/cas.14934; Julien S, 2012, CLIN CANCER RES, V18, P5314, DOI 10.1158/1078-0432.CCR-12-0372; Kersten K, 2017, EMBO MOL MED, V9, P137, DOI 10.15252/emmm.201606857; Kieler M, 2018, PANCREAS, V47, P142, DOI 10.1097/MPA.0000000000000970; King MA, 2009, CLIN EXP IMMUNOL, V157, P104, DOI 10.1111/j.1365-2249.2009.03933.x; Lin SH, 2018, MABS-AUSTIN, V10, P1301, DOI 10.1080/19420862.2018.1518948; May KF, 2005, BLOOD, V105, P1114, DOI 10.1182/blood-2004-07-2561; McCormack E, 2013, CANCER IMMUNOL IMMUN, V62, P773, DOI 10.1007/s00262-012-1384-4; Morillon YM, 2020, ANTICANCER RES, V40, P5329, DOI 10.21873/anticanres.14540; Morton JJ, 2016, ONCOGENE, V35, P290, DOI 10.1038/onc.2015.94; Mosely SIS, 2017, CANCER IMMUNOL RES, V5, P29, DOI 10.1158/2326-6066.CIR-16-0114; Mutis T, 2006, CLIN CANCER RES, V12, P5520, DOI 10.1158/1078-0432.CCR-06-0035; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; Ordemann R, 2002, J CLIN INVEST, V109, P1249, DOI 10.1172/JCI200214793; Morelli MP, 2012, J CLIN ONCOL, V30, pE45, DOI 10.1200/JCO.2011.36.9678; Rongvaux A, 2014, NAT BIOTECHNOL, V32, P364, DOI 10.1038/nbt.2858; Saha A, 2016, J CLIN INVEST, V126, P2642, DOI 10.1172/JCI85796; Sakai R, 1997, BONE MARROW TRANSPL, V20, P183, DOI 10.1038/sj.bmt.1700865; Sanmamed MF, 2015, CANCER RES, V75, P3466, DOI 10.1158/0008-5472.CAN-14-3510; Schmid P, 2020, NEW ENGL J MED, V382, P810, DOI 10.1056/NEJMoa1910549; Shenoy GN, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1246; Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311; Shultz LD, 2010, P NATL ACAD SCI USA, V107, P13022, DOI 10.1073/pnas.1000475107; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Vatakis DN, 2011, P NATL ACAD SCI USA, V108, pE1408, DOI 10.1073/pnas.1115050108; Zeng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173754; Zhu Y, 2018, MOL THER, V26, P744, DOI 10.1016/j.ymthe.2017.12.023	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0273076	10.1371/journal.pone.0273076	http://dx.doi.org/10.1371/journal.pone.0273076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095023	Green Published, gold			2022-12-26	WOS:000892376500015
J	Rahim, N; Nesar, S; Mumtaz, T; Naeem, S; Ali, M				Rahim, Najia; Nesar, Shagufta; Mumtaz, Tayyaba; Naeem, Sadaf; Ali, Muhammad			Validation of questionnaire regarding online teaching (QOT) during Covid-19 in Karachi, Pakistan	PLOS ONE			English	Article							PHARMACY EDUCATION	The present study involved an extra-cultural adaptation and validation of questionnaire regarding online teaching (QOT) to know faculty perception, attitude and experiences of online teaching. Cronbach's alpha was determined for assessing internal reliability of QOT and found to be 0.886, confirmed that the scale have good reliability. Factor Analysis of the scale (Principal Component Analysis) was used to examine factor structure and then trailed by varimax rotation. The items were allocated four sub scales. A survey technique was used for the validation of QOT and the survey was conducted during September-December' 2020 in private and public universities of Karachi to determine the pharmacy faculty's perception and experience regarding online teaching. Approximately 35% responded that "It is very easy to prepare and deliver an online course" and 45% opined that "The universities offering Pharm.D should adopt the use of e-learning for teaching in future to complement traditional teaching". Majority of the faculty were in favor of starting online teaching during pandemic to complete semester on time (72%). However, in-campus courses contribute more to students' learning than online courses in pharmaceutical sciences (65.5%). The present study summarizes that academic staff did opt online teaching over one-to-one teaching in the lock down situation during Covid-19 pandemic however, they agreed not to replace traditional teaching to online teaching. Teachers recognized some difficulties and challenges during online teaching including difficulty in preparing lecture for online teaching than traditional classroom teaching, shortage of long time training sessions. Female teachers were inclined to online teaching than male and lecturers tend to prefer online teaching compared to senior teachers. Universities and administration should take imperative acts for improving online teaching for better learning during lock down or any other situation where social distancing is required.	[Rahim, Najia] Dow Univ Hlth Sci, Fac Pharmaceut Sci, Dept Pharm Practice, Karachi, Pakistan; [Nesar, Shagufta; Mumtaz, Tayyaba; Ali, Muhammad] Sohail Univ, Jinnah Coll Pharm, Karachi, Pakistan; [Naeem, Sadaf] Jinnah Sindh Med Univ, Dept Pharm Practice, Fac Pharm, Karachi, Pakistan	Dow University of Health Sciences; Jinnah Sindh Medical University - Pakistan	Rahim, N (corresponding author), Dow Univ Hlth Sci, Fac Pharmaceut Sci, Dept Pharm Practice, Karachi, Pakistan.	najia.rahim@duhs.edu.pk						Abdullah MS, 2018, EURASIA J MATH SCI T, V14, P1097, DOI 10.12973/ejmste/81554; Altwaijry N, 2021, RISK MANAG HEALTHC P, V14, P2099, DOI 10.2147/RMHP.S308998; Alzubaidi H, 2021, INT J PHARM PRACT, V29, P633, DOI 10.1093/ijpp/riab064; Anasel M, 2020, ADOPTION ONLINE COUR; Bartolo NS, 2020, PHARM EDUC, V20, P290, DOI 10.46542/pe.2020.202.290296; Saiz-Manzanares MC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051589; Donkin R, 2019, BMC MED EDUC, V19, DOI 10.1186/s12909-019-1745-1; Farid S, 2015, COMPUT HUM BEHAV, V51, P161, DOI 10.1016/j.chb.2015.04.037; Farooq Fareeha, 2020, J Coll Physicians Surg Pak, V30, P67, DOI 10.29271/jcpsp.2020.Supp1.S67; Gostin LO, 2020, JAMA-J AM MED ASSOC, V323, P2137, DOI 10.1001/jama.2020.5460; Hung WC, 2013, BRIT J EDUC TECHNOL, V44, P255, DOI 10.1111/j.1467-8535.2012.01294.x; Hussain K., 2020, S E ASIAN J MEDICAL, V14; Kabassi K, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1705-8; Kawaguchi-Suzuki M, 2020, AM J PHARM EDUC, V84, P1045, DOI 10.5688/ajpe8197; Kelling A., 2019, INT J TEACHING LEARN, V31, P128; Lakbala Parvin, 2015, Glob J Health Sci, V8, P83, DOI 10.5539/gjhs.v8n7p83; Lawal BK, 2020, PHARM EDUC, V20, P15, DOI 10.46542/pe.2020.202.1516; Lyons KM, 2020, AM J PHARM EDUC, V84, P667, DOI 10.5688/ajpe8088; Martin F, 2019, ONLINE LEARN, V23, P97, DOI 10.24059/olj.v23i3.1555; Moazami F, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-45; Mukhtar K, 2020, PAK J MED SCI, V36, pS27, DOI 10.12669/pjms.36.COVID19-S4.2785; Mumtaz N, 2021, PAK J MED SCI, V37, P283, DOI 10.12669/pjms.37.1.2894; Nesar S, 2021, J EDUC HEALTH PROMOT, V10, DOI 10.4103/jehp.jehp_951_20; Panda DS, 2020, PHARM EDUC, V20, P297, DOI 10.46542/pe.2020.202.297301; Shahzad SK., 2020, ENGLISH LANGUAGE TEA, V13, P1; Syofyan S, 2020, PHARM EDUC, V20, P302, DOI 10.46542/pe.2020.202.302309; Tariq MA., 2021, J CONT ISSUES BUSINE, V27, P6548; Wang Y, 2019, J COMPUT EDUC, V6, P363, DOI 10.1007/s40692-019-00140-w; Woolliscroft JO, 2020, ACAD MED, V95, P1140, DOI 10.1097/ACM.0000000000003402	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274268	10.1371/journal.pone.0274268	http://dx.doi.org/10.1371/journal.pone.0274268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094923	Green Published, gold			2022-12-26	WOS:000892376500032
J	de Fallois, J; Schenk, S; Kowald, J; Lindner, TH; Engesser, M; Munch, J; Meigen, C; Halbritter, J				de Fallois, Jonathan; Schenk, Soeren; Kowald, Jan; Lindner, Tom H.; Engesser, Marie; Muench, Johannes; Meigen, Christof; Halbritter, Jan			The diagnostic value of native kidney biopsy in low grade, subnephrotic, and nephrotic range proteinuria: A retrospective cohort study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; COLLABORATIVE METAANALYSIS; CARDIOVASCULAR-DISEASE; RISK-FACTORS; ALBUMINURIA; MORTALITY; EXCRETION; POPULATION; PREDICTION	Background In nephrotic range proteinuria of adult-onset, kidney biopsy is the diagnostic gold standard in determining the underlying cause of disease. However, in low grade or subnephrotic proteinuria the diagnostic value of kidney biopsy as first-line diagnostics is less well established. Methods We conducted a retrospective analysis of all native kidney biopsies at our institution (n = 639) between 01/2012 and 05/2021 for comparison of histological diagnoses and clinical outcomes stratified by amount of proteinuria at the time of kidney biopsy: A: <300mg/g creatinine (low grade), B: 300-3500mg/g creatinine (subnephrotic), C >3500mg/g creatinine (nephrotic). Results Nephrotic range proteinuria was associated with the highest frequency (49.3%) of primary glomerulopathies followed by subnephrotic (34.4%) and low grade proteinuria (37.7%). However, within the subnephrotic group, the amount of proteinuria at kidney biopsy was linearly associated with renal and overall survival (HR 1.05 per A100mg protein/g creatinine (95% CI: 1.02-1.09, p = 0.001)) independent of present histological diagnoses and erythrocyturia. Conclusion Frequency of primary glomerulopathies supports to perform kidney biopsy in patients with subnephrotic proteinuria. These patients have a substantial risk of ESKD and death upon follow up. Therefore, diagnostic accuracy including histopathology is essential to guide personalized treatment and avert detrimental courses.	[de Fallois, Jonathan; Schenk, Soeren; Kowald, Jan; Lindner, Tom H.; Engesser, Marie; Muench, Johannes; Halbritter, Jan] Univ Leipzig, Med Ctr, Div Nephrol, Med Dept 3, Leipzig, Germany; [Muench, Johannes; Halbritter, Jan] Charite, Dept Nephrol & Med Intens Care, Berlin, Germany; [Meigen, Christof] Univ Leipzig, Fac Med, LIFE Child Hosp Children & Adolescents, Leipzig, Germany	Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University	de Fallois, J (corresponding author), Univ Leipzig, Med Ctr, Div Nephrol, Med Dept 3, Leipzig, Germany.	Jonathan.defallois@medizin.uni-leipzig.de						AlYousef A, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-020-01836-3; Amano H, 2020, CLIN EXP NEPHROL, V24, P688, DOI 10.1007/s10157-020-01885-w; Anyanwagu U, 2019, AM J NEPHROL, V49, P146, DOI 10.1159/000496276; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; Barbour SJ, 2015, KIDNEY INT, V88, P1392, DOI 10.1038/ki.2015.241; Blecker S, 2011, AM J KIDNEY DIS, V58, P47, DOI 10.1053/j.ajkd.2011.02.391; Corapi KM, 2012, AM J KIDNEY DIS, V60, P62, DOI 10.1053/j.ajkd.2012.02.330; Fangel MV, 2020, AM J MED, V133, pE269, DOI 10.1016/j.amjmed.2019.10.042; Ganesh K, 2018, INDIAN J NEPHROL, V28, P28, DOI 10.4103/ijn.IJN_256_16; Gipson DS, 2016, CLIN J AM SOC NEPHRO, V11, P81, DOI 10.2215/CJN.02560315; Go AS, 2021, J AM SOC NEPHROL, V32, P2303, DOI 10.1681/ASN.2020111583; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hogan MC, 2016, KIDNEY INT, V90, P1080, DOI 10.1016/j.kint.2016.06.020; Huang JA, 2019, J STROKE CEREBROVASC, V28, DOI 10.1016/j.jstrokecerebrovasdis.2019.104322; Kang Minjung, 2022, Kidney360, V3, P74, DOI 10.34067/KID.0003912021; Kerlin BA, 2012, CLIN J AM SOC NEPHRO, V7, P513, DOI 10.2215/CJN.10131011; Kolb A, 2021, KIDNEY INT REP, V6, P449, DOI 10.1016/j.ekir.2020.10.033; Lee T, 2016, KIDNEY INT, V89, P1111, DOI 10.1016/j.kint.2015.12.041; Levey AS, 2015, JAMA-J AM MED ASSOC, V313, P837, DOI 10.1001/jama.2015.0602; Levitt DG, 2016, INT J GEN MED, V9, P229, DOI 10.2147/IJGM.S102819; Li J, 2017, J INT MED RES, V45, P2139, DOI 10.1177/0300060517715339; Loscalzo J, 2013, NEW ENGL J MED, V368, P956, DOI 10.1056/NEJMcibr1209459; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Moledina DG, 2018, CLIN J AM SOC NEPHRO, V13, P1633, DOI 10.2215/CJN.04910418; OGI M, 1994, AM J KIDNEY DIS, V24, P427, DOI 10.1016/S0272-6386(12)80899-7; Price CP, 2005, CLIN CHEM, V51, P1577, DOI 10.1373/clinchem.2005.049742; Rees F, 2017, RHEUMATOLOGY, V56, P1945, DOI 10.1093/rheumatology/kex260; Rovin BH, 2021, KIDNEY INT, V100, pS1, DOI 10.1016/j.kint.2021.05.021; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Seidu S, 2020, PRIM CARE DIABETES, V14, P370, DOI 10.1016/j.pcd.2020.02.006; Shlipak MG, 2021, KIDNEY INT, V99, P34, DOI 10.1016/j.kint.2020.10.012; Stehouwer CDA, 2006, J AM SOC NEPHROL, V17, P2106, DOI 10.1681/ASN.2005121288; Vaziri ND, 2016, KIDNEY INT, V90, P41, DOI 10.1016/j.kint.2016.02.026; Waller AP, 2021, THROMB RES, V201, P50, DOI 10.1016/j.thromres.2021.02.007; Yang Y, 2018, CHINESE MED J-PEKING, V131, P731, DOI 10.4103/0366-6999.226906	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273671	10.1371/journal.pone.0273671	http://dx.doi.org/10.1371/journal.pone.0273671			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054109	gold, Green Published			2022-12-26	WOS:000892641400027
J	do Prado, CB; Emerick, GS; Cevolani Pires, LB; Salaroli, LB				do Prado, Camila Bruneli; Emerick, Giselly Storch; Cevolani Pires, Luciana Bicalho; Salaroli, Luciane Bresciani			Impact of long-term COVID on workers: A systematic review protocol	PLOS ONE			English	Review								Introduction Part of the patients infected by COVID-19 have at least one lasting sequel of the disease and may be framed in the concept of long Covid. These sequelae can compromise the quality of life, increase dependence on other people for personal care, impair the performance of activities of daily living, thus compromising work activities and harming the health of the worker. This protocol aims to critically synthesize the scientific evidence on the effects of Covid-19 among workers and its impact on their health status and professional life. Method Searches will be performed in MEDLINE via PubMed, EMBASE, Cochrane Library Central, Web of Science, Scopus, LILACS and Epistemonikos. Included studies will be those that report the prevalence of long-term signs and symptoms in workers and/or the impact on their health status and work performance, which may be associated with Covid-19 infection. Data extraction will be conducted by 3 reviewers independently. For data synthesis, a results report will be carried out, based on the main outcome of this study. Discussion This review will provide evidence to support health surveillance to help decision makers (i.e. healthcare providers, stakeholders and governments) regarding long-term Covid.	[do Prado, Camila Bruneli; Emerick, Giselly Storch; Salaroli, Luciane Bresciani] Univ Fed Espirito Santo, Grad Program Collect Hlth, Hlth Sci Ctr, Vitoria, ES, Brazil; [Cevolani Pires, Luciana Bicalho; Salaroli, Luciane Bresciani] Univ Fed Espirito Santo, Grad Program Nutr & Hlth, Hlth Sci Ctr, Vitoria, ES, Brazil	Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo	Salaroli, LB (corresponding author), Univ Fed Espirito Santo, Grad Program Collect Hlth, Hlth Sci Ctr, Vitoria, ES, Brazil.; Salaroli, LB (corresponding author), Univ Fed Espirito Santo, Grad Program Nutr & Hlth, Hlth Sci Ctr, Vitoria, ES, Brazil.	lucianebresciani@gmail.com		STORCH EMERICK, GISELLY/0000-0001-7056-0159; Bruneli do Prado, Camila/0000-0002-1762-6064				Aguiar BF., 2021, RSD, V10, DOI [10.33448/rsd-v10i14.21886, DOI 10.33448/RSD-V10I14.21886]; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Campbell M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.l6890; CDC, 2021, CTR DIS CONTROL PREV; Mesquita RD, 2021, WIEN KLIN WOCHENSCHR, V133, P377, DOI 10.1007/s00508-020-01760-4; de Castro Hermano Albuquerque, 2022, Lancet Reg Health Am, V11, P100245, DOI 10.1016/j.lana.2022.100245; Delbressine JM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18116017; Ghulam A, 2021, BIOSCI RES, V18, P47; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Iqbal A, 2021, CUREUS, V13, DOI 10.7759/cureus.13080; JBI. Joanna Briggs Institute, 2020, CRIT APPR TOOLS; Lefebvre C., 2021, COCHRANE HDB SYSTEMA; Li RY, 2020, SCIENCE, V368, P489, DOI [10.1126/science.abb3221, 10.1101/2020.02.14.20023127]; Madan I., 2021, GUIDANCE HEALTHCARE; Martinez MC, 2010, CIENC SAUDE COLETIVA, V15, P1553, DOI 10.1590/S1413-81232010000700067; Morgan RL, 2018, ENVIRON INT, V121, P1027, DOI 10.1016/j.envint.2018.07.015; OPAS, 2021, EXPANDIR NOSSO ENTEN, DOI [10.37774/9789275723999, DOI 10.37774/9789275723999]; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Page MJ, 2021, BMJ-BRIT MED J, V372, DOI [10.1136/bmj.n71, 10.1016/j.ijsu.2021.105906]; Rathore FA, 2020, HEART LUNG CIRC, V29, P1893, DOI 10.1016/j.hlc.2020.08.011; Rezende ACC., 2021, BELO HORIZONTE PUBLI; Tang DL, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008536; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; WHO, 2020, DIR GEN OP REM MED B; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0265705	10.1371/journal.pone.0265705	http://dx.doi.org/10.1371/journal.pone.0265705			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054105	gold, Green Submitted, Green Published			2022-12-26	WOS:000892641400001
J	Guo, X; Zhang, Y; Liu, C; Ren, LL; Gao, S; Bi, J; Liang, J; Wang, P				Guo, Xun; Zhang, Yang; Liu, Chang; Ren, Lili; Gao, Shuang; Bi, Jing; Liang, Jia; Wang, Peng			Intranasal administration of beta-1, 3-galactosyltransferase 2 confers neuroprotection against ischemic stroke by likely inhibiting oxidative stress and NLRP3 inflammasome activation	FASEB JOURNAL			English	Article						B3galt2; ischemic stroke; NLRP3 inflammasome; oxidative stress; TGF-beta 1	CEREBRAL-ARTERY OCCLUSION; NF-KAPPA-B; DRUG-DELIVERY; BRAIN; MECHANISMS; PATHWAYS; INJURY; MICE	Ischemic stroke is one of the major causes of morbidity and mortality. The beta-1, 3-galactosyltransferase 2 (B3galt2), a member of beta-1, 3-galactosyltransferase family, is playing a vital role in the pathological process of cerebral ischemic injury, but its underlying mechanisms remain unclear. In the present study, we examined the involvement of oxidative stress and NLRP3 inflammasome activation in the neuroprotective effect of B3galt2. Cerebral ischemia/reperfusion (I/R) injury was simulated in a mouse middle cerebral artery occlusion (MCAO) model. Recombinant human B3galt2 (rh-B3galt2) was administered intranasally 1 h post MCAO, and TGF-beta 1-siRNA was administered intracerebroventricularly 24 h before MCAO. Outcome measures included brain infarct volume, neurological function, blood-brain barrier (BBB) permeability, neuronal apoptosis, oxidative stress, and the inflammatory response. First, we found that rh-B3galt2 significantly alleviated brain infarct volume and BBB permeability, improved neurological function, and attenuated I/R-induced neuron apoptosis and oxidative stress. Furthermore, rh-B3galt2 attenuated pro-inflammatory cytokines, NF-kappa B, IL-6, TNF-alpha, and IL-1 beta, and inhibited NLRP3 inflammasome activation. Finally, inhibition of TGF-beta 1 by TGF-beta 1-siRNA abolished the anti-oxidative and anti-inflammatory effects of rh-B3galt2 in mice after I/R. Collectively, our study demonstrated that rh-B3galt2 exerts neuroprotective effects by regulating cerebral ischemia-induced oxidative stress and NLRP3 inflammasome, which is mainly dependent on the heightening of the TGF-beta 1 pathway. Thus, B3galt2 might be considered a new therapeutic target for ischemic stroke treatment.	[Guo, Xun; Zhang, Yang; Liu, Chang; Ren, Lili; Gao, Shuang; Bi, Jing; Wang, Peng] Jinzhou Med Univ, Dept Neurobiol, Jinzhou 121001, Liaoning, Peoples R China; [Guo, Xun; Zhang, Yang; Liu, Chang; Ren, Lili; Gao, Shuang; Bi, Jing; Wang, Peng] Jinzhou Med Univ, Key Lab Neurodegenerat Dis Liaoning Prov, Jinzhou, Peoples R China; [Liang, Jia] Jinzhou Med Univ, Inst Life Sci, Jinzhou 121001, Liaoning, Peoples R China	Jinzhou Medical University; Jinzhou Medical University; Jinzhou Medical University	Wang, P (corresponding author), Jinzhou Med Univ, Dept Neurobiol, Jinzhou 121001, Liaoning, Peoples R China.; Liang, J (corresponding author), Jinzhou Med Univ, Inst Life Sci, Jinzhou 121001, Liaoning, Peoples R China.	liangjia@jzmu.edu.cn; wangpeng@jzmu.edu.cn			National Natural Science Foundation of China (NSFC) [81971231]; Natural Science Foundation of Liaoning Province (Liaoning Province Natural Science Foundation) [2022--MS--391]; educational department of Liaoning province [JYTQN2020011]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province (Liaoning Province Natural Science Foundation); educational department of Liaoning province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81971231; Natural Science Foundation of Liaoning Province (Liaoning Province Natural Science Foundation), Grant/Award Number: 2022--MS--391; Scientific research project from the educational department of Liaoning province, Grant/Award Number: JYTQN2020011	Alishahi M, 2019, INT J STROKE, V14, P574, DOI 10.1177/1747493019841242; Allen CL, 2009, INT J STROKE, V4, P461, DOI 10.1111/j.1747-4949.2009.00387.x; Angata K, 2006, METHOD ENZYMOL, V417, P25, DOI 10.1016/S0076-6879(06)17003-2; Chan PH, 2001, J CEREBR BLOOD F MET, V21, P2, DOI 10.1097/00004647-200101000-00002; Chen H, 2011, ANTIOXID REDOX SIGN, V14, P1505, DOI 10.1089/ars.2010.3576; Chen HY, 2020, CHEM-BIOL INTERACT, V331, DOI 10.1016/j.cbi.2020.109249; Cherait A, 2021, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.585082; Feng YS, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00155; Feng ZH, 2019, J CEREBR BLOOD F MET, V39, P97, DOI 10.1177/0271678X17725211; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; Franke M, 2021, BRAIN BEHAV IMMUN, V92, P221, DOI 10.1016/j.bbi.2020.12.009; Gamdzyk M, 2020, MOL NEUROBIOL, V57, P2600, DOI 10.1007/s12035-020-01904-7; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Jia MJ, 2021, BRAIN RES BULL, V169, P104, DOI 10.1016/j.brainresbull.2021.01.010; Kaur H, 2019, NEUROPHARMACOLOGY, V158, DOI 10.1016/j.neuropharm.2019.107727; Khatri V, 2021, FASEB J, V35, DOI 10.1096/fj.202002622R; Kozlovskaya L, 2014, J CONTROL RELEASE, V189, P133, DOI 10.1016/j.jconrel.2014.06.053; Kroes RA, 2010, P NATL ACAD SCI USA, V107, P12646, DOI 10.1073/pnas.0909862107; Li LZ, 2020, CNS NEUROSCI THER, V26, P288, DOI 10.1111/cns.13291; Lyu JX, 2021, CNS NEUROSCI THER, V27, P515, DOI 10.1111/cns.13620; Mao LL, 2021, TRANSL STROKE RES, V12, P711, DOI 10.1007/s12975-021-00912-6; Marsh JD, 2010, J AM COLL CARDIOL, V56, P683, DOI 10.1016/j.jacc.2009.12.072; McGonigal R, 2019, J NEUROSCI, V39, P63, DOI 10.1523/JNEUROSCI.2095-18.2018; Minutoli L, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2183026; Moll T, 2020, BRAIN, V143, P1332, DOI 10.1093/brain/awz358; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Okada T, 2019, MOL NEUROBIOL, V56, P8203, DOI 10.1007/s12035-019-01668-9; Orellana-Urzua S, 2020, CURR PHARM DESIGN, V26, P4246, DOI 10.2174/1381612826666200708133912; Pardeshi CV, 2013, EXPERT OPIN DRUG DEL, V10, P957, DOI 10.1517/17425247.2013.790887; Pu HJ, 2021, J CEREBR BLOOD F MET, V41, P2870, DOI 10.1177/0271678X211028680; Rodriguez R, 2005, J NEUROSCI METH, V147, P22, DOI 10.1016/j.jneumeth.2005.02.013; Ruegsegger GN, 2019, FASEB J, V33, P4458, DOI 10.1096/fj.201802043R; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi XD, 2017, J CEREBR BLOOD F MET, V37, P1447, DOI 10.1177/0271678X16656201; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Tymianski M, 2011, NAT NEUROSCI, V14, P1369, DOI 10.1038/nn.2951; Wang P, 2021, J CEREBR BLOOD F MET, V41, P641, DOI 10.1177/0271678X20926787; Xu QX, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02137-8; Yang JL, 2018, REDOX BIOL, V16, P263, DOI 10.1016/j.redox.2018.03.002; Yang X, 2021, NEUROCHEM INT, V144, DOI 10.1016/j.neuint.2021.104976; Yao DG, 2014, J NEUROSCI, V34, P880, DOI 10.1523/JNEUROSCI.3996-13.2014; Yu YH, 2018, INT J BIOL MACROMOL, V116, P537, DOI 10.1016/j.ijbiomac.2018.04.113; Zhang L, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04363-7; Zhang S, 2014, FASEB J, V28, P4394, DOI 10.1096/fj.14-253625; Zhang Y, 2015, STROKE, V46, P2637, DOI 10.1161/STROKEAHA.115.009792	46	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22542	10.1096/fj.202200456RR	http://dx.doi.org/10.1096/fj.202200456RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4L5YD	36094000				2022-12-26	WOS:000852705800001
J	Khokhlatchev, AV; Sharma, A; Deering, TG; Shaw, JJP; Costa-Pinheiro, P; Golla, U; Annageldiyev, C; Cabot, MC; Conaway, MR; Tan, SF; Ung, J; Feith, DJ; Loughran, TP; Claxton, DF; Fox, TE; Kester, M				Khokhlatchev, Andrei, V; Sharma, Arati; Deering, Tye G.; Shaw, Jeremy J. P.; Costa-Pinheiro, Pedro; Golla, Upendarrao; Annageldiyev, Charyguly; Cabot, Myles C.; Conaway, Mark R.; Tan, Su-Fern; Ung, Johnson; Feith, David J.; Loughran, Thomas P., Jr.; Claxton, David F.; Fox, Todd E.; Kester, Mark			Ceramide nanoliposomes augment the efficacy of venetoclax and cytarabine in models of acute myeloid leukemia	FASEB JOURNAL			English	Article						cell death; ceramides; cytarabine; drug resistance; leukemia; myeloid; acute; models; animal; recurrence; signal transduction; standard of care; venetoclax	LONG-CHAIN CERAMIDES; HUMAN BREAST; RESISTANCE; AUTOPHAGY	Despite several new therapeutic options for acute myeloid leukemia (AML), disease relapse remains a significant challenge. We have previously demonstrated that augmenting ceramides can counter various drug-resistance mechanisms, leading to enhanced cell death in cancer cells and extended survival in animal models. Using a nanoscale delivery system for ceramide (ceramide nanoliposomes, CNL), we investigated the effect of CNL within a standard of care venetoclax/cytarabine (Ara-C) regimen. We demonstrate that CNL augmented the efficacy of venetoclax/cytarabine in in vitro, ex vivo, and in vivo models of AML. CNL treatment induced non-apoptotic cytotoxicity, and augmented cell death induced by Ara-C and venetoclax. Mechanistically, CNL reduced both venetoclax (Mcl-1) and cytarabine (Chk1) drug-resistant signaling pathways. Moreover, venetoclax and Ara-C augmented the generation of endogenous pro-death ceramide species, which was intensified with CNL. Taken together, CNL has the potential to be utilized as an adjuvant therapy to improve outcomes, potentially extending survival, in patients with AML.	[Khokhlatchev, Andrei, V; Deering, Tye G.; Fox, Todd E.; Kester, Mark] Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA; [Sharma, Arati; Golla, Upendarrao; Annageldiyev, Charyguly; Claxton, David F.] Penn State Univ, Div Hematol & Oncol, Coll Med, Dept Med, Hershey, PA USA; [Sharma, Arati] Penn State Univ, Dept Pharmacol, Coll Med, Hershey, PA USA; [Sharma, Arati; Golla, Upendarrao; Annageldiyev, Charyguly; Claxton, David F.] Penn State Univ, Penn State Canc Inst, Coll Med, Hershey, PA USA; [Shaw, Jeremy J. P.; Costa-Pinheiro, Pedro] Univ Virginia, Dept Expt Pathol, Charlottesville, VA USA; [Cabot, Myles C.] East Carolina Univ, Brody Sch Med, Dept Biochem & Mol Biol, Greenville, NC 27858 USA; [Cabot, Myles C.] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA; [Conaway, Mark R.] Univ Virginia, Sch Med, Publ Hlth Sci, Charlottesville, VA 22908 USA; [Tan, Su-Fern; Ung, Johnson; Feith, David J.; Loughran, Thomas P., Jr.] Univ Virginia, Sch Med, Dept Med, Div Hematol & Oncol, Charlottesville, VA 22908 USA; [Tan, Su-Fern; Feith, David J.; Loughran, Thomas P., Jr.; Kester, Mark] Univ Virginia, Ctr Canc, Charlottesville, VA 22908 USA; [Ung, Johnson] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Kester, Mark] NanoSTAR Inst, Charlottesville, VA USA	University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Virginia; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Fox, TE (corresponding author), Univ Virginia, Dept Pharmacol, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	tfox@virginia.edu	Golla, Upendar Rao/D-5933-2017	Golla, Upendar Rao/0000-0003-0519-7087; Ung, Johnson/0000-0002-3275-0530	HHS | NIH | National Cancer Institute (NCI) [P01-CA171983, F99CA245802, P30-CA044579, F31-CA271809]	HHS | NIH | National Cancer Institute (NCI)	HHS | NIH | National Cancer Institute (NCI), Grant/Award Number: P01-CA171983, F99CA245802, P30-CA044579 and F31-CA271809	Alhoshani A, 2020, ONCOTARGETS THER, V13, P13357, DOI 10.2147/OTT.S281519; Annageldiyev C, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00393; Annageldiyev C, 2020, HAEMATOLOGICA, V105, P687, DOI 10.3324/haematol.2018.212886; Anroedh S, 2018, J LIPID RES, V59, P1729, DOI 10.1194/jlr.P081281; Barth BM, 2019, BLOOD ADV, V3, P2598, DOI 10.1182/bloodadvances.2018021295; Bose P, 2017, LEUKEMIA LYMPHOMA, V58, P2026, DOI 10.1080/10428194.2017.1283032; Cingolani F, 2016, CHEM PHYS LIPIDS, V197, P25, DOI 10.1016/j.chemphyslip.2015.07.026; Dany M, 2016, BLOOD, V128, P1944, DOI 10.1182/blood-2016-04-708750; David L, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac9704; De Kouchkovsky I, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.50; DiNardo CD, 2020, BLOOD, V135, P791, DOI 10.1182/blood.2019003988; DiNardo CD, 2019, BLOOD, V133, P7, DOI 10.1182/blood-2018-08-868752; Hartmann D, 2012, INT J BIOCHEM CELL B, V44, P620, DOI 10.1016/j.biocel.2011.12.019; Jayappa KD, 2017, BLOOD ADV, V1, P933, DOI 10.1182/bloodadvances.2016004176; Kantarjian H, 2021, BLOOD CANCER J, V11, DOI 10.1038/s41408-021-00425-3; Kao LP, 2019, J LIPID RES, V60, P1590, DOI 10.1194/jlr.RA119000251; Kester M, 2015, BIOL CHEM, V396, P737, DOI 10.1515/hsz-2015-0129; Lewis AC, 2022, BLOOD, V139, P3737, DOI 10.1182/blood.2021013277; Liu FB, 2022, EXP HEMATOL, V105, P39, DOI 10.1016/j.exphem.2021.10.006; Liu K, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01304-w; Liu X, 2010, BLOOD, V116, P4192, DOI 10.1182/blood-2010-02-271080; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Montgomery D.C., 2005, DESIGN ANAL EXPT; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Pearson JM, 2020, MOL CANCER RES, V18, P352, DOI 10.1158/1541-7786.MCR-19-0619; Ricci C, 2006, BBA-BIOMEMBRANES, V1758, P2121, DOI 10.1016/j.bbamem.2006.06.016; Sampath D, 2006, BLOOD, V107, P2517, DOI 10.1182/blood-2005-08-3351; Shaw JJP, 2020, MOL CANCER THER, V19, P2621, DOI 10.1158/1535-7163.MCT-20-0182; Sheridan M, 2021, CANCERS, V13, DOI 10.3390/cancers13102475; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Steensma DP, 2006, LEUKEMIA, V20, P971, DOI 10.1038/sj.leu.2404206; Stefanko A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168781; Stiban J, 2015, BBA-BIOMEMBRANES, V1848, P561, DOI 10.1016/j.bbamem.2014.11.018; Stover TC, 2005, CLIN CANCER RES, V11, P3465, DOI 10.1158/1078-0432.CCR-04-1770; Tippetts TS, 2018, J LIPID RES, V59, P1549, DOI 10.1194/jlr.C088377; Vincelette ND, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40218-0; Wang Z, 2017, ONCOTARGET, V8, P104022, DOI 10.18632/oncotarget.21955; Wei AH, 2020, BLOOD, V135, P2137, DOI 10.1182/blood.2020004856; Yamada Osamu, 2013, JAKSTAT, V2, pe25256, DOI 10.4161/jkst.25256; Yamamoto JF, 2008, CANCER CAUSE CONTROL, V19, P379, DOI 10.1007/s10552-007-9097-2; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Zheng Shuyu, 2022, Genomics Proteomics Bioinformatics, V20, P587, DOI 10.1016/j.gpb.2022.01.004; Zhou FJ, 2021, J CANCER, V12, P6727, DOI 10.7150/jca.60208	45	1	1	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22514	10.1096/fj.202200765R	http://dx.doi.org/10.1096/fj.202200765R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4N0XZ	36106439	hybrid, Green Published			2022-12-26	WOS:000853744300001
J	Chen, YY; Pan, F				Chen, Yuyang; Pan, Feng			Multimodal detection of hateful memes by applying a vision-language pre-training model	PLOS ONE			English	Article							ETHNOPHAULISMS	Detrimental to individuals and society, online hateful messages have recently become a major social issue. Among them, one new type of hateful message, "hateful meme", has emerged and brought difficulties in traditional deep learning-based detection. Because hateful memes were formatted with both text captions and images to express users' intents, they cannot be accurately identified by singularly analyzing embedded text captions or images. In order to effectively detect a hateful meme, the algorithm must possess strong vision and language fusion capability. In this study, we move closer to this goal by feeding a triplet by stacking the visual features, object tags, and text features of memes generated by the object detection model named Visual features in Vision-Language (VinVI) and the optical character recognition (OCR) technology into a Transformer-based Vision-Language Pre-Training Model (VL-PTM) OSCAR+ to perform the cross-modal learning of memes. After fine-tuning and connecting to a random forest (RF) classifier, our model (OSCAR+RF) achieved an average accuracy and AUROC of 0.684 and 0.768, respectively, on the hateful meme detection task in a public test set, which was higher than the other eleven (11) published baselines. In conclusion, this study has demonstrated that VL-PTMs with the addition of anchor points can improve the performance of deep learning-based detection of hateful memes by involving a more substantial alignment between the text caption and visual information.	[Chen, Yuyang] Putnam Sci Acad, Putnam, CT USA; [Pan, Feng] Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China	Huazhong University of Science & Technology	Pan, F (corresponding author), Huazhong Univ Sci & Technol, Dept Radiol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China.	uh_fengpan@hust.edu.cn		Pan, Feng/0000-0003-2820-768X				Anderson P, 2018, PROC CVPR IEEE, P6077, DOI 10.1109/CVPR.2018.00636; Antol S, 2015, IEEE I CONF COMP VIS, P2425, DOI 10.1109/ICCV.2015.279; Auer S, 2007, LECT NOTES COMPUT SC, V4825, P722, DOI 10.1007/978-3-540-76298-0_52; Badjatiya P, 2017, WWW'17 COMPANION: PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB, P759, DOI 10.1145/3041021.3054223; Cho-Jui Hsieh, 2019, Arxiv, DOI arXiv:1908.03557; Danqi Chen, 2019, Arxiv, DOI arXiv:1907.11692; Davide Testuggine, 2020, Arxiv, DOI arXiv:1909.02950; Fasoli F, 2015, BRIT J SOC PSYCHOL, V54, P383, DOI 10.1111/bjso.12090; Gitari N. D., 2015, INT J MULTIMEDIA UBI, V10, P215, DOI DOI 10.14257/IJMUE.2015.10.4.21; GREENBERG J, 1985, J EXP SOC PSYCHOL, V21, P61, DOI 10.1016/0022-1031(85)90006-X; He P., 2020, INT C LEARN REPR; Hong L., 2009, P CONTENT ANAL WEB, V2, P1; Jacob Devlin, 2019, Arxiv, DOI arXiv:1810.04805; Kiela D., 2020, ARXIV200504790, V33, P2611; Konikoff D, 2021, POLICY INTERNET, V13, P502, DOI 10.1002/poi3.265; Li X, 2020, EUROPEAN C COMPUTER; Li YA, 2021, AAAI CONF ARTIF INTE, V35, P8518; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Lu JS, 2019, ADV NEUR IN, V32; Mehdad Y., 2016, P 17 ANN M SPECIAL I; Mithe R., 2013, INT J RECENT TECHNOL, V2, P72; Mogadala Aditya, 2021, Journal of Artificial Intelligence Research, V71, P1183; Mullen B, 2004, PSYCHOSOM MED, V66, P343, DOI 10.1097/01.psy.0000126197.59447.b3; Mullen B, 2003, PERS SOC PSYCHOL B, V29, P1056, DOI 10.1177/0146167203254505; Mutanga RT, 2020, INT J ADV COMPUT SC, V11, P614; Newton C., 2019, VERGE, V25; Ni B, 2022, NEURAL COMPUT APPL, DOI 10.1007/s00521-022-07054-2; Nobata C, 2016, PROCEEDINGS OF THE 25TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'16), P145, DOI 10.1145/2872427.2883062; Raffel C, 2020, J MACH LEARN RES, V21; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Rodriguez A, 2019, 2019 1ST INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE IN INFORMATION AND COMMUNICATION (ICAIIC 2019), P169, DOI 10.1109/ICAIIC.2019.8669073; Schieb C., 2016, 66 ICA ANN C FUKUOKA; Sharma P, 2018, PROCEEDINGS OF THE 56TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL), VOL 1, P2556; Soral W, 2018, AGGRESSIVE BEHAV, V44, P136, DOI 10.1002/ab.21737; Specia L., 2016, P 1 C MACHINE TRANSL, P543, DOI [10.18653/v1/w16-2346, DOI 10.18653/V1/W16-2346]; Su W., 2019, INT C LEARNING REPRE; Vaswani A., 2017, PROC ANN C NEURAL IN, V30, P5998; Vrandecic D, 2014, COMMUN ACM, V57, P78, DOI 10.1145/2629489; Wang A., 2019, ICLR; Wang HY, 2021, NAT NANOTECHNOL, V16, P811, DOI [10.1038/s41565-021-00903-6, 10.1007/s00521-021-06546-x]; Williams ML, 2020, BRIT J CRIMINOL, V60, P93, DOI 10.1093/bjc/azz049; Xie SN, 2017, PROC CVPR IEEE, P5987, DOI 10.1109/CVPR.2017.634; Zellers R, 2019, PROC CVPR IEEE, P6713, DOI 10.1109/CVPR.2019.00688; Zhang PC, 2021, PROC CVPR IEEE, P5575, DOI 10.1109/CVPR46437.2021.00553; Zhang ZQ, 2018, LECT NOTES COMPUT SC, V10843, P745, DOI 10.1007/978-3-319-93417-4_48; Zhou LW, 2020, AAAI CONF ARTIF INTE, V34, P13041	46	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274300	10.1371/journal.pone.0274300	http://dx.doi.org/10.1371/journal.pone.0274300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095029	Green Published, gold, Green Submitted			2022-12-26	WOS:000892376500036
J	Fang, JA; Wang, CD; Zheng, J; Liu, YX				Fang, Jingai; Wang, Chendan; Zheng, Jie; Liu, Yuxiang			Network pharmacology study of Yishen capsules in the treatment of diabetic nephropathy	PLOS ONE			English	Article							B SIGNALING PATHWAY; KAPPA-B; OXIDATIVE STRESS; ANTIOXIDANT; QUERCETIN; ASSOCIATION; MECHANISMS; EXPRESSION; VARIANTS; SYSTEM	Objective In this study, we used network pharmacology to explore the possible therapeutic mechanism underlying the treatment of diabetic nephropathy with Yishen capsules. Methods The active chemical constituents of Yishen capsules were acquired using the Traditional Chinese Medicine Systems Pharmacology platform and the Encyclopedia of Traditional Chinese Medicine. Component target proteins were then searched and screened in the BATMAN database. Target proteins were cross-validated using the Comparative Toxicogenomics Database, and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses of the target proteins were performed. Then, protein-protein interaction (PPI) analysis was performed using the STRING database. Finally, a pharmacological network was constructed to show the component-target-pathway relationships. Molecular docking was used to analyse the interaction between drug components and target proteins. Results In total, 285 active chemical components were found, including 85 intersection targets against DN. In the pharmacological network, 5 key herbs (A. membranaceus, A. sinensis, E. ferox, A. orientate, and R. rosea) and their corresponding 12 key components (beta-sitosterol, beta-carotene, stigmasterol, alisol B, mairin, quercetin, caffeic acid, 1-monolinolein, kaempferol, jaranol, formononetin, and calycosin) were screened. Furthermore, the 12 key components were related to 24 target protein nodes (e.g., AGT, AKT1, AKT2, BCL2, NFKB1, and SIRT1) and enriched in 24 pathway nodes (such as the NF-kappa B, AGE-RAGE, toll-like receptor, and relaxin signaling pathways). Molecular docking revealed that hydrogen bond was formed between drug components and target proteins. Conclusion In conclusion, the active constituents of Yishen capsules modulate targets or signaling pathways in DN pathogenesis.	[Fang, Jingai; Liu, Yuxiang] Shanxi Med Univ 1 Hosp, Dept Nephrol, Taiyuan, Peoples R China; [Wang, Chendan; Liu, Yuxiang] Shanxi Prov Peoples Hosp, Dept Nephrol, Taiyuan, Peoples R China; [Zheng, Jie] Shanxi Med Univ, Grad Coll, Taiyuan, Peoples R China	Shanxi People's Hospital; Shanxi Medical University	Liu, YX (corresponding author), Shanxi Med Univ 1 Hosp, Dept Nephrol, Taiyuan, Peoples R China.; Liu, YX (corresponding author), Shanxi Prov Peoples Hosp, Dept Nephrol, Taiyuan, Peoples R China.	liuyuxiang@tmu.edu.cn		Fang, Jingai/0000-0002-2659-6477	Applied Basic Research Project (Natural Science Foundation Project) in Shanxi Province [201901D211485]	Applied Basic Research Project (Natural Science Foundation Project) in Shanxi Province	This work was supported by the [Applied Basic Research Project (Natural Science Foundation Project) in Shanxi Province] under Grant [number 201901D211485]. Include this sentence at the end of your statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2016, JAMA-J AM MED ASSOC, V316, P602, DOI 10.1001/jama.2016.10924; Anjaneyulu M, 2004, CLIN EXP PHARMACOL P, V31, P244, DOI 10.1111/j.1440-1681.2004.03982.x; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chatr-aryamontri A, 2017, NUCLEIC ACIDS RES, V45, pD369, DOI 10.1093/nar/gkw1102; Cheng YL, 2020, INT J BIOL SCI, V16, P553, DOI 10.7150/ijbs.40643; Cipollone F, 2005, INT J IMMUNOPATH PH, V18, P625, DOI 10.1177/039463200501800403; Coldiron AD, 2002, J BIOCHEM MOL TOXIC, V16, P197, DOI 10.1002/jbt.10035; Coto E, 2018, HUM IMMUNOL, V79, P494, DOI 10.1016/j.humimm.2018.03.008; Fang JG, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-76; Fang Y, 2012, INT J MOL MED, V30, P85, DOI 10.3892/ijmm.2012.977; Gautam A, 2017, WORLD J DIABETES, V8, P66, DOI 10.4239/wjd.v8.i2.66; Han HY, 2017, CELL PHYSIOL BIOCHEM, V42, P1934, DOI 10.1159/000479834; He D, 2019, DRUG DES DEV THER, V13, P3989, DOI 10.2147/DDDT.S216644; Ho C, 2008, RENAL FAILURE, V30, P557, DOI 10.1080/08860220802064457; Huang A, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/5191362; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jingai F., 2005, CHINESE J INTEGRATED; Kamiyama M, 2013, INT J MOL SCI, V14, P23045, DOI 10.3390/ijms141123045; Kanwar YS, 2011, ANNU REV PATHOL-MECH, V6, P395, DOI 10.1146/annurev.pathol.4.110807.092150; Karan S. K., 2012, Journal of Medicinal Plants Research, V6, P1219; Katopodis KP, 2013, ARCH HELL MED, V30, P555; Kumar GS, 2014, CHEM-BIOL INTERACT, V223, P125, DOI 10.1016/j.cbi.2014.09.017; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]; Li TB, 2017, NAT METHODS, V14, P61, DOI 10.1038/nmeth.4083; Liu YX, 2021, RENAL FAILURE, V43, P128, DOI 10.1080/0886022X.2020.1869043; Liu ZH, 2013, NAT REV NEPHROL, V9, P523, DOI 10.1038/nrneph.2013.146; Luis-Rodriguez D, 2012, WORLD J DIABETES, V3, P7, DOI 10.4239/wjd.v3.i1.7; Magee C, 2017, CARDIOVASC DRUG THER, V31, P579, DOI 10.1007/s10557-017-6755-9; Mamal E., 2012, J CYTOLOGY HISTOLOGY, V3; Marquez DF, 2015, EXPERT OPIN PHARMACO, V16, P2283, DOI 10.1517/14656566.2015.1079623; Matboli M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02320-z; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Packer M, 2020, J DIABETES COMPLICAT, V34, DOI 10.1016/j.jdiacomp.2020.107647; Piccoli Giorgina B, 2015, Rev Diabet Stud, V12, P87, DOI 10.1900/RDS.2015.12.87; Ponnulakshmi R, 2019, TOXICOL MECH METHOD, V29, P276, DOI 10.1080/15376516.2018.1545815; Qi CY, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8637138; Qian Lu., 2015, PHARMACOL RES; Rogus JJ, 1998, HYPERTENSION, V31, P627, DOI 10.1161/01.HYP.31.2.627; Sanders RA, 2001, J BIOCHEM MOL TOXIC, V15, P143, DOI 10.1002/jbt.11; Saravanan R., 2020, DRUG INVENTION TODAY, V13; Shaikh R, 2014, J RENIN-ANGIO-ALDO S, V15, P124, DOI 10.1177/1470320313512390; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Szrejder M, 2019, BIOL CELL, V111, P109, DOI 10.1111/boc.201800077; Thomas S., 2019, MEDICINE, V47, P86, DOI [10.1016/j.mpmed.2018.11.010, DOI 10.1016/J.MPMED.2018.11.010]; Toyoda M, 2004, KIDNEY INT, V66, P1107, DOI 10.1111/j.1523-1755.2004.00798.x; Turei D, 2016, NAT METHODS, V13, P965, DOI 10.1038/nmeth.4077; Veiga GLd, 2020, NF KB GENE EXPRESSIO; Wang J, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/9123103; Wang Y, 2015, INT J MOL MED, V35, P1067, DOI 10.3892/ijmm.2015.2095; Wang Yuan-Yuan, 2011, Shengli Xuebao, V63, P325; Wu CC, 2016, J FOOD DRUG ANAL, V24, P136, DOI 10.1016/j.jfda.2015.10.001; Xie X, 2013, MOL CELL ENDOCRINOL, V369, P86, DOI 10.1016/j.mce.2013.01.007; Xin C, 2016, INT J OBESITY, V40, P443, DOI 10.1038/ijo.2015.199; Yasuda F, 2018, HUM PATHOL, V75, P95, DOI 10.1016/j.humpath.2018.01.019; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang Y, 2020, J GENE MED, V22, DOI 10.1002/jgm.3212; Zhao HS, 2013, CHINESE MED J-PEKING, V126, P1693, DOI 10.3760/cma.j.issn.0366-6999.20123457; [赵学兰 ZHAO Xuelan], 2007, [中成药, Chinese Traditional Patent Medicine], V29, P641	60	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0273498	10.1371/journal.pone.0273498	http://dx.doi.org/10.1371/journal.pone.0273498			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094934	Green Published, gold			2022-12-26	WOS:000892376500019
J	Mongin, D; Chabert, C; Extremera, MG; Hue, O; Courvoisier, DS; Carpena, P; Galvan, PAB				Mongin, Denis; Chabert, Clovis; Extremera, Manuel Gomez; Hue, Olivier; Courvoisier, Delphine Sophie; Carpena, Pedro; Galvan, Pedro Angel Bernaola			Decrease of heart rate variability during exercise: An index of cardiorespiratory fitness	PLOS ONE			English	Article							RATE RECOVERY; OXYGEN-CONSUMPTION; AUTONOMIC ACTIVITY; MORTALITY; ASSOCIATION; PREDICTOR; SERIES; REST	The present study proposes to measure and quantify the heart rate variability (HRV) changes during effort as a function of the heart rate and to test the capacity of the produced indices to predict cardiorespiratory fitness measures. Therefore, the beat-to-beat cardiac time interval series of 18 adolescent athletes (15.2 +/- 2.0 years) measured during maximal graded effort test were detrended using a dynamical first-order differential equation model. HRV was then calculated as the standard deviation of the detrended RR intervals (SDRR) within successive windows of one minute. The variation of this measure of HRV during exercise is properly fitted by an exponential decrease of the heart rate: the SDRR is divided by 2 every increase of heart rate of 20 beats/min. The HR increase necessary to divide by 2 the HRV is linearly inversely correlated with the maximum oxygen consumption (r = -0.60, p = 0.006), the maximal aerobic power (r = -0.62, p = 0.006), and, to a lesser extent, to the power at the ventilatory thresholds (r = -0.53, p = 0.02 and r = -0.47, p = 0.05 for the first and second threshold). It indicates that the decrease of the HRV when the heart rate increases is faster among athletes with better fitness. This analysis, based only on cardiac measurements, provides a promising tool for the study of cardiac measurements generated by portable devices.	[Mongin, Denis; Courvoisier, Delphine Sophie] Univ Geneva, Fac Med, Geneva, Switzerland; [Chabert, Clovis] Univ Grenoble Alpes, Inst Adv Biosci IAB, Grenoble, France; [Extremera, Manuel Gomez; Carpena, Pedro; Galvan, Pedro Angel Bernaola] Univ Malaga, Dept Appl Phys 2, ETSI Telecomunicac, Malaga, Spain; [Hue, Olivier] Univ French West Indies, ACTES Iab, UPRES EA 3596 UFR STAPS, Pointe A Pitre, Guadeloupe, France; [Courvoisier, Delphine Sophie] Univ Hosp Geneva, Qual Care Unit, Geneva, Switzerland	University of Geneva; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Universidad de Malaga; University of Geneva	Mongin, D (corresponding author), Univ Geneva, Fac Med, Geneva, Switzerland.	denis.mongin@unige.ch			Swiss National Foundation for Science [IZSEZ_0183540, 100019_166010]	Swiss National Foundation for Science(Swiss National Science Foundation (SNSF))	DM: grant IZSEZ_0183540 from the Swiss National Foundation for Science DSC: project fund 100019_166010 from the Swiss National Foundation for Science The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAI Y, 1989, AM J PHYSIOL, V256, pH132, DOI 10.1152/ajpheart.1989.256.1.H132; Aubert AE, 2003, SPORTS MED, V33, P889, DOI 10.2165/00007256-200333120-00003; Bashan A, 2008, PHYSICA A, V387, P5080, DOI 10.1016/j.physa.2008.04.023; Bearden SE, 2001, J APPL PHYSIOL, V90, P2081, DOI 10.1152/jappl.2001.90.6.2081; Bellenger CR, 2016, SPORTS MED, V46, P1461, DOI 10.1007/s40279-016-0484-2; Bernaola-Galvan PA, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.032218; Bernard T, 1997, EUR J APPL PHYSIOL, V75, P170, DOI 10.1007/s004210050143; BIGGER JT, 1992, CIRCULATION, V85, P164, DOI 10.1161/01.CIR.85.1.164; Boettger S, 2010, MED SCI SPORT EXER, V42, P443, DOI 10.1249/MSS.0b013e3181b64db1; Borresen J, 2008, SPORTS MED, V38, P633, DOI 10.2165/00007256-200838080-00002; Buchheit M, 2012, EUR J APPL PHYSIOL, V112, P711, DOI 10.1007/s00421-011-2014-0; Camm AJ, 1996, CIRCULATION, V93, P1043; Carnethon MR, 2005, MED SCI SPORT EXER, V37, P606, DOI 10.1249/01.MSS.0000158190.56061.32; Chabert Clovis, 2022, PN, DOI 10.13026/2QS3-KH43; Cole CR, 2000, ANN INTERN MED, V132, P552, DOI 10.7326/0003-4819-132-7-200004040-00007; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; Cottin FO, 2004, MED SCI SPORT EXER, V36, P594, DOI 10.1249/01.MSS.0000121982.14718.2A; FRANCIS KT, 1990, PHYS THER, V70, P734, DOI 10.1093/ptj/70.11.734; Gastin PB, 2001, SPORTS MED, V31, P725, DOI 10.2165/00007256-200131100-00003; Gregoire J, 1996, Can J Appl Physiol, V21, P455; Hirsh DS, 2006, J HEART LUNG TRANSPL, V25, P942, DOI 10.1016/j.healun.2006.04.006; Karapetian GK, 2012, INT J SPORTS MED, V33, P507, DOI 10.1055/s-0032-1301904; Karasik R, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.062902; KLEIGER RE, 1987, AM J CARDIOL, V59, P256, DOI 10.1016/0002-9149(87)90795-8; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Lewis MJ, 2007, SCAND J MED SCI SPOR, V17, P696, DOI 10.1111/j.1600-0838.2006.00616.x; Lewis MJ, 2010, SCAND J MED SCI SPOR, V20, P794, DOI 10.1111/j.1600-0838.2010.01150.x; Machhada A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15097; MCCRATY R, 1995, AM J CARDIOL, V76, P1089, DOI 10.1016/S0002-9149(99)80309-9; Michael S, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00301; Mongin D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69218-1; Mongin D, 2021, RES SPORTS MED, DOI 10.1080/15438627.2021.1954513; Mongin D, 2020, PHYSIOL MEAS, V41, DOI 10.1088/1361-6579/abbb6e; Mongin D, 2021, MULTIVAR BEHAV RES, V56, P649, DOI 10.1080/00273171.2020.1754155; Perini R, 2003, EUR J APPL PHYSIOL, V90, P317, DOI 10.1007/s00421-003-0953-9; Pichot V, 2002, MED SCI SPORT EXER, V34, P1660, DOI 10.1097/00005768-200210000-00019; Platisa MM, 2008, PHYSIOL MEAS, V29, P439, DOI 10.1088/0967-3334/29/4/002; R Core Team, 2021, R LANGUAGE ENV STAT; ROBINSON BF, 1966, CIRC RES, V19, P400, DOI 10.1161/01.RES.19.2.400; Ross R, 2016, CIRCULATION, V134, pE653, DOI 10.1161/CIR.0000000000000461; Sandercock GRH, 2006, SCAND J MED SCI SPOR, V16, P302, DOI 10.1111/j.1600-0838.2006.00556.x; Smith D J, 1988, J R Nav Med Serv, V74, P107; Swinscow T. D. V., 2002, STAT SQUARE ONE; Sydo N, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008143; Tulppo MP, 1996, AM J PHYSIOL-HEART C, V271, pH244, DOI 10.1152/ajpheart.1996.271.1.H244; WASSERMAN K, 1973, J APPL PHYSIOL, V35, P236, DOI 10.1152/jappl.1973.35.2.236; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zimatore G, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249504	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273981	10.1371/journal.pone.0273981	http://dx.doi.org/10.1371/journal.pone.0273981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054204	gold, Green Submitted, Green Published			2022-12-26	WOS:000892641400048
J	Sternjakob-Marthaler, A; Berko-Gottel, B; Rissland, J; Schope, J; Taurian, E; Muller, H; Weber, G; Lohse, S; Lamberty, T; Holleczek, B; Stoffel, H; Hauptmann, G; Giesen, M; Firk, C; Schanzenbach, A; Brandt, F; Hohmann, H; Werthner, Q; Selzer, D; Lehr, T; Wagenpfeil, S; Smola, S				Sternjakob-Marthaler, Anna; Berko-Goettel, Barbara; Rissland, Juergen; Schoepe, Jakob; Taurian, Emeline; Mueller, Hanna; Weber, Gero; Lohse, Stefan; Lamberty, Thomas; Holleczek, Bernd; Stoffel, Harry; Hauptmann, Gunter; Giesen, Martin; Firk, Christiane; Schanzenbach, Alexandra; Brandt, Florian; Hohmann, Heike; Werthner, Quirin; Selzer, Dominik; Lehr, Thorsten; Wagenpfeil, Stefan; Smola, Sigrun			Human papillomavirus vaccination of girls in the German model region Saarland: Insurance data-based analysis and identification of starting points for improving vaccination rates	PLOS ONE			English	Article							HPV VACCINATION; GENITAL WARTS; UNITED-STATES; CANCER; INDIVIDUALS; ASSOCIATION; PREVENTION; LESIONS	In Germany, the incidence of cervical cancer, a disease caused by human papillomaviruses (HPV), is higher than in neighboring European countries. HPV vaccination has been recommended for girls since 2007. However, it continues to be significantly less well received than other childhood vaccines, so its potential for cancer prevention is not fully realized. To find new starting points for improving vaccination rates, we analyzed pseudonymized routine billing data from statutory health insurers in the PRAZIS study (prevention of cervical carcinoma and its precursors in women in Saarland) in the federal state Saarland serving as a model region. We show that lowering the HPV vaccination age to 9 years led to more completed HPV vaccinations already in 2015. Since then, HPV vaccination rates and the proportion of 9- to 11-year-old girls among HPV-vaccinated females have steadily increased. However, HPV vaccination rates among 15-year-old girls in Saarland remained well below 50% in 2019. Pediatricians vaccinated the most girls overall, with a particularly high proportion at the recommended vaccination age of 9-14 years, while gynecologists provided more HPV catch-up vaccinations among 15-17-year-old girls, and general practitioners compensated for HPV vaccination in Saarland communities with fewer pediatricians or gynecologists. We also provide evidence for a significant association between attendance at the children's medical check-ups "U11" or "J1" and HPV vaccination. In particular, participation in HPV vaccination is high on the day of U11. However, obstacles are that U11 is currently not financed by all statutory health insurers and there is a lack of invitation procedures for both U11 and J1, resulting in significantly lower participation rates than for the earlier U8 or U9 screenings, which are conducted exclusively with invitations and reminders. Based on our data, we propose to restructure U11 and J1 screening in Germany, with mandatory funding for U11 and organized invitations for HPV vaccination at U11 or J1 for both boys and girls.	[Sternjakob-Marthaler, Anna; Berko-Goettel, Barbara; Rissland, Juergen; Taurian, Emeline; Mueller, Hanna; Lohse, Stefan; Smola, Sigrun] Saarland Univ, Inst Virol, Med Ctr, Homburg, Germany; [Smola, Sigrun] Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland HIPS, Saarbrucken, Germany; [Schoepe, Jakob; Wagenpfeil, Stefan] Saarland Univ, Inst Med Biometry Epidemiol & Med Informat, Med Ctr, Homburg, Germany; [Weber, Gero] Saarland Univ, Phys Geog & Environm Res, Saarbrucken, Germany; [Lamberty, Thomas; Holleczek, Bernd] Minist Hlth Social Affairs Women & Family, Saarbrucken, Germany; [Holleczek, Bernd] Saarland Canc Registry, Saarbrucken, Germany; [Stoffel, Harry; Hauptmann, Gunter] Kassenarztl Vereinigung Saarland, Saarbrucken, Germany; [Giesen, Martin; Firk, Christiane; Schanzenbach, Alexandra] AOK Rheinland Pfalz Saarland, Saarbrucken, Germany; [Brandt, Florian; Hohmann, Heike] IKK Sudwest, Saarbrucken, Germany; [Werthner, Quirin; Selzer, Dominik; Lehr, Thorsten] Univ Saarland, Clin Pharm, Saarbrucken, Germany	Universitatsklinikum des Saarlandes; Helmholtz Association; Helmholtz-Center for Infection Research; Universitatsklinikum des Saarlandes; Saarland University; Saarland University	Smola, S (corresponding author), Saarland Univ, Inst Virol, Med Ctr, Homburg, Germany.; Smola, S (corresponding author), Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland HIPS, Saarbrucken, Germany.	sigrun.smola@uks.eu		Brandt, Florian/0000-0003-4947-1770; Lehr, Thorsten/0000-0002-8372-1465	Gemeinsamer Bundesausschuss Innovationsfonds (PRA ZIS grant) [01VSF16050]; Saarland Staatskanzlei (Sinfonica grant) [WT/2 LFFP 14/15]; PRA ZIS [01VSF16050]; Sinfonica [WT/2 LFFP 14/15]	Gemeinsamer Bundesausschuss Innovationsfonds (PRA ZIS grant); Saarland Staatskanzlei (Sinfonica grant); PRA ZIS; Sinfonica	This work was supported by a grant of the Gemeinsamer Bundesausschuss Innovationsfonds (PRA ZIS grant no. 01VSF16050) to SS (project leader), BH, GH, CF, AS, TLe, SW and the Saarland Staatskanzlei (Sinfonica grant no. WT/2 LFFP 14/15) to SS. PRA ZIS (01VSF16050): https://innovationsfonds.g-ba.de Sinfonica (WT/2 LFFP 14/15: https://www.saarland.de/stk/DE/portale/wissenschaftforschungtechnologie/informationen/foerderung/landesforschungsfoerderung/landesforschungsfoerderung_node.html PRA ZIS (01VSF16050): No role in the study design, data collection and analysis, or preparation of the manuscript Sinfonica (WT/2 LFFP 14/15): No role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-140; Bosch FX, 2013, VACCINE, V31, pF1, DOI [10.1016/j.vaccine.2013.10.001, 10.1016/j.vaccine.2013.07.026, 10.1016/j.vaccine.2013.10.003]; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Buttmann-Schweiger N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128073; Drolet M, 2019, LANCET, V394, P497, DOI 10.1016/S0140-6736(19)30298-3; Drolet M, 2015, LANCET INFECT DIS, V15, P565, DOI 10.1016/S1473-3099(14)71073-4; Esser S, 2015, J DTSCH DERMATOL GES, V13, P1302, DOI 10.1111/ddg.12726; EUCAN, EUR CANC OB ECO; G-BA, 2018, RES FED JOINT COMM A; Gemeinsamer Bundesausschuss, 2018, PRESSEMITTEILUNG G B; Gemeinsamer Bundesausschuss Innovationsausschuss, 2021, PRAZIS PRAV ZERV DES; Gross GE, 2021, J DTSCH DERMATOL GES, V19, P479, DOI 10.1111/ddg.14438; health.gov, US; Holleczek B, 2018, ACTA ONCOL, V57, P324, DOI 10.1080/0284186X.2017.1360513; International Papillomavirus Society, 2018, CRIT ROL STAK COLL A; Jansen L, 2018, ORAL ONCOL, V76, P8, DOI 10.1016/j.oraloncology.2017.11.015; Lei JY, 2020, NEW ENGL J MED, V383, P1340, DOI 10.1056/NEJMoa1917338; Machalek DA, 2012, LANCET ONCOL, V13, P487, DOI 10.1016/S1470-2045(12)70080-3; Maulbecker-Armstrong C., 2018, DTSCH ARZTEBL INT, V115, P22; Novakovic Daniel, 2018, J Infect Dis, V217, P208, DOI 10.1093/infdis/jix498; Osmani V, 2021, BUNDESGESUNDHEITSBLA, V64, P590, DOI 10.1007/s00103-021-03316-x; Poethko-Muller C, 2014, BUNDESGESUNDHEITSBLA, V57, P869, DOI 10.1007/s00103-014-1987-3; Rai Y., 2020, HLTH PROTECTION REPO, P1; Rieck T., 2020, EPIDEMIOLOGISCHES B, V32/33, P9, DOI DOI 10.25646/7027.4; Rieck T., 2018, EPIDEMIOLOGISCHES B, V1, P1; Rieck T, 2014, VACCINE, V32, P5564, DOI 10.1016/j.vaccine.2014.07.105; Riesen M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021006; RKI G, 2019, CANC GERMANY 2015 20, V12th; Schulein S, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3663-z; Shefer A, 2008, VACCINE, V26, pK68, DOI 10.1016/j.vaccine.2008.05.065; Silverberg MJ, 2012, CLIN INFECT DIS, V54, P1026, DOI 10.1093/cid/cir1012; Standige Impfkommission (STIKO) am Robert Koch-Institut, 2014, EPIDEMIOLOGISCHES B, V35, P341; Standige Impfkommission (STIKO) am Robert Koch-Institut, 2007, EPIDEMIOLOGISCHES B, V12; Standige Impfkommission (STIKO) am Robert Koch-Institut, 2018, WISSENSCHAFTLICHE BE, V26; statista, US; Takla A., 2022, EPID B, V20, P3, DOI [10.25646/10039, DOI 10.25646/10039]; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; WHO IARC, GLOBOCAN 2020 EST CA; Wittekindt C, 2019, CANCER PREV RES, V12, P375, DOI 10.1158/1940-6207.CAPR-19-0098; zur Hausen H, 2009, VIROLOGY, V384, P260, DOI 10.1016/j.virol.2008.11.046	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273332	10.1371/journal.pone.0273332	http://dx.doi.org/10.1371/journal.pone.0273332			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054196	Green Published, gold			2022-12-26	WOS:000892641400020
J	Johnson, DA; Piper, IM; Vogel, BA; Jackson, SN; Svendsen, JE; Kodama, HM; Lee, DE; Lindblom, KM; McCarty, J; Antos, JM; Amacher, JF				Johnson, D. Alex; Piper, Isabel M.; Vogel, Brandon A.; Jackson, Sophie N.; Svendsen, Justin E.; Kodama, Hanna M.; Lee, Darren E.; Lindblom, Katy M.; McCarty, James; Antos, John M.; Amacher, Jeanine F.			Structures of Streptococcus pyogenes class A sortase in complex with substrate and product mimics provide key details of target recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; GRAM-POSITIVE BACTERIA; CELL-WALL; SURFACE-PROTEINS; SORTING SIGNAL; LIPID-II; TRANSPEPTIDASE; SPECIFICITY; ENZYME; MECHANISM	The cell wall is a critical extracellular barrier for bacteria and many other organisms. In bacteria, this structural layer consists of peptidoglycan, which maintains cell shape and structural integrity and provides a scaffold for displaying various protein factors. To attach proteins to the cell wall, Gram-positive bacteria utilize sortase enzymes, which are cysteine trans -peptidases that recognize and cleave a specific sorting signal, followed by ligation of the sorting signal???containing protein to the peptidoglycan precursor lipid II (LII). This mechanism is the subject of considerable interest as a target for therapeutic intervention and as a tool for protein engineering, where sor-tases have enabled sortase-mediated ligation or sortagging strategies. Despite these uses, there remains an incomplete understanding of the stereochemistry of substrate recognition and ligation product formation. Here, we solved the first structures of sortase A from Streptococcus pyogenes bound to two substrate sequences, LPATA and LPATS. In addition, we synthesized a mimetic of the product of sortase-mediated ligation involving LII (LPAT-LII) and solved the complex structure in two ligand conformations. These structures were further used as the basis for molecular dynamics simulations to probe sortase A-ligand dynamics and to construct a model of the acyl???enzyme intermediate, thus providing a structural view of multiple key states in the catalytic mechanism. Overall, this structural information provides new insights into the recog-nition of the sortase substrate motif and LII ligation partner and will support the continued development of sortases for protein engineering applications.	[Johnson, D. Alex; Piper, Isabel M.; Vogel, Brandon A.; Jackson, Sophie N.; Svendsen, Justin E.; Kodama, Hanna M.; Lee, Darren E.; Lindblom, Katy M.; McCarty, James; Antos, John M.; Amacher, Jeanine F.] Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA; [Johnson, D. Alex] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA; [Piper, Isabel M.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Svendsen, Justin E.] Univ Oregon, Dept Chem & Biochem, Eugene, OR 97403 USA	Western Washington University; California Institute of Technology; University of California System; University of California Berkeley; University of Oregon	Antos, JM; Amacher, JF (corresponding author), Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA.	antosj@wwu.edu; amachej@wwu.edu		Svendsen, Justin/0000-0002-5873-5339; Vogel, Brandon/0000-0003-2563-0677; Piper, Isabel/0000-0001-9347-2645; Johnson, David/0000-0001-5675-685X; Jackson, Sophie/0000-0001-9133-6906				Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Antos JM, 2016, CURR OPIN STRUC BIOL, V38, P111, DOI 10.1016/j.sbi.2016.05.021; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Barca GMJ, 2020, J CHEM PHYS, V152, DOI 10.1063/5.0005188; Biswas T, 2014, BIOCHEMISTRY-US, V53, P2515, DOI 10.1021/bi4016023; Bradshaw WJ, 2015, FEBS J, V282, P2097, DOI 10.1111/febs.13288; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chan AH, 2015, J BIOL CHEM, V290, P25461, DOI 10.1074/jbc.M115.670984; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; CORNELL WD, 1993, J AM CHEM SOC, V115, P9620, DOI 10.1021/ja00074a030; Dai XL, 2019, RSC ADV, V9, P4700, DOI 10.1039/c8ra06705h; Dorr BM, 2014, P NATL ACAD SCI USA, V111, P13343, DOI 10.1073/pnas.1411179111; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frankel BA, 2007, BIOCHEMISTRY-US, V46, P7269, DOI 10.1021/bi700448e; Freund C, 2021, CHEMBIOCHEM, V22, P1347, DOI 10.1002/cbic.202000745; Gao M, 2022, PROTEIN SCI, V31, P701, DOI 10.1002/pro.4266; Guimaraes CP, 2013, NAT PROTOC, V8, P1787, DOI 10.1038/nprot.2013.101; Hadi T, 2013, BIOCHEMISTRY-US, V52, P9358, DOI 10.1021/bi4010446; Hendrickx APA, 2011, NAT REV MICROBIOL, V9, P166, DOI 10.1038/nrmicro2520; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hirakawa H, 2012, BIOTECHNOL BIOENG, V109, P2955, DOI 10.1002/bit.24585; Ilangovan U, 2001, P NATL ACAD SCI USA, V98, P6056, DOI 10.1073/pnas.101064198; Jacobitz AW, 2017, ADV PROTEIN CHEM STR, V109, P223, DOI 10.1016/bs.apcsb.2017.04.008; Jacobitz AW, 2014, J BIOL CHEM, V289, P8891, DOI 10.1074/jbc.M113.509273; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Lindahl H., 2020, GROMACS 2020 4 MANUA; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Litou Zoi I., 2008, Journal of Bioinformatics and Computational Biology, V6, P387, DOI 10.1142/S0219720008003382; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Munch D, 2015, BBA-BIOMEMBRANES, V1848, P3062, DOI 10.1016/j.bbamem.2015.04.014; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nikghalb KD, 2018, CHEMBIOCHEM, V19, P185, DOI 10.1002/cbic.201700517; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Piper IM, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100981; Podracky CJ, 2021, NAT CHEM BIOL, V17, P317, DOI 10.1038/s41589-020-00706-1; Popp MW, 2011, P NATL ACAD SCI USA, V108, P3169, DOI 10.1073/pnas.1016863108; Pritz S, 2007, J ORG CHEM, V72, P3909, DOI 10.1021/jo062331l; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Raz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140784; Ruzin A, 2002, J BACTERIOL, V184, P2141, DOI 10.1128/JB.184.8.2141-2147.2002; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmohl L, 2017, BIOORGAN MED CHEM, V25, P5002, DOI 10.1016/j.bmc.2017.06.033; Schmohl L, 2017, J PEPT SCI, V23, P631, DOI 10.1002/psc.2980; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Theile CS, 2013, NAT PROTOC, V8, P1800, DOI 10.1038/nprot.2013.102; Tian BX, 2011, J PHYS CHEM B, V115, P13003, DOI 10.1021/jp2058113; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Towns J, 2014, COMPUT SCI ENG, V16, P62, DOI 10.1109/MCSE.2014.80; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wilkins MR, 1999, METH MOL B, V112, P531; Wojcik M, 2019, PROTEIN ENG DES SEL, V32, P555, DOI 10.1093/protein/gzaa018; Zhang J, 2014, P NATL ACAD SCI USA, V111, P13517, DOI 10.1073/pnas.1408601111; Zhang YH, 2021, RSC ADV, V11, P16522, DOI 10.1039/d1ra01549d; Zong YN, 2004, J BIOL CHEM, V279, P31383, DOI 10.1074/jbc.M401374200; Zou Z, 2020, BIOCONJUGATE CHEM, V31, P2476, DOI 10.1021/acs.bioconjchem.0c00486; Zwart PH, 2008, ACTA CRYSTALLOGR D, V64, P99, DOI 10.1107/S090744490705531X	70	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102446	10.1016/j.jbc.2022.102446	http://dx.doi.org/10.1016/j.jbc.2022.102446			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5H2JF	36055407	gold, Green Published			2022-12-26	WOS:000867509200002
J	Iacopucci, APM; Pereira, PD; Pereira, DA; Calmasini, FB; Pittala, V; Reis, LO; Burnett, AL; Costa, FF; Silva, FH				Magrini Iacopucci, Ana Paula; Pereira, Pamela da Silva; Pereira, Dalila Andrade; Calmasini, Fabiano Beraldi; Pittala, Valeria; Reis, Leonardo Oliveira; Burnett, Arthur L.; Costa, Fernando Ferreira; Silva, Fabio Henrique			Intravascular hemolysis leads to exaggerated corpus cavernosum relaxation: Implication for priapism in sickle cell disease	FASEB JOURNAL			English	Article						anemia; cGMP; erectile dysfunction; heme oxygenase; nitric oxide; oxidative stress; PDE5	NITRIC-OXIDE; HEME OXYGENASE-1; CARBON-MONOXIDE; NADPH OXIDASE; EXCESS ADENOSINE; CYCLASE; CONTRIBUTES; HAPTOGLOBIN; ACTIVATION; INHIBITORS	Patients with sickle cell disease (SCD) display priapism. Clinical studies have shown a strong positive correlation between priapism and high levels of intravascular hemolysis in men with SCD. However, there are no experimental studies that show that intravascular hemolysis promotes alterations in erectile function. Therefore, we aimed to evaluate the corpus cavernosum smooth muscle relaxant function in a murine model that displays intravascular hemolysis induced by phenylhydrazine (PHZ), as well as the role of intravascular hemolysis in increasing the stress oxidative in the penis. Corpus cavernosum strips were dissected free and placed in organ baths. Acetylcholine and electrical field stimulation (EFS)-induced corpus cavernosum relaxations in vitro were obtained. Increased corpus cavernosum relaxant responses to acetylcholine and EFS were observed in the PHZ group. Protein expression of heme oxygenase-1 increased in the corpus cavernosum of the PHZ group, but PDE5 protein expression was not modified. Preincubation with the heme oxygenase inhibitor 1 J completely reversed the increased relaxant responses to acetylcholine and EFS in PHZ mice. Protein expression of NADPH oxidase subunit gp91phox, 3-nitrotyrosine, and 4-hydroxynonenal increased in the corpus cavernosum of the PHZ group, suggesting a state of oxidative stress. Basal cGMP production was lower in the PHZ group. Our results show that intravascular hemolysis promotes increased corpus cavernosum smooth muscle relaxation associated with increased HO-1 expression, as well as increased oxidative stress associated with upregulation of gp91phox expression. Moreover, our study supports clinical studies that point to a strong positive correlation between priapism and high levels of intravascular hemolysis in men with SCD.	[Magrini Iacopucci, Ana Paula; Pereira, Dalila Andrade; Calmasini, Fabiano Beraldi; Silva, Fabio Henrique] Sao Francisco Univ Med Sch, Lab Multidisciplinary Res, Rua Sao Francisco 218, BR-2916900 Braganca Paulista, SP, Brazil; [Pereira, Pamela da Silva; Costa, Fernando Ferreira] Univ Estadual Campinas, Hematol & Hemotherapy Ctr, Campinas, Brazil; [Pittala, Valeria] Univ Catania, Dept Drug & Hlth Sci, Catania, Italy; [Reis, Leonardo Oliveira] Pontifical Catholic Univ Campinas, UroSci, Campinas, SP, Brazil; [Burnett, Arthur L.] Johns Hopkins Sch Med, James Buchanan Brady Urol Inst, Baltimore, MD USA; [Burnett, Arthur L.] Johns Hopkins Sch Med, Dept Urol, Baltimore, MD USA	Universidade Estadual de Campinas; University of Catania; Pontificia Universidade Catolica de Campinas; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Silva, FH (corresponding author), Sao Francisco Univ Med Sch, Lab Multidisciplinary Res, Rua Sao Francisco 218, BR-2916900 Braganca Paulista, SP, Brazil.	fabiohsilva87@gmail.com			Sao Paulo Research Foundation [2019/18886-1, 2017/08122-9]	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Sao Paulo Research Foundation, Grant/Award Number: 2019/18886-1 and 2017/08122-9	Ahmed A, 2000, MOL MED, V6, P391, DOI 10.1007/BF03401783; Belcher JD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196455; Belcher JD, 2014, BLOOD, V123, P377, DOI 10.1182/blood-2013-04-495887; Bivalacqua TJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068028; Bivalacqua TJ, 2010, UROLOGY, V76, DOI 10.1016/j.urology.2010.02.050; Carson CC, 2005, BJU INT, V96, P257, DOI 10.1111/j.1464-410X.2005.05614.x; Cita KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154866; Gbotosho OT, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.561917; Hanson MS, 2011, BRIT J HAEMATOL, V154, P502, DOI 10.1111/j.1365-2141.2011.08738.x; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; Kato GJ, 2006, BLOOD, V107, P2279, DOI 10.1182/blood-2005-06-2373; Kato GJ, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.10; Lagoda G, 2013, J UROLOGY, V189, P762, DOI 10.1016/j.juro.2012.08.198; Mi T, 2008, J CLIN INVEST, V118, P1491, DOI 10.1172/JCI33467; MULLEREBERHARD U, 1968, BLOOD, V32, P811, DOI 10.1182/blood.V32.5.811.811; Musicki B, 2018, ANDROLOGY-US, V6, P184, DOI 10.1111/andr.12442; Musicki B, 2021, J CELL PHYSIOL, V236, P3073, DOI 10.1002/jcp.30075; Musicki B, 2012, J SEX MED, V9, P1980, DOI 10.1111/j.1743-6109.2012.02798.x; Mustafa AK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.268re2; Ning C, 2014, FASEB J, V28, P2725, DOI 10.1096/fj.13-247833; Nolan VG, 2005, BLOOD, V106, P3264, DOI 10.1182/blood-2005-04-1594; Nunes KP, 2015, J PHARMACOL EXP THER, V353, P330, DOI 10.1124/jpet.114.220970; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Salerno L, 2019, EUR J MED CHEM, V167, P439, DOI 10.1016/j.ejmech.2019.02.027; Salerno L, 2018, EUR J MED CHEM, V148, P54, DOI 10.1016/j.ejmech.2018.02.007; Salonia A, 2014, EUR UROL, V65, P480, DOI 10.1016/j.eururo.2013.11.008; Schaer CA, 2016, AM J RESP CRIT CARE, V193, P1111, DOI 10.1164/rccm.201510-2058OC; Schaer DJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00415; Silva FH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166291; Silva FH, 2016, J PHARMACOL EXP THER, V359, P230, DOI 10.1124/jpet.116.235473; Silva FH, 2018, J PHARMACOL EXP THER, V367, P194, DOI 10.1124/jpet.118.249581; Sopko NA, 2015, J SEX MED, V12, P1878, DOI 10.1111/jsm.12976; Sorrenti V, 2012, CHEM BIOL DRUG DES, V80, P876, DOI 10.1111/cbdd.12015; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; Teixeira CE, 2007, J PHARMACOL EXP THER, V322, P1093, DOI 10.1124/jpet.107.124594; Ushiyama M, 2004, HYPERTENS RES, V27, P253, DOI 10.1291/hypres.27.253; Vendrame F, 2018, J CLIN LIPIDOL, V12, P1532, DOI 10.1016/j.jacl.2018.08.002; Wang R, 1997, BRIT J PHARMACOL, V121, P927, DOI 10.1038/sj.bjp.0701222	39	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22535	10.1096/fj.202200867R	http://dx.doi.org/10.1096/fj.202200867R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4I5AY	36070139				2022-12-26	WOS:000850590800001
J	Xing, LY; Chai, R; Wang, JQ; Lin, JQ; Li, HY; Wang, YQ; Lai, BQ; Sun, JJ; Chen, G				Xing, Lingyan; Chai, Rui; Wang, Jiaqi; Lin, Jiaqi; Li, Hanyang; Wang, Yueqi; Lai, Biqin; Sun, Junjie; Chen, Gang			Expression of myelin transcription factor 1 and lamin B receptor mediate neural progenitor fate transition in the zebrafish spinal cord pMN domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							OLIGODENDROCYTE LINEAGE; FUNCTIONAL-NEURONS; CELL LINEAGES; GLIAL-CELLS; IN-VIVO; DIFFERENTIATION; SPECIFICATION; REGENERATION; GENERATION; HEDGEHOG	The pMN domain is a restricted domain in the ventral spinal cord, defined by the expression of the olig2 gene. Though it is known that the pMN progenitor cells can sequentially generate motor neurons and oligodendrocytes, the lineages of these progenitors are controversial and how their progeny are generated is not well understood. Using single-cell RNA sequencing, here, we identified a previously unknown hetero-geneity among pMN progenitors with distinct fates and molecular signatures in zebrafish. Notably, we characterized two distinct motor neuron lineages using bioinformatic analysis. We then went on to investigate specific molecular programs that regulate neural progenitor fate transition. We validated experimentally that expression of the transcription factor myt1 (myelin transcription factor 1) and inner nuclear membrane integral proteins lbr (lamin B receptor) were critical for the development of motor neurons and neural progenitor maintenance, respectively. We anticipate that the transcriptome features and molecular programs identified in zebrafish pMN progenitors will not only provide an in-depth understanding of previous findings regarding the lineage analysis of oligoden-drocyte progenitor cells and motor neurons but will also help in further understanding of the molecular programming involved in neural progenitor fate transition.	[Xing, Lingyan; Chai, Rui; Li, Hanyang; Sun, Junjie; Chen, Gang] Nantong Univ, Key Lab Neuroregenerat, Coinnovat Ctr Neuroregenerat, Jiangsu & Minist Educ,NMPA Key Lab Res & Evaluat, Nantong, Peoples R China; [Wang, Jiaqi; Lin, Jiaqi] Nantong Univ, Sch Med, Dept Physiol, Nantong, Peoples R China; [Wang, Yueqi] Univ Utah, Sch Med, Salt Lake City, UT USA; [Lai, Biqin] Sun Yat Sen Univ, Key Lab Stem Cells & Tissue Engn, Minist Educ, Coinnovat Ctr Neuroregenerat, Nantong, Peoples R China; [Chen, Gang] Nantong Univ, Basic Med Res Ctr, Sch Med, Nantong, Peoples R China	Nantong University; Nantong University; Utah System of Higher Education; University of Utah; Sun Yat Sen University; Nantong University	Xing, LY; Chen, G (corresponding author), Nantong Univ, Key Lab Neuroregenerat, Coinnovat Ctr Neuroregenerat, Jiangsu & Minist Educ,NMPA Key Lab Res & Evaluat, Nantong, Peoples R China.; Chen, G (corresponding author), Nantong Univ, Basic Med Res Ctr, Sch Med, Nantong, Peoples R China.	xlyan011@163.com; chengang6626@ntu.edu.cn		sun, junjie/0000-0001-8710-7318; wang, jiaqi/0000-0001-7255-4342; Chen, Gang/0000-0003-3669-5687; Wang, Yueqi/0000-0001-8828-3516	National Key Research and Development Program of China [2017YFA0104704]; National Natural Science Foundation of China [81701127, 31872773, 32070998]; Key Research and Development Program (Social Development) of Jiangsu Province [BE2020667]; Foundation of Jiangsu Province "333 Project High-level Talents" [BRA2020076]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Research and Development Program (Social Development) of Jiangsu Province; Foundation of Jiangsu Province "333 Project High-level Talents"; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was funded by the National Key Research and Development Program of China (2017YFA0104704), the National Natural Science Foundation of China (81701127, 31872773, 32070998), the Key Research and Development Program (Social Development) of Jiangsu Province (BE2020667), the Foundation of Jiangsu Province "333 Project High-level Talents" (BRA2020076), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). We also thank Lingfang Zhang and Xiang Miu, who provided essential help for bioinformatics analysis and FACS, respectively.	Andrzejczuk LA, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00170; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Briona LK, 2015, DEV BIOL, V403, P15, DOI 10.1016/j.ydbio.2015.03.025; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Chen JA, 2011, NEURON, V69, P721, DOI 10.1016/j.neuron.2011.01.014; Clovis YM, 2016, CELL REP, V16, P1642, DOI 10.1016/j.celrep.2016.06.100; Ding SJ, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02276-1; Farrell JA, 2018, SCIENCE, V360, P979, DOI 10.1126/science.aar3131; Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044; Gong J, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00034; Guo ZY, 2014, CELL STEM CELL, V14, P188, DOI 10.1016/j.stem.2013.12.001; Johnson K, 2016, GLIA, V64, P1170, DOI 10.1002/glia.22990; Juarez-Morales JL, 2016, NEURAL DEV, V11, DOI 10.1186/s13064-016-0059-9; Jurisch-Yaksi N, 2020, GLIA, V68, P2451, DOI 10.1002/glia.23849; Lange C, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.185595; LEBER SM, 1995, J NEUROSCI, V15, P1236; LEBER SM, 1990, J NEUROSCI, V10, P2451; Liang XG, 2018, CNS NEUROSCI THER, V24, P801, DOI 10.1111/cns.12821; Mathews ES, 2016, METHOD CELL BIOL, V134, P69, DOI 10.1016/bs.mcb.2015.12.004; Mizuguchi R, 2001, NEURON, V31, P757, DOI 10.1016/S0896-6273(01)00413-5; Mouhieddine TH, 2014, NEURAL REGEN RES, V9, P901, DOI 10.4103/1673-5374.133129; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; Park HC, 2004, DEVELOPMENT, V131, P5959, DOI 10.1242/dev.01456; Perestrelo T, 2018, TRENDS CELL BIOL, V28, P1014, DOI 10.1016/j.tcb.2018.09.005; Qian H, 2020, NATURE, V582, P550, DOI 10.1038/s41586-020-2388-4; Qian XM, 1998, DEVELOPMENT, V125, P3143; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; Ravanelli AM, 2015, GENE DEV, V29, P2504, DOI 10.1101/gad.271312.115; Reimer MM, 2008, J NEUROSCI, V28, P8510, DOI 10.1523/JNEUROSCI.1189-08.2008; Reimer MM, 2013, DEV CELL, V25, P478, DOI 10.1016/j.devcel.2013.04.012; Reimer MM, 2009, J NEUROSCI, V29, P15073, DOI 10.1523/JNEUROSCI.4748-09.2009; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Schild-Prufert K, 2006, EUR J CELL BIOL, V85, P813, DOI 10.1016/j.ejcb.2006.04.009; Schmid A, 1999, DEVELOPMENT, V126, P4653; Scott K, 2021, DEV BIOL, V479, P37, DOI 10.1016/j.ydbio.2021.07.010; Seredick SD, 2012, NEURAL DEV, V7, DOI 10.1186/1749-8104-7-35; Shin Jimann, 2003, Methods in Cell Science, V25, P7, DOI 10.1023/B:MICS.0000006847.09037.3a; Solovei I, 2013, CELL, V152, P584, DOI 10.1016/j.cell.2013.01.009; Subramanian G, 2012, J IMMUNOL, V188, P85, DOI 10.4049/jimmunol.1003804; Takada N, 2010, DEV DYNAM, V239, P2041, DOI 10.1002/dvdy.22338; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vasconcelos FF, 2016, CELL REP, V17, P469, DOI 10.1016/j.celrep.2016.09.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wagner DE, 2020, NAT REV GENET, V21, P410, DOI 10.1038/s41576-020-0223-2; Wagner DE, 2018, SCIENCE, V360, P981, DOI 10.1126/science.aar4362; Weinberger M, 2020, DEV CELL, V52, P574, DOI 10.1016/j.devcel.2020.01.023; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Xie YY, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002257; Xing LY, 2015, J NEUROSCI, V35, P14794, DOI 10.1523/JNEUROSCI.1295-15.2015; Yang T, 2020, FASEB J, V34, P15504, DOI 10.1096/fj.202001657RR; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7	54	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102452	10.1016/j.jbc.2022.102452	http://dx.doi.org/10.1016/j.jbc.2022.102452			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5L6PJ	36063998	Green Published, gold			2022-12-26	WOS:000870533300007
J	Kang, S; Wang, LX; Xu, L; Wang, RQ; Kang, QZ; Gao, XF; Yu, L				Kang, Synat; Wang, Lixin; Xu, Lu; Wang, Ruiqi; Kang, Qingzheng; Gao, Xuefeng; Yu, Li			Decitabine enhances targeting of AML cells by NY-ESO-1-specific TCR-T cells and promotes the maintenance of effector function and the memory phenotype	ONCOGENE			English	Article							CANCER-TESTIS ANTIGEN; ACUTE MYELOID-LEUKEMIA; DNA METHYLTRANSFERASE; EPIGENETIC MODULATION; EXPRESSION; METHYLATION; LYMPHOCYTES; INDUCTION; IMMUNOTHERAPY; AZACITIDINE	NY-ESO-1 is a well-known cancer-testis antigen (CTA) with re-expression in numerous cancer types, but its expression is suppressed in myeloid leukemia cells. Patients with acute myeloid leukemia (AML) receiving decitabine (DAC) exhibit induced expression of NY-ESO-1 in blasts; thus, we investigated the effects of NY-ESO-1-specific TCR-engineered T (TCR-T) cells combined with DAC against AML. NY-ESO-1-specific TCR-T cells could efficiently eliminate AML cell lines (including U937, HL60, and Kasumi-1cells) and primary AML blasts in vitro by targeting the DAC-induced NY-ESO-1 expression. Moreover, the incubation of T cells with DAC during TCR transduction (designated as dTCR-T cells) could further enhance the anti-leukemia efficacy of TCR-T cells and increase the generation of memory-like phenotype. The combination of DAC with NY-ESO-1-specific dTCR-T cells showed a superior anti-tumor efficacy in vivo and prolonged the survival of an AML xenograft mouse model, with three out of five mice showing complete elimination of AML cells over 90 days. This outcome was correlated with enhanced expressions of IFN-gamma and TNF-alpha, and an increased proportion of central memory T cells (CD45RO(+)CD62L(+) and CD45RO(+)CCR7(+)). Taken together, these data provide preclinical evidence for the combined use of DAC and NY-ESO-1-specific dTCR-T cells for the treatment of AML.	[Kang, Synat; Wang, Lixin; Xu, Lu; Kang, Qingzheng; Gao, Xuefeng; Yu, Li] Shenzhen Univ, Clin Med Acad, Dept Hematol & Oncol,Int Canc Ctr,Hlth Sci Ctr, Gen Hosp,Shenzhen Key Lab Precis Med Hematol Mali, Shenzhen 518000, Guangdong, Peoples R China; [Wang, Ruiqi] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Gao, Xuefeng] Shenzhen Univ, Cent Lab, Shenzhen Key Lab Precis Med Hematol Malignancies, Gen Hosp, Shenzhen 518000, Guangdong, Peoples R China	Shenzhen University; Nankai University; Shenzhen University	Gao, XF; Yu, L (corresponding author), Shenzhen Univ, Clin Med Acad, Dept Hematol & Oncol,Int Canc Ctr,Hlth Sci Ctr, Gen Hosp,Shenzhen Key Lab Precis Med Hematol Mali, Shenzhen 518000, Guangdong, Peoples R China.; Gao, XF (corresponding author), Shenzhen Univ, Cent Lab, Shenzhen Key Lab Precis Med Hematol Malignancies, Gen Hosp, Shenzhen 518000, Guangdong, Peoples R China.	xfgao@szu.edu.cn; yuli@szu.edu.cn	kang, synat/GRO-6634-2022	kang, synat/0000-0001-6898-5289; Gao, Xuefeng/0000-0002-1904-392X	Chinese National Major Project for New Drug Innovation [2019ZX09201002003]; National Natural Science Foundation of China [82030076, 82070161, 81970151, 81670162, 81870134, 81900474]; Shenzhen Science and Technology Foundation [JCYJ20190808163601776, JCYJ20200109113810154]; Shenzhen Key Laboratory Foundation [ZDSYS20200811143757022]; Sanming Project of Medicine in Shenzhen [SZSM202111004]; Stability support project in colleges and universities of Shenzhen Science and technology innovation Commission [20200830182623001]; Shenzhen Peacock Talent Programs Research Start-up Grant [827000644]; Natural Science Foundation of Shenzhen University General Hospital [SUGH2019QD012]	Chinese National Major Project for New Drug Innovation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Science and Technology Foundation; Shenzhen Key Laboratory Foundation; Sanming Project of Medicine in Shenzhen; Stability support project in colleges and universities of Shenzhen Science and technology innovation Commission; Shenzhen Peacock Talent Programs Research Start-up Grant; Natural Science Foundation of Shenzhen University General Hospital	This work was supported by grants Chinese National Major Project for New Drug Innovation (2019ZX09201002003), National Natural Science Foundation of China (82030076, 82070161, 81970151, 81670162, 81870134 and 81900474), Shenzhen Science and Technology Foundation (JCYJ20190808163601776, JCYJ20200109113810154), Shenzhen Key Laboratory Foundation (ZDSYS20200811143757022), Sanming Project of Medicine in Shenzhen (SZSM202111004), Stability support project in colleges and universities of Shenzhen Science and technology innovation Commission (20200830182623001), Shenzhen Peacock Talent Programs Research Start-up Grant (827000644 to XG), and Natural Science Foundation of Shenzhen University General Hospital (SUGH2019QD012).	Acheampong DO, 2018, BIOMED PHARMACOTHER, V97, P225, DOI 10.1016/j.biopha.2017.10.100; Almstedt M, 2010, LEUKEMIA RES, V34, P899, DOI 10.1016/j.leukres.2010.02.004; Arai Y, 2015, BLOOD, V126, P415, DOI 10.1182/blood-2015-04-642652; Atanackovic D, 2011, AM J HEMATOL, V86, P918, DOI 10.1002/ajh.22141; Raneros AB, 2015, GENES IMMUN, V16, P71, DOI 10.1038/gene.2014.58; Bethune MT, 2018, P NATL ACAD SCI USA, V115, pE10702, DOI 10.1073/pnas.1810653115; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Cany J, 2018, BLOOD, V131, P202, DOI 10.1182/blood-2017-06-790204; Cer?n-Maldonado R., 2015, REV MED HOSP GEN MEX, V78, P78; Chapuis AG, 2019, NAT MED, V25, P1064, DOI 10.1038/s41591-019-0472-9; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Chou J, 2012, J IMMUNOTHER, V35, P131, DOI 10.1097/CJI.0b013e31824300c7; Dubovsky JA, 2007, PROSTATE, V67, P1781, DOI 10.1002/pros.20665; Elegheert J, 2018, NAT PROTOC, V13, P2991, DOI 10.1038/s41596-018-0075-9; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Goodyear O, 2010, BLOOD, V116, P1908, DOI 10.1182/blood-2009-11-249474; Gore SD, 2006, CANCER RES, V66, P6361, DOI 10.1158/0008-5472.CAN-06-0080; Griffiths EA, 2018, CLIN CANCER RES, V24, P1019, DOI 10.1158/1078-0432.CCR-17-1792; Jahn L, 2016, ONCOTARGET, V7, P77021, DOI 10.18632/oncotarget.12778; June CH, 2018, NEW ENGL J MED, V379, P64, DOI 10.1056/NEJMra1706169; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Kang S, 2019, FRONT MED-PRC, V13, P69, DOI 10.1007/s11684-018-0677-1; Klar AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139221; Leonard SM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087475; Lim SH, 1999, BRIT J CANCER, V81, P1162, DOI 10.1038/sj.bjc.6690824; Lyko F, 2005, JNCI-J NATL CANCER I, V97, P1498, DOI 10.1093/jnci/dji311; Mardiana S, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00697; McCormack E, 2013, CANCER IMMUNOL IMMUN, V62, P773, DOI 10.1007/s00262-012-1384-4; Natsume A, 2008, INT J CANCER, V122, P2542, DOI 10.1002/ijc.23407; Negrotto S, 2012, LEUKEMIA, V26, P244, DOI 10.1038/leu.2011.207; Odunsi K, 2014, CANCER IMMUNOL RES, V2, P37, DOI 10.1158/2326-6066.CIR-13-0126; Rapoport AP, 2015, NAT MED, V21, P914, DOI 10.1038/nm.3910; Robbins PF, 2008, J IMMUNOL, V180, P6116, DOI 10.4049/jimmunol.180.9.6116; Robbins PF, 2015, CLIN CANCER RES, V21, P1019, DOI 10.1158/1078-0432.CCR-14-2708; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rohner A, 2007, LEUKEMIA RES, V31, P1393, DOI 10.1016/j.leukres.2007.02.020; Srivastava P., 2015, BLOOD, V126, P2873, DOI [10.1182/blood.V126.23.2873.2873, DOI 10.1182/BLOOD.V126.23.2873.2873]; Srivastava P, 2016, ONCOTARGET, V7, P12840, DOI 10.18632/oncotarget.7326; Srivastava P, 2015, EPIGENETICS-US, V10, P237, DOI 10.1080/15592294.2015.1017198; Stadtmauer EA, 2019, BLOOD ADV, V3, P2022, DOI 10.1182/bloodadvances.2019000194; Storb R, 2013, J CLIN ONCOL, V31, P1530, DOI 10.1200/JCO.2012.45.0247; Tawara I, 2017, BLOOD, V130, P1985, DOI 10.1182/blood-2017-06-791202; Topfer K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/918471; Toor AA, 2012, BRIT J HAEMATOL, V158, P700, DOI 10.1111/j.1365-2141.2012.09225.x; Tsai HC, 2012, CANCER CELL, V21, P430, DOI 10.1016/j.ccr.2011.12.029; Turtle CJ, 2016, J CLIN INVEST, V126, P2123, DOI 10.1172/JCI85309; Wakamatsu M, 2019, BLOOD ADV, V3, P105, DOI 10.1182/bloodadvances.2018025643; Walter RB, 2020, BLOOD REV, V44, DOI 10.1016/j.blre.2020.100679; Wang BH, 2021, HEMATOLOGY, V26, P371, DOI 10.1080/16078454.2021.1921434; Wang Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20696-x; Weiser TS, 2001, J IMMUNOTHER, V24, P151, DOI 10.1097/00002371-200103000-00010; Woloszynska-Read A, 2008, CLIN CANCER RES, V14, P3283, DOI 10.1158/1078-0432.CCR-07-5279; Xia Y, 2018, ONCOL LETT, V16, P6998, DOI 10.3892/ol.2018.9534; Xu Y, 2016, J CLIN INVEST, V126, P35, DOI 10.1172/JCI85631; Xu Y, 2014, BLOOD, V123, P3750, DOI 10.1182/blood-2014-01-552174; Yao YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070522; You LS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01787; Zeiser R, 2019, BLOOD, V133, P1290, DOI 10.1182/blood-2018-10-846824; Zhang YK, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-018-0720-y; Zhou JH, 2013, MOL MED REP, V8, P1549, DOI 10.3892/mmr.2013.1659	62	0	0	7	7	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 14	2022	41	42					4696	4708		10.1038/s41388-022-02455-y	http://dx.doi.org/10.1038/s41388-022-02455-y		SEP 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5I4GP	36097193	hybrid, Green Published			2022-12-26	WOS:000852927100001
J	Shahrour, G; Dardas, L; Aldalaykeh, M				Shahrour, Ghada; Dardas, Latefa; Aldalaykeh, Mohammed			COVID-19 related stigma, empathy and intention for testing in Jordan	PLOS ONE			English	Article							MENTAL-ILLNESS; HEALTH; VACCINATION; BEHAVIORS	Stigmatization of COVID-19 disease has been speculated due to misinformation about the disease, fearing of contracting the infection, absence of available cure, and holding responsibility for infecting others. We aimed to establish the prevalence of COVID-19 related stigma and its association with empathic responding, in addition to exploring predictors of stigma and testing intention among Jordanian people. A quantitative, descriptive and predictive design was used and data were collected using a web-based survey from 1074 adults. Findings showed that participants had high stigmatization against COVID-19 infection. Higher empathic responding (both cognitive and affective), being a female participant, and older age resulted in higher stigmatization. Only stigmatization of COVID-19 negatively predicted individuals' intention for testing. These findings warrant intensive efforts from the Jordanian government on a local and national level to provide ongoing public education related to several aspects of COVID-19 disease, in order to reduce or prevent the associated stigma and increase people's intention for testing.	[Shahrour, Ghada; Aldalaykeh, Mohammed] Jordan Univ Sci & Technol, Fac Nursing, Dept Community & Mental Hlth Nursing, Irbid, Jordan; [Dardas, Latefa] Univ Jordan, Sch Nursing, Dept Community & Mental Hlth Nursing, Amman, Jordan; [Shahrour, Ghada] Jordan Univ Sci & Technol, Fac Nursing, Irbid, Jordan; [Dardas, Latefa] Univ Jordan, Sch Nursing, Amman, Jordan	Jordan University of Science & Technology; University of Jordan; Jordan University of Science & Technology; University of Jordan	Shahrour, G (corresponding author), Jordan Univ Sci & Technol, Fac Nursing, Dept Community & Mental Hlth Nursing, Irbid, Jordan.; Shahrour, G (corresponding author), Jordan Univ Sci & Technol, Fac Nursing, Irbid, Jordan.	gmshahrour@just.edu.jo		Shahrour, Ghada/0000-0002-6929-3361				Abuhammad S, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13899; Adom D., 2020, SOC SCI HUMANIT OPEN; Ahmed W., 2018, P 9 INT C SOCIAL MED; Akour Amal, 2021, SN Soc Sci, V1, P240, DOI 10.1007/s43545-021-00252-0; Alnazly E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247679; Alsawalqa RO, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06711; Beaulieu M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1246; Bhanot D, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.577018; Bish A, 2011, VACCINE, V29, P6472, DOI 10.1016/j.vaccine.2011.06.107; BRISLIN RW, 1970, J CROSS CULT PSYCHOL, V1, P185, DOI 10.1177/135910457000100301; Bu NN, 2020, 80 1000 COVID 19 SUR; Capurro G, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0261942; Cenat JM, 2021, PSYCHIAT RES, V297, DOI 10.1016/j.psychres.2021.113714; Cennimo DJ., 2020, WHAT IS GLOBAL US PR; Chapman D.W., 1979, EDUC EVAL POLICY AN, V1, P71, DOI [10.3102/01623737001003071, DOI 10.3102/01623737001003071]; Corrigan PW, 2002, SCHIZOPHRENIA BULL, V28, P293, DOI 10.1093/oxfordjournals.schbul.a006939; Daniel WW, 1999, BIOSTATISTICS FDN AN, V7th; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; Do CD, 2020, PSYCHIAT CLIN NEUROS, V74, P566, DOI 10.1111/pcn.13120; Duan WJ, 2020, SOC SCI MED, V266, DOI 10.1016/j.socscimed.2020.113425; Earnshaw VA, 2020, STIGMA HEALTH, V5, P390, DOI 10.1037/sah0000255; Galinsky AD, 2000, J PERS SOC PSYCHOL, V78, P708, DOI 10.1037//0022-3514.78.4.708; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Hawk ST, 2013, J PERS ASSESS, V95, P96, DOI 10.1080/00223891.2012.696080; Healthline, 2020, WHY WOM AR TAK COVID; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; King DB, 2016, INT J HEALTH PROMOT, V54, P283, DOI 10.1080/14635240.2016.1174950; Knolhof QA., 2018, THESIS E ILLINOIS U; Krendl AC, 2018, EXP AGING RES, V44, P271, DOI 10.1080/0361073X.2018.1475152; Kwaghe AV, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-021-03540-4; Lee SW., 2022, LIFE CYCLE, V2, pe3, DOI [10.54724/lc.2022.e3, DOI 10.54724/LC.2022.E3]; Lee-Baggley D, 2004, ASIAN J SOC PSYCHOL, V7, P9, DOI 10.1111/j.1467-839X.2004.00131.x; Leslie M., 2006, CAN J COMMUN, V31, P367, DOI [10.22230/cjc.2006v31n2a1544, DOI 10.22230/CJC.2006V31N2A1544]; Li YC, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186847; Lin BH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258042; Lohiniva AL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247962; Mahmud Ashek, 2021, Int J Community Wellbeing, V4, P315, DOI 10.1007/s42413-020-00071-w; McFarland S, 2010, POLIT PSYCHOL, V31, P453, DOI 10.1111/j.1467-9221.2010.00765.x; Mo PKH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213920; Musumari PM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237393; Nashwan AJ, 2022, HELIYON, V8, DOI 10.1016/j.heliyon.2022.e09300; Olapegba PO, 2010, J APPL SOC PSYCHOL, V40, P956, DOI 10.1111/j.1559-1816.2010.00606.x; Pan SW, 2021, ETHNIC HEALTH, V26, P110, DOI 10.1080/13557858.2020.1849570; Phelan JE, 2007, J APPL SOC PSYCHOL, V37, P2877, DOI 10.1111/j.1559-1816.2007.00286.x; Puterman E, 2009, GLOB PUBLIC HEALTH, V4, P69, DOI 10.1080/17441690802063304; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Sandelowski M, 2004, J NURS SCHOLARSHIP, V36, P122, DOI 10.1111/j.1547-5069.2004.04024.x; Smith A, 2006, PSYCHOL REC, V56, P3, DOI 10.1007/BF03395534; Smith AL., 2011, PROFESSIONAL COUNSEL, V1, P13, DOI DOI 10.15241/ALS.1.1.13; Stangl AL, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1271-3; Treves-Kagan S, 2017, AIDS BEHAV, V21, P2579, DOI 10.1007/s10461-016-1671-8; Turner-Musa J, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020168; Uvais NA, 2020, J NEPHROL, V33, P1121, DOI 10.1007/s40620-020-00833-x; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Yuan Y, 2021, GLOBALIZATION HEALTH, V17, DOI 10.1186/s12992-021-00705-4; Zhang TM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph182111718	56	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274323	10.1371/journal.pone.0274323	http://dx.doi.org/10.1371/journal.pone.0274323			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095025	gold, Green Published			2022-12-26	WOS:000892376500037
J	Liu, XH; Chen, Y; Zhang, JX; He, YF; Ya, HY; Gao, K; Yang, HZ; Xie, WY; Li, LM				Liu, Xianghui; Chen, Ye; Zhang, Jingxiao; He, Yifan; Ya, Huiyuan; Gao, Kai; Yang, Huizhi; Xie, Wanyue; Li, Lingmei			Widely targeted metabolomics reveals stamen petaloid tissue of Paeonia lactiflora Pall. being a potential pharmacological resource	PLOS ONE			English	Article							IN-VITRO EVALUATION; OXIDATIVE STRESS; PAEONIFLORIN; ANTIOXIDANT; POLYPHENOLS; FLOWERS	Paeonia lactiflflora Pall. has a long edible and medicinal history because of the very high content of biologically active compounds. However, little information is available about the metabolic basis of pharmacological values of P. lactiflora flowers. In this study, we investigated metabolites in the different parts of P. lactiflora flowers, including petal, stamen petaloid tissue and stamen, by widely targeted metabolomics approach. A total of 1102 metabolites were identified, among which 313 and 410 metabolites showed differential accumulation in comparison groups of petal vs. stamen petaloid tissue and stamen vs. stamen petaloid tissue. Differential accumulated metabolites analysis and KEGG pathway analysis showed that the flavonoids were the most critical differential metabolites. Furthermore, difference accumulation of flavonoids, phenolic acids, tannins and alkaloids might lead to the differences in antioxidant activities and tyrosinase inhibition effects. Indeed, stamen petaloid tissue displayed better antioxidant and anti-melanin production activities than petal and stamen through experimental verification. These results not only expand our understanding of metabolites in P. lactiflora flowers, but also reveal that the stamen petaloid tissues of P. lactiflora hold the great potential as promising ingredients for pharmaceuticals, functional foods and skincare products.	[Liu, Xianghui; Chen, Ye; Zhang, Jingxiao; Ya, Huiyuan; Yang, Huizhi; Xie, Wanyue; Li, Lingmei] Luoyang Normal Univ, Sch Food & Drug, Henan Funct Cosmet Engn Technol Res Ctr, Luoyang, Henan, Peoples R China; Beijing Technol & Business Univ, Inst Regulatory Sci, Beijing, Peoples R China; Luoyang Acad Agr & Forestry Sci, Peony Inst, Luoyang, Henan, Peoples R China	Luoyang Normal University; Beijing Technology & Business University	Ya, HY (corresponding author), Luoyang Normal Univ, Sch Food & Drug, Henan Funct Cosmet Engn Technol Res Ctr, Luoyang, Henan, Peoples R China.	yahuiyuan@lynu.edu.cn			Open Research Fund Program of Institute of cosmetic regulatory science, Beijing Technology and Business University [CRS-2021-04]; Luoyang Normal University [2018-PYJJ-007]	Open Research Fund Program of Institute of cosmetic regulatory science, Beijing Technology and Business University; Luoyang Normal University	The funder of Open Research Fund Program of Institute of cosmetic regulatory science, Beijing Technology and Business University (No. CRS-2021-04) will provide financial support, and the authors, including Xianghui Liu, Jingxiao Zhang, Yifan He and Huiyuan Ya, are the principal members of this project and contribute to study design, data collection and analysis, decision to publish, and preparation of the manuscript. Besides, as the principal members of National level project cultivation fund of Luoyang Normal University (No. 2018-PYJJ-007), Xianghui Liu, Ye Chen, Jingxiao Zhang and Lingmei Li contribute much to this study.	Ai ZP, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.742511; Ortega-Ramirez LA, 2014, J FOOD SCI, V79, pR129, DOI 10.1111/1750-3841.12341; Arentz S, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-511; Awasthi A, 2019, PATHOL ONCOL RES, V25, P301, DOI 10.1007/s12253-017-0347-7; Chinese Pharmacopoeia Commission, 2020, PHARMACOPOEIA PEOPLE; Choi SW, 2007, J AGR FOOD CHEM, V55, P3920, DOI 10.1021/jf0635154; Chung KT, 1998, CRIT REV FOOD SCI, V38, P421, DOI 10.1080/10408699891274273; Cherubim DJD, 2020, J COSMET DERMATOL-US, V19, P33, DOI 10.1111/jocd.13093; Dong LL, 2022, INT J BIOL MACROMOL, V208, P530, DOI 10.1016/j.ijbiomac.2022.03.128; Draelos Zoe Diana, 2010, Plast Reconstr Surg, V125, P719, DOI 10.1097/PRS.0b013e3181c83192; Duan XC, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1203285; Goboza M, 2020, MOLECULES, V25, DOI 10.3390/molecules25235546; Huang WS, 2017, J SCI FOOD AGR, V97, P4760, DOI 10.1002/jsfa.8345; Huang Xue, 2010, Acta Horticulturae Sinica, V37, P817; Ji Y, 2013, J ETHNOPHARMACOL, V149, P825, DOI 10.1016/j.jep.2013.08.017; Jin YS, 2013, ASIAN J CHEM, V25, P3835, DOI 10.14233/ajchem.2013.13808; Jin YS., 2016, ASIAN J CHEM, V28, P1144; Jing DL, 2020, PHYSIOL PLANTARUM, V168, P893, DOI 10.1111/ppl.13029; Jo GH, 2018, J TOXICOL ENV HEAL A, V81, P502, DOI 10.1080/15287394.2018.1460785; Kai-Li Xie, 2020, Zhongguo Zhong Yao Za Zhi, V45, P4643, DOI 10.19540/j.cnki.cjcmm.20200725.301; Kang L, 2020, J ETHNOPHARMACOL, V261, DOI 10.1016/j.jep.2020.113054; Khan N, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010039; Li SP, 2021, MOLECULES, V26, DOI 10.3390/molecules26041126; Li SP, 2021, FOOD CHEM, V347, DOI 10.1016/j.foodchem.2021.129005; Li W, 2021, FOOD CHEM, V357, DOI 10.1016/j.foodchem.2021.129791; Li WenXia, 2018, Food and Fermentation Industries, V44, P228; Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513; Lin ZY, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8050135; Lin ZY, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4950-0; Liu YX, 2020, FOOD NUTR RES, V64, DOI 10.29219/fnr.v64.3782; Lu BW, 2020, PEERJ, V8, DOI 10.7717/peerj.8895; Miyata Y, 2019, MOLECULES, V24, DOI 10.3390/molecules24010193; Morikawa H, 2004, CHEM PHARM BULL, V52, P1086, DOI 10.1248/cpb.52.1086; Muller L, 2011, FOOD CHEM, V129, P139, DOI 10.1016/j.foodchem.2011.04.045; Neha K, 2019, EUR J MED CHEM, V178, P687, DOI 10.1016/j.ejmech.2019.06.010; Ning CL, 2015, EUR J LIPID SCI TECH, V117, P532, DOI 10.1002/ejlt.201400212; Ou TT, 2011, J ETHNOPHARMACOL, V135, P162, DOI 10.1016/j.jep.2011.03.011; Park MJ, 2020, ANIM REPROD, V17, DOI [10.1590/1984-3143-AR2020-0013, 10.1590/1984-3143-ar2020-0013]; Pillaiyar T, 2017, J ENZYM INHIB MED CH, V32, P403, DOI 10.1080/14756366.2016.1256882; Qiu J, 2016, INT J COSMETIC SCI, V38, P444, DOI 10.1111/ics.12309; Roh E, 2017, CRIT REV FOOD SCI, V57, P1631, DOI 10.1080/10408398.2014.1003365; Searle T, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14095; Shkondrov A, 2020, NAT PROD RES, V34, P511, DOI 10.1080/14786419.2018.1491040; Shu Xi-kai, 2014, Zhong Yao Cai, V37, P66; Shu XK, 2014, J CHROMATOGR B, V947, P62, DOI 10.1016/j.jchromb.2013.12.004; Szczurek A, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11030442; Tian GeiLin, 2013, Guizhou Agricultural Sciences, P172; Wang JG., 2005, HERBACEOUS PEONIES C; Wang QS, 2014, PHARM BIOL, V52, P1189, DOI 10.3109/13880209.2014.880490; Wang SY, 2020, INT J BIOL MACROMOL, V164, P1554, DOI 10.1016/j.ijbiomac.2020.07.214; Wu YQ, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181485; Wu YC, 2021, J CHROMATOGR SCI, V59, P795, DOI 10.1093/chromsci/bmab005; Yan BJ, 2018, J PHARMACEUT BIOMED, V160, P276, DOI 10.1016/j.jpba.2018.08.009; Yang CS, 2018, J AGR FOOD CHEM, V66, P3063, DOI 10.1021/acs.jafc.7b05830; Yang Y, 2020, PHYTOCHEMISTRY, V174, DOI 10.1016/j.phytochem.2020.112331; Yin B, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/9615429; Zhang HQ, 2015, FREE RADICAL BIO MED, V88, P314, DOI 10.1016/j.freeradbiomed.2015.05.036; Zhang TB, 2020, J ETHNOPHARMACOL, V253, DOI 10.1016/j.jep.2020.112671; Zhao DQ, 2015, BIOCHEM BIOPH RES CO, V459, P450, DOI 10.1016/j.bbrc.2015.02.126; Zhao DQ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-689; Zhao DQ, 2012, MOL BIOL REP, V39, P11263, DOI 10.1007/s11033-012-2036-7; Zhao HJ., 1999, NO HORTICULT, V5, P26; Zhao J., 2010, J S CHINA NORM NAT S, P92; Zhao Y, 2020, J SCI FOOD AGR, V100, P897, DOI 10.1002/jsfa.10049; [钟培星 Zhong Peixing], 2012, [园艺学报, Acta Horticulturae Sinica], V39, P2271; Zhu XT, 2018, APPL MICROBIOL BIOT, V102, P8145, DOI 10.1007/s00253-018-9241-9	66	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274013	10.1371/journal.pone.0274013	http://dx.doi.org/10.1371/journal.pone.0274013			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054136	Green Published, gold			2022-12-26	WOS:000892641400052
J	Lascano, J; Oshins, R; Eagan, C; Wadood, Z; Qiang, X; Flagg, T; Scindia, Y; Mehrad, B; Brantly, ML; Khodayari, N				Lascano, J.; Oshins, R.; Eagan, C.; Wadood, Z.; Qiang, X.; Flagg, T.; Scindia, Y.; Mehrad, B.; Brantly, M. L.; Khodayari, N.			Correlation of Alpha-1 Antitrypsin Levels and Exosome-Associated Neutrophil Elastase Endothelial Injury in Subjects with SARS-CoV2 Infection	AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE			English	Meeting Abstract	International Conference of the American-Thoracic-Society	MAY 13-18, 2022	San Francisco, CA	Amer Thorac Soc					[Lascano, J.; Oshins, R.; Eagan, C.; Wadood, Z.; Flagg, T.; Scindia, Y.; Mehrad, B.; Brantly, M. L.; Khodayari, N.] Univ Florida, Div Pulm Crit Care & Sleep Med, Gainesville, FL USA; [Qiang, X.] MilliporeSigma, Burlington, MO USA	State University System of Florida; University of Florida; Merck KGaA; MilliporeSigma					Alpha-1 Foundation	Alpha-1 Foundation	This abstract is funded by: Alpha-1 Foundation, John W Walsh Tranlational Research Award.		0	0	0	1	1	AMER THORACIC SOC	NEW YORK	25 BROADWAY, 18 FL, NEW YORK, NY 10004 USA	1073-449X	1535-4970		AM J RESP CRIT CARE	Am. J. Respir. Crit. Care Med.	MAY 1	2022	205			S		A3624								1	Critical Care Medicine; Respiratory System	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Respiratory System	1B5MH	36084115	gold, Green Submitted, Green Published			2022-12-26	WOS:000792480403495
J	Takahashi, H; Tokura, M; Kawarasaki, S; Nagai, H; Iwase, M; Nishitani, K; Okaze, H; Mohri, S; Ito, T; Ara, T; Jheng, HF; Nomura, W; Kawada, T; Inoue, K; Goto, T				Takahashi, Haruya; Tokura, Motohiro; Kawarasaki, Satoko; Nagai, Hiroyuki; Iwase, Mari; Nishitani, Kento; Okaze, Haruka; Mohri, Shinsuke; Ito, Tetsuro; Ara, Takeshi; Jheng, Huei-Fen; Nomura, Wataru; Kawada, Teruo; Inoue, Kazuo; Goto, Tsuyoshi			Metabolomics reveals inosine 5'-monophosphate is increased during mice adipocyte browning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; MYCOPHENOLIC-ACID; IMP DEHYDROGENASE; FAT DEVELOPMENT; BEIGE FAT; EXPRESSION; ENERGY; CELLS; ADIPOGENESIS; INHIBITION	Adipocyte browning is one of the potential strategies for the prevention of obesity-related metabolic syndromes, but it is a complex process. Although previous studies make it increasingly clear that several transcription factors and enzymes are essential to induce browning, it is unclear what dynamic and metabolic changes occur in induction of browning. Here, we analyzed the effect of a beta-adrenergic receptor agonist (CL316243, accelerator of browning) on metabolic change in mice adipose tissue and plasma using metabolome analysis and speculated that browning is regulated partly by inosine 5'-monophosphate (IMP) metabolism. To test this hypothesis, we investigated whether Ucp-1, a functional marker of browning, mRNA expression is influenced by IMP metabolism using immortalized adipocytes. Our study showed that mycophenolic acid, an IMP dehydrogenase inhibitor, increases the mRNA expression of Ucp-1 in immortalized adipocytes. Furthermore, we performed a single administration of mycophenolate mofetil, a prodrug of mycophenolic acid, to mice and demonstrated that mycophenolate mofetil induces adipocyte browning and miniaturization of adipocyte size, leading to adipose tissue weight loss. These findings showed that IMP metabolism has a significant effect on adipocyte browning, suggesting that the regulator of IMP metabolism has the potential to prevent obesity.	[Takahashi, Haruya; Tokura, Motohiro; Kawarasaki, Satoko; Iwase, Mari; Nishitani, Kento; Okaze, Haruka; Mohri, Shinsuke; Ara, Takeshi; Jheng, Huei-Fen; Nomura, Wataru; Kawada, Teruo; Inoue, Kazuo; Goto, Tsuyoshi] Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Japan; [Nagai, Hiroyuki; Ito, Tetsuro] Gifu Prefectural Res Inst Hlth & Environm Sci, Gifu, Japan; [Ito, Tetsuro] Gifu Univ Med Sci, Fac Pharm, Dept Pharm, Lab Pharmacognosy, Gifu, Japan; [Nomura, Wataru; Kawada, Teruo; Inoue, Kazuo; Goto, Tsuyoshi] Kyoto Univ, Res Unit Physiol Chem, Kyoto, Japan	Kyoto University; Kyoto University	Goto, T (corresponding author), Kyoto Univ, Grad Sch Agr, Div Food Sci & Biotechnol, Uji, Japan.; Goto, T (corresponding author), Kyoto Univ, Res Unit Physiol Chem, Kyoto, Japan.	goto.tsuyoshi.6x@kyoto-u.ac.jp	Iwase, Mari/GZH-2961-2022	Iwase, Mari/0000-0002-6494-8787				Akimoto N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01390-3; Altshuler-Keylin S, 2016, CELL METAB, V24, P402, DOI 10.1016/j.cmet.2016.08.002; An JY, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201700688; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; CRABTREE GW, 1971, CANCER RES, V31, P985; Crews B, 2009, ANAL CHEM, V81, P8538, DOI 10.1021/ac9014947; Demirkiran A, 2009, TRANSPLANTATION, V87, P1062, DOI 10.1097/TP.0b013e31819d2032; Evans BA, 1998, BRIT J PHARMACOL, V124, P763, DOI 10.1038/sj.bjp.0701867; Farazi T, 1997, J BIOL CHEM, V272, P961, DOI 10.1074/jbc.272.2.961; Franklin TJ, 1996, CANCER RES, V56, P984; Fujimoto Y, 2019, J CELL BIOCHEM, V120, P821, DOI 10.1002/jcb.27443; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Hanatani S, 2016, J CLIN BIOCHEM NUTR, V59, P207, DOI 10.3164/jcbn.16-23; Hara H, 2019, J AGR FOOD CHEM, V67, P10595, DOI 10.1021/acs.jafc.9b01930; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Iijima Y, 2008, PLANT J, V54, P949, DOI 10.1111/j.1365-313X.2008.03434.x; Inokuma K, 2006, AM J PHYSIOL-ENDOC M, V290, pE1014, DOI 10.1152/ajpendo.00105.2005; Irie Y, 1999, BIOCHEM BIOPH RES CO, V255, P221, DOI 10.1006/bbrc.1998.9999; Iwase M, 2020, J BIOL CHEM, V295, P7033, DOI 10.1074/jbc.RA119.011658; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Kajimura S, 2014, ANNU REV PHYSIOL, V76, P225, DOI 10.1146/annurev-physiol-021113-170252; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kawarasaki S, 2019, FEBS LETT, V593, P1201, DOI 10.1002/1873-3468.13430; Kwan HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02263-5; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Mills EL, 2018, NATURE, V560, P102, DOI 10.1038/s41586-018-0353-2; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Papageorgiou Christos, 2001, Mini-Reviews in Medicinal Chemistry, V1, P71, DOI 10.2174/1389557013407269; Sakurai N, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00114; Schweizer S, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000412; Shinoda K, 2015, CELL METAB, V22, P997, DOI 10.1016/j.cmet.2015.09.029; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Simon BR, 2013, J BIOL CHEM, V288, P32475, DOI 10.1074/jbc.M113.514034; SNYDER FF, 1972, BIOCHEM PHARMACOL, V21, P2351, DOI 10.1016/0006-2952(72)90386-3; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; SOLLINGER HW, 1995, TRANSPLANTATION, V60, P225, DOI 10.1097/00007890-199508000-00003; Takahashi H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254190; Takahashi H, 2017, BIOCHEM BIOPH RES CO, V493, P108, DOI 10.1016/j.bbrc.2017.09.067; Takahashi H, 2015, J LIPID RES, V56, P254, DOI 10.1194/jlr.M052464; Takahashi H, 2015, LIPIDS, V50, P3, DOI 10.1007/s11745-014-3972-x; von Vietinghoff S, 2010, KIDNEY INT, V78, P79, DOI 10.1038/ki.2010.84; WEBER G, 1983, CANCER RES, V43, P3466; Yoneshiro T, 2019, NATURE, V572, P614, DOI 10.1038/s41586-019-1503-x; Yoneshiro T, 2015, ANN MED, V47, P133, DOI 10.3109/07853890.2014.911595; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803	52	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	298	10							102456	10.1016/j.jbc.2022.102456	http://dx.doi.org/10.1016/j.jbc.2022.102456			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5K6GU	36063990	Green Published, gold			2022-12-26	WOS:000869823800015
J	Tan, SPN; Cho, KL; Nodwell, JR				Tan, Stephanie; Cho, Kelvin; Nodwell, Justin R.			A defect in cell wall recycling confers antibiotic resistance and sensitivity in Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VANCOMYCIN RESISTANCE; KINASE PKNB; BIOSYNTHESIS; INSIGHTS; SYSTEM; SIGNAL	WalKR is a two-component system that is essential for viability in Gram-positive bacteria that regulates the all-important autolysins in cell wall homeostasis. Further investi-gation of this essential system is important for identifying ways to address antibiotic resistance. Here, we show that a T101M mutation in walR confers a defect in autolysis, a thickened cell wall, and decreased susceptibility to antibiotics that target lipid II cycle, a phenotype that is reminiscent of the clinical resis-tance form known as vancomycin intermediate-resistant Staphylococcus aureus. Importantly, this is accompanied by dramatic sensitization to tunicamycin. We demonstrate that this phenotype is due to partial collapse of a pathway consisting of autolysins, AtlA and Sle1, a transmembrane sugar permease, MurP, and GlcNAc recycling enzymes, MupG and MurQ. We suggest that this causes a shortage of substrate for the pepti-doglycan biosynthesis enzyme MraY, causing it to be hyper-sensitive to competitive inhibition by tunicamycin. In conclusion, our results constitute a new molecular model for antibiotic sensitivity in S. aureus and a promising new route for antibiotic discovery.	[Tan, Stephanie; Cho, Kelvin; Nodwell, Justin R.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto	Nodwell, JR (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	justin.nodwell@utoronto.ca		Tan, Stephanie/0000-0001-7829-2064	Canadian Institutes for Health Research;  [MID-406688]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); 	Acknowledgments-We thank Dr David Heinrichs for the generous gift of the pRMC2 plasmid for S. aureus genetics and Dr Ronald Flannagan for guidance on plasmid optimization. We thank the Canadian Institutes for Health Research (Grant MID-406688) .	Borisova M, 2016, MBIO, V7, DOI 10.1128/mBio.00923-16; Cameron DR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30823; Carroll RK, 2016, METHODS MOL BIOL, V1373, P131, DOI 10.1007/7651_2014_192; Corrigan RM, 2009, PLASMID, V61, P126, DOI 10.1016/j.plasmid.2008.10.001; Cui LZ, 2000, ANTIMICROB AGENTS CH, V44, P2276, DOI 10.1128/AAC.44.9.2276-2285.2000; Donat S, 2009, J BACTERIOL, V191, P4056, DOI 10.1128/JB.00117-09; Dubrac S, 2007, J BACTERIOL, V189, P8257, DOI 10.1128/JB.00645-07; Gajdiss M, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8060870; GEORGOPAPADAKOU NH, 1982, ANTIMICROB AGENTS CH, V22, P172, DOI 10.1128/AAC.22.1.172; Grein F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15257-1; Hafer C, 2012, ANTIMICROB AGENTS CH, V56, P5845, DOI 10.1128/AAC.01139-12; Hardt P, 2017, INT J MED MICROBIOL, V307, P1, DOI 10.1016/j.ijmm.2016.12.001; Holland TL, 2014, JAMA-J AM MED ASSOC, V312, P1330, DOI 10.1001/jama.2014.9743; Hoskisson PA, 2006, TRENDS MICROBIOL, V14, P444, DOI 10.1016/j.tim.2006.08.005; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Jaeger T, 2008, J BACTERIOL, V190, P6598, DOI 10.1128/JB.00642-08; Jorge AM, 2017, MOL MICROBIOL, V103, P229, DOI 10.1111/mmi.13552; Katayama Y, 2016, ANTIMICROB AGENTS CH, V60, P3730, DOI 10.1128/AAC.00420-16; King A. M., 2016, NATURE, V510, P503; Kluj RM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02725; Lin LC, 2018, INFECT DRUG RESIST, V11, P113, DOI 10.2147/IDR.S148335; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mak S, 2017, MOL MICROBIOL, V106, P597, DOI 10.1111/mmi.13837; Mayer C, 2019, INT J MED MICROBIOL, V309, DOI 10.1016/j.ijmm.2019.06.006; Meredith TC, 2008, J BACTERIOL, V190, P3046, DOI 10.1128/JB.01880-07; Miethke M, 2021, NAT REV CHEM, V5, P726, DOI 10.1038/s41570-021-00313-1; Monk IR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10932-4; Porankiewicz J, 1999, MOL MICROBIOL, V32, P449, DOI 10.1046/j.1365-2958.1999.01357.x; Poupel O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151449; Prestinaci F, 2015, PATHOG GLOB HEALTH, V109, P309, DOI 10.1179/2047773215Y.0000000030; Roemer T, 2013, NAT CHEM BIOL, V9, P222, DOI [10.1038/NCHEMBIO.1205, 10.1038/nchembio.1205]; Schneider T, 2009, ANTIMICROB AGENTS CH, V53, P1610, DOI 10.1128/AAC.01040-08; Shariati A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69058-z; Stavri M, 2007, J ANTIMICROB CHEMOTH, V59, P1247, DOI 10.1093/jac/dkl460; Sugden R, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.187, 10.1038/nmicrobiol.2016.187]; Tan S, 2019, ACS CHEM BIOL, V14, P966, DOI 10.1021/acschembio.9b00157; Tenover FC, 2001, EMERG INFECT DIS, V7, P327, DOI 10.3201/eid0702.010237; Vaz F., 2015, ELIFE, V5, DOI [10.21769/BioProtoc.1687, DOI 10.21769/BIOPROTOC.1687]; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wagner C, 2002, INFECT IMMUN, V70, P6121, DOI 10.1128/IAI.70.11.6121-6128.2002; Wang YB, 2017, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02163; Werth BJ, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.07.028; WHO, 2021, GLOB ANT RES US SURV; Winkler ME, 2008, J BACTERIOL, V190, P2645, DOI 10.1128/JB.01682-07	44	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102473	10.1016/j.jbc.2022.102473	http://dx.doi.org/10.1016/j.jbc.2022.102473			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5S8ED	36089064	Green Published, gold			2022-12-26	WOS:000875415100010
J	Wu, CS; Xu, GH; Bao, GF; Gao, H; Chen, JJ; Zhang, JL; Chen, C; Hong, HX; Xue, PF; Jiang, JW; Liu, Y; Huang, JY; Sun, Y; Fu, JW; Li, YQ; Cui, ZM				Wu, Chunshuai; Xu, Guanhua; Bao, Guofeng; Gao, Hong; Chen, Jiajia; Zhang, Jinlong; Chen, Chu; Hong, Hongxiang; Xue, Pengfei; Jiang, Jiawei; Liu, Yang; Huang, Jiayi; Sun, Yue; Fu, Jiawei; Li, Yiqiu; Cui, Zhiming			Ubiquitin ligase Triad1 promotes neurite outgrowth by inhibiting MDM2-mediated ubiquitination of the neuroprotective factor pleiotrophin br	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; REGENERATION; MODULATION; MICROGLIA; NEURON; BDNF; NGF; P53	Spinal cord injury (SCI) is the most severe result of spine injury, but no effective therapy exists to treat SCI. We have previously shown that the E3 ubiquitin ligase Two RING fin-gers and DRIL 1 (Triad1) promotes neurite outgrowth after SCI. However, the mechanism by which Triad1 affects neuron growth and the potential involvement of its ubiquitination activity is unclear. Neuroprotective cytokine pleiotrophin (PTN) can promote microglia proliferation and neurotrophic factor secretion to achieve neuroprotection. We find using immunostaining and behavioral assays in rats that the expression of Triad1 and the PTN was peaked at 1 day after SCI and Triad1 improved motor function and histomorpho-logical injury after SCI. We show using flow cytometry and astrocyte/neuronal coculture assays that Triad1 overexpression promoted PTN protein levels, neurotrophic growth factor (NGF) expression, brain-derived neurotrophic factor (BDNF) expression, astrocyte and neuronal viability, and neurite outgrowth but suppressed astrocyte apoptosis, while shRNA-mediated knockdown of Triad1 and PTN had the opposite effects. Ubiquitin ligase murine double mutant 2 (MDM2) has previously been demonstrated to participate in the process of neurite outgrowth and mediate ubiquitination of p53. Furthermore, we demonstrate overexpression of MDM2 downregulated PTN protein levels, NGF expression and BDNF expression in astrocytes, and inhibited neurite outgrowth of neurons. In addition, MDM2 facilitated PTN ubiquitination, which was reversed by Triad1. Finally, we show simultaneous sh-PTN and MDM2 overexpression attenuated the neurite outgrowth-promoting effect of Triad1 overexpression. In conclusion, we propose Triad1 promotes astrocyte-dependent neurite outgrowth to accelerate recovery after SCI by inhibit-ing MDM2-mediated PTN ubiquitination.	[Wu, Chunshuai; Xu, Guanhua; Bao, Guofeng; Gao, Hong; Chen, Jiajia; Zhang, Jinlong; Chen, Chu; Hong, Hongxiang; Xue, Pengfei; Jiang, Jiawei; Liu, Yang; Huang, Jiayi; Sun, Yue; Fu, Jiawei; Li, Yiqiu; Cui, Zhiming] Nantong Univ, Affiliated Hosp 2, Peoples Hosp Nantong 1, Dept Spine Surg, Nantong, Peoples R China; [Wu, Chunshuai; Cui, Zhiming] Key Lab Restorat Mech & Clin Translat Spinal Cord, Nantong, Peoples R China; [Wu, Chunshuai; Cui, Zhiming] Nantong Univ, Res Inst Spine & Spinal Cord Dis, Nantong, Peoples R China	Nantong University; Nantong University	Cui, ZM (corresponding author), Nantong Univ, Affiliated Hosp 2, Peoples Hosp Nantong 1, Dept Spine Surg, Nantong, Peoples R China.; Cui, ZM (corresponding author), Key Lab Restorat Mech & Clin Translat Spinal Cord, Nantong, Peoples R China.; Cui, ZM (corresponding author), Nantong Univ, Res Inst Spine & Spinal Cord Dis, Nantong, Peoples R China.	zhimingcuispine@163.com			National Natural Science Foundation of China [81771319]; Medical Scientific Research Project of Jiangsu Provincial Health Commission [ZDB2020004]; Six Talent Peak Funding Projects in Jiangsu Province [2017-WSW-156]; Scientific Research Project of Nantong Municipal Health Commission [MA2021016]; Youth Fund of National Natural Science Foundation of China [82002394]; Jiangsu Young Medical Talents Funding Project [QNRC2016413]; Nantong Social Livelihood Science and Technology Project [MS12019027]; Jiangsu Graduate Research and Practice Innovation Program [KYCX21_3107]; Nantong Science and Technology Project [JC2020013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Project of Jiangsu Provincial Health Commission; Six Talent Peak Funding Projects in Jiangsu Province; Scientific Research Project of Nantong Municipal Health Commission; Youth Fund of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Young Medical Talents Funding Project; Nantong Social Livelihood Science and Technology Project; Jiangsu Graduate Research and Practice Innovation Program; Nantong Science and Technology Project	This work was supported by the National Natural Science Foundation of China [81771319] ; the Medical Scientific Research Project of Jiangsu Provincial Health Commission [ZDB2020004] ; the Six Talent Peak Funding Projects in Jiangsu Province [2017-WSW-156] ; the Scientific Research Project of Nantong Municipal Health Commission [MA2021016] ; the Youth Fund of National Natural Science Foundation of China [82002394] ; the Jiangsu Young Medical Talents Funding Project [QNRC2016413] ; the Nantong Social Livelihood Science and Technology Project [MS12019027] ; the Jiangsu Graduate Research and Practice Innovation Program [KYCX21_3107] ; the Nantong Science and Technology Project [JC2020013] .	Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Ashammakhi N, 2019, TISSUE ENG PART B-RE, V25, P471, DOI [10.1089/ten.teb.2019.0182, 10.1089/ten.TEB.2019.0182]; Bae S, 2012, FEBS LETT, V586, P3057, DOI 10.1016/j.febslet.2012.07.022; Bae S, 2012, ONCOL REP, V28, P1924, DOI 10.3892/or.2012.2005; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; Carter G. T., 2014, PHYS MED REH CLIN N, V25, pxiii; Cho KS, 2013, GLIA, V61, P694, DOI 10.1002/glia.22463; Cotton TR, 2020, BIOCHEM SOC T, V48, P1737, DOI 10.1042/BST20200237; Eckert MJ, 2017, SURG CLIN N AM, V97, P1031, DOI 10.1016/j.suc.2017.06.008; Faktor J, 2019, Klin Onkol, V32, P56, DOI 10.14735/amko20193S; Fan BY, 2018, CELL TRANSPLANT, V27, P853, DOI 10.1177/0963689718755778; Guizzetti M, 2008, J BIOL CHEM, V283, P31884, DOI 10.1074/jbc.M801316200; Guo MM, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.646720; Hassink G, 2012, BIOL OPEN, V1, P607, DOI 10.1242/bio.2012778; Holmes D, 2017, NATURE, V552, pS49, DOI 10.1038/d41586-017-07550-9; Hu J, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8020054; Jiang R, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1024-9; Joshi Y, 2015, BRAIN, V138, P1843, DOI 10.1093/brain/awv125; Kroner A, 2019, NEUROSCI LETT, V709, DOI 10.1016/j.neulet.2019.134370; Kwon BK, 2019, SPINAL CORD, V57, P819, DOI 10.1038/s41393-019-0319-8; Lee J, 2017, J CELL BIOCHEM, V118, P1733, DOI 10.1002/jcb.25831; Lee YK, 2009, NEUROCHEM RES, V34, P2251, DOI 10.1007/s11064-009-0024-7; Li DB, 2013, J MOL HISTOL, V44, P381, DOI 10.1007/s10735-013-9499-2; Louveau A, 2015, GLIA, V63, P2298, DOI 10.1002/glia.22894; Miao JY, 2012, NEUROSCI RES, V74, P269, DOI 10.1016/j.neures.2012.09.001; Nakamura N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041080; Nikolakopoulou AM, 2019, NAT NEUROSCI, V22, P1089, DOI 10.1038/s41593-019-0434-z; Numakawa T, 2010, HISTOL HISTOPATHOL, V25, P237, DOI 10.14670/HH-25.237; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Sandoval-Castellanos AM, 2020, BIOTECHNOL BIOENG, V117, P3124, DOI 10.1002/bit.27466; Shen X., 2022, COMPUT MATH MET MED, V2022; Shimizu S, 2011, JOVE-J VIS EXP, DOI 10.3791/3257; Tang CY, 2019, NEURON, V101, P32, DOI 10.1016/j.neuron.2018.10.051; Wang CG, 2018, J CELL MOL MED, V22, P1148, DOI 10.1111/jcmm.13368; Wang CJ, 2021, J NEUROINFLAMM, V18, DOI 10.1186/s12974-021-02092-4; Wang D, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.609613; Wang H, 2018, ONCOGENE, V37, P2532, DOI 10.1038/s41388-018-0131-5; Wang JY, 2018, NEUROSCIENCE, V383, P12, DOI 10.1016/j.neuroscience.2018.04.045; Wang SY, 2020, INT J NEUROSCI, V130, P759, DOI 10.1080/00207454.2019.1705807; Wang ZR, 2021, ACTA PHARM SIN B, V11, P694, DOI 10.1016/j.apsb.2020.11.005; Wu CS, 2022, SOMATOSENS MOT RES, V39, P21, DOI 10.1080/08990220.2021.1986385; Wu CS, 2019, J CELL BIOCHEM, V120, P5355, DOI 10.1002/jcb.27814; Zhao YZ, 2016, ACTA BIOMATER, V29, P71, DOI 10.1016/j.actbio.2015.10.014	44	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102443	10.1016/j.jbc.2022.102443	http://dx.doi.org/10.1016/j.jbc.2022.102443			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5H1DF	36055408	gold, Green Published			2022-12-26	WOS:000867425500007
J	Yang, CY; Liu, Y; Wang, ZY; Lin, MM; Liu, C				Yang, Chengyu; Liu, Yang; Wang, Ziyan; Lin, Minmin; Liu, Chao			Controlled mechanical loading improves bone regeneration by regulating type H vessels in a S1Pr1-dependent manner	FASEB JOURNAL			English	Article						angiogenesis; bone regeneration; mechanobiology; osteoprogenitors; S1Pr1	PROTEIN-COUPLED RECEPTOR; SPHINGOSINE 1-PHOSPHATE; STEM-CELLS; SPHINGOSINE-1-PHOSPHATE; ANGIOGENESIS; S1P; DIFFERENTIATION; OSTEOGENESIS	Despite the best treatment, approximately 10% of fractures still face undesirable repair and result in delayed unions or non-unions. Dynamic mechanical stimulation promotes bone formation, when applied at the correct time frame, with optimal loading magnitude, frequency, and repetition. Controlled mechanical loading significantly increases osteogenic cells during the matrix deposition phase of bone repair. In the bone defect, the blood vessel network guides the initial bone formation activities. A unique blood vessel subtype (Type H) exists in bone, which expresses high levels of CD31 and endomucin, and functions to couple angiogenesis and osteogenesis. However, how this form of controlled mechanical loading regulates the Type H vessels and promotes bone formation is still not clear. Sphingosine 1-phosphate (S1P) participates in the bone anabolic process and is a key regulator of the blood vessel. Its receptor, sphingosine 1-phosphate receptor 1 (S1Pr1), is a mechanosensitive protein that regulates vascular integrity. Therefore, we hypothesis that controlled anabolic mechanical loading promotes bone repair by acting on Type H vessels. To study the effect of S1Pr1 on loading induced-bone repair, we utilized a stabilized tibial defect model, which allows for the application of anabolic mechanical loading. Mechanical loading upregulated S1Pr1 within the entire defect, with up to 80% expressed in blood vessels, as observed by deep tissue imaging. Additionally, S1Pr1 antagonism by W146 inhibited the anabolic effects of mechanical loading. We showed that mechanical loading or activating S1Pr1 could induce YAP nuclear translocation, a key regulator in the cell's mechanical response, in endothelial cells (ECs) in vitro. Inhibition of S1Pr1 in endothelial cells by siRNA reduced loading-induced YAP nuclear translocation and expressions of angiogenic genes. In vivo, YAP nuclear translocation in Type H vessels was up-regulated after mechanical loading but was inhibited by antagonizing S1Pr1. S1Pr1 agonist, FTY720, increased bone volume and Type H vessel volume, similar to that of mechanical stimulation. In conclusion, controlled anabolic mechanical loading enhanced bone formation mainly through Type H vessels in a S1Pr1-dependent manner.	[Yang, Chengyu; Liu, Yang; Wang, Ziyan; Lin, Minmin; Liu, Chao] Southern Univ Sci & Technol, Coll Engn, Dept Biomed Engn, 1088 Xueyuan Ave,Coll Engn Bldg,South Room 732, Shenzhen 518055, Peoples R China; [Yang, Chengyu; Liu, Yang; Wang, Ziyan; Lin, Minmin; Liu, Chao] Southern Univ Sci & Technol, Guangdong Prov Key Lab Adv Biomat, Shenzhen, Peoples R China	Southern University of Science & Technology; Southern University of Science & Technology	Liu, C (corresponding author), Southern Univ Sci & Technol, Coll Engn, Dept Biomed Engn, 1088 Xueyuan Ave,Coll Engn Bldg,South Room 732, Shenzhen 518055, Peoples R China.	liuc33@sustech.edu.cn	Wang, Ziyan/HII-8458-2022; Liu, Chao/E-2667-2019	Liu, Yang/0000-0002-2226-0941; Liu, Chao/0000-0001-6637-1689	Shenzhen Science and Technology Innovation Commission [JCYJ20190809114209434, KQTD20200820113012029]; Guangdong Provincial Key Laboratory of Advanced Biomaterials [2022B1212010003]	Shenzhen Science and Technology Innovation Commission; Guangdong Provincial Key Laboratory of Advanced Biomaterials	The work was supported by Shenzhen Science and Technology Innovation Commission (Grant No. JCYJ20190809114209434, KQTD20200820113012029), Guangdong Provincial Key Laboratory of Advanced Biomaterials (2022B1212010003) for financial support. We acknowledge the assistance of Ying Wang for the micro-CT imaging and confocal imaging from the SUSTech Core Research Core Research Facilities. The authors also would like to thank Mr. Hui Guo from SUSTech Laboratory Animal Center for her generous help during the animal tests.	Aronin CEP, 2010, TISSUE ENG PT A, V16, P1801, DOI [10.1089/ten.tea.2009.0539, 10.1089/ten.TEA.2009.0539]; Augat P, 2005, OSTEOPOROSIS INT, V16, pS36, DOI 10.1007/s00198-004-1728-9; Bao XM, 2020, GLIA, V68, P1757, DOI 10.1002/glia.23803; Ben Shoham A, 2012, DEVELOPMENT, V139, P3859, DOI 10.1242/dev.078550; Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108; Cartier A, 2020, P NATL ACAD SCI USA, V117, P3157, DOI 10.1073/pnas.1906246117; Castillo AB, 2015, CURR RHEUMATOL REP, V17, DOI 10.1007/s11926-015-0537-9; Chen Q, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107828; Geng X, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.137652; Golan K, 2013, PHARMACEUTICALS, V6, P1145, DOI 10.3390/ph6091145; Grewe JM, 2022, BONE RES, V10, DOI 10.1038/s41413-022-00205-0; Higashi K, 2016, BONE, V93, P1, DOI 10.1016/j.bone.2016.09.003; Huang C, 2016, MOL MED REP, V14, P927, DOI 10.3892/mmr.2016.5342; Huang C, 2012, CELL TISSUE RES, V347, P553, DOI 10.1007/s00441-011-1217-3; Ishii M, 2010, J EXP MED, V207, P2793, DOI 10.1084/jem.20101474; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jung B, 2012, DEV CELL, V23, P600, DOI 10.1016/j.devcel.2012.07.015; Kusumbe AP, 2014, NATURE, V507, P323, DOI 10.1038/nature13145; Lin CW, 2017, ELIFE, V6, DOI 10.7554/eLife.21130; Liu C, 2019, J BONE MINER RES, V34, P896, DOI 10.1002/jbmr.3668; Liu C, 2018, BONE, V108, P145, DOI 10.1016/j.bone.2017.12.027; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Main RP, 2020, J ORTHOP RES, V38, P233, DOI 10.1002/jor.24466; Matsuzaki E, 2022, J DENT SCI, V17, P787, DOI 10.1016/j.jds.2021.10.004; McDermott AM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav7756; Meshcheryakova A, 2017, EXPERT OPIN THER TAR, V21, P725, DOI 10.1080/14728222.2017.1332180; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Nakajima H, 2017, DEV CELL, V40, P523, DOI 10.1016/j.devcel.2017.02.019; Newby J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00739-6; Prasad J, 2010, J BIOMECH, V43, P2765, DOI 10.1016/j.jbiomech.2010.06.030; Ramasamy SK, 2014, NATURE, V507, P376, DOI 10.1038/nature13146; Ruehle MA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb6351; Ryu J, 2006, EMBO J, V25, P5840, DOI 10.1038/sj.emboj.7601430; Salhotra A, 2020, NAT REV MOL CELL BIO, V21, P696, DOI 10.1038/s41580-020-00279-w; Shen B, 2021, NATURE, V591, P438, DOI 10.1038/s41586-021-03298-5; Sivaraj KK, 2016, DEVELOPMENT, V143, P2706, DOI 10.1242/dev.136861; Tantikanlayaporn D, 2018, JBMR PLUS, V2, P217, DOI 10.1002/jbm4.10037; Thompson MS, 2007, MED ENG PHYS, V29, P820, DOI 10.1016/j.medengphy.2006.08.012; Wang XH, 2017, DEV CELL, V42, P462, DOI 10.1016/j.devcel.2017.08.002; Wang XT, 2021, FASEB J, V35, DOI 10.1096/fj.202001080RR; Wang ZY, 2021, FASEB J, V35, DOI 10.1096/fj.202101045RR; Weske S, 2018, NAT MED, V24, P667, DOI 10.1038/s41591-018-0005-y; Wildemann B, 2021, NAT REV DIS PRIMERS, V7, DOI 10.1038/s41572-021-00289-8; Xiao L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01409; Xiao L, 2018, J BONE MINER RES, V33, P1090, DOI 10.1002/jbmr.3396; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yuan Y, 2021, CELL RES, V31, P1263, DOI 10.1038/s41422-021-00566-x	47	0	0	6	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22530	10.1096/fj.202200339RRR	http://dx.doi.org/10.1096/fj.202200339RRR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4I1IL	36063128				2022-12-26	WOS:000850330000001
J	Santoro, FR; Richeri, M; Ladio, AH				Rosa Santoro, Flavia; Richeri, Marina; Ladio, Ana Haydee			Factors affecting local plant knowledge in isolated communities from Patagonian steppe: Metacommunity theory is revealed as a methodological approach	PLOS ONE			English	Article							WILD EDIBLE PLANTS; TRADITIONAL KNOWLEDGE; RURAL-COMMUNITY; MEDICINAL-PLANTS; PATTERNS; MAPUCHE; INHABITANTS; RESILIENCE	The Patagonian steppe is a refuge for several indigenous peoples who live in relatively isolated communities, depending heavily on natural resources for their activities, health, and food security. The local ecological knowledge is a reservoir that generates full wellbeing and for which it must be the object of protection and local development. In this study, we aimed to find which factors can influence local ecological knowledge from a metacommunity on the Patagonian steppe. We analyzed variation in knowledge about cultivated and gathered plants used as medicinal, edible, and firewood according to multiple factors widely discussed in the ethnobiological literature: age, gender, formal education, occupation, indigenous identity, contact with urban centers, use of biomedicine, hunting, and handcrafted textile production. We conducted semi-structured interviews with local experts, accessed by the snowball technique. We found that formal education is a key factor in the variation of local ecological knowledge among people. In addition, we found that knowledge varies between people who practice activities inside and outside the home, concentrating knowledge between cultivated and gathered plants, respectively. Our urbanization proxies did not point to an influence of this factor on local knowledge, but specialists living in a larger community with signs of internal urbanization processes had much less knowledge. Our results allowed us to visualize the importance of studying metacommunities as a whole, to verify complexities and intersections of overlapping factors. Studies in metacommunities open up a range of possibilities for ethnobiological analysis.	[Rosa Santoro, Flavia] Univ Nacl Cordoba, IMBIV CONICET, Cordoba, Argentina; [Richeri, Marina] Univ Nacl Patagonia San Juan Bosco, Puerto Madryn, Argentina; [Ladio, Ana Haydee] Univ Nacl Comahue, INIBIOMA CONICET, San Carlos De Bariloche, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Universidad Nacional de la Patagonia San Juan Bosco; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional del Comahue	Santoro, FR (corresponding author), Univ Nacl Cordoba, IMBIV CONICET, Cordoba, Argentina.	flaviarsantoro@gmail.com		Ladio, Ana/0000-0002-2844-6704	FONCYT [PICT 2018-03395]; CONICET-National Council for Scientific Research, Argentina	FONCYT(FONCyT); CONICET-National Council for Scientific Research, Argentina	This work was carried out with funding to AHL from FONCYT (PICT 2018-03395). This research was also supported by a postdoctoral fellowship assigned to FRS by CONICET-National Council for Scientific Research, Argentina. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque UP, 2020, HUM ECOL, V48, P557, DOI 10.1007/s10745-020-00189-7; Albuquerque UP., 2014, METHODS TECHNIQUES E, V1, DOI [10.1007/978-1-4614-8636-7, DOI 10.1007/978-1-4614-8636-7]; Athayde S, 2017, HUM ECOL, V45, P533, DOI 10.1007/s10745-017-9919-0; Banales-Seguel C, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12197895; Barreau A, 2016, J ETHNOBIOL, V36, P412; Barthel S, 2013, ECOL SOC, V18, DOI 10.5751/ES-06207-180471; Bechtold T., 2009, HDB NATURAL COLORANT; Benencia R., 1995, ESTUDIOS MIGRATORIOS, V31, P576; Nascimento ALB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206190; Cabrera AL., 1971, BOLET N SOC ARGENTIN, V14, P1; Campos MT, 2003, ECON BOT, V57, P324, DOI 10.1663/0013-0001(2003)057[0324:PVAITE]2.0.CO;2; Cardoso MB, 2013, J ARID ENVIRON, V98, P146, DOI 10.1016/j.jaridenv.2012.09.013; Castillo L, 2020, RANGELAND ECOL MANAG, V73, P594, DOI 10.1016/j.rama.2020.06.001; Castillo L, 2018, ENVIRON DEV SUSTAIN, V20, P2161, DOI 10.1007/s10668-017-9983-z; Eyssartier C, 2011, J ARID ENVIRON, V75, P78, DOI 10.1016/j.jaridenv.2010.09.006; Ferreira Junior WS., 2016, INTRO ETHNOBIOLOGY, P251; Godoy R, 2007, COMP EDUC, V43, P137, DOI 10.1080/03050060601162677; Gonzalez S, 2020, B SOC ARGENT BOT, V55, P641, DOI 10.31055/1851.2372.v55.n4.29305; Gundermann H., 2009, J THEOR APPL LING, V47, P37; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Howard P.L., 2006, TROPICAL HOMEGARDENS, P159; Huai HY, 2011, ECON BOT, V65, P345, DOI 10.1007/s12231-011-9172-1; Inta A, 2013, J ETHNOPHARMACOL, V149, P344, DOI 10.1016/j.jep.2013.06.047; Ochoa JJ, 2010, B LATINOAM CARIBE PL, V9, P269; Klooster CV., 2019, ETHNOBOT RES APPL, V18, P11; Ladio A. H., 2021, Ethnoscientia, V6, P1, DOI 10.18542/ethnoscientia.v6i2.10361; Ladio AH, 2013, LEARN INDIVID DIFFER, V27, P241, DOI 10.1016/j.lindif.2013.04.002; Ladio A. H., 2011, Bioremediation, Biodiversity and Bioavailability, V5, P60; Ladio AH, 2009, J ARID ENVIRON, V73, P222, DOI 10.1016/j.jaridenv.2008.02.006; Ladio AH, 2004, BIODIVERS CONSERV, V13, P1153, DOI 10.1023/B:BIOC.0000018150.79156.50; Ladio AH, 2003, BIODIVERS CONSERV, V12, P937, DOI 10.1023/A:1022873725432; Ladio AH., 2013, CONTINUITY CHANGE CU, P259; Laveglia F., 2004, APUNTES EC CHUBUT VI; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Leon Rolando J. C., 1998, Ecologia Austral, V8, P125; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lozada M, 2006, ECON BOT, V60, P374, DOI 10.1663/0013-0001(2006)60[374:CTOEKI]2.0.CO;2; MacArthur R.H., 1967, THEORY ISLAND BIOGEO; Marini-Filho OJ., 2000, 101 NCIA HOJE, V27, P22; Medeiros PM., 2016, INTRO ETHNOBIOLOGY, P245; Mesoudi A., 2011, CULTURAL EVOLUTION D; Molares S, 2009, J ETHNOPHARMACOL, V122, P251, DOI 10.1016/j.jep.2009.01.003; Perez de Micou C, 2007, AQUI VIVIERON ARQUEO; Pfeiffer Jeanine M., 2005, Journal of Ethnobiology, V25, P240, DOI 10.2993/0278-0771(2005)25[240:ACAEVI]2.0.CO;2; Pieroni A, 2011, HUM ECOL, V39, P333, DOI 10.1007/s10745-011-9401-3; Raats M. M., 1991, Food Quality and Preference, V3, P89, DOI 10.1016/0950-3293(91)90028-D; Reyes-Garcia V, 2013, EVOL HUM BEHAV, V34, P249, DOI 10.1016/j.evolhumbehav.2013.03.002; Reyes-Garcia V, 2010, INT J EDUC DEV, V30, P305, DOI 10.1016/j.ijedudev.2009.11.007; Richeri M., 2016, THESIS U NACL COMAHU; Rodriguez ME, 2000, GRAN LIBRO PROVINCIA; Rozzi R, 2012, ENVIRON ETHICS, V34, P27, DOI 10.5840/enviroethics20123414; Ruiz-Mallen I, 2009, INT RES GEOGR ENVIRO, V18, P82, DOI 10.1080/10382040902861155; Salama P., 2021, SETBACKS ADV MODERN, P31; Santoro FR, 2020, ACTA BOT BRAS, V34, P720, DOI [10.1590/0102-33062020abb0002, 10.1590/0102-33062020abb002]; Silva FD, 2011, REV BRAS FARMACOGN, V21, P382, DOI 10.1590/S0102-695X2011005000054; Srithi K, 2009, J ETHNOPHARMACOL, V123, P335, DOI 10.1016/j.jep.2009.02.035; Torres-Avilez W, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/6592363; Torres-Avilez WM., 2016, INTRO ETHNOBIOLOGY, P239, DOI DOI 10.1007/978-3-319-28155-1_35; van Luijk N, 2021, J ETHNOBIOL ETHNOMED, V17, DOI 10.1186/s13002-021-00461-0; Vandebroek I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037643; Viveiros de Castro Eduardo, 2004, TIPITI J SOC ANTHR L, P3; Zank S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174731	62	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274481	10.1371/journal.pone.0274481	http://dx.doi.org/10.1371/journal.pone.0274481			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094933	gold, Green Published			2022-12-26	WOS:000892376500046
J	Giroux, S; Waldman, K; Burris, M; Valliant, JCD; Babb, AM; Stafford, P; Fobi, D; Czebotar, K; Knudsen, DC				Giroux, Stacey; Waldman, Kurt; Burris, Mecca; Valliant, Julia C. D.; Babb, Angela M.; Stafford, Philip; Fobi, Daniel; Czebotar, Kamila; Knudsen, Daniel C.			Food security and well-being among older, rural Americans before and during the COVID-19 pandemic	PLOS ONE			English	Article								The COVID-19 pandemic has impacted many aspects of our lives. Older adults, those with less income or fewer resources, and those living in rural parts of the United States are potentially more vulnerable. To understand the negative impact of COVID-19 on perceived food security, physical and mental health, and loneliness in a sample of older, rural, low-income adults in the United States, we use results from a mailed survey in which residents of four Indiana counties contrasted their status during the early period of the pandemic to their typical pre-pandemic status. We test for significant changes in status and what predicts negative impacts to food security, health, and loneliness. We asked respondents to report on both pre-pandemic and since-pandemic experiences in the instrument, which was administered after the pandemic had begun, in May 2020. We measure food security using the U.S. Household Food Security Survey Module (six-item short form; HFSSM), physical and mental health using the Centers for Disease Control's Healthy Days Measures (HRQOL-4), and loneliness using the UCLA Revised Loneliness Scale. A binomial test identified significant declines in status for all three measures. Logistic regressions identified factors associated with each of the measures worsening. Fear of going to the store or food pantry was associated with all three measures. Decreased store hours and closed food pantries were associated with lower food security. More education, fewer years of age, being female, decreased income, and stockpiling were associated with more reported days of poor physical or mental health. Fewer years of age, lack of transportation, and eating less often with others were associated with perceived increased loneliness. The pandemic had a negative impact on respondents' food security, unhealthy days, and loneliness, but different factors were associated with each measure for this population. Our findings provide insight for targeted recovery efforts.	[Giroux, Stacey; Valliant, Julia C. D.] Indiana Univ, Ostrom Workshop, Bloomington, IN USA; [Waldman, Kurt; Fobi, Daniel; Knudsen, Daniel C.] Indiana Univ, Dept Geog, Bloomington, IN 47408 USA; [Burris, Mecca] Indiana Univ, Dept Anthropol, Bloomington, IN USA; [Stafford, Philip] CoDesign Commons, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Giroux, S (corresponding author), Indiana Univ, Ostrom Workshop, Bloomington, IN USA.	sagiroux@indiana.edu		Valliant, Julia CD/0000-0002-4194-8063	Center for Rural Engagement at Indiana University	Center for Rural Engagement at Indiana University	Study funded by the Center for Rural Engagement at Indiana University awarded to SG, KW, MB, JCDV, AB, PS, and DCK.	Blumberg SJ, 1999, AM J PUBLIC HEALTH, V89, P1231, DOI 10.2105/AJPH.89.8.1231; Cacioppo S, 2014, PSYCHOL BULL, V140, P1464, DOI 10.1037/a0037618; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Center for Disease Control and Prevention, 2000, MEAS HLTH DAYS POP A; Choi SWE, 2021, J GERONTOL B-PSYCHOL, V76, pE93, DOI 10.1093/geronb/gbaa182; Coleman-Jensen A., 2021, Economic Research Report - Economic Research Service, USDA; Cosby AG, 2019, AM J PUBLIC HEALTH, V109, P155, DOI [10.2105/ajph.2018.304787, 10.2105/AJPH.2018.304787]; Cutler DM, 2006, ED HLTH EVALUATING T; Economic Research Service US Dept. of Agriculture, DEFINITIONS FOOD SEC; Estes KD, 2020, PSYCHOL TRAUMA-US, V12, pS31, DOI 10.1037/tra0000853; Feeding America, MAP MEAL GAP; Fischler C, 2011, SOC SCI INFORM, V50, P528, DOI 10.1177/0539018411413963; Fitzpatrick KM, 2020, PSYCHOL TRAUMA-US, V12, pS17, DOI 10.1037/tra0000924; Food Research and Action Center (FRAC), NEW CENS USDA DAT FO; Fox J., 2018, R COMPANION APPL REG, VThird; Gallardo R, INDIANA BUSINESS REV; Harrington K., 2020, INNOV AGING, V4, P955, DOI [10.1093/geroni/igaa057.3494, DOI 10.1093/GERONI/IGAA057.3494]; Henning-Smith C, 2020, J AGING SOC POLICY, V32, P396, DOI 10.1080/08959420.2020.1770036; Herman CP., 2019, SOCIAL INFLUENCES EA, P215; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Jensen L, 2020, AM J PUBLIC HEALTH, V110, P1328, DOI 10.2105/AJPH.2020.305782; Kaplan KH, 2020, NAT FOOD, V1, P284, DOI 10.1038/s43016-020-0079-9; Kelfve S, 2020, BMC MED RES METHODOL, V20, DOI 10.1186/s12874-020-01138-0; Krendl AC, 2021, J GERONTOL B-PSYCHOL, V76, pE53, DOI 10.1093/geronb/gbaa110; Leider JP, 2020, AM J PUBLIC HEALTH, V110, P1283, DOI 10.2105/AJPH.2020.305728; Leung CW, 2020, PREV MED REP, V20, DOI 10.1016/j.pmedr.2020.101211; MacLeod S, 2021, GERIATRICS-BASEL, V6, DOI 10.3390/geriatrics6020052; Micalizzi L, 2021, BRIT J HEALTH PSYCH, V26, P535, DOI 10.1111/bjhp.12480; Miller IF, 2020, NAT MED, V26, P1212, DOI 10.1038/s41591-020-0952-y; Nantz EL, 2020, LOCAL ENVIRON, V25, P921, DOI 10.1080/13549839.2020.1845638; Niles MT, 2021, CURR DEV NUTR, V5, DOI 10.1093/cdn/nzab135; Peters DJ, 2020, J RURAL HEALTH, V36, P446, DOI 10.1111/jrh.12477; Reimold AE, 2021, PREV MED REP, V23, DOI 10.1016/j.pmedr.2021.101500; Sanchez EJ, 2020, AM J PUBLIC HEALTH, V110, P1340, DOI 10.2105/AJPH.2020.305856; Smith Amy S, 2019, OLDER POPULATION RUR; Team R. R, 2020, R LANG ENV STAT COMP; Thibaut Florence, 2020, Front Glob Womens Health, V1, P588372, DOI 10.3389/fgwh.2020.588372; US Census Bureau, COUNT RUR LEV; US Census Bureau, QUICKFACTS; Vahia IV, 2020, JAMA-J AM MED ASSOC, V324, P2253, DOI 10.1001/jama.2020.21753; Valliant JCD, 2022, J HUNGER ENVIRON NUT, V17, P593, DOI 10.1080/19320248.2021.1977208	41	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274020	10.1371/journal.pone.0274020	http://dx.doi.org/10.1371/journal.pone.0274020			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054130	gold, Green Published			2022-12-26	WOS:000892641400053
J	Torres-Bautista, A; Torres-Acosta, MA; Gonzalez-Valdez, J				Torres-Bautista, Abril; Torres-Acosta, Mario A.; Gonzalez-Valdez, Jose			Characterization and optimization of polymer-polymer aqueous two-phase systems for the isolation and purification of CaCo2 cell-derived exosomes	PLOS ONE			English	Article							DELIVERY; BEHAVIOR; FRACTIONATION; THERAPEUTICS; RECOVERY; BLOOD	Exosomes are cell-derived vesicles that present attractive characteristics such as nano size and unique structure for their use as drug delivery systems for drug therapy, biomarkers for prognostic, diagnostic and personalized treatments. So far, one of the major challenges for therapeutic applications of exosomes is the development of optimized isolation methods. In this context, aqueous two-phase systems (ATPS) have been used as an alternative method to isolate biological molecules and particles with promising expectations for exosomes. In this work, fractionation of exosomes obtained from CaCo2 cell line and culture media contaminants were individually performed in 20 polymer-polymer ATPS. The effect of design parameters such as polymer composition, molecular weight, and tie-line length (TLL) on polyethylene glycol (PEG)-Dextran, Dextran-Ficoll and PEG-Ficoll systems was studied. After partition analysis, 4 of the 20 systems presented the best exosome fractionation from contaminants under initial conditions, which were optimized via salt addition (NaCl) to a final concentration of 25 mM, to improve collection efficiency. The PEG 10,000 gmol-(1)-Dextran 10,000 gmol-(1) system at TLL 25% w/w with NaCl, showed the best potential isolation efficiency. Following this proposed strategy, an exosome purification factor of 2 in the top PEG-rich phase can be expected furtherly demonstrating that ATPS have the potential for the selective recovery of these promising nanovesicles.	[Torres-Bautista, Abril; Gonzalez-Valdez, Jose] Tecnol Monterrey, Sch Sci & Engn, Monterrey, Nuevo Leon, Mexico; [Torres-Acosta, Mario A.] UCL, Adv Ctr Biochem Engn, Dept Biochem Engn, London, England	Tecnologico de Monterrey; University of London; University College London	Gonzalez-Valdez, J (corresponding author), Tecnol Monterrey, Sch Sci & Engn, Monterrey, Nuevo Leon, Mexico.	jose_gonzalez@tec.mx	; Gonzalez-Valdez, Jose/F-8260-2011	Torres-Acosta, Mario/0000-0002-0846-2184; Gonzalez-Valdez, Jose/0000-0001-6734-8245	School of Engineering and Science at Tecnologico de Monterrey through the Molecular and Systems Bioengineering Research Group; FEMSA-Biotechnology Center at Tecnologico de Monterrey through the Molecular and Systems Bioengineering Research Group; National Council on Science and Technology of Mexico (CONACyT) [967183]	School of Engineering and Science at Tecnologico de Monterrey through the Molecular and Systems Bioengineering Research Group; FEMSA-Biotechnology Center at Tecnologico de Monterrey through the Molecular and Systems Bioengineering Research Group; National Council on Science and Technology of Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors would like to thank the School of Engineering and Science and the FEMSA-Biotechnology Center at Tecnologico de Monterrey for their support through the Molecular and Systems Bioengineering Research Group. Abril Torres thanks the National Council on Science and Technology of Mexico (CONACyT) for scholarship number 967183.	Mejia-Manzano LA, 2017, J CHEM TECHNOL BIOT, V92, P2519, DOI 10.1002/jctb.5307; Ayala-Mar S, 2019, ANAL CHEM, V91, P14975, DOI 10.1021/acs.analchem.9b03448; Ayala-Mar S, 2019, ELECTROPHORESIS, V40, P3036, DOI 10.1002/elps.201800526; Bruce TF, 2019, ELECTROPHORESIS, V40, P571, DOI 10.1002/elps.201800417; Chia BS, 2017, TRAC-TREND ANAL CHEM, V86, P93, DOI 10.1016/j.trac.2016.10.012; Chow YH, 2013, J CHROMATOGR B, V934, P71, DOI 10.1016/j.jchromb.2013.06.034; Croll T, 2003, BIOTECHNOL PROGR, V19, P1269, DOI 10.1021/bp025711a; Desmet C, 2017, J NANOPART RES, V19, DOI [10.1007/s11051-017-3804-z, 10.1007/s11051-017-3804]; Donoso-Quezada J, 2019, MATER TODAY-PROC, V13, P362, DOI 10.1016/j.matpr.2019.03.166; Gonzalez-Valdez J, 2018, J CHEM TECHNOL BIOT, V93, P1836, DOI 10.1002/jctb.5434; Gonzalez-Valdez J, 2011, J CHEM TECHNOL BIOT, V86, P26, DOI 10.1002/jctb.2507; Hernandez-Vargas G, 2019, J CHROMATOGR B, V1105, P120, DOI 10.1016/j.jchromb.2018.12.020; Huang SS, 2019, ANAL BIOANAL CHEM, V411, P6591, DOI 10.1007/s00216-019-02022-7; Hyejin Kang, 2017, Micro and Nano Systems Letters, V5, DOI 10.1186/s40486-017-0049-7; Inamdar S, 2017, BIOENG TRANSL MED, V2, P70, DOI 10.1002/btm2.10059; Iqbal M, 2016, BIOL PROCED ONLINE, V18, DOI 10.1186/s12575-016-0048-8; Ivanova V, 2001, MICROBIOL RES, V156, P19, DOI 10.1078/0944-5013-00082; Kim J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129760; Kirbas OK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55477-0; Lopes AM, 2018, SEP PURIF TECHNOL, V206, P39, DOI 10.1016/j.seppur.2018.04.090; Martins M, 2021, ACS SUSTAIN CHEM ENG, V9, P6599, DOI 10.1021/acssuschemeng.0c09110; Midekessa G, 2020, ACS OMEGA, V5, P16701, DOI 10.1021/acsomega.0c01582; Monterroso B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35140; Morishita M, 2016, BIOMATERIALS, V111, P55, DOI 10.1016/j.biomaterials.2016.09.031; Munagala R, 2016, CANCER LETT, V371, P48, DOI 10.1016/j.canlet.2015.10.020; Nisslein M, 2021, SEP PURIF TECHNOL, V257, DOI 10.1016/j.seppur.2020.117830; Raja S., 2012, SCI TECHNOL HUM VAL, V1, P7; Seo H, 2020, ACS APPL MATER INTER, V12, P55467, DOI 10.1021/acsami.0c16968; Shin H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194818; Shin H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13103; Slyusarenko M, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13030458; Sun DM, 2013, ADV DRUG DELIVER REV, V65, P342, DOI 10.1016/j.addr.2012.07.002; Tian YH, 2014, BIOMATERIALS, V35, P2383, DOI 10.1016/j.biomaterials.2013.11.083; Toh WS, 2018, BIOCHEM SOC T, V46, P843, DOI 10.1042/BST20180079; Torres-Acosta M, 2020, J CHEM TECHNOL BIOT, V95, P2822, DOI 10.1002/jctb.6526; Torres-Acosta MA, 2019, BIOTECHNOL J, V14, DOI 10.1002/biot.201800117; Whiteside TL, 2016, ADV CLIN CHEM, V74, P103, DOI 10.1016/bs.acc.2015.12.005; Yamashita T, 2018, BIOL PHARM BULL, V41, P835, DOI 10.1248/bpb.b18-00133; Yang TZ, 2015, PHARM RES-DORDR, V32, P2003, DOI 10.1007/s11095-014-1593-y; Yu LL, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3634563; Zaslavsky BY., 1994, AQUEOUS 2 PHASE PART; Zhou Y, 2018, MOL THER, V26, P1375, DOI 10.1016/j.ymthe.2018.02.020	42	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273243	10.1371/journal.pone.0273243	http://dx.doi.org/10.1371/journal.pone.0273243			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054216	Green Published, gold			2022-12-26	WOS:000892641400018
J	Arias-Rosales, A				Arias-Rosales, Andres			The perceived value of human-AI collaboration in early shape exploration: An exploratory assessment	PLOS ONE			English	Article							DESIGN; OPTIMIZATION; INTERVAL; ALGORITHMS; PRODUCTS; SUPPORT; MODELS; TOOLS	As a vital element of early shape exploration, divergence can be time-consuming and challenging, with iterative cycles where idea fixation and creative blocks must be overcome for fuzzy ideas to be fully expanded and understood. Despite interesting tools that have been developed for this purpose, some important challenges remain, as it appears that many designers still prefer simple freehand sketching and tend to defer the use of computational tools to later stages. This work presents an exploratory assessment of the perceived value of a new tool, Shapi, developed to assist early shape exploration by addressing some of the pitfalls reported in the literature. Shapi is envisioned as an autonomous assistant that provides local and global shape variations in the form of rough sketches based on an initial human sketch and interactive cycles. These shape variations are What-If scenarios and cognitive facilitators that may spark new ideas or enable a deeper understanding of the shape and the identification of interesting patterns. Shapi's capabilities are explored in a diverse set of case studies with different purposes: nine implementations in industrial design, three in graphic design, and five with open-ended artistic purposes. These implementations are then used in a survey about initial perceived value in which the majority gave high ratings in terms of exploration (75.5% >= 4 out of 5), interpretation (83.7% >= 4), adaptation (77.6% >= 4), value (73.5% >= 4), creativity (69.4% >= 4), and general interest in the tool (79.6% >= 4). This work brings insight into promising functionalities, opportunities, and risks in the intersection between artificial intelligence, design, and art.	[Arias-Rosales, Andres] Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Arias-Rosales, A (corresponding author), Carnegie Mellon Univ, Dept Mech Engn, Pittsburgh, PA 15213 USA.	aariasro@andrew.cmu.edu		Arias-Rosales, Andres/0000-0002-9266-8950	Mechanical Engineering Department at Carnegie Mellon University; Colciencias-Fulbright Scholarship	Mechanical Engineering Department at Carnegie Mellon University; Colciencias-Fulbright Scholarship	The author greatly appreciates the support provided by the Mechanical Engineering Department at Carnegie Mellon University, the Colciencias-Fulbright Scholarship for Doctoral studies, cohort 2018, and Professor Philip LeDuc as the main advisor and mentor.	Abdalla SB, 2021, J ARCHIT ENG, V27, DOI 10.1061/(ASCE)AE.1943-5568.0000457; Agudelo LM, 2017, INT J INTERACT DES M, V11, P397, DOI 10.1007/s12008-016-0337-0; Alcaide-Marzal J, 2020, DESIGN STUD, V66, P144, DOI 10.1016/j.destud.2019.11.003; Anderson MJ, 2001, AUST NZ J STAT, V43, P75, DOI 10.1111/1467-842X.00156; Arias-Rosales Andres, 2022, Mendeley Data, V2, DOI 10.17632/ZGNJYXDMP4.2; Arias-Rosales A, 2018, APPL ENERG, V212, P122, DOI 10.1016/j.apenergy.2017.11.106; Belmonte MV, 2014, DESIGN STUD, V35, P392, DOI 10.1016/j.destud.2014.01.002; Berger SR., 1980, DESIGN STUD, V1, P166; Bernal M, 2015, DESIGN STUD, V41, P163, DOI 10.1016/j.destud.2015.08.001; Boden MA., 2004, CREATIVE MIND MYTHS; Boden MA, 2009, AI MAG, V30, P23, DOI 10.1609/aimag.v30i3.2254; Bonnema GM, 2006, J ENG DESIGN, V17, P549, DOI 10.1080/09544820600664994; Booth TW, 2016, DESIGN STUD, V43, P1, DOI 10.1016/j.destud.2015.11.002; Chapra Steven C., 2010, NUMERICAL METHODS EN; Chau HH., 2006, DESIGN COMPUTING COG, P521; Chen KZ, 2003, PATTERN RECOGN, V36, P123, DOI 10.1016/S0031-3203(02)00067-5; Chesky B, 2006, VIEW WORK; Cheutet V, 2007, J ENG DESIGN, V18, P395, DOI 10.1080/09544820701403714; Chong YT, 2009, RES ENG DES, V20, P97, DOI 10.1007/s00163-008-0059-9; Cluzel F, 2012, ENG APPL ARTIF INTEL, V25, P1413, DOI 10.1016/j.engappai.2012.02.011; David Ha, 2017, Arxiv, DOI arXiv:1704.03477; De-Arteaga M, 2020, PROCEEDINGS OF THE 2020 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'20), DOI 10.1145/3313831.3376638; Dieter GE., 2009, ENG DESIGN; Dorta T, 2008, DESIGN STUD, V29, P121, DOI 10.1016/j.destud.2007.12.004; Dou RL, 2016, KNOWL-BASED SYST, V92, P43, DOI 10.1016/j.knosys.2015.10.013; Dunoon, 2021, DUN MUGS; Easton M., 2015, EASTON; Ewens WJ, 2003, AM J HUM GENET, V72, P496, DOI 10.1086/346174; Freeman LC., 1965, ELEMENTARY APPL STAT; Giannini F, 2006, J ENG DESIGN, V17, P193, DOI 10.1080/09544820500275396; Goldschmidt G., 1994, DESIGN STUD, V15, P158, DOI DOI 10.1016/0142-694X(94)90022-1; Gotelli NJ, 2013, ECOSIMR 1 00; Gu ZY, 2006, COMPUT AIDED DESIGN, V38, P224, DOI 10.1016/j.cad.2005.10.008; Hartmann C, 2018, J ENG DESIGN, V29, P665, DOI 10.1080/09544828.2018.1532494; Hua M, 2019, DES J, V22, P895, DOI 10.1080/14606925.2019.1655187; Hutto C., 2014, 8 INT C WEBL SOC MED, P1, DOI DOI 10.1093/A0BPLA/PLV053; Isola P., 2017, P IEEE C COMPUTER VI, P5967; Jianning Su, 2010, 2010 IEEE 11th International Conference on Computer-Aided Industrial Design & Conceptual Design (CAIDCD 2010), P301, DOI 10.1109/CAIDCD.2010.5681350; Jowers I, 2010, RES ENG DES, V21, P235, DOI 10.1007/s00163-010-0088-z; Kelly J, 2008, AAAI SPRING S CREATI, P34; Khakimov B, 2015, DRAW CARS SIDE VIEW; Khan S, 2018, ADV ENG INFORM, V38, P712, DOI 10.1016/j.aei.2018.10.005; Khaslavsky J, 1999, COMMUN ACM, V42, P45, DOI 10.1145/301353.301407; KNAPP TR, 1990, NURS RES, V39, P121; Krish S, 2011, COMPUT AIDED DESIGN, V43, P88, DOI 10.1016/j.cad.2010.09.009; Leahy K, 2020, J MECH DESIGN, V142, DOI 10.1115/1.4046446; Lee JW, 2021, J ENG DESIGN, V32, P300, DOI 10.1080/09544828.2021.1887462; Lee YJ, 2011, ACM T GRAPHIC, V30, DOI 10.1145/1964921.1964922; Li CX, 2016, J COMPUT DES ENG, V3, P286, DOI 10.1016/j.jcde.2016.04.003; Liu H, 2004, ADV ENG SOFTW, V35, P261, DOI 10.1016/j.advengsoft.2004.03.006; Liu Y.-C., 2003, Design Studies, V24, P341, DOI 10.1016/S0142-694X(03)00003-6; Liverani A, 2019, INT J INTERACT DES M, V13, P309, DOI 10.1007/s12008-019-00548-9; Lopez C., 2018, AM SOC MECH ENG; Lopez-Mesa B, 2011, J ENG DESIGN, V22, P31, DOI 10.1080/09544820902911366; Loria S., 2020, TEXTBLOB; Lucchi F, 2015, INT J INTERACT DES M, V9, P135, DOI 10.1007/s12008-014-0211-x; Manly BFJ., 2018, RANDOMIZATION BOOTST; Martin K., 2021, FORM EXPLORATION; Martino M, 2017, FORMA FLUENS; Mehta U., 2021, J INNOVATIVE ENG RES, V4, P10; Dang M, 2015, ACM T GRAPHIC, V34, DOI 10.1145/2816795.2818069; Mueller A., 2020, WORDCLOUD; Nam TJ, 2009, INT J INTERACT DES M, V3, P147, DOI 10.1007/s12008-009-0069-5; Orbay G, 2012, J MECH DESIGN, V134, DOI 10.1115/1.4007147; Ostrosi E, 2019, J COMPUT DES ENG, V6, P719, DOI 10.1016/j.jcde.2018.10.005; Oxford University Press, 2022, CASE; Oxman R., 2002, DESIGN STUD, V23, P135; Pena JM, 1999, PATTERN RECOGN LETT, V20, P1027, DOI 10.1016/S0167-8655(99)00069-0; Pernot JP, 2005, J ENG DESIGN, V16, P115, DOI 10.1080/09544820500031617; Perttula M, 2007, J ENG DESIGN, V18, P93, DOI 10.1080/09544820600679679; Prats M., 2006, DESIGN COMPUTING COG, P83; Prats M, 2007, SHAPE EXPLORATION PR; Prats M, 2009, DESIGN STUD, V30, P503, DOI 10.1016/j.destud.2009.04.002; Prickett R., 2017, R PRICKETT; Pugliese MJ, 2002, RES ENG DES, V13, P139, DOI 10.1007/s00163-002-0013-1; Roy R, 2002, J ENG DESIGN, V13, P121, DOI 10.1080/09544820210129797; Rusak Z, 2005, J ENG DESIGN, V16, P135, DOI 10.1080/09544820500031625; Schon DA., 1992, DESIGN STUD, V13, P135, DOI DOI 10.1016/0142-694X(92)90268-F; Shieh MD, 2018, ADV ENG INFORM, V36, P31, DOI 10.1016/j.aei.2018.02.002; Shiffman D., 2012, D SHIFFMAN; Shih-Wen Hsiao, 1998, Design Studies, V19, P309, DOI 10.1016/S0142-694X(98)00009-X; Smithers T., 2001, VISUAL SPATIAL REASO, P165; Stones C, 2010, DESIGN STUD, V31, P439, DOI 10.1016/j.destud.2010.05.003; Sun J, 2007, COMPUT IND ENG, V53, P200, DOI 10.1016/j.cie.2007.06.010; Sun LY, 2014, DESIGN STUD, V35, P593, DOI 10.1016/j.destud.2014.04.004; Sung E, 2019, J ENG DESIGN, V30, P199, DOI 10.1080/09544828.2019.1617413; Turrin M, 2011, ADV ENG INFORM, V25, P656, DOI 10.1016/j.aei.2011.07.009; Vajna S, 2005, J ENG DESIGN, V16, P423, DOI 10.1080/09544820500267781; van Belle G., 2011, STAT RULES THUMB, V699; VELLEMAN PF, 1993, AM STAT, V47, P65, DOI 10.2307/2684788; von der Heyde S., 2013, BEHANCE; Walters K, 2018, BEHANCE; Woodbury R, 2017, DESIGN STUD, V52, P40, DOI 10.1016/j.destud.2017.05.001; Yannou B, 2013, MECH IND, V14, P1, DOI 10.1051/meca/2013053; Yeh RY, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.9.36; Zboinska MA, 2019, J COMPUT DES ENG, V6, P675, DOI 10.1016/j.jcde.2018.12.002	98	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274496	10.1371/journal.pone.0274496	http://dx.doi.org/10.1371/journal.pone.0274496			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095028	gold, Green Published			2022-12-26	WOS:000892376500050
J	Yamada, K; Mibu, A; Kogo, S; Sullivan, M; Nishigami, T				Yamada, Keiko; Mibu, Akira; Kogo, Sonora; Sullivan, Michael; Nishigami, Tomohiko			Reliability and validity of the Japanese version of Pain Disability Index	PLOS ONE			English	Article							WHIPLASH-ASSOCIATED DISORDERS; CORE OUTCOME DOMAINS; CLINICAL-TRIALS; SAMPLE-SIZE; FIT INDEXES; TRANSLATION; ADAPTATION; VALIDATION; EXERCISE; QUALITY	This study evaluated the reliability and validity of a Japanese version of Pain Disability Index (PDI). Analyses were conducted on a 7-item version (PDI-J) and a 5-item (PDI-5-J version of the PDI). Using a web-based survey system, we recruited 300 individuals with chronic low back pain (lasting >= 3 months) and 300 individuals with chronic daily headache (lasting >= 15 days per month for 3 months) aged 20-64 years. Analyses revealed a one-factor with goodness-of-fit indices assessed by confirmatory factor analysis. For concurrent validity, we calculated Pearson's correlation coefficients among the PDI-J, PDI-5-J, Pain Disability Assessment Scale, Pain numerical rating scale, and revised version of Short-Form McGill Pain Questionnaire. Internal consistency was evaluated by Cronbach's alpha, and test-retest reliability was assessed with intraclass correlations (ICCs) in 100 of 600 participants a week after the first response. Both Japanese adaptations of the PDI demonstrated good concurrent validity and reliability (Cronbach's a was 0.89 for PDI-J in chronic low back pain or chronic daily headache, and 0.94 and 0.93 for PDI-5-J in chronic low back pain and chronic daily headache, respectively). The PDI-J and PDI-5-J showed were highly correlated (r = 0.98). ICCs were 0.67 and 0.59 for the PDI-J and 0.59 and 0.63 for the PDI-5-J in chronic low back pain and chronic daily headache, respectively. In conclusion, these two PDI versions can be potentially used for evaluating pain-related interference with daily activities among the Japanese general population.	[Yamada, Keiko] Juntendo Univ, Grad Sch Med, Pain Med, Tokyo, Japan; [Yamada, Keiko] Juntendo Univ, Fac Med, Dept Anesthesiol & Pain Med, Tokyo, Japan; [Yamada, Keiko; Sullivan, Michael] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Mibu, Akira] Konan Womens Univ, Dept Phys Therapy, Kobe, Hyogo, Japan; [Mibu, Akira] Tanabe Orthoped, Dept Rehabil, Osaka, Japan; [Kogo, Sonora] Concordia Univ, Dept Psychol, Montreal, PQ, Canada; [Nishigami, Tomohiko] Prefectural Univ Hiroshima, Dept Phys Therapy, Mihara, Hiroshima, Japan	Juntendo University; Juntendo University; McGill University; Concordia University - Canada	Yamada, K (corresponding author), Juntendo Univ, Grad Sch Med, Pain Med, Tokyo, Japan.; Yamada, K (corresponding author), Juntendo Univ, Fac Med, Dept Anesthesiol & Pain Med, Tokyo, Japan.; Yamada, K (corresponding author), McGill Univ, Dept Psychol, Montreal, PQ, Canada.	keiko-yamada@umin.org		Mibu, Akira/0000-0002-6141-7809	Japan Society for the Promotion of Science (JSPS) [21K18100]; Ministry of Health, Labor and Welfare Scientific Research Grant [19FG1001]; JSPS Overseas Research Fellowships	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare Scientific Research Grant; JSPS Overseas Research Fellowships	This research was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Grant-in-Aid for Early-Career Scientists (Grant Number 21K18100), and was funded by the Ministry of Health, Labor and Welfare Scientific Research Grant (Grant Number 19FG1001). This research was also supported by JSPS Overseas Research Fellowships (to K.Y.).	Ben-Haim S, 2018, NEUROSURG FOCUS, V45, DOI 10.3171/2018.5.FOCUS18160; Bishop SR, 2003, J BEHAV MED, V26, P265, DOI 10.1023/A:1023464621554; Byrne B.M., 2010, STRUCTURAL EQUATION, DOI DOI 10.4324/9781410600219; Carroll LJ, 2014, CLIN J PAIN, V30, P1, DOI 10.1097/AJP.0b013e3182869d50; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; CHIBNALL JT, 1994, ARCH PHYS MED REHAB, V75, P1082, DOI 10.1016/0003-9993(94)90082-5; Comrey A.L., 2013, 1 COURSE FACTOR ANAL, DOI [10.4324/9781315827506, DOI 10.4324/9781315827506]; Denison E, 2004, PAIN, V111, P245, DOI 10.1016/j.pain.2004.07.001; Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012; Dworkin RH, 2009, PAIN, V144, P35, DOI 10.1016/j.pain.2009.02.007; Fan XT, 1999, STRUCT EQU MODELING, V6, P56, DOI 10.1080/10705519909540119; Gauthier N, 2008, PAIN RES MANAG, V13, P327, DOI 10.1155/2008/461436; Geelen CC, 2017, PAIN PRACT, V17, P320, DOI 10.1111/papr.12449; George D, 2003, SPSS WINDOWS STEP ST, V4th, DOI DOI 10.1080/13803395.2011.614598; GitHub. Inc, 2008, GITHUB JUST EN RMOD; Hair J.F., 1995, MULTIVARIATE DATA AN, V4th; Hogarty KY, 2005, EDUC PSYCHOL MEAS, V65, P202, DOI 10.1177/0013164404267287; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jensen M., 1993, HDB PAIN ASSESSMENT, P15; Karsdorp PA, 2009, PAIN, V147, P29, DOI 10.1016/j.pain.2009.07.019; Katz J, 2004, ANESTHESIOLOGY, V101, P169, DOI 10.1097/00000542-200407000-00026; Kerschan K, 1998, AM J PHYS MED REHAB, V77, P326, DOI 10.1097/00002060-199807000-00013; Lemstra M, 2005, CLIN J PAIN, V21, P166, DOI 10.1097/00002508-200503000-00008; MacCallum RC, 1999, PSYCHOL METHODS, V4, P84, DOI 10.1037/1082-989x.4.1.84; Magown P, 2021, CAN J NEUROL SCI, V48, P690, DOI 10.1017/cjn.2020.259; Maruo T, 2013, PAIN RES, V28, P43, DOI 10.11154/pain.28.43; Morgalla MH, 2018, PAIN PHYSICIAN, V21, pE377; Mulla SM, 2015, PAIN, V156, P1615, DOI 10.1097/j.pain.0000000000000241; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; O'Rourke N., 2014, STEP BY STEP APPROAC; Osterweis M., 1987, PAIN DISABILITY CLIN; Peolsson A, 2016, ARCH PHYS MED REHAB, V97, P189, DOI 10.1016/j.apmr.2015.10.087; Pett MA, 2003, USE FACTOR ANAL INST; POLLARD CA, 1984, PERCEPT MOTOR SKILL, V59, P974, DOI 10.2466/pms.1984.59.3.974; Portney LG, 2009, FDN CLIN RES APPL PR; Rhodes SD, 2003, J EPIDEMIOL COMMUN H, V57, P68, DOI 10.1136/jech.57.1.68; Rittweger J, 2002, SPINE, V27, P1829, DOI 10.1097/00007632-200209010-00003; Ruscheweyh R, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-0962-7; Schumacker R.E., 2010, BEGINNERS GUIDE STRU, V3rd ed., DOI DOI 10.4324/9781410610904; Soer R, 2015, SPINE, V40, pE545, DOI 10.1097/BRS.0000000000000827; Soer R, 2013, SPINE, V38, pE562, DOI 10.1097/BRS.0b013e31828af21f; Staal E, 2008, HERNIA, V12, P153, DOI 10.1007/s10029-007-0297-1; Stovner LJ, 2007, CEPHALALGIA, V27, P193, DOI 10.1111/j.1468-2982.2007.01288.x; TAIT RC, 1990, PAIN, V40, P171, DOI 10.1016/0304-3959(90)90068-O; TAIT RC, 1987, ARCH PHYS MED REHAB, V68, P438; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Treede RD, 2015, PAIN, V156, P1003, DOI 10.1097/j.pain.0000000000000160; Turk DC, 1998, PAIN, V74, P247, DOI 10.1016/S0304-3959(97)00187-5; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Turk DC, 2008, PAIN, V137, P276, DOI 10.1016/j.pain.2007.09.002; Wild D, 2005, VALUE HEALTH, V8, P94, DOI 10.1111/j.1524-4733.2005.04054.x; Yamada K., 2021, PAIN RES, V36, P1; Yamashiro K, 2011, CLIN J PAIN, V27, P338, DOI 10.1097/AJP.0b013e318204858a	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274445	10.1371/journal.pone.0274445	http://dx.doi.org/10.1371/journal.pone.0274445			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094940	gold, Green Published			2022-12-26	WOS:000892376500042
J	Zukifli, NA; Ibrahim, Z; Othman, I; Ismail, AK; Chaisakul, J; Hodgson, WC; Ahmad Rusmili, MR				Zukifli, Nor Asyikin; Ibrahim, Zalikha; Othman, Iekhsan; Ismail, Ahmad Khaldun; Chaisakul, Janeyuth; Hodgson, Wayne C.; Ahmad Rusmili, Muhamad Rusdi			In Vitro neurotoxicity and myotoxicity of Malaysian Naja sumatrana and Naja kaouthia venoms: Neutralization by monovalent and Neuro Polyvalent Antivenoms from Thailand	PLOS ONE			English	Article							MONOCLED COBRA; PROTEOMIC CHARACTERIZATION; 3-FINGER TOXIN; PURIFICATION; SNAKES; BITES	Naja sumatrana and Naja kaouthia are medically important elapids species found in Southeast Asia. Snake bite envenoming caused by these species may lead to morbidity or mortality if not treated with the appropriate antivenom. In this study, the in vitro neurotoxic and myotoxic effects N. sumatrana and N. kaouthia venoms from Malaysian specimens were assessed and compared. In addition, the neutralizing capability of Cobra Antivenom (CAV), King Cobra Antivenom (KCAV) and Neuro Polyvalent Antivenom (NPAV) from Thailand were compared. Both venoms produced concentration-dependent neurotoxic and myotoxic effects in the chick biventer cervicis nerve-muscle preparation. Based on the time to cause 90% inhibition of twitches (i.e. t 90 ) N. kaouthia venom displayed more potent neurotoxic and myotoxic effects than N. sumatrana venom. All three of the antivenoms significantly attenuated venom-induced twitch reduction of indirectly stimulated tissues when added prior to venom. When added after N. sumatrana venom, at the t 90 time point, CAV and NPAV partially restored the twitch height but has no significant effect on the reduction in twitch height caused by N. kaouthia venom. The addition of KCAV, at the t 90 time point, did not reverse the attenuation of indirectly stimulated twitches caused by either venom. In addition, none of the antivenoms, when added prior to venom, prevented attenuation of directly stimulated twitches. Differences in the capability of antivenoms, especially NPAV and CAV, to reverse neurotoxicity and myotoxicity indicate that there is a need to isolate and characterize neurotoxins and myotoxins from Malaysian N. kaouthia and N. sumatrana venoms to improve neutralization capability of the antivenoms.	[Zukifli, Nor Asyikin; Ahmad Rusmili, Muhamad Rusdi] Int Islamic Univ Malaysia, Dept Basic Med Sci, Kulliyyah Pharm, Kuantan Campus, Bandar Indera Mahkota, Kuantan, Malaysia; [Ibrahim, Zalikha] Int Islamic Univ Malaysia, Dept Pharmaceut Chem, Kulliyyah Pharm, Kuantan Campus, Bandar Indera Mahkota, Kuantan, Malaysia; [Othman, Iekhsan] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Bandar Sunway, Subang Jaya, Malaysia; [Ismail, Ahmad Khaldun] Univ Kebangsaan Malaysia, Dept Emergency Med, Univ Kebangsaan Malaysia Med Ctr, Cheras, Malaysia; [Chaisakul, Janeyuth] Phramongkutklao Coll Med, Dept Pharmacol, Bangkok, Thailand; [Hodgson, Wayne C.] Monash Univ, Monash Venom Grp, Dept Pharmacol, Biomed Discovery Inst, Clayton, Vic, Australia	International Islamic University Malaysia; International Islamic University Malaysia; Monash University; Monash University Sunway; Universiti Kebangsaan Malaysia; Phramongkutklao College of Medicine; Monash University	Ahmad Rusmili, MR (corresponding author), Int Islamic Univ Malaysia, Dept Basic Med Sci, Kulliyyah Pharm, Kuantan Campus, Bandar Indera Mahkota, Kuantan, Malaysia.	rusdirusmili@iium.edu.my	Ismail, Ahmad Khaldun/L-9989-2017	Ismail, Ahmad Khaldun/0000-0003-3213-0240	Ministry of Higher Education (MOHE), Government of Malaysia [FRGS19040-0648]; National Health and Medical Research Council (NHMRC) Centres for Research Excellence Grant [1110343]; Terengganu Foundation scholarship	Ministry of Higher Education (MOHE), Government of Malaysia; National Health and Medical Research Council (NHMRC) Centres for Research Excellence Grant(National Health and Medical Research Council (NHMRC) of Australia); Terengganu Foundation scholarship	This research was funded by Fundamental Research Grant Scheme (FRGS19040-0648) from the Ministry of Higher Education (MOHE), Government of Malaysia. WCH was supported by a National Health and Medical Research Council (NHMRC) Centres for Research Excellence Grant (ID:1110343). NAZ is a recipient of Terengganu Foundation scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah NAH, 2021, TOXINS, V13, DOI 10.3390/toxins13120859; Ali SA, 2013, J PROTEOMICS, V89, P15, DOI 10.1016/j.jprot.2013.05.015; [Anonymous], 1999, Southeast Asian J Trop Med Public Health, V30 Suppl 1, P1; Barber CM, 2016, TOXINS, V8, DOI 10.3390/toxins8030058; Chang KC, 2020, TOXINS, V12, DOI 10.3390/toxins12090576; Chew KS, 2011, INT J EMERG MED, V4, DOI 10.1186/1865-1380-4-41; Chong HP, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.583587; Das Diganta, 2013, J Venom Res, V4, P31; Deka A, 2019, J PROTEOMICS, V207, DOI 10.1016/j.jprot.2019.103463; Deka A, 2019, TOXICON, V164, P31, DOI 10.1016/j.toxicon.2019.03.025; Doley R, 2003, TOXICON, V41, P81, DOI 10.1016/S0041-0101(02)00213-1; Faiz MA, 2017, AM J TROP MED HYG, V96, P876, DOI 10.4269/ajtmh.16-0842; Fernandez S, 2014, TOXINS, V6, P1586, DOI 10.3390/toxins6051586; Gutierrez JM, 2006, PLOS MED, V3, P727, DOI 10.1371/journal.pmed.0030150; Gutierrez JM, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.79, 10.1038/nrdp.2017.63]; Heyborne WH, 2013, BIOCHIMIE, V95, P1923, DOI 10.1016/j.biochi.2013.06.025; Hodgson WC, 2002, CLIN EXP PHARMACOL P, V29, P807, DOI 10.1046/j.1440-1681.2002.03740.x; Ismail AK, 2015, TOXINOLOGY, P71, DOI 10.1007/978-94-007-6386-9_54; Ismail AK, 2012, CLIN TOXICOL, V50, P518, DOI 10.3109/15563650.2012.696119; Jamaiah I., 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P962; Jamunaa A, 2012, J VENOM ANIM TOXINS, V18, P150, DOI 10.1590/S1678-91992012000200004; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kunalan S, 2018, TOXINS, V10, DOI 10.3390/toxins10110434; Leong PK, 2015, ACTA TROP, V149, P86, DOI 10.1016/j.actatropica.2015.05.020; Leong PK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001672; Liang Q, 2020, BIOCHEM PHARMACOL, V181, DOI 10.1016/j.bcp.2020.114059; Meng QX, 2002, COMP BIOCHEM PHYS C, V132, P113, DOI 10.1016/S1532-0456(02)00049-2; Mordvintsev DY, 2007, BASIC CLIN PHARMACOL, V100, P273, DOI 10.1111/j.1742-7843.2007.00045.x; Osipov AV, 2008, J BIOL CHEM, V283, P14571, DOI 10.1074/jbc.M802085200; Pawlak J, 2006, J BIOL CHEM, V281, P29030, DOI 10.1074/jbc.M605850200; Pawlak J, 2009, FASEB J, V23, P534, DOI 10.1096/fj.08-113555; Rashmi U, 2021, J PROTEOMICS, V242, DOI 10.1016/j.jprot.2021.104256; Reali M, 2003, TOXICON, V41, P657, DOI 10.1016/S0041-0101(03)00005-9; Rossetto Ornella, 2008, V184, P129; Rusmili MRA, 2014, BIOCHEM PHARMACOL, V88, P229, DOI 10.1016/j.bcp.2014.01.004; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shafie NA., 2020, MED J MALAY, V75, P217; Shankar PG, 2021, MOL PHYLOGENET EVOL, V165, DOI 10.1016/j.ympev.2021.107300; Silva A, 2017, TOXINS, V9, DOI 10.3390/toxins9040143; Tan CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19271; Tan CH, 2022, TOXINS, V14, DOI 10.3390/toxins14080522; Tan CH, 2019, TOXINS, V11, DOI 10.3390/toxins11010003; Tan CH, 2017, TOXINOLOGY, P3, DOI 10.1007/978-94-007-6410-1_13; Tan CH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1828-2; Tan CH, 2015, TOXINS, V7, P572, DOI 10.3390/toxins7020572; Tan KY, 2016, COMP BIOCHEM PHYS C, V185, P77, DOI 10.1016/j.cbpc.2016.03.005; Tan KY, 2015, J PROTEOMICS, V120, P105, DOI 10.1016/j.jprot.2015.02.012; TAN KK, 1990, TOXICON, V28, P225, DOI 10.1016/0041-0101(90)90416-5; Wongtongkam N, 2005, MIL MED, V170, P336, DOI 10.7205/MILMED.170.4.336; Wuster W, 1996, TOXICON, V34, P399, DOI 10.1016/0041-0101(95)00139-5; Yap MKK, 2011, J VENOM ANIM TOXINS, V17, P451, DOI 10.1590/S1678-91992011000400012; Yap MKK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002890; Yap MKK, 2014, ACTA TROP, V133, P15, DOI 10.1016/j.actatropica.2014.01.014	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274488	10.1371/journal.pone.027448	http://dx.doi.org/10.1371/journal.pone.027448			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094937				2022-12-26	WOS:000892376500047
J	Hu, MN; Bao, RX; Lin, M; Han, XR; Ai, YJ; Gao, Y; Guan, KL; Xiong, Y; Yuan, HX				Hu, Mengnan; Bao, Ruoxuan; Lin, Miao; Han, Xiao-Ran; Ai, Ying-Jie; Gao, Yun; Guan, Kun-Liang; Xiong, Yue; Yuan, Hai-Xin			ALK fusion promotes metabolic reprogramming of cancer cells by transcriptionally upregulating PFKFB3	ONCOGENE			English	Article							ANAPLASTIC LYMPHOMA KINASE; 6-PHOSPHOFRUCTO-2-KINASE PFKFB3; TYROSINE KINASE; PROTEIN-KINASE; GROWTH-FACTOR; GLYCOLYSIS; IDENTIFICATION; INHIBITION; MECHANISMS; STRATEGY	Anaplastic lymphoma kinase (ALK), a receptor tyrosine kinase of the insulin receptor kinase subfamily, is activated in multiple cancer types through translocation or overexpression. Although several generations of ALK tyrosine kinase inhibitors (TKIs) have been developed for clinic use, drug resistance remains a major challenge. In this study, by quantitative proteomic approach, we identified the glycolytic regulatory enzyme, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3), as a new target of ALK. Expression of PFKFB3 is highly dependent on ALK activity in ALK(+) anaplastic large cell lymphoma and non-small-cell lung cancer (NSCLC) cells. Notably, ALK and PFKFB3 expressions exhibit significant correlation in clinic ALK(+) NSCLC samples. We further demonstrated that ALK promotes PFKFB3 transcription through the downstream transcription factor STAT3. Upregulation of PFKFB3 by ALK is important for high glycolysis level as well as oncogenic activity of ALK(+) lymphoma cells. Finally, targeting PFKFB3 by its inhibitor can overcome drug resistance in cells bearing TKI-resistant mutants of ALK. Collectively, our studies reveal a novel ALK-STAT3-PFKFB3 axis to promote cell proliferation and tumorigenesis, providing an alternative strategy for the treatment of ALK-positive tumors.	[Hu, Mengnan; Bao, Ruoxuan; Gao, Yun; Yuan, Hai-Xin] Fudan Univ, Peoples Hosp Shanghai 5, Shanghai, Peoples R China; [Hu, Mengnan; Bao, Ruoxuan; Gao, Yun; Yuan, Hai-Xin] Fudan Univ, Mol & Cell Biol Lab, Inst Biomed Sci, Shanghai, Peoples R China; [Lin, Miao] Fudan Univ, Zhongshan Hosp, Dept Thorac Surg, Shanghai, Peoples R China; [Lin, Miao] Fudan Univ, Zhongshan Hosp Xiamen, Dept Thorac Surg, Xiamen, Peoples R China; [Han, Xiao-Ran] Cullgen Shanghai Inc, Pu Dong New Area, 230 Chuan Hong Rd, Shanghai, Peoples R China; [Ai, Ying-Jie] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol & Hepatol, Shanghai, Peoples R China; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Xiong, Yue] Cullgen Inc, 12671 High Bluff Dr, San Diego, CA 92130 USA; [Yuan, Hai-Xin] Chongqing Med Univ, Ctr Novel Target & Therapeut Intervent, Chongqing, Peoples R China	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; Chongqing Medical University	Yuan, HX (corresponding author), Fudan Univ, Peoples Hosp Shanghai 5, Shanghai, Peoples R China.; Yuan, HX (corresponding author), Fudan Univ, Mol & Cell Biol Lab, Inst Biomed Sci, Shanghai, Peoples R China.; Yuan, HX (corresponding author), Chongqing Med Univ, Ctr Novel Target & Therapeut Intervent, Chongqing, Peoples R China.	yuanhaixin@fudan.edu.cn		Yuan, Hai-Xin/0000-0002-1624-3934	NSFC [82172595, 81773190]; National Key Research and Development Project of China [2018YFA0800304]; Supporting Program of Health Commission of Fujian Province for junior talents [2021GGB03]; Shanghai Pujiang Program [2020PJD009]; Innovative Research Team of High-level Local University in Shanghai	NSFC(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project of China; Supporting Program of Health Commission of Fujian Province for junior talents; Shanghai Pujiang Program(Shanghai Pujiang Program); Innovative Research Team of High-level Local University in Shanghai	We thank Xian Chen and Ling Xie (UNC) for their aid with mass spectrometry analysis, and Jian Jin (Mount Sinai) and Jing Liu (Cullgen Inc.) for providing ALK degrader compound. We appreciate Hongbin Ji and Zhen Qin (SIBCB, CAS) for their help in the analysis of ALK mutant tumors. We also thank Kuirong Luo (Zhongshan Hospital, Fudan University) for the help with the interpretation of IHC results. This work was supported by the NSFC grants (No. 82172595 and 81773190 to H-XY), the National Key Research and Development Project of China (No. 2018YFA0800304 to H-XY), Supporting Program of Health Commission of Fujian Province for junior talents (2021GGB03 to ML) and Shanghai Pujiang Program (2020PJD009 to ML). H-XY is also supported by the Innovative Research Team of High-level Local University in Shanghai.	Almeida A, 2004, NAT CELL BIOL, V6, P45, DOI 10.1038/ncb1080; Ambrogio C, 2005, BLOOD, V106, P3907, DOI 10.1182/blood-2005-03-1204; Amin HM, 2007, BLOOD, V110, P2259, DOI 10.1182/blood-2007-04-060715; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Cantelmo AR, 2016, CANCER CELL, V30, P968, DOI 10.1016/j.ccell.2016.10.006; Chaft JE, 2012, MOL CANCER THER, V11, P485, DOI 10.1158/1535-7163.MCT-11-0692; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Clem BF, 2013, MOL CANCER THER, V12, P1461, DOI 10.1158/1535-7163.MCT-13-0097; De Bock K, 2013, CELL, V154, P651, DOI 10.1016/j.cell.2013.06.037; Domenech E, 2015, NAT CELL BIOL, V17, P1304, DOI 10.1038/ncb3231; Faubert B, 2020, SCIENCE, V368, P152, DOI 10.1126/science.aaw5473; Fontana D, 2015, CANCER MED-US, V4, P953, DOI 10.1002/cam4.413; Gainor JF, 2013, J CLIN ONCOL, V31, P3987, DOI 10.1200/JCO.2012.45.2029; Gustafsson NMS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06287-x; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hrustanovic G, 2015, NAT MED, V21, P1038, DOI 10.1038/nm.3930; Li FL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02950-5; Lovly CM, 2014, NAT MED, V20, P1027, DOI 10.1038/nm.3667; Ma Y, 2016, ONCOGENE, V35, P6132, DOI 10.1038/onc.2016.150; Marsin AS, 2002, J BIOL CHEM, V277, P30778, DOI 10.1074/jbc.M205213200; McDonnell SRP, 2013, BLOOD, V122, P958, DOI 10.1182/blood-2013-01-482026; Minami M, 1996, P NATL ACAD SCI USA, V93, P3963, DOI 10.1073/pnas.93.9.3963; Minchenko A, 2002, J BIOL CHEM, V277, P6183, DOI 10.1074/jbc.M110978200; MORRIS SW, 1995, SCIENCE, V267, P316, DOI 10.1126/science.267.5196.316-b; Mosse YP, 2009, CLIN CANCER RES, V15, P5609, DOI 10.1158/1078-0432.CCR-08-2762; Normant E, 2011, ONCOGENE, V30, P2581, DOI 10.1038/onc.2010.625; Olsen TK, 2015, NEURO-ONCOLOGY, V17, P1365, DOI 10.1093/neuonc/nov039; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Ros S, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-8; Schoors S, 2014, CELL METAB, V19, P37, DOI 10.1016/j.cmet.2013.11.008; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Stoica GE, 2002, J BIOL CHEM, V277, P35990, DOI 10.1074/jbc.M205749200; Stoica GE, 2001, J BIOL CHEM, V276, P16772, DOI 10.1074/jbc.M010660200; Touriol Christian, 2000, Blood, V95, P3204; Tudzarova S, 2011, P NATL ACAD SCI USA, V108, P5278, DOI 10.1073/pnas.1102247108; US Food and Drug Administration, 2016, US; Wang YH, 2020, EUR J MED CHEM, V203, DOI 10.1016/j.ejmech.2020.112612; Wasik MA, 2009, SEMIN ONCOL, V36, pS27, DOI 10.1053/j.seminoncol.2009.02.007; Yalcin A, 2009, J BIOL CHEM, V284, P24223, DOI 10.1074/jbc.M109.016816; Yalcin A, 2009, EXP MOL PATHOL, V86, P174, DOI 10.1016/j.yexmp.2009.01.003; Yamamoto T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4480; Zhang CW, 2018, EUR J MED CHEM, V151, P304, DOI 10.1016/j.ejmech.2018.03.071	44	0	0	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 30	2022	41	40					4547	4559		10.1038/s41388-022-02453-0	http://dx.doi.org/10.1038/s41388-022-02453-0		SEP 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4Z8CT	36064579				2022-12-26	WOS:000849997400001
J	Ballash, GA; Baesu, A; Lee, S; Mills, MC; Mollenkopf, DF; Sullivan, SMP; Lee, J; Bayen, S; Wittum, TE				Ballash, Gregory A.; Baesu, Anca; Lee, Seungjun; Mills, Molly C.; Mollenkopf, Dixie F.; Sullivan, S. Mazeika P.; Lee, Jiyoung; Bayen, Stephen; Wittum, Thomas E.			Fish as sentinels of antimicrobial resistant bacteria, epidemic carbapenemase genes, and antibiotics in surface water	PLOS ONE			English	Article							BETA-LACTAM ANTIBIOTICS; WASTE-WATER; ESCHERICHIA-COLI; TRANSFORMATION PRODUCTS; AMOXICILLIN	Surface waters, especially those receiving wastewater flows, can disseminate antimicrobial resistant bacteria (ARB), antimicrobial resistance genes (ARG), and antibiotics. In the Scioto River of central Ohio, United States, we evaluated fishes as potential sentinels of ARB and antimicrobial contamination and investigated the influence of antimicrobial exposure on the fish intestinal resistome. Seventy-seven fish were collected from river reaches receiving inputs from two wastewater treatment plants that serve the greater Columbus Metropolitan Area. Fish were screened for the presence of cephalosporin-resistant (CeRO) and carbapenem-resistant (CRO) organisms, epidemic carbapenemase genes, and antibiotic drugs and metabolites using culture methods, droplet digital PCR, and ultra-high performance liquid chromatography tandem mass spectroscopy (UHPLC-MS/MS). Nearly 21% of fish harbored a CeRO in their resistome, with 19.4% exhibiting bacteria expressing an AmpC genotype encoded by bla(CMY), and 7.7% with bacteria expressing an extended-spectrum beta-lactamase phenotype encoded by bla(CTX-M). bia(KPC) and bla(NDM) were present in 87.7% (57/65) and 80.4% (37/46) of the intestinal samples at an average abundance of 10(4) copies. Three antibiotics-lincomycin (19.5%), azithromycin (31.2%) and sulfamethoxazole (3.9%)-were found in hepatic samples at average concentrations between 25-31 ng/g. Fish harboring bla(CTX-M) and those exposed to azithromycin were at greater odds of being downstream of a wastewater treatment plant. Fish that bioconcentrated antibiotics in their liver were not at greater odds of harboring CeRO, CRO, or epidemic carbapenemase gene copies in their resistome. Our findings confirm that fishes can be effective bioindicators of surface waters contaminated with ARB, ARG, and antibiotics. Moreover, our findings highlight the varying importance of different mechanisms that facilitate establishment of ARB in aquatic ecosystems.	[Ballash, Gregory A.; Mollenkopf, Dixie F.; Wittum, Thomas E.] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Baesu, Anca; Bayen, Stephen] McGill Univ, Dept Food Sci & Agr Chem, Ste Anne De Bellevue, PQ, Canada; [Lee, Seungjun; Mills, Molly C.; Lee, Jiyoung] Ohio State Univ, Coll Publ Hlth, Div Environm Hlth Sci, Columbus, OH USA; [Sullivan, S. Mazeika P.] Ohio State Univ, Coll Food Agr & Environm Sci, Sch Environm & Nat Resources, Schiermeier Olentangy River Wetland Res Pk, Columbus, OH USA; [Lee, Jiyoung] Ohio State Univ, Dept Food Sci & Technol, Columbus, OH USA	University System of Ohio; Ohio State University; McGill University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Wittum, TE (corresponding author), Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA.	Wittum.1@osu.edu		Wittum, Thomas/0000-0002-9216-1308; Baesu, Anca/0000-0003-1419-9316	United States Centers for Disease Control and Prevention [BAA 2017-OADS-01]; Ohio Department of Natural Resources, Division of Wildlife; Ohio Biodiversity Conservation Partnership; Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN/04800-2017]; Canada Foundation for Innovation/John R. Evans Leaders Fund [35318]	United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Ohio Department of Natural Resources, Division of Wildlife; Ohio Biodiversity Conservation Partnership; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Foundation for Innovation/John R. Evans Leaders Fund	This project was financially supported in part by a contract from the United States Centers for Disease Control and Prevention awarded to T.E. W, S.M.P.S and J.L. (BAA 2017-OADS-01). This work was also supported by the Ohio Department of Natural Resources, Division of Wildlife and the Ohio Biodiversity Conservation Partnership (S.M.P. S). Funding for antibiotic residue testing was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC) (RGPIN/04800-2017) and the Canada Foundation for Innovation/John R. Evans Leaders Fund grant (Project#35318) to S.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baesu A, 2021, SCI TOTAL ENVIRON, V783, DOI 10.1016/j.scitotenv.2021.146902; Ballash GA, 2020, J ENVIRON MANAGE, V265, DOI 10.1016/j.jenvman.2020.110529; Berglund B, 2015, ENVIRON TOXICOL CHEM, V34, P192, DOI 10.1002/etc.2784; Capkin E, 2017, AQUAC RES, V48, P5561, DOI 10.1111/are.13378; Cha JM, 2006, J CHROMATOGR A, V1115, P46, DOI 10.1016/j.chroma.2006.02.086; Dorobek Alayna, 2015, River Systems, V21, P125, DOI 10.1127/rs/2015/0098; Furness LE, 2017, ENVIRON RES, V154, P28, DOI 10.1016/j.envres.2016.12.014; Higuera-Llanten S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203641; Hirte K, 2016, WATER RES, V88, P880, DOI 10.1016/j.watres.2015.11.028; Jobbins SE, 2015, J WILDLIFE DIS, V51, P811, DOI 10.7589/2014-11-257; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; Koczura R, 2012, SCI TOTAL ENVIRON, V414, P680, DOI 10.1016/j.scitotenv.2011.10.036; Kulkarni P, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060668; LaPara TM, 2015, ENVIRON SCI TECHNOL, V49, P11509, DOI 10.1021/acs.est.5b02803; Mathys DA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218650; Maupin MA., 2014, 1405 USGS, DOI [10.3133/cir1405, DOI 10.3133/CIR1405]; Mills MC, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113143; Nordmann P, 2012, EMERG INFECT DIS, V18, P1503, DOI 10.3201/eid1809.120355; Perez-Parada A, 2011, RAPID COMMUN MASS SP, V25, P731, DOI 10.1002/rcm.4902; Rodriguez-Mozaz S, 2020, ENVIRON INT, V140, DOI 10.1016/j.envint.2020.105733; Sabri NA, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140199; Semedo-Lemsaddek T, 2018, ECOL INDIC, V85, P1113, DOI 10.1016/j.ecolind.2017.11.029; Sullivan SMP, 2012, ENVIRON TOXICOL CHEM, V31, P1175, DOI 10.1002/etc.1842; Timm A, 2019, SCI TOTAL ENVIRON, V651, P1605, DOI 10.1016/j.scitotenv.2018.09.248; Watkinson AJ, 2009, SCI TOTAL ENVIRON, V407, P2711, DOI 10.1016/j.scitotenv.2008.11.059; Winokur PL, 2000, ANTIMICROB AGENTS CH, V44, P2777, DOI 10.1128/AAC.44.10.2777-2783.2000; Wittum TE, 2010, FOODBORNE PATHOG DIS, V7, P1575, DOI 10.1089/fpd.2010.0615; Yi XZ, 2015, ANAL BIOANAL CHEM, V407, P9071, DOI 10.1007/s00216-015-9074-7	28	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0272806	10.1371/journal.pone.0272806	http://dx.doi.org/10.1371/journal.pone.0272806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054112	Green Published, gold			2022-12-26	WOS:000892641400012
J	Thevkar-Nagesh, P; Habault, J; Voisin, M; Ruff, SE; Ha, S; Ruoff, R; Chen, X; Rawal, S; Zahr, T; Szabo, G; Rogatsky, I; Fisher, EA; Garabedian, MJ				Thevkar-Nagesh, Prashanth; Habault, Justine; Voisin, Maud; Ruff, Sophie E.; Ha, Susan; Ruoff, Rachel; Chen, Xi; Rawal, Shruti; Zahr, Tarik; Szabo, Gyongyi; Rogatsky, Inez; Fisher, Edward A.; Garabedian, Michael J.			Transcriptional regulation of Acsl1 by CHREBP and NF-kappa B in macrophages during hyperglycemia and inflammation	PLOS ONE			English	Article							COA SYNTHETASE 1; ELEMENT-BINDING PROTEIN; IN-VIVO; ACTIVATION; ATHEROSCLEROSIS; EXPRESSION; GLUCOSE; ACID; LIPOPOLYSACCHARIDE; LIVER	Acyl-CoA synthetase 1 (ACSL1) is an enzyme that converts fatty acids to acyl-CoA-derivatives for lipid catabolism and lipid synthesis in general and can provide substrates for the production of mediators of inflammation in monocytes and macrophages. Acsl1 expression is increased by hyperglycemia and inflammatory stimuli in monocytes and macrophages, and promotes the pro-atherosclerotic effects of diabetes in mice. Yet, surprisingly little is known about the mechanisms underlying Acsl1 transcriptional regulation. Here we demonstrate that the glucose-sensing transcription factor, Carbohydrate Response Element Binding Protein (CHREBP), is a regulator of the expression of Acsl1 mRNA by high glucose in mouse bone marrow-derived macrophages (BMDMs). In addition, we show that inflammatory stimulation of BMDMs with lipopolysaccharide (LPS) increases Acsl1 mRNA via the transcription factor, NF-kappa B. LPS treatment also increases ACSL1 protein abundance and localization to membranes where it can exert its activity. Using an Acsl1 reporter gene containing the promoter and an upstream regulatory region, which has multiple conserved CHREBP and NF-kappa B (p65/RELA) binding sites, we found increased Acsl1 promoter activity upon CHREBP and p65/RELA expression. We also show that CHREBP and p65/ RELA occupy the Acsl1 promoter in BMDMs. In primary human monocytes cultured in high glucose versus normal glucose, ACSL1 mRNA expression was elevated by high glucose and further enhanced by LPS treatment. Our findings demonstrate that CHREBP and NF-kappa B control Acsl1 expression under hyperglycemic and inflammatory conditions.	[Thevkar-Nagesh, Prashanth; Habault, Justine; Voisin, Maud; Ruff, Sophie E.; Ruoff, Rachel; Fisher, Edward A.; Garabedian, Michael J.] NYU, Dept Microbiol, Sch Med, New York, NY 10012 USA; [Thevkar-Nagesh, Prashanth; Rawal, Shruti; Zahr, Tarik; Fisher, Edward A.] NYU, Sch Med, Dept Med, New York, NY 10012 USA; [Thevkar-Nagesh, Prashanth; Chen, Xi; Szabo, Gyongyi] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA; [Ha, Susan] NYU, Dept Urol, Sch Med, New York, NY USA; [Chen, Xi; Rogatsky, Inez] Hosp Special Surg, New York, NY USA; [Rogatsky, Inez] Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY USA	New York University; New York University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; New York University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Fisher, EA; Garabedian, MJ (corresponding author), NYU, Dept Microbiol, Sch Med, New York, NY 10012 USA.; Fisher, EA (corresponding author), NYU, Sch Med, Dept Med, New York, NY 10012 USA.	Edward.Fisher@nyulangone.org		Chen, Xi/0000-0003-2894-0363; Szabo, Gyongyi/0000-0003-0836-2527; Zahr, Tarik/0000-0002-2754-6092; Habault, Justine/0000-0001-6375-6428	NIH [R01AA011576, R01DK099087, R21NS110520, R01AI148129, P01HL131481]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants (R01DK099087, R21NS110520 and R01AI148129) to I.R., an NIH grant (P01HL131481) to E.A.F and M.J.G and an NIH grant (R01AA011576) to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Wahed A, 2017, CELL METAB, V26, P324, DOI 10.1016/j.cmet.2017.07.004; Adelman K, 2009, P NATL ACAD SCI USA, V106, P18207, DOI 10.1073/pnas.0910177106; Al-Rashed Fatema, 2019, Cell Physiol Biochem, V52, P397, DOI 10.33594/000000028; Coleman RA, 2019, J LIPID RES, V60, P490, DOI 10.1194/jlr.S091843; Dominguez-Andres Jorge, 2021, STAR Protoc, V2, P100365, DOI 10.1016/j.xpro.2021.100365; Dorrington MG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00705; Dreos R, 2015, NUCLEIC ACIDS RES, V43, pD92, DOI 10.1093/nar/gku1111; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Hu FB, 2002, DIABETES CARE, V25, P1129, DOI 10.2337/diacare.25.7.1129; del Pozo CH, 2011, BBA-MOL CELL BIOL L, V1811, P1194, DOI 10.1016/j.bbalip.2011.07.016; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; John S, 2009, ENDOCRINOLOGY, V150, P1766, DOI 10.1210/en.2008-0863; Kanter JE, 2013, TRENDS ENDOCRIN MET, V24, P137, DOI 10.1016/j.tem.2012.10.002; Kanter JE, 2012, P NATL ACAD SCI USA, V109, pE715, DOI 10.1073/pnas.1111600109; Lee YH, 2002, MOL CELL BIOL, V22, P3621, DOI 10.1128/MCB.22.11.3621-3632.2002; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Li TT, 2020, INT J MED SCI, V17, P720, DOI 10.7150/ijms.42248; Manichaikul A, 2016, J LIPID RES, V57, P433, DOI 10.1194/jlr.M064592; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Natarajan K, 1996, P NATL ACAD SCI USA, V93, P9090, DOI 10.1073/pnas.93.17.9090; Poungvarin N, 2015, ENDOCRINOLOGY, V156, P1982, DOI 10.1210/en.2014-1666; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Roelands J, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02410; Rubinow KB, 2013, J BIOL CHEM, V288, P9957, DOI 10.1074/jbc.M113.458372; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Singh AB, 2016, J BIOL CHEM, V291, P5373, DOI 10.1074/jbc.M115.696872; So AYL, 2008, P NATL ACAD SCI USA, V105, P5745, DOI 10.1073/pnas.0801551105; Soupene E, 2008, EXP BIOL MED, V233, P507, DOI 10.3181/0710-MR-287; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Watkins SM, 2012, CIRC RES, V111, P394, DOI 10.1161/CIRCRESAHA.112.273508; Xavier GD, 2006, J LIPID RES, V47, P2482, DOI 10.1194/jlr.M600289-JLR200; Yang LP, 2017, EXP THER MED, V14, P4065, DOI 10.3892/etm.2017.5091	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0272986	10.1371/journal.pone.0272986	http://dx.doi.org/10.1371/journal.pone.0272986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054206	Green Submitted, gold, Green Published			2022-12-26	WOS:000892641400014
J	Khoubza, L; Gilbert, N; Kim, EJ; Chatelain, FC; Feliciangeli, S; Abelanet, S; Kang, DW; Lesage, F; Bichet, D				Khoubza, Lamyaa; Gilbert, Nicolas; Kim, Eun-Jin; Chatelain, Franck C.; Feliciangeli, Sylvain; Abelanet, Sophie; Kang, Dawon; Lesage, Florian; Bichet, Delphine			Alkaline-sensitive two-pore domain potassium channels form functional heteromers in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; PH SENSITIVITY; K-2P CHANNELS; HETERODIMERS; EXPRESSION; FAMILY; MODULATION; TASK-4; TALK-1; TREK	Two-pore domain K+ channels (K2P channels), active as dimers, produce inhibitory currents regulated by a variety of stimuli. Among them, TWIK1-related alkalinization-activated K+ channel 1 (TALK1), TWIK1-related alkalinization-activated K+ channel 2 (TALK2), and TWIK1-related acid-sensitive K+ channel 2 (TASK2) form a subfamily of structurally related K2P channels stimulated by extracellular alkalosis. The human genes encoding these proteins are clustered at chromosomal region 6p21 and coexpressed in multiple tissues, including the pancreas. The question whether these channels form functional heteromers remained open. By analyzing single-cell transcriptomic data, we show that these channels are coexpressed in insulin-secreting pancreatic 8-cells. Using in situ proximity ligation assay and electrophysiology, we show that they form functional heterodimers both upon heterologous expression and under native conditions in human pancreatic 8-cells. We demonstrate that heteromerization of TALK2 with TALK1 or with TASK2 endows TALK2 with sensitivity to extracellular alkalosis in the physiological range. We further show that the association of TASK2 with TALK1 and TALK2 increases their unitary conductance. These results provide a new example of heteromerization in the K2P channel family expanding the range of the potential physiological and pathophysiological roles of TALK1/TALK2/TASK2 channels, not only in insulin-secreting cells but also in the many other tissues in which they are coexpressed.	[Khoubza, Lamyaa; Gilbert, Nicolas; Chatelain, Franck C.; Feliciangeli, Sylvain; Abelanet, Sophie; Lesage, Florian; Bichet, Delphine] Univ Cote Azur, Lab Excellence ICST, CNRS, IPMC UMR7275, Valbonne, France; [Kim, Eun-Jin; Kang, Dawon] Gyeongsang Natl Univ, Coll Med, Dept Physiol, Jinju, South Korea; [Kim, Eun-Jin; Kang, Dawon] Gyeongsang Natl Univ, Inst Hlth Sci, Jinju, South Korea; [Lesage, Florian] Inserm, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Gyeongsang National University; Gyeongsang National University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lesage, F (corresponding author), Univ Cote Azur, Lab Excellence ICST, CNRS, IPMC UMR7275, Valbonne, France.; Lesage, F (corresponding author), Inserm, Paris, France.	lesage@ipmc.cnrs.fr			Ministry of Education;  [NRF-2021R1I1A3044128]	Ministry of Education; 	Funding and additional information-This work was funded by the Ministry of Education (NRF-2021R1I1A3044128) to D. K.	Anazco C, 2013, PFLUG ARCH EUR J PHY, V465, P1715, DOI 10.1007/s00424-013-1314-0; Barriere H, 2003, J GEN PHYSIOL, V122, P177, DOI 10.1085/jgp.200308820; Blin S, 2016, P NATL ACAD SCI USA, V113, P4200, DOI 10.1073/pnas.1522748113; Blin S, 2014, J BIOL CHEM, V289, P28202, DOI 10.1074/jbc.M114.600437; Cazals Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9780; Cho YS, 2012, CURR DIABETES REP, V12, P686, DOI 10.1007/s11892-012-0326-z; Choi Jae Hyouk, 2018, Exp Mol Med, V50, P1, DOI 10.1038/s12276-018-0172-4; Czirjak G, 2002, J BIOL CHEM, V277, P5426, DOI 10.1074/jbc.M107138200; Decher N, 2001, FEBS LETT, V492, P84, DOI 10.1016/S0014-5793(01)02222-0; Dickerson MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175069; Duprat F, 2005, J PHYSIOL-LONDON, V562, P235, DOI 10.1113/jphysiol.2004.071266; Feliciangeli S, 2015, J PHYSIOL-LONDON, V593, P2587, DOI 10.1113/jphysiol.2014.287268; Fernandez-Orth J, 2017, TRAFFIC, V18, P29, DOI 10.1111/tra.12455; Friedrich C, 2014, EMBO MOL MED, V6, P937, DOI 10.15252/emmm.201303783; Gestreau C, 2010, P NATL ACAD SCI USA, V107, P2325, DOI 10.1073/pnas.0910059107; Girard C, 2001, BIOCHEM BIOPH RES CO, V282, P249, DOI 10.1006/bbrc.2001.4562; Gob E, 2015, PFLUG ARCH EUR J PHY, V467, P973, DOI 10.1007/s00424-014-1626-8; Graff SM, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.138057; Han J, 2003, AM J PHYSIOL-CELL PH, V285, pC529, DOI 10.1152/ajpcell.00601.2002; Hwang EM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4227; Niemeyer MI, 2016, MOL PHARMACOL, V90, P309, DOI 10.1124/mol.116.103895; Niemeyer MI, 2010, J BIOL CHEM, V285, P16467, DOI 10.1074/jbc.M110.107060; Kang DW, 2004, BIOCHEM BIOPH RES CO, V315, P836, DOI 10.1016/j.bbrc.2004.01.137; Khoubza L, 2021, J PHYSIOL-LONDON, V599, P1041, DOI 10.1113/JP279870; Kim HJ, 2016, EUR J PHARMACOL, V791, P686, DOI 10.1016/j.ejphar.2016.08.030; Kindler CH, 2003, J PHARMACOL EXP THER, V306, P84, DOI 10.1124/jpet.103.049809; Lengyel M, 2020, J BIOL CHEM, V295, P12408, DOI 10.1074/jbc.RA120.014125; Lengyel M, 2016, J BIOL CHEM, V291, P13649, DOI 10.1074/jbc.M116.719039; Lesage F, 2011, PHYSIOLOGY, V26, P424, DOI 10.1152/physiol.00029.2011; Levitz J, 2016, P NATL ACAD SCI USA, V113, P4194, DOI 10.1073/pnas.1522459113; Li BB, 2020, NATURE, V586, P457, DOI 10.1038/s41586-020-2770-2; Mahajan Rajiv, 2014, Int J Appl Basic Med Res, V4, pS1, DOI 10.4103/2229-516X.140704; Niemeyer MI, 2006, BIOCHEM SOC T, V34, P899, DOI 10.1042/BST0340899; Niemeyer MI, 2007, P NATL ACAD SCI USA, V104, P666, DOI 10.1073/pnas.0606173104; Niemeyer MI, 2017, SCI REP-UK, V7, DOI 10.1038/srep45407; Plant LD, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003431; Reed AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156456; Renigunta V, 2015, PFLUG ARCH EUR J PHY, V467, P867, DOI 10.1007/s00424-015-1703-7; Reyes R, 1998, J BIOL CHEM, V273, P30863, DOI 10.1074/jbc.273.47.30863; Rinne S, 2015, J MOL CELL CARDIOL, V81, P71, DOI 10.1016/j.yjmcc.2015.01.017; Royal P, 2019, NEURON, V101, P232, DOI 10.1016/j.neuron.2018.11.039; Saez-Hernandez L, 2003, EPILEPSY RES, V56, P155, DOI 10.1016/j.eplepsyres.2003.09.002; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Shi YT, 2017, J NEUROSCI, V37, P11744, DOI 10.1523/JNEUROSCI.2055-17.2017; Staudacher I, 2018, N-S ARCH PHARMACOL, V391, P1119, DOI 10.1007/s00210-018-1535-z; Suzuki Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186252; Toncheva D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/920723; Tsai WH, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101998; Vierra NC, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aan2883; Vierra NC, 2015, DIABETES, V64, P3818, DOI 10.2337/db15-0280; Wang S, 2013, J NEUROSCI, V33, P16033, DOI 10.1523/JNEUROSCI.2451-13.2013; Warth R, 2004, P NATL ACAD SCI USA, V101, P8215, DOI 10.1073/pnas.0400081101; Zuniga L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016141	53	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	298	10							102447	10.1016/j.jbc.2022.102447	http://dx.doi.org/10.1016/j.jbc.2022.102447			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5K6GU	36063992	Green Published, gold			2022-12-26	WOS:000869823800007
J	Sethakorn, N; Heninger, E; Breneman, MT; Recchia, E; Ding, AB; Jarrard, DF; Hematti, P; Beebe, DJ; Kosoff, D				Sethakorn, Nan; Heninger, Erika; Breneman, Matthew T.; Recchia, Emma; Ding, Adeline B.; Jarrard, David F.; Hematti, Peiman; Beebe, David J.; Kosoff, David			Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform	FASEB JOURNAL			English	Article						high throughput; microfluidics; multi-culture; multiplex; organoid; primary cells; tumor microenvironment	CANCER; POLARIZATION	The tumor microenvironment (TME) is a complex network of non-malignant cells and stroma that perform a wide array of vital roles in tumor growth, immune evasion, metastasis, and therapeutic resistance. These highly diverse roles have been shown to be critically important to the progression of cancers and have already shown potential as therapeutic targets. Therefore, there has been a tremendous push to elucidate the pathways that underlie these roles and to develop new TME-directed therapies for cancer treatment. Unfortunately, TME-focused research has been limited by a lack of translational in vitro culture platforms that can model this highly complex niche and can support the integrated analysis of cell biology and function. In the current study, we investigate whether an independently developed reconfigurable microfluidic platform, known as Stacks, can address the critical need for translational multi-cellular tumor models and integrated analytics in TME research. We present data on multi-cellular culture of primary human cells in Stacks as well as the orthogonal analysis of cellular polarization, differentiation, migration, and cytotoxicity in this reconfigurable system. These expanded capabilities of Stacks are highly relevant to the cancer research community with the potential to enhance clinical translation of pre-clinical TME studies and to yield novel biological insight into TME crosstalk, metastasis, and responses to novel drug combinations or immune therapies.	[Sethakorn, Nan; Ding, Adeline B.; Hematti, Peiman; Kosoff, David] Univ Wisconsin, Dept Med, Madison, WI USA; [Sethakorn, Nan; Heninger, Erika; Breneman, Matthew T.; Recchia, Emma; Hematti, Peiman; Beebe, David J.; Kosoff, David] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Jarrard, David F.] Univ Wisconsin, Dept Urol, Madison, WI USA; [Beebe, David J.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA; [Beebe, David J.] Univ Wisconsin, Dept Biomed Engn, Madison, WI USA; [Kosoff, David] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Kosoff, D (corresponding author), Univ Wisconsin, Dept Med, Carbone Canc Ctr, 1111 Highland Ave,WIMR 7105, Madison, WI 53705 USA.	dkosoff1@medicine.wisc.edu		Heninger, Erika/0000-0003-0166-9972; Kosoff, David/0000-0001-8559-6357	US Department of Defense [W81XWH-18-1-0273]; US Department of Veteran Affairs Advanced Fellowship in Womens Health; University of Wisconsin Department of Hematology [T32 HL07899]; National Institutes of Health [P30 CA014520]	US Department of Defense(United States Department of Defense); US Department of Veteran Affairs Advanced Fellowship in Womens Health(US Department of Veterans Affairs); University of Wisconsin Department of Hematology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	US Department of Defense, Grant/Award Number: W81XWH-18-1-0273; US Department of Veteran Affairs Advanced Fellowship in Womens Health and the University of Wisconsin Department of Hematology, Grant/Award Number: T32 HL07899; National Institutes of Health, Grant/Award Number: P30 CA014520	Bejarano L, 2021, CANCER DISCOV, V11, P933, DOI 10.1158/2159-8290.CD-20-1808; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Chinnadurai R, 2019, STEM CELLS, V37, P1119, DOI 10.1002/stem.3035; Correia AL, 2012, DRUG RESIST UPDATE, V15, P39, DOI 10.1016/j.drup.2012.01.006; Daya S, 2007, DIFFERENTIATION, V75, P360, DOI 10.1111/j.1432-0436.2006.00146.x; De Palma M, 2013, CANCER CELL, V23, P277, DOI 10.1016/j.ccr.2013.02.013; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Diedrich JD, 2016, ONCOTARGET, V7, P64854, DOI 10.18632/oncotarget.11712; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Donnenberg AD, 2007, CLIN LAB MED, V27, P627, DOI 10.1016/j.cll.2007.05.013; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Emont MP, 2015, ENDOCRINOLOGY, V156, P4761, DOI 10.1210/en.2015-1567; Escamilla J, 2015, CANCER RES, V75, P950, DOI 10.1158/0008-5472.CAN-14-0992; Giraldo NA, 2019, BRIT J CANCER, V120, P45, DOI 10.1038/s41416-018-0327-z; Hallin J, 2020, CANCER DISCOV, V10, P54, DOI 10.1158/2159-8290.CD-19-1167; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardaway AL, 2015, CLIN EXP METASTAS, V32, P353, DOI 10.1007/s10585-015-9714-5; Heninger E, 2021, MED ONCOL, V38, DOI 10.1007/s12032-021-01582-y; House IG, 2020, CLIN CANCER RES, V26, P487, DOI 10.1158/1078-0432.CCR-19-1868; Kim J, 2009, EXP HEMATOL, V37, P1445, DOI 10.1016/j.exphem.2009.09.004; Kosoff D, 2018, LAB CHIP, V18, P3011, DOI 10.1039/c8lc00431e; Linxweiler J, 2019, J CANCER RES CLIN, V145, P551, DOI 10.1007/s00432-018-2803-5; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Paguirigan AL, 2009, INTEGR BIOL, V1, P182, DOI 10.1039/b814565b; Pittenger MF, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0083-6; Roederer M, 2008, CYTOM PART A, V73A, P384, DOI 10.1002/cyto.a.20549; Shen JX, 2021, ADV SCI, V8, DOI 10.1002/advs.202100106; Skoulidis F, 2021, NEW ENGL J MED, V384, P2371, DOI 10.1056/NEJMoa2103695; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Weber CE, 2012, SURG ONCOL, V21, P172, DOI 10.1016/j.suronc.2011.09.001; Wessely A, 2019, FASEB J, V33, P11884, DOI 10.1096/fj.201900925R; Wolff A, 2022, CELLS-BASEL, V11, DOI 10.3390/cells11081313; Wu MM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026447; Yu JQ, 2019, NAT BIOMED ENG, V3, P830, DOI 10.1038/s41551-019-0421-4; Yu K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11415-2	42	0	0	7	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22540	10.1096/fj.202200684RR	http://dx.doi.org/10.1096/fj.202200684RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4J8EX	36083096	hybrid, Green Published			2022-12-26	WOS:000851497300001
J	van Senten, JR; Moller, TC; Von Moo, E; Seiersen, SD; Brauner-Osborne, H				van Senten, Jeffrey R.; Moller, Thor C.; Von Moo, Ee; Seiersen, Sofie D.; Brauner-Osborne, Hans			Use of CRISPR/Cas9-edited HEK293 cells reveals that both conventional and novel protein kinase C isozymes are involved in mGlu5a receptor internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-ALPHA-Q; PHOSPHORYLATION; BINDING; TRAFFICKING; DOMAIN; DESENSITIZATION; UBIQUITINATION; PHARMACOLOGY; IMPACT	The internalization of G protein???coupled receptors (GPCRs) can be regulated by PKC. However, most tools available to study the contribution of PKC isozymes have considerable limitations, including a lack of selectivity. In this study, we generated and characterized human embryonic kidney 293A (HEK293A) cell lines devoid of conventional or novel PKC isozymes (??cPKC and ??nPKC) and employ these to investigate the contribution of PKC isozymes in the internalization of the metabotropic glutamate receptor 5 (mGlu5). Direct activation of PKC and mutation of rat mGlu5a Ser901, a PKC-dependent phosphorylation site in the receptor C-tail, both showed that PKC isozymes facilitate approximately 40% of the receptor internalization. Nonetheless, we determined that mGlu5a internalization was not altered upon the loss of cPKCs or nPKCs. This indicates that isozymes from both classes are involved, compensate for the absence of the other class, and thus fulfill dispensable functions. Additionally, using the G??q/ 11 inhibitor YM-254890, GPCR kinase 2 and 3 (GRK2 and GRK3) KO cells, and a receptor containing a mutated putative adaptor protein complex 2 (AP-2) interaction motif, we demonstrate that internalization of rat mGlu5a is mediated by G??q/11 proteins (77% of the response), GRK2 (27%), and AP-2 (29%), but not GRK3. Our PKC KO cell lines expand the repertoire of KO HEK293A cell lines available to research GPCR pharmacology. Moreover, since pharmacological tools to study PKC isozymes generally lack specificity and/or potency, we present the PKC KO cell lines as more specific research tools to investigate PKC-mediated aspects of cell biology.	[van Senten, Jeffrey R.; Moller, Thor C.; Von Moo, Ee; Seiersen, Sofie D.; Brauner-Osborne, Hans] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark	University of Copenhagen	Brauner-Osborne, H (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen, Denmark.	hbo@sund.ku.dk	; Brauner-Osborne, Hans/D-7260-2011; Moller, Thor/T-9452-2018	van Senten, Jeffrey Roy/0000-0002-1096-6891; Brauner-Osborne, Hans/0000-0001-9495-7388; Moller, Thor/0000-0002-2256-577X				Abreu N, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109050; Anastassiadis T, 2011, NAT BIOTECHNOL, V29, P1039, DOI 10.1038/nbt.2017; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Bradley SJ, 2009, MOL PHARMACOL, V76, P1302, DOI 10.1124/mol.109.059170; Bulanova DR, 2017, CELL ADHES MIGR, V11, P434, DOI 10.1080/19336918.2016.1245264; Chen B, 2011, J BIOL CHEM, V286, P40760, DOI 10.1074/jbc.M111.299776; Corbalan-Garcia S, 2006, BBA-MOL CELL BIOL L, V1761, P633, DOI 10.1016/j.bbalip.2006.04.015; Cui K, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.624159; Drube J, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28152-8; Fourgeaud L, 2003, J BIOL CHEM, V278, P12222, DOI 10.1074/jbc.M205663200; Fu G, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002058; Giorgione JR, 2006, J BIOL CHEM, V281, P1660, DOI 10.1074/jbc.M510251200; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Hiroki S, 2022, P NATL ACAD SCI USA, V119, DOI [10.1073/pnas.2106974119, 10.1073/pnas.2210665119]; Inoue A, 2019, CELL, V177, P1933, DOI 10.1016/j.cell.2019.04.044; Isobe K, 2017, P NATL ACAD SCI USA, V114, pE8875, DOI 10.1073/pnas.1709123114; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Kang JH, 2012, BIOTECHNOL ADV, V30, P1662, DOI 10.1016/j.biotechadv.2012.07.004; Kazanietz MG, 2002, MOL PHARMACOL, V61, P759, DOI 10.1124/mol.61.4.759; Kim CH, 2005, J BIOL CHEM, V280, P25409, DOI 10.1074/jbc.M502644200; Ko SJ, 2012, J NEUROSCI, V32, P16391, DOI 10.1523/JNEUROSCI.1964-12.2012; Koehl A, 2019, NATURE, V566, P79, DOI 10.1038/s41586-019-0881-4; Lee JH, 2008, P NATL ACAD SCI USA, V105, P12575, DOI 10.1073/pnas.0712033105; Levoye A, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00167; Lonowski LA, 2017, NAT PROTOC, V12, P581, DOI 10.1038/nprot.2016.165; Luttrell LM, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat7650; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Milligan G, 2018, TRENDS PHARMACOL SCI, V39, P481, DOI 10.1016/j.tips.2018.02.005; Moller TC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73674-0; Moriyoshi K, 2004, P NATL ACAD SCI USA, V101, P8614, DOI 10.1073/pnas.0403042101; Namkung Y, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat1631; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Newton AC, 2018, CRIT REV BIOCHEM MOL, V53, P208, DOI 10.1080/10409238.2018.1442408; Nguyen HT, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00497-x; Okochi Y, 2005, EMBO J, V24, P2127, DOI 10.1038/sj.emboj.7600697; ORR JW, 1992, J BIOL CHEM, V267, P15263; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Pascolutti R, 2019, CELL REP, V27, P3049, DOI 10.1016/j.celrep.2019.05.017; Pass JM, 2001, AM J PHYSIOL-HEART C, V280, pH946, DOI 10.1152/ajpheart.2001.280.3.H946; Pfeil EM, 2020, MOL CELL, V80, P940, DOI 10.1016/j.molcel.2020.10.027; Quann EJ, 2011, NAT IMMUNOL, V12, P647, DOI 10.1038/ni.2033; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ribeiro FM, 2009, J BIOL CHEM, V284, P23444, DOI 10.1074/jbc.M109.000778; Roed SN, 2014, MOL CELL ENDOCRINOL, V382, P938, DOI 10.1016/j.mce.2013.11.010; Sanchez-Fernandez G, 2016, J BIOL CHEM, V291, P9513, DOI 10.1074/jbc.M115.684308; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schwendt M, 2017, J NEUROSCI RES, V95, P1079, DOI 10.1002/jnr.23868; Sengmany K, 2016, BRIT J PHARMACOL, V173, P3001, DOI 10.1111/bph.13281; Sorensen SD, 2003, NEUROPHARMACOLOGY, V44, P699, DOI 10.1016/S0028-3908(03)00053-4; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Tedja R, 2019, J BIOL CHEM, V294, P5082, DOI 10.1074/jbc.RA118.005921; Teegala LR, 2022, FASEB J, V36, DOI 10.1096/fj.202101838RRR; Thuille N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053709; Tobin AB, 1997, PHARMACOL THERAPEUT, V75, P135, DOI 10.1016/S0163-7258(97)00053-3; Vergouts M, 2017, J NEUROCHEM, V141, P387, DOI 10.1111/jnc.14007; Violin JD, 2003, J CELL BIOL, V161, P899, DOI 10.1083/jcb.200302125; Von Moo E, 2021, MOL PHARMACOL, V99, P242, DOI 10.1124/molpharm.120.000192; Wang QY, 2020, STEM CELLS, V38, P653, DOI 10.1002/stem.3156; White CW, 2020, CELL CHEM BIOL, V27, P499, DOI 10.1016/j.chembiol.2020.01.010; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220	60	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102466	10.1016/j.jbc.2022.102466	http://dx.doi.org/10.1016/j.jbc.2022.102466			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5H2JF	36087841	Green Published, gold			2022-12-26	WOS:000867509200001
J	Baddela, VS; Michaelis, M; Sharma, A; Plinski, C; Viergutz, T; Vanselow, J				Baddela, Vijay Simha; Michaelis, Marten; Sharma, Arpna; Plinski, Christian; Viergutz, Torsten; Vanselow, Jens			Estradiol production of granulosa cells is unaffected by the physiological mix of nonesterified fatty acids in follicular fluid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PALMITIC ACID; OLEIC-ACID; ACTIVATION; APOPTOSIS; EXPRESSION; PATHWAYS; OOCYTES; STRESS; ERK1/2; AKT	Ovarian cycle is controlled by circulating levels of the steroid hormone 17-beta-estradiol, which is predominantly synthesized by the granulosa cells (GCs) of ovarian follicles. Our earlier studies showed that unsaturated fatty acids (USFs) downregulate and saturated fatty acids (SFAs) upregulate estradiol production in GCs. However, it was unclear whether pituitary gonadotropins induce accumulation of free fatty acids (FFAs) in the follicular fluid since follicle-stimulating hormone induces and luteinizing hormone inhibits estradiol production in the mammalian ovary. Interestingly, we show here the gas chromatography analysis of follicular fluid revealed no differential accumulation of FFAs between pre-and post-luteinizing hormone surge follicles. We therefore wondered how estradiol production is regulated in the physiological context, as USFs and SFAs are mutually present in the follicular fluid. We thus performed in vitro primary GC cultures with palmitate, palmitoleate, stearate, oleate, linoleate, and alpha-linolenate, representing >80% of the FFA fraction in the follicular fluid, and analyzed 62 different cell culture con-ditions to understand the regulation of estradiol biosynthesis under diverse FFA combinations. Our analyses showed co -supplementation of SFAs with USFs rescued estradiol produc-tion by restoring gonadotropin receptors and aromatase, antagonizing the inhibitory effects of USFs. Furthermore, tran-scriptome data of oleic acid-treated GCs indicated USFs induce the ERK and Akt signaling pathways. We show SFAs inhibit USF-induced ERK1/2 and Akt activation, wherein ERK1/2 acts as a negative regulator of estradiol synthesis. We propose SFAs are vital components of the follicular fluid, without which gonado-tropin signaling and the ovarian cycle would probably be shat-tered by USFs.	[Baddela, Vijay Simha; Michaelis, Marten; Sharma, Arpna; Plinski, Christian; Viergutz, Torsten; Vanselow, Jens] Res Inst Farm Anim Biol FBN, Inst Reprod Biol, Dummerstorf, Germany	Forschungsinstitut fur Nutztierbiologie (FBN)	Baddela, VS (corresponding author), Res Inst Farm Anim Biol FBN, Inst Reprod Biol, Dummerstorf, Germany.	baddel@fbn-dummerstorf.de		Vanselow, Jens/0000-0001-7374-4615	Deutsche Forschungsgemeinschaft (DFG);  [BA 6909/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); 	Funding and additional information-This work is funded by Deutsche Forschungsgemeinschaft (DFG; grant No. BA 6909/1-1) to V. S. B.	Aardema H, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.106062; Aardema H, 2011, BIOL REPROD, V85, P62, DOI 10.1095/biolreprod.110.088815; Baddela VS, 2022, BBA-MOL CELL BIOL L, V1867, DOI 10.1016/j.bbalip.2022.159159; Baddela VS, 2020, REPROD BIOL ENDOCRIN, V18, DOI 10.1186/s12958-020-00617-9; Baufeld A, 2018, JOVE-J VIS EXP, DOI 10.3791/58208; Baufeld A, 2013, CELL TISSUE RES, V354, P869, DOI 10.1007/s00441-013-1712-9; Baumgarten SC, 2014, J CLIN ENDOCR METAB, V99, P2995, DOI 10.1210/jc.2014-1139; Calonge R., 2018, ENDOCRINOL METAB INT, V6; Christenson LK, 2013, MOL ENDOCRINOL, V27, P1153, DOI 10.1210/me.2013-1093; Coyral-Castel S, 2010, DOMEST ANIM ENDOCRIN, V38, P272, DOI 10.1016/j.domaniend.2009.12.002; Dannenberger D, 2017, J FOOD COMPOS ANAL, V56, P47, DOI 10.1016/j.jfca.2016.11.015; Deura C, 2020, J REPROD DEVELOP, V66, P143, DOI 10.1262/jrd.2019-144; Dierich A, 1998, P NATL ACAD SCI USA, V95, P13612, DOI 10.1073/pnas.95.23.13612; Fan HY, 2009, SCIENCE, V324, P938, DOI 10.1126/science.1171396; Ferst JG, 2020, ANIM REPROD SCI, V219, DOI 10.1016/j.anireprosci.2020.106536; Gao WW, 2018, J CELL MOL MED, V22, P3408, DOI 10.1111/jcmm.13617; Georges A, 2014, J MOL ENDOCRINOL, V52, pR17, DOI 10.1530/JME-13-0159; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Hormone Health Network, 2014, J CLIN ENDOCR METAB, V99, p31A; Huang X, 2016, GYNECOL ENDOCRINOL, V32, P201, DOI 10.3109/09513590.2015.1106470; Huang YH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12123739; Jungheim ES, 2011, FERTIL STERIL, V95, P1970, DOI 10.1016/j.fertnstert.2011.01.154; Lee Ji-Eun, 2017, Dev Reprod, V21, P205, DOI 10.12717/DR.2017.21.2.205; Leroy JLMR, 2005, REPRODUCTION, V130, P485, DOI 10.1530/rep.1.00735; Leroy JLMR, 2017, ANIM REPROD, V14, P497, DOI 10.21451/1984-3143-AR992; Li Q, 2021, DOMEST ANIM ENDOCRIN, V74, DOI 10.1016/j.domaniend.2020.106509; Li Y., 2022, J ANIM SCI BIOTECHNO, V13, P1; Lim JH, 2013, J BIOL CHEM, V288, P7117, DOI 10.1074/jbc.M112.415729; Mani AM, 2010, REPRODUCTION, V139, P139, DOI 10.1530/REP-09-0050; Miklos C, 2016, ORVOSI HETILAP, V157, P733, DOI 10.1556/650.2016.30439; Mu YM, 2001, ENDOCRINOLOGY, V142, P3590, DOI 10.1210/en.142.8.3590; Palomer X, 2018, TRENDS ENDOCRIN MET, V29, P178, DOI 10.1016/j.tem.2017.11.009; Portela VM, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.121376; Pu J, 2011, J LIPID RES, V52, P1319, DOI 10.1194/jlr.M011254; Rada P, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03003-w; Rajaram S, 2014, AM J CLIN NUTR, V100, p443S, DOI 10.3945/ajcn.113.071514; Ricchi M, 2009, J GASTROEN HEPATOL, V24, P830, DOI 10.1111/j.1440-1746.2008.05733.x; Richards JS, 2018, VITAM HORM, V107, P1, DOI 10.1016/bs.vh.2018.01.009; Rieder JK, 2020, INT J BEHAV MED, V27, P294, DOI 10.1007/s12529-019-09820-4; Sharma A, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00087; Sharma A, 2019, ENDOCR CONNECT, V8, P493, DOI 10.1530/EC-19-0011; Shibahara H, 2020, THERIOGENOLOGY, V141, P54, DOI 10.1016/j.theriogenology.2019.09.006; Sutton-McDowall ML, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.131862; Valckx SDM, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-13; van der Vusse GJ, 2009, DRUG METAB PHARMACOK, V24, P300, DOI 10.2133/dmpk.24.300; Vanholder T, 2005, ANIM REPROD SCI, V87, P33, DOI 10.1016/j.anireprosci.2004.09.006; Wang T, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00284; Wu MZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006430; Xu L, 2019, J MOL ENDOCRINOL, V62, P197, DOI 10.1530/JME-18-0214; Yang X, 2012, FERTIL STERIL, V97, P1438, DOI 10.1016/j.fertnstert.2012.02.034; Yenuganti VR, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07817-6; Yenuganti VR, 2016, GEN COMP ENDOCR, V232, P134, DOI 10.1016/j.ygcen.2016.04.020; Yew Tan C., 2015, SCI REP-UK, V5, P1; Yousif MD, 2020, REPROD SCI, V27, P2038, DOI 10.1007/s43032-020-00223-5; Yu YS, 2004, CELL RES, V14, P341, DOI 10.1038/sj.cr.7290234; Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172; Zhang NN, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9060374	57	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102477	10.1016/j.jbc.2022.102477	http://dx.doi.org/10.1016/j.jbc.2022.102477			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5S8ED	36096202	Green Published, gold			2022-12-26	WOS:000875415100011
J	Amissah-Arthur, MB; Gyaban-Mensah, A; Boima, V; Yorke, E; Dey, D; Ganu, V; Mate-Kole, C				Amissah-Arthur, Maame-Boatemaa; Gyaban-Mensah, Anna; Boima, Vincent; Yorke, Ernest; Dey, Dzifa; Ganu, Vincent; Mate-Kole, Charles			Health-seeking behaviour, referral patterns and associated factors among patients with autoimmune rheumatic diseases in Ghana: A cross-sectional mixed method study	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HELP-SEEKING; ARTHRITIS; ONSET	Background Challenges exist in the diagnosis and management of autoimmune rheumatic diseases in low and middle income countries due to factors, such as poverty and under-resourced healthcare infrastructure. Furthermore, other contributory factors such as societal, cultural and religious practices influence health seeking behaviour which has a bearing on access and delivery of healthcare. Objectives To examine the health seeking behaviour and referral patterns of Ghanaian patients with autoimmune rheumatic diseases and assess the associated factors that influence these. Method A cross-sectional study using an explanatory sequential mixed method design was carried out in a Rheumatology clinic at a national referral centre. 110 participants were purposively recruited for the quantitative phase. The qualitative phase comprised 10 participants for indepth interviews and 10 participants for a focus group discussion. Analysis using descriptive statistics, t-tests and logistic regression models were performed. Transcripts generated from the interviews and focused group discussion were analysed using thematic analysis. Results Median duration from onset of symptoms until seeking help was 1 week (IQR = 12); from seeking help until obtaining a final diagnosis was 12 months (IQR = 33). Multiple factors determined the choice of first facility visited, X-2 (12, N = 107) = 32.29, p = .001. Only twenty-one participants (19.6%) had knowledge of their disease prior to diagnosis. Education predicted prior knowledge [OR = 2.6 (95% CI = .66-10.12), p < .021]. Unemployed participants had increased odds of seeking help after a month compared to those who were employed [Odds ratio = 2.60 (95% CI = 1.14-5.90), p = .02]. Knowledge of autoimmune rheumatic diseases was low with multiple causative factors such as biomedical, environmental and spiritual causes determining where patients accessed care. Forty (36.4%) participants utilised complementary and alternative treatment options. Conclusion We observed that knowledge about autoimmune rheumatic diseases among Ghanaian patients was low. Patients sought help from numerous medical facilities, traditional healers and prayer camps often contributing to a delay in diagnosis for most patients. This was influenced by individual perceptions, cultural beliefs and socioeconomic status. Active awareness and educational programmes for the public and healthcare workers are required, as well as strategic planning to integrate the biomedical and traditional care services to enable earlier presentation, accurate diagnosis and better clinical outcomes for the patients.	[Amissah-Arthur, Maame-Boatemaa; Boima, Vincent; Yorke, Ernest; Dey, Dzifa] Univ Ghana, Univ Ghana Med Sch, Coll Hlth Sci, Dept Med & Therapeut, Accra, Ghana; [Gyaban-Mensah, Anna; Mate-Kole, Charles] Korle Bu Teaching Hosp, Dept Psychiat, Accra, Ghana; [Ganu, Vincent] Korle Bu Teaching Hosp, Dept Med & Therapeut, Accra, Ghana; [Mate-Kole, Charles] Univ Ghana, Coll Humanities, Ctr Ageing Studies, Legon, Ghana; [Mate-Kole, Charles] Univ Ghana, Dept Psychol, Coll Humanities, Legon, Ghana	University of Ghana; University of Ghana; University of Ghana	Amissah-Arthur, MB (corresponding author), Univ Ghana, Univ Ghana Med Sch, Coll Hlth Sci, Dept Med & Therapeut, Accra, Ghana.	mbaarthur@doctors.net.uk						Abebe G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013339; Abubakar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071998; Adelowo O, 2021, NAT REV RHEUMATOL, V17, P363, DOI 10.1038/s41584-021-00603-4; Aikins AD, 2005, BMJ-BRIT MED J, V331, P737, DOI 10.1136/bmj.331.7519.737; Al-Busaidi Zakiya Q, 2008, Sultan Qaboos Univ Med J, V8, P11; [Anonymous], 2018, HLTH SECT GHAN FACTS; Barber MRW, 2021, NAT REV RHEUMATOL, V17, P515, DOI 10.1038/s41584-021-00668-1; Bartlett JE., 2001, INF TECHNOL LEARN PE, V19, P43; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buabeng KO, 2004, J PHARM PHARM SCI, V7, P350; Creswell J.W., 2011, DESIGNING CONDUCTING; De Cock D, 2014, SCAND J RHEUMATOL, V43, P1, DOI 10.3109/03009742.2013.805242; de Graft Aikins A, 2012, Ghana Med J, V46, P59; Essouma M, 2020, J AUTOIMMUN, V106, DOI 10.1016/j.jaut.2019.102348; Gergianaki I, 2019, LUPUS, V28, P104, DOI 10.1177/0961203318816820; Kretchy IA, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-44; Lartey GA., 2012, FACTORS INFLUENCING; Latunji O O, 2018, Ann Ib Postgrad Med, V16, P52; Mak A, 2012, SEMIN ARTHRITIS RHEU, V41, P830, DOI 10.1016/j.semarthrit.2011.11.002; Mezalek ZT, 2014, PRESSE MED, V43, pE209, DOI 10.1016/j.lpm.2014.04.002; Nanji JA, 2012, J RHEUMATOL, V39, P707, DOI 10.3899/jrheum.110818; Nightingale AL, 2017, LUPUS SCI MED, V4, DOI 10.1136/lupus-2016-000172; Owoahene-Acheampong S., 1998, INCULTURATION AFRICA; Quandt SA, 2009, J ALTERN COMPLEM MED, V15, P331, DOI 10.1089/acm.2008.0521; Rees F, 2017, ARTHRIT CARE RES, V69, P833, DOI 10.1002/acr.23021; Shaikh Babar T, 2008, J Pak Med Assoc, V58, P33; Stack RJ, 2012, ANN RHEUM DIS, V71, P493, DOI 10.1136/ard.2011.155416; Stack RJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024361; Tsey K, 1997, SOC SCI MED, V45, P1065, DOI 10.1016/S0277-9536(97)00034-8; Uribe AG, 2004, AUTOIMMUN REV, V3, P321, DOI 10.1016/j.autrev.2003.11.005; Usenbo A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133858; Van Den Boom G., 2008, EC GHANA, P392; van Nies JAB, 2013, ANN RHEUM DIS, V72, P1302, DOI 10.1136/annrheumdis-2012-201995; Wadee S, 2007, RHEUMATOLOGY, V46, P1487, DOI 10.1093/rheumatology/kem180	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0271892	10.1371/journal.pone.0271892	http://dx.doi.org/10.1371/journal.pone.0271892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094929	gold, Green Published			2022-12-26	WOS:000892376500011
J	Kada, A; Chouikh, A; Mellouli, S; Prashad, AJ; Straus, SE; Fahim, C				Kada, Amine; Chouikh, Arbi; Mellouli, Sehl; Prashad, Anupa J.; Straus, Sharon E.; Fahim, Christine			An exploration of Canadian government officials' COVID-19 messages and the public's reaction using social media data	PLOS ONE			English	Article							RISK COMMUNICATION; TWITTER; TOOL	Governments can use social media platforms such as Twitter to disseminate health information to the public, as evidenced during the COVID-19 pandemic [Pershad (2018)]. The purpose of this study is to gain a better understanding of Canadian government and public health officials' use of Twitter as a dissemination platform during the pandemic and to explore the public's engagement with and sentiment towards these messages. We examined the account data of 93 Canadian public health and government officials during the first wave of the pandemic in Canada (December 31, 2019 August 31, 2020). Our objectives were to: 1) determine the engagement rates of the public with Canadian federal and provincial/territorial governments and public health officials' Twitter posts; 2) conduct a hashtag trend analysis to explore the Canadian public's discourse related to the pandemic during this period; 3) provide insights on the public's reaction to Canadian authorities' tweets through sentiment analysis. To address these objectives, we extracted Twitter posts, replies, and associated metadata available during the study period in both English and French. Our results show that the public demonstrated increased engagement with federal officials' Twitter accounts as compared to provincial/territorial accounts. For the hashtag trends analysis of the public discourse during the first wave of the pandemic, we observed a topic shift in the Canadian public discourse over time between the period prior to the first wave and the first wave of the pandemic. Additionally, we identified 11 sentiments expressed by the public when reacting to Canadian authorities' tweets. This study illustrates the potential to leverage social media to understand public discourse during a pandemic. We suggest that routine analyses of such data by governments can provide governments and public health officials with real-time data on public sentiments during a public health emergency. These data can be used to better disseminate key messages to the public.	[Kada, Amine; Chouikh, Arbi; Mellouli, Sehl] Univ Laval, Fac Business Adm, Dept Management Informat Syst, Laval, PQ, Canada; [Prashad, Anupa J.; Straus, Sharon E.; Fahim, Christine] Unity Hlth Toronto, Fac Business Adm, Dept Management Informat Syst, Toronto, ON, Canada; [Straus, Sharon E.; Fahim, Christine] Univ Toronto, Dalla Lana Sch Publ Hlth, IHPME, Toronto, ON, Canada	Laval University; University of Toronto	Mellouli, S (corresponding author), Univ Laval, Fac Business Adm, Dept Management Informat Syst, Laval, PQ, Canada.	sehl.mellouli@fsa.ulaval.ca		Mellouli, Sehl/0000-0003-0977-4603; Chouikh, Arbi/0000-0003-0447-9357	Government of Canada	Government of Canada(CGIAR)	This research is part of a Government of Canada funded COVID-19 research project called "Combating misinformation, fear and stigma in response to the Covid-19 outbreak: An international collaboration between Canada and Singapore". The website of the funder is the following: https://www.canada.ca/en/instituteshealth-research/news/2020/03/government-of-canada-funds-49-additional-covid-19-researchprojects-details-of-the-funded-projects.html To the best of our knowledge, the funder [Government of Canada] had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, Bull World Health Organ, V80, P983; [Anonymous], 2020, THE NATIONAL; [Anonymous], 2020, GOOGLE TRENDS; [Anonymous], 2020, MONKEY LEARN; [Anonymous], 2020, MEDIA UPDATE; [Anonymous], 2020, DIGITAL TRENDS; BCCDC, 2021, NEW LANG GUID HELPS; BCCDC, 2020, BBCDC COVID 19 LANG; Bobicev V., 2017, RANLP 2017 RECENT AD, P97, DOI [10.26615/978-954-452-049-6_015, DOI 10.26615/978-954-452-049-6_015]; Bruns Axel, 2012, First Monday, V17, DOI 10.5210/fm.v17i4.3937; Bruns A, 2014, IT-INF TECHNOL, V56, P240, DOI 10.1515/itit-2014-1049; CDC, 2020, 2009 H1N1 PAND H1N1P; Cervellin G, 2017, J EPIDEMIOL GLOB HEA, V7, P185, DOI 10.1016/j.jegh.2017.06.001; Che WX, 2015, IEEE-ACM T AUDIO SPE, V23, P2111, DOI 10.1109/TASLP.2015.2443982; Chen C, 2015, IEEE TRANS COMPUT SO, V2, P65, DOI 10.1109/TCSS.2016.2516039; Cheng Y, 2022, MANAG DECIS ECON, V43, P496, DOI 10.1002/mde.3397; Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118; Cho HY, 2021, ETHNIC HEALTH, V26, P94, DOI 10.1080/13557858.2020.1830035; CPHO, 2020, CHIEF PUBL HLTH OFF; Daly M, 2021, JAMA-J AM MED ASSOC, V325, P2397, DOI 10.1001/jama.2021.8246; Darling E. S., 2013, ARXIV; Dhaoui C, 2017, J CONSUM MARK, V34, P480, DOI 10.1108/JCM-03-2017-2141; Duffy B., 2020, LIFE LOCKDOWN CORONA; Fan Lizhou, 2020, Proc Assoc Inf Sci Technol, V57, pe313, DOI 10.1002/pra2.313; Fewtrell L., 2001, WATER QUALITY GUIDEL; Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123; Goldust M, 2020, J EUR ACAD DERMATOL, V34, pE454, DOI 10.1111/jdv.16574; Gozgor G, 2022, APPL RES QUAL LIFE, V17, P559, DOI 10.1007/s11482-020-09902-6; Gruia D., 2022, WHO WHY STUDY BRIT D; Haman M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05540; Han X, 2019, COGENT BUS MANAG, V6, DOI 10.1080/23311975.2018.1564168; Hauer MK, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.568324; Herring Susan C., 2020, ACM Transactions on Social Computing, V3, DOI 10.1145/3375629; Johns Hopkins University, 2021, COVID 19 DASHB CTR S; Johns Hopkins University, 2020, COVID 19 DAT REP CTR; Kolchyna O., 2015, ARXIV; Kouzy R, 2020, CUREUS, V12, DOI 10.7759/cureus.7255; Kumar S., 2014, TWITTER DATA ANAL, P1041; Kwon ES, 2014, INT J ADVERT, V33, P657, DOI 10.2501/IJA-33-4-657-680; Ligthart A, 2021, ARTIF INTELL REV, V54, P4997, DOI 10.1007/s10462-021-09973-3; Lwin May Oo, 2020, JMIR Public Health Surveill, V6, pe19447, DOI 10.2196/19447; Lyu JC, 2021, J MED INTERNET RES, V23, DOI 10.2196/24435; Marcel S, 2020, SWISS MED WKLY, V150, DOI 10.4414/smw.2020.20225; Menon KU, 2005, J COMMUN MANAG, V9, P375, DOI 10.1108/13632540510621614; Miller H. J., 2016, P ICWSM, P259; Munoz-Exposito M, 2017, INTERNET RES, V27, P1122, DOI 10.1108/IntR-06-2016-0170; Pershad Y, 2018, J CLIN MED, V7, DOI 10.3390/jcm7060121; Petersen K, 2021, HEALTH POLICY, V125, P541, DOI 10.1016/j.healthpol.2021.01.001; Petts J., 2010, RISK COMMUNICATION P, P147; Pozzi FA, 2017, SENTIMENT ANALYSIS IN SOCIAL NETWORKS, P1, DOI 10.1016/B978-0-12-804412-4.00001-2; R Project, 2020, R PROJECT STAT COMPU; Rahman E.-U., 2018, INT J COMPUTER SCI E, V6, P644; Ravenscroft J, 2016, LREC 2016 - TENTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, P4115; Rickard LN, 2021, RISK ANAL, V41, P466, DOI 10.1111/risa.13415; Rieger MO, 2022, SOC INDIC RES, V159, P967, DOI 10.1007/s11205-021-02772-x; Rtweet, 2020, US; Scholz J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256113; Sinnenberg L, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2016.303512; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Statistics Canada, 2020, US; Stieglitz S., 2012, 2012 45th Hawaii International Conference on System Sciences (HICSS), P3500, DOI 10.1109/HICSS.2012.476; Stieglitz S, 2013, SOC NETW ANAL MIN, V3, P1277, DOI 10.1007/s13278-012-0079-3; Twitter, 2020, VER ACC; Twitter API, 2020, TWITT API V1 1; van Velsen L, 2012, J MED INTERNET RES, V14, P265, DOI 10.2196/jmir.2123; Vaughan E, 2009, AM J PUBLIC HEALTH, V99, pS324, DOI 10.2105/AJPH.2009.162537; Wang ZY, 2016, NAT HAZARDS, V83, P523, DOI 10.1007/s11069-016-2329-6; Whitlock C., 2021, J BRAND STRATEGY, V10, P36; World Health Organization, 2021, NOV COR 2019 NCOV SI; World Health Organization (WHO), 2003, SUMM PROB SARS CAS O; World Health Organization (WHO), 2019, MIDDLE E RESP SYNDRO; World Health Organization (WHO-1), 2020, WHO OUTBR COMM GUID; Wu S., 2011, P 20 INT C WORLD WID	73	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273153	10.1371/journal.pone.027315	http://dx.doi.org/10.1371/journal.pone.027315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054094				2022-12-26	WOS:000892641400016
J	Nkurunziza, JC; Nabukeera-Barungi, N; Kalyango, JN; Niyongabo, A; Mwanja, MM; Mupere, E; Nankabirwa, JI				Nkurunziza, Jean Claude; Nabukeera-Barungi, Nicolette; Kalyango, Joan Nakayaga; Niyongabo, Aloys; Mwanja, Mercy Muwema; Mupere, Ezekiel; Nankabirwa, Joaniter I.			Prevalence and factors associated with anaemia in children aged 6-24 months living a high malaria transmission setting in Burundi	PLOS ONE			English	Article							IRON-DEFICIENCY; IMPACT; INCOME; AREA	Background In very young children, anaemia has been linked to increased morbidity, mortality and poor cognitive development. Although Burundi has a high burden of anaemia, which may be worsened by the high burden of malaria, little is known about the extent of the problem in very young children who are most at risk of severe disease. We estimated the prevalence, and assessed the factors associated with anaemia in children aged 6-24 months using baseline data collected as part of an on-going study evaluating the effect of Micronutrient supplementation on anaemia and cognition among children in high malaria transmission settings in Burundi. Methods Between February and March 2020, surveys were conducted in 498 households within the catchment area of Mukenke Health Center. One child aged 6-24 months was selected per household to participate in the survey. Following written informed consent, we administered a questionnaire to the child's primary caregiver to capture information on child's demographics, nutritional status, food intake, health (status, and morbidity and treatment-seeking practices), as well as the household markers of wealth. A physical exam was conducted, and a blood sample was collected to: 1) assess for presence of plasmodium infection using a rapid diagnosis test; 2) estimate the haemoglobin levels using a portable haemocue machine. A stool sample was also collected to examine for the presence of helminth infections. Results The prevalence of anaemia was 74.3% (95% confidence interval [CI] 61.5%-84.0%), with most of the anaemic study participants classified as having moderate anaemia (59.2%). A total of 62 (12.5%) participants had positive malaria rapid diagnosis tests. Factors significantly associated with higher odds of developing anaemia included not receiving deworming medication (adjusted Odd ratio [aOR] = 3.54, 95% CI 1.79-6.99, p<0.001), the child's home location (Mukenke II: aOR = 2.22, 95% CI 1.89-2.62, p<0.001; Mukenke: aOR = 2.76, 95% CI 2.46-3.10, p<0.001 and Budahunga: aOR = 3.12, 95% CI 2. 94-3.31, p<0.001) and the child's age group (Children aged 6-11 months: aOR = 2.27, 95% CI 1.32-3.91, p<0.001). Education level was inversely associated with less odds of anaemia: child's primary care giver with a secondary (aOR = 0.67; 95% CI: 0.47-0.95, p = 0,024) and tertiary education level (aOR = 0.48; 95% CI: 0.38-0.61, p<0.001). Conclusion Anaemia is highly prevalent among young children in high malaria transmission setting. Anaemia is more prevalent among children who not dewormed and those with malaria. To prevent the long-term adverse outcomes of the anaemia in children, policy makers should focus on improving uptake of the deworming and malaria prevention programs, promote preventive interventions and improve the education of women especially in families with very young children.	[Nkurunziza, Jean Claude; Kalyango, Joan Nakayaga; Mwanja, Mercy Muwema; Nankabirwa, Joaniter I.] Makerere Univ, Coll Hlth Sci, Clin Epidemiol Unit, Kampala, Uganda; [Nkurunziza, Jean Claude] Univ Burundi, Kamenge Univ Hosp Ctr CHUK, Dept Community Med, Bujumbura, Burundi; [Nabukeera-Barungi, Nicolette; Mupere, Ezekiel] Makerere Univ Kampala, Coll Hlth Sci, Dept Paediat & Child Hlth, Sch Med, Kampala, Uganda; [Kalyango, Joan Nakayaga] Makerere Univ, Coll Hlth Sci, Dept Pharm, Kampala, Uganda; [Niyongabo, Aloys] Univ Burundi, Kamenge Univ Hosp Ctr CHUK, Dept Lab, Bujumbura, Burundi; [Nankabirwa, Joaniter I.] Infect Dis Res Collaborat, Kampala, Uganda	Makerere University; Makerere University; Makerere University	Nkurunziza, JC (corresponding author), Makerere Univ, Coll Hlth Sci, Clin Epidemiol Unit, Kampala, Uganda.; Nkurunziza, JC (corresponding author), Univ Burundi, Kamenge Univ Hosp Ctr CHUK, Dept Community Med, Bujumbura, Burundi.	jeanclaudenkuru2012@gmail.com		Jean Claude, Nkurunziza/0000-0002-2706-6339	African Union; Fogarty International Center (Emerging Global Leader Award) [K43TW010365]; European Union-IntraACP Mobility Partnering for Health Professionals Training in African Universities (P4HPT)	African Union; Fogarty International Center (Emerging Global Leader Award); European Union-IntraACP Mobility Partnering for Health Professionals Training in African Universities (P4HPT)	JCN got a two years doctoral fellowship from the African Union and European Union-IntraACP Mobility Partnering for Health Professionals Training in African Universities (P4HPT). JIN is supported by the Fogarty International Center (Emerging Global Leader Award grant number K43TW010365). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour N, 2014, J RES MED SCI, V19, P164; Alemayehu M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206268; [Anonymous], 2021, ELEVATION MAP ELEVAT; Balarajan Y, 2011, LANCET, V378, P2123, DOI 10.1016/S0140-6736(10)62304-5; Bosch F, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009032; Burundi MoH, 2019, ANN STAT; Burundi MoH, 2018, NATL MALARIA REDUCTI, P91; Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P400; Chaparro CM, 2008, J NUTR, V138, P2529, DOI 10.1093/jn/138.12.2529; Chaparro CM, 2019, ANN NY ACAD SCI, V1450, P15, DOI 10.1111/nyas.14092; Crawley J, 2004, AM J TROP MED HYG, V71, P25, DOI 10.4269/ajtmh.2004.71.25; Demirchyan A, 2016, PUBLIC HEALTH NUTR, V19, P1260, DOI 10.1017/S1368980015002451; Grantham-McGregor S, 2001, J NUTR, V131, p649S, DOI 10.1093/jn/131.2.649S; Hasan MM, 2021, PUBLIC HEALTH NUTR, V24, P6236, DOI 10.1017/S1368980021002482; Heinrichs H, 2021, MATERN CHILD NUTR, V17, DOI 10.1111/mcn.13082; Hotez PJ, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P467; Hurlimann E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-411; Institut de Statistiques et d'Etudes Economiques du Burundi (ISTEEBU) Ministere de la Sante Publique et de la Lutte contre le Sida [Burundi] (MSPLS) et ICF International, 2012, ENQ DEM SANT BUR 201; Janus J, 2010, AM FAM PHYSICIAN, V81, P1462; Jauregui-Lobera I, 2014, NEUROPSYCH DIS TREAT, V10, P2087, DOI 10.2147/NDT.S72491; Khan JR, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-015-0536-z; Kuziga F, 2017, BMC PEDIATR, V17, DOI 10.1186/s12887-017-0782-3; Legason Ismail Dragon, 2017, BMC Hematol, V17, P10, DOI 10.1186/s12878-017-0081-0; Li HX, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09129-y; Logan S, 1999, BRIT MED J, V318, P697; LOOAREESUWAN S, 1991, ACTA TROP, V48, P263, DOI 10.1016/0001-706X(91)90014-B; Lozoff B, 2007, FOOD NUTR BULL, V28, pS560, DOI 10.1177/15648265070284S409; LUBY SP, 1995, B WORLD HEALTH ORGAN, V73, P477; Martinsson A, 2014, EUR J EPIDEMIOL, V29, P489, DOI 10.1007/s10654-014-9929-9; Ministere a la Presidence charge de la Bonne Gouvernance et du Plan (MPBGP) MSPLS -Ministere de la Sante Publique et de la Lutte contre le Sida [Burundi] ISTEEBU -Institut de Statistiques et d'Etudes Economiques du Burundi e ICF, 2017, DHS 3 3 ENQ DEM SANT; Moschovis PP, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019654; Nambiema A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6547-1; Obasohan PE, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17238829; Obeagu Obeagu E, 2015, SICKLE CELL ANAEMIA, V3, P2244; Pearson MS, 2012, J ALLERGY CLIN IMMUN, V130, P13, DOI 10.1016/j.jaci.2012.05.029; Prentice AM, 2017, NUTR REV, V75, P49, DOI 10.1093/nutrit/nuw055; Prieto-Patron A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091269; Sanou D., 2012, RISK FACTORS ANEMIA; Schellenberg D, 1999, AM J TROP MED HYG, V61, P431, DOI 10.4269/ajtmh.1999.61.431; Scott SP, 2014, NUTRIENTS, V6, P5915, DOI 10.3390/nu6125915; Sharma AJ, 2019, ANN NY ACAD SCI, V1450, P190, DOI 10.1111/nyas.14167; Sharma H, 2020, CLIN EPIDEMIOL GLOB, V8, P1158, DOI 10.1016/j.cegh.2020.04.009; SMART, 2011, ENA SOFTW SMART; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Tesema GA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249978; United States Bureau of Census U.S. DoC, 2019, CSPRO US GUID, P612; Watthanakulpanich D, 2011, SE ASIAN J TROP MED, V42, P782; White NJ, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2509-9; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2011, WHO TECH REP SER, V959, P1; WHO, 2002, TECHNICAL SERIES REP, V912; WHO, 2017, NUTR AN TOOLS EFF PR; WHO, 2019, BENCH AIDS DIAGN INT; WHO, 2003, GLOB STRAT INF YOUNG; Woldie H, 2015, J NUTR METAB, V2015, DOI 10.1155/2015/928632; World Bank Group, 2016, PREV AN CHILDR CHILD; World Health Organization, 2010, Indicators for assessing infant and young child feeding practices, part 2: measurement; World Health Organization (WHO), 2006, WHO CHILD GROWTH STA, DOI DOI 10.4067/S0370-41062009000400012; Zimmermann MB, 2007, LANCET, V370, P511, DOI 10.1016/S0140-6736(07)61235-5	59	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273651	10.1371/journal.pone.0273651	http://dx.doi.org/10.1371/journal.pone.0273651			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054118	gold, Green Published			2022-12-26	WOS:000892641400026
J	Ronish, LA; Sidner, B; Yu, YF; Piepenbrink, KH				Ronish, Leslie A.; Sidner, Ben; Yu, Yafan; Piepenbrink, Kurt H.			Recognition of extracellular DNA by type IV pili promotes biofilm formation by Clostridioides difficile	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BUNDLE-FORMING PILUS; PSEUDOMONAS-AERUGINOSA; STRUCTURE/FUNCTION ANALYSIS; NATURAL TRANSFORMATION; NEISSERIA-MENINGITIDIS; MINOR PILINS; VIRULENCE; PROTEINS; BINDING; AGGREGATION	Clostridioides difficile is a Gram-positive bacillus, which is a frequent cause of gastrointestinal infections triggered by the depletion of the gut microbiome. Because of the frequent recurrence of these infections after antibiotic treatment, mechanisms of C. difficile persistence and recurrence, including biofilm formation, are of increasing interest. Previ-ously, our group and others found that type IV pili, filamentous helical appendages polymerized from protein subunits, pro-moted microcolony and biofilm formation in C. difficile. In Gram-negative bacteria, the ability of type IV pili to mediate bacterial self-association has been explained through in-teractions between the pili of adjacent cells, but type IV pili from several Gram-negative species are also required for nat-ural competence through DNA uptake. Here, we report the ability of two C. difficile pilin subunits, PilJ and PilW, to bind to DNA in vitro, as well as the defects in biofilm formation in the pili and pilW gene-interruption mutants. Additionally, we have resolved the X-ray crystal structure of PilW, which we use to model possible structural mechanisms for the formation of C. difficile biofilm through interactions between type IV pili and the DNA of the extracellular matrix. Taken together, our results provide further insight into the relationship between type IV pilus function and biofilm formation in C. difficile and, more broadly, suggest that DNA recognition by type IV pili and related structures may have functional importance beyond DNA uptake for natural competence.	[Ronish, Leslie A.; Yu, Yafan; Piepenbrink, Kurt H.] Univ Nebraska Lincoln, Dept Biochem, Lincoln, NE 68588 USA; [Sidner, Ben; Yu, Yafan; Piepenbrink, Kurt H.] Univ Nebraska Lincoln, Dept Food Sci & Technol, Lincoln, NE 68588 USA; [Piepenbrink, Kurt H.] Univ Nebraska Lincoln, Dept Chem, Lincoln, NE 68588 USA; [Piepenbrink, Kurt H.] Univ Nebraska Lincoln, Nebraska Food Hlth Ctr, Lincoln, NE 68588 USA; [Piepenbrink, Kurt H.] Univ Nebraska Lincoln, Ctr Integrated Biomol Commun, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln	Piepenbrink, KH (corresponding author), Univ Nebraska Lincoln, Dept Biochem, Lincoln, NE 68588 USA.; Piepenbrink, KH (corresponding author), Univ Nebraska Lincoln, Dept Food Sci & Technol, Lincoln, NE 68588 USA.; Piepenbrink, KH (corresponding author), Univ Nebraska Lincoln, Dept Chem, Lincoln, NE 68588 USA.; Piepenbrink, KH (corresponding author), Univ Nebraska Lincoln, Nebraska Food Hlth Ctr, Lincoln, NE 68588 USA.; Piepenbrink, KH (corresponding author), Univ Nebraska Lincoln, Ctr Integrated Biomol Commun, Lincoln, NE 68588 USA.	kurt.piepenbrink@unl.edu		Piepenbrink, Kurt/0000-0002-2527-0301	National Institutes of Health [K22-AI123467, P20-GM113126];  [T32-GM107001]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	This work was supported by National Institutes of Health grants K22-AI123467 (to K. H. P.) and P20-GM113126 (K. H. P. was a young investigator through the Nebraska Center for Integrated Biomolecular Communication). Additionally, L. A. R. was supported by T32-GM107001. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aas FE, 2002, MOL MICROBIOL, V46, P749, DOI 10.1046/j.1365-2958.2002.03193.x; Adams DW, 2019, NAT MICROBIOL, V4, P1545, DOI 10.1038/s41564-019-0479-5; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine PV, 2015, ACTA CRYSTALLOGR D, V71, P646, DOI 10.1107/S1399004714028132; Angelov A, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00084; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Barnier JP, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2109364118; Berry JL, 2019, J BIOL CHEM, V294, P6796, DOI 10.1074/jbc.RA118.006917; Berry JL, 2016, STRUCTURE, V24, P926, DOI 10.1016/j.str.2016.04.001; Berry JL, 2015, FEMS MICROBIOL REV, V39, P134, DOI 10.1093/femsre/fuu001; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Boddicker JD, 2002, MOL MICROBIOL, V45, P1255, DOI 10.1046/j.1365-2958.2002.03121.x; Bordeleau E, 2015, J BACTERIOL, V197, P819, DOI 10.1128/JB.02340-14; BRADLEY DE, 1980, CAN J MICROBIOL, V26, P146, DOI 10.1139/m80-022; Buckley AM, 2011, J MED MICROBIOL, V60, P1174, DOI 10.1099/jmm.0.028514-0; Cehovin A, 2013, P NATL ACAD SCI USA, V110, P3065, DOI 10.1073/pnas.1218832110; Cehovin A, 2011, VACCINE, V29, P6858, DOI 10.1016/j.vaccine.2011.07.060; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; Clausen M, 2009, J BACTERIOL, V191, P4633, DOI 10.1128/JB.00396-09; Cole SA, 2015, CLIN COLON RECT SURG, V28, P65, DOI 10.1055/s-0035-1547333; Craig L, 2003, MOL CELL, V11, P1139, DOI 10.1016/S1097-2765(03)00170-9; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Das J, 2017, MBIO, V8, DOI 10.1128/mBio.01466-17; Dawson LF, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-78437-5; Ellison CK, 2018, NAT MICROBIOL, V3, P773, DOI 10.1038/s41564-018-0174-y; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engevik MA, 2021, GASTROENTEROLOGY, V160, P1301, DOI 10.1053/j.gastro.2020.11.034; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Foadi J, 2013, ACTA CRYSTALLOGR D, V69, P1617, DOI 10.1107/S0907444913012274; Gellatly SL, 2013, PATHOG DIS, V67, P159, DOI 10.1111/2049-632X.12033; Giltner CL, 2012, MICROBIOL MOL BIOL R, V76, P740, DOI 10.1128/MMBR.00035-12; Giltner CL, 2010, J MOL BIOL, V398, P444, DOI 10.1016/j.jmb.2010.03.028; GIRON JA, 1991, SCIENCE, V254, P710, DOI 10.1126/science.1683004; Gurung I, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1177; Gurung I, 2016, MOL MICROBIOL, V99, P380, DOI 10.1111/mmi.13237; Harding CM, 2015, MOL MICROBIOL, V96, P1023, DOI 10.1111/mmi.12986; Harding CM, 2013, MBIO, V4, DOI 10.1128/mBio.00360-13; Helaine S, 2005, MOL MICROBIOL, V55, P65, DOI 10.1111/j.1365-2958.2004.04372.x; Helaine S, 2007, P NATL ACAD SCI USA, V104, P15888, DOI 10.1073/pnas.0707581104; Hendrick WA, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00034-17; Jacobsen T, 2020, MED MICROBIOL IMMUN, V209, P301, DOI 10.1007/s00430-019-00642-5; Jin TC, 2017, SCI REP-UK, V7, DOI 10.1038/srep40991; Jude BA, 2011, J STRUCT BIOL, V175, P1, DOI 10.1016/j.jsb.2011.04.008; Jurcisek JA, 2017, P NATL ACAD SCI USA, V114, pE6632, DOI 10.1073/pnas.1705508114; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kavanaugh JS, 2019, MBIO, V10, DOI 10.1128/mBio.01137-19; Kennan RM, 2001, J BACTERIOL, V183, P4451, DOI 10.1128/JB.183.15.4451-4458.2001; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Korotkov KV, 2008, NAT STRUCT MOL BIOL, V15, P462, DOI 10.1038/nsmb.1426; Laurenceau R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004835; Laurenceau R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003473; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Li W, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00813; Lim ES, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46363-w; Liu HL, 2013, J BACTERIOL, V195, P629, DOI 10.1128/JB.01288-12; Maldarelli GA, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw061; Maldarelli GA, 2014, PATHOG DIS, V71, P302, DOI 10.1111/2049-632X.12137; Martini AM, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.01752-21; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McKee RW, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00943-17; Melville S, 2013, MICROBIOL MOL BIOL R, V77, P323, DOI 10.1128/MMBR.00063-12; Meza-Torres J, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9091922; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Muschiol S, 2015, BIOESSAYS, V37, P426, DOI 10.1002/bies.201400125; Ng D, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006109; Nolan LM, 2020, MICROBIOL-SGM, V166, P995, DOI 10.1099/mic.0.000956; Normington C, 2021, NPJ BIOFILMS MICROBI, V7, DOI 10.1038/s41522-021-00184-w; Okahashi N, 2011, MICROB PATHOGENESIS, V50, P148, DOI 10.1016/j.micpath.2011.01.005; Okahashi N, 2010, BIOCHEM BIOPH RES CO, V391, P1192, DOI 10.1016/j.bbrc.2009.12.029; Okshevsky M, 2015, CURR OPIN BIOTECH, V33, P73, DOI 10.1016/j.copbio.2014.12.002; Panlilio H, 2021, BIOTECHNOL BIOENG, V118, P2129, DOI 10.1002/bit.27760; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Petersen FC, 2005, J BACTERIOL, V187, P4392, DOI 10.1128/JB.187.13.4392-4400.2005; Piepenbrink KH, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00001; Piepenbrink KH, 2016, BIOCHEM SOC T, V44, P1659, DOI 10.1042/BST20160221; Piepenbrink KH, 2016, J BIOL CHEM, V291, P22924, DOI 10.1074/jbc.M116.751099; Piepenbrink KH, 2015, STRUCTURE, V23, P385, DOI 10.1016/j.str.2014.11.018; Piepenbrink KH, 2014, J BIOL CHEM, V289, P4334, DOI 10.1074/jbc.M113.534404; Porstendorfer D, 2000, J BACTERIOL, V182, P3673, DOI 10.1128/JB.182.13.3673-3680.2000; Pucci F, 2017, BIOINFORMATICS, V33, P3415, DOI 10.1093/bioinformatics/btx417; Purcell EB, 2016, J BACTERIOL, V198, P565, DOI 10.1128/JB.00816-15; Ramboarina S, 2005, J BIOL CHEM, V280, P40252, DOI 10.1074/jbc.M508099200; Raynaud C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2102092118; Reynolds D, 2021, DRUGS, V81, P2117, DOI 10.1007/s40265-021-01635-6; Ronish LA, 2019, J BIOL CHEM, V294, P218, DOI 10.1074/jbc.RA118.005814; Salleh MZ, 2019, MBIO, V10, DOI 10.1128/mBio.00614-19; Schlafer S, 2017, CARIES RES, V51, P436, DOI 10.1159/000477447; Schreiber W, 2002, MICROBIOL-SGM, V148, P2507, DOI 10.1099/00221287-148-8-2507; Sheppard D, 2020, J BIOL CHEM, V295, P6594, DOI 10.1074/jbc.RA120.013316; Sinha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035620; Slater RT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46143-6; Soncini SR, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6453-z; Taggart MG, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009817; Tan RM, 2014, J INNATE IMMUN, V6, P227, DOI 10.1159/000354304; Terrier MCZ, 2014, WORLD J GASTROENTERO, V20, P7416, DOI 10.3748/wjg.v20.i23.7416; Tickle I, 2019, ACTA CRYSTALLOGR A, V75, pE162, DOI 10.1107/S205327331909394X; Tijerina-Rodriguez L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220671; Toma C, 2002, FEMS IMMUNOL MED MIC, V33, P35, DOI 10.1111/j.1574-695X.2002.tb00569.x; Tremblay YDN, 2021, ISME J, V15, P3623, DOI 10.1038/s41396-021-01042-5; Wang FB, 2017, STRUCTURE, V25, P1423, DOI 10.1016/j.str.2017.07.016; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330	106	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102449	10.1016/j.jbc.2022.102449	http://dx.doi.org/10.1016/j.jbc.2022.102449			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5S8ED	36064001	Green Published, gold			2022-12-26	WOS:000875415100012
J	Shen, ZM; Chen, M; Gao, Y; Dong, FF; Cen, CH; Wu, HW; Wang, N; Cui, XH; Han, CS; Gao, F				Shen, Zhiming; Chen, Min; Gao, Yang; Dong, Fangfang; Cen, Changhuo; Wu, Haowei; Wang, Nan; Cui, Xiuhong; Han, Chunsheng; Gao, Fei			The function of Foxo1 in spermatogonia development is independent of PI3K/PTEN signaling	FASEB JOURNAL			English	Article						fertility; Foxo1; Pten; spermatogenesis; spermatogonia	PRIMORDIAL GERM-CELLS; STEM-CELLS; MOUSE; GENERATION; GONOCYTES; PROGRAM; SPERMATOGENESIS; PLURIPOTENCY	Spermatogenesis is a highly coordinated process that initiates shortly after birth and continues throughout the lifespan of male animals. Foxo1 is a transcription factor and is involved in many biological processes. It has been reported that the inactivation of Foxo1 in gonocytes during the embryonic stage causes the defects of spermatogenesis. In the present study, we found that the inactivation of Foxo1 in spermatogonia after birth also caused germ cell loss and male infertility. We found that the initiation of meiosis was not affected; however, the germ cell development was arrested after meiosis and lack of mature spermatozoa in the cauda epididymis. We also found that the proliferation of Foxo1-deficient spermatogonia stem cells was significantly reduced under in vitro conditions. Further study revealed that inactivation of Pten in postnatal spermatogonia using Stra8-Cre did not affect germ cell development and the subcellular location of FOXO1 in Pten-deficient spermatogonia. This study demonstrated that Foxo1 was involved in the development of spermatogonia after birth and the function of Foxo1 was probably not regulated by PI3K/PTEN signaling.	[Shen, Zhiming; Chen, Min; Gao, Yang; Dong, Fangfang; Cen, Changhuo; Wu, Haowei; Wang, Nan; Cui, Xiuhong; Han, Chunsheng; Gao, Fei] Chinese Acad Sci, Inst Zool, State Key Lab Stern Cell & Reprod Biol, Beijing, Peoples R China; [Shen, Zhiming; Chen, Min; Gao, Yang; Dong, Fangfang; Cen, Changhuo; Wu, Haowei; Wang, Nan; Cui, Xiuhong; Han, Chunsheng; Gao, Fei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Shen, Zhiming; Chen, Min; Gao, Yang; Dong, Fangfang; Cen, Changhuo; Wu, Haowei; Wang, Nan; Han, Chunsheng; Gao, Fei] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China; [Chen, Min; Han, Chunsheng; Gao, Fei] Beijing Inst Stem Cell & Regenerat Med, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Gao, F (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stern Cell & Reprod Biol, Beijing, Peoples R China.	gaof@ioz.ac.cn			National Key Research and Development Program of China [2018YFA0107700]; National Natural Science Foundation of China (NSFC) [32170855, 31970785]	National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Key Research and Development Program of China, Grant/Award Number: 2018YFA0107700; National Natural Science Foundation of China (NSFC), Grant/Award Number: 32170855 and 31970785	Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen J, 2017, NUCLEIC ACIDS RES, V45, P4142, DOI 10.1093/nar/gkw1287; Culty M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110544; Culty M, 2009, BIRTH DEFECTS RES C, V87, P1, DOI 10.1002/bdrc.20142; De Rooij DG, 1998, INT J EXP PATHOL, V79, P67, DOI 10.1046/j.1365-2613.1998.00057.x; Dong FF, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.673258; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Goertz MJ, 2011, J CLIN INVEST, V121, P3456, DOI 10.1172/JCI57984; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Huang Y, 2011, CELL BIOL INT, V35, P905, DOI 10.1042/CBI20110161; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; LAWSON KA, 1994, CIBA F SYMP, V182, P68; Liu PL, 2017, CELL DEATH DIFFER, V24, P1672, DOI 10.1038/cdd.2017.90; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; Nagano R, 2000, ANAT REC, V258, P210; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Pui HP, 2017, MECH DEVELOP, V144, P125, DOI 10.1016/j.mod.2017.03.002; Qin Y, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.174128; Sadate-Ngatchou PI, 2008, GENESIS, V46, P738, DOI 10.1002/dvg.20437; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Sinha D, 2018, FASEB J, V32, P4984, DOI 10.1096/fj.201701096RR; Wang S, 2015, STEM CELLS DEV, V24, P471, DOI 10.1089/scd.2014.0376; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Zhang X, 2011, NAT CELL BIOL, V13, P1092, DOI 10.1038/ncb2293	30	0	0	10	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22522	10.1096/fj.202200640RR	http://dx.doi.org/10.1096/fj.202200640RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H1FA	36052752				2022-12-26	WOS:000849626700001
J	Caya, C; Maheu-Giroux, M; Xia, YQ; Serhir, B; Morin, V; Libman, M; Corsini, R; Goldfarb, DM; Wong, T; Singh, AE; Yansouni, CP				Caya, Chelsea; Maheu-Giroux, Mathieu; Xia, Yiqing; Serhir, Bouchra; Morin, Veronique; Libman, Michael; Corsini, Rachel; Goldfarb, David M.; Wong, Tom; Singh, Ameeta E.; Yansouni, Cedric P.			Stopping syphilis transmission in Arctic communities through rapid diagnostic testing: The STAR study protocol	PLOS ONE			English	Article							OF-CARE TEST; TREPONEMAL ANTIBODIES	Background Intense transmission of syphilis has emerged in some Canadian Arctic communities despite screening and prevention efforts. The remoteness of most communities and limited diagnostic infrastructure yield long delays (>= 14 days) between screening and treatment of cases. These hamper syphilis control efforts and may contribute to sustained transmission. Syphilis rapid diagnostic tests (RDTs) have been developed to make screening more accessible and to inform clinical decision-making within the same clinical encounter. These RDTs have been successfully deployed in several countries, but not yet in Canada. Methods and design We describe the methodology of the "Stopping Syphilis Transmission in Arctic Communities Through Rapid Diagnostic Testing"(STAR) study, wherein the clinical and epidemiological impact of deploying a dual syphilis RDT in the context of ongoing transmission in Nunavut and Nunavik will be evaluated. In this prospective multisite field evaluation, sexually active individuals aged >= 14 years at risk for syphilis will be offered screening by an RDT at the point-of-care by non-laboratory trained registered nurses. Whole blood and serum specimens will be concurrently collected, when feasible, for rapid testing with an RDT containing both treponemal and non-treponemal components (Chembio DPP (R) Syphilis Screen & Confirm) and compared to laboratory-based reference testing according to a reverse sequence algorithm. The diagnostic accuracy of the RDT, using both whole blood and centrifuged serum specimens, will be validated under real-world conditions in remote Northern settings, outside of specialized laboratories. Additionally, screening-to-treatment time, case detection rates, and the number of infectious contacts averted by using the RDT relative to reference testing will be estimated. The impact of both diagnostic approaches on syphilis transmission dynamics will also be modeled. Discussion This study will provide much needed evidence for strengthening rapid responses to emerging syphilis outbreaks in remote Arctic regions, by supplementing traditional diagnostic strategies with an RDT to rapidly triage patients likely in need of treatment. These results will also inform the development and tailoring of future diagnostic strategies and public health responses to emerging outbreaks in the North.	[Caya, Chelsea; Corsini, Rachel; Yansouni, Cedric P.] McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Caya, Chelsea; Corsini, Rachel; Yansouni, Cedric P.] McGill Interdisciplinary Initiat Infect & Immun, Montreal, PQ, Canada; [Maheu-Giroux, Mathieu; Xia, Yiqing] McGill Univ, Sch Populat & Global Hlth, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Serhir, Bouchra] Inst Natl Sante Publ, Lab Sante Publ Quebec, Ste Anne De Bellevue, PQ, Canada; [Morin, Veronique] Nunavik Reg Board Hlth & Social Serv, Kuujjuaq, PQ, Canada; [Libman, Michael; Yansouni, Cedric P.] McGill Univ, JD MacLean Ctr Trop Dis, Ctr Hlth, Montreal, PQ, Canada; [Libman, Michael; Yansouni, Cedric P.] McGill Univ, Div Infect Dis, Ctr Hlth, Montreal, PQ, Canada; [Libman, Michael; Yansouni, Cedric P.] McGill Univ, Div Infect Med Microbiol, Ctr Hlth, Montreal, PQ, Canada; [Goldfarb, David M.] Univ British Columbia, BC Childrens Hosp, Vancouver, BC, Canada; [Wong, Tom] Govt Canada, Indigenous Serv Canada, Ottawa, ON, Canada; [Wong, Tom] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Singh, Ameeta E.] Univ Alberta, Dept Med, Edmonton, AB, Canada	McGill University; McGill University; Institut national de sante publique du Quebec (INSPQ); McGill University; McGill University; McGill University; BC Childrens Hospital; University of British Columbia; University of Toronto; University of Alberta	Yansouni, CP (corresponding author), McGill Univ, Res Inst, Ctr Hlth, Montreal, PQ, Canada.; Yansouni, CP (corresponding author), McGill Interdisciplinary Initiat Infect & Immun, Montreal, PQ, Canada.; Yansouni, CP (corresponding author), McGill Univ, JD MacLean Ctr Trop Dis, Ctr Hlth, Montreal, PQ, Canada.; Yansouni, CP (corresponding author), McGill Univ, Div Infect Dis, Ctr Hlth, Montreal, PQ, Canada.; Yansouni, CP (corresponding author), McGill Univ, Div Infect Med Microbiol, Ctr Hlth, Montreal, PQ, Canada.	cedric.yansouni@mcgill.ca		Serhir, Bouchra/0000-0003-0735-0452	Canadian Institutes of Health Research [PJT162262]; Fonds de recherche du Quebec -Sante (FRQS)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec -Sante (FRQS)	This study is funded by the Canadian Institutes of Health Research (Grant number PJT162262 to CPY). CPY holds a "Chercheur-boursier clinicien" clinician-scholar career award from the Fonds de recherche du Quebec -Sante (FRQS). The funders had and will not have any role in study	[Anonymous], 2017, NEXT GENERATION DPP; Boulin K., 2019, PORTRAIT INFECT TRAN; Castro AR, 2010, J CLIN MICROBIOL, V48, P4615, DOI 10.1128/JCM.00624-10; Causer LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091504; Caya C, 2017, ARCTICNET ANN SCI ME; Choudhri Y, 2018, Can Commun Dis Rep, V44, P43, DOI 10.14745/ccdr.v44i02a02; Chow EPF, 2017, CLIN INFECT DIS, V65, P389, DOI 10.1093/cid/cix326; Coughlin KW, 2018, PAED CHILD HEALT-CAN, V23, P138, DOI 10.1093/pch/pxx127; Duhaime G., 2015, NUNAVIK FIGURES 2015; Educaloi, MED DEC CHILDR 14 17; Fortin C., 2015, ANAL LAB RECOMMANDEE; Grassly NC, 2005, NATURE, V433, P417, DOI 10.1038/nature03072; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hess KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112190; Mabey DC, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001233; Nunavik Regional Board of Health and Social Services, 2019, ANN REP 2018 2019; Nunavut Department of Health, 2018, NUN COMM DIS SURV MA; Office of the Chief Medical Officer of Health Department of Health, 2016, REP COMM DIS NUN 200; Papenburg J, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2022.10559; Public Health Agency of Canada, CAN GUID SEX TRANSM; Public Health Agency of Canada, SYPH KEY INF RES; Public Health Agency of Canada, 2020, SYPH CAN TECHN REP E; Singh Ameeta E, 2022, Can Commun Dis Rep, V48, P102, DOI [10.14745/ccdr.v48i23a08, 10.10.14745/ccdr.v48i23a08]; Statistics Canada, CRUD BIRTH RAT AG SP; The Sexually Transmitted Diseases Diagnostics Initiative, 2016, US RAP SYPH TESTS; Tsang Raymond Sw, 2022, Can Commun Dis Rep, V48, P82, DOI 10.14745/ccdr.v48i23a05; Vargas SK, 2022, MICROBIOL SPECTR, V10, DOI 10.1128/spectrum.02642-21; Yin YP, 2013, CLIN INFECT DIS, V56, P659, DOI 10.1093/cid/cis928; Zorzi A, 2017, SEX TRANSM INFECT, V93, pS51, DOI 10.1136/sextrans-2016-053065	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0273713	10.1371/journal.pone.0273713	http://dx.doi.org/10.1371/journal.pone.0273713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094912	Green Published, gold			2022-12-26	WOS:000892376500023
J	Derbie, A; Amare, B; Misgan, E; Nibret, E; Maier, M; Woldeamanuel, Y; Abebe, T				Derbie, Awoke; Amare, Bereket; Misgan, Eyaya; Nibret, Endalkachew; Maier, Melanie; Woldeamanuel, Yimtubezinash; Abebe, Tamrat			Histopathological profile of cervical punch biopsies and risk factors associated with high- grade cervical precancerous lesions and cancer in northwest Ethiopia	PLOS ONE			English	Article							WOMEN; PROGRESSION; POPULATION	Introduction Cervical cancer is an important public health problem in Ethiopia. However, the disease is not well characterized and studied in various parts of the country. This study was designed to describe the histopathological profile of cervical biopsies and to identify risk factors associated with high-grade cervical lesions and cancer (CIN2+C). Methods A cross-sectional study was conducted at Felege Hiwot Compressive Specialized Hospital (FHCSH) between 1 March 2019 and 30 October 2021. A structured questionnaire was used to collect data on the participants' demographic, reproductive and gynecologic history. From women presented with different degrees of cervical lesions, a senior gynecologist collected cervical swabs using (Digene HC2 DNA collection device: Qiagen, Hilden, Germany) for detection of high-risk Human papillomaviruses (HR-HPV) and punch biopsy for histopathological examinations. HR-HPVs were detected using the Abbott Alinity m system following the manufacturer protocol at the Institute of Virology, Leipzig University Hospital, Germany. Collected data entered and analyzed using SPSS version 25. A logistic regression model was used for both bivariable & multivariable analysis in order to determine the association between independent variables and CIN2+C. Statistical significance was set at a p-value <0.05. Results In this study, 335 women were included; the mean age was at 46.5 +/- 11.4 years. Most were living in rural settings, 221(66%) and had no formal education, 259 (77.3%). More than half of the participants, 193(57.6%) were unaware of cervical cancer. The prevalence of HIV infection and previous history of cervical screening were 44(13.1%) and 93(27.8%), respectively. HR-HPVs were detected in 178(54.3%) of the participants. The majority of biopsies, 140(41.8%; 95%CI: 36.6-47.1%), were diagnosed as cervical carcinoma. Normal histology, cervicitis, cervical intraepithelial neoplasia (CIN)-1, CIN-2, and CIN-3 accounted for 74 (22.1%), 30(9.0%), 40(11.9%), 12(3.6%), and 12(3.6%), respectively. High-grade lesions and cancer (CIN2+C) together accounted 164(49.0%; 95%CI: 43.6-54.2). Cervical cancer increased steadily with the age of the participants (p<0.001) in which women above the age of fifty were approximately four times more likely to develop CIN2+C than the younger ones (AOR: 3.73; 95%CI: 1.80-7.82; p<0.001). Likewise, no screening history in the last five years (AOR: 2.03; 95%CI: 1.05-3.92; p= 0.035) and being infected with HR-HPVs (AOR: 14.23; 95%CI: 7.9-25.64; p<0.001) were found significantly associated with CIN2+C. Conclusions The findings of this study revealed that cervical cancer continues to be an important women's health challenge in northwest Ethiopia. Postmenopausal women, who had no screening history within a five-year period and those women who tested positive for HR-HPV need special attention. It is important to increase the awareness of women about cervical cancer and actions for early detection of precancerous lesions should be expanded.	[Derbie, Awoke] Bahir Dar Univ, Dept Med Microbiol, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Derbie, Awoke; Woldeamanuel, Yimtubezinash] Addis Ababa Univ, Coll Hlth Sci, Ctr Innovat Drug Dev & Therapeut Trials Africa CD, Addis Ababa, Ethiopia; [Derbie, Awoke; Nibret, Endalkachew] Bahir Dar Univ, Inst Biotechnol, Dept Hlth Biotechnol, Bahir Dar, Ethiopia; [Derbie, Awoke; Woldeamanuel, Yimtubezinash; Abebe, Tamrat] Addis Ababa Univ, Sch Med, Dept Med Microbiol Immunol & Parasitol, Coll Hlth Sci, Addis Ababa, Ethiopia; [Amare, Bereket] Bahir Dar Univ, Dept Pathol, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Misgan, Eyaya] Bahir Dar Univ, Dept Gynecol & Obstet, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Nibret, Endalkachew] Bahir Dar Univ, Dept Biol, Coll Sci, Bahir Dar, Ethiopia; [Maier, Melanie] Leipzig Univ Hosp, Inst Virol, Dept Diagnost, Leipzig, Germany	Bahir Dar University; Addis Ababa University; Bahir Dar University; Addis Ababa University; Bahir Dar University; Bahir Dar University; Bahir Dar University; Leipzig University	Derbie, A (corresponding author), Bahir Dar Univ, Dept Med Microbiol, Coll Med & Hlth Sci, Bahir Dar, Ethiopia.; Derbie, A (corresponding author), Addis Ababa Univ, Coll Hlth Sci, Ctr Innovat Drug Dev & Therapeut Trials Africa CD, Addis Ababa, Ethiopia.; Derbie, A (corresponding author), Bahir Dar Univ, Inst Biotechnol, Dept Hlth Biotechnol, Bahir Dar, Ethiopia.; Derbie, A (corresponding author), Addis Ababa Univ, Sch Med, Dept Med Microbiol Immunol & Parasitol, Coll Hlth Sci, Addis Ababa, Ethiopia.	awoke.derbie@bdu.edu.et		Derbie, Awoke/0000-0002-6949-3494; Nibret, Endalkachew/0000-0002-7063-2877	Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa); College of Health Sciences; Addis Ababa University; Ethiopia and Biotechnology Research Institute; Bahir Dar University Ethiopia	Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa); College of Health Sciences; Addis Ababa University; Ethiopia and Biotechnology Research Institute; Bahir Dar University Ethiopia	The study was financially supported by Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), College of Health Sciences, Addis Ababa University, Ethiopia and Biotechnology Research Institute, Bahir Dar University Ethiopia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameya G, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0444-5; Anchalee C., 2021, J NAKORNPING HOSP, V12; Bakari F, 2017, ANN AFR MED, V16, P74, DOI 10.4103/aam.aam_35_16; Baldur-Felskov B, 2019, TROP MED INT HEALTH, V24, P229, DOI 10.1111/tmi.13184; Barchitta M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040469; Begoihn M, 2019, INFECT AGENTS CANCER, V14, DOI 10.1186/s13027-019-0255-4; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bruni L., 2017, ICO IARC INFORM CTR; Bruni L AG., 2021, 22 HUM PAP REL DIS W; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Cancer.Net , 2017, CERVICAL CANC SYMPTO; Cancer WIAfRo, 2020, CANC TOMORROW ESTIMA; De Vuyst H, 2013, VACCINE, V31, pF32, DOI 10.1016/j.vaccine.2012.07.092; Derbie A, 2021, INFECT AGENTS CANCER, V16, DOI 10.1186/s13027-021-00350-x; Desta M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259339; Ergete WaTA, 2001, ETHIOP J HEALTH DEV, V15, P39; Fernandes A, 2021, INT J GYNECOL CANCER, DOI 10.1136/ijgc-2021-003014; Getachew S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216522; Girianelli VR, 2009, INT J GYNECOL OBSTET, V107, P228, DOI 10.1016/j.ijgo.2009.07.036; Gizaw M, 2019, CANCER PREV RES, V12, P609, DOI 10.1158/1940-6207.CAPR-19-0156; Gyenwali D, 2013, ASIAN PAC J CANCER P, V14, P4373, DOI 10.7314/APJCP.2013.14.7.4373; Hammer A, 2019, CANCER MED-US, V8, P418, DOI 10.1002/cam4.1926; Health FDRoEMo, 2015, GUID CERV CANC PREV; Hu SY, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006689; Hull R, 2020, ONCOL LETT, V20, P2058, DOI 10.3892/ol.2020.11754; Jain AD., 2018, INT J HLTH SCI RES, V8, P82; Johnson LG, 2020, CANCER MED-US, V9, P6813, DOI 10.1002/cam4.3329; Kasa AS, 2021, SYST REV-LONDON, V10, DOI 10.1186/s13643-021-01840-0; Kassie AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239927; Loopik DL, 2019, J OBSTET GYNAECOL CA, V41, P292, DOI 10.1016/j.jogc.2018.06.021; Luhn P, 2013, GYNECOL ONCOL, V128, P265, DOI 10.1016/j.ygyno.2012.11.003; Makuza JD, 2015, PAN AFR MED J, V22, DOI 10.11604/pamj.2015.22.26.7116; Mittal S, 2017, INT J CANCER, V140, P1850, DOI 10.1002/ijc.30609; Niccolai LM, 2017, CLIN INFECT DIS, V65, P884, DOI 10.1093/cid/cix455; P. U. Kaseka, 2021, medRxiv, DOI 10.1101/2020.12.28.20248949; Society AC., 2017, CERVICAL CANC STAGES; Tesfaw G, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07201-9; Tifaoui N, 2018, J CLIN VIROL, V108, P12, DOI 10.1016/j.jcv.2018.08.010; Titiloye NA, 2020, J MED BIOMED SCI, V7, P19; Vaiday KB G., 2017, NJOG, V23, P65; Wang ZL, 2017, J CANCER, V8, P924, DOI 10.7150/jca.17416; Wei LS, 2017, COMPUT ASSIST SURG, V22, P186, DOI 10.1080/24699322.2017.1389397; WHO, 2013, WHO GUID SCREEN TREA; WHO, 2016, HUMAN PAPILLOMAVIRUS, DOI 10.12968/indn.2020.2.20; WHO, 2014, WHO GUIDELINES TREAT; WHO, 2014, INT AFR CANC FACTSH; WHO, 2022, CERV CANC; Wolday D, 2018, INFECT AGENTS CANCER, V13, DOI 10.1186/s13027-018-0201-x; Wudtisan Jongpeeti, 2019, Asian Pac J Cancer Prev, V20, P1031; Zeferino LC, 2006, BEST PRACT RES CL OB, V20, P339, DOI 10.1016/j.bpobgyn.2006.01.018; Zhang XX, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10907-5; Zhu MH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1748-1	52	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274466	10.1371/journal.pone.0274466	http://dx.doi.org/10.1371/journal.pone.0274466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094938	Green Published, gold			2022-12-26	WOS:000892376500044
J	Mukushev, M; Ubingazhibov, A; Kydyrbekova, A; Imashev, A; Kimmelman, V; Sandygulova, A				Mukushev, Medet; Ubingazhibov, Aidyn; Kydyrbekova, Aigerim; Imashev, Alfarabi; Kimmelman, Vadim; Sandygulova, Anara			FluentSigners-50: A signer independent benchmark dataset for sign language processing	PLOS ONE			English	Article							RECOGNITION	This paper presents a new large-scale signer independent dataset for Kazakh-Russian Sign Language (KRSL) for the purposes of Sign Language Processing. We envision it to serve as a new benchmark dataset for performance evaluations of Continuous Sign Language Recognition (CSLR) and Translation (CSLT) tasks. The proposed FluentSigners-50 dataset consists of 173 sentences performed by 50 KRSL signers resulting in 43,250 video samples. Dataset contributors recorded videos in real-life settings on a wide variety of backgrounds using various devices such as smartphones and web cameras. Therefore, distance to the camera, camera angles and aspect ratio, video quality, and frame rates varied for each dataset contributor. Additionally, the proposed dataset contains a high degree of linguistic and inter-signer variability and thus is a better training set for recognizing a real-life sign language. FluentSigners-50 baseline is established using two state-of-the-art methods, Stochastic CSLR and TSPNet. To this end, we carefully prepared three benchmark train-test splits for models' evaluations in terms of: signer independence, age independence, and unseen sentences. FluentSigners-50 is publicly available at https://krslproject.github.io/FluentSigners-50/	[Mukushev, Medet; Kydyrbekova, Aigerim; Imashev, Alfarabi; Sandygulova, Anara] Nazarbayev Univ, Sch Engn & Digital Sci, Dept Robot & Mechatron, Nur Sultan, Kazakhstan; [Ubingazhibov, Aidyn] Nazarbayev Univ, Sch Engn & Digital Sci, Dept Comp Sci, Nur Sultan, Kazakhstan; [Kimmelman, Vadim] Univ Bergen, Dept Linguist Literary & Aesthet Studies, Bergen, Norway	Nazarbayev University; Nazarbayev University; University of Bergen	Sandygulova, A (corresponding author), Nazarbayev Univ, Sch Engn & Digital Sci, Dept Robot & Mechatron, Nur Sultan, Kazakhstan.	anara.sandygulova@nu.edu.kz		Kimmelman, Vadim/0000-0002-8748-6845; Mukushev, Medet/0000-0002-3655-9928	Nazarbayev University Faculty Development Competitive Research Grant Program 2019-2021 [110119FD4545]	Nazarbayev University Faculty Development Competitive Research Grant Program 2019-2021	A.S. was awarded the funding by Nazarbayev University Faculty Development Competitive Research Grant Program 2019-2021 for the project "Kazakh Sign Language Automatic Recognition System (K-SLARS)". Award number is 110119FD4545. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanie S, 2020, EUR C COMP VIS; Alexei Baevski, 2019, Arxiv, DOI arXiv:1904.01038; Allen TE, 2015, RES METHODS SIGN LAN; Alptekin Orbay, 2020, Arxiv, DOI arXiv:2002.00479; Duarte A, 2020, Arxiv, DOI arXiv:2008.08143; Bayley R., 2000, J SOCIOLING, V4, P81, DOI [10.1111/1467-9481.00104, DOI 10.1111/1467-9481.00104]; Ben Swift, 2020, Arxiv, DOI arXiv:2010.05468; Benchiheub M, 2016, 7 INT C LANG RES EV, P7; Bragg D, 2019, ASSETS'19: THE 21ST INTERNATIONAL ACM SIGACCESS CONFERENCE ON COMPUTERS AND ACCESSIBILITY, P16, DOI 10.1145/3308561.3353774; Camgoz Necati Cihan, 2020, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR). Proceedings, P10020, DOI 10.1109/CVPR42600.2020.01004; Camgoz NC, 2018, PROC CVPR IEEE, P7784, DOI 10.1109/CVPR.2018.00812; Cao Z, 2021, IEEE T PATTERN ANAL, V43, P172, DOI 10.1109/TPAMI.2019.2929257; Carreira J, 2017, PROC CVPR IEEE, P4724, DOI 10.1109/CVPR.2017.502; Cecchetto C., 2012, SIGN LANGUAGE INT HD, P292, DOI DOI 10.1515/9783110261325.292; Chai X., 2014, VIPLTR14SLR001 I COM; Cooper H, 2012, J MACH LEARN RES, V13, P2205; Dreuw P, 2008, SIXTH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION, LREC 2008, P1115; Graves A., 2006, ACM INT C PROCEEDING, P369; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Houqiang Li, 2018, Arxiv, DOI arXiv:1801.10111; Huang J., 2018, 32 AAAI C ARTIFICIAL, DOI [10.1609/aaai.v32i1.11903, DOI 10.48550/ARXIV.1801.10111]; Johnston T, 2018, LINGUIST TYPOL, V22, P185, DOI 10.1515/lingty-2018-0008; Kimmelman V, 2022, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.740734; Kimmelman V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233731; Ko SK, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9132683; Koller O, 2020, IEEE T PATTERN ANAL, V42, P2306, DOI 10.1109/TPAMI.2019.2911077; Koller O, 2016, PROC CVPR IEEE, P3793, DOI 10.1109/CVPR.2016.412; Koller O, 2015, COMPUT VIS IMAGE UND, V141, P108, DOI 10.1016/j.cviu.2015.09.013; Lu P., 2010, P NAACL HLT 2010 WOR, P89; Oomen M, 2017, LINGUIST TYPOL, V21, P1, DOI 10.1515/lingty-2017-0001; Oscar Koller, 2020, Arxiv, DOI arXiv:2008.09918; Oszust M, 2013, C HUM SYST INTERACT, P219, DOI 10.1109/HSI.2013.6577826; Papineni K, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P311, DOI 10.3115/1073083.1073135; Paszke A, 2019, ADV NEUR IN, V32; Reza H., 2019, ARXIV; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Schembri A., 2012, SIGN LANGUAGE INT HD, P788, DOI DOI 10.1515/9783110261325.788; Szegedy C, 2016, P IEEE C COMP VIS PA, P2818; Vaswani A., 2017, PROC ANN C NEURAL IN, V30, P5998; Von Agris U., 2007, HUM COMP INT SIM LIS, V11; Zhang ZH, 2019, IEEE IMAGE PROC, P285, DOI 10.1109/ICIP.2019.8802972; Zhe Niu, 2020, Computer Vision - ECCV 2020 16th European Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12361), P172, DOI 10.1007/978-3-030-58517-4_11; Zhou H, 2019, IEEE INT CON MULTI, P1282, DOI 10.1109/ICME.2019.00223; Zorzi G, 2022, FRONT PSYCHOL, V13, DOI 10.3389/fpsyg.2022.716554	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0273649	10.1371/journal.pone.0273649	http://dx.doi.org/10.1371/journal.pone.0273649			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094924	Green Published, gold			2022-12-26	WOS:000892376500022
J	Tagawa, M; Ooto, S; Yamashiro, K; Tamura, H; Oishi, A; Uji, A; Miyata, M; Miyake, M; Takahashi, A; Ichioka, A; Tsujikawa, A				Tagawa, Miho; Ooto, Sotaro; Yamashiro, Kenji; Tamura, Hiroshi; Oishi, Akio; Uji, Akihito; Miyata, Manabu; Miyake, Masahiro; Takahashi, Ayako; Ichioka, Ai; Tsujikawa, Akitaka			Choriocapillaris flow deficit in a pachychoroid spectrum disease using en face optical coherence tomography angiography averaging	PLOS ONE			English	Article							GEOGRAPHIC ATROPHY; EYES	Purpose To investigate the choriocapillaris changes associated with pachychoroid pigment epitheliopathy (PPE) in comparison with healthy eyes. Methods Nine 3 x 3 mm macular optical coherence tomography angiography images were acquired in patients with PPE and age-matched healthy participants. Multiple en face image averaging of the choriocapillaris was binarized for quantitative image analysis of the flow voids. In PPE eyes, we evaluated the presence of pachyvessels and the association between the location of the choriocapillaris flow deficit and pachyvessels. Results Thirty-two eyes with PPE and 30 eyes of healthy participants were included. In PPE eyes, the mean total area (1.16 +/- 0.18 vs. 0.91 +/- 0.16, p < 0.001) and average size of the flow voids (790 +/- 144 vs. 520 +/- 138; p < 0.001) were significantly larger than those in control eyes. Composite images of the choriocapillaris and choroid showed choriocapillaris flow deficits just above and outside the pachyvessels. The mean proportion of the flow void area overlying the pachyvessels against the whole flow void area of the choriocapillaris was 21.3% +/- 10.2% (9.38%-44.42%) in PPE eyes. Conclusions In PPE eyes, the blood flow area of the choriocapillaris decreased diffusely within the macular area compared to control eyes, and the choriocapillaris flow deficit was not necessarily related to pachyvessel location.	[Tagawa, Miho; Ooto, Sotaro; Yamashiro, Kenji; Tamura, Hiroshi; Oishi, Akio; Uji, Akihito; Miyata, Manabu; Miyake, Masahiro; Takahashi, Ayako; Ichioka, Ai; Tsujikawa, Akitaka] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Yamashiro, Kenji] Japanese Red Cross Otsu Hosp, Otsu, Shiga, Japan	Kyoto University	Ooto, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	ohoto@kuhp.kyoto-u.ac.jp	Tamura, Hiroshi/H-1855-2011	Tamura, Hiroshi/0000-0002-7740-2732	Japan Society for the Promotion of Science (JSPS), Tokyo, Japan [16K11321]	Japan Society for the Promotion of Science (JSPS), Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by the Japan Society for the Promotion of Science (JSPS), Tokyo, Japan (Grant-in-Aid for Scientific Research, no. 16K11321). The funding body had no role in the design or conduct of the study, management, analysis, and interpretation of the data, or the preparation, review, or approval of the manuscript.	Balaratnasingam C, 2016, RETINA-J RET VIT DIS, V36, P1, DOI 10.1097/IAE.0000000000000774; Cheung CMG, 2019, EYE, V33, P14, DOI 10.1038/s41433-018-0158-4; Chhablani J, 2015, RETINA-J RET VIT DIS, V35, P2489, DOI 10.1097/IAE.0000000000000655; Dansingani KK, 2016, RETINA-J RET VIT DIS, V36, P499, DOI 10.1097/IAE.0000000000000742; Gal-Or O, 2018, RETINA-J RET VIT DIS, V38, P1984, DOI 10.1097/IAE.0000000000002051; Hata M, 2017, INVEST OPHTH VIS SCI, V58, P292, DOI 10.1167/iovs.16-20967; Hiroe T, 2018, OPHTHALMOL RETINA, V2, P152, DOI 10.1016/j.oret.2017.05.013; Ichioka A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259880; Kishi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206646; Lee JH, 2016, RETINA-J RET VIT DIS, V36, P889, DOI 10.1097/IAE.0000000000000809; Lee M, 2018, INVEST OPHTH VIS SCI, V59, P4896, DOI 10.1167/iovs.18-25018; Liu KK, 2020, GRAEF ARCH CLIN EXP, V258, P979, DOI 10.1007/s00417-020-04610-1; Matsumoto H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51268-9; Miyake M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16204; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; OLVER JM, 1990, EYE, V4, P262, DOI 10.1038/eye.1990.38; Pang CE, 2015, RETINA-J RET VIT DIS, V35, P1, DOI 10.1097/IAE.0000000000000331; Pang CE, 2014, AM J OPHTHALMOL, V158, P362, DOI 10.1016/j.ajo.2014.04.021; Phansalkar Neerad, 2011, 2011 International Conference on Communications and Signal Processing (ICCSP), P218, DOI 10.1109/ICCSP.2011.5739305; RAMRATTAN RS, 1994, INVEST OPHTH VIS SCI, V35, P2857; Saito M, 2015, INVEST OPHTH VIS SCI, V56, P6515, DOI 10.1167/iovs.15-17246; Sakurada Y, 2020, RETINA-J RET VIT DIS, V40, P657, DOI 10.1097/IAE.0000000000002635; SCHATZ H, 1989, OPHTHALMOLOGY, V96, P1541; Spaide RF, 2016, AM J OPHTHALMOL, V170, P58, DOI 10.1016/j.ajo.2016.07.023; Spaide RF, 2015, RETINA-J RET VIT DIS, V35, P2163, DOI 10.1097/IAE.0000000000000765; Sunness JS, 1997, OPHTHALMOLOGY, V104, P1677, DOI 10.1016/S0161-6420(97)30079-7; Tagawa M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73303-w; Takahashi A, 2018, OPHTHALMOL RETINA, V2, P295, DOI 10.1016/j.oret.2017.08.016; Takahashi K., 2019, NIPPON GANKA GAKKAI, V123, P284; Uji A, 2017, JAMA OPHTHALMOL, V135, P1197, DOI 10.1001/jamaophthalmol.2017.3904; Uji A, 2017, OPHTHALMOLOGY, V124, P944, DOI 10.1016/j.ophtha.2017.02.006; Warrow DJ, 2013, RETINA-J RET VIT DIS, V33, P1659, DOI 10.1097/IAE.0b013e3182953df4; Yanagi Y, 2020, JPN J OPHTHALMOL, V64, P323, DOI 10.1007/s10384-020-00740-5; YONEYA S, 1987, ARCH OPHTHALMOL-CHIC, V105, P681	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0271747	10.1371/journal.pone.0271747	http://dx.doi.org/10.1371/journal.pone.0271747			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094941	gold, Green Published			2022-12-26	WOS:000892376500010
J	Liu, W; Shen, DX; Ju, LA; Zhang, RJ; Du, WZ; Jin, W; Xiong, KP; Wang, G; Qian, KY; Zhang, Y; Xiao, Y; Wang, XH				Liu, Wei; Shen, Dexin; Ju, Lingao; Zhang, Renjie; Du, Wenzhi; Jin, Wan; Xiong, Kangping; Wang, Gang; Qian, Kaiyu; Zhang, Yi; Xiao, Yu; Wang, Xinghuan			MYBL2 promotes proliferation and metastasis of bladder cancer through transactivation of CDCA3	ONCOGENE			English	Article							CELL-CYCLE; B-MYB; TARGET; FOXM1	The transcription factor MYB proto-oncogene like 2 (MYBL2) is critical in regulating gene expression and tumorigenesis. However, the biological function of MYBL2 in bladder cancer (BLCA) remains to be elucidated. Here, we first revealed that MYBL2 was elevated in BLCA tissues and significantly correlated with clinicopathological parameters and cancer-specific survival in BLCA patients. Phenotypic assays showed that MYBL2 deficiency suppressed the proliferation and migration of BLCA cells in vitro and in vivo, whereas MYBL2 overexpression contributed to the opposite phenotype. Mechanistically, MYBL2 could bind to the promoter of its downstream target gene cell division cycle-associated protein 3 (CDCA3) and transactivate it, which in turn promoted the malignant phenotype of BLCA cells. Further investigations revealed that MYBL2 interacted with forkhead box M1 (FOXM1) to co-regulate the transcription of CDCA3. In addition, MYBL2/FOXM1 and CDCA3 might activate Wnt/beta-catenin signaling, thereby promoting the malignant phenotype of BLCA cells. In conclusion, the current study identifies MYBL2 as an oncogene in BLCA. MYBL2 can accelerate the proliferation and metastasis of BLCA through the transactivation of CDCA3.	[Liu, Wei; Shen, Dexin; Zhang, Renjie; Du, Wenzhi; Xiong, Kangping; Qian, Kaiyu; Xiao, Yu; Wang, Xinghuan] Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan, Peoples R China; [Ju, Lingao; Jin, Wan; Wang, Gang; Qian, Kaiyu; Xiao, Yu; Wang, Xinghuan] Wuhan Univ, Dept Biol Repositories, Zhongnan Hosp, Wuhan, Peoples R China; [Jin, Wan; Zhang, Yi] Euler Technol, ZGC Life Sci Pk, Beijing, Peoples R China; [Zhang, Yi] Peking Univ, Ctr Quantitat Biol, Sch Life Sci, Beijing, Peoples R China; [Wang, Xinghuan] Chinese Acad Med Sci, Wuhan Res Ctr Infect Dis & Canc, Wuhan, Peoples R China	Wuhan University; Wuhan University; Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College	Xiao, Y; Wang, XH (corresponding author), Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan, Peoples R China.; Xiao, Y; Wang, XH (corresponding author), Wuhan Univ, Dept Biol Repositories, Zhongnan Hosp, Wuhan, Peoples R China.; Zhang, Y (corresponding author), Euler Technol, ZGC Life Sci Pk, Beijing, Peoples R China.; Zhang, Y (corresponding author), Peking Univ, Ctr Quantitat Biol, Sch Life Sci, Beijing, Peoples R China.; Wang, XH (corresponding author), Chinese Acad Med Sci, Wuhan Res Ctr Infect Dis & Canc, Wuhan, Peoples R China.	zy@eulertechnology.com; yu.xiao@whu.edu.cn; wangxinghuan@whu.edu.cn		Liu, Wei/0000-0002-7908-8476; Qian, Kaiyu/0000-0003-4153-1265; Zhang, Yi/0000-0001-5388-1276	National Natural Science Foundation of China [82172985, 81772730]; Improvement Project for Theranostic Ability on Difficulty Miscellaneous Disease (Tumor) from National Health Commission of China [ZLYNXM202006]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences [2020-PT320-004]; Research Fund of Zhongnan Hospital of Wuhan University [ZNJC201915, SWYBK00-03, 413100049, PTXM2020024]; Science and Technology Department of Hubei Province Key Project [2022EJD001, YYXKNL2022001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Improvement Project for Theranostic Ability on Difficulty Miscellaneous Disease (Tumor) from National Health Commission of China; Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences; Research Fund of Zhongnan Hospital of Wuhan University; Science and Technology Department of Hubei Province Key Project	The excellent technical assistance of Ms. Yayun Fang and Ms. Danni Shan are gratefully acknowledged. Part of the analysis was performed on the High Performance Computing Platform of the Center for Life Science (Peking University). The study was funded by National Natural Science Foundation of China (82172985 and 81772730), Improvement Project for Theranostic Ability on Difficulty Miscellaneous Disease (Tumor) from National Health Commission of China (ZLYNXM202006), Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences (2020-PT320-004), Research Fund of Zhongnan Hospital of Wuhan University (ZNJC201915, SWYBK00-03, 413100049, and PTXM2020024), Science and Technology Department of Hubei Province Key Project (2022EJD001 and YYXKNL2022001).	[Anonymous], 2001, B WORLD HEALTH ORGAN, V79, P373; Ayad NG, 2003, CELL, V113, P101, DOI 10.1016/S0092-8674(03)00232-0; Bayley R, 2020, BBA-REV CANCER, V1874, DOI 10.1016/j.bbcan.2020.188407; Bian J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092125; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao R, 2018, CANCER LETT, V414, P278, DOI 10.1016/j.canlet.2017.11.015; Chen G, 2018, BIO-PROTOCOL, V8, DOI 10.21769/BioProtoc.2994; Choi BR, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107540; Ciciro Y, 2021, ONCOGENESIS, V10, DOI 10.1038/s41389-021-00309-y; Engeland K, 2018, CELL DEATH DIFFER, V25, P114, DOI 10.1038/cdd.2017.172; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P6070, DOI 10.1093/nar/gkw523; Gong AH, 2012, CANCER RES, V72, P5658, DOI 10.1158/0008-5472.CAN-12-0953; Guiley KZ, 2018, P NATL ACAD SCI USA, V115, P10016, DOI 10.1073/pnas.1808136115; Han J, 2021, TRANSL CANCER RES, V10, P4076, DOI 10.21037/tcr-21-175; He S, 2020, BIOMED PHARMACOTHER, V132, DOI 10.1016/j.biopha.2020.110851; Heinrichs S, 2013, ELIFE, V2, DOI 10.7554/eLife.00825; Hou XY, 2020, EXPERT REV ANTICANC, V20, P1107, DOI 10.1080/14737140.2020.1838280; Iness AN, 2019, ONCOGENE, V38, P1080, DOI 10.1038/s41388-018-0490-y; Li MS, 2019, AGING-US, V11, P10626, DOI 10.18632/aging.102481; Li QJ, 2021, THERANOSTICS, V11, P5794, DOI 10.7150/thno.56604; Liu Q, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03969-1; Okumura F, 2016, MOL CELL BIOL, V36, P1803, DOI 10.1128/MCB.00067-16; Pan CW, 2016, ONCOTARGET, V7, P35119, DOI 10.18632/oncotarget.9046; Ramirez JG, 2021, CANCERS, V13, DOI 10.3390/cancers13194980; Rimar KJ, 2017, CANCER-AM CANCER SOC, V123, P1912, DOI 10.1002/cncr.30631; Sadasivam S, 2012, GENE DEV, V26, P474, DOI 10.1101/gad.181933.111; Salik B, 2020, CANCER CELL, V38, P263, DOI 10.1016/j.ccell.2020.05.014; Shen DX, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-01969-x; Sheng Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14590-9; Wang ZW, 2010, CANCER TREAT REV, V36, P151, DOI 10.1016/j.ctrv.2009.11.006; Xie HY, 2021, J CELL MOL MED, V25, P1958, DOI 10.1111/jcmm.15948; Xiong YC, 2020, MOL CELL BIOCHEM, V468, P185, DOI 10.1007/s11010-020-03721-x; Xue YJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-200; Xueling GE, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-33; Yu RJ, 2017, PATHOL RES PRACT, V213, P964, DOI 10.1016/j.prp.2017.04.024; Zhang X, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0573-6	36	0	0	5	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 7	2022	41	41					4606	4617		10.1038/s41388-022-02456-x	http://dx.doi.org/10.1038/s41388-022-02456-x		SEP 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5D7BH	36071275				2022-12-26	WOS:000850752600001
J	Afolabi, EO; Quilliam, RS; Oliver, DM				Afolabi, Emmanuel O.; Quilliam, Richard S.; Oliver, David M.			Time since faecal deposition influences mobilisation of culturable E. coli and intestinal enterococci from deer, goose and dairy cow faeces	PLOS ONE			English	Article							ESCHERICHIA-COLI; INDICATOR ORGANISMS; SOURCE TRACKING; MANURE; RELEASE; PHOSPHORUS; SOIL; REMOVAL; MODEL; MICROORGANISMS	Mobilisation is a term used to describe the supply of a pollutant from its environmental source, e.g., soil or faeces, into a hydrological transfer pathway. The overarching aim of this study was to determine, using a laboratory-based approach, whether faecal indicator bacteria (FIB) are hydrologically mobilised in different quantities from a typical agricultural, wildlife and wildfowl source, namely dairy cattle, red deer and greylag goose faeces. The mobilisation of FIB from fresh and ageing faeces under two contrasting temperatures was determined, with significant differences in the concentrations of both E. co/iand intestinal enterococci lost from all faecal sources. FIB mobilisation from these faecal matrices followed the order of dairy cow > goose > deer (greatest to least, expressed as a proportion of the total FIB present). Significant changes in mobilisation rates from faecal sources over time were also recorded and this was influenced by the temperature at which the faecal material had aged over the course of the 12-day study. Characterising how indicators of waterborne pathogens are mobilised in the environment is of fundamental importance to inform models and risk assessments and develop effective strategies for reducing microbial pollution in catchment drainage waters and associated downstream impacts. Our findings add quantitative evidence to support the understanding of FIB mobilisation potential from three important faecal sources in the environment.	[Afolabi, Emmanuel O.; Quilliam, Richard S.; Oliver, David M.] Univ Stirling, Fac Nat Sci Biol & Environm Sci, Stirling, Scotland	University of Stirling	Oliver, DM (corresponding author), Univ Stirling, Fac Nat Sci Biol & Environm Sci, Stirling, Scotland.	david.oliver@stir.ac.uk		Oliver, David/0000-0002-6200-562X	Nigerian Government Petroleum Technology Development Fund via an overseas postgraduate scholarship	Nigerian Government Petroleum Technology Development Fund via an overseas postgraduate scholarship	This research was funded by the Nigerian Government Petroleum Technology Development Fund via an overseas postgraduate scholarship (https://ptdf.gov.ng/) awarded to EA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afolabi EO, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17196999; Alegbeleye OO, 2020, INT J HYG ENVIR HEAL, V227, DOI 10.1016/j.ijheh.2020.113524; Blaustein RA, 2015, J ENVIRON QUAL, V44, P1338, DOI 10.2134/jeq2015.02.0077; Blaustein RA, 2016, SCI TOTAL ENVIRON, V539, P583, DOI 10.1016/j.scitotenv.2015.07.108; Blaustein RA, 2015, ENVIRON SCI TECHNOL, V49, P7860, DOI 10.1021/acs.est.5b01095; Buckerfield SJ, 2019, WATER RES X, V5, DOI 10.1016/j.wroa.2019.100038; Ding T, 2017, J MICROBIOL BIOTECHN, V27, P417, DOI 10.4014/jmb.1609.09063; Djodjic F, 2018, AMBIO, V47, P45, DOI 10.1007/s13280-017-0935-5; Farnleitner AH, 2010, J APPL MICROBIOL, V109, P1599, DOI 10.1111/j.1365-2672.2010.04788.x; Fish R, 2009, ENVIRON SCI POLICY, V12, P281, DOI 10.1016/j.envsci.2009.02.002; Garcia-Aljaro C, 2017, WATER RES, V112, P248, DOI 10.1016/j.watres.2017.02.003; Gray CW, 2022, NEW ZEAL J AGR RES, V65, P445, DOI 10.1080/00288233.2021.1910319; Guber AK, 2007, LETT APPL MICROBIOL, V44, P161, DOI 10.1111/j.1472-765X.2006.02065.x; Guber AK, 2015, APPL ENVIRON MICROB, V81, P1168, DOI 10.1128/AEM.03295-14; Haygarth PM, 2005, SCI TOTAL ENVIRON, V344, P5, DOI 10.1016/j.scitotenv.2005.02.001; Hodgson CJ, 2009, LETT APPL MICROBIOL, V49, P124, DOI 10.1111/j.1472-765X.2009.02630.x; Jeong J, 2019, SCI TOTAL ENVIRON, V648, P164, DOI 10.1016/j.scitotenv.2018.08.097; Kendon M, 2020, INT J CLIMATOL, V40, DOI 10.1002/joc.6726; Kim K, 2016, J WATER HEALTH, V14, P443, DOI 10.2166/wh.2016.239; Martin M, 2015, SCI TOTAL ENVIRON, V536, P973, DOI 10.1016/j.scitotenv.2015.06.008; Mugler C, 2021, ENVIRON SCI POLLUT R, V28, P33009, DOI 10.1007/s11356-021-13011-8; Muirhead RW, 2011, WATER RES, V45, P2863, DOI 10.1016/j.watres.2011.03.001; Neill AJ, 2020, J ENVIRON MANAGE, V270, DOI 10.1016/j.jenvman.2020.110903; Neill AJ, 2019, J HYDROL, V570, P423, DOI 10.1016/j.jhydrol.2018.12.066; Oliver DM, 2018, SCI TOTAL ENVIRON, V616, P678, DOI 10.1016/j.scitotenv.2017.10.263; Oliver DM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37101; Oliver DM, 2010, HYDROL PROCESS, V24, P2973, DOI 10.1002/hyp.7837; Oliver DM, 2010, ENVIRON MODELL SOFTW, V25, P503, DOI 10.1016/j.envsoft.2009.10.003; Pascual-Benito M, 2020, J ENVIRON MANAGE, V261, DOI 10.1016/j.jenvman.2020.110220; Porter KDH, 2019, WASTE MANAGE, V87, P537, DOI 10.1016/j.wasman.2019.02.037; Sepehrnia N, 2018, J ENVIRON MANAGE, V227, P209, DOI 10.1016/j.jenvman.2018.08.086; Sepehrnia N, 2017, J ENVIRON MANAGE, V201, P388, DOI 10.1016/j.jenvman.2017.07.009; Sepehrnia N, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e07038; Sinton LW, 2007, APPL ENVIRON MICROB, V73, P7917, DOI 10.1128/AEM.01620-07; SNH, 2017, GOOS POL NAT GOOS PO; SNH, 2016, DEER MAN SCOTL REP S; Stocker M, 2018, WATER AIR SOIL POLL, V229, DOI 10.1007/s11270-018-3807-0; Stocker MD, 2020, J ENVIRON QUAL, V49, P1633, DOI 10.1002/jeq2.20164; Stocker MD, 2020, WATER AIR SOIL POLL, V231, DOI 10.1007/s11270-020-04556-4; Villa A, 2014, SOIL USE MANAGE, V30, P342, DOI 10.1111/sum.12121; Wang C, 2018, ADV WATER RESOUR, V111, P1, DOI 10.1016/j.advwatres.2017.10.028; Withers PJA, 2007, SOIL USE MANAGE, V23, P57, DOI 10.1111/j.1475-2743.2007.00117.x	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274138	10.1371/journal.pone.027413	http://dx.doi.org/10.1371/journal.pone.027413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054151				2022-12-26	WOS:000892641400065
J	Ricketts, MD; Emptage, RP; Blobel, GA; Marmorstein, R				Ricketts, M. Daniel; Emptage, Ryan P.; Blobel, Gerd A.; Marmorstein, Ronen			The heme-regulated inhibitor kinase requires dimerization for heme-sensing activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR 2-ALPHA KINASE; EIF2-ALPHA KINASE; SEDIMENTATION-VELOCITY; EIF-2-ALPHA KINASE; FETAL-HEMOGLOBIN; PROTEIN-KINASES; ACTIVATION; PHOSPHORYLATION; HRI; BINDING	The heme-regulated inhibitor (HRI) is a heme-sensing kinase that regulates mRNA translation in erythroid cells. In heme deficiency, HRI is activated to phosphorylate eukaryotic initiation factor 2 alpha and halt production of globins, thus avoiding accumulation of heme-free globin chains. HRI is inhibited by heme via binding to one or two heme-binding domains within the HRI N-terminal and kinase domains. HRI has recently been found to inhibit fetal hemoglobin (HbF) production in adult erythroid cells. Depletion of HRI increases HbF production, presenting a therapeutically exploitable target for the treatment of patients with sickle cell disease or thalassemia, which benefit from elevated HbF levels. HRI is known to be an oligomeric enzyme that is activated through autophosphorylation, although the exact nature of the HRI oligomer, its relation to autophosphorylation, and its mode of heme regulation remain unclear. Here, we employ biochemical and biophysical studies to demonstrate that HRI forms a dimeric species that is not dependent on autophosphorylation, the C-terminal coiled-coil domain in HRI is essential for dimer formation, and dimer formation facilitates efficient autophosphorylation and activation of HRI. We also employ kinetic studies to demonstrate that the primary avenue by which heme inhibits HRI is through the heme-binding site within the kinase domain, and that this inhibition is relatively independent of binding of ATP and eukaryotic initiation factor 2 alpha substrates. Together, these studies highlight the mode of heme inhibition and the importance of dimerization in human HRI hemesensing activity.	[Ricketts, M. Daniel; Emptage, Ryan P.; Marmorstein, Ronen] Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Ricketts, M. Daniel; Emptage, Ryan P.; Marmorstein, Ronen] Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA; [Blobel, Gerd A.] Univ Penn, Childrens Hosp Philadelphia, Perelman Sch Med, Div Hematol, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Marmorstein, R (corresponding author), Univ Penn, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.; Marmorstein, R (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Perelman Sch Med, Philadelphia, PA 19104 USA.	marmor@upenn.edu			National Institutes of Health;  [R01 CA226888];  [P01 AG031862];  [R01HL119479];  [T32 CA115299];  [T32 DK007780]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; ; 	Funding and additional information-This work was supported by the National Institutes of Health grants R01 CA226888 and P01 AG031862 awarded to R.M., R01HL119479 awarded to G.A.B., T32 CA115299 awarded to M.D.R., and T32 DK007780 awarded toR.P.E. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams JA, 2003, BIOCHEMISTRY-US, V42, P601, DOI 10.1021/bi020617o; Baier A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111546; Bauer BN, 2001, BIOCHEMISTRY-US, V40, P11543, DOI 10.1021/bi010983s; Bhavnani V, 2018, J BIOMOL STRUCT DYN, V36, P2845, DOI 10.1080/07391102.2017.1368417; Chefalo PJ, 1998, EUR J BIOCHEM, V258, P820, DOI 10.1046/j.1432-1327.1998.2580820.x; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chen JJ, 2019, BLOOD, V134, P1697, DOI 10.1182/blood.2019001915; Cole JL, 2008, METHOD CELL BIOL, V84, P143, DOI 10.1016/S0091-679X(07)84006-4; Delorenzi M, 2002, BIOINFORMATICS, V18, P617, DOI 10.1093/bioinformatics/18.4.617; Dey M, 2014, J BIOL CHEM, V289, P5747, DOI 10.1074/jbc.M113.527796; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; FAGARD R, 1981, P NATL ACAD SCI-BIOL, V78, P866, DOI 10.1073/pnas.78.2.866; Girardin SE, 2021, FEBS J, V288, P3094, DOI 10.1111/febs.15553; Grevet JD, 2018, SCIENCE, V361, P285, DOI 10.1126/science.aao0932; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Han AP, 2005, J CLIN INVEST, V115, P1562, DOI 10.1172/JCI24141; Han AP, 2001, EMBO J, V20, P6909, DOI 10.1093/emboj/20.23.6909; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hirai K, 2007, J INORG BIOCHEM, V101, P1172, DOI 10.1016/j.jinorgbio.2007.05.004; Huang P, 2020, BLOOD, V135, P2121, DOI 10.1182/blood.2020005301; Igarashi J, 2004, J BIOL CHEM, V279, P15752, DOI 10.1074/jbc.M310273200; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Igarashi J, 2011, FEBS J, V278, P918, DOI 10.1111/j.1742-4658.2011.08007.x; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Kanelakis K. C., 2009, ADV HEMATOL, V2009, P1; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Miksanova M, 2006, BIOCHEMISTRY-US, V45, P9894, DOI 10.1021/bi060556k; Modi V, 2019, P NATL ACAD SCI USA, V116, P6818, DOI 10.1073/pnas.1814279116; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Peslak SA, 2020, BLOOD ADV, V4, P4560, DOI 10.1182/bloodadvances.2020002475; Rafie-Kolpin M, 2000, J BIOL CHEM, V275, P5171, DOI 10.1074/jbc.275.7.5171; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sot B, 2003, J BIOL CHEM, V278, P32083, DOI 10.1074/jbc.M303958200; Suragani RNVS, 2012, BLOOD, V119, P5276, DOI 10.1182/blood-2011-10-388132; Thulasiraman V, 1998, EUR J BIOCHEM, V255, P552, DOI 10.1046/j.1432-1327.1998.2550552.x; Trigg J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023519; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; Vattem KM, 2001, EUR J BIOCHEM, V268, P3674, DOI 10.1046/j.1432-1327.2001.02273.x; WEINER MP, 1994, PCR METH APPL, V4, pS131; Xu ZY, 1997, EUR J BIOCHEM, V246, P461, DOI 10.1111/j.1432-1033.1997.t01-1-00461.x; Zhao Huaying, 2013, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2012s71	45	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102451	10.1016/j.jbc.2022.102451	http://dx.doi.org/10.1016/j.jbc.2022.102451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5H1DF	36063997	gold, Green Published			2022-12-26	WOS:000867425500008
J	Brinkerhoff, SA; Mathew, GM; Murrah, WM; Chang, AM; Roper, JA; Neely, KA				Brinkerhoff, Sarah A.; Mathew, Gina M.; Murrah, William M.; Chang, Anne-Marie; Roper, Jaimie A.; Neely, Kristina A.			Sleep restriction impairs visually and memory- guided force control	PLOS ONE			English	Article							SUSTAINED ATTENTION; DEPRIVATION; PERFORMANCE; DEGRADATION	Sleep loss is a common phenomenon with consequences to physical and mental health. While the effects of sleep restriction on working memory are well documented, it is unknown how sleep restriction affects continuous force control. The purpose of this study was to determine the effects of sleep restriction on visually and memory-guided force production magnitude and variability. We hypothesized that both visually and memory-guided force production would be impaired after sleep restriction. Fourteen men participated in an elevenday inpatient sleep study and completed a grip force task after two nights of ten hours' time in bed (baseline); four nights of five hours' time in bed (sleep restriction); and one night of ten hours' time in bed (recovery). The force task entailed four 20-second trials of isometric force production with the thumb and index finger targeting 25% of the participant's maximum voluntary contraction. During visually guided trials, participants had continuous visual feedback of their force production. During memory-guided trials, visual feedback was removed for the last 12 seconds of each trial. During both conditions, participants were told to maintain the target force production. After sleep restriction, participants decreased the magnitude of visually guided, but not memory-guided, force production, suggesting that visual attention tasks are more affected by sleep loss than memory-guided tasks. Participants who reported feeling more alert after sleep restriction and recovery sleep produced higher force during memory-guided, but not visually guided, force production, suggesting that the perception of decreased alertness may lead to more attention to the task during memory-guided visual tasks.	[Brinkerhoff, Sarah A.; Roper, Jaimie A.; Neely, Kristina A.] Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA; [Mathew, Gina M.] SUNY Stony Brook, Renaissance Sch Med, Program Publ Hlth, Stony Brook, NY USA; [Murrah, William M.] Auburn Univ, Dept Educ Fdn Leadership & Technol, Auburn, AL USA; [Chang, Anne-Marie] Penn State Univ, Dept Biobehav Hlth, Coll Hlth & Human Dev, University Pk, PA USA	Auburn University System; Auburn University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital; Auburn University System; Auburn University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Brinkerhoff, SA (corresponding author), Auburn Univ, Sch Kinesiol, Auburn, AL 36849 USA.	sbrinkerhoff@auburn.edu		Brinkerhoff, Sarah/0000-0002-1030-5233; Neely, Kristina/0000-0002-3008-8707	Pennsylvania State University Clinical and Translational Sciences Institute - National Center for Advancing Translational Sciences, National Institutes of Health (NIH) [UL1TR002014]; College of Health and Human Development of the Pennsylvania State University; National Center for Advancing Translational Sciences, NIH [UL1 TR002014, UL1 TR00045]	Pennsylvania State University Clinical and Translational Sciences Institute - National Center for Advancing Translational Sciences, National Institutes of Health (NIH); College of Health and Human Development of the Pennsylvania State University; National Center for Advancing Translational Sciences, NIH	This project was supported by a pilot grant (PI: A-M. Chang) from the Pennsylvania State University Clinical and Translational Sciences Institute (funded by the National Center for Advancing Translational Sciences, National Institutes of Health (NIH), through Grant UL1TR002014) and institutional funds from the College of Health and Human Development of the Pennsylvania State University (to A-M. Chang and O.M. Buxton). The Research Electronic Data Capture (REDCap) survey platform and the Clinical Research Center are supported by the National Center for Advancing Translational Sciences, NIH, through grants UL1 TR002014 and UL1 TR00045.	ADAMS JA, 1971, J MOTOR BEHAV, V3, P111; AKERSTEDT T, 1990, INT J NEUROSCI, V52, P29, DOI 10.3109/00207459008994241; [Anonymous], 2017, SLEEP SLEEP DIS DAT; BADDELEY A, 1992, SCIENCE, V255, P556, DOI 10.1126/science.1736359; Baker FC, 2007, SLEEP MED, V8, P613, DOI 10.1016/j.sleep.2006.09.011; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Chang AM, 2015, P NATL ACAD SCI USA, V112, P1232, DOI 10.1073/pnas.1418490112; Dinges DF, 1997, SLEEP, V20, P267; Doran SM, 2001, ARCH ITAL BIOL, V139, P253; DOUGLASS AB, 1994, SLEEP, V17, P160, DOI 10.1093/sleep/17.2.160; Drake CL, 2001, PSYCHOPHYSIOLOGY, V38, P979, DOI 10.1111/1469-8986.3860979; Figueiro MG, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-105; Fitts PM., 1964, PERCEPTUAL MOTOR SKI, P243, DOI [10.1016/B978-1-4832-3145, DOI 10.1016/B978-1-4832-3145-7.50016-9]; Gelman A, 2006, TECHNOMETRICS, V48, P432, DOI 10.1198/004017005000000661; Gerver CR, 2020, AGING NEUROPSYCHOL C, V27, P864, DOI 10.1080/13825585.2019.1700898; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Heaton KJ, 2014, AVIAT SPACE ENVIR MD, V85, P497, DOI 10.3357/ASEM.3882.2014; Jung CM, 2011, J SLEEP RES, V20, P348, DOI 10.1111/j.1365-2869.2010.00877.x; Lim JL, 2008, ANN NY ACAD SCI, V1129, P305, DOI 10.1196/annals.1417.002; Lim J, 2010, PSYCHOL BULL, V136, P375, DOI 10.1037/a0018883; Lohse KR, 2020, J MOTOR LEARN DEV, V8, P145, DOI 10.1123/jmld.2019-0007; Mahajan K, 2021, ACCIDENT ANAL PREV, V156, DOI 10.1016/j.aap.2021.106123; Mahajan K, 2020, ACCIDENT ANAL PREV, V142, DOI 10.1016/j.aap.2020.105545; Mander BA, 2017, NEURON, V94, P19, DOI 10.1016/j.neuron.2017.02.004; Marino M, 2013, SLEEP, V36, P1747, DOI 10.5665/sleep.3142; Marshall MM, 2004, J OCCUP REHABIL, V14, P281, DOI 10.1023/B:JOOR.0000047430.22740.57; Marvel CL, 2019, NEUROSCI BIOBEHAV R, V102, P184, DOI 10.1016/j.neubiorev.2019.04.017; Mathew GM, 2021, NAT SCI SLEEP, V13, P1117, DOI 10.2147/NSS.S294409; Neely KA, 2019, J AUTISM DEV DISORD, V49, P2675, DOI 10.1007/s10803-016-2806-5; Neely KA, 2017, EXP BRAIN RES, V235, P2473, DOI 10.1007/s00221-017-4987-3; Neely KA, 2017, NEUROPSYCHOLOGIA, V99, P172, DOI 10.1016/j.neuropsychologia.2017.03.012; Neely KA, 2016, EXP BRAIN RES, V234, P3203, DOI 10.1007/s00221-016-4718-1; Neely KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058403; Ness KM, 2019, AM J PHYSIOL-REG I, V316, pR697, DOI 10.1152/ajpregu.00336.2018; R Core Team, 2021, R LANGUAGE ENV STAT; Santisteban JA, 2019, SLEEP HEALTH, V5, P101, DOI 10.1016/j.sleh.2018.09.007; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; Vaillancourt DE, 2001, NEUROPSYCHOLOGIA, V39, P1410, DOI 10.1016/S0028-3932(01)00061-6; Van Dongen HPA, 2003, SLEEP, V26, P117, DOI 10.1093/sleep/26.2.117; Wang Z, 2015, J NEUROPHYSIOL, V113, P1989, DOI 10.1152/jn.00661.2014; Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274121	10.1371/journal.pone.0274121	http://dx.doi.org/10.1371/journal.pone.0274121			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054227	Green Published, gold			2022-12-26	WOS:000892641400062
J	Ebonwu, J; Lassauniere, R; Paximadis, M; Strehlau, R; Gray, GE; Kuhn, L; Tiemessen, CT				Ebonwu, J.; Lassauniere, R.; Paximadis, M.; Strehlau, R.; Gray, G. E.; Kuhn, L.; Tiemessen, C. T.			FCGR3Agene duplication, Fc gamma RIIb-232TT and Fc gamma RIIIb-HNA1a associate with an increased risk of vertical acquisition of HIV-1	JOURNAL OF THE INTERNATIONAL AIDS SOCIETY			English	Meeting Abstract									[Ebonwu, J.; Paximadis, M.; Tiemessen, C. T.] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa; [Ebonwu, J.] Natl Inst Communicable Dis, Div Publ Hlth Surveillance & Response, Johannesburg, South Africa; [Lassauniere, R.] Statens Serum Inst, Dept Virus & Microbiol Special Diagnost, Copenhagen, Denmark; [Paximadis, M.; Tiemessen, C. T.] Natl Inst Communicable Dis, Ctr HIV STIs, Johannesburg, South Africa; [Strehlau, R.] Rahima Moosa Mother & Child Hosp, Empilweni Serv & Res Unit, Johannesburg, South Africa; [Strehlau, R.] Univ Witwatersrand, Pediat & Child Hlth, Fac Hlth Scinces, Johannesburg, South Africa; [Gray, G. E.] Univ Witwatersrand, Perinatal HIV Res Unit, Fac Hlth Sci, Johannesburg, South Africa; [Gray, G. E.] South African Med Res Council, Cape Town, South Africa; [Kuhn, L.] Columbia Univ, Mailman Sch Publ Hlth, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY USA; [Kuhn, L.] Dept Epidemiol, New York, NY USA	University of Witwatersrand; National Institute for Communicable Diseases (NICD); Statens Serum Institut; National Institute for Communicable Diseases (NICD); University of Witwatersrand; University of Witwatersrand; South African Medical Research Council; Columbia University				Ebonwu, Joy/0000-0002-1329-7785; Lassauniere, Ria/0000-0002-3910-7185					0	0	0	2	2	JOHN WILEY & SONS LTD	CHICHESTER	THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND		1758-2652		J INT AIDS SOC	J. Int. AIDS Soc.	AUG	2022	25			3	SI	PESAC16	87	87						1	Immunology; Infectious Diseases	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Infectious Diseases	3L6JO	36084039	Green Published, gold			2022-12-26	WOS:000834867400164
J	Shi, ZH; Zhao, Z; Liu, LZ; Bian, XL; Zhang, Y				Shi, Zhi-Hong; Zhao, Zhong; Liu, Ling-Zhen; Bian, Xian-Ling; Zhang, Yun			Pore-forming protein beta gamma-CAT promptly responses to fasting with capacity to deliver macromolecular nutrients	FASEB JOURNAL			English	Article						albumin; fasting; fatty acid; nutrient; pore-forming protein	ALBUMIN; MACROPINOCYTOSIS; HOST	During animal fasting, the nutrient supply and metabolism switch from carbohydrates to a new reliance on the catabolism of energy-dense lipid stores. Assembled under tight regulation, beta gamma-CAT (a complex of non-lens beta gamma-crystallin and trefoil factor) is a pore-forming protein and trefoil factor complex identified in toad Bombina maxima. Here, we determined that this protein complex is a constitutive component in toad blood, that actively responds to the animal fasting. The protein complex was able to promote cellular albumin and albumin-bound fatty acid (FA) uptake in a variety of epithelial and endothelial cells, and the effects were attenuated by a macropinocytosis inhibitor. Endothelial cell-derived exosomes containing largely enriched albumin and FAs, called nutrisomes, were released in the presence of beta gamma-CAT. These specific nutrient vesicles were readily taken up by starved myoblast cells to support their survival. The results uncovered that pore-forming protein beta gamma-CAT is a fasting responsive element able to drive cell vesicular import and export of macromolecular nutrients.	[Shi, Zhi-Hong; Zhao, Zhong; Liu, Ling-Zhen; Bian, Xian-Ling; Zhang, Yun] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Engn Lab Peptides, Kunming, Yunnan, Peoples R China; [Shi, Zhi-Hong; Zhao, Zhong; Liu, Ling-Zhen; Bian, Xian-Ling; Zhang, Yun] Chinese Acad Sci, Kunming Inst Zool, 17 Longxin Rd, Kunming 650201, Yunnan, Peoples R China; [Shi, Zhi-Hong; Liu, Ling-Zhen] Univ Chinese Acad Sci, Kunming Coll Life Sci, Kunming, Yunnan, Peoples R China; [Zhao, Zhong] Chinese Acad Med Sci, Peking Union Med Coll, Sch Basic Med, Inst Basic Med Sci, Beijing, Peoples R China; [Bian, Xian-Ling] Univ Sci & Technol China, Div Life Sci & Med, Sch Life Sci, Hefei, Peoples R China; [Zhang, Yun] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences	Zhang, Y (corresponding author), Chinese Acad Sci, Kunming Inst Zool, 17 Longxin Rd, Kunming 650201, Yunnan, Peoples R China.	zhangy@mail.kiz.ac.cn		Shi, Zhi-Hong/0000-0002-7665-6685	National Natural Science Foundation of China (NSFC) [31572268, U1602225, 31872226]; Yunling Scholar Program	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Yunling Scholar Program	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31572268, U1602225 and 31872226; Yunling Scholar Program to Yun Zhang	Antonescu CN, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016964; Chung JJ, 2015, J CLIN INVEST, V125, P2307, DOI 10.1172/JCI79641; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Dang LY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01368; Deng CJ, 2020, FASEB J, V34, P13609, DOI 10.1096/fj.202001176R; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; Finicle BT, 2018, NAT REV CANCER, V18, P619, DOI 10.1038/s41568-018-0048-x; Fung KYY, 2018, TRAFFIC, V19, P5, DOI 10.1111/tra.12533; Gao ZH, 2019, FASEB J, V33, P782, DOI 10.1096/fj.201800087R; Giovannoli C, 2012, TALANTA, V94, P65, DOI 10.1016/j.talanta.2012.02.052; Grasselli E, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00418; Guo XL, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0304-y; Hillyard SD, 2011, ACTA PHYSIOL, V202, P533, DOI 10.1111/j.1748-1716.2010.02200.x; Jorgensen CB, 1997, BIOL REV, V72, P153, DOI 10.1017/S0006323196004963; Kimura I, 2020, PHYSIOL REV, V100, P171, DOI 10.1152/physrev.00041.2018; Klumperman J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016857; Ko CW, 2020, NAT REV GASTRO HEPAT, V17, P169, DOI 10.1038/s41575-019-0250-7; Ktistakis Nicholas T, 2015, Cold Spring Harb Protoc, V2015, P751, DOI 10.1101/pdb.prot086264; Li SA, 2017, J INFECT DIS, V215, P1753, DOI 10.1093/infdis/jix183; Liu L, 2021, J IMMUNOL, V207, P888, DOI 10.4049/jimmunol.2001056; Liu SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001770; Maisonneuve S, 2010, PLANT PHYSIOL, V152, P670, DOI 10.1104/pp.109.148247; Mayor S, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016758; Mobley CB, 2017, J DAIRY SCI, V100, P48, DOI 10.3168/jds.2016-11341; Palm W, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0285; Palm W, 2017, NATURE, V546, P234, DOI 10.1038/nature22379; Secor SM, 2016, COMPR PHYSIOL, V6, P773, DOI 10.1002/cphy.c150013; Shao HL, 2018, CHEM REV, V118, P1917, DOI 10.1021/acs.chemrev.7b00534; SPECTOR AA, 1986, METHOD ENZYMOL, V128, P320; Sun XL, 2020, CELL METAB, V31, P189, DOI 10.1016/j.cmet.2019.10.014; Swanson JA, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0146; Szczesny P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020349; van der Vusse GJ, 2009, DRUG METAB PHARMACOK, V24, P300, DOI 10.2133/dmpk.24.300; van Niel G, 2018, NAT REV MOL CELL BIO, V19, P213, DOI 10.1038/nrm.2017.125; Varga JFA, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03128; Vicencio JM, 2015, J AM COLL CARDIOL, V65, P1525, DOI 10.1016/j.jacc.2015.02.026; Viscarra JA, 2013, METABOLISM, V62, P889, DOI 10.1016/j.metabol.2012.12.014; Wang QQ, 2020, J BIOL CHEM, V295, P10293, DOI 10.1074/jbc.RA120.013556; Wu LG, 2014, ANNU REV PHYSIOL, V76, P301, DOI 10.1146/annurev-physiol-021113-170305; Wu W, 2020, THERANOSTICS, V10, P2859, DOI 10.7150/thno.41279; Xiang Y, 2014, P NATL ACAD SCI USA, V111, P6702, DOI 10.1073/pnas.1321317111; Yang TQ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081287; Yen CLE, 2015, J LIPID RES, V56, P489, DOI 10.1194/jlr.R052902; Young SG, 2013, GENE DEV, V27, P459, DOI 10.1101/gad.209296.112; Zhang Y, 2021, ZOOL RES, V42, P141, DOI 10.24272/j.issn.2095-8137.2020.358; Zhang Yun, 2015, Zoological Research, V36, P183, DOI 10.13918/j.issn.2095-8137.2015.4.183; Zhang YX, 2005, PROTEIN SCI, V14, P2469, DOI 10.1110/ps.051551105; Zhao Z, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03686-1	48	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22533	10.1096/fj.202200528R	http://dx.doi.org/10.1096/fj.202200528R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H7GW	36065711	hybrid, Green Submitted			2022-12-26	WOS:000850045800001
J	Chu, TH; Ko, CY; Tai, PH; Chang, YC; Huang, CC; Wu, TY; Chan, HH; Wu, PH; Weng, CH; Lin, YW; Kung, ML; Fang, CC; Wu, JC; Wen, ZH; Lee, YK; Hu, TH; Tai, MH				Chu, Tian-Huei; Ko, Chou-Yuan; Tai, Po-Han; Chang, Yi-Chen; Huang, Chao-Cheng; Wu, Tung-Yang; Chan, Hoi-Hung; Wu, Ping-Hsuan; Weng, Chien-Hui; Lin, Yu-Wei; Kung, Mei-Lang; Fang, Cheng-Chieh; Wu, Jian-Ching; Wen, Zhi-Hong; Lee, Yung-Kuo; Hu, Tsung-Hui; Tai, Ming-Hong			Leukocyte cell-derived chemotaxin 2 regulates epithelial-mesenchymal transition and cancer stemness in hepatocellular carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CATENIN; WNT/BETA-CATENIN; SORAFENIB; CONTRIBUTES; AMYLOIDOSIS; ACTIVATION; MECHANISMS; BLOCKADE; INVASION; PATHWAY	Leukocyte cell-derived chemotaxin 2 (LECT2) acts as a tu-mor suppressor in hepatocellular carcinoma (HCC). However, the antineoplastic mechanism of LECT2, especially its influ-ence on hepatic cancer stem cells (CSCs), remains largely un-known. In The Cancer Genome Atlas cohort, LECT2 mRNA expression was shown to be associated with stage, grade, recurrence, and overall survival in human HCC patients, and LECT2 expression was downregulated in hepatoma tissues compared with the adjacent nontumoral liver. Here, we show by immunofluorescence and immunoblot analyses that LECT2 was expressed at lower levels in tumors and in poorly differ-entiated HCC cell lines. Using functional assays, we also found LECT2 was capable of suppressing oncogenic behaviors such as cell proliferation, anchorage-independent growth, migration, invasiveness, and epithelial-mesenchymal transition in hepa-toma cells. Moreover, we show exogenous LECT2 treatment inhibited CSC functions such as tumor sphere formation and drug efflux. Simultaneously, hepatic CSC marker expression was also downregulated, including expression of CD133 and CD44. This was supported by infection with adenovirus encoding LECT2 (Ad-LECT2) in HCC cells. Furthermore, in animal experiments, Ad-LECT2 gene therapy showed potent efficacy in treating HCC. We demonstrate LECT2 over -expression significantly promoted cell apoptosis and reduced neovascularization/CSC expansion in rat hepatoma tissues. Mechanistically, we showed using immunoblot and immuno-fluorescence analyses that LECT2 inhibited beta-catenin signaling via the suppression of the hepatocyte growth factor/c-MET axis to diminish CSC properties in HCC cells. In summary, we reveal novel functions of LECT2 in the suppression of he-patic CSCs, suggesting a potential alternative strategy for HCC therapy.	[Chu, Tian-Huei; Lee, Yung-Kuo] Kaohsiung Armed Forces Gen Hosp, Med Educ & Res Ctr, Med Lab, Kaohsiung, Taiwan; [Ko, Chou-Yuan] Kaohsiung Armed Forces Gen Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan; [Ko, Chou-Yuan] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung, Taiwan; [Tai, Po-Han; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan; [Chang, Yi-Chen; Wu, Jian-Ching; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan; [Chang, Yi-Chen; Wu, Jian-Ching; Tai, Ming-Hong] Acad Sinica, Kaohsiung, Taiwan; [Huang, Chao-Cheng] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Huang, Chao-Cheng] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Wu, Tung-Yang] Kaohsiung Armed Forces Gen Hosp, Dept Chest Med, Kaohsiung, Taiwan; [Chan, Hoi-Hung] Conde S Januario Hosp, Dept Med, Div Gastroenterol, Macau, Peoples R China; [Wu, Ping-Hsuan; Weng, Chien-Hui; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan; [Lin, Yu-Wei] Kaohsiung Vet Gen Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan; [Kung, Mei-Lang] Kaohsiung Vet Gen Hosp, Dept Med Educ & Res, Kaohsiung, Taiwan; [Fang, Cheng-Chieh; Tai, Ming-Hong] Natl Sun Yat Sen Univ, Ctr Neurosci, Kaohsiung, Taiwan; [Wu, Jian-Ching] LabTurbo Biotech Corp, Taipei, Taiwan; [Wen, Zhi-Hong] Natl Sun Yat Sen Univ, Asia Pacific Ocean Res Ctr, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Hu, Tsung-Hui] Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol,Coll Med, Kaohsiung, Taiwan	National Sun Yat Sen University; National Sun Yat Sen University; National Sun Yat Sen University; Academia Sinica - Taiwan; Chang Gung Memorial Hospital; Chang Gung University; National Sun Yat Sen University; Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Sun Yat Sen University; National Sun Yat Sen University; Chang Gung Memorial Hospital; Chang Gung University	Tai, MH (corresponding author), Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung, Taiwan.; Tai, MH (corresponding author), Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan.; Tai, MH (corresponding author), Acad Sinica, Kaohsiung, Taiwan.; Tai, MH (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung, Taiwan.; Tai, MH (corresponding author), Natl Sun Yat Sen Univ, Ctr Neurosci, Kaohsiung, Taiwan.; Hu, TH (corresponding author), Chang Gung Univ, Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol,Coll Med, Kaohsiung, Taiwan.	dr.hu@msa.hinet.net; minghongtai@gmail.com		Chu, Tian-Huei/0000-0003-1197-5754	Ministry of Science and Technology, Taiwan [MOST108-2314-B110-003-MY2, MOST109-2314-B-182A-058, MOST110-2311-B-110-001, MOST110-2314-B-182A-057-MY3, MOST111-2320-B-393-001]; Kaohsiung Armed Forces General Hospital [KAFGH-D-10836, KAFGH-D-10907, KAFGH-D11150]; Chang Gung Medical Foundation [CMRPG8J1481, CMRPG8K0371]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Armed Forces General Hospital; Chang Gung Medical Foundation	This work was supported by grants from Ministry of Science and Technology, Taiwan (MOST108-2314-B110-003-MY2, MOST109-2314-B-182A-058, MOST110-2311-B-110-001, MOST110-2314-B-182A-057-MY3 and MOST111-2320-B-393-001), Kaohsiung Armed Forces General Hospital (KAFGH-D-10836, KAFGH-D-10907 and KAFGH-D11150), and Chang Gung Medical Foundation (CMRPG8J1481 and CMRPG8K0371).	Anson M, 2012, J CLIN INVEST, V122, P586, DOI 10.1172/JCI43937; Asuthkar S, 2012, J BIOL CHEM, V287, P20576, DOI 10.1074/jbc.M112.348888; Bruix J, 2017, LANCET, V389, P56, DOI 10.1016/S0140-6736(16)32453-9; Chan HH, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-83; Chang YC, 2021, PHYTOTHER RES, V35, P3954, DOI 10.1002/ptr.7111; Chen CK, 2016, SCI REP-UK, V6, DOI 10.1038/srep31398; Chen CK, 2014, HEPATOLOGY, V59, P974, DOI 10.1002/hep.26738; Chen SC, 2015, ONCOTARGET, V6, P16253, DOI 10.18632/oncotarget.3608; Cheng HJ, 2019, AM J CANCER RES, V9, P1536; Choi WM, 2020, J HEPATOL, V73, pS39, DOI 10.1002/hep4.1523; Chu TH, 2019, ONCOGENE, V38, P6461, DOI 10.1038/s41388-019-0886-3; Chu TH, 2018, CANCER MED-US, V7, P2567, DOI 10.1002/cam4.1487; Chu TH, 2014, ONCOTARGET, V5, P1475, DOI 10.18632/oncotarget.1745; de Sousa EMF, 2011, CLIN CANCER RES, V17, P647, DOI 10.1158/1078-0432.CCR-10-1204; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Folegatti PM, 2020, LANCET, V396, P467, DOI 10.1016/S0140-6736(20)31604-4; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Hung WY, 2018, CELL PHYSIOL BIOCHEM, V51, P337, DOI 10.1159/000495233; Jeong WJ, 2018, NPJ PRECIS ONCOL, V2, DOI 10.1038/s41698-018-0049-y; Ko CY, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22083946; Kuo HM, 2012, ATHEROSCLEROSIS, V221, P341, DOI 10.1016/j.atherosclerosis.2010.08.067; L'Hermitte A, 2019, HEPATOLOGY, V69, P160, DOI 10.1002/hep.30140; Lal M, 2008, HUM MOL GENET, V17, P3105, DOI 10.1093/hmg/ddn208; Lan F, 2014, DIABETES, V63, P1649, DOI 10.2337/db13-0728; Larsen CP, 2016, MODERN PATHOL, V29, P416, DOI 10.1038/modpathol.2016.29; Lee TKW, 2021, NAT REV GASTRO HEPAT, DOI 10.1038/s41575-021-00508-3; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Li X, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.661122; Liao CH, 2012, HEPATOLOGY, V55, P910, DOI 10.1002/hep.24740; Liu Q, 2005, J VIROL, V79, P14507, DOI 10.1128/JVI.79.23.14507-14515.2005; LIU TZ, 1994, CANCER LETT, V87, P193, DOI 10.1016/0304-3835(94)90222-4; Liu YC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061331; Lizarraga-Verdugo E, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00413; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Marrero JA, 2018, HEPATOLOGY, V68, P723, DOI 10.1002/hep.29913; McCubrey JA, 2014, LEUKEMIA, V28, P15, DOI 10.1038/leu.2013.184; Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56; Mereuta OM, 2014, BLOOD, V123, P1479, DOI 10.1182/blood-2013-07-517938; Ong HT, 2011, CANCER GENE THER, V18, P399, DOI 10.1038/cgt.2011.5; Ovejero C, 2004, HEPATOLOGY, V40, P167, DOI 10.1002/hep.20286; Pattabiraman DR, 2014, NAT REV DRUG DISCOV, V13, P497, DOI 10.1038/nrd4253; Phesse TJ, 2008, MOL CELL BIOL, V28, P6094, DOI 10.1128/MCB.00539-08; Saito T, 2004, J IMMUNOL, V173, P579, DOI 10.4049/jimmunol.173.1.579; Schulte LA, 2020, CANCERS, V12, DOI 10.3390/cancers12030684; Song J, 2020, CLIN MOL HEPATOL, V26, P484, DOI 10.3350/cmh.2020.0220; Takata N, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80689-0; Tang ZH, 2020, J NEURO-ONCOL, V149, P231, DOI 10.1007/s11060-020-03602-9; WALZ TM, 1995, BLOOD, V85, P2385, DOI 10.1182/blood.V85.9.2385.bloodjournal8592385; Wang EM, 2020, FASEB J, V34, P16163, DOI 10.1096/fj.202000511RR; Wang JH, 2021, LIVER INT, V41, P777, DOI 10.1111/liv.14816; Wilson MM, 2020, TRENDS CANCER, V6, P775, DOI 10.1016/j.trecan.2020.03.011; Xiang DM, 2017, HEPATOLOGY, V65, P1566, DOI 10.1002/hep.28919; Xu M, 2019, CELL, V178, P1478, DOI 10.1016/j.cell.2019.07.021; Yamagoe S, 1996, IMMUNOL LETT, V52, P9, DOI 10.1016/0165-2478(96)02572-2; Zhu YJ, 2017, ACTA PHARMACOL SIN, V38, P614, DOI 10.1038/aps.2017.5; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	58	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	298	10							102442	10.1016/j.jbc.2022.102442	http://dx.doi.org/10.1016/j.jbc.2022.102442			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5K6GU	36055405	Green Published, gold			2022-12-26	WOS:000869823800006
J	Watanabe, Y; Sakaguchi, Y				Watanabe, Yuya; Sakaguchi, Yutaka			Effects of a body manipulation of Japanese martial arts on interpersonal correlation of postural sway	PLOS ONE			English	Article							LIGHT TOUCH; APPROXIMATE ENTROPY; FRACTAL DYNAMICS; BALANCE; VARIABILITY; STIFFNESS; POSITION	This study aimed to investigate the nature of a specific body manipulation named Suichoku-Ririku (SR) in Japanese martial arts. SR is regarded as a method to change the way of stance and to distort the balance control of the opponent, but its nature and mechanism are unknown. In the present study, we attempted to determine the effect of SR in the cases that a person stood alone (Expt. 1) and that two persons stood in contact (Expt. 2). We compared several center of pressure (COP) measures between the normal stance and SR stance conditions. When participants stood independently (Expt. 1), the COP path length, standard deviation of COP velocity and permutation entropy of the COP increased with the SR stance, which suggested that the SR maneuver destabilized a quiet stance. When two participants stood (with normal stance) in contact by wrist-holding or by a light touch (Expt. 2), their COP motions were correlated with each other, as previously reported. When one of the participants took the SR maneuver, their correlation and mutual information were maintained, denying the view that SR would diminish the interpersonal correlation of body sway. On the other hand, a fluctuation in the COP increased only for the participant taking the SR maneuver, and not for the other participant. This asymmetric effect of the SR maneuver between two participants, irrespective of maintained mutual correlation, suggest that the relationship between balance controls of two participants was partly disrupted. We discuss possible mechanisms for the present results.	[Watanabe, Yuya; Sakaguchi, Yutaka] Univ Electrocommun, Grad Sch Informat & Engn, Dept Mech Engn & Intelligent Syst, Chofu, Tokyo, Japan; [Watanabe, Yuya] Mitsubishi Heavy Ind Machinery Syst Ltd, Infrastruct Facil Business Div, Sagamihara, Kanagawa, Japan	University of Electro-Communications - Japan	Sakaguchi, Y (corresponding author), Univ Electrocommun, Grad Sch Informat & Engn, Dept Mech Engn & Intelligent Syst, Chofu, Tokyo, Japan.	yutaka.sakaguchi@uec.ac.jp		Sakaguchi, Yutaka/0000-0002-5573-8462	JSPS (Japan Society for Promotion of Science) Kakenhi [18H03167, 19K22866]	JSPS (Japan Society for Promotion of Science) Kakenhi	YS received a grant from JSPS (Japan Society for Promotion of Science) Kakenhi 18H03167 and 19K22866. URL of JSPS website is https://www.jsps.go.jp/index.html.The funders did not play any role in role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Caballero C, 2015, J MOTOR BEHAV, V47, P550, DOI 10.1080/00222895.2015.1014545; Franklin DW, 2003, EXP BRAIN RES, V152, P211, DOI 10.1007/s00221-003-1540-3; Goldberger AL, 2002, NEUROBIOL AGING, V23, P23, DOI 10.1016/S0197-4580(01)00266-4; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Heitmann Stewart, 2011, Front Neurorobot, V5, P5, DOI 10.3389/fnbot.2011.00005; Holden M, 1994, J Vestib Res, V4, P285; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Ishigaki T, 2022, HUM MOVEMENT SCI, V81, DOI 10.1016/j.humov.2021.102909; Ishikawa Y., 2016, IEICE TECHNICAL REPO; Jeka J, 1998, J NEUROPHYSIOL, V79, P1661, DOI 10.1152/jn.1998.79.4.1661; Jeka JJ, 1995, ECOL PSYCHOL, V7, P321, DOI 10.1207/s15326969eco0704_7; JEKA JJ, 1994, EXP BRAIN RES, V100, P495, DOI 10.1007/BF02738408; Johannsen L, 2017, REHABIL NURS, V42, P131, DOI 10.1002/rnj.197; Johannsen L, 2012, J NEUROPHYSIOL, V107, P216, DOI 10.1152/jn.00149.2011; Johannsen L, 2009, J MOTOR BEHAV, V41, P397, DOI 10.3200/35-09-001; LO PC, 1989, P IEEE EMBS, V11, P638, DOI 10.1109/IEMBS.1989.95911; NIELSEN J, 1994, EXP BRAIN RES, V102, P350; Peng CK, 2002, ANN BIOMED ENG, V30, P683, DOI 10.1114/1.1481053; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Podobnik B, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.084102; Polskaia N, 2016, HUM MOVEMENT SCI, V46, P177, DOI 10.1016/j.humov.2015.12.013; Richer N, 2017, GAIT POSTURE, V54, P45, DOI 10.1016/j.gaitpost.2017.02.022; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Riley MA, 2003, BRAIN RES BULL, V62, P191, DOI 10.1016/j.brainresbull.2003.09.012; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Watanabe Y., 2020, P 37 ANN M JAPANESE, P364; Wing AM, 2011, PHILOS T R SOC B, V366, P3133, DOI 10.1098/rstb.2011.0169; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9; Zebende GF, 2011, PHYSICA A, V390, P614, DOI 10.1016/j.physa.2010.10.022	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274294	10.1371/journal.pone.0274294	http://dx.doi.org/10.1371/journal.pone.0274294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094944	gold, Green Published, Green Submitted			2022-12-26	WOS:000892376500035
J	Li, M; Xu, H; Qi, YH; Pan, ZW; Li, BY; Gao, ZJ; Zhao, RR; Xue, H; Li, G				Li, Ming; Xu, Hao; Qi, Yanhua; Pan, Ziwen; Li, Boyan; Gao, Zijie; Zhao, Rongrong; Xue, Hao; Li, Gang			Tumor-derived exosomes deliver the tumor suppressor miR-3591-3p to induce M2 macrophage polarization and promote glioma progression	ONCOGENE			English	Article							IMMUNITY; BRAIN; CELLS	Exosomes can selectively secrete harmful metabolic substances from cells to maintain cellular homeostasis, and complex crosstalk occurs between exosomes and tumor-associated macrophages (TAMs) in the glioma immune microenvironment. However, the precise mechanisms by which these exosome-encapsulated cargos create an immunosuppressive microenvironment remain unclear. Herein, we investigated the effect of glioma-derived exosomes (GDEs) on macrophage polarization and glioma progression. We performed sequencing analysis of cerebrospinal fluid (CSF) and tumor tissues from glioma patients to identify functional microRNAs (miRNAs). High levels of miR-3591-3p were found in CSF and GDEs but not in normal brain tissue or glial cells. Functionally, GDEs and miR-3591-3p significantly induced M2 macrophage polarization and increased the secretion of IL10 and TGF beta 1, which in turn promoted glioma invasion and migration. Moreover, miR-3591-3p overexpression in glioma cell lines resulted in G2/M arrest and markedly increased apoptosis. Mechanistically, miR-3591-3p can directly target CBLB and MAPK1 in macrophages and glioma cells, respectively, and further activate the JAK2/PI3K/AKT/mTOR, JAK2/STAT3, and MAPK signaling pathways. In vivo experiments confirmed that macrophages lentivirally transduced with miR-3591-3p can significantly promote glioma progression. Thus, our study demonstrates that tumor-suppressive miR-3591-3p in glioma cells can be secreted via exosomes and target TAMs to induce the formation of an immunosuppressive microenvironment. Collectively, these findings provide new insights into the role of glioma exosomal miRNAs in mediating the establishment of an immunosuppressive tumor microenvironment and show that miR-3591-3p may be a valuable biomarker and that blocking the encapsulation of miR-3591-3p into exosomes may become a novel immunotherapeutic strategy for glioma.	[Li, Ming; Xu, Hao; Qi, Yanhua; Pan, Ziwen; Li, Boyan; Gao, Zijie; Zhao, Rongrong; Xue, Hao; Li, Gang] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurosurg, Jinan 250012, Shandong, Peoples R China; [Li, Ming; Xu, Hao; Qi, Yanhua; Pan, Ziwen; Li, Boyan; Gao, Zijie; Zhao, Rongrong; Xue, Hao; Li, Gang] Shandong Univ, Inst Brain & Braininspired Sci, Jinan 250012, Shandong, Peoples R China; [Li, Ming; Xu, Hao; Qi, Yanhua; Pan, Ziwen; Li, Boyan; Gao, Zijie; Zhao, Rongrong; Xue, Hao; Li, Gang] Shandong Key Lab Brain Funct Remodeling, Jinan 250012, Shandong, Peoples R China; [Li, Ming] Qingdao Univ, Affiliated Taian City Cent Hosp, Dept Neurosurg, Tai An 271000, Shandong, Peoples R China; [Xu, Hao] Qingdao Univ, Affiliated Yantai Yuhuangding Hosp, Dept Neurosurg, Yantai 264000, Shandong, Peoples R China	Shandong University; Shandong University; Qingdao University; Qingdao University	Xue, H; Li, G (corresponding author), Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Neurosurg, Jinan 250012, Shandong, Peoples R China.; Xue, H; Li, G (corresponding author), Shandong Univ, Inst Brain & Braininspired Sci, Jinan 250012, Shandong, Peoples R China.; Xue, H; Li, G (corresponding author), Shandong Key Lab Brain Funct Remodeling, Jinan 250012, Shandong, Peoples R China.	xuehao@sdu.edu.cn; dr.ligang@sdu.edu.cn			National Natural Science Foundation of China [82273195, 81874083, 82072776, 82273286, 82072775, 82203419]; Natural Science Foundation of Shandong Province of China [ZR2019BH057, ZR2020QH174, ZR2021LSW025]; Jinan Science and Technology Bureau of Shandong Province [2021GXRC029]; Key clinical Research project of Clinical Research Center of Shandong University [2020SDUCRCA011]; Taishan Pandeng Scholar Program of Shandong Province [tspd20210322]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province of China(Natural Science Foundation of Shandong Province); Jinan Science and Technology Bureau of Shandong Province; Key clinical Research project of Clinical Research Center of Shandong University; Taishan Pandeng Scholar Program of Shandong Province	We are grateful to the surgeons, physicians, and patients who participated in our studies. We thank the Novogene Co. Ltd and Tianjin Novogene Bioinformatics Technology Co., Ltd for miRNA and mRNA Sequencing technical development and support. This work was supported by grants from the National Natural Science Foundation of China (Nos. 82273195; 81874083; 82072776; 82273286; 82072775; 82203419), Natural Science Foundation of Shandong Province of China (Nos. ZR2019BH057; ZR2020QH174; ZR2021LSW025), the Jinan Science and Technology Bureau of Shandong Province (2021GXRC029), Key clinical Research project of Clinical Research Center of Shandong University (2020SDUCRCA011) and Taishan Pandeng Scholar Program of Shandong Province (No. tspd20210322).	Aldape K, 2019, NAT REV CLIN ONCOL, V16, P509, DOI 10.1038/s41571-019-0177-5; Anderson NR, 2021, CANCER RES, V81, P1201, DOI 10.1158/0008-5472.CAN-20-2990; Antunes ARP, 2021, NAT NEUROSCI, V24, P595, DOI 10.1038/s41593-020-00789-y; Barthel L, 2022, CANCER METAST REV, V41, P53, DOI 10.1007/s10555-021-09997-9; Chen CY, 2022, MOL CANCER, V21, DOI 10.1186/s12943-022-01511-1; Chen DG, 2021, THERANOSTICS, V11, P1016, DOI 10.7150/thno.51777; Chen PW, 2019, CANCER CELL, V35, P868, DOI 10.1016/j.ccell.2019.05.003; Cheng J, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01189-3; Dapash M, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10092257; Franklin RA, 2014, SCIENCE, V344, P921, DOI 10.1126/science.1252510; Guo X, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2020-001975; He GP, 2022, MOL CANCER, V21, DOI 10.1186/s12943-021-01440-5; Hoshino A, 2020, CELL, V182, P1044, DOI 10.1016/j.cell.2020.07.009; Hosseini R, 2022, MOL CANCER, V21, DOI 10.1186/s12943-021-01492-7; Iguchi Y, 2016, BRAIN, V139, P3187, DOI 10.1093/brain/aww237; Janjua TI, 2021, ADV DRUG DELIVER REV, V171, P108, DOI 10.1016/j.addr.2021.01.012; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kaneda MM, 2016, NATURE, V539, P437, DOI 10.1038/nature19834; Kang M, 2021, ADV MATER, V33, DOI 10.1002/adma.202103258; Lavoie H, 2020, NAT REV MOL CELL BIO, V21, P607, DOI 10.1038/s41580-020-0255-7; Li X, 2020, J EXP MED, V217, DOI 10.1084/jem.20191537; Li Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00299-9; Liu TQ, 2022, ONCOIMMUNOLOGY, V11, DOI 10.1080/2162402X.2022.2031499; Lv KS, 2017, GENE DEV, V31, P1007, DOI 10.1101/gad.297135.117; Ma FY, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-003217; Miller KD, 2021, CA-CANCER J CLIN, V71, P381, DOI 10.3322/caac.21693; Morrissey SM, 2021, CELL METAB, V33, P2040, DOI 10.1016/j.cmet.2021.09.002; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Nguyen TTT, 2021, J EXP MED, V218, DOI 10.1084/jem.20202477; O'Brien K, 2020, NAT REV MOL CELL BIO, V21, P585, DOI 10.1038/s41580-020-0251-y; Ostrom QT, 2014, NEURO-ONCOLOGY, V16, P1, DOI 10.1093/neuonc/nou223; Pan ZW, 2022, MOL CANCER, V21, DOI 10.1186/s12943-021-01485-6; Qiu W, 2021, MOL THER, V29, P3449, DOI 10.1016/j.ymthe.2021.06.023; TAKAHASHI A, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms15287, DOI 10.1038/NCOMMS15287]; Teng Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14448; Tzetzo SL, 2021, CANCER CELL, V39, P734, DOI 10.1016/j.ccell.2021.03.002; Vignard V, 2020, CANCER IMMUNOL RES, V8, P255, DOI 10.1158/2326-6066.CIR-19-0522; Villarino AV, 2017, NAT IMMUNOL, V18, P374, DOI 10.1038/ni.3691; Wang YJ, 2021, CANCER CELL, V39, P1375, DOI 10.1016/j.ccell.2021.07.023; Wang Z, 2020, J CELL PHYSIOL, V235, P2825, DOI 10.1002/jcp.29188; Xia YQ, 2020, ADV MATER, V32, DOI 10.1002/adma.202002054; Xu JY, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03664-1; Yan SJ, 2021, FEBS J, V288, P6174, DOI 10.1111/febs.15726; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zhang ZP, 2020, CANCER IMMUNOL RES, V8, P966, DOI 10.1158/2326-6066.CIR-19-0759; Zhou HH, 2021, MOL THER, V29, P3465, DOI 10.1016/j.ymthe.2021.06.019	46	0	0	15	15	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 7	2022	41	41					4618	4632		10.1038/s41388-022-02457-w	http://dx.doi.org/10.1038/s41388-022-02457-w		SEP 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5D7BH	36085418	hybrid, Green Published			2022-12-26	WOS:000852095400001
J	Jiang, FF; Zhao, Y; Bai, JL; Yang, XY; Zhang, JJ; Lin, DH; Li, XM				Jiang, Fangfang; Zhao, Yang; Bai, Jianling; Yang, Xueying; Zhang, Jiajia; Lin, Danhua; Li, Xiaoming			Perceived health literacy and COVID-19 vaccine acceptance among Chinese college students: A mediation analysis	PLOS ONE			English	Article							INFLUENZA VACCINATION; ATTITUDES; HESITANCY	Background Although COVID-19 vaccines hold the potential to dramatically alter the COVID-19 pandemic, vaccine hesitancy remains a serious threat to the management and control of COVID-19 infections. Vaccination of young adults plays a crucial role in achieving herd immunity. However, the determinants of COVID-19 vaccine acceptance among the youth in China have not been fully explored. Our study aims to investigate the direct and indirect effects of perceived health literacy on COVID-19 vaccine acceptance. Methods This survey was conducted among Chinese college students during September and October, 2020. COVID-19 vaccine acceptance was defined as the likelihood that participants would get a COVID-19 vaccine. A mediation analysis was employed to explore the direct and indirect effects of perceived health literacy on COVID-19 vaccine acceptance. Results A total of 2,587 college students were included in our study. The results of the survey revealed that the majority (80.40%) of the participants expressed high COVID-19 vaccine acceptance. After controlling for demographic characteristics, the relationship between perceived health literacy and COVID-19 vaccine acceptance was mediated by positive attitudes toward general vaccination (std.beta = 0.004, p = 0.037) and self-efficacy of COVID-19 vaccine (std.beta = 0.053, p < 0.001). Conclusions The findings suggest that interventions targeting health literacy to promote COVID-19 vaccination coverage might consider placing greater emphasis on enhancing the positive attitude towards and self-efficacy of vaccines among youth.	[Jiang, Fangfang] Univ Southampton, Sch Social Sci, Dept Math Sci, Southampton, Hants, England; [Zhao, Yang; Bai, Jianling] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China; [Yang, Xueying; Zhang, Jiajia; Li, Xiaoming] Univ South Carolina, Arnold Sch Publ Hlth, South Carolina SmartState Ctr Healthcare Qual, Columbia, SC 29208 USA; [Yang, Xueying; Li, Xiaoming] Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA; [Zhang, Jiajia] Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC USA; [Lin, Danhua] Beijing Normal Univ, Fac Psychol, Inst Dev Psychol, Beijing, Peoples R China	University of Southampton; Nanjing Medical University; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; Beijing Normal University	Yang, XY (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, South Carolina SmartState Ctr Healthcare Qual, Columbia, SC 29208 USA.; Yang, XY (corresponding author), Univ South Carolina, Arnold Sch Publ Hlth, Dept Hlth Promot Educ & Behav, Columbia, SC 29208 USA.	xueyyang@mailbox.sc.edu		YANG, Xueying/0000-0001-6788-0688; Jiang, Fangfang/0000-0002-1500-494X				Abubakar AR, 2020, INFECT DRUG RESIST, V13, P4673, DOI 10.2147/IDR.S289037; Afonso N, 2014, VACCINE, V32, P502, DOI 10.1016/j.vaccine.2013.11.043; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P221; [Anonymous], WHO CORONAVIRUS COVI, DOI DOI 11/44679/INDEX.HTM; [Anonymous], 2021, WHO PREQUALIFICATION; [Anonymous], COVID 19 VACCINES; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bai W, 2021, INT J BIOL SCI, V17, P1469, DOI 10.7150/ijbs.58835; Barello S, 2020, EUR J EPIDEMIOL, V35, P781, DOI 10.1007/s10654-020-00670-z; Brown AL, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00011618, 10.1590/0102-311x00011618]; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chu HR, 2021, PATIENT EDUC COUNS, V104, P1878, DOI 10.1016/j.pec.2021.02.031; Cohen MS, 2020, SCIENCE, V368, P551, DOI 10.1126/science.abc5798; Costantini H, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9081038; Dong D, 2020, HEALTH EXPECT, V23, P1543, DOI 10.1111/hex.13140; Finbraten HS, 2017, J ADV NURS, V73, P2730, DOI 10.1111/jan.13342; Francis AI, 2022, POSTGRAD MED J, V98, P389, DOI 10.1136/postgradmedj-2021-140654; Ghazy RM, 2022, VACCINES-BASEL, V10, DOI 10.3390/vaccines10030350; Graffigna G, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040576; Ipsos survey for The World Economic Forum, GLOB ATT COVID 19 VA; Jara A, 2021, NEW ENGL J MED, V385, P875, DOI 10.1056/NEJMoa2107715; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Malik AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100495; Mitchell C, 2019, PAHO WHO 10 THREATS; Neumann-Bohme S, 2020, EUR J HEALTH ECON, V21, P977, DOI 10.1007/s10198-020-01208-6; Painter JE, 2011, J SCHOOL HEALTH, V81, P304, DOI 10.1111/j.1746-1561.2011.00595.x; Patil U, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18063301; Paul E, 2021, LANCET REG HEALTH-EU, V1, DOI 10.1016/j.lanepe.2020.100012; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Saied SM, 2021, J MED VIROL, V93, P4280, DOI 10.1002/jmv.26910; Sallam M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052407; Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE210, DOI 10.1016/S2468-2667(21)00012-8; Sharma M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18094617; Siedner MJ., 2022, J INFECT DIS, DOI [10.1093/infdis/jiac243, DOI 10.1093/INFDIS/JIAC243, 10.1101/2021.04.28.21256237, DOI 10.1101/2021.04.28.21256237V1, 10.1101/2021.04.28.21256237v1, DOI 10.1101/2021.04.28.21256237]; Tam CC, 2021, AIDS BEHAV, V25, P9, DOI 10.1007/s10461-020-03068-w; Thomas SJ, 2021, NEW ENGL J MED, V385, P1761, DOI 10.1056/NEJMoa2110345; Umakanthan S, 2022, FRONT PUBLIC HEALTH, V10, DOI 10.3389/fpubh.2022.844333; Umakanthan S, 2022, POSTGRAD MED J, V98, P756, DOI 10.1136/postgradmedj-2021-141365; Umakanthan S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101064; Umakanthan Srikanth, 2021, Transl Med Commun, V6, P22, DOI 10.1186/s41231-021-00102-4; Umakanthan S, 2020, POSTGRAD MED J, V96, P753, DOI 10.1136/postgradmedj-2020-138234; Van Duong T, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9090985; Wang Chao, 2022, Vaccines (Basel), V10, DOI 10.3390/vaccines10060920; Wang JH, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030191; Ye Z, 2020, APPL PSYCHOL-HLTH WE, V12, P1074, DOI 10.1111/aphw.12211; Zhang XJ, 2020, CELL METAB, V32, P176, DOI 10.1016/j.cmet.2020.06.015	49	1	1	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273285	10.1371/journal.pone.0273285	http://dx.doi.org/10.1371/journal.pone.0273285			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054110	gold, Green Published			2022-12-26	WOS:000892641400019
J	Lin, X; Li, XQ; Bai, YQ; Liu, Q; Xiang, WL				Lin, Xi; Li, Xiaoqin; Bai, Yongqi; Liu, Qin; Xiang, Weilan			Death-coping self-efficacy and its influencing factors among Chinese nurses: A cross-sectional study	PLOS ONE			English	Article							PALLIATIVE CARE; HOSPICE; PERSPECTIVES	Background Nurses are the main caregivers of dying patients. Facing or dealing with death-related events is inevitable. Death-coping self-efficacy (DCS) is very important, as it can reduce the risk of nursing staff to adverse emotional distress, help them participate in end-of-life care and improve the quality of care of patients. Methods Using the convenient sampling method, this study included a total of 572 nurses from a tertiary hospital in Hangzhou, China. The status and influencing factors of the DCS of nurses were explored using a general information questionnaire and DCS scale. Results The scores of each parameter, ranging from low to high, were in the order of coping with grief, preparation for death and hospice care. Factors influencing nurses' DCS included attendance in hospice care education courses within the previous year, experience of accompanying the family members of the deceased and attitude towards death. Conclusions The overall self-efficacy of nurses in palliative care was at a medium level. Moreover, their self-efficacy in coping with grief and preparation for death should be strengthened. Managers of medical institutions can assess the death-coping ability of nurses, which helps provide corresponding support and training for nurses at an early stage. Nurses should receive guidance in grief adjustment and emotion regulation. Medical units should provide nurses with a platform for continuous training and education, use of death-related theoretical models and frameworks to guide nurses in dealing with death-related events, reduce nurses' negative mood and jointly promote their mental health.	[Lin, Xi; Li, Xiaoqin; Bai, Yongqi; Liu, Qin] Southwest Med Univ, Affiliated Hosp, Dept Pediat, Luzhou, Sichuan, Peoples R China; [Lin, Xi; Li, Xiaoqin; Bai, Yongqi; Liu, Qin] Sichuan Clin Res Ctr Birth Defects, Luzhou, Sichuan, Peoples R China; [Lin, Xi; Liu, Qin] Southwest Med Univ, Affiliated Hosp, Dept Nursing, Luzhou, Sichuan, Peoples R China; [Xiang, Weilan] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Nursing, Hangzhou, Zhejiang, Peoples R China	Southwest Medical University; Southwest Medical University; Zhejiang University	Bai, YQ; Liu, Q (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Pediat, Luzhou, Sichuan, Peoples R China.; Bai, YQ; Liu, Q (corresponding author), Sichuan Clin Res Ctr Birth Defects, Luzhou, Sichuan, Peoples R China.; Liu, Q (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Nursing, Luzhou, Sichuan, Peoples R China.	luzhou1991@yeah.net; liuqin18@126.com						Ay MA, 2019, NURS ETHICS, V26, P1442, DOI 10.1177/0969733017748481; Barnett MD, 2021, J CLIN PSYCHOL MED S, V28, P295, DOI 10.1007/s10880-020-09714-8; Barnett MD, 2019, J NURS MANAGE, V27, P775, DOI 10.1111/jonm.12737; Bernales-Turpo D, 2022, J PRIM CARE COMMUNIT, V13, DOI 10.1177/21501319221101845; Blazeviciene A, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-00637-7; Buss MK, 2017, MAYO CLIN PROC, V92, P280, DOI 10.1016/j.mayocp.2016.11.007; Candela ML, 2020, SUPPORT CARE CANCER, V28, P4493, DOI 10.1007/s00520-020-05300-8; Chang LJ., 2006, TAIWAN J HOSPICE PAL, V11, P1; Chang WP, 2018, APPL NURS RES, V44, P25, DOI 10.1016/j.apnr.2018.09.005; Chen HY., 2017, TAIWAN J HLTH SCI, V4, P21; Cheung JTK, 2018, BMC PALLIAT CARE, V17, DOI 10.1186/s12904-018-0317-1; Dahlin C, 2015, SEMIN ONCOL NURS, V31, P327, DOI 10.1016/j.soncn.2015.08.008; Dehghani F, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-00567-4; Dong FQ, 2016, EUR J ONCOL NURS, V21, P189, DOI 10.1016/j.ejon.2015.10.003; Evenblij K, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-018-0388-z; Ganz FD, 2019, NURS CRIT CARE, V24, P141, DOI 10.1111/nicc.12395; Henderson A, 2016, NURS EDUC TODAY, V39, P141, DOI 10.1016/j.nedt.2016.01.005; Holland DE, 2021, PROF CASE MANAG, V26, P53, DOI 10.1097/NCM.0000000000000485; Holopainen G, 2019, NURS ETHICS, V26, P7, DOI 10.1177/0969733016687161; Huang QS, 2015, CHINESE MED J-PEKING, V128, P279, DOI 10.4103/0366-6999.149241; Ibanez-Masero O, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142469; Kaasalainen S, 2013, INT J PALLIAT NURS, V19, P477, DOI 10.12968/ijpn.2013.19.10.477; Kapoor S, 2018, AM J HOSP PALLIAT ME, V35, P1337, DOI 10.1177/1049909118768247; Kim JS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236390; Kim S, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-00581-6; Lee TW, 2010, J ADV NURS, V66, P839, DOI 10.1111/j.1365-2648.2009.05244.x; Lien Ru-Yu, 2020, Hu Li Za Zhi, V67, P33, DOI 10.6224/JN.202010_67(5).06; Lin X, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252430; Ling M, 2020, CURR ONCOL REP, V22, DOI 10.1007/s11912-020-00959-y; LOCKE EA, 1987, ACAD MANAGE REV, V12, P169, DOI 10.2307/258004; McNeil MJ, 2022, JAMA NETW OPEN, V5, DOI [10.1001/jamanetworkopen.20223245, 10.1001/jamanetworkopen.2022.1245]; Miller-Lewis L, 2019, PALLIAT SUPPORT CARE, V17, P550, DOI 10.1017/S1478951518000937; Mo YY, 2020, J NURS MANAGE, V28, P1002, DOI 10.1111/jonm.13014; [彭晶 Peng Jing], 2019, [中国护理管理, Chinese Nursing Management], V19, P1306; Pesut B, 2020, BMC NURS, V19, DOI 10.1186/s12912-020-0404-5; Pfister D, 2013, J PALLIAT MED, V16, P794, DOI 10.1089/jpm.2012.0586; ROBBINS RA, 1992, DEATH STUD, V16, P557, DOI 10.1080/07481189208252598; Malak-Kolaei FS, 2020, OMEGA-J DEATH DYING, DOI 10.1177/0030222820959235; Tjernberg J, 2020, BMC NURS, V19, DOI 10.1186/s12912-020-00514-x; Wallace CL, 2020, J PAIN SYMPTOM MANAG, V60, pE70, DOI 10.1016/j.jpainsymman.2020.04.012; White C, 2019, BMJ SUPPORT PALLIAT, V9, P202, DOI 10.1136/bmjspcare-2015-000935; Yang HL., 2016, TAIWAN J HOSPICE PAL, V21, P16; Zhang YT, 2018, INT EMERG NURS, V37, P13, DOI 10.1016/j.ienj.2017.07.001; Zheng RS, 2021, J ADV NURS, V77, P795, DOI 10.1111/jan.14621; Zheng RS, 2022, CANCER NURS, V45, pE388, DOI 10.1097/NCC.0000000000000839; Zheng ZH, 2020, BMC PALLIAT CARE, V19, DOI 10.1186/s12904-020-00692-0	46	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274540	10.1371/journal.pone.0274540	http://dx.doi.org/10.1371/journal.pone.0274540			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094947	Green Published, gold			2022-12-26	WOS:000892376500054
J	Farjallah, MA; Ghattassi, K; Kamoun, A; Graja, A; Ben Mahmoud, L; Driss, T; Jamoussi, K; Sahnoun, Z; Souissi, N; Zmijewski, P; Hammouda, O				Farjallah, Mohamed Amine; Ghattassi, Kais; Kamoun, Anis; Graja, Ahmed; Ben Mahmoud, Lobna; Driss, Tarak; Jamoussi, Kamel; Sahnoun, Zouheir; Souissi, Nizar; Zmijewski, Piotr; Hammouda, Omar			Melatonin supplementation alleviates cellular damage and physical performance decline induced by an intensive training period in professional soccer players	PLOS ONE			English	Article							MUSCLE DAMAGE; EXERCISE; RECOVERY; INGESTION; OXIDATION; MARKERS	Melatonin has been proved to have positive effects on cellular damage and metabolic regulation. The aim of the study was to determine the effect of melatonin supplementation during an intensive training period on physical performance decline, oxidative stress and cellular damage state. The investigation was conducted on 20 soccer players who participated in an exhaustive six-day training schedule associated with daily 5 mg oral melatonin or placebo ingestion. Resting blood samples and physical performance were measured before and after the training period. The mixed 2-way ANOVA (group x training camp) showed that compared to placebo, melatonin intake prevented an increase in advanced oxidation protein products (p>0.05) and increased the antioxidant enzyme activity (i.e., superoxide dismutase; p<0.001). In addition, melatonin prevented an increase of biomarkers of renal function (e.g., creatinine; p>0.05) and biomarkers of muscle (e.g., creatine kinase; p>0.05) and liver (e.g., gamma-glutamyltransferase; p>0.05) damage. Furthermore, melatonin alleviated the deterioration in physical performance (countermovement jump, five-jump test and 20-m sprint; p>0.05). In conclusion, the obtained data showed increased oxidative stress and renal, muscle and liver damage in professional soccer players during an exhaustive training schedule. Melatonin intake during the training period exerts beneficial effects on physical performance and protects tissues against the deleterious effects of reactive oxygen species and cellular damage.	[Farjallah, Mohamed Amine; Graja, Ahmed; Hammouda, Omar] Univ Sfax, Res Lab, Fac Med, Mol Bases Human Pathol,LR19ES13, Sfax, Tunisia; [Farjallah, Mohamed Amine; Souissi, Nizar] Natl Sport Observ, Phys Activ Sport & Hlth Res Unit, UR18JS01, Tunis, Tunisia; [Ghattassi, Kais] Univ Sfax, High Inst Sport & Phys Educ, Res Unit, Educ Motr Sport & Hlth,UR15JS01, Sfax, Tunisia; [Kamoun, Anis] Univ Sfax, Res Lab Evaluat & Management Musculoskeletal Syst, LR20ES09, Sfax, Tunisia; [Ben Mahmoud, Lobna; Sahnoun, Zouheir] Univ Sfax, Dept Pharmacol, Fac Med, Sfax, Tunisia; [Driss, Tarak; Hammouda, Omar] Paris Nanterre Univ, Interdisciplinary Lab Neurosci Physiol & Psychol, UFR STAPS, Nanterre, France; [Jamoussi, Kamel] Univ Sfax, Biochem Lab, CHU Hedi Chaker, Sfax, Tunisia; [Zmijewski, Piotr] Jozef Pilsudski Univ Phys Educ Warsaw, Warsaw, Poland	Universite de Sfax; Universite de Sfax; Universite de Sfax; Universite de Sfax; Universite de Sfax; Hopital Hedi Chaker; Jozef Pilsudski University Physical Education in Warsaw	Farjallah, MA (corresponding author), Univ Sfax, Res Lab, Fac Med, Mol Bases Human Pathol,LR19ES13, Sfax, Tunisia.; Farjallah, MA (corresponding author), Natl Sport Observ, Phys Activ Sport & Hlth Res Unit, UR18JS01, Tunis, Tunisia.	aminefarjallah@hotmail.fr		DRISS, Tarak/0000-0001-6109-7393; Farjallah, Mohamed Amine/0000-0002-4491-5427				Altarriba-Bartes A, 2021, PHYSICIAN SPORTSMED, V49, P297, DOI 10.1080/00913847.2020.1819150; Ammar A, 2018, BRIT J NUTR, V120, P1201, DOI 10.1017/S0007114518002696; Banfi G, 2012, ADV CLIN CHEM, V56, P1, DOI 10.1016/B978-0-12-394317-0.00015-7; Bazzucchi I, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092850; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Ceraulo L, 1999, J PINEAL RES, V26, P108, DOI 10.1111/j.1600-079X.1999.tb00570.x; Cheikh M, 2020, CHRONOBIOL INT, V37, P236, DOI 10.1080/07420528.2019.1692348; Cheikh M, 2018, CHRONOBIOL INT, V35, P1281, DOI 10.1080/07420528.2018.1474891; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Czuczejko J, 2019, FREE RADICAL RES, V53, P198, DOI 10.1080/10715762.2018.1563688; de Hoyo M, 2016, J SPORT SCI, V34, P1363, DOI 10.1080/02640414.2016.1150603; Debold EP, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00239; Delanghe JR, 2011, CLIN KIDNEY J, V4, P83, DOI 10.1093/ndtplus/sfq211; DEPAZ JA, 1995, MED SCI SPORT EXER, V27, P1590; Farjallah MA, 2018, PHYSIOL INT, V105, P358, DOI 10.1556/2060.105.2018.4.24; Farjallah MA, 2022, BIOL SPORT, V39, P473, DOI 10.5114/biolsport.2022.106385; Farjallah MA, 2020, CHRONOBIOL INT, V37, P686, DOI 10.1080/07420528.2020.1746797; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fragala MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180840; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Hody S, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00536; Ives SJ, 2017, J INT SOC SPORT NUTR, V14, DOI 10.1186/s12970-017-0179-6; Karp DR, 2001, J BIOL CHEM, V276, P3798, DOI 10.1074/jbc.M008484200; Kayali R, 2006, CELL BIOCHEM FUNCT, V24, P79, DOI 10.1002/cbf.1190; Krustrup P, 2003, MED SCI SPORT EXER, V35, P697, DOI 10.1249/01.MSS.0000058441.94520.32; Leonardo-Mendonca RC, 2017, APPL PHYSIOL NUTR ME, V42, P700, DOI 10.1139/apnm-2016-0677; Maarman GJ, 2018, J SPORT SCI, V36, P1897, DOI 10.1080/02640414.2018.1424491; Mendes C, 2013, J PINEAL RES, V55, P229, DOI 10.1111/jpi.12065; Mero AA, 2006, EUR J APPL PHYSIOL, V96, P729, DOI 10.1007/s00421-005-0119-z; Mezil YA, 2015, MED SCI SPORT EXER, V47, P1495, DOI 10.1249/MSS.0000000000000555; Moopanar TR, 2005, J PHYSIOL-LONDON, V564, P189, DOI 10.1113/jphysiol.2005.083519; Nedelec M, 2013, SPORTS MED, V43, P9, DOI 10.1007/s40279-012-0002-0; NYMAN MT, 1991, ANN CHIR GYNAECOL, V80, P289; Pettersson J, 2008, BRIT J CLIN PHARMACO, V65, P253, DOI 10.1111/j.1365-2125.2007.03001.x; Reiter RJ, 2002, J PHARM PHARMACOL, V54, P1299, DOI 10.1211/002235702760345374; Reiter RJ, 2014, PHYSIOLOGY, V29, P325, DOI 10.1152/physiol.00011.2014; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Silva SO, 2004, J PINEAL RES, V37, P171, DOI 10.1111/j.1600-079X.2004.00149.x; Stratos I, 2012, J PINEAL RES, V52, P62, DOI 10.1111/j.1600-079X.2011.00919.x; Whitfield JB, 2001, CRIT REV CL LAB SCI, V38, P263, DOI 10.1080/20014091084227; Zhang JJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040673	42	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273719	10.1371/journal.pone.0273719	http://dx.doi.org/10.1371/journal.pone.0273719			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054089	Green Published, gold			2022-12-26	WOS:000892641400031
J	Setsuko, S; Sugai, K; Tamaki, I; Takayama, K; Kato, H				Setsuko, Suzuki; Sugai, Kyoko; Tamaki, Ichiro; Takayama, Koji; Kato, Hidetoshi			Contrasting genetic diversity between Planchonella obovata sensu lato (Sapotaceae) on old continental and young oceanic island populations in Japan	PLOS ONE			English	Article							JUAN FERNANDEZ ARCHIPELAGO; BONIN ISLANDS; MAINLAND POPULATIONS; DIFFERENTIATION; PLANTS; DISPERSAL; SEA; CONSERVATION; BIODIVERSITY; MIGRATION	Genetic diversity of plant populations on islands is likely to be influenced by characteristics such as island origin (oceanic or continental) and their age, size, and distance to continental landmasses. In Japan, Planchonella obovata sensu lato which is found on both continental and oceanic islands of varying age, size, and distance to East Asian continental areas-is an ideal system in which to investigate the factors influencing genetic diversity of island plant species. In this study, we examined the genetic diversity of P. obovata s.l. populations, in the context of the species population genetic structure, demography, and between island migration, from 668 individuals, 28 populations and 14 islands including both continental (the Yaeyama Islands) and oceanic islands (the Daito, Bonin, and Volcano Islands) using 11 microsatellite markers. The Yaeyama and Volcano Islands respectively had the highest and lowest genetic diversity, and island origin and age significantly affected genetic diversity. Clustering analysis revealed that populations were grouped into Bonin, Volcano, and Yaeyama + Daito groups. However, Bonin and Volcano groups were distinct despite the relatively short geographical distance between them. Approximate Bayesian Computation analysis suggested that the population size was stable in Bonin and Yaeyama + Daito groups, whereas population reduction occurred in Volcano group, and migration between groups were very limited. Younger oceanic islands showed lower genetic diversity, probably due to limited gene flow and a lack of time to accumulate unique alleles. Genetic structure was generally consistent with the geographic pattern of the islands, but in Volcano, a limited number of founders and limited gene flow among islands are likely to have caused the large genetic divergence observed.	[Setsuko, Suzuki] Forest Res & Management Org, Forestry & Forest Prod Res Inst, Dept Forest Mol Genet & Biotechnol, Tsukuba, Ibaraki, Japan; [Sugai, Kyoko] Shimane Univ, Acad Assembly, Inst Agr & Life Sci, Matsue, Shimane, Japan; [Tamaki, Ichiro] Gifu Acad Forest Sci & Culture, Mino, Gifu, Japan; [Takayama, Koji] Kyoto Univ, Grad Sch Sci, Dept Bot, Sakyo Ku, Kyoto, Japan; [Kato, Hidetoshi] Tokyo Metropolitan Univ, Makino Herbarium, Hachioji, Tokyo, Japan	Forestry & Forest Products Research Institute - Japan; Shimane University; Kyoto University; Tokyo Metropolitan University	Setsuko, S (corresponding author), Forest Res & Management Org, Forestry & Forest Prod Res Inst, Dept Forest Mol Genet & Biotechnol, Tsukuba, Ibaraki, Japan.	setsukos@affrc.go.jp		Setsuko, Suzuki/0000-0002-0612-1853	Japanese Society for Promotion of Science [18370038, 23310167, 26290073, 15K07203, 21K05694]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [4-1402]; FFPRI	Japanese Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Environment Research and Technology Development Fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); FFPRI	This work was funded by Grants-in-Aid for Science Research from the Japanese Society for Promotion of Science (18370038, 23310167, 26290073, 15K07203, 21K05694), the Environment Research and Technology Development Fund of the Ministry of the Environment, Japan (4-1402), and the support program of FFPRI for researchers having family responsibilities. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Abe T, 2006, ANN BOT-LONDON, V98, P317, DOI 10.1093/aob/mcl117; Akaike H., 1973, P 2 INT S INF THEOR; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bottin L, 2005, MOL ECOL, V14, P1979, DOI 10.1111/j.1365-294X.2005.02576.x; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Chen C, 2017, HEREDITY, V119, P95, DOI 10.1038/hdy.2017.19; Chiba S, 2002, POPUL ECOL, V44, P179, DOI 10.1007/s101440200021; Costanzi JM, 2019, ECOL EVOL, V9, P3837, DOI 10.1002/ece3.5007; Crawford DJ, 2001, AM J BOT, V88, P2195, DOI 10.2307/3558381; Curto M, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1031-y; Darwin C., 1842, STRUCTURE DISTRIBUTI; Dunbar-Co S, 2008, AM J BOT, V95, P1177, DOI 10.3732/ajb.0800132; Duryea MC, 2015, HEREDITY, V115, P225, DOI 10.1038/hdy.2015.31; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fernandez Mazuecos M, 2011, PLOS ONE, V6; Fox J., 2018, R COMPANION APPL REG, VThird; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; Franks SJ, 2010, J PLANT BIOL, V53, P1, DOI 10.1007/s12374-009-9086-y; Fukui Akiko, 2003, Ornithological Science, V2, P41, DOI 10.2326/osj.2.41; Garcia-Verdugo C, 2015, MOL ECOL, V24, P726, DOI 10.1111/mec.13060; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202; Hayashi F, 2009, ZOOL SCI, V26, P543, DOI 10.2108/zsj.26.543; Heleno R, 2015, GLOBAL ECOL BIOGEOGR, V24, P518, DOI 10.1111/geb.12273; Higgins SI, 2003, ECOLOGY, V84, P1945, DOI 10.1890/01-0616; Hill R, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1810; Hufford KM, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plt055; Ito M., 1998, EVOLUTION SPECIATION, P141; Iwatsuki K, 1993, FLORA JAPAN KODANSHA; James JE, 2016, GENOME BIOL EVOL, V8, P1876, DOI 10.1093/gbe/evw120; Kaizuka S., 1977, B OGASAWARA RES, V1, P29; Kamiya K, 2015, 300 MILLION YEARS HI; Kato H, 2016, OGASAWARA RES, V42, P9; Kawakami K, 2009, ECOL RES, V24, P741, DOI 10.1007/s11284-008-0543-8; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Langella O, POPULATIONS 1232; Liu U., 2019, BIODIVERS INF SCI ST; Lopez-Sepulveda P, 2015, J PLANT RES, V128, P73, DOI 10.1007/s10265-014-0666-7; MAC ARTHUR ROBERT H., 1967; Machida H., 2001, REGIONAL GEOMORPHOLO; Maki M, 2003, J PLANT RES, V116, P169, DOI 10.1007/s10265-003-0083-9; MANTEL N, 1967, CANCER RES, V27, P209; Meirmans PG, 2019, HEREDITY, V122, P276, DOI 10.1038/s41437-018-0124-8; Nakano S., 2009, JAPAN GEOSCIENCE UNI; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M., 1987, MOL EVOLUTIONARY GEN; Ohashi H, 2017, WILD FLOWERS JAPAN, P183; OHDE S, 1992, EARTH PLANET SC LETT, V113, P473, DOI 10.1016/0012-821X(92)90125-F; Ohkawa T., 2016, TREES SHRUBS RYUKYU; PAULAY G, 1994, AM ZOOL, V34, P134; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pennington TD, 2004, FA GE VAS P, V6, P390; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2020, R LUNG ENV STAT COMP; Rousset F, 1997, GENETICS, V145, P1219; Ryukyu Plant Research Group, 2018, DAT RYUK PLANTS; Saro I, 2015, TREE GENET GENOMES, V11, DOI 10.1007/s11295-014-0815-0; Sato JJ, 2017, ZOOL SCI, V34, P112, DOI 10.2108/zs160113; Setsuko S, 2020, MOL ECOL, V29, P1050, DOI 10.1111/mec.15383; Setsuko S, 2017, PLANT SPEC BIOL, V32, P13, DOI 10.1111/1442-1984.12121; Stuessy TF, 2014, BOT J LINN SOC, V174, P276, DOI 10.1111/boj.12088; Sugai K, 2019, J PLANT RES, V132, P759, DOI 10.1007/s10265-019-01144-4; Sugai K, 2013, J PLANT RES, V126, P763, DOI 10.1007/s10265-013-0571-5; Swenson U, 2019, SYST BIOL, V68, P1020, DOI 10.1093/sysbio/syz025; Swenson U, 2013, TAXON, V62, P746, DOI 10.12705/624.11; Takayama K, 2005, MOL ECOL, V14, P1059, DOI 10.1111/j.1365-294X.2005.02462.x; Tennekes H., 2009, SIMPLE SCI FLIGHT IN; Toyoda T., 2003, FLORA BONIN ISLANDS; Tsujimura M, 2016, OGASAWARA RES, V42, P23; Umino S., 2008, CHIZUCHUSHIN, V430, P6; Umino S., 2016, GEOLOGY HAHAJIMA RET; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vellend M, 2005, ECOL LETT, V8, P767, DOI 10.1111/j.1461-0248.2005.00775.x; Vellend M, 2010, THEORY OF ISLAND BIOGEOGRAPHY REVISITED, P439; Wang SP, 2014, MOL ECOL, V23, P637, DOI 10.1111/mec.12634; Wright S, 1943, GENETICS, V28, P114; Yamada T, 2012, J BIOGEOGR, V39, P901, DOI 10.1111/j.1365-2699.2011.02634.x	79	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273871	10.1371/journal.pone.0273871	http://dx.doi.org/10.1371/journal.pone.0273871			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054192	gold, Green Published			2022-12-26	WOS:000892641400038
J	Hendryx, M; Dong, Y; Ndeke, JM; Luo, JH				Hendryx, Michael; Dong, Yi; Ndeke, Jonas M.; Luo, Juhua			Sodium-glucose cotransporter 2 (SGLT2) inhibitor initiation and hepatocellular carcinoma prognosis	PLOS ONE			English	Article							POPULATION-ATTRIBUTABLE FRACTIONS; FIBROSIS STAGE; LIVER-DISEASE; RISK-FACTORS; FATTY LIVER; CANCER; MORTALITY; OBESITY	Introduction Sodium-glucose cotransporter 2 (SGLT2) inhibitors are a relatively new class of antidiabetic drugs. Emerging findings from laboratory studies indicate that SGLT2 inhibitors can improve liver function and suppress the proliferation of hepatocellular carcinoma (HCC) cells. The aim of this study was to test the hypothesis that initiation of SGLT2 inhibitors improves HCC prognosis in a human population. Methods We used National Surveillance, Epidemiology and End Results (SEER)-Medicare linked data in the United States to evaluate the role of SGLT2 inhibitor initiation on the survival of HCC patients. 3,185 HCC patients newly diagnosed between 2014 and 2017 aged 66 years or older with pre-existing type 2 diabetes were included and followed to the end of 2019. Information on SGLT2 inhibitor initiation was extracted from the Medicare Part D file. Results SGLT2 inhibitor initiation was associated with significantly lower mortality risk after adjusting for potential confounders (HR = 0.68, 95% CI = 0.54-0.86) with stronger association for longer duration of use (HR = 0.60, 95% CI = 0.41-0.88). Further, we found that SGLT2 inhibitor initiation was associated with a lower risk mortality risk ranging from 14% to 60% regardless of patient demographic variables, tumor characteristics, and cancer treatments. Conclusion Our large SEER-Medicare linked data study indicates that SGLT2 inhibitor initiation was associated with improved overall survival of HCC patients with pre-existing type 2 diabetes compared with no SGLT2 inhibitor use. Further studies are needed to confirm our findings and elucidate the possible mechanisms behind the association.	[Hendryx, Michael] Indiana Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Bloomington, IN 47405 USA; [Dong, Yi] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA; [Dong, Yi] Indiana Univ Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN 46202 USA; [Ndeke, Jonas M.; Luo, Juhua] Indiana Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Bloomington, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Hendryx, M (corresponding author), Indiana Univ, Sch Publ Hlth, Dept Environm & Occupat Hlth, Bloomington, IN 47405 USA.	hendryx@indiana.edu		Hendryx, Michael/0000-0002-2764-387X; Ndeke, Jonas/0000-0002-5433-0991	National Institutes of Health [R03CA256238]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health (R03CA256238) received by JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.cancer.gov/.	[Anonymous], SEER; Bonnet F, 2018, DIABETES METAB, V44, P457, DOI 10.1016/j.diabet.2018.09.005; Brar G, 2020, HEPATOL COMMUN, V4, P1541, DOI 10.1002/hep4.1564; Bray JJH, 2020, DIABETES RES CLIN PR, V168, DOI 10.1016/j.diabres.2020.108368; Cavaiola TS, 2018, DIABET METAB SYND OB, V11, P133, DOI 10.2147/DMSO.S154602; CCDW, CHRON COND DAT WAR; ClinCalc, 2021, TOP 200 2021 PROV CL; CMS, CMS; Coelho FD, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3413; Daniele G, 2016, DIABETES CARE, V39, P2036, DOI 10.2337/dc15-2688; Dulai PS, 2017, HEPATOLOGY, V65, P1557, DOI 10.1002/hep.29085; Dyson J, 2014, J HEPATOL, V60, P110, DOI 10.1016/j.jhep.2013.08.011; Engels EA, 2011, AM J EPIDEMIOL, V174, P860, DOI 10.1093/aje/kwr146; Ferrannini E, 2016, DIABETES, V65, P1190, DOI 10.2337/db15-1356; Forner A, 2018, LANCET, V391, P1301, DOI 10.1016/S0140-6736(18)30010-2; Gallwitz Baptist, 2018, Eur Endocrinol, V14, P17, DOI 10.17925/EE.2018.14.1.17; Hagstrom H, 2017, J HEPATOL, V67, P1265, DOI 10.1016/j.jhep.2017.07.027; Huang DIQ, 2021, NAT REV GASTRO HEPAT, V18, P223, DOI 10.1038/s41575-020-00381-6; Hung MH, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1646-6; Ishibashi Y, 2016, HORM METAB RES, V48, P191, DOI 10.1055/s-0035-1555791; Jojima T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205237; Kaji K, 2018, INT J CANCER, V142, P1712, DOI 10.1002/ijc.31193; Komiya C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151511; Kotsis V, 2020, J HYPERTENS, V38, P377, DOI 10.1097/HJH.0000000000002279; Li LR, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.589273; Makarova-Rusher OV, 2016, CANCER-AM CANCER SOC, V122, P1757, DOI 10.1002/cncr.29971; Marengo A, 2016, ANNU REV MED, V67, P103, DOI 10.1146/annurev-med-090514-013832; McGlynn KA, 2021, HEPATOLOGY, V73, P4, DOI 10.1002/hep.31288; Nainggolan L, 2013, FDA APPROVES CANAGLI; Nakano D, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232283; Noone AM, 2016, MED CARE, V54, pE55, DOI 10.1097/MLR.0000000000000073; Obara K, 2017, ONCOTARGET, V8, P58353, DOI 10.18632/oncotarget.16874; Osorio H, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/542042; Peacock A, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030605; Rosenwasser RF, 2013, DIABETES METAB SYNDR, V6, P453, DOI 10.2147/DMSO.S34416; Scafoglio C, 2015, P NATL ACAD SCI USA, V112, pE4111, DOI 10.1073/pnas.1511698112; Scafoglio CR, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat5933; SEER-Medicare, 2021, BRIEF DESCR SEER MED; Shao SC, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2020-001956; Shao SC, 2020, DIABETES OBES METAB, V22, P128, DOI 10.1111/dom.13875; Shearer JE, 2022, ALIMENT PHARM THER, V55, P645, DOI 10.1111/apt.16806; Shiba K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19658-7; Sugizaki T, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0012-0; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Tentolouris A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162965; Wang YG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095485; Welzel TM, 2013, AM J GASTROENTEROL, V108, P1314, DOI 10.1038/ajg.2013.160; Wright EM, 2011, PHYSIOL REV, V91, P733, DOI 10.1152/physrev.00055.2009; Xu DY, 2020, INT J ONCOL, V57, P1223, DOI 10.3892/ijo.2020.5120; Yaribeygi H, 2019, J CELL PHYSIOL, V234, P3231, DOI 10.1002/jcp.26760; Younossi ZM, 2021, AM J GASTROENTEROL, V116, P254, DOI 10.14309/ajg.0000000000001054; Zhang XL, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007165; Zhou J, 2020, BIOMED PHARMACOTHER, V132, DOI 10.1016/j.biopha.2020.110821	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274519	10.1371/journal.pone.0274519	http://dx.doi.org/10.1371/journal.pone.0274519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094949	Green Published, gold			2022-12-26	WOS:000892376500051
J	Paul, EE; Marintchev, A				Paul, Eleanor Elise; Marintchev, Assen			The PCI domains are "winged" HEAT domains	PLOS ONE			English	Article							FISSION YEAST HOMOLOG; C-TERMINAL DOMAIN; FACTOR 3 SUBUNITS; TRANSLATION INITIATION; CRYSTAL-STRUCTURE; PROTEIN; EIF3; REPEATS; BINDING; IDENTIFICATION	The HEAT domains are a family of helical hairpin repeat domains, composed of four or more hairpins. HEAT is derived from the names of four family members: huntingtin, eukaryotic translation elongation factor 3 (eEF3), protein phosphatase 2 regulatory A subunit (PP2A), and mechanistic target of rapamycin (mTOR). HEAT domain-containing proteins play roles in a wide range of cellular processes, such as protein synthesis, nuclear transport and metabolism, and cell signaling. The PCI domains are a related group of helical hairpin domains, with a "winged-helix" (WH) subdomain at their C-terminus, which is responsible for multi-subunit complex formation with other PCI domains. The name is derived from the complexes, where these domains are found: the 26S Proteasome "lid" regulatory subcomplex, the COP9 signalosome (CSN), and eukaryotic translation initiation factor 3 (eIF3). We noted that in structure similarity searches using HEAT domains, sometimes PCI domains appeared in the search results ahead of other HEAT domains, which indicated that the PCI domains could be members of the HEAT domain family, and not a related but separate group, as currently thought. Here, we report extensive structure similarity analysis of HEAT and PCI domains, both within and between the two groups of proteins. We present evidence that the PCI domains as a group have greater structural similarity with individual groups of HEAT domains than some of the HEAT domain groups have among each other. Therefore, our results indicate that the PCI domains have evolved from a HEAT domain that acquired a WH subdomain. The WH subdomain in turn mediated self-association into a multi-subunit complex, which eventually evolved into the common ancestor of the Proteasome lid/CSN/eIF3.	[Paul, Eleanor Elise; Marintchev, Assen] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Boston University	Marintchev, A (corresponding author), Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA.	amarint@bu.edu		Paul, Eleanor/0000-0002-8937-795X; Marintchev, Assen/0000-0002-9901-3500	National Institute of Health [GM134113]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institute of Health [GM134113 to A.M.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi Y, 2001, J BIOL CHEM, V276, P10056, DOI 10.1074/jbc.M010188200; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Aravind L, 2000, GENOME RES, V10, P1172, DOI 10.1101/gr.10.8.1172; Aravind L, 1998, PROTEIN SCI, V7, P1250, DOI 10.1002/pro.5560070521; Asano K, 1998, J BIOL CHEM, V273, P18573, DOI 10.1074/jbc.273.29.18573; Asano K, 1999, EMBO J, V18, P1673, DOI 10.1093/emboj/18.6.1673; Asano K, 1997, J BIOL CHEM, V272, P27042, DOI 10.1074/jbc.272.43.27042; Asano K., 2013, ENCY SYSTEMBIOL, P682; Bandyopadhyay A, 2002, J BIOL CHEM, V277, P2360, DOI 10.1074/jbc.M107790200; Bellsolell L, 2006, STRUCTURE, V14, P913, DOI 10.1016/j.str.2006.03.012; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bieniossek C, 2006, J MOL BIOL, V360, P457, DOI 10.1016/j.jmb.2006.05.021; Boesen T, 2004, J BIOL CHEM, V279, P10584, DOI 10.1074/jbc.M311055200; Burks EA, 2001, J BIOL CHEM, V276, P2122, DOI 10.1074/jbc.M007236200; Cheng H, 2015, PROTEINS, V83, P1238, DOI 10.1002/prot.24818; Cheng H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003926; Crane R, 2000, MOL BIOL CELL, V11, P3993, DOI 10.1091/mbc.11.11.3993; des Georges A, 2015, NATURE, V525, P491, DOI 10.1038/nature14891; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Holm L, 2020, METHODS MOL BIOL, V2112, P29, DOI 10.1007/978-1-0716-0270-6_3; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; KOONIN EV, 1995, PROTEIN SCI, V4, P1608, DOI 10.1002/pro.5560040819; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Marcotrigiano J, 2001, MOL CELL, V7, P193, DOI 10.1016/S1097-2765(01)00167-8; Marintchev A, 2004, Q REV BIOPHYS, V37, P197, DOI 10.1017/S0033583505004026; Marintchev A, 2005, BIOCHEMISTRY-US, V44, P12265, DOI 10.1021/bi051271v; Phan L, 1998, MOL CELL BIOL, V18, P4935, DOI 10.1128/MCB.18.8.4935; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P423, DOI 10.1016/S0968-0004(00)01628-5; Ponting CP, 2000, ADV PROTEIN CHEM, V54, P185, DOI 10.1016/S0065-3233(00)54007-8; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Scheel H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-71; Schrodinger L., 2020, PYMOL; Singh CR, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109376; Singh CR, 2011, NUCLEIC ACIDS RES, V39, P8314, DOI 10.1093/nar/gkr339; Varadi M, 2022, NUCLEIC ACIDS RES, V50, pD439, DOI 10.1093/nar/gkab1061; Wei J, 2010, PROTEIN CELL, V1, P595, DOI 10.1007/s13238-010-0070-6; Wei ZY, 2006, J MOL BIOL, V359, P1, DOI 10.1016/j.jmb.2006.03.037; Wei ZY, 2004, J BIOL CHEM, V279, P34983, DOI 10.1074/jbc.M405158200; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yoshimura SH, 2016, J CELL SCI, V129, P3963, DOI 10.1242/jcs.185710	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0268664	10.1371/journal.pone.0268664	http://dx.doi.org/10.1371/journal.pone.0268664			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094910	Green Submitted, gold, Green Published			2022-12-26	WOS:000892376500004
J	Bove, CB; Davies, SW; Ries, JB; Umbanhowar, J; Thomasson, BC; Farquhar, EB; McCoppin, JA; Castillo, KD				Bove, Colleen B.; Davies, Sarah W.; Ries, Justin B.; Umbanhowar, James; Thomasson, Bailey C.; Farquhar, Elizabeth B.; McCoppin, Jess A.; Castillo, Karl D.			Global change differentially modulates Caribbean coral physiology	PLOS ONE			English	Article							RAPID CLIMATE-CHANGE; OCEAN ACIDIFICATION; PORITES-ASTREOIDES; THERMAL-STRESS; REEF CORALS; CALCIFICATION RATES; PARTIAL-PRESSURE; TISSUE BIOMASS; FLORIDA-KEYS; GROWTH	Global change driven by anthropogenic carbon emissions is altering ecosystems at unprecedented rates, especially coral reefs, whose symbiosis with algal symbionts is particularly vulnerable to increasing ocean temperatures and altered carbonate chemistry. Here, we assess the physiological responses of three Caribbean coral (animal host + algal symbiont) species from an inshore and offshore reef environment after exposure to simulated ocean warming (28, 31 degrees C), acidification (300-3290 mu atm), and the combination of stressors for 93 days. We used multidimensional analyses to assess how a variety of coral physiological parameters respond to ocean acidification and warming. Our results demonstrate reductions in coral health in Siderastrea siderea and Porites astreoides in response to projected ocean acidification, while future warming elicited severe declines in Pseudodiploria strigosa. Offshore S. siderea fragments exhibited higher physiological plasticity than inshore counterparts, suggesting that this offshore population was more susceptible to changing conditions. There were no plasticity differences in P. strigosa and P. astreoides between natal reef environments, however, temperature evoked stronger responses in both species. Interestingly, while each species exhibited unique physiological responses to ocean acidification and warming, when data from all three species are modelled together, convergent stress responses to these conditions are observed, highlighting the overall sensitivities of tropical corals to these stressors. Our results demonstrate that while ocean warming is a severe acute stressor that will have dire consequences for coral reefs globally, chronic exposure to acidification may also impact coral physiology to a greater extent in some species than previously assumed. Further, our study identifies S. siderea and P. astreoides as potential 'winners' on future Caribbean coral reefs due to their resilience under projected global change stressors, while P. strigosa will likely be a 'loser' due to their sensitivity to thermal stress events. Together, these species-specific responses to global change we observe will likely manifest in altered Caribbean reef assemblages in the future.	[Bove, Colleen B.; Umbanhowar, James; Farquhar, Elizabeth B.; Castillo, Karl D.] Univ North Carolina Chapel Hill, Environm Ecol & Energy Program, Chapel Hill, NC 27599 USA; [Bove, Colleen B.; Davies, Sarah W.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA; [Ries, Justin B.] Northeastern Univ, Dept Marine & Environm Sci, Nahant, MA USA; [Umbanhowar, James; Thomasson, Bailey C.; McCoppin, Jess A.] Univ North Carolina Chapel Hill, Dept Biol, Chapel Hill, NC USA; [Thomasson, Bailey C.] Coral Restorat Fdn, Key Largo, FL USA; [Farquhar, Elizabeth B.] Univ North Carolina Wilmington, Ctr Marine Sci, Wilmington, NC USA; [Castillo, Karl D.] Univ North Carolina Chapel Hill, Dept Earth, Marine & Environm Sci, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Boston University; Northeastern University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Wilmington; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bove, CB (corresponding author), Univ North Carolina Chapel Hill, Environm Ecol & Energy Program, Chapel Hill, NC 27599 USA.; Bove, CB (corresponding author), Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.	colleenbove@gmail.com		Umbanhowar, James/0000-0002-8251-9388; Bove, Colleen B./0000-0003-0340-1371	Women Diver Hall of Fame Sea of Change Foundation Marine Conservation Scholarship; LernerGray Memorial Fund of the American Museum of Natural History Grants for Marine Research; NSF BIO-OCE award [1437371]	Women Diver Hall of Fame Sea of Change Foundation Marine Conservation Scholarship; LernerGray Memorial Fund of the American Museum of Natural History Grants for Marine Research; NSF BIO-OCE award	This research was partially supported by the Women Diver Hall of Fame Sea of Change Foundation Marine Conservation Scholarship (https://www.wdhof.org/scholarship/marineconservation-scholarship-graduate) and LernerGray Memorial Fund of the American Museum of Natural History Grants for Marine Research (https://www.amnh.org/research/richard-gildergraduate-school/academics-and-research/ fellowship-and-grant-opportunities/researchgrants-and-graduate-student-exchange- fellowships/the-lerner-gray-fund-for-marineresearch) awarded to CBB. JBR acknowledges support from NSF BIO-OCE award #1437371 (https://www.nsf.gov/geo/oce/programs/biores. jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichelman HE, 2021, LIMNOL OCEANOGR, V66, P3100, DOI 10.1002/lno.11863; Alemu JB I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083829; Allemand D, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P119, DOI 10.1007/978-94-007-0114-4_9; Alves C, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0249155; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Anthony KRN, 2002, LIMNOL OCEANOGR, V47, P1417, DOI 10.4319/lo.2002.47.5.1417; Anthony KRN, 2000, J EXP MAR BIOL ECOL, V252, P221, DOI 10.1016/S0022-0981(00)00237-9; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Baker AC, 2001, NATURE, V411, P765, DOI 10.1038/35081151; Baker DM, 2018, ISME J, V12, P921, DOI 10.1038/s41396-018-0046-8; Barott KL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025435118; Baumann JH, 2021, CORAL REEFS, V40, P1181, DOI 10.1007/s00338-021-02124-8; Baumann JH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162098; Bove CB., 2021, CORAL LIPID ASSAY 96, DOI [10.17504/protocols.io.bvcfn2tn, DOI 10.17504/PROTOCOLS.IO.BVCFN2TN]; Bove CB., 2022, PLOS CLIM, V1, DOI [DOI 10.1371/JOURNAL.PCLM.0000002, 10.1371/journal.pclm.0000002]; Bove CB., 2021, CORAL CARBOHYDRATE A, DOI [10.17504/protocols.io.bvb9n2r6, DOI 10.17504/PROTOCOLS.IO.BVB9N2R6]; Bove CB, 2020, CORAL REEFS, V39, P1675, DOI 10.1007/s00338-020-01995-7; Bove CB, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2018.2840; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Burriesci MS, 2012, J EXP BIOL, V215, P3467, DOI 10.1242/jeb.070946; Camp EF, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00433; Castillo KD, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1856; Cheng YS, 2011, LIPIDS, V46, P95, DOI 10.1007/s11745-010-3494-0; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Cohen AL, 2009, OCEANOGRAPHY, V22, P118, DOI 10.5670/oceanog.2009.102; Coles SL, 2003, ADV MAR BIOL, V46, P183, DOI 10.1016/S0065-2881(03)46004-5; Comeau S, 2013, LIMNOL OCEANOGR, V58, P388, DOI 10.4319/lo.2013.58.1.0388; Cornwall CE, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2015265118; Crawley A, 2010, GLOBAL CHANGE BIOL, V16, P851, DOI 10.1111/j.1365-2486.2009.01943.x; Crook ED, 2013, P NATL ACAD SCI USA, V110, P11044, DOI 10.1073/pnas.1301589110; Cunning R, 2020, MOL ECOL, V29, P2940, DOI 10.1111/mec.15526; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Davies SW, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00150; Delworth TL, 2016, NAT GEOSCI, V9, P509, DOI [10.1038/ngeo2738, 10.1038/NGEO2738]; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Eakin CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013969; Edmunds PJ, 2021, ECOSPHERE, V12, DOI 10.1002/ecs2.3517; Edmunds PJ, 2012, MAR BIOL, V159, P2149, DOI 10.1007/s00227-012-2001-y; Edmunds PJ, 2012, GLOBAL CHANGE BIOL, V18, P2173, DOI 10.1111/j.1365-2486.2012.02695.x; Enochs IC, 2014, CORAL REEFS, V33, P477, DOI 10.1007/s00338-014-1132-7; Fabricius KE, 2011, NAT CLIM CHANGE, V1, P165, DOI 10.1038/NCLIMATE1122; Fitt WK, 2000, LIMNOL OCEANOGR, V45, P677, DOI 10.4319/lo.2000.45.3.0677; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fox RJ, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0174; Fox-Kemper B., 2021, CLIMATE CHANGE 2021, P1211, DOI [10.5285/77B64C55-7166-4A06-9DEF-2E400398E452, 10.1017/9781009157896.011, DOI 10.1109/OCEANSE.2009.5278204]; Glynn PW, 1996, GLOBAL CHANGE BIOL, V2, P495, DOI 10.1111/j.1365-2486.1996.tb00063.x; GNAIGER E, 1984, OECOLOGIA, V62, P289, DOI 10.1007/BF00384259; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Gregoire V, 2017, J APPL PHYCOL, V29, P1893, DOI 10.1007/s10811-017-1127-1; Greve P, 2018, EARTH SYST DYNAM, V9, P227, DOI 10.5194/esd-9-227-2018; Guillermic M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.aba9958; Habary A, 2017, GLOBAL CHANGE BIOL, V23, P566, DOI 10.1111/gcb.13488; Hii Yii-Siang, 2009, Journal of Marine Biology, V2009, P1; Hoadley KD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46412-4; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Horvath KM, 2016, SCI REP-UK, V6, DOI 10.1038/srep29613; Hughes TP, 2018, NATURE, V556, P492, DOI 10.1038/s41586-018-0041-2; Jackson EJ., 2012, STATUS TRENDS CARIBB, P306; Jones RJ, 1997, MAR ECOL PROG SER, V158, P51, DOI 10.3354/meps158051; Kenkel CD, 2013, MOL ECOL, V22, P4322, DOI 10.1111/mec.12390; Kenkel CD, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0014; Kenkel CD, 2015, ECOLOGY, V96, P3197, DOI 10.1890/14-2297.1; Kleypas JA., 2019, CUAD INVESTIG UNED, V11, P24; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; LaJeunesse TC, 2002, MAR BIOL, V141, P387, DOI 10.1007/s00227-002-0829-2; LaJeunesse TC, 2018, CURR BIOL, V28, P2570, DOI 10.1016/j.cub.2018.07.008; LEWIS JB, 1975, J ZOOL, V176, P527, DOI 10.1111/j.1469-7998.1975.tb03219.x; Lin ZY, 2022, SCI TOTAL ENVIRON, V810, DOI 10.1016/j.scitotenv.2021.152266; MacLean SA, 2017, GLOBAL CHANGE BIOL, V23, P4094, DOI 10.1111/gcb.13736; Mangiafico Salvatore, 2021, CRAN; Manzello DP, 2015, J EXP MAR BIOL ECOL, V471, P198, DOI 10.1016/j.jembe.2015.06.010; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; MUCCI A, 1983, AM J SCI, V283, P780, DOI 10.2475/ajs.283.7.780; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Nagelkerken I, 2015, P NATL ACAD SCI USA, V112, P13272, DOI 10.1073/pnas.1510856112; Neal BP, 2017, ECOL EVOL, V7, P1339, DOI 10.1002/ece3.2706; Norin T, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0180; Okazaki RR, 2017, GLOBAL CHANGE BIOL, V23, P1023, DOI 10.1111/gcb.13481; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Parsons T.R., 1984, MANUAL CHEM BIOL MET; Pierrot DE., 2006, MS EXCEL PROGRAM DEV, DOI [10.3334/CDIAC/otg.CO2SYS_XLS_CDIAC105a, DOI 10.3334/CDIAC/OTG.CO2SYS_XLS_CDIAC105A]; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Prada F, 2017, SCI REP-UK, V7, DOI 10.1038/srep40842; Putnam HM, 2016, EVOL APPL, V9, P1165, DOI 10.1111/eva.12408; Renegar DA, 2005, MAR ECOL PROG SER, V293, P69, DOI 10.3354/meps293069; Ries JB, 2010, CORAL REEFS, V29, P661, DOI 10.1007/s00338-010-0632-3; Rippe JP, 2018, GLOBAL CHANGE BIOL, V24, P5205, DOI 10.1111/gcb.14422; Rodrigues LJ, 2007, LIMNOL OCEANOGR, V52, P1874, DOI 10.4319/lo.2007.52.5.1874; ROY RN, 1993, MAR CHEM, V44, P249, DOI 10.1016/0304-4203(93)90207-5; Rutzler K, 1982, ATLANTIC BARRIER REE; Scheufen T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04927-8; Schoepf V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075049; Seebacher F, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.140251; Speare L, 2020, MOL ECOL, V29, P2334, DOI 10.1111/mec.15497; Suggett DJ, 2008, J PHYCOL, V44, P948, DOI 10.1111/j.1529-8817.2008.00537.x; SZMANT AM, 1990, CORAL REEFS, V8, P217, DOI 10.1007/BF00265014; Tambutte E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8368; Taylor FJR, 1991, BIOL DINOFLAGELLATES, V1st, P174; Thornhill DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029535; Timmers MA, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2103275118; Towle EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123394; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; Venti A, 2014, CORAL REEFS, V33, P979, DOI 10.1007/s00338-014-1191-9; Von Euw S, 2017, SCIENCE, V356, P933, DOI 10.1126/science.aam6371; Wall CB, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170683; Warner DA, 2018, J EXP ZOOL PART A, V329, P153, DOI 10.1002/jez.2199; Weis VM, 2010, MOL ECOL, V19, P1515, DOI 10.1111/j.1365-294X.2010.04575.x; Winters G, 2009, J EXP MAR BIOL ECOL, V380, P25, DOI 10.1016/j.jembe.2009.09.004; Wooldridge SA, 2010, BIOESSAYS, V32, P615, DOI 10.1002/bies.200900182; Wright Kevin, 2021, CRAN; YOUNG SD, 1971, COMP BIOCHEM PHYSIOL, V40, P945, DOI 10.1016/0305-0491(71)90040-X; Zhang Y, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02167-5; Ziegler M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14213; Ziegler M, 2014, CORAL REEFS, V33, P1115, DOI 10.1007/s00338-014-1192-8	114	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273897	10.1371/journal.pone.0273897	http://dx.doi.org/10.1371/journal.pone.0273897			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054126	Green Published, gold, Green Submitted			2022-12-26	WOS:000892641400041
J	Solinc, G; Svigelj, T; Omersa, N; Snoj, T; Pirc, K; Znidarsic, N; Yamaji-Hasegawa, A; Kobayashi, T; Anderluh, G; Podobnik, M				Solinc, Gasper; Svigelj, Tomaz; Omersa, Neza; Snoj, Tina; Pirc, Katja; Znidarsic, Nada; Yamaji-Hasegawa, Akiko; Kobayashi, Toshihide; Anderluh, Gregor; Podobnik, Marjetka			Pore-forming moss protein bryoporin is structurally and mechanistically related to actinoporins from evolutionarily distant cnidarians	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOLYSIN EQUINATOXIN-II; SEA-ANEMONE; MEMBRANE-BINDING; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE; SWISS-MODEL; TOXIN; SPHINGOMYELIN; SPHINGOLIPIDS; CLONING	Pore-forming proteins perforate lipid membranes and consequently affect their integrity and cell fitness. Therefore, it is not surprising that many of these proteins from bacteria, fungi, or certain animals act as toxins. While pore-forming proteins have also been found in plants, there is little information about their molecular structure and mode of action. Bryoporin is a protein from the moss Physcomitrium patens, and its corresponding gene was found to be upregulated by various abiotic stresses, especially dehydration, as well as upon fungal infection. Based on the amino acid sequence, it was suggested that bryoporin was related to the actinoporin family of pore-forming proteins, originally discovered in sea anemones. Here, we provide the first detailed structural and functional analysis of this plant cytolysin. The crystal structure of monomeric bryoporin is highly similar to those of actinoporins. Our cryo-EM analysis of its pores showed an actinoporin-like octameric structure, thereby revealing a close kinship of proteins from evolutionarily distant organisms. This was further confirmed by our observation of bryoporin's preferential binding to and formation of pores in membranes containing animal sphingolipids, such as sphingomyelin and ceramide phosphoethanolamine; however, its binding affinity was weaker than that of actinoporin equinatoxin II. We determined bryoporin did not bind to major sphingolipids found in fungi or plants, and its membrane-binding and pore-forming activity was enhanced by various sterols. Our results suggest that bryoporin could represent a part of the moss defense arsenal, acting as a pore-forming toxin against membranes of potential animal pathogens, parasites, or predators.	[Solinc, Gasper; Svigelj, Tomaz; Omersa, Neza; Snoj, Tina; Pirc, Katja; Anderluh, Gregor; Podobnik, Marjetka] Natl Inst Chem, Dept Mol Biol & Nanobiotechnol, Ljubljana, Slovenia; [Znidarsic, Nada] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Yamaji-Hasegawa, Akiko; Kobayashi, Toshihide] RIKEN, Lipid Biol Lab, Wako, Saitama, Japan; [Kobayashi, Toshihide] Univ Strasbourg, CNRS, UMR 7021, Illkirch Graffenstaden, France	National Institute of Chemistry - Slovenia; University of Ljubljana; RIKEN; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Podobnik, M (corresponding author), Natl Inst Chem, Dept Mol Biol & Nanobiotechnol, Ljubljana, Slovenia.	marjetka.podobnik@ki.si	Anderluh, Gregor/C-6905-2014; Kobayashi, Toshihide/B-6298-2015	Anderluh, Gregor/0000-0002-9916-8465; Solinc, Gasper/0000-0001-8243-0781; Podobnik, Marjetka/0000-0001-6786-9737; Kobayashi, Toshihide/0000-0002-4811-7270; Omersa, Neza/0000-0003-3889-7645	Slovenian Research Agency [P1-0391]; Japan Society for the Promotion of Science (JSPS) [18K06648]; RIKEN Integrated Lipidology Program; European Community's Seventh Framework Programme BioStruct-X [N283570]; RIKEN Glyco-lipidologue Initiative	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); RIKEN Integrated Lipidology Program; European Community's Seventh Framework Programme BioStruct-X; RIKEN Glyco-lipidologue Initiative	This work was supported by the Slovenian Research Agency (P1-0391: G. ~S., T. ~S., N. O., T. S., K. P., G. A., M. P.), Grants-in Aid for Scientific Research (18K06648, A. Y.-H.) from the Japan Society for the Promotion of Science (JSPS), RIKEN Integrated Lipidology Program (A. Y.-H., T. K.), RIKEN Glyco-lipidologue Initiative (T. K.) and European Community's Seventh Framework Programme BioStruct-X N283570.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Alvarez C, 2009, TOXICON, V54, P1135, DOI 10.1016/j.toxicon.2009.02.022; Ameirika, 2017, TOXICON, V133, P153, DOI 10.1016/j.toxicon.2017.05.007; Anderluh G, 2005, ANAL BIOCHEM, V344, P43, DOI 10.1016/j.ab.2005.06.013; Anderluh G, 1996, BIOCHEM BIOPH RES CO, V220, P437, DOI 10.1006/bbrc.1996.0391; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Anderluh G, 2008, TRENDS BIOCHEM SCI, V33, P482, DOI 10.1016/j.tibs.2008.07.004; Arenas YC, 2010, PHYSIOL MOL PLANT P, V74, P376, DOI 10.1016/j.pmpp.2010.06.003; Athanasiadis A, 2001, STRUCTURE, V9, P341, DOI 10.1016/S0969-2126(01)00592-5; Baker MAB, 2014, CHEMBIOCHEM, V15, P2139, DOI 10.1002/cbic.201300799; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Bakrac B, 2010, ADV EXP MED BIOL, V677, P106; BELMONTE G, 1993, J MEMBRANE BIOL, V131, P11, DOI 10.1007/BF02258530; Ben-Ari H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18355-1; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Birck C, 2004, J MOL BIOL, V344, P1409, DOI 10.1016/j.jmb.2004.10.007; Bure C, 2011, RAPID COMMUN MASS SP, V25, P3131, DOI 10.1002/rcm.5206; Castrillo I, 2009, BIOMOL NMR ASSIGN, V3, P5, DOI 10.1007/s12104-008-9127-3; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; Dang LY, 2015, PHYTOCHEMISTRY, V117, P51, DOI 10.1016/j.phytochem.2015.05.020; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frazao B, 2012, MAR DRUGS, V10, P1812, DOI 10.3390/md10081812; Garcia-Linares S, 2016, BIOCHEMISTRY-US, V55, P6630, DOI 10.1021/acs.biochem.6b01007; Gerdol M, 2018, MOL BIOL EVOL, V35, P2654, DOI 10.1093/molbev/msy156; Gilbert RJC, 2014, TRENDS BIOCHEM SCI, V39, P510, DOI 10.1016/j.tibs.2014.09.002; Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6; GRUNWALD C, 1975, ANNU REV PLANT PHYS, V26, P209, DOI 10.1146/annurev.pp.26.060175.001233; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Gunji K, 2010, PROTEIN J, V29, P487, DOI 10.1007/s10930-010-9277-x; Gutierrez-Aguirre I, 2006, BIOCHEM J, V398, P381, DOI 10.1042/BJ20060206; Hannich JT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004762; Hartmann MA, 1998, TRENDS PLANT SCI, V3, P170, DOI 10.1016/S1360-1385(98)01233-3; Hinds MG, 2002, J MOL BIOL, V315, P1219, DOI 10.1006/jmbi.2001.5321; Hoang QT, 2009, NEW PHYTOL, V184, P502, DOI 10.1111/j.1469-8137.2009.02975.x; Hodnik Vesna, 2013, Methods Mol Biol, V974, P23, DOI 10.1007/978-1-62703-275-9_2; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Huang G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08761-6; Huang G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01006-4; Iturriaga G, 2006, PLANT SCI, V170, P1173, DOI 10.1016/j.plantsci.2006.02.004; Jiang XY, 2002, TOXICON, V40, P1563, DOI 10.1016/S0041-0101(02)00173-3; Jurrus E, 2018, PROTEIN SCI, V27, P112, DOI 10.1002/pro.3280; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kawashima Y, 2003, TOXICON, V42, P491, DOI 10.1016/S0041-0101(03)00226-5; Kelker MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112555; KENNEDY JF, 1995, CARBOHYD POLYM, V26, P219, DOI 10.1016/0144-8617(94)00091-7; Ker D-S., 2021, SCI REP-UK, V11, P1; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kristan K, 2004, J BIOL CHEM, V279, P46509, DOI 10.1074/jbc.M406193200; Kristan K, 2007, FEBS J, V274, P539, DOI 10.1111/j.1742-4658.2006.05608.x; Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026; Lenarcic T, 2017, SCIENCE, V358, P1431, DOI 10.1126/science.aan6874; Los FCO, 2013, MICROBIOL MOL BIOL R, V77, P173, DOI 10.1128/MMBR.00052-12; Luberacki B, 2008, ACTA CRYSTALLOGR F, V64, P1178, DOI 10.1107/S1744309108037640; Lucas FLR, 2021, ACS NANO, V15, P9600, DOI 10.1021/acsnano.0c09958; MACEK P, 1994, TOXICOLOGY, V87, P205, DOI 10.1016/0300-483X(94)90252-6; Macrander J, 2016, TOXINS, V8, DOI 10.3390/toxins8120368; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Manzano S, 2017, PLANT J, V89, P58, DOI 10.1111/tpj.13322; Martinez D, 2007, TOXICON, V49, P68, DOI 10.1016/j.toxicon.2006.09.019; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mechaly AE, 2011, STRUCTURE, V19, P181, DOI 10.1016/j.str.2010.11.013; Morante K, 2019, TOXINS, V11, DOI 10.3390/toxins11070401; Mutter NL, 2019, J AM CHEM SOC, V141, P14356, DOI 10.1021/jacs.9b06998; Nagai H, 2002, BIOSCI BIOTECH BIOCH, V66, P2621, DOI 10.1271/bbb.66.2621; Nishiyama T, 2003, P NATL ACAD SCI USA, V100, P8007, DOI 10.1073/pnas.0932694100; Oliver MJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-89; Olsen I, 2001, ANAEROBE, V7, P103, DOI 10.1006/anae.2001.0376; Ottmann C, 2009, P NATL ACAD SCI USA, V106, P10359, DOI 10.1073/pnas.0902362106; Palacios-Ortega J, 2016, LANGMUIR, V32, P3476, DOI 10.1021/acs.langmuir.6b00082; Panevska A, 2019, BBA-BIOMEMBRANES, V1861, P1284, DOI 10.1016/j.bbamem.2019.05.001; Podobnik M, 2017, SEMIN CELL DEV BIOL, V72, P133, DOI 10.1016/j.semcdb.2017.07.026; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Ramirez-Carreto S, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040539; Reboledo G, 2021, PLANT MOL BIOL, V107, P365, DOI 10.1007/s11103-021-01116-0; Resemann HC, 2021, NAT PLANTS, V7, DOI 10.1038/s41477-020-00844-3; Rojko N, 2016, BBA-BIOMEMBRANES, V1858, P446, DOI 10.1016/j.bbamem.2015.09.007; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scott C, 2015, J GEN VIROL, V96, P2000, DOI 10.1099/vir.0.000201; Seidl MF, 2019, ANNU REV PHYTOPATHOL, V57, P367, DOI 10.1146/annurev-phyto-082718-100054; Slotte JP, 2013, PROG LIPID RES, V52, P424, DOI 10.1016/j.plipres.2013.05.001; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; SOUSA MV, 1993, ENTOMOL EXP APPL, V69, P231, DOI 10.1007/BF02381995; Studer G, 2020, BIOINFORMATICS, V36, P1765, DOI 10.1093/bioinformatics/btz828; Subburaj Y, 2015, J BIOL CHEM, V290, P4856, DOI 10.1074/jbc.M114.600676; Sychta K, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10010065; Tamura K, 2021, MOL BIOL EVOL, V38, P3022, DOI 10.1093/molbev/msab120; Tanaka K, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0216; Tanaka K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7337; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Valle A, 2015, TOXICON, V103, P176, DOI 10.1016/j.toxicon.2015.06.028; Wang YW, 2000, BBA-PROTEIN STRUCT M, V1478, P9, DOI 10.1016/S0167-4838(99)00289-7; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weber DK, 2015, BIOPHYS J, V108, P1987, DOI 10.1016/j.bpj.2015.03.024; Wloka C, 2016, ANGEW CHEM INT EDIT, V55, P12494, DOI 10.1002/anie.201606742; Yap WY, 2019, TOXICON, V170, P10, DOI 10.1016/j.toxicon.2019.09.007; Zuckerkandl E, 1965, EVOL GENES PROTEINS, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	98	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102455	10.1016/j.jbc.2022.102455	http://dx.doi.org/10.1016/j.jbc.2022.102455			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5H2JF	36063994	Green Published, gold			2022-12-26	WOS:000867509200009
J	Meyer, SB; Lunnay, B; Warin, M; Foley, K; Olver, IN; Wilson, C; Macdonald, SS; Ward, PR				Meyer, Samantha B.; Lunnay, Belinda; Warin, Megan; Foley, Kristen; Olver, Ian N.; Wilson, Carlene; Macdonald, Sara S.; Ward, Paul R.			Examining social class as it relates to heuristics women use to determine the trustworthiness of information regarding the link between alcohol and breast cancer risk	PLOS ONE			English	Article							TRUST; CONSUMPTION; PREVENTION; STRATEGIES; MESSAGES; LANGUAGE; BELIEFS; SOCIETY; IMPACT	Background High rates of alcohol consumption by midlife women, despite the documented risks associated with breast cancer, varies according to social class. However, we know little about how to develop equitable messaging regarding breast cancer prevention that takes into consideration class differences in the receipt and use of such information. Objective To explore the heuristics used by women with different (inequitable) life chances to determine the trustworthiness of information regarding alcohol as a modifiable risk factor for breast cancer risk. Methods and materials Interviews were conducted with 50 midlife (aged 45-64) women living in South Australia, diversified by self-reported alcohol consumption and social class. Women were asked to describe where they sought health information, how they accessed information specific to breast cancer risk as it relates to alcohol, and how they determined whether (or not) such information was trustworthy. De-identified transcripts were analysed following a three-step progressive method with the aim of identifying how women of varying life chances determine the trustworthiness of alcohol and breast cancer risk information. Three heuristics were used by women: (1) consideration of whose interests are being served; (2) engagement with 'common sense'; and (3) evaluating the credibility of the message and messenger. Embedded within each heuristic are notable class-based distinctions. Conclusions More equitable provision of cancer prevention messaging might consider how social class shapes the reception and acceptance of risk information. Class should be considered in the development and tailoring of messages as the trustworthiness of organizations behind public health messaging cannot be assumed.	[Meyer, Samantha B.] Univ Waterloo, Sch Publ Hlth Sci, Waterloo, ON, Canada; [Lunnay, Belinda; Foley, Kristen; Ward, Paul R.] Torrens Univ Australia, Res Ctr Publ Hlth Equ & Human Flourishing, Adelaide, SA, Australia; [Warin, Megan] Univ Adelaide, Sch Social Sci, Adelaide, SA, Australia; [Olver, Ian N.] Univ Adelaide, Sch Psychol, Fac Hlth & Med Sci, Adelaide, SA, Australia; [Wilson, Carlene] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Wilson, Carlene] La Trobe Univ, Olivia Newton John Canc Wellness & Res Ctr, Austin Hlth, Melbourne, Vic, Australia; [Macdonald, Sara S.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	University of Waterloo; Torrens University Australia; University of Adelaide; Flinders University South Australia; University of Adelaide; La Trobe University; Florey Institute of Neuroscience & Mental Health; La Trobe University; Olivia Newton-John Cancer Research Institute; University of Glasgow	Meyer, SB (corresponding author), Univ Waterloo, Sch Publ Hlth Sci, Waterloo, ON, Canada.	samantha.meyer@uwaterloo.ca	; Olver, Ian/I-1518-2015	Foley, Kristen/0000-0002-8169-8652; Ward, Paul/0000-0002-5559-9714; Lunnay, Belinda/0000-0002-9103-0445; Olver, Ian/0000-0001-5478-1576; Meyer, Samantha/0000-0002-2098-2828	Australian Research Council (ARC) [DP190103434]; ARC DP	Australian Research Council (ARC)(Australian Research Council); ARC DP(Australian Research Council)	The funding source is the Australian Research Council (ARC) DP190103434. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author BL received a salary from the ARC DP.	Arif N, 2018, BREAST, V37, P6, DOI 10.1016/j.breast.2017.10.004; Attwell K, 2017, J BIOETHIC INQ, V14, P65, DOI 10.1007/s11673-016-9756-7; Australian Bureau of Statistics, 2009, NAT HLTH SURV SUMM R; Australian Institute of Health and Welfare, 2021, CANC DATA AUSTR; Australian Institute of Health and Welfare, 2017, NAT DRUG STRAT HOUS; Bagnardi V, 2015, BRIT J CANCER, V112, P580, DOI 10.1038/bjc.2014.579; Beck Ulrich., 1992, RISK SOC NEW MODERNI; Bourdieu, 1984, DISTINCTION SOCIAL C, P331; Breimaier HE, 2015, BMC NURS, V14, DOI 10.1186/s12912-015-0088-4; Brown PR, 2015, CURR SOCIOL, V63, P729, DOI 10.1177/0011392115590091; Calnan M., 2020, UNCERTAIN TIMES TRUS; Cancer Council SA, 2020, NEW DAT SHOWS HIGH R; Cane J, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-37; Clayman ML, 2010, J HEALTH COMMUN, V15, P252, DOI 10.1080/10810730.2010.522697; Colditz GA, 2014, CA-CANCER J CLIN, V64, P186, DOI 10.3322/caac.21225; Commonwealth of Australia, 2019, NAT ALC STRAT 2019 2; Cortis LJ, 2017, EUR J CANCER CARE, V26, DOI 10.1111/ecc.12689; Creswell J.W., 2011, DESIGNING CONDUCTING; Curran D, 2016, J CLASS SOCIOL, V16, P280, DOI 10.1177/1468795X15600929; Curran D, 2013, BRIT J SOCIOL, V64, P44, DOI 10.1111/1468-4446.12004; Donat-Vargas C., 2021, BRIT J CANCER, V125, P1168; Falzon C, 2015, SUPPORT CARE CANCER, V23, P761, DOI 10.1007/s00520-014-2422-x; Foley KM, 2021, SOCIOLOGY, V55, P751, DOI 10.1177/0038038520973580; Francis JJ, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-35; Frederikson M., 2014, J TRUST RES, V4, P167; Giddens Anthony, 1990, CONSEQUENCES MODERNI; Gualda E., 2019, COMUN SOC-NAVARRA, V32; Haught HM, 2016, PSYCHOL HEALTH, V31, P21, DOI 10.1080/08870446.2015.1068313; Heath T, 2006, C HUM FACT COMP SYST; Henderson J., 2016, HEALTH PROMOT INT, P1; Hopf H, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190161; Iwase M, 2021, INT J CANCER, V148, P2736, DOI 10.1002/ijc.33478; Jackson DN, 2019, AM J HEALTH PROMOT, V33, P1187, DOI 10.1177/0890117119861280; Jones SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184705; Kellner D., 2005, DISCOURSE-ABINGDON, V26, P369, DOI [10.1080/01596300500200169, DOI 10.1080/01596300500200169]; Keogh LA, 2019, BREAST, V43, P39, DOI 10.1016/j.breast.2018.11.002; Levesque J., 2016, CANC CHRONIC CONDITI, P71; Liu Y, 2015, WOMENS HEALTH, V11, P65, DOI [10.2217/WHE.14.62, 10.2217/whe.14.62]; Lovatt Melanie, 2017, J Med Internet Res, V19, pe175, DOI 10.2196/jmir.7471; Luhmann N., 2000, TRUST MAKING BREAKIN, P94; Lunnay B, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.645376; Lunnay B, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.616870; Lyle G, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0676-x; McQueen A, 2011, HEALTH PSYCHOL, V30, P674, DOI 10.1037/a0025395; Meyer S, 2008, HEALTH SOCIOL REV, V17, P177, DOI 10.5172/hesr.451.17.2.177; Meyer S, 2014, SOCIOL COMPASS, V8, P525, DOI 10.1111/soc4.12155; Meyer SB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211293; Meyer SB, 2013, SOCIOL RES ONLINE, V18, DOI 10.5153/sro.2819; Meyer SB, 2013, HEALTH RISK SOC, V15, P279, DOI 10.1080/13698575.2013.776017; Miller ER, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.642950; Miller ER, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2812-8; Navarro-Carrillo G, 2018, SOC INDIC RES, V135, P585, DOI 10.1007/s11205-016-1527-7; Peacey V, 2006, EUR J CANCER, V42, P2585, DOI 10.1016/j.ejca.2006.03.017; Peterson EB, 2020, TRANSL BEHAV MED, V10, P978, DOI 10.1093/tbm/ibz066; Petticrew M, 2018, DRUG ALCOHOL REV, V37, P313, DOI 10.1111/dar.12677; Pettigrew S., 2002, QUAL MARK RES, V5, P112, DOI DOI 10.1108/13522750210423814; Pettigrew S, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00217; Popay J, 1996, SOC SCI MED, V42, P759, DOI 10.1016/0277-9536(95)00341-X; Prati G, 2011, HEALTH EDUC RES, V26, P761, DOI 10.1093/her/cyr035; QSR International Pty Ltd, 2018, NVIVO VERS 12; Radin P, 2006, SOC SCI MED, V62, P591, DOI 10.1016/j.socscimed.2005.06.022; Ross DG, 2012, SOC EPISTEMOL, V26, P115, DOI 10.1080/02691728.2011.634530; Rudge A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18147657; Rumgay H, 2021, LANCET ONCOL, V22, P1071, DOI 10.1016/S1470-2045(21)00279-5; Sarich P, 2021, BRIT J CANCER, V124, P513, DOI 10.1038/s41416-020-01101-2; Sassi F., 2015, TACKLING HARMFUL ALC, DOI [10.1787/9789264181069-en, DOI 10.1787/9789264181069]; Savage M, 2013, SOCIOLOGY, V47, P219, DOI 10.1177/0038038513481128; Scoccianti C, 2014, AM J PREV MED, V46, pS16, DOI 10.1016/j.amepre.2013.10.031; Sheppard J, 2017, AUST J POLIT SCI, V52, P500, DOI 10.1080/10361146.2017.1364342; Siegrist M, 2014, EUR PSYCHOL, V19, P23, DOI 10.1027/1016-9040/a000169; Smith SW, 2009, J HEALTH COMMUN, V14, P293, DOI 10.1080/10810730902805903; Thai C., 2018, TRUST HLTH INFORM SO, P43; Van den Broeck W, 2011, BMC INFECT DIS, V11, DOI [10.1186/1471-2334-11-37, 10.1186/1471-2458-11-575]; Viswanath K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014550; Ward PR, 2018, J RISK RES, V21, P1117, DOI 10.1080/13669877.2017.1391318; Ward PR, 2022, SOCIOL HEALTH ILL, V44, P488, DOI 10.1111/1467-9566.13440; Ward PR, 2015, SOCIOL HEALTH ILL, V37, P988, DOI 10.1111/1467-9566.12280; Ward PR, 2018, EMOTIONS SOCIAL THEO; Watling H., 2014, MEDIA RELEASE MIDDLE; West R., 2020, QEIOS, DOI [10.32388/WW04E6.2, DOI 10.32388/WW04E6, DOI 10.32388/WW04E6.2]; Zinn JO, 2008, HEALTH RISK SOC, V10, P439, DOI 10.1080/13698570802380891	81	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0270936	10.1371/journal.pone.027093	http://dx.doi.org/10.1371/journal.pone.027093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095014				2022-12-26	WOS:000892376500008
J	Ryu, S; Nam, HJ; Jhon, M; Lee, JY; Kim, JM; Kim, SW				Ryu, Seunghyong; Nam, Hee Jung; Jhon, Min; Lee, Ju-Yeon; Kim, Jae-Min; Kim, Sung-Wan			Trends in suicide deaths before and after the COVID-19 outbreak in Korea	PLOS ONE			English	Article							EAST JAPAN EARTHQUAKE; MENTAL-HEALTH; RATES	We investigated the effect of the coronavirus disease-2019 (COVID-19) pandemic on suicide trends in Korea via a time-series analysis. We used Facebook Prophet to generate forecasting models based on the monthly numbers of suicide deaths in Korea between 1997 and 2018, validated the models by comparison with the 2019 numbers, and predicted the numbers of suicides in 2020. We compared the expected and observed numbers of suicides during the COVID-19 pandemic. The total numbers of suicides during the COVID-19 pandemic did not deviate from projections based on the pre-pandemic period. However, the number of suicides among women and those under the age of 34 years significantly exceeded the expected level. The COVID-19 pandemic did not increase the overall suicide rate significantly. However, suicides among women and young people increased, suggesting that the pandemic might drive more members of these groups to suicide. Further studies are needed to verify the long-term impact of the COVID-19 pandemic on suicide.	[Ryu, Seunghyong; Jhon, Min; Lee, Ju-Yeon; Kim, Jae-Min; Kim, Sung-Wan] Chonnam Natl Univ, Dept Psychiat, Sch Med, Gwangju, South Korea; [Nam, Hee Jung] Seoul Med Ctr, Dept Psychiat, Seoul, South Korea; [Kim, Sung-Wan] Gwangju Bukgu Mental Hlth Ctr, Mindlink, Gwangju, South Korea	Chonnam National University; Seoul Medical Center	Kim, SW (corresponding author), Chonnam Natl Univ, Dept Psychiat, Sch Med, Gwangju, South Korea.; Kim, SW (corresponding author), Gwangju Bukgu Mental Hlth Ctr, Mindlink, Gwangju, South Korea.	swkim@chonnam.ac.kr		Ryu, Seunghyong/0000-0001-6127-760X; Kim, Sung-Wan/0000-0002-6739-2163	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI19C0481, HC19C0316]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by grants of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grants number: HI19C0481, HC19C0316). The funders were not involved in the conception, design, analysis or interpretation of this study.	Brenner MH, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.592467; Creswell C, 2021, LANCET CHILD ADOLESC, V5, P535, DOI 10.1016/S2352-4642(21)00177-2; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Daly M, 2022, PSYCHOL MED, V52, P2549, DOI 10.1017/S0033291720004432; Dean DJ, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113593; Faust JS, 2021, JAMA-J AM MED ASSOC, V326, P84, DOI 10.1001/jama.2021.8012; Faust JS, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.34273; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; Kim JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084876; Kim M, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.593105; Kim S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238684; Kim SW, 2021, BMC PSYCHIATRY, V21, DOI 10.1186/s12888-021-03449-y; Kim SW, 2013, J KOREAN MED SCI, V28, P345, DOI 10.3346/jkms.2013.28.3.345; Korea S, DEATHS CAUS; Lee CM, 2020, J ADOLESCENT HEALTH, V67, P714, DOI 10.1016/j.jadohealth.2020.08.009; Lee HS, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113570; Lee M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092977; Lee SU, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023144; Liu CH, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113172; Manzar MD, 2021, J CHILD ADOL PS NURS, V34, P139, DOI 10.1111/jcap.12313; Moutier C, 2021, JAMA PSYCHIAT, V78, P433, DOI 10.1001/jamapsychiatry.2020.3746; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; O'Connor RC, 2021, BRIT J PSYCHIAT, V218, P326, DOI 10.1192/bjp.2020.212; Odone Anna, 2020, Acta Biomed, V91, P87, DOI 10.23750/abm.v91i9-S.10122; OECD, SUIC RAT; Orui M, 2015, TOHOKU J EXP MED, V235, P215, DOI 10.1620/tjem.235.215; Orui M, 2014, ENVIRON HEALTH PREV, V19, P459, DOI 10.1007/s12199-014-0418-2; Osaki Y, 2021, J PSYCHIATR RES, V140, P39, DOI 10.1016/j.jpsychires.2021.05.035; Papastefanopoulos V, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10113880; Park SC, 2020, PSYCHIAT INVEST, V17, P911, DOI 10.30773/pi.2020.0166; Pirkis J, 2021, LANCET PSYCHIAT, V8, P579, DOI 10.1016/S2215-0366(21)00091-2; Pompili M, 2012, FORENSIC SCI INT, V223, P1, DOI 10.1016/j.forsciint.2012.04.012; Reger MA, 2020, JAMA PSYCHIAT, V77, P1093, DOI 10.1001/jamapsychiatry.2020.1060; Ryu S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246894; Ryu S, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020006; Tanaka T, 2021, NAT HUM BEHAV, V5, P229, DOI 10.1038/s41562-020-01042-z; Taylor S, PROPHET AUTOMATIC FO; Yu J, 2020, EPIDEMIOL PSYCH SCI, V29, DOI 10.1017/S2045796020000748	38	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0273637	10.1371/journal.pone.0273637	http://dx.doi.org/10.1371/journal.pone.0273637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094911	gold, Green Published			2022-12-26	WOS:000892376500021
J	Wang, WY; Li, SH				Wang, Weiying; Li, Shu Hua			Use of common blood parameters for the differential diagnosis of childhood infections	PLOS ONE			English	Article							C-REACTIVE PROTEIN; VIRAL-INFECTIONS; BACTERIAL; NEUTROPHIL/LYMPHOCYTE; PROCALCITONIN; DISTINCTION; BIOMARKERS; CHILDREN	Background Routine laboratory investigations are not rapidly available to assist clinicians in the diagnosis of pediatric acute infections. Our objective was to evaluate some common blood parameters and use them for the differential diagnosis of childhood infections. Methods This retrospective study was conducted between October 2019 and September 2020 at Guangzhou Women and Children's Medical Center, China. We performed blood tests in patients infected with DNA viruses (n = 402), RNA viruses (n = 602), gram-positive organisms (G+; n = 421), gram-negative organisms (G-; n = 613), or Mycoplasma pneumoniae (n = 387), as well as in children without infection (n = 277). The diagnostic utility of blood parameters to diagnose various infections was evaluated by logistic regression analysis. Results The most common G+ organism, G- organism, and virus were Streptococcus pneumoniae (39.7%), Salmonella typhimurium (18.9%), and influenza A virus (40.2%), respectively. The value of logit (P) = 0.003 x C-reactive protein (CRP) - 0.011 x hemoglobin (HGB) + 0.001 x platelets (PLT) was significantly different between the control, RNA virus, DNA virus, M. pneumoniae, G- organism, and G+ organism groups (2.46 [95% CI, 2.41-2.52], 2.60 [2.58-2.62], 2.70 [2.67-2.72], 2.78 [2.76-2.81], 2.88 [2.85-2.91], and 2.97 [2.93-3.00], respectively; p = 0.00 for all). The logistic regression-based model showed significantly greater accuracy than the best single discriminatory marker for each group (logit [P-infection] vs. CRP, 0.90 vs. 0.84, respectively; logit [P-RNA] vs. lymphocytes, 0.83 vs. 0.77, respectively; p = 0.00). The area under curve values were 0.72 (0.70-0.74) for HGB and 0.81 (0.79-0.82) for logit (P-virus/bacteria) to diagnose bacterial infections, whereas they were 0.72 (0.68-0.74) for eosinophils and 0.80 (0.78-0.82) for logit (P-virus/bacteria) to diagnose viral infections. Logit (P-virus/bacteria) < -0.45 discriminated bacterial from viral infection with 78.9% specificity and 70.7% sensitivity. Conclusions The combination of CRP, HGB, PLT, eosinophil, monocyte, and lymphocyte counts can distinguish between the infectious pathogens in children.	[Wang, Weiying; Li, Shu Hua] Guangzhou Women & Childrens Med Ctr, Dept Pediat Outpatient, Guangzhou, Peoples R China		Wang, WY (corresponding author), Guangzhou Women & Childrens Med Ctr, Dept Pediat Outpatient, Guangzhou, Peoples R China.	xiaobaihuaqimei@sina.com		Wang, Weiying/0000-0002-1956-9147				Al-Zwaini E J, 2009, East Mediterr Health J, V15, P269; Alfaraidi H, 2020, BMJ PAEDIATR OPEN, V4, DOI 10.1136/bmjpo-2020-000640; Andreeva E, 2014, BMC FAM PRACT, V15, DOI 10.1186/1471-2296-15-80; Ansar W, 2013, IMMUNOL RES, V56, P131, DOI 10.1007/s12026-013-8384-0; Appenzeller C, 2002, SWISS MED WKLY, V132, P345; Ballin A, 2009, J PEDIAT HEMATOL ONC, V31, P750, DOI 10.1097/MPH.0b013e3181b79696; Bekdas M, 2014, SAUDI MED J, V35, P442; Bellamy GJ, 2000, CLIN LAB HAEMATOL, V22, P81, DOI 10.1046/j.1365-2257.2000.00288.x; Chiu IM, 2019, PEDIATR NEONATOL, V60, P197, DOI 10.1016/j.pedneo.2018.06.004; Feng M, 2019, LUPUS, V28, P304, DOI 10.1177/0961203319827646; Hamiel U, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018092; Hirosawa T, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4814-5; Hopstaken RM, 2003, BRIT J GEN PRACT, V53, P358; Juskewitch JE, 2015, PEDIATR RES, V78, P683, DOI 10.1038/pr.2015.164; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Klastersky J, 2016, ANN ONCOL, V27, pv111, DOI 10.1093/annonc/mdw325; Lemeshow S, 2009, AM J OPHTHALMOL, V147, P766, DOI 10.1016/j.ajo.2008.07.042; Li ZH, 2019, INFLUENZA OTHER RESP, V13, P184, DOI 10.1111/irv.12621; Mathew B, 2013, J CLIN DIAGN RES, V7, P305, DOI 10.7860/JCDR/2013/4739.2753; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nuutila J, 2008, J CLIN VIROL, V43, P49, DOI 10.1016/j.jcv.2008.04.004; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pugni L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146020; Seymour CW, 2017, NEW ENGL J MED, V376, P2235, DOI 10.1056/NEJMoa1703058; Tacke F, 2016, CRIT CARE MED, V44, P1049, DOI 10.1097/CCM.0000000000001607; van der Starre WE, 2014, CLIN MICROBIOL INFEC, V20, P1048, DOI 10.1111/1469-0691.12645; Yazici M, 2010, TURKISH J PEDIATR, V52, P400; Yu Z, 2016, J IMMUNOL METHODS, V432, P82, DOI 10.1016/j.jim.2016.02.014; Yusa T, 2017, J INFECT CHEMOTHER, V23, P96, DOI 10.1016/j.jiac.2016.11.002	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0273236	10.1371/journal.pone.0273236	http://dx.doi.org/10.1371/journal.pone.0273236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095013	Green Published, gold			2022-12-26	WOS:000892376500016
J	Katz, BA; Yovel, I				Katzid, Benjamin A.; Yovel, Iftah			Mood symptoms predict COVID-19 pandemic distress but not vice versa: An 18-month longitudinal study	PLOS ONE			English	Article							MENTAL-HEALTH; MECHANICAL TURK; DEPRESSION; ANXIETY; STRESS; ASSOCIATION; CONSEQUENCES; PERSONALITY; SCALE	The COVID-19 pandemic has had medical, economic and behavioral implications on a global scale, with research emerging to indicate that it negatively impacted the population's mental health as well. The current study utilizes longitudinal data to assess whether the pandemic led to an increase in depression and anxiety across participants or whether a diathesis-stress model would be more appropriate. An international group of 218 participants completed measures of depression, anxiety, rumination and distress intolerance at two baselines six months apart as well as during the onset of the COVID-19 pandemic exactly 12 months later. Contrary to expectations, depression, rumination, and distress intolerance were at equivalent levels during the pandemic as they were at baseline. Anxiety was reduced by a trivial degree (d = .10). Furthermore, a comparison of quantitative explanatory models indicated that symptom severity and pandemic-related environmental stressors predicted pandemic-related distress. Pandemic-related distress did not predict symptom severity. These findings underscore the necessity of longitudinal designs and diathesis-stress models in the study of mental health during the COVID-19 pandemic. They also emphasize that individuals with higher rates of baseline psychopathology are as particularly at risk for higher levels of distress in response to disaster-related stressors.	[Katzid, Benjamin A.; Yovel, Iftah] Hebrew Univ Jerusalem, Jerusalem, Israel	Hebrew University of Jerusalem	Katz, BA (corresponding author), Hebrew Univ Jerusalem, Jerusalem, Israel.	Benjamin.katz@mail.huji.ac.il			Israeli Science Foundation [886/18]	Israeli Science Foundation(Israel Science Foundation)	This research was supported by the Israeli Science Foundation Grant 886/18 to IY. (https://www.isf.org.il).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ghebreyesus TA, 2020, WORLD PSYCHIATRY, V19, P129, DOI 10.1002/wps.20768; Alimoradi Z, 2022, BJPSYCH OPEN, V8, DOI 10.1192/bjo.2022.26; Alimoradi Z, 2022, J SLEEP RES, V31, DOI 10.1111/jsr.13432; Avena NM, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.653674; Berman NC, 2022, J OBSESS-COMPULS REL, V33, DOI 10.1016/j.jocrd.2022.100727; Borsboom D, 2021, PERSPECT PSYCHOL SCI, V16, P756, DOI 10.1177/1745691620969647; Bourmistrova NW, 2022, J AFFECT DISORDERS, V299, P118, DOI 10.1016/j.jad.2021.11.031; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Chan RCK, 2012, PSYCHIAT RES, V200, P879, DOI 10.1016/j.psychres.2012.06.041; Cokley K, 2022, J COMMUNITY PSYCHOL, V50, P2542, DOI 10.1002/jcop.22747; De Witte H, 2016, AUST PSYCHOL, V51, P18, DOI 10.1111/ap.12176; Drotning KJ, 2022, J FAM VIOLENCE, DOI 10.1007/s10896-022-00372-y; European Centre for Disease Prevention and Control, 2021, TOD DAT GEOGR DISTR; Fried EI, 2022, CLIN PSYCHOL SCI, V10, P340, DOI 10.1177/21677026211017839; Friedman A, 2021, J PERS ASSESS, V103, P380, DOI 10.1080/00223891.2020.1754230; Goldmann E, 2014, ANNU REV PUBL HEALTH, V35, P169, DOI 10.1146/annurev-publhealth-032013-182435; Gruber J, 2021, AM PSYCHOL, V76, P409, DOI 10.1037/amp0000707; Hammen C, 2005, ANNU REV CLIN PSYCHO, V1, P293, DOI 10.1146/annurev.clinpsy.1.102803.143938; Hawes MT, 2022, PSYCHOL MED, V52, P3222, DOI 10.1017/S0033291720005358; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ingram RE., 2005, DEV PSYCHOPATHOL, P37; Katz BA, 2022, J AFFECT DISORDERS, V301, P117, DOI 10.1016/j.jad.2022.01.017; Katz BA, 2020, CLIN PSYCHOL REV, V77, DOI 10.1016/j.cpr.2020.101842; Kazdin AE, 2007, ANNU REV CLIN PSYCHO, V3, P1, DOI 10.1146/annurev.clinpsy.3.022806.091432; Kessler RC, 2008, MOL PSYCHIATR, V13, P374, DOI 10.1038/sj.mp.4002119; Kline RB., 2015, METHODOLOGY SOCIAL S, V4th ed; Kopala-Sibley DC, 2016, J ABNORM PSYCHOL, V125, P471, DOI 10.1037/abn0000152; Lakens D, 2018, ADV METH PRACT PSYCH, V1, P259, DOI 10.1177/2515245918770963; LeMoult J, 2020, CURR DIR PSYCHOL SCI, V29, P592, DOI 10.1177/0963721420964039; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Luchetti M, 2020, AM PSYCHOL, V75, P897, DOI 10.1037/amp0000690; McLaughlin KA, 2022, BEHAV RES THER, V154, DOI 10.1016/j.brat.2022.104121; Milman Evgenia, 2020, J Affect Disord Rep, V2, P100023, DOI 10.1016/j.jadr.2020.100023; Holgado-Tello FP, 2010, QUAL QUANT, V44, P153, DOI 10.1007/s11135-008-9190-y; Paolacci G, 2014, CURR DIR PSYCHOL SCI, V23, P184, DOI 10.1177/0963721414531598; Perrino T, 2013, PERSPECT PSYCHOL SCI, V8, P433, DOI 10.1177/1745691613491579; Robinson E, 2022, J AFFECT DISORDERS, V296, P567, DOI 10.1016/j.jad.2021.09.098; Rogers JP, 2020, LANCET PSYCHIAT, V7, P611, DOI 10.1016/S2215-0366(20)30203-0; Savalei V, 2013, BRIT J MATH STAT PSY, V66, P201, DOI 10.1111/j.2044-8317.2012.02049.x; Seon J, 2022, J FAM VIOLENCE, V37, P691, DOI 10.1007/s10896-021-00286-1; Shanahan L, 2022, PSYCHOL MED, V52, P824, DOI 10.1017/S003329172000241X; Shapiro DN, 2013, CLIN PSYCHOL SCI, V1, P213, DOI 10.1177/2167702612469015; Sheeran P, 2019, SOC SCI MED, V228, P68, DOI 10.1016/j.socscimed.2019.03.015; Shoham V, 2011, PERSPECT PSYCHOL SCI, V6, P478, DOI 10.1177/1745691611418526; Simons JS, 2005, MOTIV EMOTION, V29, P83, DOI 10.1007/s11031-005-7955-3; Taquet M, 2021, JAMA PSYCHIAT, V78, P110, DOI 10.1001/jamapsychiatry.2020.2389; Taylor S, 2020, DEPRESS ANXIETY, V37, P706, DOI 10.1002/da.23071; Trapnell PD, 1999, J PERS SOC PSYCHOL, V76, P284, DOI 10.1037/0022-3514.76.2.284; Uddin M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050526; Viner R, 2022, JAMA PEDIATR, DOI 10.1001/jamapediatrics.2021.5840; Yadav UN, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00508; Yarrington JS, 2021, J AFFECT DISORDERS, V286, P64, DOI 10.1016/j.jad.2021.02.056	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273945	10.1371/journal.pone.0273945	http://dx.doi.org/10.1371/journal.pone.0273945			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054108	Green Published, Green Submitted, gold			2022-12-26	WOS:000892641400043
J	Kim, JC; Lee, MR; Yu, JS; Park, SE; Ha, P; Kim, JS				Kim, Jong-Cheol; Lee, Mi Rong; Yu, Jeong Seon; Park, So Eun; Ha, Panjung; Kim, Jae Su			Management of overwintering pine sawyer beetle, Monochamus alternatus with colonized Beauveria bassiana ERL836	PLOS ONE			English	Article							NONWOVEN FABRIC STRIPS; BURSAPHELENCHUS-XYLOPHILUS; WOOD NEMATODE; WILT DISEASE; VECTOR; COLEOPTERA; ADULTS; STRAIN	Monochamus alternatus is a major forest pest that spreads pine wilt disease in pine trees as a vector of pine wilt nematodes. Chemical insecticides used as fumigants to control overwintering M. alternatus in forests are highly toxic to the environment, so we investigated entomopathogenic fungus Beauveria bassiana ERL836 as an eco-friendly and alternative material to control overwintering M. alternatus. In this work, we evaluated the insecticidal activity of B. bassiana ERL836 against M. alternatus adults, the possibility of fungal colonization on pine tree bark, and finally the control efficacy of fungal pre-treatment on pine tree logs against emerging M. alternatus adults in semi-field and field conditions. M. alternatus adults were killed on the pine tree logs pre-treated with the B. bassiana ERL836. White conidia were observed not only on the surface of the dead adults but also on the pine tree logs, suggesting that the adults were killed by the fungus on the pine. A formulated ERL836 powder treatment on larvae-infested pine logs showed high insecticidal activity against adults, similar to that with the fungal powder suspension treatment, but we demonstrated that using the fungal powder was simpler than using the suspension in field conditions. Even in the field condition, the fungal powder treatment showed high insecticidal activity against M. alternatus adults, which we attribute to its ability to maintain fungal activity for a long time in field conditions by covering the pine tree logs with a film during overwintering. We confirmed that the risk that fungus-infected M. alternatus adults would spread the fungus to other non-target forest insects was low. Thus, even a high-concentration treatment in a specific area is unlikely to transmit the fungus outside that area, so it can be safely used to control this pine wilt nematode vector in forest ecosystems.	[Kim, Jong-Cheol; Lee, Mi Rong; Park, So Eun; Kim, Jae Su] Jeonbuk Natl Univ, Dept Agr Biol, Coll Agr Life Sci, Jeonju, South Korea; [Ha, Panjung] Farm Hannong LG Affiliated Co, Crop Protect R Ctr, Nonsan, South Korea; [Kim, Jae Su] Jeonbuk Natl Univ, Dept Agr Convergence Technol, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University	Kim, JS (corresponding author), Jeonbuk Natl Univ, Dept Agr Biol, Coll Agr Life Sci, Jeonju, South Korea.; Kim, JS (corresponding author), Jeonbuk Natl Univ, Dept Agr Convergence Technol, Jeonju, South Korea.	jskim10@jbnu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2020R1I1A3057522]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant No. 2020R1I1A3057522). The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelleira A, 2011, PLANT DIS, V95, P776, DOI 10.1094/PDIS-12-10-0902; Alvarez-Baz G, 2015, J INVERTEBR PATHOL, V132, P48, DOI 10.1016/j.jip.2015.08.006; Cox C., 2006, Journal of Pesticide Reform, V26, P12; Dungan RS, 2003, VADOSE ZONE J, V2, P279, DOI 10.2113/2.3.279; Dwinell LD, 1997, ANNU REV PHYTOPATHOL, V35, P153, DOI 10.1146/annurev.phyto.35.1.153; Han B., 2007, CHIN AGR SCI B, V23, P146; Hirata A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182837; Humber Richard A., 1997, P153, DOI 10.1016/B978-012432555-5/50011-7; Kamata N., 2008, PINE WILT DIS, P304, DOI [10.1007/978-4-431-75655-2_32, DOI 10.1007/978-4-431-75655-2_32]; Kim Dong-Soo, 2003, Korean Journal of Applied Entomology, V42, P307; Kim JC, 2020, J ASIA-PAC ENTOMOL, V23, P224, DOI 10.1016/j.aspen.2019.12.012; Kim JC, 2020, FUNGAL BIOL-UK, V124, P125, DOI 10.1016/j.funbio.2019.12.006; Kim JC, 2019, J ASIA-PAC ENTOMOL, V22, P537, DOI [10.21289/KSIC.2019.22.5.537, 10.1016/j.aspen.2019.04.001]; Kim JC, 2018, J ASIA-PAC ENTOMOL, V21, P196, DOI 10.1016/j.aspen.2017.11.018; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; KOBAYASHI F, 1984, ANNU REV ENTOMOL, V29, P115, DOI 10.1146/annurev.en.29.010184.000555; Lee Sang Myeong, 2003, Journal of Korean Forestry Society, V92, P191; LINGG AJ, 1981, J INVERTEBR PATHOL, V38, P191, DOI 10.1016/0022-2011(81)90122-1; MAMIYA Y, 1988, J NEMATOL, V20, P219; Mota MM, 1999, NEMATOLOGY, V1, P727, DOI 10.1163/156854199508757; Nai YS, 2015, J ASIA-PAC ENTOMOL, V18, P677, DOI 10.1016/j.aspen.2015.07.013; Okitsu M, 2005, JPN J APPL ENTOMOL Z, V49, P223, DOI 10.1303/jjaez.2005.223; Okitsu M., 2000, Journal of the Japanese Forestry Society, V82, P276; Petersen-Silva R, 2015, INT J PEST MANAGE, V61, P106, DOI 10.1080/09670874.2015.1016472; Sederholm MR, 2018, APPL SOIL ECOL, V124, P27, DOI 10.1016/j.apsoil.2017.10.012; Shimazu M, 2004, APPL ENTOMOL ZOOL, V39, P469, DOI 10.1303/aez.2004.469; SHIMAZU M, 1995, APPL ENTOMOL ZOOL, V30, P207, DOI 10.1303/aez.30.207; Shimazu M., 1992, Journal of the Japanese Forestry Society, V74, P325; Shin S-C., 2008, PINE WILT DIS, P26, DOI [10.1007/978-4-431-75655-2_5, DOI 10.1007/978-4-431-75655-2_5]; Shin TY, 2011, J BASIC MICROB, V51, P531, DOI 10.1002/jobm.201000348; White TJ, 1990, PCR PROTOCOLS GUIDE, DOI [DOI 10.1016/B978-0-12-372180-8.50042-1, 10.1016/B978-0-12-372180-8.50042-1]; WINGFIELD MJ, 1984, J FOREST, V82, P232; Xu M, 2015, CAN ENTOMOL, V147, P628, DOI 10.4039/tce.2014.74; Yen J. H., 1997, Plant Pathology Bulletin, V6, P49	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274086	10.1371/journal.pone.0274086	http://dx.doi.org/10.1371/journal.pone.0274086			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054240	Green Published, gold			2022-12-26	WOS:000892641400060
J	Li, Y; Batinovic, E; Milic, P; Markic, J				Li, You; Batinovic, Ena; Milic, Petra; Markic, Josko			The role of birth month in the burden of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in Croatia	PLOS ONE			English	Article							SEASONALITY; INFLUENZA	Background Birth month was an important risk factor for respiratory syncytial virus (RSV) hospitalisation in infants. However, little is known about the role of birth month in RSV hospitalisation in finer age bands during infancy, which is relevant to strategies for RSV passive immunisations for infants. We aimed to understand the role of birth month in the burden of RSV-associated acute lower respiratory infection (ALRI) hospitalisation in finer age bands of the first year of life. Methods In this retrospective study, we analysed the hospitalisation records during 2014-19 at the University Hospital of Split, Split-Dalmatia County, Croatia. We estimated all-cause and RSV associated ALRI hospitalisation rates among children under five years, with a focus on infants by finer age band and birth month. Results We included 1897 ALRI hospitalisations during the study period. Overall in children under five years, annual hospitalisation rate was 14.66/1000 (95% CI: 14.01-15.34) for all-cause ALRI, and was 7.56/1000 (95% CI: 6.83-8.34) for RSV-ALRI. RSV-ALRI hospitalisation rate was highest in infants aged 28 days-<3 months (61.15/1000, 95% CI: 52.91-70.31). Infants born in November, December and January (2-3 months before RSV peak) had the highest hospitalisation rates during infancy. Depending on the birth month of infants, the risk of RSV-ALRI hospitalisation peaked at different months of age; infants who were born in September had the highest RSV-ALRI hospitalisation rate at the age of 3-<6 months. Conclusions Our study underlines the importance of birth month in planning RSV immunisation strategies for infants, and provides useful baseline data for effectiveness analysis of novel RSV prophylactic products.	[Li, You] Univ Edinburgh, Usher Inst, Ctr Global Hlth, Edinburgh, Scotland; [Li, You] Nanjing Med Univ, Sch Publ Hlth, Nanjing, Peoples R China; [Batinovic, Ena; Milic, Petra; Markic, Josko] Univ Hosp Ctr Split, Dept Pediat, Split, Croatia; [Markic, Josko] Univ Split, Sch Med, Split, Croatia	University of Edinburgh; Nanjing Medical University; University of Split; University of Split	Li, Y (corresponding author), Univ Edinburgh, Usher Inst, Ctr Global Hlth, Edinburgh, Scotland.; Li, Y (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Nanjing, Peoples R China.	You.Li2@ed.ac.uk	; Markic, Josko/C-2044-2008	Li, You/0000-0002-8506-8439; Markic, Josko/0000-0001-9469-9278				Benet T, 2017, CLIN INFECT DIS, V65, P604, DOI 10.1093/cid/cix378; Croatian Bureau of Statistics, 2020, NAT CHANG POP 2019; Griffin MP, 2020, NEW ENGL J MED, V383, P415, DOI 10.1056/NEJMoa1913556; Li You, 2022, Lancet, V399, P2047, DOI 10.1016/S0140-6736(22)00478-0; Li Y, 2021, LANCET RESP MED, V9, P175, DOI 10.1016/S2213-2600(20)30322-2; Li Y, 2020, J INFECT DIS, V222, P1090, DOI 10.1093/infdis/jiaa436; Li Y, 2019, LANCET GLOB HEALTH, V7, pE1031, DOI 10.1016/S2214-109X(19)30264-5; Lloyd PC, 2014, PEDIATR INFECT DIS J, V33, pE135, DOI 10.1097/INF.0000000000000250; Madhi SA, 2020, NEW ENGL J MED, V383, P426, DOI 10.1056/NEJMoa1908380; Midgley CM, 2017, J INFECT DIS, V216, P345, DOI 10.1093/infdis/jix275; Mlinaric Galinovic G., 2009, PAEDIATR CROAT, V53; Mlinaric-Galinovic G., 2012, MED FLUMINENSIS, V48, P79; Mlinaric-Galinovic G, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-18; O'Brien KL, 2019, LANCET, V394, P757, DOI 10.1016/S0140-6736(19)30721-4; PATH, 2020, RSV VACC MAB SNAPSH; Reeves RM, 2016, EPIDEMIOL INFECT, V144, P2049, DOI 10.1017/S0950268816000352; Shi T, 2017, LANCET, V390, P946, DOI [10.1016/s0140-6736(17)30938-8, 10.1016/S0140-6736(17)30938-8]; Staadegaard L, 2021, INFLUENZA OTHER RESP, V15, P732, DOI 10.1111/irv.12885; TABAIN I., 2017, ACTA MED CROAT, V71, P115; ULM K, 1990, AM J EPIDEMIOL, V131, P373, DOI 10.1093/oxfordjournals.aje.a115507; Wang X, 2020, LANCET GLOB HEALTH, V8, pE497, DOI 10.1016/S2214-109X(19)30545-5; Wang X, 2019, CLIN INFECT DIS, V68, P1067, DOI 10.1093/cid/ciy815	22	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273962	10.1371/journal.pone.0273962	http://dx.doi.org/10.1371/journal.pone.0273962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054117	gold, Green Published			2022-12-26	WOS:000892641400045
J	Wiegel, PS; Mach, R; Nolte, I; Freise, F; Levicar, C; Merhof, K; Bach, JP				Wiegel, Pia Saskia; Mach, Rebekka; Nolte, Ingo; Freise, Fritjof; Levicar, Charanthorn; Merhof, Kristina; Bach, Jan-Peter			Breed-specific values for vertebral heart score (VHS), vertebral left atrial size (VLAS), and radiographic left atrial dimension (RLAD) in pugs without cardiac disease, and their relationship to Brachycephalic Obstructive Airway Syndrome (BOAS)	PLOS ONE			English	Article							KING CHARLES SPANIELS; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; ECHOCARDIOGRAPHIC-ASSESSMENT; CHAMBER QUANTIFICATION; SCALE; DOGS; MALFORMATIONS; GUIDELINES; RECOMMENDATIONS	This prospective study aims to establish reference ranges for vertebral heart score (VHS), vertebral left atrial size (VLAS), and radiographic left atrial dimension (RLAD) in pugs. The impact of clinical severity of Brachycephalic Obstructive Airway Syndrome (BOAS), gender, body condition score, and body weight on VHS, VLAS, and RLAD were investigated. Intraand interobserver correlation was determined. Correlation of radiographic scores to echocardiographic left atrial dimension was inspected. Additionally, for VLAS and RLAD, correlation to VHS was examined. Additionally, an assessment of thoracic and vertebral malformations was performed. Forty-seven privately owned pugs underwent physical examination, echocardiography, and thoracic radiography to determine cardiac health. Thirty-two pugs were eligible for establishing reference ranges for VHS in right lateral radiographs, which was 11.25 +/- 0.62 (95% range, 10.1-12.8). Reference ranges for VHS in left lateral, and for VLAS and RLAD in right lateral radiograph were determined in 30 pugs. The VHS in left lateral radiograph was 11.01 +/- 0.70 (95% range, 9.4-12.6), VLAS was 1.96 +/- 0.38 (95% range, 1.1-2.8), and RLAD was 1.59 +/- 0.34 (95% range, 0.7-2.4). Clinical severity of BOAS did not show any impact on radiographic measurements. For VLAS, a significant correlation to VHS was detected by all observers. No other variables had a consistent influence on the radiographic scores given by all observers. Interobserver agreement was almost perfect for VHS (0.89 on right lateral and 0.91 on left lateral image), moderate for VLAS (0.49), and fair for RLAD (0.22). More than one third of the entire study population (18 of 47 pugs) showed at least one thoracic cavity or spine abnormality, often leading to considerable changes in vertebral body shape and size.	[Wiegel, Pia Saskia; Mach, Rebekka; Nolte, Ingo; Levicar, Charanthorn; Merhof, Kristina; Bach, Jan-Peter] Univ Vet Med Hannover, Clin Small Anim, Hannover, Germany; [Freise, Fritjof] Univ Vet Med Hannover, Inst Biometry Epidemiol & Informat Proc, Hannover, Germany	University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation	Nolte, I (corresponding author), Univ Vet Med Hannover, Clin Small Anim, Hannover, Germany.	ingo.nolte.IR@tiho-hannover.de			"Konrad Adenauer Stiftung e.V. (Konrad Adenauer Foundation)"; "Gesellschaft zur Forderung Kynologischer Forschung e.V."; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [LE 824/10-1]; University of Veterinary Medicine Hannover, Foundation	"Konrad Adenauer Stiftung e.V. (Konrad Adenauer Foundation)"; "Gesellschaft zur Forderung Kynologischer Forschung e.V."; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation	PSW was the recipient of a scholarship from the "Konrad Adenauer Stiftung e.V. (Konrad Adenauer Foundation)" https://www.kas.de/de/.The study was financially supported by the "Gesellschaft zur Forderung Kynologischer Forschung e.V."https://www.gkf-bonn.de/index.php/startseite.html.This Open Access publication was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within the programme LE 824/10-1 "Open Access Publication Costs" and University of Veterinary Medicine Hannover, Foundation.	Avner A, 2005, J SMALL ANIM PRACT, V46, P491, DOI 10.1111/j.1748-5827.2005.tb00278.x; Bagardi M, 2022, VET RADIOL ULTRASOUN, V63, P156, DOI 10.1111/vru.13036; Bagardi M, 2021, VET RADIOL ULTRASOUN, V62, P161, DOI 10.1111/vru.12930; Baisan RA, 2022, VET RADIOL ULTRASOUN, V63, P18, DOI 10.1111/vru.13027; Birks R, 2017, J AM ANIM HOSP ASSOC, V53, P73, DOI [10.5326/JAAHA-MS-6474, 10.5326/jaaha-ms-6474]; Blackman NJM, 2000, STAT MED, V19, P723, DOI 10.1002/(SICI)1097-0258(20000315)19:5<723::AID-SIM379>3.0.CO;2-A; BUCHANAN JW, 1995, J AM VET MED ASSOC, V206, P194; Chetboul V, 2012, J VET CARDIOL, V14, P127, DOI 10.1016/j.jvc.2011.11.005; Deinert M, 2012, TIERAERZTL PRAX K H, V40, P283; Duler L, 2018, J VET CARDIOL, V20, P319, DOI 10.1016/j.jvc.2018.07.004; Duler L, 2021, VET RADIOL ULTRASOUN, V62, P271, DOI 10.1111/vru.12949; Ekenstedt KJ, 2020, J COMP PATHOL, V176, P109, DOI 10.1016/j.jcpa.2020.02.008; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Guglielmini C, 2012, JAVMA-J AM VET MED A, V241, P1048, DOI 10.2460/javma.241.8.1048; Gutierrez-Quintana R, 2014, VET RADIOL ULTRASOUN, V55, P585, DOI 10.1111/vru.12172; Haimel G, 2015, J SMALL ANIM PRACT, V56, P714, DOI 10.1111/jsap.12408; Hansson K, 2005, VET RADIOL ULTRASOUN, V46, P122, DOI 10.1111/j.1740-8261.2005.00024.x; Hansson K, 2002, VET RADIOL ULTRASOUN, V43, P568, DOI 10.1111/j.1740-8261.2002.tb01051.x; HENDRICKS JC, 1992, VET CLIN N AM-SMALL, V22, P1145, DOI 10.1016/S0195-5616(92)50306-0; Jepsen-Grant K, 2013, VET RADIOL ULTRASOUN, V54, P3, DOI 10.1111/j.1740-8261.2012.01976.x; Keene BW, 2019, J VET INTERN MED, V33, P1127, DOI 10.1111/jvim.15488; Kim SunHwa, 2020, Journal of Veterinary Clinics, V37, P9, DOI 10.17555/jvc.2020.02.37.1.9; Koch DA, 2003, COMP CONT EDUC PRACT, V25, P48; Komsta R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223642; Kraetschmer S, 2008, J SMALL ANIM PRACT, V49, P240, DOI 10.1111/j.1748-5827.2007.00531.x; Kresken JG., 2019, PRAXIS KARDIOLOGIE H, V2nd ed.; Lam CM, 2021, J LARYNGOL OTOL, DOI [10.1111/jvim.16073, 10.1017/S0022215121004072]; Lamb CR, 2000, VET REC, V146, P687, DOI 10.1136/vr.146.24.687; Lamb CR, 2001, VET REC, V148, P707, DOI 10.1136/vr.148.23.707; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Liu NC, 2016, J VET INTERN MED, V30, P853, DOI 10.1111/jvim.13933; Liu NC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130741; Lord PF, 2011, J VET INTERN MED, V25, P1312, DOI 10.1111/j.1939-1676.2011.00792.x; Luciani MG, 2019, ANAT HISTOL EMBRYOL, V48, P264, DOI 10.1111/ahe.12434; Malcolm EL, 2018, JAVMA-J AM VET MED A, V253, P1038, DOI 10.2460/javma.253.8.1038; Mikawa S, 2020, J VET CARDIOL, V30, P92, DOI 10.1016/j.jvc.2020.06.001; Oechtering G., 2010, Veterinary Focus, V20, P2; Oechtering G U, 2010, Pneumologie, V64, P450, DOI 10.1055/s-0030-1255513; Pinto A. C. B. C. F., 2004, Brazilian Journal of Veterinary Research and Animal Science, V41, P261, DOI 10.1590/S1413-95962004000400007; Poad MH, 2020, J VET INTERN MED, V34, P1728, DOI 10.1111/jvim.15854; Puccinelli C, 2021, VET RADIOL ULTRASOUN, V62, P20, DOI 10.1111/vru.12919; Roedler FS, 2013, VET J, V198, P606, DOI 10.1016/j.tvjl.2013.09.009; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Ryan R, 2017, VET J, V221, P25, DOI 10.1016/j.tvjl.2017.01.018; Saida Y., 2006, Advances in Animal Cardiology, V39, P55; Salguero XS, 2019, IRISH VET J, V72, DOI 10.1186/s13620-019-0152-6; Salguero XS, 2018, IRISH VET J, V71, DOI 10.1186/s13620-018-0137-x; Schlensker E, 2016, VET J, V207, P188, DOI 10.1016/j.tvjl.2015.10.044; Stepien RL, 2020, JAVMA-J AM VET MED A, V256, P1129, DOI 10.2460/javma.256.10.1129; Taylor CJ, 2020, VET RADIOL ULTRASOUN, V61, P10, DOI 10.1111/vru.12813; Vezzosi T, 2020, VET RADIOL ULTRASOUN, V61, P507, DOI 10.1111/vru.12896; Viera AJ, 2005, FAM MED, V37, P360; Westworth DR, 2010, VET CLIN N AM-SMALL, V40, P951, DOI 10.1016/j.cvsm.2010.05.009	54	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274085	10.1371/journal.pone.0274085	http://dx.doi.org/10.1371/journal.pone.0274085			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054125	Green Published, gold			2022-12-26	WOS:000892641400059
J	Dukatz, M; Dittrich, M; Stahl, E; Adam, S; de Mendoza, A; Bashtrykov, P; Jeltsch, A				Dukatz, Michael; Dittrich, Marianna; Stahl, Elias; Adam, Sabrina; de Mendoza, Alex; Bashtrykov, Pavel; Jeltsch, Albert			DNA methyltransferase DNMT3A forms interaction networks with the CpG site and flanking sequence elements for efficient methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; RECOGNITION; BINDING; SHAPE; READ; CG	Specific DNA methylation at CpG and non-CpG sites is essential for chromatin regulation. The DNA methyltransferase DNMT3A interacts with target sites surrounded by variable DNA sequences with its TRD and RD loops, but the functional necessity of these interactions is unclear. We investigated CpG and non-CpG methylation in a randomized sequence context using WT DNMT3A and several DNMT3A variants containing mutations at DNA-interacting residues. Our data revealed that the flanking sequence of target sites between the -2 and up to the +8 position modulates methylation rates >100-fold. Non-CpG methylation flanking preferences were even stronger and favor C(+1). R836 and N838 in concert mediate recogni-tion of the CpG guanine. R836 changes its conformation in a flanking sequence-dependent manner and either contacts the CpG guanine or the +1/+2 flank, thereby coupling the inter-action with both sequence elements. R836 suppresses activity at CNT sites but supports methylation of CAC substrates, the preferred target for non-CpG methylation of DNMT3A in cells. N838 helps to balance this effect and prevent the preference for C(+1) from becoming too strong. Surprisingly, we found L883 reduces DNMT3A activity despite being highly conserved in evolution. However, mutations at L883 disrupt the DNMT3A-specific DNA interactions of the RD loop, leading to altered flanking sequence preferences. Similar effects occur after the R882H mutation in cancer cells. Our data reveal that DNMT3A forms flexible and interdependent interaction networks with the CpG guanine and flanking residues that ensure recognition of the CpG and efficient methylation of the cytosine in contexts of variable flanking sequences.	[Dukatz, Michael; Dittrich, Marianna; Stahl, Elias; Adam, Sabrina; Bashtrykov, Pavel; Jeltsch, Albert] Univ Stuttgart, Inst Biochem & Tech Biochem, Stuttgart, Germany; [de Mendoza, Alex] Queen Mary Univ London, Sch Biol & Behav Sci, London, England	University of Stuttgart; University of London; Queen Mary University London	Jeltsch, A (corresponding author), Univ Stuttgart, Inst Biochem & Tech Biochem, Stuttgart, Germany.	albert.jeltsch@ibtb.uni-stuttgart.de		de Mendoza, Alex/0000-0002-6441-6529	Deutsche Forschungsgemeinschaft;  [JE 252/10];  [JE252/36]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; 	Acknowledgments - This work has been supported by the Deutsche Forschungsgemeinschaft (JE 252/10 and JE252/36) .	Abe N, 2015, CELL, V161, P307, DOI 10.1016/j.cell.2015.02.008; Adam S, 2022, COMMUN BIOL, V5, DOI 10.1038/s42003-022-03033-4; Adam S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17531-8; Anteneh H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16213-9; Baubec T, 2015, NATURE, V520, P243, DOI 10.1038/nature14176; Bergman Y, 2013, NAT STRUCT MOL BIOL, V20, P274, DOI 10.1038/nsmb.2518; Chen ZY, 2020, ANNU REV BIOCHEM, V89, P135, DOI 10.1146/annurev-biochem-103019-102815; Christian DL, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108416; de Mendoza A, 2021, NAT ECOL EVOL, V5, DOI 10.1038/s41559-020-01371-2; Dukatz M, 2020, NUCLEIC ACIDS RES, V48, P11495, DOI 10.1093/nar/gkaa938; Emperle M, 2021, NUCLEIC ACIDS RES, V49, P8294, DOI 10.1093/nar/gkab600; Emperle M, 2019, NUCLEIC ACIDS RES, V47, P11355, DOI 10.1093/nar/gkz911; Emperle M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31635-8; Emperle M, 2018, NUCLEIC ACIDS RES, V46, P3130, DOI 10.1093/nar/gky168; Gao LF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17109-4; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Gowher H, 2018, BIOCHEM SOC T, V46, P1191, DOI 10.1042/BST20170574; Guo JU, 2014, NAT NEUROSCI, V17, P215, DOI 10.1038/nn.3607; Hamidi T, 2015, EPIGENOMICS-UK, V7, P247, DOI [10.2217/EPI.14.80, 10.2217/epi.14.80]; He YP, 2015, ANNU REV GENOM HUM G, V16, P55, DOI 10.1146/annurev-genom-090413-025437; Jeltsch A, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.167186; Jeltsch A, 2019, GENES-BASEL, V10, DOI 10.3390/genes10050388; Jeltsch A, 2016, NUCLEIC ACIDS RES, V44, P8556, DOI 10.1093/nar/gkw723; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jurkowska RZ, 2011, J BIOL CHEM, V286, P24200, DOI 10.1074/jbc.M111.254987; Jurkowska RZ, 2008, NUCLEIC ACIDS RES, V36, P6656, DOI 10.1093/nar/gkn747; Kinde B, 2015, P NATL ACAD SCI USA, V112, P6800, DOI 10.1073/pnas.1411269112; Kribelbauer JF, 2017, CELL REP, V19, P2383, DOI 10.1016/j.celrep.2017.05.069; Lee JH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11800-1; Liu K, 2018, J BIOL CHEM, V293, P7344, DOI 10.1074/jbc.RA118.001785; Mack A, 2022, J MOL BIOL, V434, DOI 10.1016/j.jmb.2022.167482; Maurano MT, 2015, CELL REP, V12, P1184, DOI 10.1016/j.celrep.2015.07.024; Norvil AB, 2020, NUCLEIC ACIDS RES, V48, P3761, DOI 10.1093/nar/gkaa139; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rohs R, 2010, ANNU REV BIOCHEM, V79, P233, DOI 10.1146/annurev-biochem-060408-091030; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Schubeler D, 2015, NATURE, V517, P321, DOI 10.1038/nature14192; Shimbo T, 2016, ADV EXP MED BIOL, V945, P303, DOI 10.1007/978-3-319-43624-1_13; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Weinberg DN, 2019, NATURE, V573, P281, DOI 10.1038/s41586-019-1534-3; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895; Yin YM, 2017, SCIENCE, V356, DOI 10.1126/science.aaj2239; Zeng Y, 2019, GENES-BASEL, V10, DOI 10.3390/genes10040257; Zhang ZM, 2018, NATURE, V554, P387, DOI 10.1038/nature25477	45	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102462	10.1016/j.jbc.2022.102462	http://dx.doi.org/10.1016/j.jbc.2022.102462			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5J0EG	36067881	Green Published, gold			2022-12-26	WOS:000868720100012
J	Halmetoja, E; Nagy, I; Szabo, Z; Alakoski, T; Yrjola, R; Vainio, L; Viitavaara, E; Lin, RZ; Rahtu-Korpela, L; Vainio, S; Kerkela, R; Magga, J				Halmetoja, Eveliina; Nagy, Irina; Szabo, Zoltan; Alakoski, Tarja; Yrjola, Raisa; Vainio, Laura; Viitavaara, Eliina; Lin, Ruizhu; Rahtu-Korpela, Lea; Vainio, Seppo; Kerkela, Risto; Magga, Johanna			Wnt11 in regulation of physiological and pathological cardiac growth	FASEB JOURNAL			English	Article						cardiac hypertrophy; left ventricle remodeling; pressure overload; Wnt11 protein	PRESSURE-OVERLOAD; CARDIOMYOCYTE PROLIFERATION; CELLS; CONTRIBUTES; ACTIVATION; PATHWAY; ROLES; WNT5A	Wnt11 regulates early cardiac development and left ventricular compaction in the heart, but it is not known how Wnt11 regulates postnatal cardiac maturation and response to cardiac stress in the adult heart. We studied cell proliferation/maturation in postnatal and adolescent Wnt11 deficient (Wnt11-/-) heart and subjected adult mice with partial (Wnt11+/-) and complete Wnt11 (Wnt11-/-) deficiency to cardiac pressure overload. In addition, we subjected primary cardiomyocytes to recombinant Wnt proteins to study their effect on cardiomyocyte growth. Wnt11 deficiency did not affect cardiomyocyte proliferation or maturation in the postnatal or adolescent heart. However, Wnt11 deficiency led to enlarged heart phenotype that was not accompanied by significant hypertrophy of individual cardiomyocytes. Analysis of stressed adult hearts from wild-type mice showed a progressive decrease in Wnt11 expression in response to pressure overload. When studied in experimental cardiac pressure overload, Wnt11 deficiency did not exacerbate cardiac hypertrophy or remodeling and cardiac function remained identical between the genotypes. When subjecting cardiomyocytes to hypertrophic stimulus, the presence of recombinant Wnt11 together with Wnt5a reduced protein synthesis. In conclusion, Wnt11 deficiency does not affect postnatal cardiomyocyte proliferation but leads to cardiac growth. Interestingly, Wnt11 deficiency alone does not substantially modulate hypertrophic response to pressure overload in vivo. Wnt11 may require cooperation with other noncanonical Wnt proteins to regulate hypertrophic response under stress.	[Halmetoja, Eveliina; Szabo, Zoltan; Alakoski, Tarja; Yrjola, Raisa; Vainio, Laura; Viitavaara, Eliina; Lin, Ruizhu; Rahtu-Korpela, Lea; Kerkela, Risto; Magga, Johanna] Univ Oulu, Res Unit Biomed, Aapistie 5B, Oulu 90220, Finland; [Nagy, Irina] Univ Oulu, Med Res Ctr, Canc & Translat Med Res Unit, Dept Clin Chem, Oulu, Finland; [Nagy, Irina] Oulu Univ Hosp, Northern Finland Lab Ctr NordLab, Oulu, Finland; [Vainio, Seppo] Univ Oulu, Ctr Cell Matrix Res, Lab Dev Biol, Oulu, Finland; [Vainio, Seppo] Univ Oulu, Kvantum Inst, Infotech Oulu, Oulu, Finland; [Kerkela, Risto] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Kerkela, Risto] Univ Oulu, Oulu, Finland; [Kerkela, Risto; Magga, Johanna] Univ Oulu, Bioctr Oulu, Oulu, Finland	University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu; University of Oulu	Magga, J (corresponding author), Univ Oulu, Res Unit Biomed, Aapistie 5B, Oulu 90220, Finland.	johanna.magga@oulu.fi			Aarne Koskelon Saatio (Aarne Koskelo Foundation); Academy of Finland (AKA) [268505, 297094]; Paavo Nurmen Saatio (Paavo Nurmi Foundation); Sydantutkimussaatio (Finnish Foundation for Cardiovascular Research)	Aarne Koskelon Saatio (Aarne Koskelo Foundation); Academy of Finland (AKA)(Academy of FinlandFinnish Funding Agency for Technology & Innovation (TEKES)); Paavo Nurmen Saatio (Paavo Nurmi Foundation); Sydantutkimussaatio (Finnish Foundation for Cardiovascular Research)	Aarne Koskelon Saatio (Aarne Koskelo Foundation); Academy of Finland (AKA), Grant/Award Number: 268505 and 297094; Paavo Nurmen Saatio (Paavo Nurmi Foundation); Sydantutkimussaatio (Finnish Foundation for Cardiovascular Research)	Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Albanese I, 2017, ARTERIOSCL THROM VAS, V37, P543, DOI 10.1161/ATVBAHA.116.308394; Alkass K, 2015, CELL, V163, P1026, DOI 10.1016/j.cell.2015.10.035; Barrick CJ, 2007, AM J PHYSIOL-HEART C, V292, pH2119, DOI 10.1152/ajpheart.00816.2006; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bisson JA, 2015, DEV BIOL, V398, P80, DOI 10.1016/j.ydbio.2014.11.015; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Burgy O, 2018, MATRIX BIOL, V68-69, P67, DOI 10.1016/j.matbio.2018.03.017; Bywater MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15552-x; Cohen ED, 2012, DEVELOPMENT, V139, P1931, DOI 10.1242/dev.069377; Doetschman T, 2012, CIRC RES, V110, P1498, DOI 10.1161/CIRCRESAHA.112.265066; Dow LE, 2015, NAT BIOTECHNOL, V33, P390, DOI 10.1038/nbt.3155; Eisenberg LM, 2007, THESCIENTIFICWORLDJO, V7, P161, DOI 10.1100/tsw.2007.71; Flaherty MP, 2008, CIRCULATION, V117, P2241, DOI 10.1161/CIRCULATIONAHA.107.741066; Flaherty MP, 2008, TRENDS CARDIOVAS MED, V18, P260, DOI 10.1016/j.tcm.2008.12.001; Foulquier S, 2018, PHARMACOL REV, V70, P68, DOI 10.1124/pr.117.013896; Gude NA, 2018, PHARMACOL RES, V127, P110, DOI 10.1016/j.phrs.2017.06.007; Hirai M, 2016, CIRC RES, V118, P916, DOI 10.1161/CIRCRESAHA.115.308101; Jiang JH, 2018, BBA-MOL BASIS DIS, V1864, P3459, DOI 10.1016/j.bbadis.2018.07.035; Kerkela R, 2013, MOL CELL BIOL, V33, P3321, DOI 10.1128/MCB.00432-13; Kerkela R, 2011, CTS-CLIN TRANSL SCI, V4, P236, DOI 10.1111/j.1752-8062.2011.00294.x; Lin H, 2016, AM J PHYSIOL-CELL PH, V311, pC710, DOI 10.1152/ajpcell.00137.2016; Magga J, 2019, MOL THER, V27, P600, DOI 10.1016/j.ymthe.2019.01.013; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mazzotta S, 2016, STEM CELL REP, V7, P764, DOI 10.1016/j.stemcr.2016.08.008; Mollova M, 2013, P NATL ACAD SCI USA, V110, P1446, DOI 10.1073/pnas.1214608110; Moon J, 2017, P NATL ACAD SCI USA, V114, P1649, DOI 10.1073/pnas.1621346114; Mori H, 2016, SCI REP-UK, V6, DOI 10.1038/srep21520; Morishita Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21705; Nagy II, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0131-z; Nagy II, 2010, CARDIOVASC RES, V85, P100, DOI 10.1093/cvr/cvp254; Naqvi N, 2014, CELL, V157, P795, DOI 10.1016/j.cell.2014.03.035; Noseda M, 2011, CIRC RES, V108, P129, DOI 10.1161/CIRCRESAHA.110.223792; Panakova D, 2010, NATURE, V466, P874, DOI 10.1038/nature09249; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sinha T, 2015, DEV BIOL, V398, P177, DOI 10.1016/j.ydbio.2014.11.005; Stubenvoll A, 2015, HUM MOL GENET, V24, P802, DOI 10.1093/hmg/ddu498; Szabo Z, 2020, FASEB J, V34, P9911, DOI 10.1096/fj.201903074RR; Szabo Z, 2014, HYPERTENSION, V63, P1235, DOI 10.1161/HYPERTENSIONAHA.114.03279; Tolonen AM, 2014, PHARMACOL RES PERSPE, V2, DOI 10.1002/prp2.56; Touma M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94904; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; Vainio LE, 2019, JACC-BASIC TRANSL SC, V4, P83, DOI 10.1016/j.jacbts.2018.10.007; van de Schans VAM, 2007, HYPERTENSION, V49, P473, DOI 10.1161/01.HYP.0000255946.55091.24; van Vliet PP, 2017, DEV BIOL, V429, P249, DOI 10.1016/j.ydbio.2017.06.021; Vogel B, 2015, METHODSX, V2, P124, DOI 10.1016/j.mex.2015.02.007; Xiang FL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00840-w; Zhong WG, 2006, EMBO J, V25, P3869, DOI 10.1038/sj.emboj.7601252; Zhou WL, 2007, NAT GENET, V39, P1225, DOI 10.1038/ng2112; Zou Y, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-04152-2; Zuo S, 2012, STEM CELLS DEV, V21, P598, DOI 10.1089/scd.2011.0071	53	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22544	10.1096/fj.202101856RRRR	http://dx.doi.org/10.1096/fj.202101856RRRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4M1HR	36098469	hybrid			2022-12-26	WOS:000853079300001
J	Li, XH; Kordsmeier, J; Nookaew, I; Kim, HN; Xiong, JH				Li, Xuehua; Kordsmeier, Jacob; Nookaew, Intawat; Kim, Ha-Neui; Xiong, Jinhu			Piezo1 stimulates mitochondrial function via cAMP signaling	FASEB JOURNAL			English	Article							GENE-EXPRESSION; CALCIUM; DIFFERENTIATION; EXERCISE; TISSUE	Mechanical signals stimulate mitochondrial function but the molecular mechanisms are not clear. Here, we show that the mechanically sensitive ion channel Piezo1 plays a critical role in mitochondrial adaptation to mechanical stimulation. The activation of Piezo1 induced mitochondrial calcium uptake and oxidative phosphorylation (OXPHOS). In contrast, loss of Piezo1 reduced the mitochondrial oxygen consumption rate (OCR) and adenosine triphosphate (ATP) production in calvarial cells and these changes were associated with increased expression of the phosphodiesterases Pde4a and lower cyclic AMP (cAMP) levels. In addition, Piezo1 increased cAMP production and the activation of a cAMP-responsive transcriptional reporter. Consistent with this, cAMP was sufficient to increase mitochondrial OCR and the inhibition of phosphodiesterases augmented the increase in OCR induced by Piezo1. Moreover, the inhibition of cAMP production or activity of protein kinase A, a kinase activated by cAMP, prevented the increase in OCR induced by Piezo1. These results demonstrate that cAMP signaling contributes to the increase in mitochondrial OXPHOS induced by activation of Piezo1.	[Li, Xuehua; Kordsmeier, Jacob; Xiong, Jinhu] Univ Arkansas Med Sci, Dept Orthopaed Surg, Little Rock, AR 72205 USA; [Li, Xuehua; Kordsmeier, Jacob; Nookaew, Intawat; Kim, Ha-Neui; Xiong, Jinhu] Univ Arkansas Med Sci, Ctr Musculoskeletal Dis Res, Little Rock, AR 72205 USA; [Nookaew, Intawat] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR 72205 USA; [Kim, Ha-Neui] Univ Arkansas Med Sci, Dept Internal Med, Div Endocrinol & Metab, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences	Xiong, JH (corresponding author), Univ Arkansas Med Sci, Dept Orthopaed Surg, Little Rock, AR 72205 USA.	jxiong@uams.edu			HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01AR076979]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [P20GM125503]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01AR076979; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: P20GM125503	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Almeida M, 2007, J BIOL CHEM, V282, P27285, DOI 10.1074/jbc.M702810200; Atcha H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23482-5; Bartolak-Suki E, 2015, NAT MATER, V14, P1049, DOI [10.1038/NMAT4358, 10.1038/nmat4358]; Boerckel JD, 2011, P NATL ACAD SCI USA, V108, pE674, DOI 10.1073/pnas.1107019108; Boppart MD, 1998, BONE, V23, P409, DOI 10.1016/S8756-3282(98)00119-7; Cahalan SM, 2015, ELIFE, V4, DOI 10.7554/eLife.07370; Chakraborty M, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108609; Chaudhry A, 2020, AM J PHYSIOL-ENDOC M, V318, pE87, DOI 10.1152/ajpendo.00457.2019; Chen X, 2018, NEURON, V100, P799, DOI 10.1016/j.neuron.2018.09.046; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; de Lima JE, 2016, ELIFE, V5, DOI 10.7554/eLife.15593; De Rasmo D, 2016, BBA-BIOENERGETICS, V1857, P350, DOI 10.1016/j.bbabio.2016.01.006; De Rasmo D, 2015, BBA-MOL CELL RES, V1853, P183, DOI 10.1016/j.bbamcr.2014.10.016; Di Benedetto G, 2013, CELL METAB, V17, P965, DOI 10.1016/j.cmet.2013.05.003; Dobson PF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68566-2; Forbes EM, 2012, NEURON, V74, P490, DOI 10.1016/j.neuron.2012.02.035; Gao J, 2018, CELL DEATH DIFFER, V25, P229, DOI 10.1038/cdd.2017.144; Giorgi C, 2018, NAT REV MOL CELL BIO, V19, P713, DOI 10.1038/s41580-018-0052-8; Gudipaty SA, 2017, NATURE, V543, P118, DOI 10.1038/nature21407; Halls ML, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004143; Hawley JA, 2018, CELL METAB, V27, P962, DOI 10.1016/j.cmet.2018.04.014; Helle SCJ, 2017, ELIFE, V6, DOI 10.7554/eLife.30292; Hendrickx G, 2021, J BONE MINER RES, V36, P369, DOI 10.1002/jbmr.4198; Hwang JH, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28247-2; Jaiswal BS, 2003, P NATL ACAD SCI USA, V100, P10676, DOI 10.1073/pnas.1831008100; Jiang F, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21178-4; Kim B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111409; Kim HN, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138815; Lee WC, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108108; Lewis KJ, 2020, JBMR PLUS, V4, DOI 10.1002/jbm4.10366; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2014, NATURE, V515, P279, DOI 10.1038/nature13701; Li XH, 2021, CURR OSTEOPOROS REP, V19, P101, DOI 10.1007/s11914-020-00650-y; Li XH, 2019, ELIFE, V8, DOI 10.7554/eLife.49631; Liu CSC, 2018, J IMMUNOL, V200, P1255, DOI 10.4049/jimmunol.1701118; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luu YK, 2009, J BONE MINER RES, V24, P50, DOI [10.1359/jbmr.080817, 10.1359/JBMR.080817]; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Nookaew I, 2012, NUCLEIC ACIDS RES, V40, P10084, DOI 10.1093/nar/gks804; Onal M, 2013, J BIOL CHEM, V288, P17432, DOI 10.1074/jbc.M112.444190; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Retailleau K, 2015, CELL REP, V13, P1161, DOI 10.1016/j.celrep.2015.09.072; Rizzuto R, 2012, NAT REV MOL CELL BIO, V13, P566, DOI 10.1038/nrm3412; Sun WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47454; Sun ZQ, 2016, J CELL BIOL, V215, P445, DOI 10.1083/jcb.201609037; Suzuki J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5153; Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369; Tharp KM, 2021, CELL METAB, V33, P1322, DOI 10.1016/j.cmet.2021.04.017; Trevellin E, 2014, DIABETES, V63, P2800, DOI 10.2337/db13-1234; van Loo G, 2002, CELL DEATH DIFFER, V9, P1031, DOI 10.1038/sj.cdd.4401088; Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111; Wescott AP, 2019, NAT METAB, V1, P975, DOI 10.1038/s42255-019-0126-8; Zannit HM, 2019, JBMR PLUS, V3, DOI 10.1002/jbm4.10227; Zhou TF, 2020, ELIFE, V9, DOI 10.7554/eLife.52779	58	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22519	10.1096/fj.202200300R	http://dx.doi.org/10.1096/fj.202200300R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4F5SO	36052712				2022-12-26	WOS:000848572100001
J	Wang, J; Jiang, BY; Wang, KZ; Dai, JF; Dong, CS; Wang, YP; Zhang, P; Li, M; Xu, W; Wei, L				Wang, Jing; Jiang, Bingyan; Wang, Kezhen; Dai, Jianfeng; Dong, Chunsheng; Wang, Yipeng; Zhang, Peng; Li, Min; Xu, Wei; Wei, Lin			A cathelicidin antimicrobial peptide from Hydrophis cyanocinctus inhibits Zika virus infection by downregulating expression of a viral entry factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEXUAL TRANSMISSION; DC-SIGN; IDENTIFICATION; BIOLOGY; CELLS	Zika virus (ZIKV) is a re-emerging flavivirus that causes conditions such as microcephaly and testis damage. The spread of ZIKV has become a major public health concern. Recent studies indicated that antimicrobial peptides are an ideal source for screening antiviral candidates with broad-spectrum antiviral activities, including against ZIKV. We herein found that Hc-CATH, a cathelicidin antimicrobial peptide identified from the sea snake Hydrophis cyanocinctus in our previous work, conferred protection against ZIKV infection in host cells and showed preventative efficacy and therapeutic efficacy in C57BL/6J mice, Ifnar1-/- mice, and pregnant mice. Intrigu-ingly, we revealed that Hc-CATH decreased the susceptibility of host cells to ZIKV by downregulating expression of AXL, a TAM (TYRO3, AXL and MERTK) family kinase receptor that mediates ZIKV infection, and subsequently reversed the negative regulation of AXL on host's type I interferon response. Furthermore, we showed that the cyclo-oxygenase-2/ prostaglandin E2/adenylyl cyclase/protein kinase A pathway was involved in Hc-CATH-mediated AXL downregulation, and Hc-CATH in addition directly inactivated ZIKV particles by disrupting viral membrane. Finally, while we found Hc-CATH did not act on the late stage of ZIKV infection, structure- function relationship studies revealed that alpha-helix and phenylalanine residues are key structural requirements for its protective efficacy against initial ZIKV infection. In summary, we demonstrate that Hc-CATH provides prophylactic and therapeutic efficacy against ZIKV infection via downregulation of AXL, as well as inactivating the virion. Our findings reveal a novel mechanism of cathelicidin against viral infection and highlight the potential of Hc-CATH to prevent and treat ZIKV infection.	[Wang, Jing; Jiang, Bingyan; Wang, Kezhen; Dai, Jianfeng; Dong, Chunsheng; Zhang, Peng; Li, Min; Xu, Wei; Wei, Lin] Soochow Univ, Inst Biol & Med Sci, Jiangsu Prov Key Lab Infect & Immun, and, Suzhou, Jiangsu, People R China; [Wang, Yipeng] Soochow Univ, Coll Pharmaceut Sci, Dept Biopharmaceut Sci, Suzhou, Jiangsu, Peoples R China; [Zhang, Peng] Soochow Univ, Affiliated Hosp 2, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China	Xu, W; Wei, L (corresponding author), Soochow Univ, Inst Biol & Med Sci, Jiangsu Prov Key Lab Infect & Immun, and, Suzhou, Jiangsu, People R China.	xuwei828@suda.edu.cn; weilin1005@126.com	Wang, Yipeng/AAA-1499-2020	Wang, Yipeng/0000-0003-1385-4470	National Natural Science Foundation of China [31870868]; Jiangsu Provincial Key Research and Development Program [BE2020652]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Hui -Chun Chin and Tsung-Dao Lee Chinese Undergraduate Endowment (CURE)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Key Research and Development Program; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Hui -Chun Chin and Tsung-Dao Lee Chinese Undergraduate Endowment (CURE)	The project was funded by National Natural Science Foundation of China (grant no.: 31870868) , Jiangsu Provincial Key Research and Development Program (grant no.: BE2020652) , Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) , and Hui -Chun Chin and Tsung-Dao Lee Chinese Undergraduate Endowment (CURE) .	Barlow PG, 2014, FUTURE MICROBIOL, V9, P55, DOI 10.2217/fmb.13.135; Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]; Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4; Coldbeck-Shackley RC, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030530; D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449; Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; Duan ZL, 2022, CELL MOL LIFE SCI, V79, DOI 10.1007/s00018-022-04309-y; Gallichotte EN, 2019, MBIO, V10, DOI 10.1128/mBio.01485-19; Garcia MG, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111473; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; He M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00722; Holthausen DJ, 2017, IMMUNITY, V46, P587, DOI 10.1016/j.immuni.2017.03.018; Hong W, 2015, J BIOL CHEM, V290, P23254, DOI 10.1074/jbc.M115.662452; Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232; Jenssen H, 2009, VIRUSES-BASEL, V1, P939, DOI 10.3390/v1030939; Ji MY, 2019, TOXINS, V11, DOI 10.3390/toxins11100584; Ji ZL, 2018, VIROL SIN, V33, P545, DOI 10.1007/s12250-018-0068-4; Lee MT, 2013, P NATL ACAD SCI USA, V110, P14243, DOI 10.1073/pnas.1307010110; Lee SH, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80596-4; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Li FF, 2019, J BIOL CHEM, V294, P182, DOI 10.1074/jbc.RA118.005015; Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792; Li SA, 2012, ANTIMICROB AGENTS CH, V56, P3309, DOI 10.1128/AAC.06304-11; Li S, 2020, LIFE SCI, V263, DOI 10.1016/j.lfs.2020.118564; Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Liu Zhen, 2022, Antiviral Res, V198, P105248, DOI 10.1016/j.antiviral.2022.105248; Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004; Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009; Mookherjee N, 2020, NAT REV DRUG DISCOV, V19, P311, DOI 10.1038/s41573-019-0058-8; Mulder KCL, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00321; Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012; Pan T, 2018, J VIROL, V92, DOI [10.1128/JVI.01018-18, 10.1128/jvi.01018-18]; Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113; Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114; Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112; Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028; Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515; Skalickova S, 2015, VIRUSES-BASEL, V7, P5428, DOI 10.3390/v7102883; Strange DP, 2019, MBIO, V10, DOI 10.1128/mBio.01372-19; Sugimoto Y, 2007, J BIOL CHEM, V282, P11613, DOI 10.1074/jbc.R600038200; Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Wang S, 2017, NAT IMMUNOL, V18, P733, DOI 10.1038/ni.3744; Wang YP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003217; Wei L, 2015, J BIOL CHEM, V290, P16633, DOI 10.1074/jbc.M115.642645; Xing MC, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01871; Yang Y, 2019, J BIOL CHEM, V294, P7615, DOI 10.1074/jbc.RA118.006968; Yu J, 2021, ANTIVIR RES, V187, DOI 10.1016/j.antiviral.2021.105021; Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147	56	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102471	10.1016/j.jbc.2022.102471	http://dx.doi.org/10.1016/j.jbc.2022.102471			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5J0EG	36089062	Green Published, gold			2022-12-26	WOS:000868720100007
J	Huschtscha, Z; Young, P; Parr, A; Porter, J; Costa, R				Huschtscha, Zoya; Young, Pascale; Parr, Alexandra; Porter, Judi; Costa, Ricardo			Does intestinal epithelial integrity status in response to high-protein dairy milk beverage with or without progressive resistance training impact systemic inflammatory responses in an active aging population?	PLOS ONE			English	Article							EXERTIONAL-HEAT-STRESS; INDUCED GASTROINTESTINAL SYNDROME; SKELETAL-MUSCLE; CIRCULATORY ENDOTOXIN; ULTRA-MARATHON; EXERCISE; HEALTH; SYMPTOMS; STRENGTH; MASS	Increased resting systemic anti-inflammatory responses have previously been reported after a period of progressive resistance training (PRT) with daily consumption of a high-protein dairy beverage. The study aimed to investigate the independent and combined effects of consuming a high protein dairy milk beverage with or without a PRT on markers of intestinal epithelial integrity and selected systemic inflammatory responses in active older (>= 50 yrs) adults. Thirty two (males n = 24, females n = 8) active older adults [mean (SD): Age 62 (7) years, weight 74.2 (14.0) kg, height 1.73 (10.0) cm, BMI 24.9 (4.0) kg/m(2), and body fat mass: 25.8 (9.1)%)], that reported exercising >= 3/week (211 (91) min/week) were randomly allocated into one of four groups: dairy milk (DM), exercise and dairy milk (EX+DM), exercise alone (EX), and control (CON). Groups with EX underwent 12-weeks whole-body PRT program (x3 sessions/week), groups with DM consumed the beverage twice daily (30g protein/day), and CON was required to carry out their ad libitum dietary and exercise habits. Plasma concentrations of CRP, IL-1 beta, IL-1ra, LBP, and sCD14 were determined by ELISA from samples collected at weeks 0, 6, and 12. Data were analyzed (SPSS v25.0) for group and time differences using a two-way repeated-measures ANOVA with post hoc analysis. No significant differences were observed for any of the measured plasma biomarkers. The previously observed increase in anti-inflammatory cytokine response is likely due to a muscular cellular response and not an indication of intestinal epithelial integrity disturbance and/ or subsequent translocation of luminal originated pathogenic bacterial compounds.	[Huschtscha, Zoya; Young, Pascale; Parr, Alexandra; Porter, Judi; Costa, Ricardo] Monash Univ, Dept Nutr Dietet Food, Notting Hill, Vic, Australia; [Porter, Judi] Deakin Univ, Sch Exercise & Nutr Sci, Burwood Campus, Melbourne, Vic, Australia	Monash University; Deakin University	Costa, R (corresponding author), Monash Univ, Dept Nutr Dietet Food, Notting Hill, Vic, Australia.	ricardo.costa@monash.edu	da Costa, Ricardo/I-1572-2014	da Costa, Ricardo/0000-0003-3069-486X	Lion Dairy and Drinks, Australia, as part of Monash University Graduate Research Industry Partnership-Food and Dairy program	Lion Dairy and Drinks, Australia, as part of Monash University Graduate Research Industry Partnership-Food and Dairy program	Research funding (ZH and RC) was provided by Lion Dairy and Drinks, Australia, as part of Monash University Graduate Research Industry Partnership-Food and Dairy program.	Alvarez-Rodriguez L, 2012, CELL IMMUNOL, V273, P124, DOI 10.1016/j.cellimm.2012.01.001; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Beaudart C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169548; Boutagy NE, 2016, BIOCHIMIE, V124, P11, DOI 10.1016/j.biochi.2015.06.020; Costa RJS, 2017, ALIMENT PHARM THER, V46, P246, DOI 10.1111/apt.14157; Costa Ricardo J S, 2020, Temperature (Austin), V7, P58, DOI 10.1080/23328940.2019.1597676; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Department of Health and Aged Care, 2021, COMM AUSTR AUSTR PHY; Draganidis D, 2016, J NUTR, V146, P1940, DOI 10.3945/jn.116.230912; Frontera WR, 2000, J APPL PHYSIOL, V88, P1321; Gaskell SK, 2021, MED SCI SPORT EXER, V53, P1056, DOI 10.1249/MSS.0000000000002546; Gaskell SK, 2020, APPL PHYSIOL NUTR ME, V45, P569, DOI 10.1139/apnm-2019-0187; Gill SK, 2015, INT J SPORTS MED, V36, P688, DOI 10.1055/s-0034-1398535; Gill SK, 2015, EXERC IMMUNOL REV, V21, P114; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Guerville M, 2016, AM J PHYSIOL-GASTR L, V311, pG1, DOI 10.1152/ajpgi.00098.2016; Hirose L, 2004, EXERC IMMUNOL REV, V10, P75; Huschtscha Z, 2021, SPORTS MED-OPEN, V7, DOI 10.1186/s40798-021-00323-9; Huschtscha Z, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.644865; Mohammad S, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.594150; Peake J, 2010, AM J PHYSIOL-REG I, V298, pR1485, DOI 10.1152/ajpregu.00467.2009; Phillips MD, 2010, MED SCI SPORT EXER, V42, P314, DOI 10.1249/MSS.0b013e3181b11ab7; Russo I, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.628863; Sardeli AV, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040423; Schaap LA, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2005.10.049; Selkirk GA, 2008, AM J PHYSIOL-REG I, V295, pR611, DOI 10.1152/ajpregu.00917.2007; Snipe RMJ, 2018, INT J SPORTS MED, V39, P255, DOI 10.1055/s-0043-122742; Snipe RMJ, 2018, EUR J APPL PHYSIOL, V118, P389, DOI 10.1007/s00421-017-3781-z; Snipe RMJ, 2017, APPL PHYSIOL NUTR ME, V42, P1283, DOI 10.1139/apnm-2017-0361; van Wijck K, 2013, AM J PHYSIOL-REG I, V304, pR356, DOI 10.1152/ajpregu.00294.2012; Visser M, 2002, J GERONTOL A-BIOL, V57, pM326, DOI 10.1093/gerona/57.5.M326; World Health Organization, GLOBAL RECOMMENDATIO	32	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274210	10.1371/journal.pone.0274210	http://dx.doi.org/10.1371/journal.pone.0274210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054131	Green Published, gold			2022-12-26	WOS:000892641400067
J	Godhe, M; Ponten, M; Nilsson, J; Kallings, LV; Andersson, EA				Godhe, Manne; Ponten, Marjan; Nilsson, Johnny; Kallings, Lena V.; Andersson, Eva A.			Reliability of the accelerometer to control the effects of physical activity in older adults	PLOS ONE			English	Article							REPLACING SEDENTARY TIME; HARMONIZED METAANALYSIS; ENERGY-EXPENDITURE; ACTIVITY PATTERNS; EXERCISE PROGRAM; SITTING TIME; FOLLOW-UP; BEHAVIOR; HEALTH; MORTALITY	Background Reliable physical activity measurements in community-dwelling older adults are important to determine effects of targeted health promotion interventions. Many exercise interventions aim to improve time spent sedentary (SED), in light-intensity-physical-activity (LPA) and moderate-to-vigorous-intensity-physical-activity (MVPA), since these parameters have independently proposed associations with health and longevity. However, many previous studies rely on self-reports which have lower validity compared to accelerometer measured physical activity patterns. In addition, separating intervention-effects from reactivity measurements requires sufficient test-retest reliability for accelerometer assessments, which is lacking in older adults. Objectives The study objective was to investigate the reliability of sensor-based PA-patterns in community-dwelling older adults. Furthermore, to investigate change over time of physical activity patterns and examine any compensatory-effect from the eight-week supervised exercise-intervention. Methods An exercise-group (n = 78, age-range:65-91yrs) performed two 1h-exercise sessions/week during eight-weeks. PA-pattern was assessed (using hip-worn accelerometers), twice before and once during the last-week of the intervention. A control-group (n = 43, age-range:65-88yrs) performed one pre-test and the end-test with no exercise-intervention. A dependent-t-test, mean-difference (95%-CI), limits-of-agreement and intraclass-correlation-coefficient-ICC were used between the two pre-tests. Repeated-measures-ANOVA were used to analyze any intervention-effects. Results The exercise-groups' two pre-tests showed generally no systematic change in any PA- or SED-parameter (ICC ranged 0.75-0.90). Compared to the control group, the exercise intervention significantly (time x group-interaction, p<0.05) increased total-PA-cpm (exercise-group/control-group +17%+47%) and MVPA-min/week (+41/-2min) and decreased %-of-wear-time for SED-total (-4.7%/-2.7%) and SED-bouts (-5.7%/-1.8%), and SED-bouts min/d (-46/-16min). At baseline level, no significant differences were found between the two groups for any parameter. Conclusions The current study presents a good test-retest-reliability of sensor-based-one-week-assessed-PA-pattern in older-adults. Participating in an 8-week supervised exercise intervention improved some physical activity and sedentary parameters compared to the control group. No compensatory-effect was noted in the intervention-group i.e., no decrease in any PA-parameter or increase in SED at End-test (in %-of-wear-time, min/day or total-PA).	[Godhe, Manne; Andersson, Eva A.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Godhe, Manne; Ponten, Marjan; Nilsson, Johnny; Kallings, Lena V.; Andersson, Eva A.] Swedish Sch Sport & Hlth Sci, Dept Phys Act & Hlth, Stockholm, Sweden; [Nilsson, Johnny; Andersson, Eva A.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden	Karolinska Institutet; Swedish School of Sport & Health Sciences; Karolinska Institutet	Godhe, M (corresponding author), Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.; Godhe, M (corresponding author), Swedish Sch Sport & Hlth Sci, Dept Phys Act & Hlth, Stockholm, Sweden.	manne.godhe@gih.se		Godhe, Manne/0000-0002-5574-4408				Aguilar-Farias N, 2014, J SCI MED SPORT, V17, P293, DOI 10.1016/j.jsams.2013.07.002; American College of Sports Medicine, 2009, Med Sci Sports Exerc, V41, P1510, DOI 10.1249/MSS.0b013e3181a0c95c; Aoyagi Y, 2013, ARCH GERONTOL GERIAT, V56, P327, DOI 10.1016/j.archger.2012.11.006; Arnardottir NY, 2013, AGE AGEING, V42, P222, DOI 10.1093/ageing/afs160; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Berkemeyer K, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-015-0316-z; Bull FC, 2020, BRIT J SPORT MED, V54, P1451, DOI 10.1136/bjsports-2020-102955; Buman MP, 2010, AM J EPIDEMIOL, V172, P1155, DOI 10.1093/aje/kwq249; Chau JY, 2015, BRIT J SPORT MED, V49, P737, DOI 10.1136/bjsports-2012-091974; Chin A Paw Marijke J M, 2006, BMC Geriatr, V6, P9; Cooper C, 2018, EXP GERONTOL, V112, P9, DOI 10.1016/j.exger.2018.08.002; Copeland JL, 2017, BRIT J SPORT MED, V51, P1539, DOI 10.1136/bjsports-2016-097210; Diniz TA, 2017, J AGING PHYS ACTIV, V25, P20, DOI 10.1123/japa.2015-0193; Dohrn IM, 2020, EUR REV AGING PHYS A, V17, DOI 10.1186/s11556-020-00241-x; Dohrn IM, 2018, J SCI MED SPORT, V21, P702, DOI 10.1016/j.jsams.2017.10.035; Dohrn IM, 2018, CLIN EPIDEMIOL, V10, P179, DOI 10.2147/CLEP.S151613; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Eckert KG, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1562-3; Ekblom O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131586; Ekblom-Bak E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126336; Ekelund U, 2020, BRIT J SPORT MED, V54, P1499, DOI 10.1136/bjsports-2020-103270; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Falck RS, 2016, BRIT J SPORT MED, V50, P464, DOI 10.1136/bjsports-2014-094413; Fanning J, 2016, Prev Med Rep, V3, P238, DOI 10.1016/j.pmedr.2016.03.005; Fehling PC, 1999, MED SCI SPORT EXER, V31, P171, DOI 10.1097/00005768-199901000-00026; French DP, 2014, ANN BEHAV MED, V48, P225, DOI 10.1007/s12160-014-9593-z; Gennuso KP, 2016, AGING CLIN EXP RES, V28, P943, DOI 10.1007/s40520-015-0386-4; Germano-Soares AH, 2018, ATHEROSCLEROSIS, V269, P211, DOI 10.1016/j.atherosclerosis.2018.01.009; Gibbs BB, 2017, J AGING HEALTH, V29, P247, DOI 10.1177/0898264316635564; GORAN MI, 1992, AM J PHYSIOL, V263, pE950, DOI 10.1152/ajpendo.1992.263.5.E950; Gorman E, 2014, EUR REV AGING PHYS A, V11, P35, DOI 10.1007/s11556-013-0132-x; Gothe NP, 2020, BEHAV SLEEP MED, V18, P797, DOI 10.1080/15402002.2019.1690493; Hagberg LA, 2006, SCAND J PUBLIC HEALT, V34, P641, DOI 10.1080/14034940600627853; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hagstromer M, 2010, AM J EPIDEMIOL, V171, P1055, DOI 10.1093/aje/kwq069; Hallgren M, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0810-1; Hart TL, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-62; Heesch KC, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0749-2; Hendelman D, 2000, MED SCI SPORT EXER, V32, pS442, DOI 10.1097/00005768-200009001-00002; Hislop JF, 2012, PEDIATR EXERC SCI, V24, P450, DOI 10.1123/pes.24.3.450; Huang YC, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-0715-z; Jefferis BJ, 2019, BRIT J SPORT MED, V53, P1013, DOI 10.1136/bjsports-2017-098733; Jefferis Barbara J, 2015, Br J Sports Med, V49, P1591, DOI 10.1136/bjsports-2014-093514; Jefferis BJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-382; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; Keadle SK, 2017, AM J PREV MED, V52, P541, DOI 10.1016/j.amepre.2016.11.010; Keadle SK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1210; Kelly Louise A, 2013, BMC Med Phys, V13, P5, DOI 10.1186/1756-6649-13-5; Kerr J, 2018, INT J BEHAV NUTR PHY, V15, DOI 10.1186/s12966-018-0658-4; Koolhaas CM, 2017, J AM MED DIR ASSOC, V18, P838, DOI 10.1016/j.jamda.2017.04.017; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lobo Alexandrina, 2010, Int J Family Med, V2010, P486097, DOI 10.1155/2010/486097; Loprinzi PD, 2015, AM J HEALTH PROMOT, V29, P277, DOI 10.4278/ajhp.130709-QUAN-354; MacRae PG, 1996, J AM GERIATR SOC, V44, P175, DOI 10.1111/j.1532-5415.1996.tb02435.x; Manas A, 2017, EUR J SPORT SCI, V17, P940, DOI 10.1080/17461391.2017.1327983; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; Meijer EP, 1999, EUR J APPL PHYSIOL O, V80, P16, DOI 10.1007/s004210050552; Migueles JH, 2017, SPORTS MED, V47, P1821, DOI 10.1007/s40279-017-0716-0; Morio B, 1998, BRIT J NUTR, V80, P511, DOI 10.1017/S0007114598001603; Nicklas BJ, 2016, J GERONTOL A-BIOL, V71, P1437, DOI 10.1093/gerona/glw131; Nicklas BJ, 2014, OBESITY, V22, P1406, DOI 10.1002/oby.20732; Nilsson A, 2018, MED SCI SPORT EXER, V50, P1502, DOI 10.1249/MSS.0000000000001582; Nilsson A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175496; Opdenacker J, 2008, PREV MED, V46, P518, DOI 10.1016/j.ypmed.2008.02.017; Peeters GMEE, 2018, J SCI MED SPORT, V21, P604, DOI 10.1016/j.jsams.2017.10.022; Piercy KL, 2018, JAMA-J AM MED ASSOC, V320, P2020, DOI 10.1001/jama.2018.14854; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Powell KE, 2019, J PHYS ACT HEALTH, V16, P1, DOI 10.1123/jpah.2018-0618; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Rava A, 2018, EXP GERONTOL, V110, P209, DOI 10.1016/j.exger.2018.06.005; Rosenberg DE, 2015, HEALTH EDUC BEHAV, V42, P669, DOI 10.1177/1090198115577378; Rossen J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181053; Saint-Maurice PF, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.007678; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Sasaki JE, 2018, J SPORT SCI, V36, P1572, DOI 10.1080/02640414.2017.1403527; Schmid D, 2016, MED SCI SPORT EXER, V48, P1312, DOI 10.1249/MSS.0000000000000913; Skelton DA HJ., 2017, SEDENTARY BEHAV EPID; Strath SJ, 2005, MED SCI SPORT EXER, V37, pS563, DOI 10.1249/01.mss.0000185650.68232.3f; Sung K, 2012, NURS HEALTH SCI, V14, P438, DOI 10.1111/j.1442-2018.2012.00690.x; Thompson WG, 2014, ARCH GERONTOL GERIAT, V58, P314, DOI 10.1016/j.archger.2014.01.004; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Towne SD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198239; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Wanigatunga AA, 2017, MED SCI SPORT EXER, V49, P2167, DOI 10.1249/MSS.0000000000001340; Westerterp K R, 2000, Curr Opin Clin Nutr Metab Care, V3, P485, DOI 10.1097/00075197-200011000-00011; Witham MD, 2005, AM J CARDIOL, V95, P1120, DOI 10.1016/j.amjcard.2005.01.031; World Health Organization, 2021, PHYS ACTIVITY	88	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274442	10.1371/journal.pone.0274442	http://dx.doi.org/10.1371/journal.pone.0274442			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095032	Green Published			2022-12-26	WOS:000892376500041
J	Green, YS; dos Santos, MCF; Fuja, D; Reichert, E; Campos, AR; Cowman, SJ; Pilarte, KA; Kohan, J; Tripp, SR; Leibold, EA; Sirohi, D; Agarwal, N; Liu, XH; Koh, MY				Green, Yangsook Song; dos Santos, Maria C. Ferreira; Fuja, Daniel; Reichert, Ethan; Campos, Alexandre R.; Cowman, Sophie J.; Pilarte, Karen Acuna; Kohan, Jessica; Tripp, Sheryl R.; Leibold, Elizabeth A.; Sirohi, Deepika; Agarwal, Neeraj; Liu, Xiaohui; Koh, Mei Yee			ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma	ONCOGENE			English	Article							OXIDATIVE-PHOSPHORYLATION; TUMOR ANGIOGENESIS; HYPOXIA; HIF-2-ALPHA; PROTEIN; HIF2-ALPHA; LIGASE; DEGRADATION; HIF-1-ALPHA; BIOGENESIS	Clear cell renal cell carcinoma (ccRCC), the most common form of kidney cancer, is typically initiated by inactivation of the von Hippel Lindau (VHL) gene, which results in the constitutive activation of the hypoxia inducible factors, HIF-1 alpha and HIF-2 alpha. Using a high throughput screen, we identify novel compounds that decrease HIF-1/2 alpha levels and induce ferroptosis by targeting Iron Sulfur Cluster Assembly 2 (ISCA2), a component of the late mitochondrial Iron Sulfur Cluster (L-ISC) assembly complex. ISCA2 inhibition either pharmacologically or using siRNA decreases HIF-2 alpha protein levels by blocking iron-responsive element (IRE)-dependent translation, and at higher concentrations, also decreases HIF-1 alpha translation through unknown mechanisms. Additionally, ISCA2 inhibition triggers the iron starvation response, resulting in iron/metals overload and death via ferroptosis. ISCA2 levels are decreased in ccRCC compared to normal kidney, and decreased ISCA2 levels are associated with pVHL loss and with sensitivity to ferroptosis induced by ISCA2 inhibition. Strikingly, pharmacological inhibition of ISCA2 using an orally available ISCA2 inhibitor significantly reduced ccRCC xenograft growth in vivo, decreased HIF-alpha levels and increased lipid peroxidation, suggesting increased ferroptosis in vivo. Thus, the targeting of ISCA2 may be a promising therapeutic strategy to inhibit HIF-1/2 alpha and to induce ferroptosis in pVHL deficient cells.	[Green, Yangsook Song; Fuja, Daniel; Reichert, Ethan; Cowman, Sophie J.; Pilarte, Karen Acuna; Leibold, Elizabeth A.; Koh, Mei Yee] Univ Utah, Salt Lake City, UT 84112 USA; [dos Santos, Maria C. Ferreira; Liu, Xiaohui; Koh, Mei Yee] Kuda Therapeut Inc, Salt Lake City, UT 84103 USA; [Campos, Alexandre R.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA; [Kohan, Jessica; Tripp, Sheryl R.; Sirohi, Deepika] ARUP Inst Clin & Expt Pathol, Salt Lake City, UT 84108 USA; [Sirohi, Deepika; Agarwal, Neeraj; Koh, Mei Yee] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Sanford Burnham Prebys Medical Discovery Institute; Utah System of Higher Education; University of Utah; ARUP Laboratories; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Koh, MY (corresponding author), Univ Utah, Salt Lake City, UT 84112 USA.; Koh, MY (corresponding author), Kuda Therapeut Inc, Salt Lake City, UT 84103 USA.; Koh, MY (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	mei.koh@utah.edu	M, Y/HHS-8019-2022	Green, Yangsook/0000-0003-3620-0971	NIH [R03DA033980, CA181106, CA217905, R43 CA217385-A1]; Dod KCRP grant [KC190022]; NIH Hematology Training Program Grant [T32DK007115]; Huntsman Cancer Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dod KCRP grant; NIH Hematology Training Program Grant; Huntsman Cancer Foundation	This work was supported by NIH grants R03DA033980, CA181106 and CA217905 and Dod KCRP grant KC190022 to MYK, NIH grant R43 CA217385-A1 to XL, and NIH Hematology Training Program Grant T32DK007115 to DF. We acknowledge financial support by the Huntsman Cancer Foundation. Research reported in this publication utilized the Preclinical Research Shared Resource at Huntsman Cancer Institute at the University of Utah. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	An WG, 1998, NATURE, V392, P405, DOI 10.1038/32925; Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; [Anonymous], ONCOGENE; Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Beilschmidt LK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15124; Bertout JA, 2009, P NATL ACAD SCI USA, V106, P14391, DOI 10.1073/pnas.0907357106; Biederbick A, 2006, MOL CELL BIOL, V26, P5675, DOI 10.1128/MCB.00112-06; Brancaccio D, 2014, J AM CHEM SOC, V136, P16240, DOI 10.1021/ja507822j; Briston T, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00388; Bussolati B, 2013, CANCER LETT, V338, P141, DOI 10.1016/j.canlet.2012.05.007; Chen X, 2021, NAT REV CLIN ONCOL, V18, P280, DOI 10.1038/s41571-020-00462-0; Choi H, 2010, CANCER RES, V70, P10101, DOI 10.1158/0008-5472.CAN-10-0505; Choueiri TK, 2021, NAT MED, V27, P802, DOI 10.1038/s41591-021-01324-7; Conrad M, 2016, NAT REV DRUG DISCOV, V15, P348, DOI 10.1038/nrd.2015.6; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Cowman SJ, 2022, TRENDS CANCER, V8, P28, DOI 10.1016/j.trecan.2021.10.004; Cowman SJ, 2020, CLIN CANCER RES, V26, P4970, DOI 10.1158/1078-0432.CCR-19-3890; De Leon JAD, 2020, JOVE-J VIS EXP, DOI 10.3791/61122; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dowd AA, 2014, AFR J UROL, V20, P25, DOI 10.1016/j.afju.2013.11.001; Du WN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01965-8; Gelling C, 2008, MOL CELL BIOL, V28, P1851, DOI 10.1128/MCB.01963-07; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gourdoupis S, 2018, J AM CHEM SOC, V140, P14401, DOI 10.1021/jacs.8b09061; Grange C, 2011, CANCER RES, V71, P5346, DOI 10.1158/0008-5472.CAN-11-0241; Gruber M, 2007, P NATL ACAD SCI USA, V104, P2301, DOI 10.1073/pnas.0608382104; Gudas LJ, 2014, J MOL MED, V92, P825, DOI 10.1007/s00109-014-1180-z; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hervouet E, 2005, CARCINOGENESIS, V26, P531, DOI 10.1093/carcin/bgi001; Hervouet E, 2008, CARCINOGENESIS, V29, P1528, DOI 10.1093/carcin/bgn125; HIRLING H, 1994, EMBO J, V13, P453, DOI 10.1002/j.1460-2075.1994.tb06280.x; Hoefflin R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17873-3; Hu CL, 2019, J NEUROCHEM, V148, P426, DOI 10.1111/jnc.14604; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Kapitsinou PP, 2010, BLOOD, V116, P3039, DOI 10.1182/blood-2010-02-270322; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Koh MY, 2015, CANCER RES, V75, P316, DOI 10.1158/0008-5472.CAN-13-2190; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Koh MY, 2011, CANCER RES, V71, P4015, DOI 10.1158/0008-5472.CAN-10-4142; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Kumar T, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00227; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lill R, 2020, ANNU REV BIOCHEM, V89, P471, DOI 10.1146/annurev-biochem-013118-111540; Lomenick Brett, 2011, Curr Protoc Chem Biol, V3, P163; Mastrogiannaki M, 2013, BLOOD, V122, P885, DOI 10.1182/blood-2012-11-427765; Micucci C, 2015, BRIT J CANCER, V113, P1178, DOI 10.1038/bjc.2015.338; Miess H, 2018, ONCOGENE, V37, P5435, DOI 10.1038/s41388-018-0315-z; Moore LE, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002312; Mou YH, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0720-y; Muhlenhoff U, 2011, J BIOL CHEM, V286, P41205, DOI 10.1074/jbc.M111.296152; Nasta V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55313-5; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; PaineMurrieta GD, 1997, CANCER CHEMOTH PHARM, V40, P209, DOI 10.1007/s002800050648; Pap EHW, 1999, FEBS LETT, V453, P278, DOI 10.1016/S0014-5793(99)00696-1; Paul VD, 2015, BBA-MOL CELL RES, V1853, P1528, DOI 10.1016/j.bbamcr.2014.12.018; Rankin EB, 2007, J CLIN INVEST, V117, P1068, DOI 10.1172/JCI30117; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Ravi R, 2000, GENE DEV, V14, P34; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schneider M, 2010, NEOPLASIA, V12, P254, DOI 10.1593/neo.91782; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Sheftel AD, 2012, MOL BIOL CELL, V23, P1157, DOI 10.1091/mbc.E11-09-0772; Society AC, SURV RAT KIDN CANC; Terzi EM, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abg4302; Vanharanta S, 2013, NAT MED, V19, P50, DOI 10.1038/nm.3029; Wada K, 2005, FEBS LETT, V579, P6543, DOI 10.1016/j.febslet.2005.10.046; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang J, 2005, BBA-MOL CELL RES, V1743, P79, DOI 10.1016/j.bbamcr.2004.08.011; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Yang D, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030275; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Zanello P, 2019, J STRUCT BIOL, V205, P103, DOI 10.1016/j.jsb.2019.01.003; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhang Y, 2019, CELL CHEM BIOL, V26, P623, DOI 10.1016/j.chembiol.2019.01.008; Zilka O, 2017, ACS CENTRAL SCI, V3, P232, DOI 10.1021/acscentsci.7b00028; Zimmer M, 2008, MOL CELL, V32, P838, DOI 10.1016/j.molcel.2008.12.004; Zou Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09277-9	80	0	0	6	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 14	2022	41	42					4709	4723		10.1038/s41388-022-02460-1	http://dx.doi.org/10.1038/s41388-022-02460-1		SEP 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5I4GP	36097192	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000852927100002
J	Konlaan, Y; Sakyi, SA; Asare, KK; Barnie, PA; Opoku, S; Nakotey, GK; Nuvor, SV; Amoani, B				Konlaan, Yatik; Sakyi, Samuel Asamoah; Asare, Kwame Kumi; Barnie, Prince Amoah; Opoku, Stephen; Nakotey, Gideon Kwesi; Nuvor, Samuel Victor; Amoani, Benjamin			Evaluating immunohaematological profile among COVID-19 active infection and recovered patients in Ghana	PLOS ONE			English	Article							IL-10 PRODUCTION; DENDRITIC CELLS; ANTIGEN; MACROPHAGES; EXPRESSION; BASOPHILS; SIGNALS; TNF	Introduction The rapid spread of COVID-19 has been a global public health problem and it is yet to be put under control. Active COVID-19 is associated with unrestrained secretion of pro-inflammatory cytokines and imbalances in haematological profile including anaemia, leukocytosis and thrombocytopaenia. However, the haematological profile and immune status following recovery from COVID-19 has not been recognized. We evaluated the immunohaematological profile among COVID-19 patients with active infection, recovered cases and unexposed healthy individuals in the Ashanti region of Ghana. Methodology A total of 95 adult participants, consisting of 35 positive, 30 recovered and 30 unexposed COVID-19 negative individuals confirmed by RT-PCR were recruited for the study. All the patients had the complete blood count performed using the haematological analyzer Sysmex XN-1500. Their plasma cytokine levels of interleukin (IL)-1 beta, IL-6, IL-10, IL-17, tumour necrosis factor-alpha (TNF-alpha) and interferon gamma (IFN-gamma) were analysed using ELISA. Statistical analyses were performed on R statistical software. Result The Patients with COVID-19 active infection had significantly higher levels of ILI 0 (181 +/- 6.14 pg/mL vs 155.00 +/- 14.32 pg/mL vs 158.80 +/- 11.70 pg/mL, p = 0.038), WBC count (5.5 +/- 0.4 x10(9)/L vs 4.5 +/- 0.6 x10(9)/L vs 3.8 +/- 0.5, p < 0.0001) and percentage basophil (1.8 +/- 0.1% vs 0.8 +/- 0.3% vs 0.7 +/- 0.2%, p =0.0040) but significantly lower levels of IFN-gamma (110.10 +/- 9.52 pg/mL vs 142.80 +/- 5.46 pg/mL vs 140.80 +/- 6.39 pg/mL, p = 0.021), haematocrit (24.1 +/- 3.7% vs 38.3 +/- 3.0% vs 38.5 +/- 2.2%, p < 0.0001), haemoglobin concentration (9.4 +/- 0.1g/dl vs 12.5 +/- 5.0g/dl vs 12.7 +/- 0.8, p< 0.0001) and MPV (9.8 +/- 0.2fL vs 11.1 +/- 0.5fL vs 11.6 +/- 0.3fL, p< 0.0001) compared to recovered and unexposed controls respectively. There were significant association between IL-1 beta & neutrophils (r= 0.42, p<0.05), IL-10 & WBC (r= 0.39, p<0.05), IL-10 & Basophils (r= -0.51, p<0.01), IL-17 & Neutrophil (r= 0.39, p<0.05) in the active COVID-19 cases. Conclusion COVID-19 active infection is associated with increased IL-10 and WBC with a concomitant decrease in IFN-gamma and haemoglobin concentration. However, recovery from the disease is associated with immune recovery with appareantly normal haematological profile.	[Konlaan, Yatik; Nuvor, Samuel Victor] Univ Cape Coast, Dept Microbiol & Immunol, Sch Med Sci, Coll Hlth & Allied Sci, Cape Coast, Ghana; [Sakyi, Samuel Asamoah; Opoku, Stephen] Kwame Nkrumah Univ Sci & Technol, Sch Med & Dent, Dept Mol Med, Kumasi, Ghana; [Asare, Kwame Kumi; Nakotey, Gideon Kwesi; Amoani, Benjamin] Univ Cape Coast, Sch Allied Hlth Sci, Dept Biomed Sci, Coll Hlth & Allied Sci, Cape Coast, Ghana; [Barnie, Prince Amoah] Univ Cape Coast, Sch Biol Sci, Dept Forens Sci, Coll Agr & Nat Sci, Cape Coast, Ghana	University of Cape Coast; Kwame Nkrumah University Science & Technology; University of Cape Coast; University of Cape Coast	Amoani, B (corresponding author), Univ Cape Coast, Sch Allied Hlth Sci, Dept Biomed Sci, Coll Hlth & Allied Sci, Cape Coast, Ghana.	bamoani@ucc.edu.gh		Opoku, Stephen/0000-0002-1949-2338; Amoani, Benjamin/0000-0002-4086-3033				Ackermann M, 2021, CELL DEATH DIFFER, V28, P3125, DOI 10.1038/s41418-021-00805-z; Akbari H, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118167; Alcock J, 2021, EVOL MED PUBLIC HLTH, V9, P83, DOI 10.1093/emph/eoab005; Andrade EB, 2013, J IMMUNOL, V191, P4759, DOI 10.4049/jimmunol.1301752; Apel F, 2018, NAT REV RHEUMATOL, V14, P467, DOI 10.1038/s41584-018-0039-z; Bell R, 2021, INT J LAB HEMATOL, V43, P148, DOI 10.1111/ijlh.13381; Bosmuller H, 2020, VIRCHOWS ARCH, V477, P349, DOI 10.1007/s00428-020-02881-x; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Chen CC, 1996, CYTOKINE, V8, P58, DOI 10.1006/cyto.1995.0008; Christie A, 2021, MMWR-MORBID MORTAL W, V70, P858, DOI 10.15585/mmwr.mm7023e2externalicon; Cohen Y., 2008, STAT DATA R APPL APP, DOI 10.1002/9780470721896; Copaescu A, 2020, J ALLERGY CLIN IMMUN, V146, P518, DOI 10.1016/j.jaci.2020.07.001; Courrol LC, 2021, PHOTODIAGN PHOTODYN, V34, DOI 10.1016/j.pdpdt.2021.102324; Criado PR, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14068; Djakpo DK, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20200817; Fara A, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200160; Fox TA, 2020, BRIT J HAEMATOL, V191, P194, DOI 10.1111/bjh.17027; Gao YM, 2021, J INTERN MED, V289, P147, DOI 10.1111/joim.13144; Gomez-Rial J, 2020, CLIN IMMUNOL, V216, DOI 10.1016/j.clim.2020.108442; Han H, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00922-20; Hasichaolu, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7570981; Henry BM, 2020, CLIN CHEM LAB MED, V58, P1021, DOI 10.1515/cclm-2020-0369; Jafarzadeh A, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118102; Jovanovic DV, 1998, J IMMUNOL, V160, P3513; Khartabil TA, 2020, CRIT REV CL LAB SCI, V57, P415, DOI 10.1080/10408363.2020.1774736; Kim S, 2009, J IMMUNOL, V183, P3033, DOI 10.4049/jimmunol.0900332; Lebeau G, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165932; Lechuga GC, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22169035; Li DP, 2012, J EXP MED, V209, P109, DOI 10.1084/jem.20110399; Li LQ, 2010, J IMMUNOL, V185, P4148, DOI 10.4049/jimmunol.1001536; Lin S, 2021, J CLIN LAB ANAL, V35, DOI 10.1002/jcla.23604; Lindner HA, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.602130; Liu ZZ, 2013, EUR J IMMUNOL, V43, P468, DOI 10.1002/eji.201242930; Ma Xiaojing, 2015, F1000Res, V4, DOI 10.12688/f1000research.7010.1; Maddur MS, 2010, TRENDS IMMUNOL, V31, P45, DOI 10.1016/j.it.2009.12.004; Mirzaei R, 2020, MOL BIOL REP, V47, P5365, DOI 10.1007/s11033-020-05621-1; Mishra KP, 2021, NEUROIMMUNOMODULAT, V27, P80, DOI 10.1159/000513198; Mohanty SK, 2020, DIAGN PATHOL, V15, DOI 10.1186/s13000-020-01017-8; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Neumann J, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1204; Niesler U, 2014, SHOCK, V42, P3, DOI 10.1097/SHK.0000000000000167; Pan YB, 2020, CLIN TRANSL MED, V10, P161, DOI 10.1002/ctm2.23; Pandey SK, 2020, INDIAN J OPHTHALMOL, V68, P939, DOI 10.4103/ijo.IJO_754_20; Paradiso AV, 2020, J MED INTERNET RES, V22, DOI 10.2196/19152; Pedersen SF, 2020, J CLIN INVEST, V130, P2202, DOI 10.1172/JCI137647; Ponti G, 2020, CRIT REV CL LAB SCI, V57, P389, DOI 10.1080/10408363.2020.1770685; Pozdnyakova O, 2021, AM J CLIN PATHOL, V155, P364, DOI [10.1093/ajcp/aqaa231, 10.1093/AJCP/AQAA231]; Pressman E, 2020, WORLD NEUROSURG, V142, pE481, DOI 10.1016/j.wneu.2020.07.083; Quan C, 2021, CLIN MICROBIOL REV, V34, DOI 10.1128/CMR.00074-20; Robinson PC, 2020, MED-CAMBRIDGE, V1, P90, DOI 10.1016/j.medj.2020.11.005; Rodrigues Patricia R S, 2020, Oxf Open Immunol, V1, piqaa005, DOI 10.1093/oxfimm/iqaa005; Sabroe I, 2002, J IMMUNOL, V168, P4701, DOI 10.4049/jimmunol.168.9.4701; Sallenave JM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01229; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schoenrich Gunther, 2020, Advances in Biological Regulation, V77, P100741, DOI 10.1016/j.jbior.2020.100741; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Song JW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17240-2; Soy M, 2020, CLIN RHEUMATOL, V39, P2085, DOI 10.1007/s10067-020-05190-5; Sun SY, 2020, CLIN CHIM ACTA, V507, P174, DOI 10.1016/j.cca.2020.04.024; Sun YT, 2021, J PERS MED, V11, DOI 10.3390/jpm11030195; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Thwaites RS, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg9873; Trivedi A, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9010053; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Velavan TP, 2020, INT J INFECT DIS, V95, P304, DOI 10.1016/j.ijid.2020.04.061; Wang J, 2020, J LEUKOCYTE BIOL, V108, P17, DOI 10.1002/JLB.3COVR0520-272R; Wu YJ, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00362-20; Yang AP, 2020, INT IMMUNOPHARMACOL, V84, DOI 10.1016/j.intimp.2020.106504; Yang XB, 2020, J THROMB HAEMOST, V18, P1469, DOI 10.1111/jth.14848; Zhao MQ, 2006, AM J PHYSIOL-LUNG C, V291, pL1018, DOI 10.1152/ajplung.00086.2006; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3	71	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0273969	10.1371/journal.pone.0273969	http://dx.doi.org/10.1371/journal.pone.0273969			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094915	Green Published, gold			2022-12-26	WOS:000892376500025
J	Liu, J; Peng, R; Tan, Q; Li, BC; Chen, JY; Liu, GY; Wang, YW; Li, C; Li, J; Wang, H				Liu, Jing; Peng, Rui; Tan, Qian; Li, Bocun; Chen, Jianyi; Liu, Guangya; Wang, Yawen; Li, Chao; Li, Jia; Wang, Hua			Proteomic analysis of rat colonic mucosa following acupuncture treatment for irritable bowel syndrome with diarrhea	PLOS ONE			English	Article							SMALL-INTESTINE; STRESS; ELECTROACUPUNCTURE; DIAGNOSIS; IDENTIFICATION; STIMULATION; PREDOMINANT; MECHANISMS; GENE; IBS	To investigate the molecular pathological mechanisms of irritable bowel syndrome with diarrhea (IBS-D) and elucidate the effects of acupuncture on IBS-D colonic mucosa protein abundance in rats, a label-free high-throughput liquid chromatography-tandem mass spectrometry (LC-MS)-based proteomics analysis was used to survey the global changes of colonic mucosa proteins between different groups. Sixteen Sprague-Dawley (SD) male rats were randomly divided into four groups: the control group (C); the IBS-D model group (M); the syndrome differentiation acupuncture group (SD) and the traditional acupuncture group (T). IBS-D model rats were obtained using the CAS (chronic acute combining stress model) method. Comparative bioinformatics analysis of the proteomic data was analyzed using MaxQuant software, Perseus software, online tools DAVID, VENNY and STRING. Functional enrichment and network analyses revealed a close relationship between IBS-D and several biological processes including energy metabolism, muscular excitation/contraction, and both traditional acupuncture and syndrome differentiation acupuncture can reverse the impairments of normal energy metabolism. Moreover, the syndrome differentiation acupuncture can regulate the protein cluster relating inflammation, wound repair and cell protection against oxidative stress which is associated with acupuncture analgesic effect. Differentially expressed proteins Atp5a1 and Bpnt1 were selected as representative proteins and subjected to western blotting. In conclusion, our study provides further insight into the pathological and molecular mechanisms of IBS-D and acupuncture treatments, and serves as an experimental basis for clinical applications.	[Liu, Jing; Peng, Rui; Tan, Qian; Li, Bocun; Chen, Jianyi; Liu, Guangya; Wang, Yawen; Li, Chao; Li, Jia; Wang, Hua] Hubei Univ Chinese Med, Acupuncture Moxibust & Orthoped Coll, Wuhan, Hubei, Peoples R China	Hubei University of Chinese Medicine	Li, J; Wang, H (corresponding author), Hubei Univ Chinese Med, Acupuncture Moxibust & Orthoped Coll, Wuhan, Hubei, Peoples R China.	ljlijia@163.com; hwang.tcm@china.com		Li, Jia/0000-0003-0444-2263	Scientific Research Plan Program of Department of Education of Hubei Province [Q20202005]	Scientific Research Plan Program of Department of Education of Hubei Province	This research was funded by the Scientific Research Plan Program of Department of Education of Hubei Province, grant number: Q20202005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai MR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03355-0; Bai T, 2017, J GASTROEN HEPATOL, V32, P1018, DOI 10.1111/jgh.13642; Boltin D, 2014, BEST PRACT RES CL GA, V28, P981, DOI 10.1016/j.bpg.2014.09.001; Bonaz B, 2009, GASTROEN CLIN BIOL, V33, pS48, DOI 10.1016/S0399-8320(09)71525-8; Brzozowski B, 2016, CURR NEUROPHARMACOL, V14, P892, DOI 10.2174/1570159X14666160404124127; Chao GQ, 2014, WORLD J GASTROENTERO, V20, P1871, DOI 10.3748/wjg.v20.i7.1871; Chen JDDZ, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/138645; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deng WK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111988; Eisenberg DM, 1998, JAMA-J AM MED ASSOC, V280, P1569, DOI 10.1001/jama.280.18.1569; El-Salhy M, 2012, WORLD J GASTROENTERO, V18, P5151, DOI 10.3748/wjg.v18.i37.5151; Fischer SGL, 2013, INT J MOL SCI, V14, P7784, DOI 10.3390/ijms14047784; Fond G, 2014, EUR ARCH PSY CLIN N, V264, P651, DOI 10.1007/s00406-014-0502-z; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Goo YA, 2012, J PROTEOME RES, V11, P5650, DOI 10.1021/pr3004437; Ho RST, 2015, ADV INTEGR MED, V2, P143, DOI 10.1016/j.aimed.2016.02.004; Holtmann GJ, 2016, LANCET GASTROENTEROL, V1, P133, DOI 10.1016/S2468-1253(16)30023-1; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Iwa M, 2006, DIGEST DIS SCI, V51, P1493, DOI 10.1007/s10620-006-9083-7; Li H, 2015, WORLD J GASTROENTERO, V21, P8304, DOI 10.3748/wjg.v21.i27.8304; Li J, 2020, NEUROSCI LETT, V723, DOI 10.1016/j.neulet.2020.134865; Li S, 2016, J NEUROGASTROENTEROL, V22, P310, DOI 10.5056/jnm15082; [李晓洁 Li Xiaojie], 2020, [中国实验动物学报, Acta Laboratorium Animalis Scientia Sinica], V28, P593; Li YJ., 2017, J TRADITIONAL CHINES, V4, P39, DOI [10.1016/j.jtcms.2017.05.006, DOI 10.1016/J.JTCMS.2017.05.006]; MacPherson H, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-150; Manabe N, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01442.x; Manheimer E, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005111.pub3; Minowa T, 2000, ELECTROPHORESIS, V21, P1782; Pei LX, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010877; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Qin HY, 2014, WORLD J GASTROENTERO, V20, P14126, DOI 10.3748/wjg.v20.i39.14126; Ren Bin-Bin, 2012, Zhongguo Zhen Jiu, V32, P765; Shi Jun-Jie, 2013, Zhen Ci Yan Jiu, V38, P181; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Sun J LR., 2020, SHANGHAI J ACUP MOXI, V39, P456; Tai ZX FX, 2020, ACTA LAB ANIM SCI SI, V28; Thakur ER, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.13143; Tian FJ HX., 2013, CHINA J CHINESE MED, V01, P125; Tsigaridas A, 2018, J PROTEOMICS, V188, P167, DOI 10.1016/j.jprot.2017.07.019; WHITEHEAD WE, 1980, DIGEST DIS SCI, V25, P404, DOI 10.1007/BF01395503; Wu IXY, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284818820438; Xing JH, 2004, ALTERN THER HEALTH M, V10, P38; Yang ZB, 2006, WORLD J GASTROENTERO, V12, P5557, DOI 10.3748/wjg.v12.i34.5557; Yin CS, 2008, RES VET SCI, V84, P159, DOI 10.1016/j.rvsc.2007.04.004; Zhao JM, 2018, CHIN J INTEGR MED, V24, P328, DOI 10.1007/s11655-018-2838-0; Zheng S XJ, 2018, J CLIN ACUPUNCTURE M, V34, P66; Zivaljevic A, 2019, WORLD J TRAD CHINESE, V5, P181, DOI 10.4103/wjtcm.wjtcm_24_19; 张艳佶, 2020, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V31, P990	48	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0273853	10.1371/journal.pone.0273853	http://dx.doi.org/10.1371/journal.pone.0273853			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094925	Green Published, gold			2022-12-26	WOS:000892376500024
J	Chen, J; Li, L; Liu, TY; Fu, HF; Lai, YH; Lei, X; Xu, JF; Yu, JS; Xia, YJ; Zhang, TH; Yang, DJ; He, YL				Chen, Jian; Li, Lu; Liu, Tian-Yu; Fu, Hua-Feng; Lai, Yuan-Hui; Lei, Xiong; Xu, Jun-Fa; Yu, Ji-Shang; Xia, Yu-Jian; Zhang, Tian-Hao; Yang, Dong-Jie; He, Yu-Long			CPEB3 suppresses gastric cancer progression by inhibiting ADAR1-mediated RNA editing via localizing ADAR1 mRNA to P bodies	ONCOGENE			English	Article							BINDING PROTEINS; GENE-THERAPY; GROWTH; GW182	Deciphering the crosstalk between RNA-binding proteins and corresponding RNAs will provide a better understanding of gastric cancer (GC) progression. The comprehensive bioinformatics study identified cytoplasmic polyadenylation element-binding protein 3 (CPEB3) might play a vital role in GC progression. Then we found CPEB3 was downregulated in GC and correlated with prognosis. In addition, CPEB3 suppressed GC cell proliferation, invasion and migration in vitro, as well as tumor growth and metastasis in vivo. Mechanistic study demonstrated CPEB3 interacted with 3 '-UTR of ADAR1 mRNA through binding to CPEC nucleotide element, and then inhibited its translation by localizing it to processing bodies (P bodies), eventually leading to the suppression of ADAR1-mediated RNA editing. Microscale thermophoresis assay further revealed that the direct interaction between CPEB3 and GW182, the P-body's major component, was through the 440-698AA region of CPEB3 binding to the 403-860AA region of GW182. Finally, AAV9-CPEB3 was developed and administrated in mouse models to assess its potential value in gene therapy. We found AAV9-CPEB3 inhibited GC growth and metastasis. Besides, AAV9-CPEB3 induced hydropic degeneration in mouse liver, but did not cause kidney damage. These findings concluded that CPEB3 suppresses GC progression by inhibiting ADAR1-mediated RNA editing via localizing ADAR1 mRNA to P bodies.	[Chen, Jian; Fu, Hua-Feng; Yu, Ji-Shang; Xia, Yu-Jian; Zhang, Tian-Hao; Yang, Dong-Jie; He, Yu-Long] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Gastrointestinal Surg, Guangzhou, Guangdong, Peoples R China; [Li, Lu] Guangdong Med Univ, Sch Med Technol, Guangdong Prov Key Lab Med Mol Diagnost, Inst Lab Med,Dept Clin Microbiol Lab, Dongguan, Guangdong, Peoples R China; [Liu, Tian-Yu] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [Lai, Yuan-Hui] Sun Yat Sen Univ, Affiliated Hosp 1, Eastern Div, Dept Thyroid & Breast Surg, Guangzhou, Guangdong, Peoples R China; [Lei, Xiong] Nanchang Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, Nanchang, Jiangxi, Peoples R China; [Xu, Jun-Fa] Guangdong Med Univ, Sch Med Technol, Guangdong Prov Key Lab Med Mol Diagnost, Dept Clin Immunol,Inst Lab Med, Dongguan, Guangdong, Peoples R China; [He, Yu-Long] Sun Yat Sen Univ, Affiliated Hosp 7, Digest Med Ctr, Shenzhen, Guangdong, Peoples R China	Sun Yat Sen University; Guangdong Medical University; Sun Yat Sen University; Sun Yat Sen University; Nanchang University; Guangdong Medical University; Sun Yat Sen University	Yang, DJ; He, YL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Gastrointestinal Surg, Guangzhou, Guangdong, Peoples R China.; He, YL (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 7, Digest Med Ctr, Shenzhen, Guangdong, Peoples R China.	ydongj@mail.sysu.edu.cn; heyulong@mail.sysu.edu.cn		Chen, Jian/0000-0002-8515-1179	National Natural Science Foundation of China [81802599, 81772579]; Center for Gastrointestinal Surgery; First Affiliated Hospital of Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Gastrointestinal Surgery; First Affiliated Hospital of Sun Yat-sen University	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81802599, 81772579). We thank Prof. Zun-Fu Ke (Department of Pathology, the First Affiliated Hospital of Sun Yat-sen University) and his colleagues for the help of pathological diagnoses and guidance. We appreciate Department of Laboratory Medicine, the First Affiliated Hospital of Sun Yat-sen University for the help of urine and serum detection. We appreciate all supports from Center for Gastrointestinal Surgery, the First Affiliated Hospital of Sun Yat-sen University.	Brannan KW, 2021, NAT METHODS, V18, P507, DOI 10.1038/s41592-021-01128-0; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chan THM, 2016, GASTROENTEROLOGY, V151, P637, DOI 10.1053/j.gastro.2016.06.043; Chan THM, 2014, GUT, V63, P832, DOI 10.1136/gutjnl-2012-304037; Chen LL, 2013, NAT MED, V19, P209, DOI 10.1038/nm.3043; Chowdhury EA, 2021, ADV DRUG DELIVER REV, V170, P214, DOI 10.1016/j.addr.2021.01.017; Crews LA, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-014-0370-3; Ballesteros-Briones MC, 2019, MOL THER, V27, P1892, DOI 10.1016/j.ymthe.2019.09.016; D'Ambrogio A, 2013, NAT REV CANCER, V13, P283, DOI 10.1038/nrc3485; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Ford L, 2019, P NATL ACAD SCI USA, V116, P18078, DOI 10.1073/pnas.1815275116; Fritzell K, 2018, SEMIN CELL DEV BIOL, V79, P123, DOI 10.1016/j.semcdb.2017.11.018; Gebauer F, 2021, NAT REV GENET, V22, P185, DOI 10.1038/s41576-020-00302-y; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Han L, 2015, CANCER CELL, V28, DOI 10.1016/j.ccell.2015.08.013; Han SW, 2014, J EXP MED, V211, P613, DOI 10.1084/jem.20132209; Hentze MW, 2018, NAT REV MOL CELL BIO, V19, P327, DOI 10.1038/nrm.2017.130; Joshi Smita S, 2021, CA Cancer J Clin, V71, P264, DOI 10.3322/caac.21657; Kamiya A, 2019, NAT NEUROSCI, V22, P1289, DOI 10.1038/s41593-019-0430-3; Lee JE, 2020, SCIENCE, V367, P527, DOI 10.1126/science.aay7108; Li CW, 2020, NAT REV GENET, V21, P255, DOI 10.1038/s41576-019-0205-4; Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178; Luo NC, 2020, J BUON, V25, P2097; Mori Takuji, 2003, Gastric Cancer, V6 Suppl 1, P13, DOI 10.1007/s10120-003-0226-7; Okugawa Y, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1740-z; Paz-Yaacov N, 2015, CELL REP, V13, P267, DOI 10.1016/j.celrep.2015.08.080; Pereira B, 2017, TRENDS CANCER, V3, P506, DOI 10.1016/j.trecan.2017.05.003; Qin YR, 2014, CANCER RES, V74, P840, DOI 10.1158/0008-5472.CAN-13-2545; Ramirez-Moya J, 2020, ONCOGENE, V39, P3738, DOI 10.1038/s41388-020-1248-x; Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905; Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004; Shiromoto Y, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21921-x; Tan P, 2015, GASTROENTEROLOGY, V149, P1153, DOI 10.1053/j.gastro.2015.05.059; Wang D, 2019, NAT REV DRUG DISCOV, V18, P358, DOI 10.1038/s41573-019-0012-9; Wang E, 2019, CANCER CELL, V35, P369, DOI 10.1016/j.ccell.2019.01.010; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Watanabe M, 2005, HUM GENE THER, V16, P699, DOI 10.1089/hum.2005.16.699; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Wu XW, 2020, CELL DEATH DIFFER, V27, P55, DOI 10.1038/s41418-019-0339-0; Yang Z, 2004, J CELL SCI, V117, P5567, DOI 10.1242/jcs.01477; Yao F, 2015, CELL REP, V12, P272, DOI 10.1016/j.celrep.2015.06.020; Youn JY, 2019, MOL CELL, V76, P286, DOI 10.1016/j.molcel.2019.09.014; Zhang H, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02984-y; Zhang Y, 2008, LIFE SCI, V82, P1154, DOI 10.1016/j.lfs.2008.03.023; Zhao WC, 2019, CELL RES, V29, P895, DOI 10.1038/s41422-019-0229-5; Zhong Q, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01637-4; Zipeto MA, 2016, CELL STEM CELL, V19, P177, DOI 10.1016/j.stem.2016.05.004	47	0	0	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 7	2022	41	41					4591	4605		10.1038/s41388-022-02454-z	http://dx.doi.org/10.1038/s41388-022-02454-z		SEP 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5D7BH	36068334				2022-12-26	WOS:000850425100002
J	Ali, AHA; Serhan, OO; Alsharif, MHK; Elamin, AY; Al-Ghamdi, S; Aldossari, KK; Alrudian, N; Alajmi, M; Alhariqi, BA; Mokhatrish, M; Palanivel, V				Ali, Ali Hassan A.; Serhan, Omar O.; Alsharif, Mohammed H. Karrar; Elamin, Abubaker Y.; Al-Ghamdi, Sameer; Aldossari, Khaled K.; Alrudian, Naif; Alajmi, Mansour; Alhariqi, Bader A.; Mokhatrish, Mohammad; Palanivel, Velmurugan			Incidental detection of paranasal sinuses abnormalities on CT imaging of the head in Saudi adult population	PLOS ONE			English	Article								The paranasal sinuses are hollowed, air-filled cavities surrounding the nasal cavity. Many pathological processes affect the sinuses, but inflammatory conditions are the commonest, even in asymptomatic patients who undergo head imaging for other indications showing one or more abnormalities of the sinuses. Our research aims to determine the prevalence of incidental paranasal sinuses abnormalities seen among patients who undergo head CT scanning. In addition, it provides baseline information for further investigations required. The study was designed to evaluate all patients who underwent head CT scanning for any reason unrelated to paranasal sinuses abnormalities. 1849 cases were selected and retrospectively analyzed from the elective and emergency CT in the last nine months, from August 2020 to April 2021. In order to meet the inclusion criteria, indications for imaging must not be sinus-related. The study was conducted on 1849 cases who had undergone head CT scans for pathology, 1204 (65%) were male and 645 (35%) were female. Abnormalities of the sinuses were found in about 617 (33%) of all patients, with a higher rate in males (22.23%) than females (11.14%). In addition, these abnormalities were found in younger patients at a higher rate than in middle and old ages 19.74%, 7.19%, and 6.44%, respectively. Our findings revealed that the prevalence of paranasal sinuses abnormalities in asymptomatic Saudi patients was high (33%). Most of the affected sinuses were the maxillary. The male patients were more affected than females in all findings.	[Ali, Ali Hassan A.; Alsharif, Mohammed H. Karrar] Prince Sattam Bin Abdulaziz Univ, Dept Anat, Coll Med, Al Kharj, Saudi Arabia; [Ali, Ali Hassan A.] Al Azhar Univ, Dept Anat, Fac Med, Cairo, Egypt; [Serhan, Omar O.] King Khalid Hosp, Dept Radiol, Minist Hlth, Al Kharj, Saudi Arabia; [Alsharif, Mohammed H. Karrar; Elamin, Abubaker Y.] Ondukuz Mayis Univ, Histol Embryol Dept, Fac Med, Samsun, Turkey; [Al-Ghamdi, Sameer; Aldossari, Khaled K.; Alajmi, Mansour] Prince Sattam Bin Abdulaziz Univ, Family & Community Med Dept, Coll Med, Al Kharj, Saudi Arabia; [Alrudian, Naif] Prince Sattam Bin Abdulaziz Univ, Dept Family & Community Med, Coll Med, Al Kharj, Saudi Arabia; [Alhariqi, Bader A.] Prince Sattam Bin Abdulaziz Univ, Dept Radiol, Coll Med, Al Kharj, Saudi Arabia; [Mokhatrish, Mohammad] Prince Sattam Bin Abdulaziz Univ, Dept Surg, Coll Med, Al Kharj, Saudi Arabia; [Palanivel, Velmurugan] Ctr Mat Engn & Regenerat Med, Bharath Inst Higher Educ & Res, Chennai, Tamil Nadu, India	Prince Sattam Bin Abdulaziz University; Egyptian Knowledge Bank (EKB); Al Azhar University; King Khalid Hospital; King Saud University; King Khalid University Hospital; Ministry of Health - Saudi Arabia; Ondokuz Mayis University; Prince Sattam Bin Abdulaziz University; Prince Sattam Bin Abdulaziz University; Prince Sattam Bin Abdulaziz University; Prince Sattam Bin Abdulaziz University; Bharath Institute of Higher Education & Research	Al-Ghamdi, S (corresponding author), Prince Sattam Bin Abdulaziz Univ, Family & Community Med Dept, Coll Med, Al Kharj, Saudi Arabia.	sh.alghamdi@psau.edu.sa			Deanship of Scientific Research, Prince SattambinAbdulaziz University,AlKharj, Saudi Arabia; Deanship of Scientific Research [2020/03/17094]	Deanship of Scientific Research, Prince SattambinAbdulaziz University,AlKharj, Saudi Arabia; Deanship of Scientific Research	We thank the Deanship of Scientific Research, Prince SattambinAbdulaziz University,AlKharj, Saudi Arabia, for its support, and this work was funded by the Deanship of Scientific Research (Project No: 2020/03/17094).	Al-Zoubi IA, 2017, J HARD TISSUE BIOL, V26, P369, DOI 10.2485/jhtb.26.369; Ali AAH, 2021, MED SCI, V25, P1572; [Anonymous], 1997, J KOREAN RADIOLOGICA, V36, P195; Avsever H, 2018, ORAL RADIOL, V34, P40, DOI 10.1007/s11282-017-0283-y; Brant William E., 2007, FUNDAMENTALS DIAGNOS, V3rd; Chaitanya CS., 2015, INT J RECENT SCI RES, V6, P5081; FLINN J, 1994, CLIN OTOLARYNGOL, V19, P287, DOI 10.1111/j.1365-2273.1994.tb01232.x; Gordts F., 1996, Acta Oto-Rhino-Laryngologica Belgica, V50, P167; Gupta M.K., 2014, ASIAN J MED SCI, V5, P40; Hajian-Tilaki K, 2014, J BIOMED INFORM, V48, P193, DOI 10.1016/j.jbi.2014.02.013; Hiari M., 1998, E MEDITERR HEALTH J, V4; Hussein A.O., 2014, INT J SCI RES, V3, P7; Kristo A, 2003, ACTA PAEDIATR, V92, P34; Lim WK, 2003, J LARYNGOL OTOL, V117, P969, DOI 10.1258/002221503322683858; MALY PV, 1995, NEURORADIOLOGY, V37, P471, DOI 10.1007/BF00600097; Nazri M, 2013, QUANT IMAGING MED SU, V3, P82, DOI 10.3978/j.issn.2223-4292.2013.03.06; Patel K, 1996, J LARYNGOL OTOL, V110, P649, DOI 10.1017/S0022215100134516; Proctor DF, 2017, NASAL TUMORS ANIMALS, P1; Standring S., 2020, GRAYS ANATOMY E BOOK; Tarp B, 2000, RHINOLOGY, V38, P33	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0270764	10.1371/journal.pone.0270764	http://dx.doi.org/10.1371/journal.pone.0270764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054106	Green Published, gold			2022-12-26	WOS:000892641400006
J	Li, DM; Zhu, GF; Yu, B; Huang, D				Li, Dong-Mei; Zhu, Gen-Fa; Yu, Bo; Huang, Dan			Comparative chloroplast genomes and phylogenetic relationships of Aglaonema modestum and five variegated cultivars of Aglaonema	PLOS ONE			English	Article								Aglaonema, commonly called Chinese evergreens, are widely used for ornamental purposes. However, attempts to identify Aglaonema species and cultivars based on leaf morphology have been challenging. In the present study, chloroplast sequences were used to elucidate the phylogenetic relationships of cultivated Aglaonema in South China. The chloroplast genomes of one green species and five variegated cultivars of Aglaonema, Aglaonema modestum, 'Red Valentine', ,Lady Valentine', 'Hong Yan', 'Hong Jian', and 'Red Vein', were sequenced for comparative and phylogenetic analyses. The six chloroplast genomes of Aglaonema had typical quadripartite structures, comprising a large single copy (LSC) region (91,092-91,769 bp), a small single copy (SSC) region (20,816-26,501 bp), and a pair of inverted repeat (IR) regions (21,703-26,732 bp). The genomes contained 112 different genes, including 79-80 protein coding genes, 28-29 tRNAs and 4 rRNAs. The molecular structure, gene order, content, codon usage, long repeats, and simple sequence repeats (SSRs) were generally conserved among the six sequenced genomes, but the IR-SSC boundary regions were significantly different, and 'Red Vein' had a distinct long repeat number and type frequency. For comparative and phylogenetic analyses, Aglaonema costatum was included; it was obtained from the GenBank database. Single-nucleotide polymorphisms (SNPs) and insertions/deletions (indels) were determined among the seven Aglaonema genomes studied. Nine divergent hotspots were identified: trnH-GUG-CDS1_psbA, trnS-GCU_trnS-CGA-CDS1, rps4-trnT-UGU, trnF-GAA-ndhJ, petD-CDS2-rpoA, ycf1-ndhF, rps15-ycf1-D2, ccsA-ndhD, and trnY-GUA-trnE-UUC. Additionally, positive selection was found for rpl2, rps2, rps3, ycf1 and ycf2 based on the analyses of Ka/Ks ratios among 16 Ara-ceae chloroplast genomes. The phylogenetic tree based on whole chloroplast genomes strongly supported monophyletic Aglaonema and clear relationships among Aroideae, Lasioideae, Lemnoideae, Monsteroideae, Orontioideae, Pothoideae and Zamioculcadoideae in the family Araceae. By contrast, protein coding gene phylogenies were poorly to strongly supported and incongruent with the whole chloroplast genome phylogenetic tree. This study provided valuable genome resources and helped identify Aglaonema species and cultivars.	[Li, Dong-Mei; Zhu, Gen-Fa; Yu, Bo; Huang, Dan] Guangdong Acad Agr Sci, Environm Hort Res Inst, Guangdong Key Lab Ornamental Plant Germplasm, Guangzhou 510640, Peoples R China	Guangdong Academy of Agricultural Sciences	Li, DM; Zhu, GF (corresponding author), Guangdong Acad Agr Sci, Environm Hort Res Inst, Guangdong Key Lab Ornamental Plant Germplasm, Guangzhou 510640, Peoples R China.	biology.li2008@163.com; genfazhu@163.com		Li, Dong-Mei/0000-0002-4657-7062	Guangdong Basic and Applied Basic Foundation Project [2021A1515010893]; Special Financial Fund of Foshan-High-level Guangdong Agricultural Science and Technology Demonstration City Project; Guangdong Province Modern Agriculture Industry Technical System-Flower Innovation Team Construction Project [2021KJ121]	Guangdong Basic and Applied Basic Foundation Project; Special Financial Fund of Foshan-High-level Guangdong Agricultural Science and Technology Demonstration City Project; Guangdong Province Modern Agriculture Industry Technical System-Flower Innovation Team Construction Project	This research was financially supported by the Guangdong Basic and Applied Basic Foundation Project (No. 2021A1515010893), Special Financial Fund of Foshan-High-level Guangdong Agricultural Science and Technology Demonstration City Project (2022), and Guangdong Province Modern Agriculture Industry Technical System-Flower Innovation Team Construction Project (2021KJ121).	Abdullah, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.610838; Abdullah, 2020, J MOL EVOL, V88, P562, DOI 10.1007/s00239-020-09958-w; Abdullah, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9060737; Abdullah, 2020, GENOMICS, V112, P581, DOI 10.1016/j.ygeno.2019.04.010; Beier S, 2017, BIOINFORMATICS, V33, P2583, DOI 10.1093/bioinformatics/btx198; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen JJ, 2004, ANN BOT-LONDON, V93, P157, DOI 10.1093/aob/mch025; Choi KS, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110324; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Greiner S, 2019, NUCLEIC ACIDS RES, V47, pW59, DOI 10.1093/nar/gkz238; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; He SL, 2020, PEERJ, V8, DOI 10.7717/peerj.9132; Henny RJ, 2008, HORTSCIENCE, V43, P1598, DOI 10.21273/HORTSCI.43.5.1598; Henny RJ, 2010, HORTSCIENCE, V45, P1281, DOI 10.21273/HORTSCI.45.8.1281; Henny RJ, 2009, HORTSCIENCE, V44, P1767, DOI 10.21273/HORTSCI.44.6.1767; Henriquez CL, 2020, PLANTA, V251, DOI 10.1007/s00425-020-03365-7; Henriquez CL, 2020, GENOMICS, V112, P2349, DOI 10.1016/j.ygeno.2020.01.006; Henriquez CL, 2014, MOL PHYLOGENET EVOL, V75, P91, DOI 10.1016/j.ympev.2014.02.017; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kim SH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194678; Kress WJ, 2002, AM J BOT, V89, P1682, DOI 10.3732/ajb.89.10.1682; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Li BC, 2022, BMC GENOMICS, V23, DOI 10.1186/s12864-022-08400-3; Li DM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236590; Li Xi-wen, 2012, Yaoxue Xuebao, V47, P124; Liu EX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37456-z; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Marcais G, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005944; Nauheimer L, 2012, NEW PHYTOL, V195, P938, DOI 10.1111/j.1469-8137.2012.04220.x; NICOLSON D H, 1969, Smithsonian Contributions to Botany, P1; R Core Team, R LANG ENV STAT COMP; Rothwell GW, 2004, MOL PHYLOGENET EVOL, V30, P378, DOI 10.1016/S1055-7903(03)00205-7; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Rozewicki J, 2019, NUCLEIC ACIDS RES, V47, pW5, DOI 10.1093/nar/gkz342; Se-Al Rambaut A., SEQUENCE ALIGNMENT E; Silva SR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246130; Tian N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192956; Wang Dapeng, 2010, Genomics Proteomics & Bioinformatics, V8, P77, DOI 10.1016/S1672-0229(10)60008-3; Wang WQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024670; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wong KH, 2022, HORTICULTURAE, V8, DOI 10.3390/horticulturae8050453; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Zheng G, 2020, PLANT MOL BIOL, V102, P659, DOI 10.1007/s11103-020-00972-6; Zhu B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248556	47	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274067	10.1371/journal.pone.0274067	http://dx.doi.org/10.1371/journal.pone.0274067			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054201	gold, Green Published			2022-12-26	WOS:000892641400056
J	Ohmoto, M; Nakamura, S; Wang, H; Jiang, P; Hirota, J; Matsumoto, I				Ohmoto, Makoto; Nakamura, Shugo; Wang, Hong; Jiang, Peihua; Hirota, Junji; Matsumoto, Ichiro			Maintenance and turnover of Sox2(+) adult stem cells in the gustatory epithelium	PLOS ONE			English	Article							TASTE RECEPTOR-CELLS; STEM/PROGENITOR CELLS; BUD CELLS; LINEAGE; TRANSDUCTION; HOMEOSTASIS; LGR5	Continuous turnover of taste bud cells in the oral cavity underlies the homeostasis of taste tissues. Previous studies have demonstrated that Sox2(+) stem cells give rise to all types of epithelial cells including taste bud cells and non-gustatory epithelial cells in the oral epithelium, and Sox2 is required for generating taste bud cells. Here, we show the dynamism of single stem cells through multicolor lineage tracing analyses in Sox2-CreERT2; Rosa26-Confetti mice. In the non-gustatory epithelium, unicolored areas populated by a cluster of cells expressing the same fluorescent protein grew over time, while epithelial cells were randomly labeled with multiple fluorescent proteins by short-term tracing. Similar phenomena were observed in gustatory epithelia. These results suggest that the Sox2(+) stem cell population is maintained by balancing the increase of certain stem cells with the reduction of the others. In the gustatory epithelia, many single taste buds contained cells labeled with different fluorescent proteins, indicating that a single taste bud is composed of cells derived from multiple Sox2(+) stem cells. Our results reveal the characteristics of Sox2(+) stem cells underlying the turnover of taste bud cells and the homeostasis of taste tissues.	[Ohmoto, Makoto; Wang, Hong; Jiang, Peihua; Matsumoto, Ichiro] Monell Chem Senses Ctr, Philadelphia, PA USA; [Ohmoto, Makoto; Hirota, Junji] Tokyo Inst Technol, Grad Sch Life Sci & Technol, Dept Life Sci & Technol, Yokohama, Kanagawa, Japan; [Nakamura, Shugo] Toyo Univ, Fac Informat Networking Innovat & Design, INIAD, Tokyo, Japan; [Ohmoto, Makoto] Takasaki Univ Hlth & Welf, Fac Hlth & Welf, Dept Nutr, Takasaki, Gunma, Japan	Monell Chemical Senses Center; Tokyo Institute of Technology; Toyo University	Ohmoto, M; Matsumoto, I (corresponding author), Monell Chem Senses Ctr, Philadelphia, PA USA.; Ohmoto, M (corresponding author), Takasaki Univ Hlth & Welf, Fac Hlth & Welf, Dept Nutr, Takasaki, Gunma, Japan.	oumoto@takasaki-u.ac.jp; imatsumoto@monell.org			NIH/NIDCD [R01DC015491, R01DC013807]; NIH Core Grant [P30DC011735]; Lotte Shigemitsu Prize	NIH/NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIH Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lotte Shigemitsu Prize	This work was supported in part by NIH/NIDCD grants R01DC015491 (to I.M.) and R01DC013807 (to P.J.). We thank the Monell Genotyping and Histology and Cellular Localization Cores, supported by funding from NIH Core Grant P30DC011735 (to Robert F. Margolskee, Monell Chemical Senses Center), for facilities. M.O. was supported by the Lotte Shigemitsu Prize. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2011, CELL STEM CELL, V9, P317, DOI 10.1016/j.stem.2011.09.001; Barker N, 2012, CELL STEM CELL, V11, P452, DOI 10.1016/j.stem.2012.09.009; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Jones KB, 2019, CELL STEM CELL, V24, P183, DOI 10.1016/j.stem.2018.10.015; Jones KB, 2013, INT J ORAL SCI, V5, P121, DOI 10.1038/ijos.2013.46; Klein AM, 2011, DEVELOPMENT, V138, P3103, DOI 10.1242/dev.060103; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Matsumoto I, 2011, NAT NEUROSCI, V14, P685, DOI 10.1038/nn.2820; Miura H, 2014, DEV DYNAM, V243, P1286, DOI [10.1002/DVDY.24121, 10.1002/dvdy.24121]; Ohmoto M, 2008, MOL CELL NEUROSCI, V38, P505, DOI 10.1016/j.mcn.2008.04.011; Ohmoto M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240848; Ohmoto M, 2017, CHEM SENSES, V42, P547, DOI 10.1093/chemse/bjx032; Ohmoto M, 2011, J COMP NEUROL, V519, P1616, DOI 10.1002/cne.22589; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Perea-Martinez I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053399; Ren WW, 2014, P NATL ACAD SCI USA, V111, P16401, DOI 10.1073/pnas.1409064111; Shindo Y, 2008, BIOCHEM BIOPH RES CO, V376, P504, DOI 10.1016/j.bbrc.2008.09.035; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Stone LM, 2002, J NEUROSCI, V22, P4522, DOI 10.1523/JNEUROSCI.22-11-04522.2002; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916; Sullivan JM, 2010, EUR J NEUROSCI, V31, P1549, DOI 10.1111/j.1460-9568.2010.07184.x; Suzuki Y, 2008, CELL TISSUE RES, V332, P393, DOI 10.1007/s00441-008-0600-1; Takeda N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066314; Tanaka T, 2013, NAT CELL BIOL, V15, P511, DOI 10.1038/ncb2719; Vermeulen L, 2014, NAT REV CANCER, V14, P468, DOI 10.1038/nrc3744; Yee KK, 2013, STEM CELLS, V31, P992, DOI 10.1002/stem.1338	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0267683	10.1371/journal.pone.0267683	http://dx.doi.org/10.1371/journal.pone.0267683			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054203	gold, Green Published			2022-12-26	WOS:000892641400003
J	Gigolaev, AM; Lushpa, VA; Pinheiro-Junior, EL; Tabakmakher, VM; Peigneur, S; Ignatova, AA; Feofanov, AV; Efremov, RG; Mineev, KS; Tytgat, J; Vassilevski, AA				Gigolaev, Andrei M.; Lushpa, Vladislav A.; Pinheiro-Junior, Ernesto L.; Tabakmakher, Valentin M.; Peigneur, Steve; Ignatova, Anastasija A.; V. Feofanov, Alexey; Efremov, Roman G.; Mineev, Konstantin S.; Tytgat, Jan; Vassilevski, Alexander A.			Artificial pore blocker acts specifically on voltage-gated potassium channel isoform KV1.6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL HAIRPIN STRUCTURE; LACHESANA-TARABAEVI; K+ CHANNEL; PURIFICATION; PEPTIDE; TOXIN; EXPRESSION; INHIBITOR; SUBTYPES; SUBUNIT	Among voltage-gated potassium channel (KV) isoforms, KV1.6 is one of the most widespread in the nervous system. However, there are little data concerning its physiological significance, in part due to the scarcity of specific ligands. The known high-affinity ligands of KV1.6 lack selectivity, and conversely, its selective ligands show low affinity. Here, we present a designer peptide with both high affinity and selectivity to KV1.6. Previously, we have demonstrated that KV isoform-selective peptides can be constructed based on the simplistic alpha-hairpinin scaffold, and we obtained a number of artificial Tk-hefu peptides showing selective blockage of KV1.3 in the submicromolar range. We have now proposed amino acid substitutions to enhance their activity. As a result, we have been able to produce Tk-hefu-11 that shows an EC50 of .70 nM against KV1.3. Quite surprisingly, Tk-hefu-11 turns out to block KV1.6 with even higher potency, presenting an EC50 of .10 nM. Furthermore, we have solved the peptide structure and used molecular dynamics to investigate the determinants of selective interactions between artificial alpha-hairpinins and KV channels to explain the dramatic increase in KV1.6 affinity. Since KV1.3 is not highly expressed in the nervous system, we hope that Tk-hefu-11 will be useful in studies of KV1.6 and its functions.	[Gigolaev, Andrei M.; Lushpa, Vladislav A.; Tabakmakher, Valentin M.; Ignatova, Anastasija A.; V. Feofanov, Alexey; Efremov, Roman G.; Mineev, Konstantin S.; Vassilevski, Alexander A.] Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Lushpa, Vladislav A.; Mineev, Konstantin S.; Vassilevski, Alexander A.] State Univ, MoscowInstitute Phys & Technol, Moscow, Russia; [Pinheiro-Junior, Ernesto L.; Peigneur, Steve; Tytgat, Jan] Univ ofLeuven, Toxicol & Pharmacol, Leuven, Belgium; [Tabakmakher, Valentin M.] Far Eastern Fed Univ, Inst Life Sci & Biomed, Vladivostok, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Far Eastern Federal University	Vassilevski, AA (corresponding author), Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.; Vassilevski, AA (corresponding author), State Univ, MoscowInstitute Phys & Technol, Moscow, Russia.	avas@ibch.ru	Vassilevski, Alexander/S-3824-2016; Mineev, Konstantin S/Q-3948-2018; Pinheiro-Junior, Ernesto/I-9481-2014	Vassilevski, Alexander/0000-0002-1359-0076; Mineev, Konstantin S/0000-0002-2418-9421; Tabakmakher, Valentin/0000-0002-6588-1561; Pinheiro-Junior, Ernesto/0000-0001-6050-8285	Russian Science Foundation; FWO-Vlaanderen; KU Leuven;  [20-44-01015];  [GOA4919N];  [GOE7120N];  [GOC2319N];  [12W7822N];  [PDM/19/164]	Russian Science Foundation(Russian Science Foundation (RSF)); FWO-Vlaanderen(FWO); KU Leuven(KU Leuven); ; ; ; ; ; 	Funding This work was supported by the Russian Science Foundation (grant no. 20-44-01015 to A. A. V.) , FWO-Vlaanderen (grants GOA4919N, GOE7120N and GOC2319N to J. T. and 12W7822N to S. P.) , and KU Leuven (PDM/19/164 to S. P.) .	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Banerjee A, 2013, ELIFE, V2, DOI 10.7554/eLife.00594; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berkut AA, 2019, J BIOL CHEM, V294, P18349, DOI 10.1074/jbc.RA119.010494; Berkut AA, 2014, J BIOL CHEM, V289, P14331, DOI 10.1074/jbc.M113.530477; Boldrini-Franca J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61258-x; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carrisoza-Gaytan R, 2014, J MOL HISTOL, V45, P583, DOI 10.1007/s10735-014-9581-4; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Chugunov AO, 2016, SCI REP-UK, V6, DOI 10.1038/srep33112; Dodson PD, 2002, J NEUROSCI, V22, P6953; Efremenko AV, 2014, PHOTOCH PHOTOBIO SCI, V13, P92, DOI 10.1039/c3pp50226k; ElFessi-Magouri R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137611; Gasparian ME, 2003, PROTEIN EXPRES PURIF, V31, P133, DOI 10.1016/S1046-5928(03)00159-1; Gigolaev AM, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01010; Gunasekaran R, 2009, BRAIN RES, V1255, P170, DOI 10.1016/j.brainres.2008.11.099; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Imperial JS, 2006, BIOCHEMISTRY-US, V45, P8331, DOI 10.1021/bi060263r; Imperial JS, 2008, J BIOL CHEM, V283, P23026, DOI 10.1074/jbc.M800084200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kasheverov IE, 2019, FEBS LETT, V593, P2779, DOI 10.1002/1873-3468.13530; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kozlov SA, 2006, J BIOL CHEM, V281, P20983, DOI 10.1074/jbc.M602168200; Kudryavtsev DS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60768-y; Kuzmenkov AI, 2018, NEUROPHARMACOLOGY, V143, P228, DOI 10.1016/j.neuropharm.2018.09.030; Kuzmenkov AI, 2016, BIOCHEM J, V473, P2495, DOI 10.1042/BCJ20160436; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Lyukmanova EN, 2015, J BIOL CHEM, V290, P23616, DOI 10.1074/jbc.M115.656595; Manicam C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20322; McCoy J, 2001, Curr Protoc Mol Biol, VChapter 16, DOI 10.1002/0471142727.mb1608s28; Nolde SB, 2011, J BIOL CHEM, V286, P25145, DOI 10.1074/jbc.M110.200378; Oparin PB, 2012, BIOCHEM J, V446, P69, DOI 10.1042/BJ20120548; Orts DJB, 2018, MAR DRUGS, V16, DOI 10.3390/md16100360; Orts DJB, 2013, MAR DRUGS, V11, P655, DOI 10.3390/md11030655; Pyrkov TV, 2007, INT J MOL SCI, V8, P1083, DOI 10.3390/i8111083; Pyrkov TV, 2009, BIOINFORMATICS, V25, P1201, DOI 10.1093/bioinformatics/btp111; Shamotienko OG, 1997, BIOCHEMISTRY-US, V36, P8195, DOI 10.1021/bi970237g; Srinivasan KN, 2002, J BIOL CHEM, V277, P30040, DOI 10.1074/jbc.M111258200; Swartz KJ, 1997, NEURON, V18, P665, DOI 10.1016/S0896-6273(00)80306-2; Tabakmakher VM, 2021, J EVOL BIOCHEM PHYS+, V57, P386, DOI 10.1134/S0022093021020186; Tabakmakher VM, 2021, BIOPHYS J, V120, P2471, DOI 10.1016/j.bpj.2021.04.020; Tao H, 2013, BIOCHEMISTRY-US, V52, P7439, DOI 10.1021/bi4006418; Vandendriessche T, 2012, BIOCHEM PHARMACOL, V83, P1307, DOI 10.1016/j.bcp.2012.01.021; Vassilevski AA, 2010, METHODS MOL BIOL, V615, P87, DOI 10.1007/978-1-60761-535-4_7; Vorontsova OV, 2011, BIOCHIMIE, V93, P227, DOI 10.1016/j.biochi.2010.09.016; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021	48	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102467	10.1016/j.jbc.2022.102467	http://dx.doi.org/10.1016/j.jbc.2022.102467			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C7OU	36087839	Green Published, gold			2022-12-26	WOS:000882199400012
J	Hsieh, YC; Wu, PS; Lin, YT; Huang, YH; Hou, MC; Lee, KC; Lin, HC				Hsieh, Yun-Cheng; Wu, Pei-Shan; Lin, Yi-Tsung; Huang, Yi-Hsiang; Hou, Ming-Chih; Lee, Kuei-Chuan; Lin, Han-Chieh			(Pro)renin receptor inhibition attenuated liver steatosis, inflammation, and fibrosis in mice with steatohepatitis	FASEB JOURNAL			English	Article						chronic liver injury; gene silencing; handle region peptide; lipid metabolism; nonalcoholic fatty liver disease	FATTY LIVER; NONPROTEOLYTIC ACTIVATION; HEPATIC STEATOSIS; LIPID-METABOLISM; HANDLE REGION; DECOY PEPTIDE; PRORENIN; MODEL; PHOSPHATIDYLCHOLINE; GLOMERULOSCLEROSIS	The (Pro)renin receptor (PRR) is reportedly involved in hepatic lipid metabolism and hepatocyte PRR knockdown protects mice against hepatosteatosis. However, the impact of PRR inhibition on liver inflammation and fibrosis in nonalcoholic steatohepatitis (NASH) remains unclear. Herein, C57BL/6 mice were fed a normal chow diet or fast food diet (FFD) for 24 weeks. Lentivirus-mediated PRR short hairpin RNA (shRNA) or handle region peptide (HRP), a PRR blocker, was administered for PRR inhibition. Mouse primary hepatocytes were cultured with palmitic acid, prorenin, siRNA-targeted PRR, and HRP. In FFD-fed mice, PRR inhibition via lentivirus-mediated PRR knockdown or HRP significantly attenuated liver steatosis, inflammation, and fibrosis. Mechanistically, PRR knockdown or HRP decreased hepatic acetyl-CoA carboxylase (ACC) abundance and upregulated peroxisome proliferator-activated receptor-alpha (PPAR alpha). HRP treatment also decreased hepatic PRR expression. In addition, intrahepatic oxidative stress, apoptosis and inflammatory cell recruitment were ameliorated by PRR knockdown or HRP treatment, along with suppression of proinflammatory cytokine expression. PRR inhibition downregulated the hepatic expression of profibrotic factors, as well as TGF-beta 1/SMAD3 pathway. In primary mouse hepatocytes, PRR knockdown with siRNA or HRP downregulated cellular ACC and increased PPAR alpha expression. In conclusion, our findings revealed that PRR inhibition attenuated hepatic steatosis, inflammation, and fibrosis in mice with NASH. Accordingly, targeting PRR signaling may serve as a potential treatment for NASH.	[Hsieh, Yun-Cheng; Huang, Yi-Hsiang; Hou, Ming-Chih; Lee, Kuei-Chuan; Lin, Han-Chieh] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, 201,Sect 2,Shih Pai Rd, Taipei 11217, Taiwan; [Hsieh, Yun-Cheng; Wu, Pei-Shan; Lin, Yi-Tsung; Huang, Yi-Hsiang; Hou, Ming-Chih; Lee, Kuei-Chuan; Lin, Han-Chieh] Natl Yang Ming Chiao Tung Univ, Sch Med, Dept Med, Taipei, Taiwan; [Wu, Pei-Shan] Taipei Vet Gen Hosp, Endoscopy Ctr Diag & Treatment, Taipei, Taiwan; [Lin, Yi-Tsung] Taipei Vet Gen Hosp, Dept Med, Div Infect Dis, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital	Lee, KC (corresponding author), Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol & Hepatol, 201,Sect 2,Shih Pai Rd, Taipei 11217, Taiwan.	kclee2@vghtpe.gov.tw			Ministry of Science and Technology, Taiwan [108-2628-B-075-016, 109-2628-B-075-016, 110-2628-B-075-016, 110-2314-B-075-006-MY3]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	The authors thank Ms. Hsiu-Ying, Chen, and Fu-Jung, Shou for their excellent technical assistance. This study was supported by the grants from the Ministry of Science and Technology, Taiwan 108-2628-B-075-016, 109-2628-B-075-016, 110-2628-B-075-016, and 110-2314-B-075-006-MY3.	Aihara Y, 2013, HEPATOL RES, V43, P1241, DOI 10.1111/hepr.12081; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 2011, HEPATOLOGY, V53, P810, DOI 10.1002/hep.24127; Calvente CJ, 2015, HEPATOLOGY, V62, P1285, DOI 10.1002/hep.27936; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Feldt S, 2008, J AM SOC NEPHROL, V19, P743, DOI 10.1681/ASN.2007091030; Foster DW, 2012, J CLIN INVEST, V122, P1958, DOI 10.1172/JCI63967; Hirose A, 2007, HEPATOLOGY, V45, P1375, DOI 10.1002/hep.21638; Hsieh YC, 2021, CELL MOL GASTROENTER, V12, P813, DOI 10.1016/j.jcmgh.2021.05.017; Huang Y, 2007, KIDNEY INT, V72, P45, DOI 10.1038/sj.ki.5002243; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Ichihara A, 2006, HYPERTENSION, V47, P894, DOI 10.1161/01.HYP.0000215838.48170.0b; Ichihara A, 2004, J CLIN INVEST, V114, P1128, DOI 10.1172/JCI200421398; Ichihara A, 2008, J MOL MED, V86, P629, DOI 10.1007/s00109-008-0327-1; Ichihara A, 2006, J AM SOC NEPHROL, V17, P1950, DOI 10.1681/ASN.2006010029; Im YR, 2021, HEPATOLOGY, V74, P1884, DOI 10.1002/hep.31897; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Krebs C, 2008, KIDNEY INT, V74, P823, DOI 10.1038/ki.2008.315; Lally JSV, 2019, CELL METAB, V29, P174, DOI 10.1016/j.cmet.2018.08.020; Lee KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077817; Lemoinne S, 2019, CURR OPIN PHARMACOL, V49, P60, DOI 10.1016/j.coph.2019.09.006; Li Yating, 2018, Oncotarget, V9, P24155, DOI 10.18632/oncotarget.23816; Lu XF, 2016, CIRC RES, V118, P222, DOI 10.1161/CIRCRESAHA.115.306799; Nabeshima Y, 2009, J HEPATOL, V50, P1226, DOI 10.1016/j.jhep.2009.01.018; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Nguyen G, 2010, J AM SOC NEPHROL, V21, P18, DOI 10.1681/ASN.2009030300; Paschos P, 2012, WORLD J HEPATOL, V4, P327, DOI 10.4254/wjh.v4.i12.327; Pawlak M, 2015, J HEPATOL, V62, P720, DOI 10.1016/j.jhep.2014.10.039; Raal FJ, 2020, NEW ENGL J MED, V382, P1520, DOI 10.1056/NEJMoa1913805; Ren LW, 2018, CIRC RES, V122, P730, DOI [10.1161/CIRCRESAHA.117.312422, 10.1161/circresaha.117.312422]; Rinella ME, 2008, J LIPID RES, V49, P1068, DOI 10.1194/jlr.M800042-JLR200; Rinella ME, 2004, J HEPATOL, V40, P47, DOI 10.1016/j.jhep.2003.09.020; Sato Y, 2008, NAT BIOTECHNOL, V26, P431, DOI 10.1038/nbt1396; Satofuka S, 2007, INVEST OPHTH VIS SCI, V48, P422, DOI 10.1167/iovs.06-0534; Suzuki F, 2003, J BIOL CHEM, V278, P22217, DOI 10.1074/jbc.M302579200; Tan P, 2014, OBESITY, V22, P2201, DOI 10.1002/oby.20844; te Riet L, 2014, AM J PHYSIOL-RENAL, V306, pF1179, DOI 10.1152/ajprenal.00010.2014; Toblli JE, 2008, OBESITY, V16, P770, DOI 10.1038/oby.2007.114; VANCE JE, 1985, CAN J BIOCHEM CELL B, V63, P870, DOI 10.1139/o85-108; Wallace MC, 2015, LAB ANIM-UK, V49, P21, DOI 10.1177/0023677215573040; Wilkinson-Berka JL, 2010, HYPERTENSION, V55, P1454, DOI 10.1161/HYPERTENSIONAHA.109.148221; Wu CH, 2016, HYPERTENSION, V68, P213, DOI 10.1161/HYPERTENSIONAHA.115.06954; YAO ZM, 1988, J BIOL CHEM, V263, P2998	45	0	0	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22526	10.1096/fj.202200594R	http://dx.doi.org/10.1096/fj.202200594R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H4LJ	36063123				2022-12-26	WOS:000849851600001
J	Matveyenka, M; Zhaliazka, K; Rizevsky, S; Kurouski, D				Matveyenka, Mikhail; Zhaliazka, Kiryl; Rizevsky, Stanislav; Kurouski, Dmitry			Lipids uniquely alter secondary structure and toxicity of lysozyme aggregates	FASEB JOURNAL			English	Article						AFM-IR; amyloid aggregates; lipids; lysozyme; ROS; toxicity	ALPHA-SYNUCLEIN OLIGOMERS; AMYLOID FIBRILS; RAMAN-SPECTROSCOPY; FIBRILLATION; ORGANIZATION; MECHANISM; KINETICS; STATE	Abrupt aggregation of misfolded proteins is a hallmark of the large group of amyloid pathologies that include diabetes type 2, Alzheimer and Parkinson's diseases. Protein aggregation yields oligomers and fibrils, beta-sheet-rich structures that exert cell toxicity. Microscopic examination of amyloid deposits reveals the presence of lipids membranes, which suggests that lipids can be involved in the process of pathogenic protein assembly. In this study, we show that lipids can uniquely alter the aggregation rates of lysozyme, a protein that is associated with systemic amyloidosis. Specifically, cardiolipin (CL), ceramide (CER), and sphingomyelin (SM) accelerate, phosphatidylcholine (PC) strongly inhibits, whereas phosphatidylserine (PS) has no effect on the rate of protein aggregation. Furthermore, lipids uniquely alter the secondary structure of lysozyme aggregates. Furthermore, we found that lysozyme aggregates grown in the presence of CL, CER, SM, PS, and CL:PC mixtures exert significantly lower production of reactive oxygen species and mitochondrial dysfunction compared to lysozyme:PC aggregates and lysozyme fibrils grown in the lipid-free environment. These findings suggest that a change in the lipid composition of cell membranes, which is taken place upon neurodegeneration, may trigger the formation of toxic protein species that otherwise would not be formed.	[Matveyenka, Mikhail; Zhaliazka, Kiryl; Rizevsky, Stanislav; Kurouski, Dmitry] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Rizevsky, Stanislav] Binh Duong Univ, Dept Biotechnol, Thu Dau Mot, Vietnam; [Kurouski, Dmitry] Texas A&M Univ, Dept Biomed Engn, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Kurouski, D (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	dkurouski@tamu.edu			National Institute of Health [R35GM142869]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to the National Institute of Health for the provided financial support (R35GM142869).	Alecu I, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00328; Alza NP, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00175; Apetri MM, 2006, J MOL BIOL, V355, P63, DOI 10.1016/j.jmb.2005.10.071; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Cataldi R, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01490-3; Chen SW, 2015, P NATL ACAD SCI USA, V112, pE1994, DOI 10.1073/pnas.1421204112; Chiti F, 2017, ANNU REV BIOCHEM, V86, P27, DOI 10.1146/annurev-biochem-061516-045115; Cremades N, 2012, CELL, V149, P1048, DOI 10.1016/j.cell.2012.03.037; Dazzi A, 2017, CHEM REV, V117, P5146, DOI 10.1021/acs.chemrev.6b00448; De Simone A, 2019, ACS OMEGA, V4, P12308, DOI 10.1021/acsomega.9b01531; Dou TY, 2021, J PHYS CHEM LETT, V12, P4407, DOI 10.1021/acs.jpclett.1c00820; Dou TY, 2020, ANAL CHEM, V92, P11297, DOI 10.1021/acs.analchem.0c01971; Fitzner D, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108132; Galvagnion C, 2017, J PARKINSON DIS, V7, P433, DOI 10.3233/JPD-171103; Galvagnion C, 2016, P NATL ACAD SCI USA, V113, P7065, DOI 10.1073/pnas.1601899113; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Guerrero-Ferreira R, 2018, ELIFE, V7, DOI 10.7554/eLife.36402; Hong DP, 2011, PROTEIN PEPTIDE LETT, V18, P230, DOI 10.2174/092986611794578332; Iadanza MG, 2018, NAT REV MOL CELL BIO, V19, P755, DOI 10.1038/s41580-018-0060-8; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kurouski D, 2020, CHEM SOC REV, V49, P3315, DOI 10.1039/c8cs00916c; Kurouski D, 2015, ANALYST, V140, P4967, DOI 10.1039/c5an00342c; Kurouski D, 2014, J AM CHEM SOC, V136, P2302, DOI 10.1021/ja407583r; Kurouski D, 2012, BIOCHEM BIOPH RES CO, V422, P97, DOI 10.1016/j.bbrc.2012.04.113; Kurouski D, 2010, CHEM COMMUN, V46, P7154, DOI 10.1039/c0cc02423f; La Rosa C, 2016, J CHEM PHYS, V144, DOI 10.1063/1.4948323; Levental I, 2020, TRENDS CELL BIOL, V30, P341, DOI 10.1016/j.tcb.2020.01.009; Li BS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05971-2; Matveyenka M, 2022, J PHYS CHEM LETT, V13, P4563, DOI 10.1021/acs.jpclett.2c00559; Matveyenka M, 2022, FEBS LETT, V596, P1424, DOI 10.1002/1873-3468.14369; MICHAELSON DM, 1983, BIOCHEM J, V211, P155, DOI 10.1042/bj2110155; Mulaj M, 2014, J AM CHEM SOC, V136, P8947, DOI 10.1021/ja502529m; O'Leary EI, 2019, BBA-PROTEINS PROTEOM, V1867, P483, DOI 10.1016/j.bbapap.2018.09.012; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Pieri L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24526; Pope S, 2008, BBA-BIOENERGETICS, V1777, P794, DOI 10.1016/j.bbabio.2008.03.011; Ramer G, 2018, ACS NANO, V12, P6612, DOI 10.1021/acsnano.8b01425; Rizevsky S, 2022, J PHYS CHEM C, V126, P4157, DOI 10.1021/acs.jpcc.1c09643; Rizevsky S, 2022, J PHYS CHEM LETT, V13, P2467, DOI 10.1021/acs.jpclett.1c04012; Ruggeri FS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8831; Ruggeri FS, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16728-1; Ruggeri FS, 2020, ACS NANO, V14, P5213, DOI 10.1021/acsnano.9b09676; Sarroukh R, 2013, BBA-BIOMEMBRANES, V1828, P2328, DOI 10.1016/j.bbamem.2013.04.012; Scollo F, 2018, J PHYS CHEM LETT, V9, P5125, DOI 10.1021/acs.jpclett.8b02241; Shashilov V, 2007, J AM CHEM SOC, V129, P6972, DOI 10.1021/ja070038c; Shashilov VA, 2008, J AM CHEM SOC, V130, P309, DOI 10.1021/ja076225s; Tycko R, 2011, ANNU REV PHYS CHEM, V62, P279, DOI 10.1146/annurev-physchem-032210-103539; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Viennet T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0049-z; Xu M, 2007, J AM CHEM SOC, V129, P11002, DOI 10.1021/ja073798w; Xu M, 2007, PROTEIN SCI, V16, P815, DOI 10.1110/ps.062639307	53	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22543	10.1096/fj.202200841R	http://dx.doi.org/10.1096/fj.202200841R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4L6CX	36094052				2022-12-26	WOS:000852719000001
J	Chikwava, F; O'Donnell, M; Ferrante, A; Pakpahan, E; Cordier, R				Chikwava, Fadzai; O'Donnell, Melissa; Ferrante, Anna; Pakpahan, Eduwin; Cordier, Reinie			Patterns of homelessness and housing instability and the relationship with mental health disorders among young people transitioning from out-of-home care: Retrospective cohort study using linked administrative data	PLOS ONE			English	Article							FOSTER-CARE; SUBSTANCE USE; YOUTH; INDIVIDUALS; ADOLESCENTS; REGRESSION; FRAMEWORK; FAMILIES; LESSONS; RISK	Objectives The study examined the relationship between mental health, homelessness and housing instability among young people aged 15-18 years old who transitioned from out-of-home in 2013 to 2014 in the state of Victoria, Australia with follow-up to 2018. We determined the various mental health disorders and other predictors that were associated with different levels of homelessness risk, including identifying the impact of dual diagnosis of mental health and substance use disorder on homelessness. Methodology Using retrospective de-identified linked administrative data from various government departments we identified various dimensions of homelessness which were mapped from the European Topology of Homelessness (ETHOS) framework and associated mental health variables which were determined from the WHO ICD-10 codes. We used ordered logistic regression and Poisson regression analysis to estimate the impact of homelessness and housing instability respectively. Results A total homelessness prevalence of 60% was determined in the care-leaving population. After adjustment, high risk of homelessness was associated with dual diagnosis of mental health and substance use disorder, intentional self-harm, anxiety, psychotic disorders, assault and maltreatment, history of involvement with the justice system, substance use prior to leaving care, residential and home-based OHC placement and a history of staying in public housing. Conclusions There is clearly a need for policy makers and service providers to work together to find effective housing pathways and integrated health services for this heterogeneous group of vulnerable young people with complex health and social needs. Future research should determine longitudinally the bidirectional relationship between mental health disorders and homelessness.	[Chikwava, Fadzai; Cordier, Reinie] Curtin Univ, Curtin Sch Allied Hlth, Perth, Australia; [O'Donnell, Melissa] Univ South Australia, Australian Ctr Child Protect, Adelaide, SA, Australia; [O'Donnell, Melissa] Univ Western Australia, Telethon Kids Inst, Nedlands, WA, Australia; [Ferrante, Anna] Curtin Univ, Curtin Sch Populat Hlth, Perth, Australia; [Pakpahan, Eduwin] Northumbria Univ, Dept Math Phys Elect Engn, Newcastle Upon Tyne, England; [Cordier, Reinie] Northumbria Univ, Dept Social Work Educ & Community Wellbeing, Newcastle Upon Tyne, England	Curtin University; University of South Australia; Telethon Kids Institute; University of Western Australia; Curtin University; Northumbria University; Northumbria University	Cordier, R (corresponding author), Curtin Univ, Curtin Sch Allied Hlth, Perth, Australia.	reinie.cordier@northumbria.ac.uk		O'Donnell, Melissa/0000-0003-2440-3667; Cordier, Reinie/0000-0002-9906-5300; Pakpahan, Eduwin/0000-0002-0058-1808; Chikwava, Fadzai/0000-0001-7751-3822	Australian Government Research Training Program (RTP); AHURI	Australian Government Research Training Program (RTP); AHURI	The first author (FC) is in receipt of the Australian Government Research Training Program (RTP) and The AHURI Scholarships.	Adair CE, 2017, CAN J PSYCHIAT, V62, P30, DOI 10.1177/0706743716645302; AIHW, 2020, AUSTR I HLTH WELF SP; AIHW . Australian Institute of Health and Welfare, 2019, AUSTR I HLTH WELF SP, V2020; Anderson I, 2003, J COMMUNITY APPL SOC, V13, P105, DOI 10.1002/casp.714; Australian Bureau of Statistics, 2012, INF PAP STAT DEF HOM; Baidawi S, 2014, CHILD AUST, V39, P200, DOI 10.1017/cha.2014.27; Bender K, 2015, CHILD YOUTH SERV REV, V55, P222, DOI 10.1016/j.childyouth.2015.06.007; Bollen KA, 2006, WILEY SER PROBAB ST, P1; Brackertz N., 2018, HOUSING HOMELESSNESS; Brakenhoff B, 2015, J YOUTH STUD, V18, P1015, DOI 10.1080/13676261.2015.1020930; Brndle G, 2015, HOUS CARE SUPPORT, V18, P113, DOI 10.1108/HCS-04-2015-0006; Busch-Geertsema V., 2010, HOMELESSNESS RES EUR; Busch-Geertsema V, 2016, HABITAT INT, V55, P124, DOI 10.1016/j.habitatint.2016.03.004; Chamberlain C., 2014, DEFINITION COUNTING, P71; Chhabra M, 2019, J GEN INTERN MED, V34, P1213, DOI 10.1007/s11606-019-04895-x; Chikwava F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249088; Chu CMT, 2020, PSYCHIAT SERV, V71, P648, DOI 10.1176/appi.ps.201900260; Corrigan M, 2009, ADV DUAL DIAGN, V2, P25, DOI 10.1108/17570972200900022; Courtney M., 2019, BENEFITS EXTENDING S, P131; Courtney M E., 2005, MIDWEST EVALUATION A; Cowal K, 2002, AM J COMMUN PSYCHOL, V30, P711, DOI 10.1023/A:1016325332527; Crawford BL, 2015, CHILD WELFARE, V94, P19; Dawson-Rose C, 2020, PUBLIC HEALTH NURS, V37, P363, DOI 10.1111/phn.12727; Dunt DR, 2017, AUST HEALTH REV, V41, P573, DOI 10.1071/AH16055; Dworsky A, 2013, AM J PUBLIC HEALTH, V103, pS318, DOI 10.2105/AJPH.2013.301455; Dworsky A, 2009, CHILD WELFARE, V88, P23; Edgar B., 2005, 4 REV STAT HOMELESSN; Farrell AF, 2017, AM J COMMUN PSYCHOL, V60, P25, DOI 10.1002/ajcp.12152; Flatau P., 2018, STATE HOMELESSNESS A; Fortier E, 2020, DRUG ALCOHOL DEPEN, V206, DOI 10.1016/j.drugalcdep.2019.107744; Fowler PJ, 2011, AM J COMMUN PSYCHOL, V47, P335, DOI 10.1007/s10464-010-9401-2; Fowler PJ, 2009, AM J PUBLIC HEALTH, V99, P1453, DOI 10.2105/AJPH.2008.142547; Fullerton AS, 2009, SOCIOL METHOD RES, V38, P306, DOI 10.1177/0049124109346162; Gaffney S, 2021, CRIT SOC POLICY, V41, P328, DOI 10.1177/0261018320986119a; Guy Johnson., 2009, 117 AHURI; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Hodgson KJ, 2013, AM J PUBLIC HEALTH, V103, pE24, DOI 10.2105/AJPH.2013.301318; Homelessness Australia, 2017, NAT HOM STRAT WHY WE; Hossain MM, 2020, INT J SOC PSYCHIATR, V66, P528, DOI 10.1177/0020764020924689; Johnson G., 2015, ENTRIES EXITS HOMELE; Johnson G, 2008, AUST J SOC ISSUES, V43, P563, DOI 10.1002/j.1839-4655.2008.tb00119.x; Jutte DP, 2011, ANNU REV PUBL HEALTH, V32, P91, DOI 10.1146/annurev-publhealth-031210-100700; Kaleveld L., 2018, HOMELESSNESS W AUSTR; Kelly P, 2020, CHILD YOUTH SERV REV, V108, DOI 10.1016/j.childyouth.2019.104589; Kertesz SG, 2017, AUST ECON REV, V50, P220, DOI 10.1111/1467-8462.12217; Lippert AM, 2015, SOCIOL INQ, V85, P343, DOI 10.1111/soin.12080; Mendes P, 2020, BRIT J SOC WORK, V50, P1513, DOI 10.1093/bjsw/bcaa028; Moss HB, 2020, COMPR PSYCHIAT, V100, DOI 10.1016/j.comppsych.2020.152175; Narendorf SC, 2017, CHILD YOUTH SERV REV, V81, P54, DOI 10.1016/j.childyouth.2017.07.024; Narendorf SC, 2017, DRUG ALCOHOL DEPEN, V175, P1, DOI 10.1016/j.drugalcdep.2017.01.028; Nilsson SF, 2019, J URBAN HEALTH, V96, P741, DOI 10.1007/s11524-019-00377-x; Piat M, 2015, URBAN STUD, V52, P2366, DOI 10.1177/0042098014548138; Pleace N., 2013, NO IRELAND HOUSING E; Robinson J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17249385; Salomonsen-Sautel S, 2008, AM J ADDICTION, V17, P224, DOI 10.1080/10550490802019964; Shah MF, 2017, AM J COMMUN PSYCHOL, V60, P33, DOI 10.1002/ajcp.12098; Shelton KH, 2009, PSYCHIAT SERV, V60, P465, DOI 10.1176/appi.ps.60.4.465; Statistics ABo, 2018, CENS POP HOUS EST HO; Stein M., 2006, CHILD FAM SOC WORK, V11, P273, DOI [DOI 10.1111/J.1365-2206.2006.00439.X, 10.1111/j.1365-2206.2006.00439.x]; Sun AP, 2012, SOC WORK, V57, P23, DOI 10.1093/sw/swr008; Tsemberis S., 2011, HOUSING 1 PATHWAYS M; van den Bree MBM, 2009, J ADOLESCENT HEALTH, V45, P571, DOI 10.1016/j.jadohealth.2009.03.027; Williams R, 2016, J MATH SOCIOL, V40, P7, DOI 10.1080/0022250X.2015.1112384	63	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274196	10.1371/journal.pone.0274196	http://dx.doi.org/10.1371/journal.pone.0274196			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054257	Green Accepted, gold, Green Published			2022-12-26	WOS:000892641400066
J	Mullins, E; McCabe, R; Bird, SM; Randell, P; Pond, MJ; Regan, L; Parker, E; McClure, M; Donnelly, CA				Mullins, Edward; McCabe, Ruth; Bird, Sheila M.; Randell, Paul; Pond, Marcus J.; Regan, Lesley; Parker, Eleanor; McClure, Myra; Donnelly, Christl A.			Tracking the incidence and risk factors for SARS-CoV-2 infection using historical maternal booking serum samples	PLOS ONE			English	Article								The early transmission dynamics of SARS-CoV-2 in the UK are unknown but their investigation is critical to aid future pandemic planning. We tested over 11,000 anonymised, stored historic antenatal serum samples, given at two north-west London NHS trusts in 2019 and 2020, for total antibody to SARS-CoV-2 receptor binding domain (anti-RBD). Estimated prevalence of seroreactivity increased from 1% prior to mid-February 2020 to 17% in September 2020. Our results show higher prevalence of seroreactivity to SARS-CoV-2 in younger, non-white ethnicity, and more deprived groups. We found no significant interaction between the effects of ethnicity and deprivation. Derived from prevalence, the estimated incidence of seroreactivity reflects the trends observed in daily hospitalisations and deaths in London that followed 10 and 13 days later, respectively. We quantified community transmission of SARS-CoV-2 in London, which peaked in late March / early April 2020 with no evidence of community transmission until after January 2020. Our study was not able to determine the date of introduction of the SARS-CoV-2 virus but demonstrates the value of stored antenatal serum samples as a resource for serosurveillance during future outbreaks.	[Mullins, Edward; Regan, Lesley] Imperial Coll London, Dept Metab Digest & Reprod, London, England; [Mullins, Edward] Queen Charlottes & Chelsea Hosp, George Inst Global Hlth, London, England; [McCabe, Ruth; Donnelly, Christl A.] Univ Oxford, Dept Stat, Oxford, England; [McCabe, Ruth; Donnelly, Christl A.] Univ Liverpool, NIHR Hlth Res Protect Unit Emerging & Zoonot Infe, Liverpool, England; [Bird, Sheila M.] Univ Cambridge, MRC Biostat Unit, Cambridge, England; [Bird, Sheila M.] Univ Edinburgh, Coll Med & Vet Med, Edinburgh, Scotland; [Randell, Paul; Pond, Marcus J.] North West London Pathol, Dept Infect & Immun, London, England; [Regan, Lesley] St Marys Hosp, Dept Obstet & Gynaecol, London, England; [Parker, Eleanor; McClure, Myra] Imperial Coll London, Dept Infect Dis, Fac Med, London, England; [Donnelly, Christl A.] Imperial Coll London, Dept Infect Dis Epidemiol, MRC Ctr Global Infect Dis Anal, London, England	Imperial College London; Imperial College London; University of Oxford; University of Liverpool; MRC Biostatistics Unit; University of Cambridge; University of Edinburgh; Imperial College London; Imperial College London; Imperial College London	Mullins, E (corresponding author), Imperial Coll London, Dept Metab Digest & Reprod, London, England.; Mullins, E (corresponding author), Queen Charlottes & Chelsea Hosp, George Inst Global Hlth, London, England.	edward.mullins@imperial.ac.uk		Mullins, Edward/0000-0003-1886-6358	Community Jameel and the Imperial President's Excellence Fund; NIHR; Public Health England (PHE); University of Oxford; University of Liverpool; Liverpool School of Tropical Medicine [NIHR200907]; MRC Centre for Global Infectious Disease Analysis - UK Medical Research Council (MRC) [MR/R015600/1]; UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement [MR/R015600/1]; European Union (EU); NIHR [CV220-111]	Community Jameel and the Imperial President's Excellence Fund; NIHR(National Institute for Health Research (NIHR)); Public Health England (PHE); University of Oxford; University of Liverpool; Liverpool School of Tropical Medicine; MRC Centre for Global Infectious Disease Analysis - UK Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union (EU)(CGIAREuropean Commission); NIHR(National Institute for Health Research (NIHR))	This research was partly funded by Community Jameel and the Imperial President's Excellence Fund. https://www.imperial.ac.uk/jameel-institute/EM was funded by an NIHR Academic Clinical Lecturer post until February 2021. https://www.nihr.ac.uk/explore-nihr/academy-programmes/integrated-academictraining.htm RM and CAD acknowledge the NIHR HPRU in Emerging and Zoonotic Infections, a partnership between Public Health England (PHE), University of Oxford, University of Liverpool and Liverpool School of Tropical Medicine [grant number NIHR200907]. CAD also acknowledges the MRC Centre for Global Infectious Disease Analysis [grant number MR/R015600/1], which is jointly funded by the UK Medical Research Council (MRC) and the UK Foreign, Commonwealth & Development Office (FCDO), under the MRC/FCDO Concordat agreement and is also part of the EDCTP2 programme supported by the European Union (EU). EP, MM and RST acknowledge support from NIHR CV220-111: Serological detection of past SARS-CoV-2 infection by noninvasive sampling for field epidemiology and quantitative antibody detection and from departmental funds. Infrastructure support was provided by the NIHR Imperial College Biomedical Research Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	[Anonymous], 2022, COR COVID 19 UK; [Anonymous], 2021, REAL TIME ASSESSMENT; [Anonymous], 2021, CORONAVIRUS COVID 19; Apolone G, 2021, TUMORI J, V107, P446, DOI 10.1177/0300891620974755; Bates TA, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108737; Buitrago-Garcia D, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003346; Daly J., 2022, ABC NEWS; Dickson E, 2021, PUBLIC HEALTH, V190, P132, DOI 10.1016/j.puhe.2020.11.014; Digital NHS., 2019, MATERNITY SERVICES M; El Bouzidi K, 2021, CRIT CARE MED, V49, P428, DOI 10.1097/CCM.0000000000004878; Fraley E, 2021, CELL MOL IMMUNOL, V18, P1826, DOI 10.1038/s41423-021-00700-0; Jamieson DJ, 2022, AM J OBSTET GYNECOL, V226, P177, DOI 10.1016/j.ajog.2021.08.054; Kontopantelis E, 2021, J EPIDEMIOL COMMUN H, V75, P213, DOI 10.1136/jech-2020-214764; Lessler J, 2016, AM J EPIDEMIOL, V183, P657, DOI 10.1093/aje/kwv452; Lumley SF, 2020, EUROSURVEILLANCE, V25, P18, DOI 10.2807/1560-7917.ES.2020.25.41.2001721; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m265; Mathur R, 2021, LANCET, V397, P1711, DOI 10.1016/S0140-6736(21)00634-6; Metcalf CJE, 2016, LANCET, V388, P728, DOI 10.1016/S0140-6736(16)30164-7; Ministry of Housing Communities & Local Government, 2019, ENGL IND DEPR; National Pathology Accreditation Advisory Council, 2018, REQ RET LAB REC DIAG; Parodi E., 2021, REUTERS; Public Health England, 2019, HLTH WOMEN PREGNANCY; Public Health England, 2021, INF DIS PREGN SCREEN; Public Health England, 2021, SER SURV COVID 19; Razai MS, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.m4921; Riley S., 2021, MEDRXIV; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Rosadas C, 2022, J VIROL METHODS, V302, DOI 10.1016/j.jviromet.2022.114475; Rosadas C, 2020, LANCET, V396, pE23, DOI 10.1016/S0140-6736(20)31830-4; Tapper J., 2022, GUARDIAN 0312; Thompson CP, 2020, EUROSURVEILLANCE, V25, P33, DOI 10.2807/1560-7917.ES.2020.25.42.2000685; Ward H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21237-w; Weaver M., 2021, GUARD	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273966	10.1371/journal.pone.0273966	http://dx.doi.org/10.1371/journal.pone.0273966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054212	Green Published, gold			2022-12-26	WOS:000892641400047
J	Xiao, F; Deng, JL; Jiao, FX; Hu, XM; Jiang, HZ; Yuan, FX; Chen, SH; Niu, YG; Jiang, XX; Guo, FF				Xiao, Fei; Deng, Jiali; Jiao, Fuxin; Hu, Xiaoming; Jiang, Haizhou; Yuan, Feixiang; Chen, Shanghai; Niu, Yuguo; Jiang, Xiaoxue; Guo, Feifan			Hepatic cytokine-inducible SH2-containing protein (CISH) regulates gluconeogenesis via cAMP-responsive element binding protein (CREB)	FASEB JOURNAL			English	Article						CISH; CREB; gluconeogenesis; liver; SOCS	INSULIN-RESISTANCE; GLUCOSE; SUPPRESSOR; DELETION; METABOLISM; SOCS-3; SIGNALING-3; INHIBITION; STEATOSIS; GLUCAGON	Impairment of gluconeogenesis is a key factor responsible for hyperglycemia in patients with type 2 diabetes. As an important member of the suppressors of cytokine signaling (SOCS) protein family, many physiological functions of cytokine-inducible SH2-containing protein (CISH) have been described; however, the role of hepatic CISH in gluconeogenesis is poorly understood. In the present study, we observed that hepatic CISH expression was reduced in fasted wild-type (WT) mice. Overexpression of CISH decreased glucose production in mouse primary hepatocytes, while silencing of CISH had the opposite effects. In addition, adenovirus-mediated hepatic CISH overexpression resulted in improved glucose tolerance and decreased gluconeogenesis in WT and leptin receptor-deficient diabetic (db/db) mice. In contrast, adenovirus-mediated hepatic CISH knockdown impaired glucose tolerance and increased gluconeogenesis in WT mice. We also generated liver-specific CISH knockout (LV-CISH KO) mice and discovered that these mice had a similar phenotype in glucose tolerance and gluconeogenesis as mice injected with adenoviruses that knockdown CISH expression. Mechanistically, we found that CISH overexpression decreased and CISH knockdown increased the mRNA and protein levels of glucose-6-phosphatase (G6Pase) and phosphoenolpyruvate carboxykinase 1 (PEPCK), two key enzymes involved in gluconeogenesis, in vitro, and in vivo. Moreover, we discovered that the phosphorylation of cAMP-responsive element binding protein 1 (CREB), a transcription factor of G6pase and Pepck, was required for regulating gluconeogenesis by CISH. Taken together, this study identifies hepatic CISH as an important regulator of gluconeogenesis. Our results also provide important insights into the metabolic functions of the SOCS protein family and the potential targets for the treatment of diabetes.	[Xiao, Fei; Hu, Xiaoming; Yuan, Feixiang; Chen, Shanghai; Guo, Feifan] Fudan Univ, MOE Frontiers Ctr Brain Sci, Inst Translat Brain Res, Jinshan Hosp,State Key Lab Med Neurobiol, 131 Dong Rd, Shanghai 200032, Peoples R China; [Deng, Jiali; Jiao, Fuxin; Jiang, Haizhou; Niu, Yuguo; Jiang, Xiaoxue] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Nutr Metab & Food Safety, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS	Guo, FF (corresponding author), Fudan Univ, MOE Frontiers Ctr Brain Sci, Inst Translat Brain Res, Jinshan Hosp,State Key Lab Med Neurobiol, 131 Dong Rd, Shanghai 200032, Peoples R China.	ffguo@fudan.edu.cn			National Natural Science Foundation of China [91957207, 31830044, 81970742, 81870592, 81770852, 82170868, 81970731, 82000764]; National Key R&D Program of China [2018YFA0800600]; CAS Interdisciplinary Innovation Team; Novo Nordisk-Chinese Academy of Sciences Research Fund [NNCAS-2008-10]; Natural Science Foundation of Shanghai "Science and Technology Innovation Action Plan" [21ZR1475900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; CAS Interdisciplinary Innovation Team; Novo Nordisk-Chinese Academy of Sciences Research Fund; Natural Science Foundation of Shanghai "Science and Technology Innovation Action Plan"	National Natural Science Foundation of China, Grant/Award Number: 91957207, 31830044, 81970742, 81870592, 81770852, 82170868, 81970731 and 82000764; National Key R&D Program of China, Grant/Award Number: 2018YFA0800600; CAS Interdisciplinary Innovation Team; Novo Nordisk-Chinese Academy of Sciences Research Fund, Grant/Award Number: NNCAS-2008-10; Natural Science Foundation of Shanghai "Science and Technology Innovation Action Plan", Grant/Award Number: 21ZR1475900	Akhtar S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90952-7; Banks AS, 2005, J CLIN INVEST, V115, P2462, DOI 10.1172/JCI23853; Carow B, 2017, TUBERCULOSIS, V107, P175, DOI 10.1016/j.tube.2017.09.007; CHAN TM, 1975, AM J PHYSIOL, V229, P1702, DOI 10.1152/ajplegacy.1975.229.6.1702; Chatterjee S, 2017, LANCET, V389, P2239, DOI 10.1016/S0140-6736(17)30058-2; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Dai ZR, 2015, AM J PHYSIOL-ENDOC M, V308, pE849, DOI 10.1152/ajpendo.00540.2014; De Felice FG, 2022, NAT REV NEUROSCI, V23, P215, DOI 10.1038/s41583-022-00558-9; Deng JL, 2020, AUTOPHAGY, V16, P451, DOI 10.1080/15548627.2019.1628537; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Feng XT, 2014, MOL BIOL REP, V41, P2265, DOI 10.1007/s11033-014-3079-8; Gaudy AM, 2010, J BIOL CHEM, V285, P41356, DOI 10.1074/jbc.M110.159111; Santos MRG, 2020, BONE, V140, DOI 10.1016/j.bone.2020.115538; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Jiang MM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00070; Jiao Y, 2013, DIABETOLOGIA, V56, P2435, DOI 10.1007/s00125-013-3014-x; Jin ES, 2013, METABOLISM, V62, P152, DOI 10.1016/j.metabol.2012.07.012; Jorgensen SB, 2013, DIABETES, V62, P56, DOI 10.2337/db12-0443; Keating N, 2019, CYTOKINE, V118, P64, DOI 10.1016/j.cyto.2018.03.033; Kim YD, 2012, J BIOL CHEM, V287, P37098, DOI 10.1074/jbc.M112.339887; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Krebs DL, 2002, MOL CELL BIOL, V22, P4567, DOI 10.1128/MCB.22.13.4567-4578.2002; Lebrun P, 2009, DIABETOLOGIA, V52, P2201, DOI 10.1007/s00125-009-1474-9; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Matsumoto A, 1997, BLOOD, V89, P3148, DOI 10.1182/blood.V89.9.3148; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; MONTGOMERY R, 1957, ARCH BIOCHEM BIOPHYS, V67, P378, DOI 10.1016/0003-9861(57)90292-8; Naser W, 2022, FASEB J, V36, DOI 10.1096/fj.202101882R; Oh KJ, 2013, BMB REP, V46, P567, DOI 10.5483/BMBRep.2013.46.12.248; Rahnert JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159181; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Senn JJ, 2003, J BIOL CHEM, V278, P13740, DOI 10.1074/jbc.M210689200; Seo HY, 2010, ENDOCRINOLOGY, V151, P561, DOI 10.1210/en.2009-0641; Sobah ML, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.727987; Strebovsky J, 2012, FRONT BIOSCI-LANDMRK, V17, P1627, DOI 10.2741/4008; Sun XJ, 2015, J BIOL CHEM, V290, P2189, DOI 10.1074/jbc.M114.612358; Ueda H, 2000, DIABETOLOGIA, V43, P932, DOI 10.1007/s001250051472; Wang HT, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00255; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Xiao F, 2019, MOL METAB, V20, P138, DOI 10.1016/j.molmet.2018.12.003; Xiao F, 2011, DIABETES, V60, P746, DOI 10.2337/db10-1246; Xie Y, 2018, BIOCHEM BIOPH RES CO, V503, P1409, DOI 10.1016/j.bbrc.2018.07.056; Ye J, 2012, PEDIATR RES, V72, P550, DOI 10.1038/pr.2012.123; YOSHIMURA A, 1995, EMBO J, V14, P2816, DOI 10.1002/j.1460-2075.1995.tb07281.x; Zadjali F, 2012, FASEB J, V26, P3282, DOI 10.1096/fj.12-205583; Zhang X, 2021, METABOLISM, V122, DOI 10.1016/j.metabol.2021.154823; Zhu H, 2020, CELL STEM CELL, V27, P224, DOI 10.1016/j.stem.2020.05.008	53	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22541	10.1096/fj.202200870R	http://dx.doi.org/10.1096/fj.202200870R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4J8GC	36083102				2022-12-26	WOS:000851500400001
J	Zou, J; Tan, W; Liu, KC; Chen, BL; Duan, TQ; Xu, HZ				Zou, Jing; Tan, Wei; Liu, Kangcheng; Chen, Bolin; Duan, TianQi; Xu, Huizhuo			Wnt inhibitory factor 1 ameliorated diabetic retinopathy through the AMPK/mTOR pathway-mediated mitochondrial function	FASEB JOURNAL			English	Article						AMPK; mTOR pathway; angiogenesis; diabetic retinopathy; mitochondrial dysfunction; wnt inhibitory factor 1	HIGH-GLUCOSE; APOPTOSIS; ANGIOGENESIS; INFLAMMATION; AUTOPHAGY; CELLS	Diabetic retinopathy (DR) is one of the most common complications of diabetes mellitus and will lead to visual impairment. We aim to explore the effects and mechanisms of wnt inhibitory factor 1 (WIF1) in the progression of DR. To establish DR in vitro and in vivo, human retinal pigment epithelium (RPE) cell line ARPE-19 was treated with high-glucose (HG) and diabetic mice models were induced by streptozotocin (STZ), respectively. Different dose of recombinant WIF1 protein was used to treat DR. qRT-PCR and western blotting results demonstrated that WIF1 was downregulated, while VEGFA was upregulated in HG-induced ARPE-19 cells. WIF1 overexpression promoted cell migration. The ARPE-19 cells culture medium treated with WIF1 inhibited retinal endothelial cell tube formation and downregulated VEGFA expression. Moreover, WIF1 decreased the levels of ROS and MDA, while increasing the activity of SOD and GPX. WIF1 increased the Delta psi m in the mitochondria and downregulated the expression of mitochondrial autophagy-related proteins including Parkin, Pink1, LC3-II/LC3-I ratio, cleaved caspase 3, and cyt-c, which ameliorated mitochondrial dysfunction. The in vivo studies further demonstrated the consistent effects of WIF1 in STZ-induced mice. Taken together, WIF1 ameliorated mitochondrial dysfunction in DR by downregulating the AMPK/mTOR pathway.	[Zou, Jing; Tan, Wei; Liu, Kangcheng; Chen, Bolin; Duan, TianQi; Xu, Huizhuo] Cent South Univ, Xiangya Hosp, Eye Ctr, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China; [Zou, Jing; Tan, Wei; Liu, Kangcheng; Chen, Bolin; Duan, TianQi; Xu, Huizhuo] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha, Peoples R China	Central South University; Central South University	Xu, HZ (corresponding author), Cent South Univ, Xiangya Hosp, Eye Ctr, 87 Xiangya Rd, Changsha 410008, Hunan, Peoples R China.	xhz1030@csu.edu.cn			Hunan Natural Science Foundation [2019JJ40528]	Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province)	This work was supported by a grant from the Hunan Natural Science Foundation (No. 2019JJ40528) to Huizhuo Xu.	AnandBabu K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216899; Bernkopf DB, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1458015; Capitao M, 2016, J CELL BIOCHEM, V117, P2443, DOI 10.1002/jcb.25575; Chang ML, 2014, ADV EXP MED BIOL, V801, P609, DOI 10.1007/978-1-4614-3209-8_77; Chen H, 2018, BIOMED PHARMACOTHER, V108, P1201, DOI 10.1016/j.biopha.2018.09.140; Cohen SR, 2016, DEV OPHTHALMOL, V55, P137, DOI 10.1159/000438970; Deissler HL, 2020, EXP EYE RES, V194, DOI 10.1016/j.exer.2020.108004; Drenser KA, 2016, EYE BRAIN, V8, P141, DOI 10.2147/EB.S94452; Due WW, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1610751; Dunlop EA, 2014, SEMIN CELL DEV BIOL, V36, P121, DOI 10.1016/j.semcdb.2014.08.006; Fu T, 2014, MOL CELL BIOL, V34, P4130, DOI 10.1128/MCB.00596-14; Hombrebueno JR, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129760; Hou J, 2021, BIOL TRACE ELEM RES, V199, P1062, DOI 10.1007/s12011-020-02212-w; Houzelle A, 2020, J CELL PHYSIOL, V235, P9851, DOI 10.1002/jcp.29797; Jenkins Alicia J, 2015, Rev Diabet Stud, V12, P159, DOI 10.1900/RDS.2015.12.159; Ji Y, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092062; Kanamori H, 2015, AUTOPHAGY, V11, P1146, DOI 10.1080/15548627.2015.1051295; Kanwar M, 2009, DIABETES, V58, P227, DOI 10.2337/db08-1025; Laferriere CA, 2020, J AM ASSOC LAB ANIM, V59, P254, DOI 10.30802/AALAS-JAALAS-19-000081; Lai AKW, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/106594; Lambuk L, 2019, INT J OPHTHALMOL-CHI, V12, P746, DOI 10.18240/ijo.2019.05.08; Liang PF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1194-5; Liu QP, 2019, CELL TISSUE RES, V376, P165, DOI 10.1007/s00441-018-2974-z; Ma MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091086; Mehta H, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011599.pub2; Miao JH, 2019, AGING CELL, V18, DOI 10.1111/acel.13004; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Poggi L, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00167; Qi F, 2020, EUR REV MED PHARMACO, V24, P6486, DOI 10.26355/eurrev_202006_21631; Qian C, 2019, RNA BIOL, V16, P1461, DOI 10.1080/15476286.2019.1637696; Qin D, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/9490642; Romero-Aroca P, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/2156273; Shao Y, 2019, STEM CELLS, V37, P1331, DOI 10.1002/stem.3049; Shi Y, 2019, BIOSCI BIOTECH BIOCH, V83, P869, DOI 10.1080/09168451.2019.1569499; Sun H, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-29277-6; Sun J, 2021, REDOX BIOL, V39, DOI 10.1016/j.redox.2020.101811; Sun Y, 2018, EUR REV MED PHARMACO, V22, P2941, DOI 10.26355/eurrev_201805_15048; Tan W, 2022, BIOFACTORS, V48, P683, DOI 10.1002/biof.1824; Wan WC, 2021, J INFLAMM RES, V14, P2411, DOI 10.2147/JIR.S303540; Wang W, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061816; Wang Y, 2020, CELL CYCLE, V19, P1314, DOI 10.1080/15384101.2020.1749484; Wu MY, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/3420187; Xi XT, 2020, BIOMED PHARMACOTHER, V125, DOI 10.1016/j.biopha.2020.109924; Xia T, 2017, VISION RES, V139, P72, DOI 10.1016/j.visres.2017.02.006; Xing JL, 2008, JNCI-J NATL CANCER I, V100, P1104, DOI 10.1093/jnci/djn213; Yang F, 2019, INT J BIOL SCI, V15, P1010, DOI 10.7150/ijbs.29680; Yang Y., 2020, J CLIN ENDOCR METAB, V105, P3404; Zha X, 2020, AGING-US, V12, P8137, DOI 10.18632/aging.103130; Zhang F, 2020, AM J PHYSIOL-CELL PH, V319, pC720, DOI 10.1152/ajpcell.00014.2020; Zhang YP, 2019, BIOMED PHARMACOTHER, V111, P1315, DOI 10.1016/j.biopha.2019.01.034; Zhao WY, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01526; Zhou LL, 2019, KIDNEY INT, V95, P830, DOI 10.1016/j.kint.2018.10.032; Zhou P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030213; Zhu ZY, 2020, ARCH MED SCI, V16, P898, DOI 10.5114/aoms.2020.95667	54	1	1	9	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22531	10.1096/fj.202200366RR	http://dx.doi.org/10.1096/fj.202200366RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4H5GL	36063130				2022-12-26	WOS:000849906800001
J	Gebeyehu, DT; East, L; Wark, S; Islam, MS				Gebeyehu, Daniel Teshome; East, Leah; Wark, Stuart; Islam, Md Shahidul			Disability-adjusted life years (DALYs) based COVID-19 health impact assessment: A systematic review protocol	PLOS ONE			English	Review							DISEASE BURDEN	Background COVID-19 is a highly contagious infectious disease that emerged in 2019. This disease is causing devastating health, socio-economic, and economic crises. More specifically COVID-19 is affecting both the quality and length of human life. The overall health impact of this disease is measured by the disability-adjusted life years which is the sum of the life years lost due to disability (the effect on the health quality) and the years life lost due to premature death (effect on the length of life). The purpose of this review is to summarise DALYs-based health impact publications and produce compiled and informative literature that can aid the health regulators to make evidence-based decisions on mitigating COVID-19. Methods The review will be conducted using the PRISMA 2020 guidelines. The DALYs-based original observational and cross-sectional studies will be collected for assessing the health impact of COVID-19. Both the life quality and length impacts of COVID-19 will be reviewed. The life quality impact of COVID-19 will be measured using the life years lost due to disability (prerecovery illness, pre-death illness, and post-acute consequences), and its impact on the length of life will be measured with years of life lost due to premature death (shortening of life expectancy). The combined health impact of COVID-19 on the quality and length of life will be measured in disability-adjusted life years. Discussion The impacts of COVID-19 on the two health outcomes (quality and length of life) will indicate the level of COVID-19 health burden. The increase or decrease of COVID-19 health impact might be due to the sample size differences of different studies and the omission of years lost due to post-acute consequences in some studies. After having a summarized systematic review health decision-makers will apply an impact-based response to COVID-19.	[Gebeyehu, Daniel Teshome; East, Leah; Islam, Md Shahidul] Univ New England, Sch Hlth, Fac Med & Hlth, Armidale, NSW, Australia; [Gebeyehu, Daniel Teshome] Wollo Univ, Sch Vet Med, Dessie, Amhara, Ethiopia; [Wark, Stuart] Univ New England, Sch Rural Med, Fac Med & Hlth, Armidale, NSW, Australia	University of New England; University of New England	Gebeyehu, DT (corresponding author), Univ New England, Sch Hlth, Fac Med & Hlth, Armidale, NSW, Australia.; Gebeyehu, DT (corresponding author), Wollo Univ, Sch Vet Med, Dessie, Amhara, Ethiopia.	daniel.teshome@wu.edu.et		Wark, Stuart/0000-0002-5366-1860; Islam, Md Shahidul/0000-0001-8984-8689; East, Leah/0000-0002-4757-2706; Gebeyehu, Daniel Teshome/0000-0002-3325-4571				Auriemma V, 2020, FRONT SOCIOL, V5, DOI 10.3389/fsoc.2020.575791; Australian Government Department of Health, COVID 19 DIS SYMPT V; Berkman ND., 2013, APPENDIX A TOOL EVAL, pChapter 15; Bonotti M., 2021, PALGRAVE MACMILLAN, DOI [10.1007/978-981-33-6706-7_1, DOI 10.1007/978-981-33-6706-7_1]; Cuschieri S, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11893-4; Fan CY, 2021, J FORMOS MED ASSOC, V120, pS106, DOI 10.1016/j.jfma.2021.05.019; Gartlehner G, 2020, J CLIN EPIDEMIOL, V121, P20, DOI 10.1016/j.jclinepi.2020.01.005; Gianino MM, 2021, EUR REV MED PHARMACO, V25, P5529, DOI 10.26355/eurrev_202109_26665; Gopalan HS, 2020, DIABETES METAB SYND, V14, P757, DOI 10.1016/j.dsx.2020.05.041; Islam N, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj-2021-066768; Jo MW, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e199; Marois G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238678; Oh IH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e300; Arolas HPI, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83040-3; Rommel A, 2021, DTSCH ARZTEBL INT, V118, P145, DOI 10.3238/arztebl.m2021.0147; Salinas-Escudero G, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.686700; Singh BB, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-06505-z; Ugarte MP, 2022, BMC PUBLIC HEALTH, V22, DOI 10.1186/s12889-021-12377-1; Whiting P, 2016, J CLIN EPIDEMIOL, V69, P225, DOI 10.1016/j.jclinepi.2015.06.005; WHO, EST MORT COVID 19 SC; WHO, METH DAT SOURC GLOB; WHO, GLOB HLTH OBS DIS AD; WHO, ROLL UPD COR DIS COV; WHO, COR COVID 19 DASHB 4; Wyper GMA, 2022, ARCH PUBLIC HEALTH, V80, DOI 10.1186/s13690-022-00862-x; Zhao JD, 2021, VALUE HEALTH, V24, P615, DOI 10.1016/j.jval.2020.12.009	26	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274468	10.1371/journal.pone.0274468	http://dx.doi.org/10.1371/journal.pone.0274468			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094922	gold, Green Published			2022-12-26	WOS:000892376500045
J	Ko, RE; Kim, S; Lee, J; Park, S; Bae, D; Choi, KH; Park, TK; Chung, CR; Yang, JH				Ko, Ryoung-Eun; Kim, Sungeun; Lee, Jihye; Park, Sojin; Bae, Daehwan; Choi, Ki Hong; Park, Taek Kyu; Chung, Chi Ryang; Yang, Jeong Hoon			Clinical phenotypes of delirium in patients admitted to the cardiac intensive care unit	PLOS ONE			English	Article							TERM COGNITIVE IMPAIRMENT; HEART-FAILURE; MORTALITY	Background Limited data are available on clinical phenotype for delirium that occurs frequently among patients admitted to the cardiac intensive care unit (CICU). The objective of this study was to investigate the clinical pictures of delirium, and their association with clinical outcomes in CICU patients. Methods A total of 4,261 patients who were admitted to the CICU between September 1 2012 to December 31 2018 were retrospectively registered. Patients were excluded if they were admitted to the CICU for less than 24 hours or had missed data. Ultimately, 2,783 patients were included in the analysis. A day of delirium was defined as any day during which at least one CAM-ICU assessment was positive. The clinical risk factors of delirium were classified by the delirium phenotype, as follows; hypoxic, septic, sedative-associated, and metabolic delirium. Results The incidence of delirium was 24.4% at the index hospitalization in all CICU patients, and 22.6% within 7 days after CICU admission. The most common delirium phenotype was septic delirium (17.2%), followed by hypoxic delirium (16.8%). Multiple phenotypes were observed during most delirium days. Delirium most frequently occurred in patients with heart failure. Of all patients affected by delirium within 7 days, both ICU and hospital mortality significantly increased according to the combined number of delirium phenotypes. Conclusions Delirium occurred in a quarter of patients admitted to the modern CICU and was associated with increased in-hospital mortality. Therefore, more efforts are needed to reduce the clinical risk factors of delirium, and to prevent it in order to improve clinical outcomes in the CICU.	[Ko, Ryoung-Eun; Kim, Sungeun; Lee, Jihye; Chung, Chi Ryang; Yang, Jeong Hoon] Sungkyunkwan Univ, Dept Crit Care Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Park, Sojin] Samsung Med Ctr, Dept Pharmaceut Serv, Seoul, South Korea; [Bae, Daehwan; Choi, Ki Hong; Park, Taek Kyu; Yang, Jeong Hoon] Sungkyunkwan Univ, Div Cardiol, Dept Med, Samsung Med Ctr,Sch Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, J (corresponding author), Sungkyunkwan Univ, Dept Crit Care Med, Samsung Med Ctr, Sch Med, Seoul, South Korea.	jhysmc@gmail.com		Yang, Jeong Hoon/0000-0001-8138-1367				American Psychiatric Association, 2000, AN DIAGN STAT MAN ME, V4th; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Bozza FA, 2010, J CEREBR BLOOD F MET, V30, P440, DOI 10.1038/jcbfm.2009.215; Colantuoni E, 2016, LANCET RESP MED, V4, P534, DOI 10.1016/S2213-2600(16)30138-2; Devlin JW, 2018, CRIT CARE MED, V46, pE825, DOI 10.1097/CCM.0000000000003299; Dewan P, 2020, EUR J HEART FAIL, V22, P2123, DOI 10.1002/ejhf.1832; Falsini G, 2018, EUR HEART J-ACUTE CA, V7, P661, DOI 10.1177/2048872617695235; Girard TD, 2018, LANCET RESP MED, V6, P213, DOI 10.1016/S2213-2600(18)30062-6; Goldberg TE, 2020, JAMA NEUROL, V77, P1373, DOI 10.1001/jamaneurol.2020.2273; Heo EY, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-94; Honda S, 2016, INT J CARDIOL, V222, P521, DOI 10.1016/j.ijcard.2016.07.236; Jentzer JC, 2020, AM HEART J, V224, P57, DOI 10.1016/j.ahj.2020.02.018; Kataja A, 2018, EUR HEART J-ACUTE CA, V7, P38, DOI 10.1177/2048872617702505; Katz JN, 2010, CRIT CARE MED, V38, P375, DOI 10.1097/CCM.0b013e3181cb0a63; Krewulak KD, 2018, CRIT CARE MED, V46, P2029, DOI 10.1097/CCM.0000000000003402; Lin SM, 2008, J CRIT CARE, V23, P372, DOI 10.1016/j.jcrc.2006.09.001; McMorris T, 2017, NEUROSCI BIOBEHAV R, V74, P225, DOI 10.1016/j.neubiorev.2017.01.019; Morrow DA, 2012, CIRCULATION, V126, P1408, DOI 10.1161/CIR.0b013e31826890b0; Na SJ, 2016, J AM COLL CARDIOL, V68, P2637, DOI 10.1016/j.jacc.2016.09.947; Naksuk N, 2017, EUR HEART J-ACUTE CA, V6, P560, DOI 10.1177/2048872615592232; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Pandharipande P, 2007, INTENS CARE MED, V33, P1726, DOI 10.1007/s00134-007-0687-y; Pauley E, 2015, AM HEART J, V170, P79, DOI 10.1016/j.ahj.2015.04.013; Salluh J, 2015, BMJ-BRIT MED J, V350, DOI [10.1136/bmj.h3129, 10.1136/bmj.h2538]; Sekhon MS, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1670-9; Thiele H, 2012, NEW ENGL J MED, V367, P1287, DOI 10.1056/NEJMoa1208410; THOMSON PD, 1973, ANN INTERN MED, V78, P499, DOI 10.7326/0003-4819-78-4-499; Vallabhajosyula S, 2018, SHOCK, V49, P144, DOI 10.1097/SHK.0000000000000952; Wildes TS, 2019, JAMA-J AM MED ASSOC, V321, P473, DOI 10.1001/jama.2018.22005	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273965	10.1371/journal.pone.0273965	http://dx.doi.org/10.1371/journal.pone.0273965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054128	Green Published, gold			2022-12-26	WOS:000892641400046
J	Nazli, SA; Chua, YA; Mohd Kasim, NA; Ismail, Z; Md Radzi, AB; Ibrahim, KS; Kasim, SS; Rosman, A; Nawawi, H				Nazli, Sukma Azureen; Chua, Yung-An; Mohd Kasim, Noor Alicezah; Ismail, Zaliha; Md Radzi, Ahmad Bakhtiar; Ibrahim, Khairul Shafiq; Kasim, Sazzli Shahlan; Rosman, Azhari; Nawawi, Hapizah			Familial hypercholesterolaemia and coronary risk factors among patients with angiogram- proven premature coronary artery disease in an Asian cohort	PLOS ONE			English	Article							CARDIOVASCULAR RISK; PREVALENCE; MANAGEMENT; EPIDEMIOLOGY; FREQUENCY; STATEMENT; SMOKING; SOCIETY; PROFILE; STROKE	Background Familial hypercholesterolaemia (FH) patients have elevated levels of low-density lipoprotein cholesterol, rendering them at high risk of premature coronary artery disease (PCAD). However, the FH prevalence among angiogram-proven PCAD (AP-PCAD) patients and their status of coronary risk factors (CRFs) have not been reported in the Asian population. Objectives This study aimed to (1) determine the prevalence of clinically diagnosed FH among AP-PCAD patients, (2) compare CRFs between AP-PCAD patients with control groups, and (3) identify the independent predictors of PCAD. Methods AP-PCAD patients and FH patients without PCAD were recruited from Cardiology and Specialist Lipid Clinics. Subjects were divided into AP-PCAD with FH (G1), AP-PCAD without FH (G2), FH without PCAD (G3) and normal controls (G4). Medical records were collected from the clinic database and standardised questionnaires. FH was clinically diagnosed using Dutch Lipid Clinic Network Criteria. Results A total of 572 subjects were recruited (males:86.4%; mean +/- SD age: 55.6 +/- 8.5years). The prevalence of Definite, Potential and All FH among AP-PCAD patients were 6%(19/319), 16% (51/319) and 45.5% (145/319) respectively. G1 had higher central obesity, family history of PCAD and family history of hypercholesterolaemia compared to other groups. Among all subjects, diabetes [OR(95% CI): 4.7(2.9,7.7)], hypertension [OR(95% CI): 14.1 (7.8,25.6)], FH [OR(95% CI): 2.9(1.5,5.5)] and Potential (Definite and Probable) FH [OR (95% CI): 4.5(2.1,9.6)] were independent predictors for PCAD. Among FH patients, family history of PCAD [OR(95% CI): 3.0(1.4,6.3)] and Definite FH [OR(95% CI): 7.1(1.9,27.4)] were independent predictors for PCAD. Conclusion Potential FH is common among AP-PCAD patients and contributes greatly to the AP-PCAD. FH-PCAD subjects have greater proportions of various risk factors compared to other groups. Presence of FH, diabetes, hypertension, obesity and family history of PCAD are independent predictors of PCAD. FH with PCAD is in very-high-risk category, hence, early management of modifiable CRFs in these patients are warranted.	[Nazli, Sukma Azureen; Chua, Yung-An; Ismail, Zaliha; Nawawi, Hapizah] Univ Teknol MARA, Inst Pathol, Lab & Forens Med I PPerForM, Shah Alam, Selangor, Malaysia; [Nazli, Sukma Azureen; Mohd Kasim, Noor Alicezah; Ismail, Zaliha; Md Radzi, Ahmad Bakhtiar; Ibrahim, Khairul Shafiq; Kasim, Sazzli Shahlan; Nawawi, Hapizah] Univ Teknol MARA, Fac Med, Shah Alam, Selangor, Malaysia; [Rosman, Azhari] Inst Jantung Negara IJN, Kuala Lumpur, Malaysia	Universiti Teknologi MARA; Universiti Teknologi MARA	Nawawi, H (corresponding author), Univ Teknol MARA, Inst Pathol, Lab & Forens Med I PPerForM, Shah Alam, Selangor, Malaysia.; Nawawi, H (corresponding author), Univ Teknol MARA, Fac Med, Shah Alam, Selangor, Malaysia.	hapizah.nawawi@gmail.com	; Chua, Yung An/N-5357-2016	Ibrahim, Khairul Shafiq/0000-0002-0507-8865; Chua, Yung An/0000-0003-2387-0087; ismail, zaliha/0000-0003-1144-4451	Malaysia Ministry of Higher Education Long Term Research Grant Scheme [RMI/ST/LRGS5/3 (2/2011)]; Universiti Teknologi MARA MITRA [600IRMI/MYRA 5/3/MITRA (003/20170)]; Malaysia Ministry of Higher Education Fundamental Research Grant Scheme (FRGS) [600-IRMI/FRGS 5/3 (067/2019)]	Malaysia Ministry of Higher Education Long Term Research Grant Scheme; Universiti Teknologi MARA MITRA; Malaysia Ministry of Higher Education Fundamental Research Grant Scheme (FRGS)	This study was funded by Malaysia Ministry of Higher Education Long Term Research Grant Scheme [RMI/ST/LRGS5/3 (2/2011)], Universiti Teknologi MARA MITRA Grant [600IRMI/MYRA 5/3/MITRA (003/20170)-1] and Malaysia Ministry of Higher Education Fundamental Research Grant Scheme (FRGS) [600-IRMI/FRGS 5/3 (067/2019)] which were awarded to the corresponding author (HN). The URL of the funders are (http://mygrants.gov.my/ main.php?Content=articles&ArticleID=3&IID=, https://rmc.uitm.edu.my/images/Download/ Guidelines/G.Dalaman/G.MITRA/ GarisPanduanMitra2017.pdf and http://mygrants. gov.my/main.php?Content=articles&ArticleID= 1 & IID=; respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Razak S, 2017, BMC CARDIOVASC DISOR, V17, DOI 10.1186/s12872-017-0694-z; Aggarwal A, 2016, WORLD J CARDIOL, V8, P728, DOI 10.4330/wjc.v8.i12.728; Alhabib KF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251560; Allard MD, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-65; Amor-Salamanca A, 2017, J AM COLL CARDIOL, V70, P1732, DOI 10.1016/j.jacc.2017.08.009; Ang C S, 2016, Med J Malaysia, V71, P42; [Anonymous], 1991, BMJ, V303, P893; Audelin MC, 2008, J CARDIOPULM REHABIL, V28, P299, DOI 10.1097/01.HCR.0000336139.48698.26; Austin MA, 2004, AM J EPIDEMIOL, V160, P407, DOI 10.1093/aje/kwh236; Bates TR, 2008, HEART LUNG CIRC, V17, P411, DOI 10.1016/j.hlc.2007.06.005; Bianconi V, 2021, TRENDS CARDIOVAS MED, V31, P205, DOI 10.1016/j.tcm.2020.03.004; Chua YA., 2021, J ATHEROSCLER THROMB; De Backer G, 2015, ATHEROSCLEROSIS, V241, P169, DOI 10.1016/j.atherosclerosis.2015.04.809; Duncan MS, 2019, JAMA-J AM MED ASSOC, V322, P642, DOI 10.1001/jama.2019.10298; Ellis KL, 2016, J CLIN LIPIDOL, V10, P1329, DOI 10.1016/j.jacl.2016.08.011; Faggiano P, 2018, INT J CARDIOL, V252, P193, DOI 10.1016/j.ijcard.2017.10.105; Ferencik M, 2012, AM J CARDIOL, V110, P183, DOI 10.1016/j.amjcard.2012.02.066; Futema M, 2013, ATHEROSCLEROSIS, V229, P161, DOI 10.1016/j.atherosclerosis.2013.04.011; Galema-Boers AM, 2018, J CLIN LIPIDOL, V12, P409, DOI 10.1016/j.jacl.2017.12.014; Gallucci G, 2020, J THORAC DIS, V12, P3866, DOI 10.21037/jtd.2020.02.47; Genest J, 2014, CAN J CARDIOL, V30, P1471, DOI 10.1016/j.cjca.2014.09.028; Gidding SS, 2015, CIRCULATION, V132, P2167, DOI 10.1161/CIR.0000000000000297; Hajar Rachel, 2017, Heart Views, V18, P109, DOI 10.4103/HEARTVIEWS.HEARTVIEWS_106_17; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Harada-Shiba M, 2012, J ATHEROSCLER THROMB, V19, P1043, DOI 10.5551/jat.14621; Hata J, 2013, CIRC J, V77, P1923, DOI 10.1253/circj.CJ-13-0786; Lim JU, 2017, INT J CHRONIC OBSTR, V12, P2465, DOI 10.2147/COPD.S141295; Lim MJ, 2013, PROG CARDIOVASC DIS, V55, P504, DOI 10.1016/j.pcad.2013.01.003; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.15829/1560-4071-2020-3826, 10.1093/eurheartj/ehz455]; Mallaina P, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-362; Ministry of Health Malaysia AoMM National Heart Association of Malaysia, 2017, 5 ED CLIN PRACT GUID; Mohammad AM, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/s12872-015-0145-7; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Muntner P, 2019, HYPERTENSION, V73, pE35, DOI 10.1161/HYP.0000000000000087; Nanchen D, 2015, EUR HEART J, V36, P2438, DOI 10.1093/eurheartj/ehv289; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Organization WH, 2011, WAIST CIRCUMFERENCE; Organization WH, 2018, NONCOMMUNICABLE DIS; Pang J, 2019, J CLIN LIPIDOL, V13, P287, DOI 10.1016/j.jacl.2019.01.009; Pang J, 2015, J CLIN LIPIDOL, V9, P703, DOI 10.1016/j.jacl.2015.07.005; Patel JV, 2008, THROMB HAEMOSTASIS, V99, P991, DOI 10.1160/TH08-05-0286; Raparelli V, 2018, CAN J CARDIOL, V34, P468, DOI 10.1016/j.cjca.2018.01.004; Rosamond W, 2007, CIRCULATION, V115, pE69, DOI 10.1161/CIRCULATIONAHA.106.179918; Ruel I, 2018, CAN J CARDIOL, V34, P1210, DOI 10.1016/j.cjca.2018.05.015; Sawhney JPS, 2019, INDIAN HEART J, V71, P118, DOI 10.1016/j.ihj.2018.12.004; Singh A, 2019, J AM COLL CARDIOL, V73, P2439, DOI 10.1016/j.jacc.2019.02.059; Teramoto T, 2018, J ATHEROSCLER THROMB, V25, P580, DOI 10.5551/jat.41483; Toell T, 2018, EUR J NEUROL, V25, P260, DOI 10.1111/ene.13485; Vallejo-Vaz AJ, 2018, ATHEROSCLEROSIS, V277, P289, DOI 10.1016/j.atherosclerosis.2018.06.855; van der Kallen CJH, 2004, OBES RES, V12, P2054, DOI 10.1038/oby.2004.256; Watts GF, 2015, INT J CARDIOL, V185, P69, DOI 10.1016/j.ijcard.2015.03.027; Watts GF., 2016, J ATHEROSCLER THROMB, P35949; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273896	10.1371/journal.pone.0273896	http://dx.doi.org/10.1371/journal.pone.0273896			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054188	Green Published, gold			2022-12-26	WOS:000892641400040
J	Rafeek, RAM; Divarathna, MVM; Morel, AJ; Noordeen, F				Rafeek, Rukshan A. M.; Divarathna, Maduja V. M.; Morel, Adrian J.; Noordeen, Faseeha			Clinical and epidemiological characteristics of influenza virus infection in hospitalized children with acute respiratory infections in Sri Lanka	PLOS ONE			English	Article							RISK-FACTORS; VIRAL-INFECTIONS; TRACT INFECTIONS; YOUNG-CHILDREN; AIR-POLLUTION; AGE; HOUSEHOLD; PARAINFLUENZA; ADMISSIONS; MORTALITY	Influenza viruses (Inf-V) are an important cause of acute respiratory infection (ARI) in children. This study was undertaken to describe the clinical and epidemiological characteristics of Inf-V infections in a sample of hospitalized children with ARI. Nasopharyngeal aspirates (NPA) from 500 children between 1 month to 5 years old with symptoms of ARI were collected at the Teaching Hospital Kegalle Sri Lanka From May 2016 to June 2018, NPAs were tested for influenza A (Inf-A) and B (Inf-B) viruses, human respiratory syncytial virus (hRSV), human parainfluenza virus (hPIV) 1-3 using an immunofluorescence assay. The Inf-V were then subtyped using a multiplex RT-PCR. Inf-V were detected in 10.75% (54/502) of the hospitalized children with ARI and in that 5.57% (28/502) were positive for Inf-A and 5.17% (26/502) were positive for Inf-B. Of the 54 Inf-V positive children, 33 were aged between 6 and 20 months. Of the 28 children infected with Inf-A, 15 had uncharacterized lower respiratory infection, 7 had bronchopneumonia and 6 had bronchiolitis. Of the 26 children infected with Inf-B, 11 had uncharacterized lower respiratory infection, 10 had bronchiolitis, and 4 had bronchopneumonia. Inf-B circulated throughout the year with a few peaks, one in June and then in August followed by November to December in 2016 and one in April 2017 and January 2018. Inf-A circulated throughout the year with a major peak in March to April 2017 and July 2018. ARI was more common in boys compared to girls. Majority of the children infected with Inf-V were diagnosed with uncharacterized lower respiratory infection and mild to moderate bronchiolitis. Inf-V infections were prevalent throughout the year in the study area of Sri Lanka with variations in the type of the circulating virus.	[Rafeek, Rukshan A. M.; Divarathna, Maduja V. M.; Noordeen, Faseeha] Univ Peradeniya, Dept Microbiol, Fac Med, Peradeniya, Sri Lanka; [Morel, Adrian J.] Teaching Hosp, Kegalle, Sri Lanka	University of Peradeniya	Noordeen, F (corresponding author), Univ Peradeniya, Dept Microbiol, Fac Med, Peradeniya, Sri Lanka.	faseeha.noordeen@med.pdn.ac.lk	; Ahamed, Rukshan/D-6272-2019	Noordeen, Faseeha/0000-0002-2018-0606; Ahamed, Rukshan/0000-0001-7190-9666	University of Peradeniya, Sri Lanka [UoP/RG/AF/2013/38/M]	University of Peradeniya, Sri Lanka	FN received funding through Grant No UoP/RG/AF/2013/38/M from University of Peradeniya, Sri Lanka. www.pdn.ac.lk The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belderok SM, 2013, EMERG INFECT DIS, V19, P925, DOI 10.3201/eid1906.111864; Ben M'hadheb M, 2015, CURR MICROBIOL, V70, P324, DOI 10.1007/s00284-014-0719-0; Blizzard L, 2003, AM J PUBLIC HEALTH, V93, P482, DOI 10.2105/AJPH.93.3.482; Breiman RF, 2013, J INFECT DIS, V208, pS167, DOI 10.1093/infdis/jit462; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; CHARLTON A, 1994, J FAM PRACTICE, V38, P267; Chow A, 2006, EMERG INFECT DIS, V12, P114, DOI 10.3201/eid1201.050826; de Oliveira PD, 2019, J PEDIAT-BRAZIL, V95, P657, DOI 10.1016/j.jped.2018.05.012; Dharan NJ, 2014, PEDIATR INFECT DIS J, V33, pE141, DOI 10.1097/INF.0000000000000283; Doshi S, 2015, TROP MED INT HEALTH, V20, P719, DOI 10.1111/tmi.12475; Dumitru IM, 2018, J ENVIRON PROT ECOL, V19, P1445; El Guerche-Seblain C, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6647-y; Hilton JM, 1999, J PAEDIATR CHILD H, V35, P383, DOI 10.1046/j.1440-1754.1999.00386.x; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Horthongkham N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158244; HURWITZ ES, 1991, PEDIATRICS, V87, P62; Klein SL, 2012, J LEUKOCYTE BIOL, V92, P67, DOI 10.1189/jlb.0811427; Klein Sabra L, 2010, Biol Sex Differ, V1, P5, DOI 10.1186/2042-6410-1-5; Liao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138684; Libster R, 2010, NEW ENGL J MED, V362, P45, DOI 10.1056/NEJMoa0907673; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Luteijn JM, 2014, HUM REPROD, V29, P809, DOI 10.1093/humrep/det455; Martin ET, 2012, INFLUENZA OTHER RESP, V6, P71, DOI 10.1111/j.1750-2659.2011.00265.x; Medical Statistic Unit, 2017, ANN HLTH B; Mengelle C, 2014, J CLIN VIROL, V61, P411, DOI 10.1016/j.jcv.2014.08.023; Meqdam MM, 2005, J TROP PEDIATRICS, V51, P160, DOI 10.1093/tropej/fmi002; MISRA PK, 1990, J TROP PEDIATRICS, V36, P24, DOI 10.1093/tropej/36.1.24; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Noordeen F., 2014, SRI LANKAN J INFECT, V4, P48, DOI [10.4038/sljid.v4i1.5988, DOI 10.4038/SLJID.V4I1.5988]; Ope MO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020111; Perera K. V. H. K. K., 2010, CEYLON MEDICAL JOURNAL, V55, P40; Rafeek RAM, 2018, INT J INFECT DIS, V73, P382, DOI 10.1016/j.ijid.2018.04.4278; Rafeek R. A. M., 2017, VirusDisease, V28, P225, DOI 10.1007/s13337-017-0390-8; Ram PK, 2014, AM J TROP MED HYG, V90, P968, DOI 10.4269/ajtmh.13-0532; Ramamurty N, 2005, INDIAN J MED RES, V121, P776; Schwarze J, 2018, ALLERGY, V73, P1151, DOI 10.1111/all.13333; SELIKOWITZ M, 1992, J PAEDIATR CHILD H, V28, P383, DOI 10.1111/j.1440-1754.1992.tb02697.x; Shapiro D, 2017, AM J TROP MED HYG, V97, P88, DOI 10.4269/ajtmh.17-0032; Szilagyi PG, 2008, ARCH PEDIAT ADOL MED, V162, P943, DOI 10.1001/archpedi.162.10.943; Tillekeratne LG, 2019, AM J TROP MED HYG, V100, P672, DOI 10.4269/ajtmh.18-0699; Troeger C, 2017, LANCET INFECT DIS, V17, P1133, DOI 10.1016/S1473-3099(17)30396-1; Vanderburg S, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040612; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628; Xu ZW, 2013, ENVIRON INT, V59, P384, DOI 10.1016/j.envint.2013.06.022; Zhang GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044568	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0272415	10.1371/journal.pone.0272415	http://dx.doi.org/10.1371/journal.pone.0272415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054097	gold, Green Published			2022-12-26	WOS:000892641400009
J	Li, YH; Deng, YR; Zhao, YN; Zhang, W; Zhang, S; Zhang, L; Wang, BY; Xu, YY; Chen, S				Li, Yaohua; Deng, Yiran; Zhao, Yannan; Zhang, Wei; Zhang, Si; Zhang, Li; Wang, Biyun; Xu, Yingying; Chen, She			Immunoglobulin superfamily 9 (IGSF9) is trans-activated by p53, inhibits breast cancer metastasis via FAK	ONCOGENE			English	Article							FOCAL-ADHESION KINASE; GENE-EXPRESSION; TUMOR-SUPPRESSOR; MUTANT P53; MUTATIONS; STATISTICS; SURVIVAL; MOLECULES; PROTEINS; GROWTH	Metastasis of breast cancer represents the major reason for its poor prognosis, leading to high mortality. In breast cancer, a tumor suppressor gene TP53 is commonly mutated. TP53 mutation leads to an altered expression of various genes, an event that is associated with aggressive tumor and is a strong independent marker for survival. In this study, we identified a novel p53 target gene, immunoglobulin superfamily 9 (IGSF9). IGSF9 is generally down-regulated in breast cancer tissues. Loss of IGSF9 is associated with frequent metastasis and poor prognosis of breast cancer patients. Wild-type p53, but not R175H mutant, trans-activates the transcription of IGSF9 via binding to its promoter (-137 to -131 bp), inhibits epithelial-mesenchymal transition (EMT), consequently the inhibition of breast cancer cells migration and invasion. IGSF9 interacts with focal adhesion kinase (FAK) and inhibits FAK/AKT signaling activity. PND1186, FAK inhibitor, inhibits breast cancer metastasis induced by IGSF9 knockdown in vitro and in vivo. Taken together, IGSF9 is trans-activated by p53 and inhibits breast cancer metastasis by modulating FAK/AKT signaling pathway. IGSF9 could serve as a prognostic marker and potential therapeutic target for breast cancer.	[Li, Yaohua; Deng, Yiran; Zhao, Yannan; Zhang, Wei; Zhang, Si; Zhang, Li; Xu, Yingying; Chen, She] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, NHC Key Lab Glycoconjugate Res, 130 Dongan Rd, Shanghai 200032, Peoples R China; [Li, Yaohua; Zhao, Yannan; Wang, Biyun] Fudan Univ, Shanghai Canc Ctr, Shanghai Med Coll, Dept Med Oncol, 270 Dongan Rd, Shanghai 200032, Peoples R China; [Li, Yaohua] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Lab Med, Sch Med, Shanghai 200080, Peoples R China	Fudan University; Fudan University; Shanghai Jiao Tong University	Xu, YY; Chen, S (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, NHC Key Lab Glycoconjugate Res, 130 Dongan Rd, Shanghai 200032, Peoples R China.	yingyingxu@fudan.edu.cn; shechen@fudan.edu.cn		zhang, Si/0000-0002-5682-4995	National Natural Science Foundation of China (NSFC) [81772615, 81972294, 81772968]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	We thank Dr. Wenjiao Zeng from the Department of Pathology, School of Basic Medical Sciences, Fudan University, for technical assistance. This work was supported by the National Natural Science Foundation of China (NSFC) (81772615, 81972294, 81772968).	Bowden NA, 2007, HERED CANCER CLIN PR, V5, P79, DOI 10.1186/1897-4287-5-2-79; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cadwell C, 2001, GENE, V277, P15, DOI 10.1016/S0378-1119(01)00696-5; CALALB MB, 1995, MOL CELL BIOL, V15, P954; Cance WG, 2000, CLIN CANCER RES, V6, P2417; Chang JW, 2018, ONCOGENE, V37, P4137, DOI 10.1038/s41388-018-0253-9; DeSantis C, 2011, CA-CANCER J CLIN, V61, P409, DOI 10.3322/caac.20134; Dong PP, 2020, J HEPATOL, V73, P1446, DOI 10.1016/j.jhep.2020.06.027; Doudney K, 2002, GENOMICS, V79, P663, DOI 10.1006/geno.2002.6757; Duffy MJ, 2018, BREAST CANCER RES TR, V170, P213, DOI 10.1007/s10549-018-4753-7; Golubovskaya VM, 2007, INT REV CYTOL, V263, P103, DOI 10.1016/S0074-7696(07)63003-4; Hansen M, 2013, NEUROCHEM RES, V38, P1236, DOI 10.1007/s11064-013-0999-y; Kaeser MD, 2002, P NATL ACAD SCI USA, V99, P95, DOI 10.1073/pnas.012283399; Kelkar MG, 2017, BREAST CANCER RES TR, V164, P603, DOI 10.1007/s10549-017-4297-2; Kim J, 2012, P NATL ACAD SCI USA, V109, P3921, DOI 10.1073/pnas.1117135109; Kim JH, 2008, TUMOR BIOL, V29, P41, DOI 10.1159/000132570; Lee BY, 2015, PHARMACOL THERAPEUT, V146, P132, DOI 10.1016/j.pharmthera.2014.10.001; Lee G, 2012, CANCER IMMUNOL IMMUN, V61, P89, DOI 10.1007/s00262-011-1088-1; Li DM, 2011, BREAST CANCER RES TR, V128, P7, DOI 10.1007/s10549-011-1499-x; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo M, 2010, CANCER LETT, V289, P127, DOI 10.1016/j.canlet.2009.07.005; Makrilia N, 2009, CANCER INVEST, V27, P1023, DOI 10.3109/07357900902769749; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Perrone C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228422; Press DJ, 2017, CLIN EXP METASTAS, V34, P457, DOI 10.1007/s10585-017-9871-9; Pylayeva Y, 2009, J CLIN INVEST, V119, P252, DOI 10.1172/JCI37160; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Schneider Christoph, 2003, Archives of Gynecology and Obstetrics, V269, P9, DOI 10.1007/s00404-002-0445-x; Shapira I, 2013, CRIT REV ONCOL HEMAT, V88, P284, DOI 10.1016/j.critrevonc.2013.05.003; Shi ZG, 2018, J ONCOL, V2018, DOI 10.1155/2018/2439527; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Sigal A, 2000, CANCER RES, V60, P6788; Silwal-Pandit L, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026252; Smith AP, 2005, CANCER BIOL THER, V4, P1018, DOI 10.4161/cbt.4.9.2165; Strano S, 2007, ONCOGENE, V26, P2212, DOI 10.1038/sj.onc.1210296; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Walsh C, 2010, CANCER BIOL THER, V9, P778, DOI 10.4161/cbt.9.10.11433; Wang XX, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100730; Watermann DO, 2005, BRIT J CANCER, V93, P694, DOI 10.1038/sj.bjc.6602744; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wu HJ, 2020, ONCOGENE, V39, P2539, DOI 10.1038/s41388-020-1162-2; Ye M, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01273-0; Zouq NK, 2009, J CELL SCI, V122, P357, DOI 10.1242/jcs.030478	49	0	0	5	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 7	2022	41	41					4658	4672		10.1038/s41388-022-02459-8	http://dx.doi.org/10.1038/s41388-022-02459-8		SEP 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5D7BH	36088502	hybrid, Green Published			2022-12-26	WOS:000852343800001
J	Adams, TM; Zhao, P; Chapla, D; Moremen, KW; Wells, L				Adams, Trevor M.; Zhao, Peng; Chapla, Digantkumar; Moremen, Kelley W.; Wells, Lance			Sequential in vitro enzymatic N-glycoprotein modification reveals site-specific rates of glycoenzyme processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SURFACE; GLYCOSYLATION; KINETICS; COMPLEX; MICROHETEROGENEITY; ACETYLGLUCOSAMINE; PHARMACOKINETICS; OLIGOSACCHARIDES; SIALYLATION; EXPRESSION	N-glycosylation is an essential eukaryotic posttranslational modification that affects various glycoprotein properties, including folding, solubility, protein-protein interactions, and half-life. N-glycans are processed in the secretory pathway to form varied ensembles of structures, and diversity at a single site on a glycoprotein is termed 'microheterogeneity'. To un-derstand the factors that influence glycan microheterogeneity, we hypothesized that local steric and electrostatic factors sur-rounding each site influence glycan availability for enzymatic modification. We tested this hypothesis via expression of re-porter N-linked glycoproteins in N-acetylglucosaminyl-transferase MGAT1-null HEK293 cells to produce immature Man5GlcNAc2 glycoforms (38 glycan sites total). These glyco-proteins were then sequentially modified in vitro from high mannose to hybrid and on to biantennary, core-fucosylated, complex structures by a panel of N-glycosylation enzymes, and each reaction time course was quantified by LC-MS/MS. Substantial differences in rates of in vitro enzymatic modifi- cation were observed between glycan sites on the same protein, and differences in modification rates varied depending on the glycoenzyme being evaluated. In comparison, proteolytic digestion of the reporters prior to N-glycan processing elimi-nated differences in in vitro enzymatic modification. Further-more, comparison of in vitro rates of enzymatic modification with the glycan structures found on the mature reporters expressed in WT cells correlated well with the enzymatic bottlenecks observed in vivo. These data suggest higher order local structures surrounding each glycosylation site contribute to the efficiency of modification both in vitro and in vivo to establish the spectrum of microheterogeneity in N-linked glycoproteins.	[Adams, Trevor M.; Zhao, Peng; Chapla, Digantkumar; Moremen, Kelley W.; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Moremen, KW; Wells, L (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	moremen@uga.edu; lwells@ccrc.uga.edu		Wells, Lance/0000-0003-4956-5363; Adams, Trevor/0000-0002-6661-1694	National Institutes of Health from NIGMS [5R01GM130915]; Glycoscience Training Program from NIGMS [5T32GM107004]	National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Glycoscience Training Program from NIGMS	This work was supported in part by National Institutes of Health Grant 5R01GM130915 from NIGMS (to K. W. M. and L. W.) and the Glycoscience Training Program (5T32GM107004) from NIGMS. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arigoni-Affolter I, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax8930; ARIMA T, 1972, J BIOL CHEM, V247, P1825; Azevedo V, 2016, CLIN RHEUMATOL, V35, P2877, DOI 10.1007/s10067-016-3427-2; Banks DD, 2011, J MOL BIOL, V412, P536, DOI 10.1016/j.jmb.2011.07.061; BRISSON JR, 1983, CAN J BIOCHEM CELL B, V61, P1067, DOI 10.1139/o83-135; Broszeit F, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25713-1; Burleigh SC, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-95; Caval T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05536-3; Cobb BA, 2020, GLYCOBIOLOGY, V30, P202, DOI 10.1093/glycob/cwz065; Cymer F, 2018, BIOLOGICALS, V52, P1, DOI 10.1016/j.biologicals.2017.11.001; FAYE L, 1986, EUR J BIOCHEM, V158, P655, DOI 10.1111/j.1432-1033.1986.tb09803.x; Garcia-Garcia A, 2021, ACS CATAL, V11, P9052, DOI 10.1021/acscatal.1c01698; Gordon RD, 2006, J MOL BIOL, V360, P67, DOI 10.1016/j.jmb.2006.04.058; Hang I, 2015, GLYCOBIOLOGY, V25, P1335, DOI 10.1093/glycob/cwv058; HARPAZ N, 1980, J BIOL CHEM, V255, P4885; HARPAZ N, 1980, J BIOL CHEM, V255, P4894; HART GW, 1979, J BIOL CHEM, V254, P9747; Hayes JM, 2017, MOL CELL PROTEOMICS, V16, P1770, DOI 10.1074/mcp.M117.066944; Higel F, 2016, EUR J PHARM BIOPHARM, V100, P94, DOI 10.1016/j.ejpb.2016.01.005; Hirschberg K, 1999, FASEB J, V13, pS251, DOI 10.1096/fasebj.13.9002.S251; Isoda Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140120; KASTURI L, 1995, J BIOL CHEM, V270, P14756, DOI 10.1074/jbc.270.24.14756; Li TZ, 2017, P NATL ACAD SCI USA, V114, P3485, DOI 10.1073/pnas.1702173114; Liu LM, 2013, PHARM RES-DORDR, V30, P803, DOI 10.1007/s11095-012-0921-3; Losfeld ME, 2017, FASEB J, V31, P4623, DOI 10.1096/fj.201700403R; Mathew C, 2021, RSC CHEM BIOL, V2, P917, DOI 10.1039/d1cb00019e; Meng L, 2013, J BIOL CHEM, V288, P34680, DOI 10.1074/jbc.M113.519041; Moremen KW, 2018, NAT CHEM BIOL, V14, P156, DOI [10.1038/NCHEMBIO.2539, 10.1038/nchembio.2539]; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Mukai Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000954; NARASIMHAN S, 1977, J BIOL CHEM, V252, P3926; Narimatsu Y, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100448; Patel K. R., 2020, J BIOL CHEM, V296, P1; Patel KR, 2019, MOL CELL PROTEOMICS, V18, P2178, DOI 10.1074/mcp.RA119.001607; Patel KR, 2018, J BIOL CHEM, V293, P3477, DOI 10.1074/jbc.RA117.001207; Rose DR, 2012, CURR OPIN STRUC BIOL, V22, P558, DOI 10.1016/j.sbi.2012.06.005; Rudd PM, 1997, CURR OPIN BIOTECH, V8, P488, DOI 10.1016/S0958-1669(97)80073-0; SAVVIDOU G, 1984, BIOCHEMISTRY-US, V23, P3736, DOI 10.1021/bi00311a026; Sinclair AM, 2005, J PHARM SCI-US, V94, P1626, DOI 10.1002/jps.20319; Sola RJ, 2009, J PHARM SCI-US, V98, P1223, DOI 10.1002/jps.21504; Stanley P., 2015, ESSENTIALS GLYCOBIOL; Stanley P., 2022, ESSENTIALS GLYCOBIOL, V4th ed.; Subedi GP, 2015, STRUCTURE, V23, P1573, DOI 10.1016/j.str.2015.06.015; SWIEDLER SJ, 1985, J BIOL CHEM, V260, P4046; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Sztain T, 2021, NAT CHEM, V13, P963, DOI [10.1101/2021.02.15.431212, 10.1038/s41557-021-00758-3]; TAKASAKI S, 1982, METHOD ENZYMOL, V83, P263; Thaysen-Andersen M, 2012, GLYCOBIOLOGY, V22, P1440, DOI 10.1093/glycob/cws110; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Watanabe Y, 2019, BBA-GEN SUBJECTS, V1863, P1480, DOI 10.1016/j.bbagen.2019.05.012; Weiss RG, 2021, J PHYS CHEM B, V125, P9467, DOI 10.1021/acs.jpcb.1c04279; Wild R, 2018, SCIENCE, V359, P545, DOI 10.1126/science.aar5140; Xiao TS, 2021, NAT STRUCT MOL BIOL, V28, P202, DOI 10.1038/s41594-020-00549-3; Yu XJ, 2013, J AM CHEM SOC, V135, P9723, DOI 10.1021/ja4014375; Zeng WF, 2021, NAT METHODS, V18, P1515, DOI 10.1038/s41592-021-01306-0; Zhao P, 2020, CELL HOST MICROBE, V28, P586, DOI [10.1016/j.chom.2020.08.004, 10.1101/2020.06.25.172403]; Zhou TQ, 2017, CELL REP, V19, P719, DOI 10.1016/j.celrep.2017.04.013	58	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102474	10.1016/j.jbc.2022.102474	http://dx.doi.org/10.1016/j.jbc.2022.102474			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5J0EG	36089065	Green Submitted, gold, Green Published			2022-12-26	WOS:000868720100006
J	Abdelhamed, H; Ramachandran, R; Narayanan, L; Islam, S; Ozan, O; Freitag, N; Lawrence, ML				Abdelhamed, Hossam; Ramachandran, Reshma; Narayanan, Lakshmi; Islam, Shamima; Ozan, Ozdemir; Freitag, Nancy; Lawrence, Mark L.			Role of FruR transcriptional regulator in virulence of Listeria monocytogenes and identification of its regulon	PLOS ONE			English	Article							PENTOSE-PHOSPHATE PATHWAY; GENE-EXPRESSION; MUTATIONAL ACTIVATION; LACTOCOCCUS-LACTIS; NITROSATIVE STRESS; ESCHERICHIA-COLI; OXIDATIVE STRESS; DEOR REPRESSOR; FRUCTOSE; PRFA	Listeria monocytogenes is a ubiquitous opportunistic foodborne pathogen capable of survival in various adverse environmental conditions. Pathogenesis of L. monocytogenes is tightly controlled by a complex regulatory network of transcriptional regulators that are necessary for survival and adaptations to harsh environmental conditions both inside and outside host cells. Among these regulatory pathways are members of the DeoR-family transcriptional regulators that are known to play a regulatory role in sugar metabolism. In this study, we deciphered the role of FruR, a DeoR family protein, which is a fructose operon transcriptional repressor protein, in L. monocytogenes pathogenesis and growth. Following intravenous (IV) inoculation in mice, a mutant strain with deletion of fruR exhibited a significant reduction in bacterial burden in liver and spleen tissues compared to the parent strain. Further, the Delta fruR strain had a defect in cell-to-cell spread in L2 fibroblast monolayers. Constitutive activation of PrfA, a pleiotropic activator of L. monocytogenes virulence factors, did not restore virulence to the Delta fruR strain, suggesting that the attenuation was not a result of impaired PrfA activation. Transcriptome analysis revealed that FruR functions as a positive regulator for genes encoding enzymes involved in the pentose phosphate pathway (PPP) and as a repressor for genes encoding enzymes in the glycolysis pathway. These results suggested that FruR may function to facilitate NADPH regeneration, which is necessary for full protection from oxidative stress. Interestingly, deletion of fruR increased sensitivity of L. monocytogenes to H2O2, confirming a role for FruR in survival of L. monocytogenes during oxidative stress. Using anti-mouse neutrophil/monocyte monoclonal antibody RB6-8C5 (RB6) in an in vivo infection model, we found that FruR has a specific function in protecting L. monocytogenes from neutrophil/monocyte-mediated killing. Overall, this work clarifies the role of FruR in controlling L. monocytogenes carbon flow between glycolysis and PPP for NADPH homeostasis, which provides a new mechanism allowing metabolic adaptation of L. monocytogenes to oxidative stress.	[Abdelhamed, Hossam; Ramachandran, Reshma; Narayanan, Lakshmi; Islam, Shamima; Ozan, Ozdemir; Lawrence, Mark L.] Mississippi State Univ, Dept Comparat Biomed Sci, Coll Vet Med, Starkville, MS 39762 USA; [Ramachandran, Reshma] Mississippi State Univ, Dept Poultry Sci, Starkville, MS USA; [Freitag, Nancy] Univ Illinois, Dept Pharmaceut Sci, Chicago, IL USA	Mississippi State University; Mississippi State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Abdelhamed, H (corresponding author), Mississippi State Univ, Dept Comparat Biomed Sci, Coll Vet Med, Starkville, MS 39762 USA.	abdelhamed@cvm.msstate.edu		abdelhamed, hossam/0000-0003-2439-0659	Center for Biomedical Research Excellence in Pathogen-Host Interactions, National Institute of General Medical Sciences, National Institutes of Health [P20 GM103646-08]	Center for Biomedical Research Excellence in Pathogen-Host Interactions, National Institute of General Medical Sciences, National Institutes of Health	This study was supported (HA) by the Center for Biomedical Research Excellence in Pathogen-Host Interactions, National Institute of General Medical Sciences, National Institutes of Health (P20 GM103646-08).	Abdelhamed H, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00087-20; Abdelhamed H, 2015, PLASMID, V81, P1, DOI 10.1016/j.plasmid.2015.05.003; Anaya-Sanchez A, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009819; Balleza E, 2009, FEMS MICROBIOL REV, V33, P133, DOI 10.1111/j.1574-6976.2008.00145.x; Barriere C, 2005, J BACTERIOL, V187, P3752, DOI 10.1128/JB.187.11.3752-3761.2005; Behari J, 1998, INFECT IMMUN, V66, P3635, DOI 10.1128/IAI.66.8.3635-3642.1998; BENTHIN S, 1993, APPL ENVIRON MICROB, V59, P3206, DOI 10.1128/AEM.59.10.3206-3211.1993; Bruno JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015138; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P1085; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chaturongakul S, 2004, APPL ENVIRON MICROB, V70, P5349, DOI 10.1128/AEM.70.9.5349-5356.2004; Chaturongakul S, 2008, TRENDS MICROBIOL, V16, P388, DOI 10.1016/j.tim.2008.05.006; Cheng CY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00287; CHIN AM, 1987, J BACTERIOL, V169, P897, DOI 10.1128/jb.169.2.897-899.1987; Christodoulou D, 2018, CELL SYST, V6, P569, DOI 10.1016/j.cels.2018.04.009; Comtois SL, 2003, MICROBIOL-SGM, V149, P121, DOI 10.1099/mic.0.25896-0; Cosgrove Shaun, 2011, Morbidity and Mortality Weekly Report, V60, P1357; Dinauer MC, 1997, J IMMUNOL, V158, P5581; Dons LE, 2014, PATHOG DIS, V70, P70, DOI 10.1111/2049-632X.12081; Drevets DA, 2008, FEMS IMMUNOL MED MIC, V53, P151, DOI 10.1111/j.1574-695X.2008.00404.x; Elgrably-Weiss M, 2006, FEMS MICROBIOL LETT, V254, P141, DOI 10.1111/j.1574-6968.2005.00020.x; Engels V, 2007, J BACTERIOL, V189, P2955, DOI 10.1128/JB.01596-06; Fox EM, 2011, APPL ENVIRON MICROB, V77, P6559, DOI 10.1128/AEM.05529-11; Freitag NE, 2006, FUTURE MICROBIOL, V1, P89, DOI 10.2217/17460913.1.1.89; Garner MR, 2006, INFECT IMMUN, V74, P876, DOI 10.1128/IAI.74.2.876-886.2006; Gaurivaud P, 2001, FEMS MICROBIOL LETT, V198, P73, DOI 10.1111/j.1574-6968.2001.tb10621.x; Ghanem ENB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003015; Han TL, 2019, NPJ BIOFILMS MICROBI, V5, DOI 10.1038/s41522-019-0086-5; Hurd S., 2000, Morbidity and Mortality Weekly Report, V49, P1129; Jiang P, 2014, PROTEIN CELL, V5, P592, DOI 10.1007/s13238-014-0082-8; JONES S, 1994, INFECT IMMUN, V62, P5608, DOI 10.1128/IAI.62.12.5608-5613.1994; Joseph B, 2006, J BACTERIOL, V188, P556, DOI 10.1128/JB.188.2.556-568.2006; Joseph B, 2008, J BACTERIOL, V190, P5412, DOI 10.1128/JB.00259-08; Kohler S, 2002, P NATL ACAD SCI USA, V99, P15711, DOI 10.1073/pnas.232454299; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; Leal SM, 2012, J CLIN INVEST, V122, P2482, DOI 10.1172/JCI63239; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; Liu XG, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0496-x; Liu XJ, 2014, APPL ENVIRON MICROB, V80, P3835, DOI 10.1128/AEM.00350-14; Liu YH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01611; Lopez S, 2000, INFECT IMMUN, V68, P4789, DOI 10.1128/IAI.68.8.4789-4791.2000; Mains DR, 2021, INFECT IMMUN, V89, DOI 10.1128/IAI.00700-20; Mead PS, 2006, EPIDEMIOL INFECT, V134, P744, DOI 10.1017/S0950268805005376; Milenbachs AA, 1997, MOL MICROBIOL, V23, P1075, DOI 10.1046/j.1365-2958.1997.2711634.x; Miner MD, 2008, MICROBIOL-SGM, V154, P3579, DOI 10.1099/mic.0.2008/021063-0; Moreau PL, 2004, J BACTERIOL, V186, P7364, DOI 10.1128/JB.186.21.7364-7368.2004; MORTENSEN L, 1989, EMBO J, V8, P325, DOI 10.1002/j.1460-2075.1989.tb03380.x; Nelson KE, 2004, NUCLEIC ACIDS RES, V32, P2386, DOI 10.1093/nar/gkh562; O'Byrne CP, 2008, ADV APPL MICROBIOL, V65, P115, DOI 10.1016/S0065-2164(08)00605-9; Olier M, 2003, INFECT IMMUN, V71, P1217, DOI 10.1128/IAI.71.3.1217-1224.2003; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Port GC, 2007, INFECT IMMUN, V75, P5886, DOI 10.1128/IAI.00845-07; PREMARATNE RJ, 1991, APPL ENVIRON MICROB, V57, P3046, DOI 10.1128/AEM.57.10.3046-3048.1991; Ramos-Aires J, 2004, ANTIMICROB AGENTS CH, V48, P843, DOI 10.1128/AAC.48.3.843-851.2004; RAMSEIER TM, 1995, MOL MICROBIOL, V16, P1157, DOI 10.1111/j.1365-2958.1995.tb02339.x; RAMSEIER TM, 1993, J MOL BIOL, V234, P28, DOI 10.1006/jmbi.1993.1561; Ramseier TM, 1996, RES MICROBIOL, V147, P489, DOI 10.1016/0923-2508(96)84003-4; Reniere ML, 2015, NATURE, V517, P170, DOI 10.1038/nature14029; Ripio MT, 1997, J BACTERIOL, V179, P7174, DOI 10.1128/jb.179.22.7174-7180.1997; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schauer K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-573; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; Shi C, 2011, J IMMUNOL, V187, P5293, DOI 10.4049/jimmunol.1101721; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; Stincone A, 2015, BIOL REV, V90, P927, DOI 10.1111/brv.12140; SUN AN, 1990, INFECT IMMUN, V58, P3770, DOI 10.1128/IAI.58.11.3770-3778.1990; Tiensuu T, 2019, MICROBIOL-SGM, V165, P819, DOI 10.1099/mic.0.000808; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Turner SE, 2020, MOL PLANT MICROBE IN, V33, P509, DOI 10.1094/MPMI-10-19-0290-R; Valdes KM, 2016, INFECT IMMUN, V84, P1016, DOI 10.1128/IAI.01296-15; Voigt C, 2014, APPL MICROBIOL BIOT, V98, P7161, DOI 10.1007/s00253-014-5809-1; VONBODMAN SB, 1992, P NATL ACAD SCI USA, V89, P643, DOI 10.1073/pnas.89.2.643; Wiedmann M, 1998, J BACTERIOL, V180, P3650, DOI 10.1128/JB.180.14.3650-3656.1998; Wong KKY, 2004, J BACTERIOL, V186, P6265, DOI 10.1128/JB.186.18.6265-6276.2004; Xayarath B, 2012, FUTURE MICROBIOL, V7, P839, DOI [10.2217/fmb.12.57, 10.2217/FMB.12.57]; Zeng XM, 2000, J BACTERIOL, V182, P1916, DOI 10.1128/JB.182.7.1916-1922.2000; Ziveri J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00889-7	80	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274005	10.1371/journal.pone.0274005	http://dx.doi.org/10.1371/journal.pone.0274005			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054213	Green Published, gold			2022-12-26	WOS:000892641400051
J	Haluszko, A; Kadej, M; Gmyrek, G; Guzinski, M				Haluszko, Agata; Kadej, Marcin; Gmyrek, Grzegorz; Guzinski, Maciej			Let's make a mess, maybe no one will notice. The impact of bioturbation activity on the urn fill condition	PLOS ONE			English	Article							LATERAL ANGLE; COMPUTED-TOMOGRAPHY; SEX DETERMINATION; TOOTH CEMENTUM; CREMATION; TAPHONOMY; PRESERVATION; EXCAVATION; COLEOPTERA; BURIALS	The research was carried out at the cremation cemetery of the Lusatian culture in Wtorek, Ostrow Wielkopolski district, Wielkopolska province, Poland. Contrary to the so-far-studied topics related to the CT imaging of burnt bones and their virtual exploration, we concentrated on the analysis of the structures formed by the soil fauna activity in the fills of urns and additional vessels, and reconstruction of the dynamics of the ecosystem variability within the cemetery area based on thereof. We also demonstrated the impact of macrofaunal activity on stratigraphy and bone fragmentation. From the total of 222 excavated burials in 18 urns and one additional vessel, the remains of macrofauna or its bioturbation activity were identified. Out of 19 vessels subjected to CT examinations, traces of macrofaunal activity were demonstrated in 13: in five vessels animal bioturbative activity was not observed and in one, observations was impossible (due to significant metal-related artifacts). In two vessels both macrofaunal remains and traces of activity were identified. Discovered bioturbations were associated with specific species or genera. Nests or their parts of the genus Geotrupes sp. beetles were the most frequently observed traces of macrofaunal activity. Tunnels and aestivation chambers of earthworms and chambers of the genus Harpalus sp. beetles filled with Setaria sp. caryopses were discovered. The chitinous parts of other insects and the humerus bones of the vole of the genus Microtus sp. were also identified. It was shown, especially due to the non-destructive method, that rodents activity had the most destructive effect on the bone stratigraphy as well as on the movement and fragmentation of the burnt bones. The chances of visualizing bioturbations decreased with time since their creation. The process of disappearance of traces of macrofaunal activity concerned both traces of rodent activity and nests set up by Geotrupes sp. and other species.	[Haluszko, Agata] Archeolodzy Org Fdn, Wroclaw, Poland; [Haluszko, Agata] Univ Wroclaw, Inst Archaeol, Wroclaw, Poland; [Kadej, Marcin] Univ Wroclaw, Fac Biol Sci, Dept Forens Biol & Entomol, Wroclaw, Poland; [Gmyrek, Grzegorz] Uslugi Archeol Grzegorz Gmyrek, Kalisz, Poland; [Guzinski, Maciej] Wroclaw Med Univ, Dept Gen & Intervent Radiol & Neuroradiol, Wroclaw, Poland	University of Wroclaw; University of Wroclaw; Wroclaw Medical University	Haluszko, A (corresponding author), Archeolodzy Org Fdn, Wroclaw, Poland.; Haluszko, A (corresponding author), Univ Wroclaw, Inst Archaeol, Wroclaw, Poland.	agata@archeolodzy.org	Kadej, Marcin/E-5916-2018	Kadej, Marcin/0000-0001-5983-0402; Haluszko, Agata/0000-0001-8312-3222	National Science Center, Poland [UMO-2018/29/N/HS3/00887]	National Science Center, Poland(National Science Centre, Poland)	The research was carried out as a part of research project no. UMO-2018/29/N/HS3/00887, funded by the National Science Center, Poland.	Ablamowicz R., 2020, CMENTARZYSKO WCZESNE; Akansel G, 2008, FORENSIC SCI INT, V178, P93, DOI 10.1016/j.forsciint.2008.02.006; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; ANDERSON T, 1995, J ARCHAEOL SCI, V22, P609, DOI 10.1016/S0305-4403(95)80146-4; Andrews C., 1994, AMULETS ANCIENT EGYP; Antosik L., 2017, NOWE ODKRYCIA TEKSTY, V12, P89; Antosik L., 2014, OPOLSKI ROCZNIK MUZE, V20, P103; Antosik L., 2019, ROCZNIK MUZEUM GORNO, P11; Baker BJ., 2005, OSTEOLOGY INFANTS CH; Baron J., 2017, SOC POLISH LANDS 1 E, P368; Betard F, 2021, EARTH SURF PROC LAND, V46, P89, DOI 10.1002/esp.4944; Brothwell D., 2002, ADV FORENSIC TAPHONO, P119; Burakowski B., 1993, MEMORABILIA ZOOLOGIC, P46; Carr G., 1997, OXBOW MONOGRAPH, P167; Cavalli F., 2012, RESTAURANDO STORIA L, P113; Cavazzuti C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209423; Chen HL, 1998, J ARCHAEOL SCI, V25, P1015, DOI 10.1006/jasc.1997.0286; Chmielewski TJ., 2021, PRAEHIST Z, DOI [10.1515/pz-2021-2042, DOI 10.1515/PZ-2021-2042]; Chochorowski J, 1978, STUDIOW OKRESEM HALS, V23, P355; Cook DC, 2014, INT J OSTEOARCHAEOL, V24, P123, DOI 10.1002/oa.1302; Corron L., 2016, BMSAP, V29, P1; Cosin DJD, 2006, INVERTEBR BIOL, V125, P250, DOI 10.1111/j.1744-7410.2006.00057.x; Cunningham C, 2016, DEVELOPMENTAL JUVENILE OSTEOLOGY, 2ND EDITION; Curate F, 2016, FORENSIC SCI INT, V266, DOI 10.1016/j.forsciint.2016.06.011; Dabrowski J, 2019, APPL SOIL ECOL, V134, P116, DOI 10.1016/j.apsoil.2018.10.015; Davidson DA, 2002, J ARCHAEOL SCI, V29, P1237; Dokladal M., 1999, MORFOLOGIE SPALENYCH; Fazekas IG., 1978, FORENSIC FETAL OSTEO; Gardawski A., 1979, PRAHISTORIA ZIEM POL, P22; Gastelum-Strozzi A, 2019, J ARCHAEOL SCI-REP, V28, DOI 10.1016/j.jasrep.2019.102053; Gediga B, 2007, PROBLEMY OBRAZU KULT, V49, P123; Gediga B., 2018, WROCLAW, V66, P137, DOI [10.23858/PA66.2018.006, DOI 10.23858/PA66.2018.006]; Gediga B., 1967, PLEMIONA KULTURY LUZ; Gedl M., 1991, HALLSTATTEINFLUSSE P; Gedl M., 1984, WCZESO UZYCKIE GROBY; Gejvall NG., 1969, SCI ARCHAEOLOGY SURV; GILLARD RD, 1994, STUD CONSERV, V39, P132, DOI 10.2307/1506562; Gladykowska-Rzeczycka J., 1974, POMORANIA ANTIQUA, V5, P27; Gladykowska-Rzeczycka J, 1971, POMORANIA ANTIQUA, V3, P101; Gocha TP, 2013, J FORENSIC SCI, V58, pS151, DOI 10.1111/1556-4029.12023; Goncalves D, 2013, J FORENSIC LEG MED, V20, P906, DOI 10.1016/j.jflm.2013.07.003; Goncalves D, 2011, J ARCHAEOL SCI, V38, P1308, DOI 10.1016/j.jas.2011.01.006; Goncalves D, 2015, INT J LEGAL MED, V129, P1183, DOI 10.1007/s00414-015-1154-x; Goncalves D, 2013, J FORENSIC SCI, V58, P1134, DOI 10.1111/1556-4029.12167; Goncalves D, 2011, HOMO, V62, P351, DOI 10.1016/j.jchb.2011.08.003; Goslar T., 2019, PRZEGL D ARCHEOLOGIC, V67, P31; Graw M, 2005, FORENSIC SCI INT, V147, P113, DOI 10.1016/j.forsciint.2004.08.006; GREVIN G, 1990, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V2, P67, DOI 10.3406/bmsap.1990.1744; GROSSKOPF B, 1990, Z RECHTSMED, V103, P351, DOI 10.1007/BF01263040; Grosskopf Birgit, 2004, Anthropologischer Anzeiger, V62, P281; Hadley A., 2010, COMBINE ZM SOFTWARE; Haluszko A., 2016, SLASKIE SPRAWOZDANIA, V58, P59; Haluszko A., 2022, ANTHROPOL REV, V85, P63; Haluszko A., 2015, ROLANTOWICE 2 SILESI, V50, P61; Haluszko A., 2016, METODY GEOFIZYCZNE A, P36; Hartke A, 1998, BIOL CONTROL, V13, P91, DOI 10.1006/bcon.1998.0645; Harvig L, 2012, ARCHAEOMETRY, V54, P369, DOI 10.1111/j.1475-4754.2011.00629.x; Harvig L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101603; Harvig L, 2013, J ARCHAEOL SCI, V40, P2713, DOI 10.1016/j.jas.2013.01.024; Henneberg M., 1974, METODY WYNIKI KONSEK, V2, P117; Hershkovitz I, 1997, AM J PHYS ANTHROPOL, V103, P393, DOI 10.1002/(SICI)1096-8644(199707)103:3<393::AID-AJPA8>3.0.CO;2-R; Higgins OA, 2020, J ARCHAEOL SCI-REP, V32, DOI 10.1016/j.jasrep.2020.102396; Hunger H., 1978, IDENTIFIKATION, P162; Innocenti D., 2015, ARCH OLOGISCHE BIOGR, P238; JAKES KA, 1986, ADV CHEM SER, P277; JAKES KA, 1984, ADV CHEM SER, P403; Kaczmarek M., 2017, SOC POLISH LANDS 1 E, P264; Kaczmarek M., 2001, SPRAWOZDANIA ARCHEOL, V53, P85; Knusel CJ, 2016, J ARCHAEOL SCI-REP, V10, P655, DOI 10.1016/j.jasrep.2016.05.031; Kosinski D., 1984, PRZEGL D ARCHEOLOGIC, V32, P61; Kromp B, 1999, AGR ECOSYST ENVIRON, V74, P187, DOI 10.1016/S0167-8809(99)00037-7; Lasak I, 1996, EPOKA BRAZU POGRANIC; Le Goff I., 1996, BMSAP, V8, P223, DOI [10.3406/bmsap.1996.2444, DOI 10.3406/BMSAP.1996.2444]; Le Goff I., 2005, ACTES CONGRES NATION, V125, P209; Leclant J., 1985, ORIENTALIA, V54, P337; Madera P., 1999, SL SKIE SPRAWOZDANIA, V41, P231; Maik J., 2016, EUROPA OKRESIE 8 WIE, P25; Malinowski T, 1962, OBRZADEK POGRZEBOWY, V14, P5; Malinowski T., 1961, KATALOG CMENTARZYSK; Mani-Caplazi G, 2019, INT J PALEOPATHOL, V27, P24, DOI 10.1016/j.ijpp.2019.07.003; McKinley JI, 2008, ANALYSIS OF BURNED HUMAN REMAINS, P163, DOI 10.1016/B978-012372510-3.50012-5; MCKINLEY JI, 1994, J ARCHAEOL SCI, V21, P339, DOI 10.1006/jasc.1994.1033; Moskal-del Hoyo M., 2009, SPRAWOZDANIA ARCHEOL, V61, P243; Moszynski K, 1939, KULTURA LUDOWA SLOWI; Naji S., 2014, COMMINGLED HUMAN REM, P33, DOI [10.1016/B978-0-12-405889-7.00003-4, DOI 10.1016/B978-0-12-405889-7.00003, DOI 10.1016/B978-0-12-405889-7.00003-4]; Noren A, 2005, AM J PHYS ANTHROPOL, V128, P318, DOI 10.1002/ajpa.20245; Pankowska A, 2017, INT J OSTEOARCHAEOL, V27, P143, DOI 10.1002/oa.2525; Pankowska A., 2014, ARCH OLOGISCHE ARBEI, P223; Pudelko E., 2006, ROCZNIK KALISKI, V32, P213; Pudelko E, 1990, ROCZNIK KALISKI, V22, P125; Purowski T., 2019, FAJANSU SZKLA KONTAK; Reiter SS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249476; RomeroSamper J, 1995, EUR J ENTOMOL, V92, P667; Ronowski F., 1996, ZMIENNO BIOLOGICZNA, V3, P167; Sikorski A., 2001, SPRAWOZDANIA ARCHEOL, V53, P377; Silva AM, 2015, HOMO, V66, P1, DOI 10.1016/j.jchb.2014.10.003; Silva AM, 2009, INT J OSTEOARCHAEOL, V19, P628, DOI 10.1002/oa.998; Sliwa J, 2000, SWIATOWIT, V2, P187; Slomska J., 2018, PRZEGL D ARCHEOLOGIC, V66, P57; Snoeck C., 2018, SCI REP-UK, V8, P1; SPRINGETT JA, 1984, SOIL BIOL BIOCHEM, V16, P185, DOI 10.1016/0038-0717(84)90110-X; Stankiewicz BA, 1997, SCIENCE, V276, P1541, DOI 10.1126/science.276.5318.1541; Valdez AS, 2020, ARCH AGRON SOIL SCI, V66, P957, DOI 10.1080/03650340.2019.1648792; Taylor N, 2020, J ARCHAEOL SCI-REP, V31, DOI 10.1016/j.jasrep.2020.102356; Ubelaker DH, 1978, HUMAN SKELETAL REMAI; Veselka B, 2021, RAPID COMMUN MASS SP, V35, DOI 10.1002/rcm.9038; WAHL J, 1980, Zeitschrift fuer Morphologie und Anthropologie, V70, P258; Waterhouse K, 2013, J FORENSIC LEG MED, V20, P489, DOI 10.1016/j.jflm.2013.03.016; WELLS C, 1960, ANTIQUITY, V34, P29, DOI 10.1017/S0003598X00035146; Wells C., 1967, DIS ANTIQUITY SURVEY, P5; White TD., 2012, HUMAN OSTEOLOGY AMST; Wilhelmson H, 2015, AM J PHYS ANTHROPOL, V157, P305, DOI 10.1002/ajpa.22715; Wilske B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126011; Young A., 2017, TAPHONOMY HUMAN REMA, P212	114	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274068	10.1371/journal.pone.0274068	http://dx.doi.org/10.1371/journal.pone.0274068			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054191	gold, Green Published			2022-12-26	WOS:000892641400057
J	Li, RM; Bhandari, S; Martinez-Zubiaurre, I; Bruun, JA; Urbarova, I; Smedsrod, B; Simon-Santamaria, J; Sorensen, KK				Li, Ruomei; Bhandari, Sabin; Martinez-Zubiaurre, Inigo; Bruun, Jack-Ansgar; Urbarova, Ilona; Smedsrod, Bard; Simon-Santamaria, Jaione; Sorensen, Karen Kristine			Changes in the proteome and secretome of rat liver sinusoidal endothelial cells during early primary culture and effects of dexamethasone	PLOS ONE			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; MANNOSE RECEPTOR; HYALURONAN RECEPTOR; SCAVENGER RECEPTOR; EXPRESSION; GENE; DIFFERENTIATION; IDENTIFICATION; HETEROGENEITY; HOMEOSTASIS	Introduction Liver sinusoidal endothelial cells (LSECs) are specialized fenestrated scavenger endothelial cells involved in the elimination of modified plasma proteins and tissue turnover waste macromolecules from blood. LSECs also participate in liver immune responses. A challenge when studying LSEC biology is the rapid loss of the in vivo phenotype in culture. In this study, we have examined biological processes and pathways affected during early-stage primary culture of rat LSECs and checked for cell responses to the pro-inflammatory cytokine interleukin (IL)-1 beta and the anti-inflammatory drug dexamethasone. Methods LSECs from male Sprague Dawley rats were cultured on type I collagen in 5% oxygen atmosphere in DMEM with serum-free supplements for 2 and 24 h. Quantitative proteomics using tandem mass tag technology was used to examine proteins in cells and supernatants. Validation was done with qPCR, ELISA, multiplex immunoassay, and caspase 3/7 assay. Cell ultrastructure was examined by scanning electron microscopy, and scavenger function by quantitative endocytosis assays. Results LSECs cultured for 24 h showed a characteristic pro-inflammatory phenotype both in the presence and absence of IL-1 beta, with upregulation of cellular responses to cytokines and interferon-gamma, cell-cell adhesion, and glycolysis, increased expression of fatty acid binding proteins (FABP4, FABP5), and downregulation of several membrane receptors (STAB1, STAB2, LYVE1, CLEC4G) and proteins in pyruvate metabolism, citric acid cycle, fatty acid elongation, amino acid metabolism, and oxidation-reduction processes. Dexamethasone inhibited apoptosis and improved LSEC viability in culture, repressed inflammatory and immune regulatory pathways and secretion of IL-16 and IL-6, and further upregulated FABP4 and FABP5 compared to time-matched controls. The LSEC porosity and endocytic activity were reduced at 24 h both with and without dexamethasone but the dexamethasone-treated cells showed a less stressed phenotype. Conclusion Rat LSECs become activated towards a pro-inflammatory phenotype during early culture. Dexamethasone represses LSEC activation, inhibits apoptosis, and improves cell viability.	[Li, Ruomei; Bhandari, Sabin; Bruun, Jack-Ansgar; Smedsrod, Bard; Simon-Santamaria, Jaione; Sorensen, Karen Kristine] UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway; [Martinez-Zubiaurre, Inigo] UiT Arctic Univ Norway, Dept Clin Med, Tromso, Norway; [Urbarova, Ilona] UiT Arctic Univ Norway, Dept Community Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso	Sorensen, KK (corresponding author), UiT Arctic Univ Norway, Dept Med Biol, Tromso, Norway.	karen.sorensen@uit.no		Urbarova, Ilona/0000-0001-6626-2917; Simon-Santamaria, Jaione/0000-0002-0688-2150	UiT The Arctic University of Norway	UiT The Arctic University of Norway	The study was supported by UiT The Arctic University of Norway. The funder had no role in study design, data collection and analysis,	Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Anasagasti MJ, 1996, J CELL PHYSIOL, V167, P314, DOI 10.1002/(SICI)1097-4652(199605)167:2<314::AID-JCP16>3.0.CO;2-7; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arimoto J, 2010, J GASTROENTEROL, V45, P317, DOI 10.1007/s00535-009-0152-5; Arteta B, 2010, HEPATOLOGY, V51, P2172, DOI 10.1002/hep.23590; Arul AB, 2019, ANAL CHEM, V91, P178, DOI 10.1021/acs.analchem.8b05626; Asumendi A, 1996, HEPATOLOGY, V23, P1521, DOI 10.1002/hep.510230632; Azimifar SB, 2014, CELL METAB, V20, P1076, DOI 10.1016/j.cmet.2014.11.002; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bhandari S, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.757469; Bhandari S, 2020, BMC MOL CELL BIOL, V21, DOI 10.1186/s12860-020-00331-9; BLOMHOFF R, 1984, BIOCHEM J, V218, P81, DOI 10.1042/bj2180081; Broering R, 2011, INT IMMUNOL, V23, P537, DOI 10.1093/intimm/dxr048; Butler LM, 2016, CELL SYST, V3, P287, DOI 10.1016/j.cels.2016.08.001; Carreira CM, 2001, CANCER RES, V61, P8079; Chen R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.337; de Haan W, 2020, AM J PHYSIOL-GASTR L, V318, pG803, DOI 10.1152/ajpgi.00215.2019; DeLeve LD, 2008, HEPATOLOGY, V48, P920, DOI 10.1002/hep.22351; DeLeve LD, 2017, SEMIN LIVER DIS, V37, P377, DOI 10.1055/s-0037-1617455; DeLeve LD, 2015, HEPATOLOGY, V61, P1740, DOI 10.1002/hep.27376; DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004; Ding BS, 2010, NATURE, V468, P310, DOI 10.1038/nature09493; Ding C, 2016, MOL CELL PROTEOMICS, V15, P3190, DOI 10.1074/mcp.M116.060145; Elmasri H, 2012, ANGIOGENESIS, V15, P457, DOI 10.1007/s10456-012-9274-0; Elvevold K, 2008, AM J PHYSIOL-GASTR L, V294, pG391, DOI 10.1152/ajpgi.00167.2007; Franco LM, 2019, J EXP MED, V216, P384, DOI 10.1084/jem.20180595; Fraser R, 2012, PATHOLOGY, V44, P181, DOI 10.1097/PAT.0b013e328351bcc8; Ganesan LP, 2012, J IMMUNOL, V189, P4981, DOI 10.4049/jimmunol.1202017; Gardner JP, 2003, P NATL ACAD SCI USA, V100, P4498, DOI 10.1073/pnas.0831128100; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Geraud C, 2010, HEPATOLOGY, V52, P313, DOI 10.1002/hep.23618; Gracia-Sancho J, 2021, NAT REV GASTRO HEPAT, V18, P411, DOI 10.1038/s41575-020-00411-3; Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026; Grontved L, 2013, EMBO J, V32, P1568, DOI 10.1038/emboj.2013.106; Gruver-Yates Amanda L, 2013, Cells, V2, P202, DOI 10.3390/cells2020202; Halliwell B, 2003, FEBS LETT, V540, P3, DOI 10.1016/S0014-5793(03)00235-7; Han ES, 2008, PHYSIOL GENOMICS, V34, P112, DOI 10.1152/physiolgenomics.00239.2007; Hansen B, 2002, MOL CELL BIOCHEM, V229, P63, DOI 10.1023/A:1017919800347; Hansen B, 2002, DIABETOLOGIA, V45, P1379, DOI 10.1007/s00125-002-0912-8; Herrera B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010039; Hu WQ, 2012, ATHEROSCLEROSIS, V222, P434, DOI 10.1016/j.atherosclerosis.2012.03.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Juin A, 2013, BIOL CELL, V105, P46, DOI 10.1111/boc.201200037; Khan SY, 2018, INVEST OPHTH VIS SCI, V59, P100, DOI 10.1167/iovs.17-21601; Kim JT, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8091106; Kjeken R, 2001, CELL TISSUE RES, V304, P221, DOI 10.1007/s004410100348; Knolle PA, 2016, CELL MOL IMMUNOL, V13, P347, DOI 10.1038/cmi.2016.5; Koch PS, 2017, BLOOD, V129, P415, DOI 10.1182/blood-2016-07-729822; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; Kus E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00006; La Mura V, 2014, J HEPATOL, V61, P1321, DOI 10.1016/j.jhep.2014.07.014; Lafoz E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040929; Laskin DL, 1996, TOXICOL PATHOL, V24, P112, DOI 10.1177/019262339602400115; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; Li RM, 2011, AM J PHYSIOL-GASTR L, V300, pG71, DOI 10.1152/ajpgi.00215.2010; Liu WL, 2004, J BIOL CHEM, V279, P18748, DOI 10.1074/jbc.M311227200; Maeso-Diaz R, 2018, AGING CELL, V17, DOI 10.1111/acel.12829; MAGNUSSON S, 1989, BIOCHEM J, V257, P651, DOI 10.1042/bj2570651; Malovic I, 2007, HEPATOLOGY, V45, P1454, DOI 10.1002/hep.21639; March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085; Maretti-Mira AC, 2019, HEPATOLOGY, V69, P1259, DOI 10.1002/hep.30227; Martin-Armas M, 2006, J HEPATOL, V44, P939, DOI 10.1016/j.jhep.2005.09.020; Martinez I, 1996, BIOCHEM BIOPH RES CO, V222, P688, DOI 10.1006/bbrc.1996.0805; MARTINEZ I, 1995, BIOCHEM BIOPH RES CO, V212, P235, DOI 10.1006/bbrc.1995.1961; Martinez Inigo, 2008, Comp Hepatol, V7, P4, DOI 10.1186/1476-5926-7-4; MCCLOSKEY TW, 1992, HEPATOLOGY, V16, P191, DOI 10.1002/hep.1840160130; McCourt PAG, 1999, HEPATOLOGY, V30, P1276, DOI 10.1002/hep.510300521; MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405; MEGO JL, 1967, J CELL BIOL, V32, P699, DOI 10.1083/jcb.32.3.699; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mousavi SA, 2007, HEPATOLOGY, V46, P871, DOI 10.1002/hep.21748; Olander M, 2020, LIVER INT, V40, P1770, DOI 10.1111/liv.14452; Pandey E, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00873; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Plubell DL, 2017, MOL CELL PROTEOMICS, V16, P873, DOI 10.1074/mcp.M116.065524; Poisson J, 2017, J HEPATOL, V66, P212, DOI 10.1016/j.jhep.2016.07.009; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Quatrini L, 2021, CELL MOL IMMUNOL, V18, P269, DOI 10.1038/s41423-020-00526-2; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rockey DC, 1996, AM J PHYSIOL-GASTR L, V271, pG260, DOI 10.1152/ajpgi.1996.271.2.G260; Ruttkay-Nedecky B, 2013, INT J MOL SCI, V14, P6044, DOI 10.3390/ijms14036044; Sadiku P, 2019, EMBO REP, V20, DOI 10.15252/embr.201847388; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shetty S, 2018, NAT REV GASTRO HEPAT, V15, P555, DOI 10.1038/s41575-018-0020-y; Shimojima M, 2014, ARCH VIROL, V159, P2023, DOI 10.1007/s00705-014-2042-2; Shimojima M, 2012, J VIROL, V86, P2067, DOI 10.1128/JVI.06451-11; Simon-Santamaria J, 2010, J GERONTOL A-BIOL, V65, P951, DOI 10.1093/gerona/glq108; Smathers Rebecca L., 2011, Human Genomics, V5, P170; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; SMEDSROD B, 1990, BIOCHEM J, V266, P313, DOI 10.1042/bj2660313; Sorensen KK, 2015, COMPR PHYSIOL, V5, P1751, DOI 10.1002/cphy.c140078; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; Soto-Heredero G, 2020, FEBS J, V287, P3350, DOI 10.1111/febs.15327; SPOLARICS Z, 1993, HEPATOLOGY, V17, P615, DOI 10.1002/hep.1840170415; SPOLARICS Z, 1991, AM J PHYSIOL, V261, pG185, DOI 10.1152/ajpgi.1991.261.2.G185; Storch J, 2010, J BIOL CHEM, V285, P32679, DOI 10.1074/jbc.R110.135210; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun XH, 2020, AM J PHYSIOL-CELL PH, V318, pC1200, DOI 10.1152/ajpcell.00062.2020; Szafranska K, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.735573; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Uhlen M, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aaz0274; Uhrig A, 2005, J LEUKOCYTE BIOL, V77, P626, DOI 10.1189/jlb.0604332; Verhulst S, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.750044; WAAGE A, 1990, EUR J IMMUNOL, V20, P2439, DOI 10.1002/eji.1830201112; Williams TA, 2006, ENDOCRINOLOGY, V147, P2496, DOI 10.1210/en.2005-1318; WISSE E, 1985, HEPATOLOGY, V5, P683, DOI 10.1002/hep.1840050427; Wu XP, 2021, ADV SCI, V8, DOI 10.1002/advs.202003721; Xiao WS, 2021, CIRC RES, V129, P9, DOI 10.1161/CIRCRESAHA.120.318805; Xie GH, 2012, GASTROENTEROLOGY, V142, P918, DOI 10.1053/j.gastro.2011.12.017; Yu CW, 2016, ANGIOGENESIS, V19, P95, DOI 10.1007/s10456-015-9491-4; Zapotoczny B, 2017, MICRON, V101, P48, DOI 10.1016/j.micron.2017.06.005; Zhang WW, 2015, J CARDIOVASC PHARM, V66, P189, DOI 10.1097/FJC.0000000000000264; Zhou B, 2000, J BIOL CHEM, V275, P37733, DOI 10.1074/jbc.M003030200; Zielinska KA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00592	118	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273843	10.1371/journal.pone.0273843	http://dx.doi.org/10.1371/journal.pone.0273843			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054185	Green Published, gold			2022-12-26	WOS:000892641400037
J	Mamdani, Z; Feldman-Kiss, D; McKenzie, S; Knott, M; Cameron, F; Voyer, R; van Norren, J; Scott, T; Pauly, B; Buxton, JA				Mamdani, Zahra; Feldman-Kiss, Damian; McKenzie, Sophie; Knott, Mike; Cameron, Fred; Voyer, Rayne; van Norren, Jessica; Scott, Tracy; Pauly, Bernie; Buxton, Jane A.			Core competencies of peer workers who use pulse oximeters to supplement their overdose response in British Columbia	PLOS ONE			English	Article							HARM REDUCTION; PREVENTION; PEOPLE; ROLES; DRUGS	Introduction Peer workers (those with lived/living experience of substance use) are at the forefront of overdose response initiatives in British Columbia, Canada. The onset of the coronavirus disease pandemic has significantly compounded the impact of the overdose crisis. Peer workers are integral in supporting people who use substances. However, despite the important work they do, peer workers often lack formalized credibility and do not have the same resources available to them as service providers without lived experience. The peer-led project titled the Peer2Peer Project implemented several support programs for peer workers, including providing pulse oximeters to peer workers to supplement their overdose response procedures. Materials and methods This study was a component of a larger evaluation of the pulse oximeter program at two organizations in BC. The study aims to highlight the competencies of peer workers who use pulse oximeters. Telephone interviews were conducted with seven peer workers who were given pulse oximeters. The transcripts were thematically coded using Covert et al.'s framework of core competencies of community health workers to compare our sample with other widely recognized professions. Findings We found that peer workers who used pulse oximeters described several core competencies in their work and these were aligned with Covert et al.'s core competencies for community health workers, including assessment, community health practice, communication, diversity and inclusion, professional practice, and disease prevention and management. Conclusion By aligning peer workers' skills to those of community health workers, we create awareness on the competencies of peer workers in using oximeters to supplement overdose response and advocate for them to receive more recognition and respect within the workplace. Further, our findings act as groundwork for future research in identifying the professional proficiencies of peer workers.	[Mamdani, Zahra; McKenzie, Sophie; Buxton, Jane A.] BC Ctr Dis Control, Vancouver, BC, Canada; [Feldman-Kiss, Damian] Univ British Columbia, Isl Med Program, Fac Med, Victoria, BC, Canada; [Knott, Mike; Cameron, Fred] SOLID Outreach Soc, Victoria, BC, Canada; [Voyer, Rayne; van Norren, Jessica; Scott, Tracy] RainCity Housing, Vancouver, BC, Canada; [Pauly, Bernie] Univ Victoria, Canadian Inst Substance Use Res, Victoria, BC, Canada; [Buxton, Jane A.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of British Columbia; University of Victoria; University of British Columbia	Buxton, JA (corresponding author), BC Ctr Dis Control, Vancouver, BC, Canada.; Buxton, JA (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	jane.buxton@bccdc.ca		Mamdani, Zahra/0000-0002-3158-9618	Health Canada's Substance Use and Addictions Program [1718-HQ-000030]	Health Canada's Substance Use and Addictions Program	This work was supported by the Health Canada's Substance Use and Addictions Program (Grant 1718-HQ-000030). The funding was awarded to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann E., 2021, QUANTITATIVE EVALUAT; Agee J, 2009, INT J QUAL STUD EDUC, V22, P431, DOI 10.1080/09518390902736512; Bardwell G, 2018, DRUG ALCOHOL DEPEN, V190, P6, DOI 10.1016/j.drugalcdep.2018.05.023; Bardwell G, 2018, INT J DRUG POLICY, V55, P40, DOI 10.1016/j.drugpo.2018.02.004; BC Centre for Disease Control, 2021, NAL HEART; BC Centre for Disease Control, 2018, PEER PAYM STAND SHOR; BC Coroners Service, 2021, ILL DRUG TOX DEATHS; BC Gov News, 2016, BC GOV NEWS 0414; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Braun V, 2019, QUAL RES SPORT EXERC, V11, P589, DOI 10.1080/2159676X.2019.1628806; Brend Yvette., 2019, CBC NEWS 0412; Clinic Mayo, 2018, WHAT AR OP WHY AR TH; Covert H, 2019, AM J PUBLIC HEALTH, V109, P320, DOI 10.2105/AJPH.2018.304737; Denis JenSt., 2020, WHY BCS ILLICIT DRUG; Dickson-Gomez J, 2003, AIDS BEHAV, V7, P303, DOI 10.1023/A:1025499904469; Elliott Malcolm, 2006, Aust Crit Care, V19, P139, DOI 10.1016/S1036-7314(06)80027-5; Farrugia A, 2020, ADDICT RES THEORY, V28, P29, DOI 10.1080/16066359.2019.1571193; Faulkner-Gurstein R, 2017, SOC SCI MED, V180, P20, DOI 10.1016/j.socscimed.2017.03.013; Feldman-Kiss D., 2020, EVALUATION REPORT US; Feldman-Kiss D., 2020, USE PULSE OXIMETERS; GALTUNG J, 1969, J PEACE RES, P167; Gillespie A., 2018, PEER SUPPORT MODELS, P1; Government of BC, 2020, STOPOVERDOSEGOVBCCA; Greer A, 2021, HARM REDUCT J, V18, DOI 10.1186/s12954-021-00507-2; Greer AM, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3136-4; Greer AM., 2018, GUIDE PAYING PEER RE; Greer AM., 2019, WORK EXPERIENCES CON, DOI [10.14288/1.0383396, DOI 10.14288/1.0383396]; Jozaghi E, 2016, HARM REDUCT J, V13, DOI 10.1186/s12954-016-0108-z; Kennedy MC, 2019, SOC SCI MED, V225, P60, DOI 10.1016/j.socscimed.2019.02.014; Latkin CA, 2003, HEALTH PSYCHOL, V22, P332, DOI 10.1037/0278-6133.22.4.332; Law M., 2018, QUESNEL CARIBOO OBSE; Mamdani Z., 2021, EVALUATION PEER ENGA; Mamdani Z., 2021, EVALUATION PEER SUPP; Mamdani Z, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-07241-2; Mamdani Z, 2021, HARM REDUCT J, V18, DOI 10.1186/s12954-020-00449-1; Marshall Z, 2015, DRUG ALCOHOL DEPEN, V151, P1, DOI 10.1016/j.drugalcdep.2015.03.002; Moustaqim-Barrette A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0259126; Neale J, 2019, ADDICTION, V114, P708, DOI 10.1111/add.14510; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Pauly B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229208; Pauly B, 2021, INT J DRUG POLICY, V88, DOI 10.1016/j.drugpo.2020.103015; Peer-2-Peer Project, 2019, ROSE IN; Peer2Peer Research Team, 2019, PEER2PEER PROJ; Plus Medline., 2022, STIM MEDLINEPLUS MED; Shapiro A., 2020, DETECTION ETIZOLAM F; Sherman SG, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-2; Smart A., 2018, NATL POST; STONEHAM MD, 1994, LANCET, V344, P1339, DOI 10.1016/S0140-6736(94)90697-1; The Peer-2-Peer Team, 2020, US OX OV RESP; Wallace B, 2019, INT J DRUG POLICY, V66, P64, DOI 10.1016/j.drugpo.2019.01.017; Walters Thomas Paul, 2007, Br J Nurs, V16, P1332	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273744	10.1371/journal.pone.0273744	http://dx.doi.org/10.1371/journal.pone.0273744			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054132	Green Published, gold			2022-12-26	WOS:000892641400035
J	Pankey, CL; Wang, QR; King, J; Ford, SP				Pankey, Christopher L.; Wang, Qiurong; King, Jessica; Ford, Stephen P.			Cardiovascular consequences of maternal obesity throughout the lifespan in first generation sheep	PLOS ONE			English	Article							DISEASE; OVERNUTRITION; HYPERTENSION; HYPERTROPHY; GESTATION; PREGNANCY; PRESSURE; GROWTH; RISK	Obesity continues to be a significant global health issue and contributes to a variety of comorbidities and disease states. Importantly, obesity contributes to adverse cardiovascular health outcomes, which is the leading cause of death worldwide. Further, maternal obesity during gestation has been shown to predispose offspring to adverse phenotypic outcomes, specifically cardiovascular outcomes. Therefore, we hypothesized that diet-induced obesity during gestation would result in adverse cardiovascular phenotypes in first-generation offspring that would have functional consequences in juvenile and advanced ages. Multiparous Rambouillet/Columbia cross ewes (FO) were fed a highly palatable, pelleted diet at either 100% (CON), or 150% (OB) of National Research Council recommendations from 60 days prior to conception, until necropsy at d 135 (90%) of gestation (CON: n = 5, OB: n = 6), or through term for lambs (F1: 2.5 mo. old; CON: n = 9, OB: n = 6) and ewes (F1:9 years old; CON: n = 5, OB: n = 8). Paraffin-embedded fetal aorta section staining revealed increased collagen:elastin ratio and greater aortic wall thickness in OBF1 fetuses. Invasive auricular blood pressure recordings revealed elevated systolic blood pressure in OBF1 lambs, but no differences in diastolic pressure. In aged F1 ewes, systolic and diastolic blood pressures were reduced in OBF1 relative to CONF1. Echocardiography revealed no treatment differences in F1 lambs, but F1 ewes show tendencies for increased end systolic volume and decreased stroke volume, and markedly reduced ejection fraction. Therefore, we conclude that maternal obesity programs altered cardiovascular development that results in a hypertensive state in OBF1 lambs. Increased cardiac workload resulting from early life hypertension precedes the failure of the heart to maintain function later in life.	[Pankey, Christopher L.; King, Jessica] West Virginia Sch Osteopath Med, Dept Biomed Sci, Lewisburg, WV 24901 USA; [Wang, Qiurong; Ford, Stephen P.] Univ Wyoming, Dept Anim Sci, Laramie, WY USA	University of Wyoming	Pankey, CL (corresponding author), West Virginia Sch Osteopath Med, Dept Biomed Sci, Lewisburg, WV 24901 USA.	cpankey@osteo.wvsom.edu		Pankey, Christopher/0000-0001-6538-5843	National Institutes of Health [R01 HD070096-01A1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Dual Purpose with Dual Benefits grant from the National Institutes of Health (https://grants.nih.gov/funding/index.htm), grant number R01 HD070096-01A1, awarded to SPF.	Adamo KB, 2012, INT J ENV RES PUB HE, V9, P1263, DOI 10.3390/ijerph9041263; Blackmore HL, 2014, ENDOCRINOLOGY, V155, P3970, DOI 10.1210/en.2014-1383; Centers for Disease Control and Prevention, BEH RISK FACT SURV S; Deputy NP, 2015, MMWR-MORBID MORTAL W, V64, P1215, DOI 10.15585/mmwr.mm6443a3; Dodson RB, 2012, PROCEEDINGS OF THE ASME SUMMER BIOENGINEERING CONFERENCE, PTS A AND B, P1251; Dong F, 2008, J NUTR BIOCHEM, V19, P409, DOI 10.1016/j.jnutbio.2007.06.003; Fan XJ, 2011, J NUTR BIOCHEM, V22, P30, DOI 10.1016/j.jnutbio.2009.11.006; Fernandez-Twinn DS, 2012, ENDOCRINOLOGY, V153, P5961, DOI 10.1210/en.2012-1508; Franklin SS, 2013, GLOB HEART, V8, P49, DOI 10.1016/j.gheart.2012.12.004; FROHLICH ED, 1979, AM J CARDIOL, V44, P959, DOI 10.1016/0002-9149(79)90229-7; Ghnenis AB, 2021, J DEV ORIG HLTH DIS, V12, P94, DOI 10.1017/S2040174420000112; Ghnenis AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189977; Hanson MA, 2008, BASIC CLIN PHARMACOL, V102, P90, DOI 10.1111/j.1742-7843.2007.00186.x; Huang Y, 2010, AM J PHYSIOL-ENDOC M, V299, pE968, DOI 10.1152/ajpendo.00434.2010; Kandadi MR, 2013, J NUTR BIOCHEM, V24, P1982, DOI 10.1016/j.jnutbio.2013.07.003; KANNEL WB, 1971, AM J CARDIOL, V27, P335, DOI 10.1016/0002-9149(71)90428-0; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Khan LY, 2003, HYPERTENSION, V41, P168, DOI 10.1161/01.HYP.0000047511.97879.FC; Kuo AH, 2018, J DEV ORIG HLTH DIS, V9, P137, DOI 10.1017/S2040174417000770; LINZBACH AJ, 1960, AM J CARDIOL, V5, P370, DOI 10.1016/0002-9149(60)90084-9; Long NM, 2010, J ANIM SCI, V88, P3546, DOI 10.2527/jas.2010-3083; Long NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122152; Menting MD, 2019, OBES REV, V20, P675, DOI 10.1111/obr.12817; Nakamura A, 2001, AM J PHYSIOL-HEART C, V281, pH1104, DOI 10.1152/ajpheart.2001.281.3.H1104; National Research Council, 1985, NUTR REQ SHEEP, V6th; Odhiambo JF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186926; Pankey CL, 2021, DOMEST ANIM ENDOCRIN, V76, DOI 10.1016/j.domaniend.2021.106628; Pankey CL, 2017, DOMEST ANIM ENDOCRIN, V60, P67, DOI 10.1016/j.domaniend.2017.04.002; Prevention CfDCa, HLTH EFF OV OB; Reynolds RM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4539; SCHMIEDER RE, 1993, CIRCULATION, V87, P1482, DOI 10.1161/01.CIR.87.5.1482; Sethi S, 2014, INTEGR BLOOD PRESS C, V7, P29, DOI 10.2147/IBPC.S59535; Stubert J, 2018, DTSCH ARZTEBL INT, V115, P276, DOI 10.3238/arztebl.2018.0276; Thompson JA, 2011, J PHYSIOL-LONDON, V589, P3319, DOI 10.1113/jphysiol.2011.210625; Thornburg KL, 2015, J DEV ORIG HLTH DIS, V6, P366, DOI 10.1017/S2040174415001300; Vitale C, 2009, NAT REV CARDIOL, V6, P532, DOI 10.1038/nrcardio.2009.105; Wang JY, 2010, FASEB J, V24, P2066, DOI 10.1096/fj.09-142315; Wang QR, 2019, FASEB J, V33, P2587, DOI 10.1096/fj.201800988R; Weintraub RG, 2017, LANCET, V390, P400, DOI 10.1016/S0140-6736(16)31713-5	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274214	10.1371/journal.pone.0274214	http://dx.doi.org/10.1371/journal.pone.0274214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054207	Green Published, gold			2022-12-26	WOS:000892641400068
J	Temme, JS; Crainic, JA; Walker, LM; Yang, WZ; Tan, ZB; Huang, XF; Gildersleeve, JC				Temme, J. Sebastian; Crainic, Jennifer A.; Walker, Laura M.; Yang, Weizhun; Tan, Zibin; Huang, Xuefei; Gildersleeve, Jeffrey C.			Microarray-guided evaluation of the frequency, B-cell origins, and selectivity of human glycan-binding antibodies reveals new insights and novel antibodies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE ARRAY; BLOOD-GROUP; IN-VITRO; AFFINITY; ANTIGENS; POLYSACCHARIDE; BIOSYNTHESIS; SPECIFICITY; AGGREGATION; EXPRESSION	The immune system produces a diverse collection of anti-glycan antibodies that are critical for host defense. At present, however, we know very little about the binding properties, origins, and sequences of these antibodies because of a lack of access to a variety of defined individual antibodies. To address this challenge, we used a glycan microarray with over 800 different components to screen a panel of 516 human mono-clonal antibodies that had been randomly cloned from different B-cell subsets originating from healthy human sub-jects. We obtained 26 antiglycan antibodies, most of which bound microbial carbohydrates. The majority of the antiglycan antibodies identified in the screen displayed selective binding for specific glycan motifs on our array and lacked poly-reactivity. We found that antiglycan antibodies were about twice as likely than expected to originate from IgG+ memory B cells, whereas none were isolated from naive, early emigrant, or immature B cells. Therefore, our results indicate that certain B-cell subsets in our panel are enriched in antiglycan antibodies, and IgG+ memory B cells may be a promising source of such antibodies. Furthermore, some of the newly identified anti-bodies bound glycans for which there are no reported mono-clonal antibodies available, and these may be useful as research tools, diagnostics, or therapeutic agents. Overall, the results provide insight into the types and properties of antiglycan antibodies produced by the human immune system and a framework for the identification of novel antiglycan antibodies in the future.	[Temme, J. Sebastian; Crainic, Jennifer A.; Gildersleeve, Jeffrey C.] NCI, Chem Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA; [Walker, Laura M.] Adimab LLC, Lebanon, NH USA; [Walker, Laura M.] Adagio Therapeut Inc, Waltham, MA USA; [Yang, Weizhun; Tan, Zibin; Huang, Xuefei] Michigan State Univ, Dept Chem, E Lansing, MI USA; [Yang, Weizhun; Tan, Zibin; Huang, Xuefei] Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI USA; [Huang, Xuefei] Michigan State Univ, Dept Biomed Engn, E Lansing, MI USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Michigan State University; Michigan State University; Michigan State University	Gildersleeve, JC (corresponding author), NCI, Chem Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA.	gildersj@mail.nih.gov		Huang, Xuefei/0000-0002-6468-5526; Temme, Joel Sebastian/0000-0001-8306-2810; Yang, Weizhun/0000-0001-5522-4026	Intramural Research Program of the National Cancer Institute, National Institutes of Health;  [GM62116]	Intramural Research Program of the National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); 	We thank the Consortium for Functional Glycomics (GM62116; The Scripps Research Institute), Xuefei Huang (Michigan State University), Thomas Tolbert (University of Kansas), Lai-Xi Wang (University of Maryland), Joseph Barchi, Jr (National Cancer Institute), Todd Lowary (University of Alberta), Beat Ernst (University of Basel), Katharina Ribbeck (Massachusetts Institute of Technology), Omicron Biochemicals Inc, GlycoHub, and Glycan Therapeutics for generously contributing glycans for the array. All IgGs were sequenced by Adimab's Molecular Core and produced by the High Throughput Expression group. We thank Laila Shehata, Daniel Maurer, and Anna Wec for coordinating IgG productions and shipments. This work was supported by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arosio P, 2011, PHARM RES-DORDR, V28, P1884, DOI 10.1007/s11095-011-0416-7; Astronomo RD, 2010, NAT REV DRUG DISCOV, V9, P308, DOI 10.1038/nrd3012; Blanas A, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00039; Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788; Bovin N, 2012, BBA-GEN SUBJECTS, V1820, P1373, DOI 10.1016/j.bbagen.2012.02.005; Campbell CT, 2014, P NATL ACAD SCI USA, V111, pE1749, DOI 10.1073/pnas.1314722111; Campbell Christopher T, 2010, Curr Protoc Chem Biol, V2, P37, DOI 10.1002/9780470559277.ch090228; Chuang PK, 2019, P NATL ACAD SCI USA, V116, P3518, DOI 10.1073/pnas.1816946116; DeAngelis PL, 2002, GLYCOBIOLOGY, V12, p9R, DOI 10.1093/glycob/12.1.9R; Dotan N, 2006, LUPUS, V15, P442, DOI 10.1191/0961203306lu2331oa; Engstrom HA, 2005, J IMMUNOL METHODS, V297, P203, DOI 10.1016/j.jim.2004.12.010; Escolano A, 2019, NATURE, V570, P468, DOI 10.1038/s41586-019-1250-z; Feldman C, 2014, J INFECTION, V69, P309, DOI 10.1016/j.jinf.2014.06.006; Free SJ, 2013, ADV GENET, V81, P33, DOI 10.1016/B978-0-12-407677-8.00002-6; Galili U, 2018, NATURAL ANTI-GAL ANTIBODY AS FOE TURNED FRIEND IN MEDICINE, P1, DOI 10.1016/C2016-0-04926-4; Geissner A, 2016, ANNU REV ANAL CHEM, V9, P223, DOI 10.1146/annurev-anchem-071015-041641; Gordus A, 2006, J AM CHEM SOC, V128, P13668, DOI 10.1021/ja065381g; Haji-Ghassemi O, 2015, GLYCOBIOLOGY, V25, P920, DOI 10.1093/glycob/cwv037; HENRY S, 1995, VOX SANG, V69, P166, DOI 10.1111/j.1423-0410.1995.tb02591.x; HISAMATSU M, 1992, CARBOHYD RES, V231, P137, DOI 10.1016/0008-6215(92)84014-J; Ibe C, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009470; Imamura H, 2016, J PHYS CHEM B, V120, P9581, DOI 10.1021/acs.jpcb.6b05473; Joseph H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01840; Kappler K, 2020, GENES IMMUN, V21, P224, DOI 10.1038/s41435-020-0105-9; Khilji SK, 2022, CELL CHEM BIOL, V29, P1353, DOI 10.1016/j.chembiol.2022.05.007; Kin NW, 2012, J IMMUNOL, V189, P2246, DOI 10.4049/jimmunol.1200702; Kubota T, 2010, ANTICANCER RES, V30, P3397; Lang SY, 2020, FRONT CHEM, V8, DOI 10.3389/fchem.2020.00284; Li JP, 2016, INT REV CEL MOL BIO, V325, P215, DOI 10.1016/bs.ircmb.2016.02.009; Li Q, 2009, MOL CANCER THER, V8, P971, DOI 10.1158/1535-7163.MCT-08-0934; Llull D, 2001, J BIOL CHEM, V276, P21053, DOI 10.1074/jbc.M010287200; Loo D, 2007, MOL CANCER THER, V6, P856, DOI 10.1158/1535-7163.MCT-06-0581; Luetscher RND, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71967-y; MacKenzie CR, 1996, J BIOL CHEM, V271, P1527, DOI 10.1074/jbc.271.3.1527; Maglione PJ, 2014, BLOOD, V124, P3561, DOI 10.1182/blood-2014-07-587824; Manimala JC, 2005, CHEMBIOCHEM, V6, P2229, DOI 10.1002/cbic.200500165; Mazzer AR, 2015, J CHROMATOGR A, V1415, P83, DOI 10.1016/j.chroma.2015.08.068; McCarthy PC, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010012; McKitrick TR, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.731008; McKitrick TR, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0819-2; Milland J, 2006, TISSUE ANTIGENS, V68, P459, DOI 10.1111/j.1399-0039.2006.00721.x; Moore JP, 2014, ANN BOT-LONDON, V114, P1279, DOI 10.1093/aob/mcu053; Moreira LRS, 2008, APPL MICROBIOL BIOT, V79, P165, DOI 10.1007/s00253-008-1423-4; Muthana SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep19509; Muthana SM, 2014, CANCER BIOMARK, V14, P29, DOI 10.3233/CBM-130383; Oberli MA, 2010, J AM CHEM SOC, V132, P10239, DOI 10.1021/ja104027w; Oyelaran O, 2009, J PROTEOME RES, V8, P4301, DOI 10.1021/pr900515y; Pedrioli A, 2021, TRENDS IMMUNOL, V42, P1143, DOI 10.1016/j.it.2021.10.008; Polonskaya Z, 2019, CURR OPIN IMMUNOL, V59, P65, DOI 10.1016/j.coi.2019.03.004; Rasko DA, 2001, J INFECT DIS, V184, P315, DOI 10.1086/322025; Reis CA, 2011, EXPERT REV PROTEOMIC, V8, P435, DOI 10.1586/EPR.11.30; Romling U, 2015, TRENDS MICROBIOL, V23, P545, DOI 10.1016/j.tim.2015.05.005; Schoonbroodt S, 2008, J IMMUNOL, V181, P6213, DOI 10.4049/jimmunol.181.9.6213; Schwarz M, 2003, GLYCOBIOLOGY, V13, P749, DOI 10.1093/glycob/cwg091; Shehata L, 2019, CELL REP, V28, P3300, DOI 10.1016/j.celrep.2019.08.056; Shoreibah MG, 2011, STEM CELLS DEV, V20, P515, DOI 10.1089/scd.2010.0172; Skurnik D, 2016, EXPERT REV VACCINES, V15, P1041, DOI 10.1586/14760584.2016.1159135; Skurnik D, 2012, J INFECT DIS, V205, P1709, DOI 10.1093/infdis/jis254; Smits NC, 2006, METHOD ENZYMOL, V416, P61, DOI 10.1016/S0076-6879(06)16005-X; Sterner E, 2016, ACS CHEM BIOL, V11, P1773, DOI 10.1021/acschembio.6b00244; Storry J R, 2009, Immunohematology, V25, P48; Temme J Sebastian, 2022, Methods Mol Biol, V2460, P67, DOI 10.1007/978-1-0716-2148-6_5; Temme JS, 2021, BIOCHEM J, V478, P1485, DOI 10.1042/BCJ20200610; Verbinnen B, 2012, J ALLERGY CLIN IMMUN, V130, P272, DOI 10.1016/j.jaci.2012.04.040; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Walchli R, 2020, BIOTECHNOL BIOENG, V117, P687, DOI 10.1002/bit.27237; Whitfield C, 2020, ANNU REV MICROBIOL, V74, P521, DOI 10.1146/annurev-micro-011420-075607; Willison HJ, 2013, TRENDS IMMUNOL, V34, P453, DOI 10.1016/j.it.2013.05.001; Xu YD, 2013, PROTEIN ENG DES SEL, V26, P663, DOI 10.1093/protein/gzt047; Zarei AE, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/7203587; Zhang T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00090; Zhang YL, 2012, METHODS MOL BIOL, V808, P155, DOI 10.1007/978-1-61779-373-8_11; Zhuo DH, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00466	73	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102468	10.1016/j.jbc.2022.102468	http://dx.doi.org/10.1016/j.jbc.2022.102468			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5S8ED	36087840	Green Published, gold			2022-12-26	WOS:000875415100008
J	Ayass, MA; Cao, WY; Zhang, J; Dai, J; Zhu, K; Tripathi, T; Griko, N; Pashkov, V; Abi-Mosleh, L				Ayass, Mohamad Ammar; Cao, Wanying; Zhang, Jin; Dai, Jun; Zhu, Kevin; Tripathi, Trivendra; Griko, Natalya; Pashkov, Victor; Abi-Mosleh, Lina			Noninvasive nasopharyngeal proteomics of COVID-19 patient identify abnormalities related to complement and coagulation cascade and mucosal immune system	PLOS ONE			English	Article							NORMALIZATION METHODS; DISEASE; BIOMARKERS; IGG4-RD	Serum or plasma have been the primary focus of proteomics studies for COVID-19 to identity biomarkers and potential drug targets. The nasal mucosal environment which consists of lipids, mucosal immune cells, and nasal proteome, has been largely neglected but later revealed to have critical role combating SARS-CoV-2 infection. We present a bottom-up proteomics investigation of the host response to SARS-CoV-2 infection in the nasopharyngeal environment, featuring a noninvasive approach using proteins in nasopharyngeal swabs collected from groups of 76 SARS-CoV-2 positive and 76 negative patients. Results showed that 31 significantly down-regulated and 6 up-regulated proteins were identified (p < 0.05, log(2) FC > 1.3) in SARS-CoV-2 positive patient samples as compared to the negatives; these proteins carry potential value as markers for the early detection of COVID-19, disease monitoring, as well as be drug targets. The down-regulation of coagulation factor 5 indicates a thrombotic abnormality in COVID-19 patients and the decreased IgG4 suggests an abnormal immune response at the point of entry in human nasopharyngeal environment, which is in consistent with KEGG and GO pathway analysis. Our study also demonstrated that mass spectrometry proteomics analysis of nasopharyngeal swabs can be used as a powerful early approach to evaluate host response to SARS-CoV-2 viral infection.	[Ayass, Mohamad Ammar; Cao, Wanying; Zhang, Jin; Dai, Jun; Zhu, Kevin; Tripathi, Trivendra; Griko, Natalya; Pashkov, Victor; Abi-Mosleh, Lina] Ayass Biosci LLC, Frisco, TX 75034 USA		Abi-Mosleh, L (corresponding author), Ayass Biosci LLC, Frisco, TX 75034 USA.	lina.a@ayassbioscience.com						Adam EH, 2020, THROMB RES, V194, P42, DOI 10.1016/j.thromres.2020.06.026; Akgun E., 2020, MEDRXIV; Akgun E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240012; Al-Samkari H, 2020, AM J HEMATOL, V95, P1479, DOI 10.1002/ajh.25962; Bankar R, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102135; Barh D, 2020, COMPUT BIOL MED, V126, DOI 10.1016/j.compbiomed.2020.104051; Benmansour NC, 2021, EUR J IMMUNOL, V51, P1652, DOI 10.1002/eji.202048959; Buonvino S, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00372-1; Cao XT, 2021, NAT IMMUNOL, V22, P1360, DOI 10.1038/s41590-021-01056-3; CDC, 2021, CDC DAT TRACK; Chakraborty S, 2021, NAT IMMUNOL, V22, P67, DOI [10.1038/s41590-020-00828-7, 10.1101/2020.05.15.20103341]; Chawade A, 2014, J PROTEOME RES, V13, P3114, DOI 10.1021/pr401264n; Chen Y, 2020, SEMIN ARTHRITIS RHEU, V50, P559, DOI 10.1016/j.semarthrit.2020.04.015; Chidambaram V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241541; D'Alessandro A, 2020, J PROTEOME RES, V19, P4417, DOI 10.1021/acs.jproteome.0c00365; de Latour RP, 2020, HAEMATOLOGICA, V105, P2847, DOI 10.3324/haematol.2020.260117; Eslamifar Z, 2020, THROMB J, V18, DOI 10.1186/s12959-020-00250-x; Froberg J, 2021, CURR OPIN INFECT DIS, V34, P181, DOI 10.1097/QCO.0000000000000724; Gallo O, 2021, MUCOSAL IMMUNOL, V14, P305, DOI 10.1038/s41385-020-00359-2; Griffith DM, 2020, PREV CHRONIC DIS, V17, DOI 10.5888/pcd17.200247; Hendaus MA, 2022, J BIOMOL STRUCT DYN, V40, P1909, DOI 10.1080/07391102.2020.1832919; Heo SH, 2007, PROTEOMICS, V7, P4292, DOI 10.1002/pmic.200700433; Hou X, 2020, MOL CELL PROTEOMICS, V19, P1749, DOI 10.1074/mcp.RP120.002128; Huckriede J, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.694186; Iturrieta-Zuazo I, 2020, CLIN IMMUNOL, V219, DOI 10.1016/j.clim.2020.108572; Jain R, 2021, COMPUT STRUCT BIOTEC, V19, P153, DOI 10.1016/j.csbj.2020.12.016; Java A, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140711; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Langton DJ, 2021, HLA, V98, P14, DOI 10.1111/tan.14284; Laurence J, 2020, CLIN IMMUNOL, V219, DOI 10.1016/j.clim.2020.108555; Lazzaroni MG, 2021, BLOOD REV, V46, DOI 10.1016/j.blre.2020.100745; Lim EHT, 2021, ECLINICALMEDICINE, V35, DOI 10.1016/j.eclinm.2021.100722; LIU XZ., 2021, BASIC CLIN MED, V41, P1174; Liu Y., 2021, IMMUNO, V1, P332, DOI [10.3390/immuno1040022, DOI 10.3390/IMMUNO1040022]; Long H, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6159720; Luo HL, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.632814; Ma CL, 2020, CELL RES, V30, P678, DOI 10.1038/s41422-020-0356-z; Maras JS, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102823; Masset C, 2021, KIDNEY INT, V100, P465, DOI 10.1016/j.kint.2021.06.002; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; Messner CB., 2020, MEDRXIV; Migliorini F, 2021, EUR J MED RES, V26, DOI 10.1186/s40001-021-00563-1; Moura AD, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95045-z; Mun DG, 2021, J PROTEOME RES, V20, P4165, DOI 10.1021/acs.jproteome.1c00506; Munnur D, 2021, NAT IMMUNOL, V22, P1416, DOI 10.1038/s41590-021-01035-8; Noris M, 2020, KIDNEY INT, V98, P314, DOI 10.1016/j.kint.2020.05.013; Peng DH, 2021, CLIN CHIM ACTA, V517, P48, DOI 10.1016/j.cca.2021.02.012; Porfidia A, 2020, THROMB RES, V196, P67, DOI 10.1016/j.thromres.2020.08.020; R Core Team, 2013, R LANG ENV STAT COMP; Reber A, 2013, EXPERT REV VACCINES, V12, P519, DOI [10.1586/erv.13.35, 10.1586/ERV.13.35]; Russell MW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.611337; Sande CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32072-3; Shaw RJ, 2020, BLOOD, V136, DOI 10.1182/blood-2020-142344; Sheir D. H., 2020, Microbial Biosystems Journal-MBJ, V5, P108, DOI 10.21608/mb.2020.33453.1019; Shen B, 2020, CELL, V182, P59, DOI 10.1016/j.cell.2020.05.032; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Shirvaliloo M, 2021, EPIGENOMICS-UK, V13, P745, DOI 10.2217/epi-2021-0057; Shu T, 2020, IMMUNITY, V53, P1108, DOI 10.1016/j.immuni.2020.10.008; Sidarta-Oliveira D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76488-2; Smith N, 2021, NAT IMMUNOL, V22, P1428, DOI 10.1038/s41590-021-01028-7; Stefely JA, 2020, AM J HEMATOL, V95, P1522, DOI 10.1002/ajh.25979; Stephenson E, 2021, NAT MED, V27, P904, DOI 10.1038/s41591-021-01329-2; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; Tellez L, 2020, GASTROENT HEPAT-BARC, V43, P472, DOI 10.1016/j.gastrohep.2020.06.006; Tomazic PV, 2020, EXPERT REV PROTEOMIC, V17, P191, DOI 10.1080/14789450.2020.1748502; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Valikangas T, 2018, BRIEF BIOINFORM, V19, P1, DOI 10.1093/bib/bbw095; Wang J., 2021, MEDRXIV; WARBURTON RJ, 1995, BBA-PROTEIN STRUCT M, V1246, P39, DOI 10.1016/0167-4838(94)00178-J; Wei X, 2020, J MED VIROL, V92, P2036, DOI 10.1002/jmv.25957; Weiner J, 2021, ECLINICALMEDICINE, V40, DOI 10.1016/j.eclinm.2021.101099; WHO, 2021, WHO COR COVID 19 DAS; Wong GLH, 2014, HEPATOLOGY, V59, P986, DOI 10.1002/hep.26739; Wu TZ, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100141; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu JC, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01445-6; Yamamotoya T, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97972-3; Yates JL, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100329; Zhang D, 2021, EUR REV MED PHARMACO, V25, P4627, DOI 10.26355/eurrev_202107_26255; Zhou C, 2018, BIOCHEM SOC T, V46, P311, DOI 10.1042/BST20170149; Zinellu A, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.696085	81	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274228	10.1371/journal.pone.0274228	http://dx.doi.org/10.1371/journal.pone.0274228			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094909	Green Published, gold			2022-12-26	WOS:000892376500029
J	Jiang, CM; Ge, JX; He, B; Zhang, Z; Hu, ZH; Li, YK; Zeng, B				Jiang, Chunmiao; Ge, Jinxin; He, Bin; Zhang, Zhe; Hu, Zhihong; Li, Yongkai; Zeng, Bin			Transcriptomic analysis reveals Aspergillus oryzae responds to temperature stress by regulating sugar metabolism and lipid metabolism	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; FATTY-ACIDS; KOJI MOLD; TREHALOSE; YEASTS; SALINITY; PATHWAY	Aspergillus oryzae is widely used in industrial applications, which always encounter changes within multiple environmental conditions during fermentation, such as temperature stress. However, the molecular mechanisms by which A. oryzae protects against temperature stress have not been elucidated. Therefore, this study aimed to characterize the fermentative behavior, transcriptomic profiles, and metabolic changes of A. oryzae in response to temperature stress. Both low and high temperatures inhibited mycelial growth and conidial formation of A. oryzae. Transcriptomic analysis revealed that most differentially expressed genes (DEGs) were involved in sugar metabolism and lipid metabolism under temperature stress. Specifically, the DEGs in trehalose synthesis and starch metabolism were upregulated under low-temperature stress, while high temperatures inhibited the expression of genes involved in fructose, galactose, and glucose metabolism. Quantitative analysis of intracellular sugar further revealed that low temperature increased trehalose accumulation, while high temperature increased the contents of intracellular trehalose, galactose, and glucose, consistent with transcriptome analysis. In addition, most DEGs involved in lipid metabolism were significantly downregulated under low-temperature stress. Furthermore, the metabolomic analysis revealed that linoleic acid, triacylglycerol, phosphatidylethanolamine, and phosphoribosyl were significantly decreased in response to low-temperature stress. These results increase our understanding of the coping mechanisms of A. oryzae in response to temperature stress, which lays the foundation for future improvements through genetic modification to enhance A. oryzae against extreme temperature stress.	[Jiang, Chunmiao; Ge, Jinxin; He, Bin; Zhang, Zhe; Hu, Zhihong; Li, Yongkai; Zeng, Bin] Jiangxi Sci & Technol Normal Univ, Coll Life Sci, Jiangxi Key Lab Bioproc Engn, Nanchang, Jiangxi, Peoples R China; [Jiang, Chunmiao; Ge, Jinxin; He, Bin; Zhang, Zhe; Hu, Zhihong; Li, Yongkai; Zeng, Bin] Jiangxi Sci & Technol Normal Univ, Coll Life Sci, Coinnovat Ctr In Vitro Diagnost Reagents & Device, Nanchang, Jiangxi, Peoples R China; [Zeng, Bin] Shenzhen Technol Univ, Coll Pharm, Shenzhen, Peoples R China	Jiangxi Science & Technology Normal University; Jiangxi Science & Technology Normal University; Shenzhen Technology University	Jiang, CM; Zeng, B (corresponding author), Jiangxi Sci & Technol Normal Univ, Coll Life Sci, Jiangxi Key Lab Bioproc Engn, Nanchang, Jiangxi, Peoples R China.; Jiang, CM; Zeng, B (corresponding author), Jiangxi Sci & Technol Normal Univ, Coll Life Sci, Coinnovat Ctr In Vitro Diagnost Reagents & Device, Nanchang, Jiangxi, Peoples R China.; Zeng, B (corresponding author), Shenzhen Technol Univ, Coll Pharm, Shenzhen, Peoples R China.	jiangcm0810@163.com; zengtx001@aliyun.com			National Natural Science Foundation of China (NSFC) [31900063]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (NSFC) (31900063 to JC). URL:https://www.nsfc.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahumada-Rudolph R, 2014, REV BIOL MAR OCEANOG, V49, P293, DOI 10.4067/S0718-19572014000200009; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Barski OA., 1996, ALDEHYDE REDUCTASE, V414, P443; BOGGS JM, 1987, BIOCHIM BIOPHYS ACTA, V906, P353, DOI 10.1016/0304-4157(87)90017-7; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Chen J, 2013, APPL ENVIRON MICROB, V79, P6140, DOI 10.1128/AEM.01953-13; Chen TT, 2011, FOOD SCI BIOTECHNOL, V20, P1633, DOI 10.1007/s10068-011-0225-0; Chi Z, 2010, J IND MICROBIOL BIOT, V37, P19, DOI 10.1007/s10295-009-0644-6; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fulda Simone, 2010, Int J Cell Biol, V2010, P214074, DOI 10.1155/2010/214074; Salmeron-Santiago KG, 2011, ARCH MICROBIOL, V193, P701, DOI 10.1007/s00203-011-0706-9; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Hirasawa T, 2006, J BIOSCI BIOENG, V102, P568, DOI 10.1263/jbb.102.568; Ianutsevich EA, 2020, EXTREMOPHILES, V24, P391, DOI 10.1007/s00792-020-01163-3; Ianutsevich EA, 2016, MICROBIOL-SGM, V162, P989, DOI 10.1099/mic.0.000279; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2019, PROTEIN SCI, V28, P1947, DOI 10.1002/pro.3715; Kitamoto K, 2015, BIOSCI BIOTECH BIOCH, V79, P863, DOI 10.1080/09168451.2015.1023249; Klose C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035063; Li LL, 2009, BIOCHEM BIOPH RES CO, V387, P778, DOI 10.1016/j.bbrc.2009.07.113; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Maury L, 2008, NAT REV GENET, V9, P583, DOI 10.1038/nrg2398; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Machida M, 2008, DNA RES, V15, P173, DOI 10.1093/dnares/dsn020; Mensonides FIC, 2013, FOOD RES INT, V54, P1103, DOI 10.1016/j.foodres.2012.12.042; Murphy RC, 2015, GLYCEROPHOSPHOLIPIDS; Mysiakina IS, 2012, MICROBIOLOGY+, V81, P669, DOI 10.1134/S0026261712060094; NicAogain K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01865; Nicholls S, 2011, FUNGAL GENET BIOL, V48, P297, DOI 10.1016/j.fgb.2010.08.010; O'Meara TR, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006142; Petzold EW, 2006, INFECT IMMUN, V74, P5877, DOI 10.1128/IAI.00624-06; Rezanka T, 2016, BBA-MOL CELL BIOL L, V1861, P1634, DOI 10.1016/j.bbalip.2016.07.005; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sancholle M, 2004, MYCOTA, V2, P391; Sangster T, 2006, ANALYST, V131, P1075, DOI 10.1039/b604498k; Santos T, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00089; Shapiro RS, 2012, MBIO, V3, DOI 10.1128/mBio.00238-12; Sripuan T, 2003, BIOSCI BIOTECH BIOCH, V67, P1485, DOI 10.1271/bbb.67.1485; Srivastava A, 2014, ANN MICROBIOL, V64, P1315, DOI 10.1007/s13213-013-0775-x; Storey JM., 2004, FUNCTIONAL METABOLIS, V17, P473, DOI DOI 10.1002/047167558X.CH17; SUUTARI M, 1995, ARCH MICROBIOL, V164, P212, DOI 10.1007/s002030050256; Umemura M, 2012, DNA RES, V19, P375, DOI 10.1093/dnares/dss019; Wang Jianbo, 2015, BioMolecular Concepts, V6, P59, DOI 10.1515/bmc-2014-0040; Want EJ, 2010, NAT PROTOC, V5, P1005, DOI 10.1038/nprot.2010.50; WIEMKEN A, 1990, ANTON LEEUW INT J G, V58, P209, DOI 10.1007/BF00548935; [辛苗苗 Xin Miaomiao], 2016, [分子植物育种, Molecular Plant Breeding], V14, P2645; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Zhao GZ, 2013, J AGR FOOD CHEM, V61, P7805, DOI 10.1021/jf400080g; Zhao X, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092330	52	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274394	10.1371/journal.pone.0274394	http://dx.doi.org/10.1371/journal.pone.0274394			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094945	Green Published, gold			2022-12-26	WOS:000892376500039
J	Ahn, S; Saha, A; Clark, R; Kolonin, MG; DiGiovanni, J				Ahn, Songyeon; Saha, Achinto; Clark, Rachel; Kolonin, Mikhail G.; DiGiovanni, John			CXCR4 and CXCR7 signaling promotes tumor progression and obesity-associated epithelial-mesenchymal transition in prostate cancer cells	ONCOGENE			English	Article							ADIPOSE-TISSUE; CHEMOKINE RECEPTOR-4; FACTOR-I; GROWTH; METASTASIS; EXPRESSION; PATHWAYS; AXIS; DIFFERENTIATION; COMBINATION	Obesity is associated with increased prostate cancer (PCa) progression and higher mortality, however, the mechanism(s) remain still unclear. Here, we investigated signaling by the ASC-secreted chemokine CXCL12 in a mouse allograft model of PCa and in HiMyc mice in the context of diet-induced obesity. Treatment of mice with CXCR4 antagonist inhibited CXCL12-induced signaling pathways, tumor growth and EMT in HMVP2 allograft tumors. Similar results were obtained following prostate epithelium-specific deletion of CXCR4 in HiMyc mice. We also show that CXCR4 signaling regulates expression of JMJD2A histone demethylase and histone methylation which is modulated by AMD3100. Importantly, treatment with a CXCR7 antagonist also inhibited allograft tumor growth and EMT. The current results demonstrate that both CXCR4 and CXCR7 play an important role in cancer progression and establish CXCL12 signaling pathways, activated in obesity, as potential targets for PCa intervention. In addition, other factors secreted by ASCs, may also contribute to cancer aggressiveness in obesity.	[Ahn, Songyeon; Saha, Achinto; Clark, Rachel; DiGiovanni, John] Univ Texas Austin, Div Pharmacol & Toxicol, Austin, TX 78723 USA; [Ahn, Songyeon; Saha, Achinto; Clark, Rachel; DiGiovanni, John] Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78723 USA; [Saha, Achinto; DiGiovanni, John] Univ Texas Austin, Ctr Mol Carcinogenesis & Toxicol, Austin, TX 78723 USA; [Saha, Achinto; DiGiovanni, John] Univ Texas Austin, Dell Med Sch, Livestrong Canc Inst, Austin, TX 78723 USA; [Kolonin, Mikhail G.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Dis, Houston, TX 77030 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Health Science Center Houston	DiGiovanni, J (corresponding author), Univ Texas Austin, Div Pharmacol & Toxicol, Austin, TX 78723 USA.; DiGiovanni, J (corresponding author), Univ Texas Austin, Dell Pediat Res Inst, Austin, TX 78723 USA.; DiGiovanni, J (corresponding author), Univ Texas Austin, Ctr Mol Carcinogenesis & Toxicol, Austin, TX 78723 USA.; DiGiovanni, J (corresponding author), Univ Texas Austin, Dell Med Sch, Livestrong Canc Inst, Austin, TX 78723 USA.	john.digiovanni@austin.utexas.edu		Kolonin, Mikhail/0000-0002-3743-7869; DiGiovanni, John/0000-0003-4233-6728	NIH [R01 CA196259]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank Steve Carbajal for his significant and extensive assistance to various aspects of this study. This study was supported by NIH grant R01 CA196259 (to JD and MGK).	Ablett MP, 2014, ONCOTARGET, V5, P599, DOI 10.18632/oncotarget.1169; Balic A, 2014, MOL CANCER THER, V13, P1758, DOI 10.1158/1535-7163.MCT-13-0948; Bellows CF, 2011, CANCER EPIDEM BIOMAR, V20, P2461, DOI 10.1158/1055-9965.EPI-11-0556; Bhurosy Trishnee, 2014, ScientificWorldJournal, V2014, P964236, DOI 10.1155/2014/964236; Blando J, 2011, CANCER PREV RES, V4, P2002, DOI 10.1158/1940-6207.CAPR-11-0182; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Cui K, 2011, J SURG RES, V171, P143, DOI 10.1016/j.jss.2010.03.001; Daquinag AC, 2015, CELL DEATH DIFFER, V22, P351, DOI 10.1038/cdd.2014.148; Daquinag AC, 2017, MOL THER-ONCOLYTICS, V6, P1, DOI 10.1016/j.omto.2017.05.003; Daquinag AC, 2011, CELL STEM CELL, V9, P74, DOI 10.1016/j.stem.2011.05.017; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; De Clercq Erik, 2019, Antiviral Chemistry & Chemotherapy, V27, p2040206619829382, DOI 10.1177/2040206619829382; Dickerman BA, 2019, CANCER-AM CANCER SOC, V125, P2877, DOI 10.1002/cncr.32167; Dubrovska A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031226; Ellerby HM, 1999, NAT MED, V5, P1032, DOI 10.1038/12469; Fryar CD, 2018, NCHS HLTH E STATS; Gong ZH, 2007, CANCER-AM CANCER SOC, V109, P1192, DOI 10.1002/cncr.22534; Hales Craig M, 2020, NCHS Data Brief, P1; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Himbert C, 2017, CANCER PREV RES, V10, P494, DOI 10.1158/1940-6207.CAPR-16-0322; Kim D, 2014, DIABETOLOGIA, V57, P1456, DOI 10.1007/s00125-014-3237-5; Kim TD, 2016, J CLIN INVEST, V126, P706, DOI 10.1172/JCI78132; Kolonin MG, 2019, TRANSL ANDROL UROL, V8, pS348, DOI 10.21037/tau.2019.04.07; Kshattry S, 2019, NPJ PRECIS ONCOL, V3, DOI 10.1038/s41698-019-0088-z; Laurent V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10230; Lawrence M, 2016, TRENDS GENET, V32, P42, DOI 10.1016/j.tig.2015.10.007; Lengyel E, 2018, TRENDS CANCER, V4, P374, DOI 10.1016/j.trecan.2018.03.004; Li M, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01177-z; Li Y, 2019, MOL MED REP, V19, P2489, DOI 10.3892/mmr.2019.9916; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2011, MOL MED, V17, P949, DOI 10.2119/molmed.2011.00115; Mochizuki H, 2004, BIOCHEM BIOPH RES CO, V320, P656, DOI 10.1016/j.bbrc.2004.06.013; Moore T, 2008, CANCER PREV RES, V1, P65, DOI 10.1158/1940-6207.CAPR-08-0022; Nunez NP, 2008, NUTR CANCER, V60, P534, DOI 10.1080/01635580801966195; Nunez NP, 2007, OBESITY, V15, P1980, DOI 10.1038/oby.2007.236; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Saglam K, 2003, J UROLOGY, V169, P1308, DOI 10.1097/01.ju.0000055903.18400.25; Saha A, 2017, CANCER RES, V77, P5158, DOI [10.1158/0008-5472.CAN-17-0284, 10.1158/0008-5472.can-17-0284]; Saha A, 2016, ONCOTARGET, V7, P25194, DOI 10.18632/oncotarget.7535; Saha A, 2015, CANCER PREV RES, V8, P597, DOI 10.1158/1940-6207.CAPR-15-0014; Scala S, 2015, CLIN CANCER RES, V21, P4278, DOI 10.1158/1078-0432.CCR-14-0914; Shappell SB, 2004, CANCER RES, V64, P2270, DOI 10.1158/0008-5472.CAN-03-0946; Shi Y, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.574667; SHIROZU M, 1995, GENOMICS, V28, P495, DOI 10.1006/geno.1995.1180; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Silva KR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174115; Singh AK, 2013, CYTOKINE GROWTH F R, V24, P41, DOI 10.1016/j.cytogfr.2012.08.007; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Song ZY, 2019, ONCOGENE, V38, P1560, DOI 10.1038/s41388-018-0519-2; Stillman B, 2018, CELL, V175, P6, DOI 10.1016/j.cell.2018.08.032; Su F, 2021, NPJ PRECIS ONCOL, V5, DOI 10.1038/s41698-021-00160-9; Su F, 2020, MOL THER-ONCOLYTICS, V18, P579, DOI 10.1016/j.omto.2020.08.012; Su F, 2019, ONCOGENE, V38, P1979, DOI 10.1038/s41388-018-0558-8; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Teicher BA, 2010, CLIN CANCER RES, V16, P2927, DOI 10.1158/1078-0432.CCR-09-2329; Tian Y, 2017, ONCOL LETT, V13, P2253, DOI 10.3892/ol.2017.5694; Trautmann F, 2014, INT J RADIAT BIOL, V90, P687, DOI 10.3109/09553002.2014.906766; Wang FY, 2019, ONCOL REP, V42, P1431, DOI 10.3892/or.2019.7246; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wang XW, 2017, ONCOTARGET, V8, P36149, DOI 10.18632/oncotarget.15254; Wright ME, 2007, CANCER-AM CANCER SOC, V109, P675, DOI 10.1002/cncr.22443; Yang JH, 2018, MED SCI MONITOR, V24, P5185, DOI 10.12659/MSM.906180; Yang N, 2020, THERANOSTICS, V10, P5790, DOI 10.7150/thno.44789; Yasumoto K, 2006, CANCER RES, V66, P2181, DOI 10.1158/0008-5472.CAN-05-3393; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zhang Y, 2009, CANCER RES, V69, P5259, DOI 10.1158/0008-5472.CAN-08-3444; Zhao HL, 2015, ONCOTARGET, V6, P5022, DOI 10.18632/oncotarget.3217; Zhao W, 2014, J BIOMOL SCREEN, V19, P817, DOI 10.1177/1087057114521867	73	0	0	5	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 7	2022	41	41					4633	4644		10.1038/s41388-022-02466-9	http://dx.doi.org/10.1038/s41388-022-02466-9		SEP 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5D7BH	36088505				2022-12-26	WOS:000852343800002
J	Wang, C; Li, WC; Hu, Q; Feng, NH; Liu, CH; Shi, NP; Chen, SQ; Chen, M; Guan, H; You, ZH; Xu, B				Wang, Can; Li, Wenchao; Hu, Qiang; Feng, Ninghan; Liu, Chunhui; Shi, Naipeng; Chen, Shuqiu; Chen, Ming; Guan, Han; You, Zonghao; Xu, Bin			Transgenic construction and functional miRNA analysis identify the role of miR-7 in prostate cancer suppression	ONCOGENE			English	Article							STEM-LIKE CELLS; GENE-EXPRESSION; IN-VITRO; MICRORNA; METASTASIS; TRANSITION; RESISTANCE; TARGETS	Although miR-7 suppresses the initiation and progression in cancers, little is known about its role in prostate cancer, especially in transgenic mouse models. In present study, we found that expression of miR-7, regulated by p53, was lower in prostate cancer tissues, and miR-7 overexpression significantly mitigated prostate cancer cells growth both in vitro, in organoids and in vivo regardless of p53 status. After we generated miR-7 overexpression transgenic mice and miR-7(+)/TRAMP mice, we found that transgenic overexpression of miR-7 in mice is safe and miR-7(+)/TRAMP mice have a preferred overall survival. Moreover, in vivo treatment of miR-7 inhibited subcutaneous tumour growth in mice and prolonged the survival of mice harboring prostate cancer lung metastasis when co-injection with PD-1 antibody. In addition, miR-7 downregulated glycolysis of prostate cancer cells by inhibiting several key pathways including HIF-1 alpha, and subsequently remodeled acidic tumour microenvironment, PanKLa level and T cell infiltration. In summary, our findings highlighted a promising target for development of miRNA-based therapeutics for prostate cancer patients regardless of p53 status.	[Wang, Can; Li, Wenchao; Hu, Qiang; Liu, Chunhui; Shi, Naipeng; Chen, Shuqiu; Chen, Ming; You, Zonghao; Xu, Bin] Southeast Univ, Dept Urol, Affiliated Zhongda Hosp, Nanjing 210009, Peoples R China; [Wang, Can; Li, Wenchao; Hu, Qiang; Liu, Chunhui; Shi, Naipeng; Chen, Shuqiu; Chen, Ming; You, Zonghao; Xu, Bin] Southeast Univ, Surg Res Ctr, Inst Urol, Med Sch, Nanjing 210009, Peoples R China; [Feng, Ninghan] Nanjing Med Univ, Wuxi 2 Hosp, Dept Urol, Wuxi 214002, Jiangsu, Peoples R China; [Guan, Han] Bengbu Med Coll, Dept Urol, Affiliated Hosp 1, Bengbu 233004, Peoples R China; [Xu, Bin] Southeast Univ, Affiliated Zhongda Hosp, Inst Med Phen Res, Nanjing 210009, Peoples R China	Southeast University - China; Southeast University - China; Nanjing Medical University; Bengbu Medical College; Southeast University - China	Chen, M; You, ZH; Xu, B (corresponding author), Southeast Univ, Dept Urol, Affiliated Zhongda Hosp, Nanjing 210009, Peoples R China.; Chen, M; You, ZH; Xu, B (corresponding author), Southeast Univ, Surg Res Ctr, Inst Urol, Med Sch, Nanjing 210009, Peoples R China.; Guan, H (corresponding author), Bengbu Med Coll, Dept Urol, Affiliated Hosp 1, Bengbu 233004, Peoples R China.; Xu, B (corresponding author), Southeast Univ, Affiliated Zhongda Hosp, Inst Med Phen Res, Nanjing 210009, Peoples R China.	mingchen0712@seu.edu.cn; gh668689@126.com; 101012899@seu.edu.cn; njxbseu@seu.edu.cn		, Zonghao/0000-0003-4807-9750; Guan, Han/0000-0002-7043-6307	National Natural Science Foundation of China [81872089, 81672551, 82102799]; Natural Science Foundation of Jiangsu Province [BK20210230]; Key Research and Development Program of Jiangsu Province [BE2019751]; Jiangsu Provincial Medical Talent [ZDRCA2016080]; Jiangsu Provincial Medical Innovation Team [CXTDA2017025]; Doctor of Entrepreneurship and Innovation in Jiangsu Province [JSSCBS20210138, JSSCBS20210088]; General Project of Medical Research of Jiangsu Health and Wellness Committee [M2020049]; Key R&D (Social Development) Projects of Jiangsu Province [BE2018629]; Wuxi "Taihu Talents Program" Medical and Health High-level Talents Project, First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars [2019BYYFYYQ09]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Key Research and Development Program of Jiangsu Province; Jiangsu Provincial Medical Talent; Jiangsu Provincial Medical Innovation Team; Doctor of Entrepreneurship and Innovation in Jiangsu Province; General Project of Medical Research of Jiangsu Health and Wellness Committee; Key R&D (Social Development) Projects of Jiangsu Province; Wuxi "Taihu Talents Program" Medical and Health High-level Talents Project, First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article. This work was supported by the National Natural Science Foundation of China (grant numbers 81872089, 81672551 and 82102799), Natural Science Foundation of Jiangsu Province (grant number BK20210230), Key Research and Development Program of Jiangsu Province (grant number BE2019751), Jiangsu Provincial Medical Talent (grant number ZDRCA2016080), The Jiangsu Provincial Medical Innovation Team (grant number CXTDA2017025), Doctor of Entrepreneurship and Innovation in Jiangsu Province (grant number JSSCBS20210138, JSSCBS20210088), The General Project of Medical Research of Jiangsu Health and Wellness Committee (grant number M2020049), Key R&D (Social Development) Projects of Jiangsu Province (BE2018629) Wuxi "Taihu Talents Program" Medical and Health High-level Talents Project, First Affiliated Hospital of Bengbu Medical College Science Fund for Outstanding Young Scholars (No. 2019BYYFYYQ09).	Bayraktar R, 2018, CLIN CANCER RES, V24, P4225, DOI 10.1158/1078-0432.CCR-17-1959; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Cardozo V, 2021, NEUROCHEM INT, V147, DOI 10.1016/j.neuint.2021.105064; Chang YL, 2015, ONCOTARGET, V6, P24017, DOI 10.18632/oncotarget.4447; Cheteh EH, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0272-5; Culp MB, 2020, EUR UROL, V77, P38, DOI 10.1016/j.eururo.2019.08.005; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Fang YX, 2012, HEPATOLOGY, V55, P1852, DOI 10.1002/hep.25576; Gao YS, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01421-6; George AL, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-80; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hu JH, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01169-0; Irizarry-Caro RA, 2020, P NATL ACAD SCI USA, V117, P30628, DOI 10.1073/pnas.2009778117; Karthaus WR, 2014, CELL, V159, P163, DOI 10.1016/j.cell.2014.08.017; Lee KS, 2008, AM J RESP CRIT CARE, V178, P787, DOI 10.1164/rccm.200801-008OC; Lequeux A, 2021, ONCOGENE, V40, P4725, DOI 10.1038/s41388-021-01846-x; Li M, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01264-z; Li ZH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16306-5; Lin CL, 2020, MOL THER-NUCL ACIDS, V20, P699, DOI 10.1016/j.omtn.2020.04.009; Lin RW, 2018, CELL CYCLE, V17, P2175, DOI 10.1080/15384101.2018.1520565; Ling H, 2013, NAT REV DRUG DISCOV, V12, P847, DOI 10.1038/nrd4140; Okuda H, 2013, CANCER RES, V73, P1434, DOI 10.1158/0008-5472.CAN-12-2037; Ottosen S, 2015, ANTIMICROB AGENTS CH, V59, P599, DOI 10.1128/AAC.04220-14; Pan CM, 2020, CANCER LETT, V493, P133, DOI 10.1016/j.canlet.2020.08.024; Qi Z., 2022, NAT COMMUN, V13, DOI 10.1038/s41467-021-27833-0; Reid MA, 2017, NAT CELL BIOL, V19, P1298, DOI 10.1038/ncb3629; Ren RY, 2020, J CELL PHYSIOL, V235, P6204, DOI 10.1002/jcp.29549; Ribas A, 2017, CELL, V170, P1109, DOI 10.1016/j.cell.2017.08.027; Riganti C, 2009, BRIT J PHARMACOL, V156, P1054, DOI 10.1111/j.1476-5381.2009.00117.x; Rupaimoole R, 2017, NAT REV DRUG DISCOV, V16, P203, DOI 10.1038/nrd.2016.246; Sahraei M, 2019, J CLIN INVEST, V129, P5518, DOI 10.1172/JCI127125; Sehrawat A, 2018, P NATL ACAD SCI USA, V115, pE4179, DOI 10.1073/pnas.1719168115; Shukla Girish C, 2011, Mol Cell Pharmacol, V3, P83; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sun YF, 2016, AM J CANCER RES, V6, P114; Thapa D, 2014, CANCER RES, V74, P5644, DOI 10.1158/0008-5472.CAN-14-0562; van Zandwijk N, 2017, LANCET ONCOL, V18, P1386, DOI 10.1016/S1470-2045(17)30621-6; Wang CQ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16966-3; Wang J, 2016, J CELL PHYSIOL, V231, P25, DOI 10.1002/jcp.25056; Ward C, 2013, CANCER TREAT REV, V39, P171, DOI 10.1016/j.ctrv.2012.08.004; Westra J, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-61; Wu ZC, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.517637; Xiong Le, 2021, Nanotheranostics, V5, P143, DOI 10.7150/ntno.53844; Yang Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08759-0; Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1; Zhang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080544; Zhu HT, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1159-2	47	0	0	22	22	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 7	2022	41	41					4645	4657		10.1038/s41388-022-02461-0	http://dx.doi.org/10.1038/s41388-022-02461-0		SEP 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	5D7BH	36088503	Green Submitted			2022-12-26	WOS:000852343800003
J	He, WT; Lin, SY; Guo, Y; Wu, YZ; Zhang, LL; Deng, QL; Du, ZM; Wei, MB; Zhu, WJ; Chen, WJ; Shao, JY; Xu, GL				He, Wenting; Lin, Shiyong; Guo, Yi; Wu, Yuanzhong; Zhang, Lu-Lu; Deng, Qiling; Du, Zi-Ming; Wei, Mingbiao; Zhu, Weijie; Chen, Wan-Juan; Shao, Jian-Yong; Xu, Guo-Liang			Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells	ONCOGENE			English	Article							TET PROTEINS; DNA METHYLATION; CANCER; GENES; 5-METHYLCYTOSINE; CONVERSION; DISEASE; LOCUS	Zinc finger protein 154 (ZNF154) is hypermethylated at the promoter in many epithelial-derived solid tumors. However, its methylation status and function in esophageal squamous carcinoma (ESCC) are poorly understood. We found that the ZNF154 promoter is hypermethylated in ESCC and portends poor prognosis. In addition, ZNF154 functions as a tumor suppressor gene (TSG) in ESCC, and is downregulated by promoter hypermethylation. We established a targeted demethylation strategy based on CRISPR/dCas9 technology and found that the hypermethylation of ZNF154 promoter repressed ZNF154 induction, which in turn promoted the proliferation and migration of ESCC cells in vitro and in vivo. Finally, high-throughput CUT&Tag analysis, GEPIA software and qPCR were used to revealed the role of ZNF154 as a transcription factor to upregulate the expression of ESCC-associated tumor suppressor genes. Taken together, hypermethylation of the ZNF154 promoter plays an important role in the development of ESCC, and epigenetic editing is a promising tool for inhibiting ESCC cells with aberrant DNA methylation.	[He, Wenting; Zhang, Lu-Lu; Deng, Qiling; Du, Zi-Ming; Wei, Mingbiao; Zhu, Weijie; Shao, Jian-Yong] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Mol Diagnost, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China; [Lin, Shiyong; Xu, Guo-Liang] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Endoscopy & Laser, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China; [Guo, Yi] Shantou Univ, Dept Endoscopy, Canc Hosp, Shantou, Peoples R China; [Wu, Yuanzhong] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Expt Res, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China; [Chen, Wan-Juan] Anhui Targene Med Technol Co Ltd, Res & Dev Dept, Wuhu, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Shantou University; State Key Lab Oncology South China; Sun Yat Sen University	Shao, JY (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Mol Diagnost, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China.; Xu, GL (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Endoscopy & Laser, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China.; Chen, WJ (corresponding author), Anhui Targene Med Technol Co Ltd, Res & Dev Dept, Wuhu, Peoples R China.	chenwanjuan@targene.cn; shaojy@sysucc.org.cn; xugl@sysucc.org.cn	he, wenting/GYD-5727-2022	Wu, Yuanzhong/0000-0002-3577-7069	National Natural Science Foundation of China [82002220]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant No. 82002220 from the National Natural Science Foundation of China. The sponsors or funding organizations had no role in the design or conduct of this research.	Aparicio Ana, 2002, Curr Opin Investig Drugs, V3, P627; Bender CM, 1998, CANCER RES, V58, P95; Chen FF, 2019, MOL MED REP, V20, P3649, DOI 10.3892/mmr.2019.10608; Chen NP, 2016, P NATL ACAD SCI USA, V113, P990, DOI 10.1073/pnas.1515605113; Cheng AW, 2013, CELL RES, V23, P1163, DOI 10.1038/cr.2013.122; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Falahi F, 2013, MOL CANCER RES, V11, P1029, DOI 10.1158/1541-7786.MCR-12-0567; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Guo JU, 2011, CELL, V145, P423, DOI 10.1016/j.cell.2011.03.022; Hamilton JP, 2006, CLIN GASTROENTEROL H, V4, P701, DOI 10.1016/j.cgh.2006.03.007; Han SC, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02859-2; He WW, 2018, J THORAC DIS, V10, P5714, DOI 10.21037/jtd.2018.09.55; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Heller EA, 2014, NAT NEUROSCI, V17, P1720, DOI 10.1038/nn.3871; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Huntley S, 2006, GENOME RES, V16, P669, DOI 10.1101/gr.4842106; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Kaz AM, 2014, CANCER LETT, V342, P193, DOI 10.1016/j.canlet.2012.02.036; Lao-Sirieix P, 2012, NAT REV CLIN ONCOL, V9, P278, DOI 10.1038/nrclinonc.2012.35; Li JS, 2013, CHIN J CANCER, V32, P3, DOI 10.5732/cjc.011.10381; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Margolin G, 2016, J MOL DIAGN, V18, P283, DOI 10.1016/j.jmoldx.2015.11.004; Masoumi KC, 2017, MOL BIOL CELL, V28, P346, DOI 10.1091/mbc.E16-07-0547; Mehdipour P, 2020, PHARMACOL THERAPEUT, V205, DOI 10.1016/j.pharmthera.2019.107416; Mocciaro A, 2010, J CELL BIOL, V189, P631, DOI 10.1083/jcb.200910057; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Pennathur A, 2009, ANN THORAC SURG, V87, P1048, DOI 10.1016/j.athoracsur.2008.12.060; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reinert T, 2011, CLIN CANCER RES, V17, P5582, DOI 10.1158/1078-0432.CCR-10-2659; Rodriguez C, 2010, BIOCHEM BIOPH RES CO, V392, P129, DOI 10.1016/j.bbrc.2009.12.159; Sarbia M, 2007, BRIT J CANCER, V97, P1404, DOI 10.1038/sj.bjc.6604037; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Verma N, 2018, NAT GENET, V50, P83, DOI 10.1038/s41588-017-0002-y; Xu XX, 2016, CELL DISCOV, V2, DOI 10.1038/celldisc.2016.9; Yang YM, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00323-3	42	0	0	8	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 30	2022	41	40					4537	4546		10.1038/s41388-022-02366-y	http://dx.doi.org/10.1038/s41388-022-02366-y		SEP 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	4Z8CT	36064578	Green Published, hybrid			2022-12-26	WOS:000849997400002
J	Buratto, A; Muttoni, M; Wrzaczek, S; Freiberger, M				Buratto, Alessandra; Muttoni, Maddalena; Wrzaczek, Stefan; Freiberger, Michael			Should the COVID-19 lockdown be relaxed or intensified in case a vaccine becomes available?	PLOS ONE			English	Article							HEALTH; LIFE	Immediately after the start of the COVID-19 pandemic in Early 2020, most affected countries reacted with strict lockdown to limit the spread of the virus. Since that time, the measures were adapted on a short time basis according to certain numbers (i.e., number of infected, utilization of intensive care units). Implementing a long-term optimal strategy was not possible since a forecast when R&D will succeed in developing an effective vaccination was not available. Our paper closes this gap by assuming a stochastic arrival rate of the COVID-19 vaccine with the corresponding change in the optimal policy regarding the accompanying optimal lockdown measures. The first finding is that the lockdown should be intensified after the vaccine approval if the pace of the vaccination campaign is rather slow. Secondly, the anticipation of the vaccination arrival also leads to a stricter lockdown in the period without vaccination. For both findings, an intuitive explanation is offered.	[Buratto, Alessandra; Muttoni, Maddalena] Univ Padua, Dipartimento Matemat Tullio Levi Civita, Padua, Italy; [Wrzaczek, Stefan; Freiberger, Michael] Int Inst Appl Syst Anal IIASA, Laxenburg, Austria; [Wrzaczek, Stefan; Freiberger, Michael] Univ Vienna, Wittgenstein Ctr, IIASA, OeAW,Vienna Inst Demog VID, Vienna, Austria	University of Padua; International Institute for Applied Systems Analysis (IIASA); International Institute for Applied Systems Analysis (IIASA); University of Vienna	Wrzaczek, S (corresponding author), Int Inst Appl Syst Anal IIASA, Laxenburg, Austria.; Wrzaczek, S (corresponding author), Univ Vienna, Wittgenstein Ctr, IIASA, OeAW,Vienna Inst Demog VID, Vienna, Austria.	wrzaczek@iiasa.ac.at		Buratto, Alessandra/0000-0001-5238-8965; Freiberger, Michael/0000-0002-7253-3282; Wrzaczek, Stefan/0000-0002-3891-5471	Austrian Science Fund [P 30665-G27]	Austrian Science Fund(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund through a grant awarded to SW (P 30665-G27).	Acemoglu D, 2021, AM ECON REV INSIGHTS, V3, P487, DOI 10.1257/aeri.20200590; Ali M, 2020, J BIOL DYNAM, V14, P389, DOI 10.1080/17513758.2020.1773000; Alvarez F, 2021, AM ECON REV INSIGHTS, V3, P367, DOI 10.1257/aeri.20200201; Aspri A, 2021, J MATH ECON, V93, DOI 10.1016/j.jmateco.2021.102490; BOUKAS EK, 1990, J OPTIMIZ THEORY APP, V64, P471, DOI 10.1007/BF00939419; Caulkins J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243413; Caulkins JP, 2021, J MATH ECON, V93, DOI 10.1016/j.jmateco.2021.102489; Caulkins JP, 2021, HAMMER JAB ARE COVID; Caulkins JP., 2021, PANDEMICS INSURANCE; El Ouardighi F, 2022, PROD OPER MANAG, V31, P1734, DOI 10.1111/poms.13641; Federico S, 2021, J MATH ECON, V93, DOI 10.1016/j.jmateco.2020.102453; Feichtinger G, 2003, J MATH ANAL APPL, V288, P47, DOI 10.1016/j.jmaa.2003.07.001; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Freiberger M, 2022, J PUBLIC ECON THEORY, V24, P1182, DOI 10.1111/jpet.12604; Fu YT, 2022, FINANC RES LETT, V45, DOI 10.1016/j.frl.2021.102123; Garriga C, HCEO WORKING PAPER S; Gonzalez-Eiras M, 2020, CEPR DISCUSSION PAPE; Grass D., 2008, OPTIMAL CONTROL NONL; Hall RE, 2007, Q J ECON, V122, P39, DOI 10.1162/qjec.122.1.39; Hinderer K., 2016, DYNAMIC OPTIMIZATION; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kniesner TJ, 2012, REV ECON STAT, V94, P74, DOI 10.1162/REST_a_00229; Mandel Antoine, 2020, Econ Disaster Clim Chang, V4, P431, DOI 10.1007/s41885-020-00066-z; Mathieu E, 2021, NAT HUM BEHAV, V5, P947, DOI 10.1038/s41562-021-01122-8; Murphy KM, 2006, J POLIT ECON, V114, P871, DOI 10.1086/508033; Schelling TC, 1968, PROBLEMS PUBLIC EXPE, DOI DOI 10.1037/12069-015; SHEPARD DS, 1984, MANAGE SCI, V30, P423, DOI 10.1287/mnsc.30.4.423; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Veliov VM, 2003, OPTIM METHOD SOFTW, V18, P689, DOI 10.1080/10556780310001639753; Wrzaczek S, 2020, J OPTIMIZ THEORY APP, V184, P1065, DOI 10.1007/s10957-019-01598-5	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273557	10.1371/journal.pone.0273557	http://dx.doi.org/10.1371/journal.pone.0273557			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054113	gold, Green Accepted, Green Published			2022-12-26	WOS:000892641400022
J	Karmacharya, MB; Hada, B; Park, SR; Kim, KH; Choi, BH				Karmacharya, Mrigendra Bir; Hada, Binika; Park, So Ra; Kim, Kil Hwan; Choi, Byung Hyune			Granulocyte-macrophage colony-stimulating factor (GM-CSF) shows therapeutic effect on dimethylnitrosamine (DMN)-induced liver fibrosis in rats	PLOS ONE			English	Article							ANTI-APOPTOTIC ACTIVITY; HEPATIC STELLATE CELLS; TGF-BETA; PATHWAY; INJURY; PROLIFERATION; EXPRESSION	This study was undertaken to investigate the inhibitory effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) on dimethylnitrosamine (DMN)-induced liver fibrosis in rats. Liver fibrosis was induced in Sprague-Dawley rats by injecting DMN intraperitoneally (at 10 mg/kg of body weight) daily for three consecutive days per week for 4 weeks. To investigate the effect of GM-CSF on disease onset, GM-CSF (50 pg/kg of body weight) was co-treated with DMN for 2 consecutive days per week for 4 weeks (4-week groups). To observe the effect of GM-CSF on the progression of liver fibrosis, GM-CSF was post-treated alone at 5-8 weeks after the 4 weeks of DMN injection (8-week groups). We found that DMN administration for 4 weeks produced molecular and pathological manifestations of liver fibrosis, that is, it increased the expressions of collagen type I, alpha-smooth muscle actin (alpha-SMA), and transforming growth factor-beta 1 (TGF-beta 1), and decreased peroxisome proliferator-activated receptor gamma (PPAR-gamma) expression. In addition, elevated serum levels of aspartate aminotransferase (AST), total bilirubin level (TBIL), and decreased albumin level (ALB) were observed. In both the 4-week and 8-week groups, GM-CSF clearly improved the pathological liver conditions in the gross and histological observations, and significantly recovered DMN-induced increases in AST and TBIL and decreases in ALB serum levels to normal. GM-CSF also significantly decreased DMN-induced increases in collagen type I, a-SMA, and TGF-beta 1 and increased DMN-induced decreases in PPAR-gamma expression. In the DMN groups, survival decreased continuously for 8 weeks after DMN treatment for the first 4 weeks. GM-CSF showed a survival benefit when co-treated for the first 4 weeks but a marginal effect when post-treated for 5-8 weeks. In conclusion, co-treatment of GM-CSF showed therapeutic effects on DMN-induced liver fibrosis and survival rates in rats, while post-treatment efficiently blocked liver fibrosis.	[Karmacharya, Mrigendra Bir; Park, So Ra; Kim, Kil Hwan; Choi, Byung Hyune] Inha Univ, Dept Physiol & Biophys, Coll Med, Incheon, South Korea; [Choi, Byung Hyune] Inha Univ, Dept Biomed Sci, Coll Med, Incheon, South Korea; [Kim, Kil Hwan] Vet Hlth Serv Med Ctr, Vet Med Res Inst, Seoul, South Korea	Inha University; Inha University; Veterans Health Service Medical Center	Choi, BH (corresponding author), Inha Univ, Dept Biomed Sci, Coll Med, Incheon, South Korea.; Kim, KH (corresponding author), Vet Hlth Serv Med Ctr, Vet Med Res Inst, Seoul, South Korea.	kimkhshep@bohun.or.kr; bryan@inha.ac.kr			VHS Medical Center Research Grant [VHSMC17013]; Inha University [63000-01]	VHS Medical Center Research Grant; Inha University	Kil Hwan Kim, VHS Medical Center Research Grant (VHSMC17013), http://seoul.bohun.or.kr Byung Hyune Choi, Inha University Research Grant (63000-01), www.inha.ac.kr	Abubakar I., 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bissell DM, 2001, EXP MOL MED, V33, P179, DOI 10.1038/emm.2001.31; Choi JH, 2017, J AGR FOOD CHEM, V65, P317, DOI 10.1021/acs.jafc.6b04805; Choi JK, 2014, MOL NEUROBIOL, V49, P724, DOI 10.1007/s12035-013-8550-3; Choi JK, 2011, APOPTOSIS, V16, P127, DOI 10.1007/s10495-010-0552-2; Choi JK, 2014, BMB REP, V47, P679, DOI 10.5483/BMBRep.2014.47.12.018; Choi MJ, 2016, MOL MED REP, V14, P4521, DOI 10.3892/mmr.2016.5809; Chooi KF, 2016, JOVE-J VIS EXP, DOI 10.3791/54208; Deng YL, 2012, HEPATOB PANCREAT DIS, V11, P467, DOI 10.1016/S1499-3872(12)60210-0; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Du JX, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-33; Eroglu A, 2002, HPB (Oxford), V4, P67, DOI 10.1080/136518202760378425; George J, 2001, TOXICOLOGY, V156, P129, DOI 10.1016/S0300-483X(00)00352-8; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Guo BL, 2004, DIABETES, V53, P200, DOI 10.2337/diabetes.53.1.200; Hernandez-Gea V, 2011, ANNU REV PATHOL-MECH, V6, P425, DOI 10.1146/annurev-pathol-011110-130246; Hong SW, 2011, BIOSCI BIOTECH BIOCH, V75, P833, DOI 10.1271/bbb.100599; Huang X, 2009, J NEUROL SCI, V277, P87, DOI 10.1016/j.jns.2008.10.022; Hunt AN, 2017, AM J RESP CELL MOL, V57, P448, DOI 10.1165/rcmb.2016-0242OC; IRONS D, 1993, STEM CELLS, V11, P235, DOI 10.1002/stem.5530110311; JENKINS SA, 1985, J HEPATOL, V1, P489, DOI 10.1016/S0168-8278(85)80747-9; Kao YH, 2020, TISSUE ENG REGEN MED, V17, P671, DOI 10.1007/s13770-020-00274-4; Karmacharya MB, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10090705; Kim J, 2019, TISSUE ENG REGEN MED, V16, P59, DOI 10.1007/s13770-018-0163-5; Kim KK, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a022293; Kondou H, 2003, J HEPATOL, V39, P742, DOI 10.1016/S0168-8278(03)00377-5; Kountouras J, 1998, HEPATO-GASTROENTEROL, V45, P2295; Koyama Y, 2017, J CLIN INVEST, V127, P55, DOI 10.1172/JCI88881; Lemoinne S, 2013, BBA-MOL BASIS DIS, V1832, P948, DOI 10.1016/j.bbadis.2013.02.019; Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054256; Liu XJ, 2006, LIVER INT, V26, P8, DOI 10.1111/j.1478-3231.2005.01192.x; Mann A, 2001, J INVEST DERMATOL, V117, P1382, DOI 10.1046/j.0022-202x.2001.01600.x; Mann A, 2006, J INVEST DERM SYMP P, V11, P87, DOI 10.1038/sj.jidsymp.5650013; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Nathwani R., 2019, EMJ, V4, P105; NOUCHI T, 1991, LIVER, V11, P100; Pinzani M, 2015, DIGEST DIS, V33, P492, DOI 10.1159/000374096; Schindelin J, 2015, MOL REPROD DEV, V82, P518, DOI 10.1002/mrd.22489; Schuppan D, 2018, MATRIX BIOL, V68-69, P435, DOI 10.1016/j.matbio.2018.04.006; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Shigeki TA, 2006, CLIN CHIM ACTA, V364, P33, DOI 10.1016/j.cca.2005.06.014; Suarez-Cuenca JA, 2008, EXP BIOL MED, V233, P827, DOI 10.3181/0709-RM-247; Tan-Garcia A, 2020, JHEP REP, V2, DOI 10.1016/j.jhepr.2019.11.006; Tekkesin N., 2013, QSCIENCE CONNECT, V2013, P1, DOI [10.5339/connect.2013.17, DOI 10.5339/CONNECT.2013.17]; Tung YT, 2014, J DAIRY SCI, V97, P3281, DOI 10.3168/jds.2013-7505; Wang J, 2019, TISSUE ENG REGEN MED, V16, P107, DOI 10.1007/s13770-019-00178-y; Wang XY, 2020, TISSUE ENG REGEN MED, V17, P683, DOI 10.1007/s13770-020-00276-2; Wu YN, 2020, WORLD J GASTROENTERO, V26, DOI 10.3748/wjg.v26.i36.5420; Xu J, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00167; Zadorozhna M, 2020, MOL BIOL REP, V47, P2279, DOI 10.1007/s11033-020-05290-0; Zhang CY, 2016, WORLD J GASTROENTERO, V22, P10512, DOI 10.3748/wjg.v22.i48.10512	52	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274126	10.1371/journal.pone.0274126	http://dx.doi.org/10.1371/journal.pone.0274126			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054162	Green Published, gold			2022-12-26	WOS:000892641400063
J	Chen, H; Gao, XY; Zhao, SY; Bao, CY; Ming, X; Qian, YJ; Zhou, Y; Jung, YS				Chen, Huan; Gao, Xiaoyu; Zhao, Shiying; Bao, Chenyi; Ming, Xin; Qian, Yingjuan; Zhou, Yan; Jung, Yong-Sam			Pirh2 restricts influenza A virus replication by modulating short-chain ubiquitination of its nucleoprotein	FASEB JOURNAL			English	Article						influenza A virus; NP; Pirh2; short-chain ubiquitination	E3 LIGASE PIRH2; VIRAL NUCLEOPROTEIN; ORF3 PROTEIN; RNA; ADAPTATION; BINDING; PB2; MONOUBIQUITINATION; INFECTION; TRANSPORT	Influenza A viruses (IAVs) rely on viral ribonucleoprotein (vRNP) complexes to control transcription and replication. Each vRNP consists of one viral genomic RNA segment associated with multiple nucleoproteins (NP) and a trimeric IAV RNA polymerase complex. Previous studies showed that post-translational modifications of vRNP components, such as NP, by host factors would in turn affect the IAV life cycle or modulate host anti-viral response. In this study, we found host E3 ubiquitin ligase Pirh2 interacted with NP and mediated short-chain ubiquitination of NP at lysine 351, which suppressed NP-PB2 interaction and vRNP formation. In addition, we showed that knockdown of Pirh2 promoted IAV replication, whereas overexpression of Pirh2 inhibited IAV replication. However, Pirh2-Delta RING lacking E3 ligase activity failed to inhibit IAV infection. Moreover, we showed that Pirh2 had no effect on the replication of a rescued virus, WSN-K351R, carrying lysine-to-arginine substitution at residue 351. Interestingly, by analyzing human and avian IAVs from 2011 to 2020 in influenza research databases, we found that 99.18% of 26 977 human IAVs encode lysine, but 95.3% of 9956 avian IAVs encode arginine at residue 351 of NP protein. Consistently, knockdown of Pirh2 failed to promote propagation of two avian-like influenza viruses, H9N2-W1 and H9N2-C1, which naturally encode arginine at residue 351 of NP. Taken together, we demonstrated that Pirh2 is a host factor restricting IAV infection by modulating short-chain ubiquitination of NP. Meanwhile, it is noteworthy that residue 351 of NP targeted by Pirh2 may associate with the evasion of human anti-viral response against avian-like influenza viruses.	[Chen, Huan; Gao, Xiaoyu; Zhao, Shiying; Bao, Chenyi; Ming, Xin; Qian, Yingjuan; Jung, Yong-Sam] Nanjing Agr Univ, Coll Vet Med, MOE Joint Int Res Lab Anim Hlth & Food Safety, Jiangsu Foreign Expert Workshop, Nanjing, Jiangsu, Peoples R China; [Qian, Yingjuan] Jiangsu Agrianim Husb Vocat Coll, Jiangsu Key Lab High Tech Res & Dev Vet Biopharma, Vet Biopharmaceut, Taizhou, Peoples R China; [Zhou, Yan] Univ Saskatchewan, Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Zhou, Yan] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Microbiol, Saskatoon, SK, Canada	Nanjing Agricultural University; Jiangsu Agri-animal Husbandry Vocational College; University of Saskatchewan; University of Saskatchewan	Jung, YS (corresponding author), Nanjing Agr Univ, Coll Vet Med, MOE Joint Int Res Lab Anim Hlth & Food Safety, Jiangsu Foreign Expert Workshop, Nanjing, Jiangsu, Peoples R China.	ysjung@njau.edu.cn		, Yan/0000-0002-4706-1543	National Natural Science Foundation of China [31900141]; Fundamental Research Funds for the Central Universities [KJQN202022]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Canada Foundation for Innovation through the Major Science Initiatives for its CL3 Facility (InterVac); Ministry of Agriculture; Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada; Innovation Saskatchewan	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions; Canada Foundation for Innovation through the Major Science Initiatives for its CL3 Facility (InterVac); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Innovation Saskatchewan	National Natural Science Foundation of China, Grant/Award Number: 31900141; Fundamental Research Funds for the Central Universities, Grant/Award Number: KJQN202022; Priority Academic Program Development of Jiangsu Higher Education Institutions; Canada Foundation for Innovation through the Major Science Initiatives for its CL3 Facility (InterVac); Innovation Saskatchewan and the Ministry of Agriculture; Canadian Institute of Health Research; Natural Sciences and Engineering Research Council of Canada	Ahmed F, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13071415; Arranz R, 2012, SCIENCE, V338, P1634, DOI 10.1126/science.1228172; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Chen GW, 2006, EMERG INFECT DIS, V12, P1353, DOI 10.3201/eid1209.060276; Chen H, 2019, J VIROL, V93, DOI 10.1128/JVI.01896-18; Chen MZ, 2005, J VIROL, V79, P11824, DOI 10.1128/JVI.79.18.11824-11836.2005; Cianci Christopher, 2013, Antiviral Chemistry & Chemotherapy, V23, P77, DOI 10.3851/IMP2235; Cui L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01816; Danzy S, 2014, J VIROL, V88, P13436, DOI 10.1128/JVI.01093-14; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Pietro A, 2013, J VIROL, V87, P4523, DOI 10.1128/JVI.02548-12; Digard P, 1999, J VIROL, V73, P2222, DOI 10.1128/JVI.73.3.2222-2231.1999; Dong LL, 2015, VIRUSES-BASEL, V7, P1668, DOI 10.3390/v7041668; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Giese S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01112-3; Hakem A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002360; Halaby MJ, 2013, CELL CYCLE, V12, P2733, DOI 10.4161/cc.25785; Hayashi H, 2009, MOL PHARMACOL, V75, P143, DOI 10.1124/mol.108.049288; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann HH, 2008, ANTIVIR RES, V80, P124, DOI 10.1016/j.antiviral.2008.05.008; Hu J, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.517461; Hutchinson EC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002993; Ikeda F, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202008031; Jung YS, 2012, FEBS LETT, V586, P1397, DOI 10.1016/j.febslet.2012.03.052; Jung YS, 2011, J BIOL CHEM, V286, P35388, DOI 10.1074/jbc.M111.261537; Jung YS, 2010, MOL CELL BIOL, V30, P1041, DOI 10.1128/MCB.01198-09; Kamsteeg EJ, 2006, P NATL ACAD SCI USA, V103, P18344, DOI 10.1073/pnas.0604073103; Karuppannan AK, 2010, VIROLOGY, V398, P1, DOI 10.1016/j.virol.2009.11.028; Liao TL, 2010, EMBO J, V29, P3879, DOI 10.1038/emboj.2010.250; Lin YC, 2017, MBIO, V8, DOI 10.1128/mBio.00597-17; Liu J, 2007, J VIROL, V81, P9560, DOI 10.1128/JVI.00681-07; Liu Q, 2013, ACTA PHARMACOL SIN, V34, P1257, DOI 10.1038/aps.2013.121; Martin-Benito J, 2001, EMBO REP, V2, P313, DOI 10.1093/embo-reports/kve063; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Min JY, 2013, J VIROL, V87, P10884, DOI 10.1128/JVI.01016-13; Mondal A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004826; Naffakh N, 2008, ANNU REV MICROBIOL, V62, P403, DOI 10.1146/annurev.micro.62.081307.162746; Ng AKL, 2009, SCI CHINA SER C, V52, P439, DOI 10.1007/s11427-009-0064-x; ONEILL RE, 1995, J BIOL CHEM, V270, P22701, DOI 10.1074/jbc.270.39.22701; Patil G, 2018, J VIROL, V92, DOI 10.1128/JVI.00905-18; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Ping JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021740; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Shao WH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081650; Shinya K, 2007, J GEN VIROL, V88, P547, DOI 10.1099/vir.0.82411-0; Su YT, 2013, MOL CELL BIOL, V33, P1546, DOI 10.1128/MCB.01146-12; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Vijaykrishna D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004902; Villalon-Letelier F, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120376; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; WHO, 2014, INFL SEAS; Wu XW, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00344; Ye QZ, 2006, NATURE, V444, P1078, DOI 10.1038/nature05379; Yip TF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01547; Zhao MM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081673; Zheng WN, 2021, SCI CHINA LIFE SCI, V64, P633, DOI 10.1007/s11427-020-1727-y; Zheng WJ, 2013, FEBS LETT, V587, P1206, DOI 10.1016/j.febslet.2013.02.048	61	0	0	9	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22537	10.1096/fj.202200473R	http://dx.doi.org/10.1096/fj.202200473R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4I5BC	36070077				2022-12-26	WOS:000850591200001
J	Zhang, XD; Jin, XX; Li, YB; Xu, MM; Yao, Y; Liu, KY; Ma, CJ; Zhang, YC; Ru, JJ; He, YF; Gao, JH				Zhang, Xiangdong; Jin, Xiaoxuan; Li, Yibao; Xu, Mimi; Yao, Yao; Liu, Kaiyang; Ma, Chijuan; Zhang, Yuchen; Ru, Jiangjiang; He, Yunfan; Gao, Jianhua			Macrophage-mediated extracellular matrix remodeling after fat grafting in nude mice	FASEB JOURNAL			English	Article						extracellular matrix remodeling; fat grafting; fibroblast; graft retention; macrophage	DECELLULARIZED ADIPOSE-TISSUE; STEM-CELL; TRANSPLANTATION; DEGRADATION; ADIPOCYTES; SCAFFOLD	Clinical unpredictability and variability following fat grafting remain non-negligible problems due to the unknown mechanism of grafted fat retention. The role of the extracellular matrix (ECM), which renders cells with structural and biochemical support, has been ignored. This study aimed to clarify the ECM remodeling process, related cellular events, and the spatiotemporal relationship between ECM remodeling and adipocyte survival and adipogenesis after fat grafting. Labeled Coleman fat by the matrix-tracing technique was grafted in nude mice. The ECM remodeling process and cellular events were assessed in vivo. The related cytokines were evaluated by qRT-PCR. An in vitro cell migration assay was performed to verify the chemotactic effect of M2-like macrophages on fibroblasts. The results demonstrated that in the periphery, most of the adipocytes of the graft survived or regenerated, and the graft-derived ECM was gradually replaced by the newly-formed ECM. In the central parts, most adipocytes in the grafts died shortly after, and a small part of the graft-derived and newly-formed ECM was expressed with irregular morphology. Adipose ECM remodeling is associated with increased infiltration of macrophages and fibroblasts, as well as up-regulated expression of cytokines in the adipose tissue. To sum up, our results describe the various preservation mode of fat grafts after transplantation and underscore the importance of macrophage-mediated ECM remodeling in graft preservation after fat grafting. The appreciation and manipulation of underlying mechanisms that are operant in this setting stand to explore new therapeutic approaches and improve clinical outcomes of fat grafting.	[Zhang, Xiangdong; Jin, Xiaoxuan; Li, Yibao; Xu, Mimi; Yao, Yao; Liu, Kaiyang; Ma, Chijuan; Zhang, Yuchen; Ru, Jiangjiang; He, Yunfan; Gao, Jianhua] Southern Med Univ, Nanfang Hosp, Dept Plast Surg, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China	He, YF; Gao, JH (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Plast Surg, 1838 Guangzhou North Rd, Guangzhou 510515, Guangdong, Peoples R China.	doctorheyunfan@hotmail.com; doctorgaojianhua@outlook.com	Zhang, Yuchen/GYI-8858-2022		National Nature Science Foundation of China [81772101, 81801933, 81871573]; Natural Science Foundation of Guangdong Province of China [2017A030313900]; Administrator Foundation of Nanfang Hospital [2016Z010, 2017C008]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Administrator Foundation of Nanfang Hospital	This work was supported by the National Nature Science Foundation of China (81772101, 81801933, 81871573), the Natural Science Foundation of Guangdong Province of China (2017A030313900), and the Administrator Foundation of Nanfang Hospital (2016Z010, 2017C008).	Abu-Ghname A, 2019, SEMIN PLAST SURG, V33, P147, DOI 10.1055/s-0039-1693438; Alcorta-Sevillano N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122630; Alharbi Z, 2013, J PLAST RECONSTR AES, V66, P1271, DOI 10.1016/j.bjps.2013.04.015; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Bhang SH, 2014, MOL THER, V22, P862, DOI 10.1038/mt.2013.301; BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033; Cai JR, 2017, BIOCHEM BIOPH RES CO, V490, P560, DOI 10.1016/j.bbrc.2017.06.078; Cheung HK, 2014, BIOMATERIALS, V35, P1914, DOI 10.1016/j.biomaterials.2013.11.067; Chung MT, 2014, PLAST RECONSTR SURG, V134, P29, DOI 10.1097/PRS.0000000000000290; Cleveland EC, 2015, PLAST RECONSTR SURG, V136, P706, DOI 10.1097/PRS.0000000000001581; Correa-Gallegos D, 2019, NATURE, V576, P287, DOI 10.1038/s41586-019-1794-y; DeLeon-Pennell KY, 2020, MATRIX BIOL, V91-92, P1, DOI 10.1016/j.matbio.2020.05.006; Derrick CJ, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.191320; Doi K, 2015, PLAST RECONSTR SURG, V135, P1607, DOI 10.1097/PRS.0000000000001292; Domingues MJ, 2017, J CELL BIOCHEM, V118, P1984, DOI 10.1002/jcb.25905; Dong ZQ, 2015, PLAST RECONSTR SURG, V135, p556E, DOI 10.1097/PRS.0000000000000965; Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19; Fisher C, 2013, PLAST RECONSTR SURG, V132, P351, DOI 10.1097/PRS.0b013e3182958796; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Hussey GS, 2018, NAT REV MATER, V3, P159, DOI 10.1038/s41578-018-0023-x; Jeon EY, 2020, ACTA BIOMATER, V114, P244, DOI 10.1016/j.actbio.2020.07.033; Jin XX, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.722427; Kato H, 2014, PLAST RECONSTR SURG, V133, p303E, DOI 10.1097/PRS.0000000000000066; Kurose H, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071716; Kurtz A, 2012, PREV MED, V54, pS50, DOI 10.1016/j.ypmed.2012.01.003; Laskin DL, 2011, ANNU REV PHARMACOL, V51, P267, DOI 10.1146/annurev.pharmtox.010909.105812; Li CX, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22189997; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Madsen DH, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.27127; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Nakayama KH, 2010, TISSUE ENG PT A, V16, P2207, DOI [10.1089/ten.tea.2009.0602, 10.1089/ten.TEA.2009.0602]; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Newby AC, 2016, EXP PHYSIOL, V101, P1327, DOI 10.1113/EP085567; Peng Z, 2021, BIOMATERIALS, V268, DOI 10.1016/j.biomaterials.2020.120555; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Phipps KD, 2015, PLAST RECONSTR SURG, V135, P140, DOI 10.1097/PRS.0000000000000793; Pu LLQ, 2012, J PLAST RECONSTR AES, V65, P413, DOI 10.1016/j.bjps.2011.09.033; Sagaradze G, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1479-3; Sainio A, 2020, CELL SIGNAL, V66, DOI 10.1016/j.cellsig.2019.109487; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shih L, 2020, SEMIN PLAST SURG, V34, P5, DOI 10.1055/s-0039-3402073; Simonacci F, 2016, ANN MED SURG, V12, P94, DOI 10.1016/j.amsu.2016.11.012; Sinno S, 2016, PLAST RECONSTR SURG, V137, P818, DOI 10.1097/01.prs.0000479966.52477.8b; Sobreiro-Almeida R, 2021, ADV HEALTHC MATER, V10, DOI 10.1002/adhm.202100160; Spencer M, 2010, AM J PHYSIOL-ENDOC M, V299, pE1016, DOI 10.1152/ajpendo.00329.2010; Sprangers S, 2019, MATRIX BIOL, V75-76, P190, DOI 10.1016/j.matbio.2017.11.008; Sterodimas A, 2011, AESTHET SURG J, V31, P682, DOI 10.1177/1090820X11415976; Strong AL, 2015, PLAST RECONSTR SURG, V136, P897, DOI 10.1097/PRS.0000000000001590; Theocharis AD, 2019, FEBS J, V286, P2830, DOI 10.1111/febs.14818; Ueshima E, 2019, AM J PHYSIOL-RENAL, V317, pF52, DOI 10.1152/ajprenal.00260.2018; Valentin JE, 2009, TISSUE ENG PT A, V15, P1687, DOI 10.1089/ten.tea.2008.0419; Wolter TP, 2005, ANN PLAS SURG, V55, P408, DOI 10.1097/01.sap.0000181345.56084.7d; Yao Y, 2017, PLAST RECONSTR SURG, V139, P867, DOI 10.1097/PRS.0000000000003214; Yi Y., 2021, CELL TRANSPLANT, V30; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4; Yu C, 2017, BIOMATERIALS, V120, P66, DOI 10.1016/j.biomaterials.2016.12.017	56	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22550	10.1096/fj.202200037R	http://dx.doi.org/10.1096/fj.202200037R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4M1TO	36098482				2022-12-26	WOS:000853111200001
J	Al-Sanea, MM; Chilingaryan, G; Abelyan, N; Mamikonyan, M; Gasparyan, H; Hovhannisyan, S; Hamdi, A; Ali, AR; Selim, S; Mohamed, AAB				Al-Sanea, Mohammad M.; Chilingaryan, Garri; Abelyan, Narek; Mamikonyan, Michael; Gasparyan, Hayk; Hovhannisyan, Sargis; Hamdi, Abdelrahman; Ali, Ahmed R.; Selim, Samy; Mohamed, Ahmed A. B.			Combination of ligand and structure based virtual screening approaches for the discovery of potential PARP1 inhibitors	PLOS ONE			English	Article							DNA-REPAIR; DOCKING; PREDICTION; CHAIN; ICM	Poly (ADP-ribose) polymerase 1 (PARP1) has high therapeutic value as biomolecular target for research and development of small molecules with antineoplastic activity, since it is upregulated in many cancers, especially in ovarian and BRCA 1/2 mutated breast cancers. Decades of investigation of PARP inhibitors (PARPi) have led to the approval of several drug compounds, however clinical application of PARPi in cancer therapy is limited due to a number of factors, including low selectivity, weak affinity and undesired side effects. Thus, identification of novel drug-like chemical compounds with alternatives to the known PARPi chemical scaffolds, binding modes and interaction patterns with amino acid residues in the active site is of high therapeutic importance. In this study we applied a combination of ligand-and structure-based virtual screening approaches with the goal of identification of novel potential PARPi.	[Al-Sanea, Mohammad M.] Jouf Univ, Dept Pharmaceut Chem, Coll Pharm, Sakaka, Saudi Arabia; [Chilingaryan, Garri] Inst Mol Med, Huntington Beach, CA 92647 USA; [Chilingaryan, Garri] Inst Mol Biol NAS RA, Yerevan, Armenia; [Chilingaryan, Garri; Abelyan, Narek; Mamikonyan, Michael] Russian Armenian Univ, Inst Biomed & Pharm, Yerevan, Armenia; [Gasparyan, Hayk; Hovhannisyan, Sargis] Yerevan State Univ, Dept Math & Mech, Yerevan, Armenia; [Hamdi, Abdelrahman] Mansoura Univ, Dept Organ Pharmaceut Chem, Fac Pharm, Mansoura, Egypt; [Ali, Ahmed R.; Mohamed, Ahmed A. B.] Mansoura Univ, Dept Med Chem, Fac Pharm, Mansoura, Egypt; [Selim, Samy] Jouf Univ, Dept Clin Lab Sci, Coll Appl Med Sci, Sakaka, Saudi Arabia	Al Jouf University; National Academy of Sciences of Armenia; Institute of Molecular Biology - NAS RA; Russian Armenian Slavonic University; Yerevan State University; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University; Al Jouf University	Chilingaryan, G (corresponding author), Inst Mol Med, Huntington Beach, CA 92647 USA.; Chilingaryan, G (corresponding author), Inst Mol Biol NAS RA, Yerevan, Armenia.; Chilingaryan, G (corresponding author), Russian Armenian Univ, Inst Biomed & Pharm, Yerevan, Armenia.	g_chilingaryan@mb.sci.am		Abelyan, Narek/0000-0002-2937-8985	Deanship of Scientific Research at Jouf University [DSR-2021-01-0105]	Deanship of Scientific Research at Jouf University	The authors extend their appreciation to the Deanship of Scientific Research at Jouf University for funding this work through research grant No (DSR-2021-01-0105).	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Chilingaryan G, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91069-7; Coleman RL, 2019, NEW ENGL J MED, V381, P2403, DOI 10.1056/NEJMoa1909707; Cross JB, 2009, J CHEM INF MODEL, V49, P1455, DOI 10.1021/ci900056c; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Dockery LE, 2017, ONCOTARGETS THER, V10, P3029, DOI 10.2147/OTT.S114714; Engbrecht M, 2020, CANCERS, V12, DOI 10.3390/cancers12071813; Eustermann S, 2015, MOL CELL, V60, P742, DOI 10.1016/j.molcel.2015.10.032; Griguolo G, 2018, EXPERT REV ANTICANC, V18, P519, DOI 10.1080/14737140.2018.1458613; Hawkins PCD, 2007, J MED CHEM, V50, P74, DOI 10.1021/jm0603365; Hopkins TA, 2019, MOL CANCER RES, V17, P409, DOI 10.1158/1541-7786.MCR-18-0138; Irwin JJ, 2020, J CHEM INF MODEL, V60, P6065, DOI 10.1021/acs.jcim.0c00675; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Jiang X, 2019, J CELL MOL MED, V23, P2303, DOI 10.1111/jcmm.14133; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Langelier MF, 2012, SCIENCE, V336, P728, DOI 10.1126/science.1216338; Litton JK, 2018, NEW ENGL J MED, V379, P753, DOI 10.1056/NEJMoa1802905; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mateo J, 2019, ANN ONCOL, V30, P1437, DOI 10.1093/annonc/mdz192; McCann Kelly E, 2018, Drugs Context, V7, P212540, DOI 10.7573/dic.212540; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; Mirza MR, 2016, NEW ENGL J MED, V375, P2154, DOI 10.1056/NEJMoa1611310; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Neves MAC, 2012, J COMPUT AID MOL DES, V26, P675, DOI 10.1007/s10822-012-9547-0; Oliver DS, 1997, MATH GEOL, V29, P61, DOI 10.1007/BF02769620; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Rose M, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.564601; Sachdev E, 2019, TARGET ONCOL, V14, P657, DOI 10.1007/s11523-019-00680-2; Sahakyan H, 2021, J COMPUT AID MOL DES, V35, P731, DOI 10.1007/s10822-021-00389-3; SHALL S, 1975, J BIOCHEM-TOKYO, V77, pP2; Shen YQ, 2013, CLIN CANCER RES, V19, P5003, DOI 10.1158/1078-0432.CCR-13-1391; Tao ZH, 2008, BIOCHEMISTRY-US, V47, P5804, DOI 10.1021/bi800018a; TERADA M, 1979, P NATL ACAD SCI USA, V76, P6411, DOI 10.1073/pnas.76.12.6411; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang L, 2019, CANCER SCI, V110, P1064, DOI 10.1111/cas.13947; Wang LY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102111; Wu XW, 2003, CHEM PHYS LETT, V381, P512, DOI 10.1016/j.cplett.2003.10.013; Zhou YJ, 2019, MOLECULES, V24, DOI 10.3390/molecules24234258	42	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0272065	10.1371/journal.pone.0272065	http://dx.doi.org/10.1371/journal.pone.0272065			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094927	gold, Green Published			2022-12-26	WOS:000892376500012
J	Iwai, T; Hoshi, M; Oebisu, N; Takada, N; Ban, Y; Nakamura, H				Iwai, Tadashi; Hoshi, Manabu; Oebisu, Naoto; Takada, Naoki; Ban, Yoshitaka; Nakamura, Hiroaki			Tumor-skin invasion is a reliable risk factor for poor prognosis in superficial soft tissue sarcomas	PLOS ONE			English	Article							CANCER; MASSES; BONE; MRI	Introduction Superficial soft tissue sarcomas are often left untreated unless they invade the skin and skin ulcers manifest. Progressive sarcomas frequently result in dismal oncological outcomes despite multidisciplinary treatment. This study aimed to identify prognostic factors for superficial soft tissue sarcomas. Materials and methods This study retrospectively analyzed the clinicopathological data of 82 patients with superficial soft tissue sarcomas treated between August 2003 and December 2020 at our institution. A superficial soft tissue sarcoma was defined if the percentage of the area occupied by the tumor in the assessed region (skin, subcutaneous) was more than 50%. Age, sex, location, tumor size, tumor-skin invasion, tumor grade, and distant metastasis at initial diagnosis were evaluated as potential prognostic factors. Cox proportional hazards regression models were used to identify the prognostic factors. Five-year survival rates were assessed by the Kaplan-Meier method. Results The mean follow-up time was 60.1 months. The 5-year overall survival, 5-year local recurrence-free survival, and 5-year metastasis survival rates were 76.4%, 60.6%, and 71.0%, respectively. Univariate analysis showed significant relationships between poor prognosis and tumor size >= 5 cm, distant metastasis at initial diagnosis, and tumor-skin invasion. In the multivariate analysis, only the tumor-skin invasion was associated with worse overall survival. Conclusions Superficial soft tissue sarcomas have biologically been considered a separate category due to their better prognosis. In this study, the tumor-skin invasion was the only significant factor associated with a poor prognosis. Therefore, all superficial soft tissue sarcomas without tumor-skin invasion should be treated as early as possible.	[Iwai, Tadashi; Hoshi, Manabu; Oebisu, Naoto; Takada, Naoki; Ban, Yoshitaka; Nakamura, Hiroaki] Osaka Metropolitan Univ, Dept Orthoped Surg, Grad Sch Med, Abeno Ku, Osaka, Japan		Iwai, T (corresponding author), Osaka Metropolitan Univ, Dept Orthoped Surg, Grad Sch Med, Abeno Ku, Osaka, Japan.	qq329xpd@opal.ocn.ne.jp						Al-Refaie WB, 2010, ANN SURG ONCOL, V17, P1732, DOI 10.1245/s10434-010-1034-z; Alexander S, 2009, J Wound Care, V18, P273; Amin MB., 2017, AJCC CANC STAGING MA, V8th ed., P507; [Anonymous], 2020, WHO CLASSIFICATION T, VFifth Edition.; Calleja M, 2012, SKELETAL RADIOL, V41, P1517, DOI 10.1007/s00256-012-1385-6; Cates JMM, 2019, HEAD NECK-J SCI SPEC, V41, P2359, DOI 10.1002/hed.25701; Cates JMM, 2018, J NATL COMPR CANC NE, V16, P144, DOI 10.6004/jnccn.2017.7042; COX DR, 1972, J R STAT SOC B, V34, P187; Dangoor A, 2016, CLIN SARCOMA RES, V6, DOI 10.1186/s13569-016-0060-4; Datir A, 2008, CLIN RADIOL, V63, P373, DOI 10.1016/j.crad.2007.08.016; Eward WC, 2017, PRS-GLOB OPEN, V5, DOI 10.1097/GOX.0000000000001553; Hoshi M, 2019, J ORTHOP SCI, V24, P1088, DOI 10.1016/j.jos.2019.07.010; Iwai T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209642; Iwai T, 2015, ONCOL LETT, V10, P1799, DOI 10.3892/ol.2015.3432; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kawaguchi N, 2004, CLIN ORTHOP RELAT R, P165, DOI 10.1097/01.blo.0000116308.86761.f5; Lachenmayer A, 2009, WORLD J SURG, V33, P1641, DOI 10.1007/s00268-009-0051-1; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Morel M, 2011, SKELETAL RADIOL, V40, P271, DOI 10.1007/s00256-009-0855-y; Mosca L, 2022, CANCERS, V14, DOI 10.3390/cancers14143414; Muhlhofer HML, 2019, ANTICANCER RES, V39, P2985, DOI 10.21873/anticanres.13430; Oettel DJ, 2022, SKELETAL RADIOL, DOI 10.1007/s00256-022-04127-0; Ogura K, 2017, J ORTHOP SCI, V22, P755, DOI 10.1016/j.jos.2017.03.017; Okajima K, 2021, JPN J CLIN ONCOL, V51, P78, DOI 10.1093/jjco/hyaa176; Salas S, 2009, EUR J CANCER, V45, P2091, DOI 10.1016/j.ejca.2009.03.006; Staudigl C, 2015, TUMOR BIOL, V36, P3423, DOI 10.1007/s13277-014-2977-7; TROJANI M, 1984, INT J CANCER, V33, P37, DOI 10.1002/ijc.2910330108; Yoneda Y, 2014, EJSO-EUR J SURG ONC, V40, P49, DOI 10.1016/j.ejso.2013.09.004	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274077	10.1371/journal.pone.0274077	http://dx.doi.org/10.1371/journal.pone.0274077			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054224	Green Published, gold			2022-12-26	WOS:000892641400058
J	Li, C; Yue, C; Liu, ZC; Gong, J; Wei, XS; Yang, H; Gilmore, C; Yu, SB; Hack, GD; Sui, HJ				Li, Chan; Yue, Chen; Liu, Zhao-Chang; Gong, Jin; Wei, Xiao-Song; Yang, Heng; Gilmore, Campbell; Yu, Sheng-Bo; Hack, Gary D.; Sui, Hong-Jin			The relationship between myodural bridges, hyperplasia of the suboccipital musculature, and intracranial pressure	PLOS ONE			English	Article							POSTERIOR MINOR MUSCLE; SPINAL DURA-MATER; CEREBROSPINAL-FLUID; CONNECTIVE-TISSUE; ANATOMIC RELATION; ATROPHY; EXPRESSION; MYOSTATIN; HEADACHE; DYNAMICS	During mammalian evolution, the Myodural Bridges (MDB) have been shown to be highly conserved anatomical structures. However, the putative physiological function of these structures remains unclear. The MDB functionally connects the suboccipital musculature to the cervical spinal dura mater, while passing through the posterior atlanto-occipital and atlanto-axial interspaces. MDB transmits the tensile forces generated by the suboccipital muscles to the cervical dura mater. Moreover, head movements have been shown to be an important contributor to human CSF circulation. In the present study, a 16-week administration of a Myostatin-specific inhibitor, ACE-031, was injected into the suboccipital musculature of rats to establish an experimental animal model of hyperplasia of the suboccipital musculature. Using an optic fiber pressure measurement instrument, the present authors observed a significant increase in intracranial pressure (ICP) while utilizing the hyperplasia model. In contrast, surgically severing the MDB connections resulted in a significant decrease in intracranial pressure. Thus, these results indicated that muscular activation of the MDB may affect CSF circulation, suggesting a potential functional role of the MDB, and providing a new research perspective on CSF dynamics.	[Li, Chan; Liu, Zhao-Chang; Gong, Jin; Wei, Xiao-Song; Yang, Heng; Yu, Sheng-Bo; Sui, Hong-Jin] Dalian Med Univ, Dept Anat, Dalian, Peoples R China; [Yue, Chen] Dalian Med Univ, Hosp 2, Dept Gynecol & Obstet, Dalian, Peoples R China; [Gilmore, Campbell] St Georges Univ London, Med Sch, London, England; [Hack, Gary D.] Univ Maryland, Dept Adv Oral Sci & Therapeut, Baltimore, MD 21201 USA	Dalian Medical University; Dalian Medical University; St Georges University London; University System of Maryland; University of Maryland Baltimore	Sui, HJ (corresponding author), Dalian Med Univ, Dept Anat, Dalian, Peoples R China.; Hack, GD (corresponding author), Univ Maryland, Dept Adv Oral Sci & Therapeut, Baltimore, MD 21201 USA.	suihj@hotmail.com		Hack, Gary/0000-0003-0381-8206	young scientist's foundation of Liaoning provincial department of education [507058]; Natural Science Foundation of China [NSFC31871213, NSFC31571234, NSFC32071184]	young scientist's foundation of Liaoning provincial department of education; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	"Grant sponsor: This work was supported by the young scientist's foundation of Liaoning provincial department of education (507058); Natural Science Foundation of China (NSFC31871213, NSFC31571234, NSFC32071184). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix ME, 1999, J MANIP PHYSIOL THER, V22, P534, DOI 10.1016/S0161-4754(99)70006-0; Alperin N, 2005, ACT NEUR S, V95, P177; Brinker T, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-10; Dean NA, 2002, CLIN ANAT, V15, P182, DOI 10.1002/ca.10001; Fardon DF, 2014, SPINE J, V14, P2525, DOI 10.1016/j.spinee.2014.04.022; Friese S, 2004, INVEST RADIOL, V39, P120, DOI 10.1097/01.rli.0000112089.66448.bd; Goldbogen JA, 2019, P NATL ACAD SCI USA, V116, P25329, DOI 10.1073/pnas.1914273116; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; HACK GD, 1995, SPINE, V20, P2484, DOI 10.1097/00007632-199512000-00003; Humphreys BK, 2003, CLIN ANAT, V16, P152, DOI 10.1002/ca.10109; Kahkeshani K, 2012, CLIN ANAT, V25, P415, DOI 10.1002/ca.21261; Kontautas Egidijus, 2005, Medicina (Kaunas), V41, P802; Liu P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200260; Liu P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173630; Luo J, 2006, CELL METAB, V3, P355, DOI 10.1016/j.cmet.2006.04.003; McPartland JM, 1997, J MANIP PHYSIOL THER, V20, P24; Murtha L, 2012, JOVE-J VIS EXP, DOI 10.3791/3689; Murtha LA, 2014, FLUIDS BARRIERS CNS, V11, DOI 10.1186/2045-8118-11-12; Nash L, 2005, SPINE, V30, P1359, DOI 10.1097/01.brs.0000166159.31329.92; Newell RLM, 1999, CLIN ANAT, V12, P375, DOI 10.1002/(SICI)1098-2353(1999)12:5<375::AID-CA7>3.0.CO;2-6; Pontell ME, 2013, ANN ANAT, V195, P522, DOI 10.1016/j.aanat.2013.04.013; Pontell ME, 2013, CLIN ANAT, V26, P450, DOI 10.1002/ca.22134; Ramadan NM, 1996, CURR OPIN NEUROL, V9, P214, DOI 10.1097/00019052-199606000-00011; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scali F, 2013, SPINE J, V13, P558, DOI 10.1016/j.spinee.2013.01.015; Scali F, 2011, SPINE, V36, pE1612, DOI 10.1097/BRS.0b013e31821129df; Shadwick Robert E., 1995, Symposia of the Society for Experimental Biology, V49, P243; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; [隋鸿锦 Sui Hongjin], 2013, [中国临床解剖学杂志, Chinese Journal of Clinical Anatomy], V31, P489; TRELEAVEN J, 1994, CEPHALALGIA, V14, P273, DOI 10.1046/j.1468-2982.1994.1404273.x; Tsuchida K, 2008, CURR OPIN DRUG DISC, V11, P487; Wadhwani S, 2004, SPINE, V29, P623, DOI 10.1097/01.BRS.0000115129.59484.24; Xu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep31787; Young BA, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10070672; Yuan XY, 2017, CEPHALALGIA, V37, P1051, DOI 10.1177/0333102416664775; Yuan XY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177120; Zhang JH, 2016, ANAT REC, V299, P1402, DOI 10.1002/ar.23445; Zheng N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06863-z; Zheng N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103451; Zhu DC, 2006, J MAGN RESON IMAGING, V24, P756, DOI 10.1002/jmri.20679; Zumpano MP, 2006, CLIN ANAT, V19, P522, DOI 10.1002/ca.20220	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273193	10.1371/journal.pone.0273193	http://dx.doi.org/10.1371/journal.pone.0273193			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054096	Green Published, gold			2022-12-26	WOS:000892641400017
J	Mavura, RA; Nyaki, AY; Leyaro, BJ; Mamseri, R; George, J; Ngocho, JS; Mboya, IB				Mavura, Rehema A.; Nyaki, Ahmed Y.; Leyaro, Beatrice J.; Mamseri, Redempta; George, Johnston; Ngocho, James S.; Mboya, Innocent B.			Prevalence of substance use and associated factors among secondary school adolescents in Kilimanjaro region, northern Tanzania	PLOS ONE			English	Article							ALCOHOL-USE; DRUG-USE; STUDENTS; BEHAVIOR	Background Substance use among school-going adolescents increases the risk of developing mental disorders, addiction, and substance use disorders. These may lead to poor academic performance and reduced productivity, which affects adolescent lives. The study aimed to determine the prevalence of substance use and associated factors among secondary school adolescents in the Kilimanjaro region, northern Tanzania. Methodology The study used secondary data from a cross-sectional survey of adolescents aged 10-19 years from public secondary schools in the Kilimanjaro Region, northern Tanzania. Substance use was measured using the Global School Health Survey (GSHS) questionnaire. Categorical variables were summarized using frequencies and percentages, while numerical variables used mean and standard deviation. Multivariable logistic regression models were used to obtain odds ratios (OR) and 95% confidence intervals (CI) to determine risk factors associated with lifetime and current (within the past 30 days preceding the survey) substance use. Results The lifetime and current prevalence of substance use among 3224 adolescents was 19.7% and 12.8%, respectively, while alcohol and cigarettes were commonly used. Female adolescents had lower odds of current substance use (OR = 0.63, 95%CI 0.50-0.80). Higher odds of current substance use were among adolescents who have ever had sex (OR = 4.31, 95%CI 3.25-5.71), ever engaged in a physical fight (OR = 2.19, 95%CI 1.73-2.78), ever been bullied (OR = 1.55, 95%CI 1.16-2.05), always seen alcohol advertisements (OR = 1.87, 95%CI 1.37-2.53), and adolescents whose parent/guardians rarely understood their problems (OR = 1.38, 95% CI = 1.03-1.85). Adolescents whose classmates always showed social support had lower odds of current substance use (AOR = 0.71, 95%CI 0.53-0.97). Similar factors were associated with lifetime substance users. Conclusion The study reflects a high prevalence of substance use among adolescents in the Kilimanjaro region. Alcohol and cigarette are the most prevalent substances used. Regulatory measures are essential to limit alcohol advertisements that are media portrayed. Efforts are needed to reduce risk behaviors, such as physical violence and bullying, through peer support groups/ clubs in school environments.	[Mavura, Rehema A.; Nyaki, Ahmed Y.; Mamseri, Redempta; George, Johnston; Mboya, Innocent B.] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Community Hlth Dept, Moshi, Tanzania; [Leyaro, Beatrice J.; Ngocho, James S.; Mboya, Innocent B.] Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi, Tanzania		Mavura, RA (corresponding author), Kilimanjaro Christian Med Univ Coll, Inst Publ Hlth, Community Hlth Dept, Moshi, Tanzania.	reyahmed1994@gmail.com		Mboya, Innocent/0000-0001-9861-5879; Mavura, Rehema/0000-0001-5693-1160				Abio A., 2020, INJ VIOLENCE, V12, P21; Ali MAEM, 2022, PROC INST CIV ENG-CO, V175, P2, DOI 10.1680/jcoma.18.00048; Alonso-Fernandez N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16214294; Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; Aryal K., 2017, REPORT GLOBAL BASED; Asante KO, 2019, CHILD ADOL PSYCH MEN, V13, DOI 10.1186/s13034-019-0293-0; Baheiraei A, 2013, IRAN RED CRESCENT ME, V15, P212, DOI 10.5812/ircmj.4022; Berhane Y, 2020, TROP MED INT HEALTH, V25, P15, DOI 10.1111/tmi.13339; Bio-sya A, 2022, BASIC CLIN PHARMACOL, V131, P205, DOI 10.1111/bcpt.13764; Birhanu AM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1186; Chivandire CT, 2016, MALAWI MED J, V28, P53, DOI 10.4314/mmj.v28i2.5; Degenhardt L, 2016, LANCET PSYCHIAT, V3, P251, DOI 10.1016/S2215-0366(15)00508-8; Dwyer T, 2019, J COMMUN HEALTH, V44, P749, DOI 10.1007/s10900-019-00673-2; Francis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140041; Gebremariam TB, 2018, SUBST ABUSE TREAT PR, V13, DOI 10.1186/s13011-018-0150-9; Gyan R., 2021, SSM POPUL HEAL, V16, DOI [10.1016/j.ssmph.2021.100929, DOI 10.1016/J.SSMPH.2021.100929]; Halladay J, 2020, DRUG ALCOHOL DEPEN, V216, DOI 10.1016/j.drugalcdep.2020.108222; Idowu A, 2018, AFR HEALTH SCI, V18, P776, DOI 10.4314/ahs.v18i3.36; Jernigan D, 2017, ADDICTION, V112, P7, DOI 10.1111/add.13591; Jones CM, 2020, MMWR-MORBID MORTAL W, V69, P38, DOI 10.15585/mmwr.su6901a5; Jumbe S., 2021, DETERMINANTS ADOLESC, P1; Ludick W., 2016, AFRICAN J DRUG ALCOH, V15, P22; Mgongo M, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050509; Mnyika Kagoma S, 2011, East Afr J Public Health, V8, P1; MoHCDGEC, 2018, REPR CHILD HLTH SECT; MoHCDGEC, 2017, TANZ MAINL GLOB SCH; Olawole-Isaac A, 2018, S AFR J CHILD HEALTH, pS79, DOI 10.7196/SAJCH.2018.v12i2.1524; Ozeylem Fatos, 2021, Addict Behav Rep, V14, P100370, DOI 10.1016/j.abrep.2021.100370; Page RM, 2009, J SCHOOL HEALTH, V79, P369, DOI 10.1111/j.1746-1561.2009.00423.x; Pengpid S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16111898; PORALG, 2011, KILIMANJARO STARTEGI, P7; Riva K., 2018, PREVALENCE PREDICTOR, P1; Siziya S, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-13; UN, 2016, ARSENIC RES GLOBAL S, P12, DOI 10.1201/b20466-7; UNICEF Tanzania, 2018, GLOB IN OUT SCH CHIL, P16; UNODC, 2020, DRUG US CONS WORLD D; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; WHO, 2015, GLOB SCH BAS STUD HL; WHO, 2021, AD YOUNG AD HLTH KEY; WHO, 2021, GSHS QUEST; Wolke D, 2015, ARCH DIS CHILD, V100, P879, DOI 10.1136/archdischild-2014-306667; World Health Organization, 2020, GLOBAL STATUS REPORT, DOI DOI 10.1037/COU0000248; Yazdi-Feyzabadi V, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0779-5; Yusoff F, 2014, ASIA-PAC J PUBLIC HE, V26, p100S, DOI 10.1177/1010539514542425; Zarrouq B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3143-5	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274102	10.1371/journal.pone.0274102	http://dx.doi.org/10.1371/journal.pone.0274102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054121	Green Published, gold			2022-12-26	WOS:000892641400061
J	Yin, N; Van Nuffelen, M; Bartiaux, M; Preseau, T; Roggen, I; Delaunoy, S; Mahadeb, B; Dahma, H; Busson, L; Vandenberg, O; Hallin, M				Yin, Nicolas; Van Nuffelen, Marc; Bartiaux, Magali; Preseau, Thierry; Roggen, Inge; Delaunoy, Sabrina; Mahadeb, Bhavna; Dahma, Hafid; Busson, Laurent; Vandenberg, Olivier; Hallin, Marie			Clinical impact of the rapid molecular detection of RSV and influenza A and B viruses in the emergency department	PLOS ONE			English	Article							DIAGNOSTIC-TESTS; MANAGEMENT; ACCURACY	Introduction Using respiratory virus rapid diagnostic tests in the emergency department could allow better and faster clinical management. Point-of-care PCR instruments now provide results in less than 30 minutes. The objective of this study was to assess the impact of the use of a rapid molecular diagnostic test, the cobas (R) Influenza A/B & RSV Assay, during the clinical management of emergency department patients. Methods Patients (adults and children) requiring admission or suffering from an underlying condition at risk of respiratory complications were prospectively recruited in the emergency department of four hospitals in the Brussels region. Physicians' intentions regarding admission, isolation, antibiotic, and antiviral use were collected before and after performing the rapid molecular test. Additionally, a comparison of the analytical performance of this test against antigen rapid tests and viral culture was performed as well as a time-to-result evaluation. Results Among the 293 patients recruited, 90 had a positive PCR, whereas 44 had a positive antigen test. PCR yielded a sensitivity of 100% for all targets. Antigen tests yielded sensitivities ranging from 66.7% for influenza B to 83.3% for respiratory syncytial virus (RSV). The use of PCR allowed a decrease in the overall need for isolation and treatment by limiting the isolation of negative patients and antibiotic use for positive patients. Meanwhile, antiviral treatments better targeted patients with a positive influenza PCR. Conclusion The use of a rapid influenza and RSV molecular test improves the clinical management of patients admitted to the emergency department by providing a fast and reliable result. Their additional cost compared to antigen tests should be balanced with the benefit of their analytical performance, leading to efficient reductions in the need for isolation and antibiotic use.	[Yin, Nicolas; Mahadeb, Bhavna; Dahma, Hafid; Busson, Laurent; Hallin, Marie] Univ Libre Bruxelles ULB, Lab Hosp Univ Bruxelles, Dept Microbiol, Univ Lab Brussel, Brussels, Belgium; [Van Nuffelen, Marc] Univ Libre Bruxelles ULB, Erasme Univ Hosp, Emergency Dept, Brussels, Belgium; [Bartiaux, Magali] Univ Libre Bruxelles ULB, St Pierre Univ Hosp, Emergency Dept, Brussels, Belgium; [Preseau, Thierry] Univ Libre Bruxelles ULB, Brugmann Univ Hosp, Emergency Dept, Brussels, Belgium; [Roggen, Inge] Univ Libre Bruxelles ULB, Queen Fabiola Pediat Univ Hosp, Emergency Dept, Brussels, Belgium; [Vandenberg, Olivier] Univ Libre Bruxelles ULB, Lab Hosp Univ Bruxelles, Univ Lab Brussel, Clin Res & Innovat Unit, Brussels, Belgium; [Vandenberg, Olivier; Hallin, Marie] Univ Libre Bruxelles ULB, Sch Publ Hlth, Ctr Environm Hlth & Occupat Hlth, Brussels, Belgium; [Vandenberg, Olivier] UCL, Div Infect & Immun, Fac Med Sci, London, England	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of London; University College London	Yin, N (corresponding author), Univ Libre Bruxelles ULB, Lab Hosp Univ Bruxelles, Dept Microbiol, Univ Lab Brussel, Brussels, Belgium.	nicolas.yin@lhub-ulb.be		Bartiaux, Magali/0000-0001-9877-9240; Yin, Nicolas/0000-0003-1706-6869; Roggen, Inge/0000-0001-6935-2723				Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Bonner AB, 2003, PEDIATRICS, V112, P363, DOI 10.1542/peds.112.2.363; Bont Louis, 2009, Paediatr Respir Rev, V10 Suppl 1, P16, DOI 10.1016/S1526-0542(09)70008-9; Busson L, 2019, INT J INFECT DIS, V83, P32, DOI 10.1016/j.ijid.2019.03.027; Centers for Disease Control and Prevention, INFL ANT MED SUMM CL; Chartrand C, 2015, J CLIN MICROBIOL, V53, P3738, DOI 10.1128/JCM.01816-15; Chartrand C, 2012, ANN INTERN MED, V156, P500, DOI 10.7326/0003-4819-156-7-201204030-00403; European Centre for Disease Prevention and Control, FACTSH SEAS INFL; Falsey AR, 2007, ARCH INTERN MED, V167, P354, DOI 10.1001/archinte.167.4.ioi60207; Gibson J, 2017, J CLIN VIROL, V95, P5, DOI 10.1016/j.jcv.2017.08.004; Lee BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011284; Maltezou HC, 2008, CURR OPIN INFECT DIS, V21, P337, DOI 10.1097/QCO.0b013e3283013945; Nomenclature des prestations de sante, SECT BIOL CLIN ARTIC; Rahamat-Langendoen J, 2019, J MED VIROL, V91, P1408, DOI 10.1002/jmv.25479; Sheridan Cormac, 2020, Nat Biotechnol, DOI 10.1038/d41587-020-00021-z; van Dijk MD, 2021, J HOSP INFECT, V109, P88, DOI 10.1016/j.jhin.2020.12.013; Vandenberg O, 2021, NAT REV MICROBIOL, V19, P171, DOI 10.1038/s41579-020-00461-z; Yin N, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.650581	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274222	10.1371/journal.pone.0274222	http://dx.doi.org/10.1371/journal.pone.0274222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054246	gold, Green Published			2022-12-26	WOS:000892641400069
J	Mondal, AK; Sengupta, N; Singh, M; Biswas, R; Lata, K; Lahiri, I; Dutta, S; Chattopadhyay, K				Mondal, Anish Kumar; Sengupta, Nayanika; Singh, Mahendra; Biswas, Rupam; Lata, Kusum; Lahiri, Indrajit; Dutta, Somnath; Chattopadhyay, Kausik			Glu289 residue in the pore-forming motif of Vibrio cholerae cytolysin is important for efficient beta-barrel pore formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE INTERACTION MECHANISM; BIOTYPE EL-TOR; CRYSTAL-STRUCTURE; HEMOLYSIN; TOXIN; VISUALIZATION; CHOLESTEROL; SEQUENCE; FEATURES; HLYA	Vibrio cholerae cytolysin (VCC) is a potent membrane-damaging fl-barrel pore-forming toxin. Upon binding to the target membranes, VCC monomers first assemble into oligo-meric prepore intermediates and subsequently transform into transmembrane fl-barrel pores. VCC harbors a designated pore-forming motif, which, during oligomeric pore formation, inserts into the membrane and generates a transmembrane fl-barrel scaffold. It remains an enigma how the molecular architecture of the pore-forming motif regulates the VCC pore -formation mechanism. Here, we show that a specific pore-forming motif residue, E289, plays crucial regulatory roles in the pore-formation mechanism of VCC. We find that the mutation of E289A drastically compromises pore-forming activity, without affecting the structural integrity and membrane-binding potential of the toxin monomers. Although our single-particle cryo-EM analysis reveals WT-like oligo-meric fl-barrel pore formation by E289A-VCC in the mem-brane, we demonstrate that the mutant shows severely delayed kinetics in terms of pore-forming ability that can be rescued with elevated temperature conditions. We find that the pore -formation efficacy of E289A-VCC appears to be more pro-foundly dependent on temperature than that of the WT toxin. Our results suggest that the E289A mutation traps membrane-bound toxin molecules in the prepore-like intermediate state that is hindered from converting into the functional fl-barrel pores by a large energy barrier, thus highlighting the impor-tance of this residue for the pore-formation mechanism of VCC.	[Mondal, Anish Kumar; Singh, Mahendra; Lata, Kusum; Lahiri, Indrajit; Chattopadhyay, Kausik] Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Manauli, Punjab, India; [Sengupta, Nayanika; Biswas, Rupam; Dutta, Somnath] Indian Inst Sci, Mol Biophys Unit, Bangalore, India	Indian Institute of Science Education & Research (IISER) - Mohali; Indian Institute of Science (IISC) - Bangalore	Chattopadhyay, K (corresponding author), Indian Inst Sci Educ & Res Mohali, Dept Biol Sci, Manauli, Punjab, India.	kausik@iisermohali.ac.in			Indian Institute of Science Education and Research Mohali; DBT-BUILDER program [BT/INF/22/SP22844/2017]; DST-FIST program [SR/FST/LSII-039/2015]; Ministry of Education [STARS-1/171]	Indian Institute of Science Education and Research Mohali; DBT-BUILDER program; DST-FIST program(Department of Science & Technology (India)); Ministry of Education	We acknowledge the Transmission Electron Microscopy (TEM) facility and Flow Cytometry facility of IISER Mohali for TEM imaging and flow cytometry-based study, respectively. This work is supported by funding from Indian Institute of Science Education and Research Mohali (IISER Mohali) . We acknowledge the DBT-BUILDER program (BT/INF/22/SP22844/2017) and DST-FIST program (SR/FST/LSII-039/2015) for funding the cryo-EM facility at the Indian Institute of Science and financial support from the Ministry of Education (grant no. STARS-1/171) .	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Barad BA, 2015, NAT METHODS, V12, P943, DOI [10.1038/NMETH.3541, 10.1038/nmeth.3541]; Coelho A, 2000, INFECT IMMUN, V68, P1700, DOI 10.1128/IAI.68.3.1700-1705.2000; Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3; De S, 2011, P NATL ACAD SCI USA, V108, P7385, DOI 10.1073/pnas.1017442108; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Grant T, 2018, ELIFE, V7, DOI 10.7554/eLife.35383; HALL RH, 1990, INFECT IMMUN, V58, P3375, DOI 10.1128/IAI.58.10.3375-3379.1990; Harris JR, 2002, J STRUCT BIOL, V139, P122; HONDA T, 1979, INFECT IMMUN, V26, P1020, DOI 10.1128/IAI.26.3.1020-1027.1979; Iacovache I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12062; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; ICHINOSE Y, 1987, INFECT IMMUN, V55, P1090, DOI 10.1128/IAI.55.5.1090-1093.1987; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; Kathuria R, 2018, BIOCHEM J, V475, P3039, DOI 10.1042/BCJ20180387; Kathuria R, 2018, IUBMB LIFE, V70, P260, DOI 10.1002/iub.1725; Kumar A, 2021, JOVE-J VIS EXP, DOI 10.3791/62832; Lohner S, 2009, FASEB J, V23, P2521, DOI 10.1096/fj.08-127688; Mondal AK, 2021, MOL MICROBIOL, V115, P508, DOI 10.1111/mmi.14631; Mondal AK, 2020, J MEMBRANE BIOL, V253, P469, DOI 10.1007/s00232-020-00141-2; Mondal AK, 2020, BIOCHEMISTRY-US, V59, P163, DOI 10.1021/acs.biochem.9b00783; Nguyen VT, 2002, MOL MICROBIOL, V45, P1485, DOI 10.1046/j.1365-2958.2002.03125.x; Olson R, 2005, J MOL BIOL, V350, P997, DOI 10.1016/j.jmb.2005.05.045; Palmer M, 1998, EMBO J, V17, P1598, DOI 10.1093/emboj/17.6.1598; Paul K, 2014, BIOCHEM BIOPH RES CO, V443, P189, DOI 10.1016/j.bbrc.2013.11.078; Paul K, 2012, FEBS J, V279, P4039, DOI 10.1111/j.1742-4658.2012.08809.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rai AK, 2015, ARCH BIOCHEM BIOPHYS, V583, P9, DOI 10.1016/j.abb.2015.07.019; Rai AK, 2015, MOL MICROBIOL, V97, P1051, DOI 10.1111/mmi.13084; Rai AK, 2015, ADV EXP MED BIOL, V842, P109, DOI 10.1007/978-3-319-11280-0_7; Rai AK, 2014, J BIOL CHEM, V289, P16978, DOI 10.1074/jbc.M114.567099; Rai AK, 2013, J BIOL CHEM, V288, P1665, DOI 10.1074/jbc.M112.430181; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scott H, 2022, J MOL BIOL, V434, DOI 10.1016/j.jmb.2022.167548; Sengupta N, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202102035; Verma P, 2021, BIOCHEM SOC T, V49, P455, DOI 10.1042/BST20200836; YAMAMOTO K, 1990, INFECT IMMUN, V58, P4106, DOI 10.1128/IAI.58.12.4106-4116.1990; Yamashita D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5897; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zitzer A, 1999, J BIOL CHEM, V274, P1375, DOI 10.1074/jbc.274.3.1375; ZITZER A, 1995, MED MICROBIOL IMMUN, V184, P37, DOI 10.1007/BF00216788	44	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2022	298	10							102441	10.1016/j.jbc.2022.102441	http://dx.doi.org/10.1016/j.jbc.2022.102441			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5H1DF	36055404	gold, Green Accepted, Green Published			2022-12-26	WOS:000867425500003
J	Ouimet, C; Bouche, G; Kimmelman, J				Ouimet, Charlotte; Bouche, Gauthier; Kimmelman, Jonathan			Diminishing clinical impact for post-approval cancer clinical trials: A retrospective cohort study	PLOS ONE			English	Article							RARE CANCERS; LIFE-CYCLE; DRUG; BENEFITS; RISKS	Background Once a drug gets FDA approved, researchers often attempt to discover new applications in different indications. The clinical impact of such post-approval activities is uncertain. We aimed to compare the clinical impact of research efforts started after approval with those started before for cancer drugs. Methods We used Drugs @ FDA to perform a retrospective cohort study of secondary approvals for cancer drugs that were initially FDA approved between 2005 and 2017. Clinicaltrials.gov was used to identify the beginning of each research trajectory that resulted in a secondary FDA approval. Each trajectory was classified as pre- or post-approval depending on if it was initiated before or after initial drug licensure. Clinical impact was assessed by comparing secondary approvals and NCCN off-label recommendations deriving from pre- vs. post-approval trajectories, pooled effect sizes, incidence, and level of evidence. Results We identified 77 broad secondary approvals, 60 of which had at least 6 years follow-up. Of these, 9 (15%) resulted from post-approval trajectories, a proportion that is significantly lower than would be expected if the timing of research didn't impact approval (McNemar's test p = 0.001). Compared to pre-approval trajectories, approvals resulting from post-approval trajectories were for cancers with lower mean incidence (6.11 vs 14.83, p = 0.006) and were based on pivotal trials with smaller pooled effect sizes (0.69 vs 0.57, p = 0.02) that were less likely to be randomized (38.5% vs 64.1%, p = 0.145). We identified 69 NCCN off-label recommendations. The proportion stemming from post-approval trajectories was similar to that for pre-approval (56.5% vs. 43.5%). However, recommendations from post-approval trajectories were significantly more likely to involve rare diseases (76.7% vs 51.4%, p = 0.019) and nonsignificantly less likely to be based on level 1 evidence (11.6% vs 22.9%, p = 0.309). Conclusion Secondary FDA approvals are less likely to result from post-approval trajectories and tend to be less impactful compared to approvals originating from research started before first FDA licensure. However, post-approval trajectories may be as likely to lead to NCCN recommendations for off-label use. Limitations of this work include our use of indirect measures of impact and limited follow-up time for trajectories. Our study protocol was pre-registered (https://osf.io/5g3jw/).	[Ouimet, Charlotte; Kimmelman, Jonathan] McGill Univ, Biomed Eth Unit, Montreal, PQ, Canada; [Bouche, Gauthier] Anticanc Fund, Brussels, Belgium	McGill University	Kimmelman, J (corresponding author), McGill Univ, Biomed Eth Unit, Montreal, PQ, Canada.	Jonathan.kimmelman@mcgill.ca		Ouimet, Charlotte/0000-0001-5465-2256; Kimmelman, Jonathan/0000-0003-1614-6779	Canadian Institutes of Health Research [244398]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research (Grant number 244398), awarded to JK. https://cihr-irsc.gc.ca/e/193.html.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Soc Clin Oncol, 2006, J CLIN ONCOL, V24, P3206, DOI 10.1200/JCO.2006.06.8940; Carlisle B, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k959; Carlisle BG, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034306; Carlisle BG, 2020, CLIN TRIALS, V17, P18, DOI 10.1177/1740774519873883; Contopoulos-Ioannidis DG, 2008, SCIENCE, V321, P1298, DOI 10.1126/science.1160622; Duncan G, 2016, PHARM PAT ANAL, V5, P137, DOI 10.4155/ppa-2016-0016; Feustel AC, 2020, NEUROLOGY, V94, pE1, DOI 10.1212/WNL.0000000000008699; Gatta G, 2011, EUR J CANCER, V47, P2493, DOI 10.1016/j.ejca.2011.08.008; Gumnit E, 2021, INVEST NEW DRUG, V39, P256, DOI 10.1007/s10637-020-00971-w; Gyawali B, 2021, JAMA INTERN MED, V181, P897, DOI 10.1001/jamainternmed.2021.1994; Gyawali B, 2017, NAT REV CLIN ONCOL, V14, P521, DOI 10.1038/nrclinonc.2017.72; Haute Autorite de Sante, DRUGS DEV MED ACTS; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Kaufman RM, 2015, ANN INTERN MED, V162, P205, DOI 10.7326/M14-1589; Kirtonia A, 2021, SEMIN CANCER BIOL, V68, P258, DOI 10.1016/j.semcancer.2020.04.006; Langedijk J, 2016, DRUG DISCOV TODAY, V21, P348, DOI 10.1016/j.drudis.2015.11.009; Medicine CfE-B., 2009, MED CFE B; Moher D., 1999, ASSESSING QUALITY RE; Panageas KS, 2015, EXPERT REV CLIN PHAR, V8, P661, DOI 10.1586/17512433.2015.1088382; Pantziarka P, 2014, ECANCERMEDICALSCIENC, V8, DOI 10.3332/ecancer.2014.442; Poonacha TK, 2011, J CLIN ONCOL, V29, P186, DOI 10.1200/JCO.2010.31.6414; Prasad V, 2017, JAMA INTERN MED, V177, P1569, DOI 10.1001/jamainternmed.2017.3601; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; Rauh S, 2020, ESMO OPEN, V5, DOI 10.1136/esmoopen-2019-000615; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; Roin BN., 2013, SOLVING PROBLEM NEW, DOI [10.2139/ssrn.2337821, DOI 10.2139/SSRN.2337821]; Sahragardjoonegani B, 2021, J PHARM POLICY PRACT, V14, DOI 10.1186/s40545-020-00282-8; Shih HP, 2018, NAT REV DRUG DISCOV, V17, P19, DOI 10.1038/nrd.2017.194; Soares HP, 2005, JAMA-J AM MED ASSOC, V293, P970, DOI 10.1001/jama.293.8.970; United States Congress, 1983, CFR TITLE 21 PART 31; Vespa J., 2018, DEMOGRAPHIC TURNING; Walsh BS, 2022, J CLIN ONCOL, V40, P1102, DOI 10.1200/JCO.21.02139; Zeitoun JD, 2018, INT J CANCER, V142, P414, DOI 10.1002/ijc.31061	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274115	10.1371/journal.pone.0274115	http://dx.doi.org/10.1371/journal.pone.0274115			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094914	Green Published, gold			2022-12-26	WOS:000892376500027
J	Rebitschek, FG; Ellermann, C; Jenny, MA; Siegel, NA; Spinner, C; Wagner, GG				Rebitschek, Felix G.; Ellermann, Christin; Jenny, Mirjam A.; Siegel, Nico A.; Spinner, Christian; Wagner, Gert G.			Fact boxes that inform individual decisions may contribute to a more positive evaluation of COVID-19 vaccinations at the population level	PLOS ONE			English	Article							PATIENT INFORMATION; VACCINE; INTENTION; BENEFITS; CANCER; HARMS; RISK; KNOWLEDGE; DRUG	Objective For an effective control of the SARS-CoV-2 pandemic with vaccines, most people in a population need to be vaccinated. It is thus important to know how to inform the public with reference to individual preferences-while also acknowledging the societal preference to encourage vaccinations. According to the health care standard of informed decision-making, a comparison of the benefits and harms of (not) having the vaccination would be required to inform undecided and skeptical people. To test evidence-based fact boxes, an established risk communication format, and to inform their development, we investigated their contribution to knowledge and evaluations of COVID-19 vaccines. Methods We conducted four studies (1, 2, and 4 were population-wide surveys with N = 1,942 to N = 6,056): Study 1 assessed the relationship between vaccination knowledge and intentions in Germany over three months. Study 2 assessed respective information gaps and needs of the population in Germany. In parallel, an experiment (Study 3) with a mixed design (presentation formats; pre-post-comparison) assessed the effect of fact boxes on risk perceptions and fear, using a convenience sample (N = 719). Study 4 examined how effective two fact box formats are for informing vaccination intentions, with a mixed experimental design: between-subjects (presentation formats) and within-subjects (pre-post-comparison). Results Study 1 showed that vaccination knowledge and vaccination intentions increased between November 2020 and February 2021. Study 2 revealed objective information requirements and subjective information needs. Study 3 showed that the fact box format is effective in adjusting risk perceptions concerning COVID-19. Based on those results, fact boxes were revised and implemented with the help of a national health authority in Germany. Study 4 showed that simple fact boxes increase vaccination knowledge and positive evaluations in skeptics and undecideds. Conclusion Fact boxes can inform COVID-19 vaccination intentions of undecided and skeptical people without threatening societal vaccination goals of the population.	[Rebitschek, Felix G.; Ellermann, Christin; Jenny, Mirjam A.; Wagner, Gert G.] Univ Potsdam, Fac Hlth Sci Brandenburg, Harding Ctr Risk Literacy, Potsdam, Brandenburg, Germany; [Rebitschek, Felix G.; Jenny, Mirjam A.; Wagner, Gert G.] Max Planck Inst Human Dev, Berlin, Germany; [Jenny, Mirjam A.] Bernhard Nocht Inst Trop Med, Hlth Commun Res Grp, Implementat Sci, Hamburg, Germany; [Jenny, Mirjam A.] Univ Erfurt, Media & Commun Sci, Erfurt, Thuringen, Germany; [Siegel, Nico A.; Spinner, Christian] Infratest Dimap, Berlin, Germany; [Wagner, Gert G.] German Socioecon Panel Study SOEP, Berlin, Germany; [Wagner, Gert G.] Fed Inst Populat Res, Wiesbaden, Hessen, Germany	University of Potsdam; Max Planck Society; Bernhard Nocht Institut fur Tropenmedizin; University of Erfurt	Rebitschek, FG (corresponding author), Univ Potsdam, Fac Hlth Sci Brandenburg, Harding Ctr Risk Literacy, Potsdam, Brandenburg, Germany.; Rebitschek, FG (corresponding author), Max Planck Inst Human Dev, Berlin, Germany.	rebitschek@uni-potsdam.de			Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [491466077]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) -Projektnummer 491466077.	Akl EA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006776.pub2; AOK-Bundesverband Harding Center for Risk Literacy, 2016, AOK FAKT; Bartsch SM, 2020, AM J PREV MED, V59, P493, DOI 10.1016/j.amepre.2020.06.011; Betsch C., 2020, PREPRINT, DOI [10.23668/PSYCHARCHIVES.3156, DOI 10.23668/PSYCHARCHIVES.3156]; Betsch C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208601; Blastland M, 2020, NATURE, V587, P362, DOI 10.1038/d41586-020-03189-1; Braddock CH, 1999, JAMA-J AM MED ASSOC, V282, P2313, DOI 10.1001/jama.282.24.2313; Brick C, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.190876; Bundesministerium fur Gesundheit, 2022, IMPFD 2022; Bundesministerium fur Gesundheit, 2013, BUNDESANZEIGER VERLA; Bunge M, 2010, PATIENT EDUC COUNS, V78, P316, DOI 10.1016/j.pec.2009.10.029; Craig P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1655; Deutsche Gesellschaft fur Psychologie, 2018, ETH HAND PSYCH FORSC; Durand MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094670; Eber MR, 2021, J RISK UNCERTAINTY, V62, P29, DOI 10.1007/s11166-021-09344-x; EDDY DM, 1990, JAMA-J AM MED ASSOC, V263, P2493, DOI 10.1001/jama.263.18.2493; Elmore Joann G., 2010, Journal of the National Cancer Institute Monographs, P204, DOI 10.1093/jncimonographs/lgq038; Enard KR, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0303-6; Frewer LJ, 2002, PUBLIC UNDERST SCI, V11, P363, DOI 10.1088/0963-6625/11/4/304; Harding Center for Risk Literacy, 2021, FACT BOX; Harding Center for Risk Literacy Robert Koch Institute, 2021, FAKT MRNA SCHUTZ GEG; Haug S., 2021, ERGEBNISSE TELEFONIS, V83, P789; Helios Kliniken, 2020, COR VERS GRIPP UNT L; Hertwig R, 2017, PERSPECT PSYCHOL SCI, V12, P973, DOI 10.1177/1745691617702496; Kerr JR, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-048025; Kerr JR, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040379; Kerridge I, 1998, BMJ-BRIT MED J, V316, P1151, DOI 10.1136/bmj.316.7138.1151; Korn L, 2020, P NATL ACAD SCI USA, V117, P14890, DOI 10.1073/pnas.1919666117; Lawes-Wickwar S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020072; Ling M, 2019, SOC SCI MED, V233, P87, DOI 10.1016/j.socscimed.2019.06.002; Lipkus IM, 2010, MED DECIS MAKING, V30, P464, DOI 10.1177/0272989X09360371; Lorenc T, 2013, J EPIDEMIOL COMMUN H, V67, P190, DOI 10.1136/jech-2012-201257; Luehnen J, 2015, Z EVIDENZ FORTBILD Q, V109, P159, DOI 10.1016/j.zefq.2015.03.004; McDowell M, 2019, MED DECIS MAKING, V39, P41, DOI 10.1177/0272989X18818166; McDowell Michelle, 2016, MDM Policy Pract, V1, p2381468316665365, DOI 10.1177/2381468316665365; Mesch GS, 2015, AM J INFECT CONTROL, V43, P1161, DOI 10.1016/j.ajic.2015.06.031; Neumann-Bohme S, 2020, EUR J HEALTH ECON, V21, P977, DOI 10.1007/s10198-020-01208-6; O'Neill J, 2014, J CLIN EPIDEMIOL, V67, P56, DOI 10.1016/j.jclinepi.2013.08.005; Palm R., 2021, FRONTIERS POLITICAL, V3, P661257, DOI [10.3389/fpos.2021.661257, DOI 10.3389/FPOS.2021.661257]; Quinn SC, 2009, BIOSECUR BIOTERROR, V7, P275, DOI 10.1089/bsp.2009.0041; Renn O., 1991, COMMUN RISKS PUBLIC, P175, DOI DOI 10.1007/978-94-009-1952-5_10; Robert Koch Institute, 2021, COVID 19 IMPFQ MON D; Schoch-Spana M, 2018, PUBLIC HEALTH REP, V133, P366, DOI 10.1177/0033354918773069; Schwartz LM, 2009, ANN INTERN MED, V150, P516, DOI 10.7326/0003-4819-150-8-200904210-00106; Siegel N., 2021, INFRATEST CORONA ONL; STIKO, 2021, EPIDEMIOLOGISCHES B, P5; Thiessen M, 2021, HIST SOC RES, V46, P316, DOI 10.12759/hsr.46.2021.4.316-338; Trevena LJ, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-S2-S7; Wegwarth O, 2014, VACCINE, V32, P1388, DOI 10.1016/j.vaccine.2013.12.038; Wegwarth O, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.32335; Wissenschaft im Dialog, 2020, WISS 2020 REP; Zheng H, 2022, PATIENT EDUC COUNS, V105, P277, DOI 10.1016/j.pec.2021.09.023; Zikmund-Fisher BJ, 2010, PATIENT EDUC COUNS, V81, pS87, DOI 10.1016/j.pec.2010.07.041	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274186	10.1371/journal.pone.0274186	http://dx.doi.org/10.1371/journal.pone.0274186			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095020	Green Published, gold			2022-12-26	WOS:000892376500028
J	Chiu, WT; Lu, YH; Chen, YT; Tan, YL; Lin, YC; Chen, YL; Chou, HC; Chen, CY; Yen, TA; Tsao, PN				Chiu, Wei-Tse; Lu, Yi-Hsuan; Chen, Yin-Ting; Tan, Yin Ling; Lin, Yi-Chieh; Chen, Yu-Lien; Chou, Hung-Chieh; Chen, Chien-Yi; Yen, Ting-An; Tsao, Po-Nien			Reducing intraventricular hemorrhage following the implementation of a prevention bundle for neonatal hypothermia	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; HEAT-LOSS PREVENTION; PRETERM INFANTS; ADMISSION HYPOTHERMIA; RANDOMIZED-TRIAL; RISK-FACTORS; POLYETHYLENE; TEMPERATURE; MORTALITY; WRAP	Introduction In very low birth weight (VLBW) infants, hypothermia immediately following birth is common even in countries rich in medical resources. The purpose of this study is to design a standard prevention bundle that decreases the rate of hypothermia among infants after birth and to investigate efficacy of the bundle and short-term outcomes for VLBW infants. Methods This quality improvement project was conducted from February 2017 to July 2018 on all VLBW preterm infants admitted at a single referral level III neonatal intensive care unit. The infants were classified into the pre-intervention (February to September 2017) and post-intervention (October 2017 to July 2018) groups according to the time periods when they were recruited. During the pre-intervention period, we analyzed the primary causes of hypothermia, developed solutions corresponding to each cause, integrated all solutions into a prevention bundle, and applied the bundle during the post-intervention period. Afterwards, the incidence of neonatal hypothermia and short-term outcomes, such as intraventricular hemorrhage (IVH), acidosis, and shock requiring inotropic agents, in each group were compared. Results A total of 95 VLBW infants were enrolled in the study, including 37 pre-intervention, and 58 post-intervention cases. The incidence of hypothermia in preterm infants decreased significantly upon the implementation of our prevention bundle, both in the delivery room (from 45.9% to 8.6%) and on admission (59.5% to 15.5%). In addition, the short-term outcomes of VLBW infants improved significantly, especially with the decreased incidence of IVH (from 21.6% to 5.2%, P = 0.015). Conclusions Our standardized prevention bundle for preventing hypothermia in VLBW infants is effective and decreased the IVH rate in VLBW infants. We strongly believe that this prevention bundle is a simple, low-cost, replicable, and effective tool that hospitals can adopt to improve VLBW infant outcomes.	[Chiu, Wei-Tse] Natl Taiwan Univ Hosp, Yun Lin Branch, Dept Pediat, Yunlin, Taiwan; [Chiu, Wei-Tse; Lu, Yi-Hsuan; Tan, Yin Ling; Lin, Yi-Chieh; Chou, Hung-Chieh; Chen, Chien-Yi; Yen, Ting-An; Tsao, Po-Nien] Natl Taiwan Univ, Dept Pediat, Children Hosp, Taipei, Taiwan; [Lu, Yi-Hsuan] Natl Taiwan Univ Hosp, Hsin Chu Branch, Dept Pediat, Hsinchu, Taiwan; [Chen, Yin-Ting] China Med Univ, Children Hosp, Div Neonatol, Dept Pediat, Taichung, Taiwan; [Chen, Yin-Ting] China Med Univ, Sch Med, Dept Med, Taichung, Taiwan; [Chen, Yu-Lien] Fu Jen Catholic Univ Hosp, Dept Pediat, Taipei, Taiwan; [Lin, Yi-Chieh] Taoyuan Gen Hosp, Minist Hlth & Welf, Taoyuan, Taiwan; [Chen, Yu-Lien] Natl Taiwan Univ Hosp, Dept Nursery, Taipei, Taiwan; [Tsao, Po-Nien] Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; China Medical University Taiwan; China Medical University Taiwan; Fu Jen Catholic University; Fu Jen Catholic University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Tsao, PN (corresponding author), Natl Taiwan Univ, Dept Pediat, Children Hosp, Taipei, Taiwan.; Tsao, PN (corresponding author), Natl Taiwan Univ, Res Ctr Dev Biol & Regenerat Med, Taipei, Taiwan.	tsaopn@ntu.edu.tw		Chiu, Wei-Tse/0000-0003-1733-3867; , TAN/0000-0003-1671-6145; TSAO, PO-NIEN/0000-0002-6114-1769				Abiramalatha T, 2021, JAMA PEDIATR, V175, DOI 10.1001/jamapediatrics.2021.0775; ADAMSONS K, 1965, ANESTHESIOLOGY, V26, P531, DOI 10.1097/00000542-196507000-00017; ADAMSONS K, 1965, J PEDIATR-US, V66, P495, DOI 10.1016/S0022-3476(65)80114-7; Bayih WA, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1632-2; Beletew B, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02024-w; Bhatt DR, 2020, J INVEST MED, V68, P1256, DOI 10.1136/jim-2020-001334; Boo NY, 2013, J TROP PEDIATRICS, V59, P447, DOI 10.1093/tropej/fmt051; Borse N, 1997, Indian Pediatr, V34, P718; de Almeida MFB, 2014, J PEDIATR-US, V164, P271, DOI 10.1016/j.jpeds.2013.09.049; Buczkowski-Bickmann M K, 1992, CRNA, V3, P77; Caglar S, 2014, JOGNN-J OBST GYN NEO, V43, P216, DOI 10.1111/1552-6909.12291; Chang HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131976; Chawla S, 2011, J PERINATOL, V31, P780, DOI 10.1038/jp.2011.33; Doglioni N, 2014, J PEDIATR-US, V165, P261, DOI 10.1016/j.jpeds.2014.04.010; Dubos C, 2021, ARCH PEDIATRIE, V28, P197, DOI 10.1016/j.arcped.2021.02.005; HAMMARLUND K, 1979, ACTA PAEDIATR SCAND, V68, P795; HARNED HS, 1970, PEDIATRICS, V45, P598; Hu XJ, 2018, J PERINATOL, V38, P332, DOI 10.1038/s41372-017-0028-0; Jia YS, 2013, J PERINATOL, V33, P264, DOI 10.1038/jp.2012.100; Laptook AR, 2007, PEDIATRICS, V119, pE643, DOI 10.1542/peds.2006-0943; Lyu YY, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.0277; MANN TP, 1957, LANCET, V1, P229; McGrory L, 2018, J PEDIATR-US, V193, P47, DOI 10.1016/j.jpeds.2017.09.006; Miller SS, 2011, J PERINATOL, V31, pS49, DOI 10.1038/jp.2010.177; Nimbalkar SM, 2019, J TROP PEDIATRICS, V65, P122, DOI 10.1093/tropej/fmy025; Reilly MC, 2015, J PEDIATR-US, V166, P262, DOI 10.1016/j.jpeds.2014.09.068; Resar R, 2005, JT COMM J QUAL PATIE, V31, P243, DOI 10.1016/S1553-7250(05)31031-2; Royal College of Paediatrics and Child Health, NAT NEON AUD PROGR 2; Rutter N, 2000, Semin Neonatol, V5, P281, DOI 10.1053/siny.2000.0014; Shabeer MP, 2018, J PERINATOL, V38, P1324, DOI 10.1038/s41372-018-0169-9; Shafie H, 2017, PEDIATR INT, V59, P776, DOI 10.1111/ped.13285; SMALES ORC, 1978, ARCH DIS CHILD, V53, P58, DOI 10.1136/adc.53.1.58; Urubuto F, 2021, J MATERN-FETAL NEO M, V34, P2793, DOI 10.1080/14767058.2019.1671334; Vermont Oxford Network, DESP DECR NEARL 4 10; Wilson E, 2016, J PEDIATR-US, V175, P61, DOI 10.1016/j.jpeds.2016.04.016; World Health Organization, 1997, THERM PROT NEWB PRAC; Yeo KT, 2020, ARCH DIS CHILD-FETAL, V105, pF145, DOI 10.1136/archdischild-2018-316664; YU VYH, 1984, ARCH DIS CHILD, V59, P430, DOI 10.1136/adc.59.5.430; Yu YH, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02221-7	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0273946	10.1371/journal.pone.0273946	http://dx.doi.org/10.1371/journal.pone.0273946			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054141	gold, Green Published			2022-12-26	WOS:000892641400044
J	Schneider, KL; Ahmadpour, D; Keuenhof, KS; Eisele-Burger, AM; Berglund, LL; Eisele, F; Babazadeh, R; Hoog, JL; Nystrom, T; Widlund, PO				Schneider, Kara L.; Ahmadpour, Doryaneh; Keuenhof, Katharina S.; Eisele-Burger, Anna Maria; Berglund, Lisa Larsson; Eisele, Frederik; Babazadeh, Roja; Hoog, Johanna L.; Nystrom, Thomas; Widlund, Per O.			Using reporters of different misfolded proteins reveals differential strategies in processing protein aggregates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAMAGED PROTEINS; SACCHAROMYCES-CEREVISIAE; ASYMMETRIC INHERITANCE; SPATIAL SEQUESTRATION; MOLECULAR CHAPERONES; GUANYLATE KINASE; MITOTIC SPINDLES; QUALITY-CONTROL; LIFE-SPAN; YEAST	The accumulation of misfolded proteins is a hallmark of aging and many neurodegenerative diseases, making it important to understand how the cellular machinery recognizes and processes such proteins. A key question in this respect is whether misfolded proteins are handled in a similar way regard less of their genetic origin. To approach this question, we compared how three different misfolded proteins, guk1-7,gus1-3, and pro3-1, are handled by the cell. We show that all three are nontoxic, even though highly overexpressed, high-lighting their usefulness in analyzing the cellular response to misfolding in the absence of severe stress. We found significant differences between the aggregation and disaggregation behavior of the misfolded proteins. Specifically, gus1-3 formed some aggregates that did not efficiently recruit the proteindisaggregase Hsp104 and did not colocalize with the other misfolded reporter proteins. Strikingly, while all three misfolded proteins generally coaggregated and colocalized to specific sites in the cell, disaggregation was notably different; the rate of aggregate clearance of pro3-1 was faster than that of the other misfolded proteins, and its clearance rate was nothindered when pro3-1 colocalized with a slowly resolved mis-folded protein. Finally, we observed using super-resolutionlight microscopy as well as immunogold labeling EM in which both showed an even distribution of the different mis-folded proteins within an inclusion, suggesting that misfolding characteristics and remodeling, rather than spatial compart-mentalization, allows for differential clearance of these mis-folding reporters residing in the same inclusion. Taken together, our results highlight how properties of misfolded proteins can significantly affect processing.	[Schneider, Kara L.; Ahmadpour, Doryaneh; Eisele-Burger, Anna Maria; Eisele, Frederik; Babazadeh, Roja; Nystrom, Thomas; Widlund, Per O.] Univ Gothenburg, Sahlgrenska Acad, Ctr Ageing & Hlth AgeCap, Inst Biomed, Gothenburg, Sweden; [Ahmadpour, Doryaneh] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden; [Keuenhof, Katharina S.; Berglund, Lisa Larsson; Hoog, Johanna L.] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Eisele-Burger, Anna Maria] Swedish Univ Agr Sci, Uppsala Bioctr, Dept Mol Sci, Uppsala, Sweden; [Eisele-Burger, Anna Maria] Linnean Ctr Plant Biol, Uppsala, Sweden; [Berglund, Lisa Larsson] Cochlear Bone Anchored Solut, S-43533 Molnlycke, Sweden; [Eisele, Frederik] AstraZeneca, Mechanist & Struct Biol, Discovery Sci R&D, Gothenburg, Sweden	University of Gothenburg; Chalmers University of Technology; University of Gothenburg; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Cochlear; AstraZeneca	Widlund, PO (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Ctr Ageing & Hlth AgeCap, Inst Biomed, Gothenburg, Sweden.	per.widlund@gu.se		Widlund, Per/0000-0002-3645-0009; Keuenhof, Katharina/0000-0003-0570-8596; Larsson Berglund, Lisa/0000-0001-6704-1876	Knut and Alice Wallenberg Grant [KAW 2017.0091]; Swedish Research Council [04004]; Bollan-stipend [GU2019/2981]; Stiftelsen Sigurd och Elsa Goljes Minne	Knut and Alice Wallenberg Grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Bollan-stipend; Stiftelsen Sigurd och Elsa Goljes Minne	This work was funded by a Knut and Alice Wallenberg Grant KAW 2017.0091 (T. N. and J. L. H.) , a Swedish Research Council Grant 2019 to 04004 (J. L. H.) , a Bollan-stipend GU2019/2981 (K. L. S.) , and Stiftelsen Sigurd och Elsa Goljes Minne (P. O. W.) . Acknowledgments - The authors are grateful to Sophie Comyn and Thibault Mayor for sharing the ts allele plasmids and to Froste Svensson for performing initial work on this study. The authors thank the Centre for Cellular Imaging at the University of Goth- enburg for assistance with superresolution microscopy (VR-RFI 2019-00022, NMI01556) .	Abrams JL, 2013, JOVE-J VIS EXP, DOI 10.3791/50432; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Andersson R, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1008951; Andersson V, 2013, AGING-US, V5, P802, DOI 10.18632/aging.100613; Babazadeh R, 2019, CELL REP, V28, P2096, DOI 10.1016/j.celrep.2019.07.053; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Blaszczyk J, 2001, J MOL BIOL, V307, P247, DOI 10.1006/jmbi.2000.4427; Bockler S, 2017, J CELL BIOL, V216, P2481, DOI 10.1083/jcb.201611197; BRANDRISS MC, 1992, J BACTERIOL, V174, P3782, DOI 10.1128/JB.174.11.3782-3788.1992; Bufalino MR, 2013, J CELL BIOL, V201, P523, DOI 10.1083/jcb.201207052; Comyn SA, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006184; DELARUE M, 1995, CURR OPIN STRUC BIOL, V5, P48, DOI 10.1016/0959-440X(95)80008-O; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Escusa-Toret S, 2013, NAT CELL BIOL, V15, P1231, DOI 10.1038/ncb2838; Frechin M, 2009, GENE DEV, V23, P1119, DOI 10.1101/gad.518109; Galani K, 2001, EMBO J, V20, P6889, DOI 10.1093/emboj/20.23.6889; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Hanna J, 2003, MOL CELL BIOL, V23, P9251, DOI 10.1128/MCB.23.24.9251-9261.2003; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hawes P, 2007, J MICROSC-OXFORD, V226, P182, DOI 10.1111/j.1365-2818.2007.01767.x; Hill SM, 2017, EMBO REP, V18, P377, DOI 10.15252/embr.201643458; Hill SM, 2014, SCIENCE, V344, P1389, DOI 10.1126/science.1252634; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Josefson R, 2017, ESSAYS BIOCHEM, V61, P317, DOI 10.1042/EBC20160085; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaganovich D, 2008, NATURE, V454, P1088, DOI 10.1038/nature07195; Khosrow-Khavar F, 2012, G3-GENES GENOM GENET, V2, P619, DOI 10.1534/g3.111.001933; KONRAD M, 1992, J BIOL CHEM, V267, P25652; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Kruegel U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002253; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Malinovska L, 2012, MOL BIOL CELL, V23, P3041, DOI 10.1091/mbc.E12-03-0194; McMurray M, 2014, BIOESSAYS, V36, P836, DOI 10.1002/bies.201400062; Miller SBM, 2015, EMBO J, V34, P778, DOI 10.15252/embj.201489524; Muller-Reichert T, 2003, CHROMOSOMA, V111, P417, DOI 10.1007/s00412-002-0220-6; Ogrodnik M, 2014, P NATL ACAD SCI USA, V111, P8049, DOI 10.1073/pnas.1324035111; Oling D, 2014, EMBO J, V33, P747, DOI 10.1002/embj.201386822; OToole ET, 1997, MOL BIOL CELL, V8, P1, DOI 10.1091/mbc.8.1.1; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Saarikangas J, 2015, ELIFE, V4, DOI 10.7554/eLife.06197; SADLER JR, 1965, J MOL BIOL, V12, P305, DOI 10.1016/S0022-2836(65)80255-8; Samant RS, 2019, METHOD ENZYMOL, V619, P27, DOI 10.1016/bs.mie.2018.12.039; Schiavi A, 2014, EXP GERONTOL, V56, P147, DOI 10.1016/j.exger.2014.02.015; Schneider KL, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92249-1; Schneider KL, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00249; Shashkova S, 2021, METHODS, V193, P46, DOI 10.1016/j.ymeth.2020.05.003; Shiber A, 2018, NATURE, V561, P268, DOI 10.1038/s41586-018-0462-y; Shimma Y, 1997, MOL GEN GENET, V256, P469, DOI 10.1007/s004380050591; Sontag EM, 2017, ANNU REV BIOCHEM, V86, P97, DOI 10.1146/annurev-biochem-060815-014616; Specht S, 2011, J CELL BIOL, V195, P617, DOI 10.1083/jcb.201106037; Spokoini R, 2012, CELL REP, V2, P738, DOI 10.1016/j.celrep.2012.08.024; Sung MK, 2007, YEAST, V24, P767, DOI 10.1002/yea.1504; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Weisberg SJ, 2012, P NATL ACAD SCI USA, V109, P15811, DOI 10.1073/pnas.1205829109; WERNERWASHBURNE M, 1987, MOL CELL BIOL, V7, P2568, DOI 10.1128/MCB.7.7.2568; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; Winkler J, 2012, J CELL BIOL, V198, P387, DOI 10.1083/jcb.201201074; Wolfe KJ, 2013, MOL BIOL CELL, V24, P3588, DOI 10.1091/mbc.E13-06-0315; Yang JS, 2016, ELIFE, V5, DOI 10.7554/eLife.11792; Zhou CK, 2014, CELL, V159, P530, DOI 10.1016/j.cell.2014.09.026	72	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2022	298	11							102476	10.1016/j.jbc.2022.102476	http://dx.doi.org/10.1016/j.jbc.2022.102476			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	6C1SV	36096201	Green Published, gold			2022-12-26	WOS:000881802600007
J	Tong, WX; Hannou, SA; Wang, Y; Astapova, I; Sargsyan, A; Monn, R; Thiriveedi, V; Li, DN; McCann, JR; Rawls, JF; Roper, J; Zhang, GF; Herman, MA				Tong, Wenxin; Hannou, Sarah A.; Wang, You; Astapova, Inna; Sargsyan, Ashot; Monn, Ruby; Thiriveedi, Venkataramana; Li, Diana; McCann, Jessica R.; Rawls, John F.; Roper, Jatin; Zhang, Guo-fang; Herman, Mark A.			The intestine is a major contributor to circulating succinate in mice	FASEB JOURNAL			English	Article						circulating biomarkers; intestine; succinate; TCA cycle intermediates	RECEPTOR GPR91; ACCUMULATION; GLUCOSE; SIGNAL; MOUSE; REPERFUSION; METABOLISM; MICROBIOTA; FRUCTOSE; MURINE	The tricarboxylic acid (TCA) cycle is the epicenter of cellular aerobic metabolism. TCA cycle intermediates facilitate energy production and provide anabolic precursors, but also function as antra- and extracellular metabolic signals regulating pleiotropic biological processes. Despite the importance of circulating TCA cycle metabolites as signaling molecules, the source of circulating TCA cycle intermediates remains uncertain. We observe that in mice, the concentration of TCA cycle intermediates in the portal blood exceeds that in tail blood indicating that the gut is a major contributor to circulating TCA cycle metabolites. With a focus on succinate as a representative of a TCA cycle intermediate with signaling activities and using a combination of gut microbiota depletion mouse models and isotopomer tracing, we demonstrate that intestinal microbiota is not a major contributor to circulating succinate. Moreover, we demonstrate that endogenous succinate production is markedly higher than intestinal succinate absorption in normal physiological conditions. Altogether, these results indicate that endogenous succinate production within the intestinal tissue is a major physiological source of circulating succinate. These results provide a foundation for an investigation into the role of the intestine in regulating circulating TCA cycle metabolites and their potential signaling effects on health and disease.	[Tong, Wenxin; Roper, Jatin] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27701 USA; [Tong, Wenxin; Hannou, Sarah A.; Wang, You; Astapova, Inna; Sargsyan, Ashot; Monn, Ruby; Zhang, Guo-fang; Herman, Mark A.] Duke Univ, Duke Mol Physiol Inst, Durham, NC 27701 USA; [Astapova, Inna; Herman, Mark A.] Duke Univ, Div Endocrinol Metab & Nutr, Durham, NC 27701 USA; [Thiriveedi, Venkataramana; Li, Diana; Roper, Jatin] Duke Univ, Div Gastroenterol, Durham, NC 27701 USA; [McCann, Jessica R.; Rawls, John F.] Duke Univ, Duke Microbiome Ctr, Dept Mol Genet & Microbiol, Durham, NC 27701 USA; [Wang, You] Jining Med Univ, Sch Basic Med, Jining, Shandong, Peoples R China; [Astapova, Inna; Herman, Mark A.] Baylor Coll Med, Sect Endocrinol Diabet & Metab, Houston, TX 77030 USA	Duke University; Duke University; Duke University; Duke University; Duke University; Jining Medical University; Baylor College of Medicine	Herman, MA (corresponding author), Duke Univ, 300 N Duke St, Durham, NC 27701 USA.	mark.herman@duke.edu	hannou, sarah/AAT-2902-2020; Tong, Wenxin/GLT-9703-2022	hannou, sarah/0000-0003-4780-5773; Tong, Wenxin/0000-0003-4116-5904	National Institute of Diabetes and Digestive and Kidney Diseases [DK121710, DK124723, DK100425]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institute of Diabetes and Digestive and Kidney Diseases, Grant/ Award Number: DK121710, DK124723 and DK100425	Ahn S, 2016, J BIOL CHEM, V291, P11928, DOI 10.1074/jbc.M115.708149; Al-Jawadi A, 2020, J NUTR, V150, P1722, DOI 10.1093/jn/nxaa113; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Borowy C.S., 2020, STATPEARLS; Bu PC, 2018, CELL METAB, V27, P1249, DOI 10.1016/j.cmet.2018.04.003; Casteleyn C, 2010, LAB ANIM-UK, V44, P176, DOI 10.1258/la.2009.009112; Chan TS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199177; Cho EH, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00455; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Correa PRAV, 2007, J HEPATOL, V47, P262, DOI 10.1016/j.jhep.2007.03.016; De Vadder F, 2016, CELL METAB, V24, P151, DOI 10.1016/j.cmet.2016.06.013; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Hannou SA, 2018, J CLIN INVEST, V128, P545, DOI 10.1172/JCI96702; He WT, 2021, MOL GENET METAB, V134, P257, DOI 10.1016/j.ymgme.2021.09.009; He WH, 2004, NATURE, V429, P188, DOI 10.1038/nature02488; Herman MA, 2021, CELL METAB, V33, P2329, DOI 10.1016/j.cmet.2021.09.010; Jang C, 2019, CELL METAB, V30, P594, DOI 10.1016/j.cmet.2019.06.002; Jang C, 2018, CELL METAB, V27, P351, DOI 10.1016/j.cmet.2017.12.016; Kim M, 2018, IMMUNITY, V49, P151, DOI 10.1016/j.immuni.2018.05.009; Kishida K, 2017, AM J PHYSIOL-GASTR L, V312, pG592, DOI 10.1152/ajpgi.00416.2016; Lai YJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26209-8; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Li XX, 2022, NAT METAB, V4, P141, DOI 10.1038/s42255-021-00517-1; Liu XD, 2022, J NUTR BIOCHEM, V100, DOI 10.1016/j.jnutbio.2021.108908; Macfarlane S, 2006, APPL ENVIRON MICROB, V72, P6204, DOI 10.1128/AEM.00754-06; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Mills EL, 2021, NAT METAB, V3, P604, DOI 10.1038/s42255-021-00389-5; Mills EL, 2018, NATURE, V560, P102, DOI 10.1038/s41586-018-0353-2; Murashige D, 2020, SCIENCE, V370, P364, DOI 10.1126/science.abc8861; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Nilsson R, 2020, MATH BIOSCI, V330, DOI 10.1016/j.mbs.2020.108481; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Rajas F, 1999, GASTROENTEROLOGY, V117, P132, DOI 10.1016/S0016-5085(99)70559-7; Reddy A, 2020, CELL, V183, P62, DOI 10.1016/j.cell.2020.08.039; Rubic T, 2008, NAT IMMUNOL, V9, P1261, DOI 10.1038/ni.1657; Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Serena C, 2018, ISME J, V12, P1642, DOI 10.1038/s41396-018-0068-2; Shree M, 2018, METABOLITES, V8, DOI 10.3390/metabo8040066; Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715; Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400; Toma I, 2008, J CLIN INVEST, V118, P2526, DOI 10.1172/JCI33293; Tretter L, 2016, BBA-BIOENERGETICS, V1857, P1086, DOI 10.1016/j.bbabio.2016.03.012; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang T, 2021, EMBO REP, V22, DOI 10.15252/embr.202153027; Wijermars LGM, 2016, AM J TRANSPLANT, V16, P2741, DOI 10.1111/ajt.13793; Woting A, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060685; Zhang GF, 2021, CELL METAB, V33, P804, DOI 10.1016/j.cmet.2020.11.020; Zhao S, 2020, NATURE, V579, P586, DOI 10.1038/s41586-020-2101-7	49	0	0	8	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22546	10.1096/fj.202200135RR	http://dx.doi.org/10.1096/fj.202200135RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4O2VR	36106538				2022-12-26	WOS:000854562800001
J	Gonzalez, KA; Stickel, AM; Kaur, SS; Ramos, AR; Gonzalez, HM; Tarraf, W				Gonzalez, Kevin A.; Stickel, Ariana M.; Kaur, Sonya S.; Ramos, Alberto R.; Gonzalez, Hector M.; Tarraf, Wassim			Serum Cystatin-C is linked to increased prevalence of diabetes and higher risk of mortality in diverse middle-aged and older adults	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; CARDIOVASCULAR EVENTS; INSULIN-RESISTANCE; RACIAL-DIFFERENCES; HEALTH; ASSOCIATION; PROGRESSION; CREATININE; LATINOS	Objective Type 2 Diabetes Mellitus (henceforth diabetes) affects roughly 35 million individuals in the US and is a major risk factor for cardiovascular and kidney disease. Serum Cystatin-C is used to monitor renal function and detect kidney damage. Recent research has focused on linking Cystatin-C to cardiovascular risk and disease, but most findings focus on small sample sizes and generalize poorly to diverse populations, thus limiting epidemiological inferences. The aim of this manuscript is to study the association between Cystatin-C, diabetes, and mortality and test for possible sex or racial/ethnic background modifications in these relationships. Methods We analyzed 8-years of biennial panel data from Health and Retirement Study participants 50-years and older who self-identified as White (unweighted N (uN) = 5,595), Black (uN = 867), or Latino (uN = 565) for a total of uN = 7,027 individuals. We modeled diabetes and death over 8-years as function of baseline Cystatin-C (log transformed) adjusting for covariates and tested modifications in associations by race/ethnic background and sex. Results Mean log Cystatin-C at visit 1 was 0.03 +/- 0.32 standard deviation. A 10% increase in Cystatin-C levels was associated with 13% increased relative risk of diabetes at baseline (11% and 9% by years 4 and 8). A 10% increase in Cystatin-C was highly associated with increased relative risk of death (28% and 31% by years 4 and 8). These associations were present even after adjusting for possible confounders and were not modified by sex or racial/ethnic background. Conclusion Despite differential risks for diabetes and mortality by racial/ethnic groups, Cystatin-C was equally predictive of these outcomes across groups. Cystatin-C dysregulations could be used as a risk indicator for diabetes and as a warning sign for accelerated risk of mortality.	[Gonzalez, Kevin A.; Stickel, Ariana M.; Gonzalez, Hector M.] Univ Calif San Diego, Sch Med, Dept Neurosci, San Diego, CA 92103 USA; [Gonzalez, Kevin A.; Stickel, Ariana M.; Gonzalez, Hector M.] Univ Calif San Diego, Sch Med, Shiley Marcos Alzheimers Dis Res Ctr, San Diego, CA 92103 USA; [Kaur, Sonya S.; Ramos, Alberto R.] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Tarraf, Wassim] Wayne State Univ, Dept Healthcare Sci, Detroit, MI 48202 USA; [Tarraf, Wassim] Wayne State Univ, Inst Gerontol, Detroit, MI 48202 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Miami; Wayne State University; Wayne State University	Tarraf, W (corresponding author), Wayne State Univ, Dept Healthcare Sci, Detroit, MI 48202 USA.; Tarraf, W (corresponding author), Wayne State Univ, Inst Gerontol, Detroit, MI 48202 USA.	wassim.tarraf@wayne.edu			National Institute on Aging [R01-AG048642, RF1 AG054548, RF1 AG061022, P30AG062429, P30AG059299]; NSF GRFP	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD))	Dr. Hector Gonzalez and colleagues are supported by R01-AG048642, RF1 AG054548 and RF1 AG061022 (National Institute on Aging). Dr. Hector Gonza ' lez also receives additional support from P30AG062429 and P30AG059299 (National Institute on Aging). Additionally, Kevin Gonzalez received support from the NSF GRFP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaal M, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.03.107; Agodoa L, 2007, SEMIN DIALYSIS, V20, P577, DOI 10.1111/j.1525-139X.2007.00350.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Astor BC, 2009, J AM SOC NEPHROL, V20, P2214, DOI 10.1681/ASN.2008090980; Baker MK, 2011, DIABETES RES CLIN PR, V91, P1, DOI 10.1016/j.diabres.2010.06.030; Benjamins MR, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.32086; Bommer C, 2018, DIABETES CARE, V41, P963, DOI 10.2337/dc17-1962; Bugliari D, 2019, RAND HRS LONGITUDINA; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; Control CfD Prevention, 2020, NAT DIAB STAT REP; Crimmins E, 2017, DOCUMENTATION BLOOD; de Boer IH, 2012, DIABETES CARE, V35, P1355, DOI 10.2337/dc11-1657; Donahue RP, 2007, DIABETES CARE, V30, P1724, DOI 10.2337/dc07-0040; Einarson TR, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0728-6; Florkowski Christopher M, 2011, Clin Biochem Rev, V32, P75; Folsom AR, 1999, DIABETES CARE, V22, P1077, DOI 10.2337/diacare.22.7.1077; Ghaderian SB, 2015, J RENAL INJ PREV, V4, P28, DOI 10.12861/jrip.2015.07; Grubb Anders, 2017, EJIFCC, V28, P268; Guilherme A, 2019, NAT REV ENDOCRINOL, V15, P207, DOI 10.1038/s41574-019-0165-y; Habib Samy L, 2013, ISRN Oncol, V2013, P583786, DOI 10.1155/2013/583786; Inker LA, 2011, AM J KIDNEY DIS, V58, P682, DOI 10.1053/j.ajkd.2011.05.019; Keisler-Starkey K, 2020, HLTH INSURANCE COVER; Kurian AK, 2007, ETHNIC DIS, V17, P143; Lee SH, 2010, METABOLISM, V59, P241, DOI 10.1016/j.metabol.2009.07.019; Li ZX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154990; Lipworth L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048407; Lontchi-Yimagou E, 2013, CURR DIABETES REP, V13, P435, DOI 10.1007/s11892-013-0375-y; Luo J, 2015, CLIN CHIM ACTA, V450, P39, DOI 10.1016/j.cca.2015.07.016; Ma CC, 2020, ARCH MED SCI, V16, P648, DOI 10.5114/aoms.2019.83511; Magnusson M, 2013, J INTERN MED, V274, P192, DOI 10.1111/joim.12051; Mays VM, 2017, MED CARE, V55, P173, DOI 10.1097/MLR.0000000000000638; McClellan W, 2006, J AM SOC NEPHROL, V17, P1710, DOI 10.1681/ASN.2005111200; Mehrotra R, 2008, J AM SOC NEPHROL, V19, P1403, DOI 10.1681/ASN.2007070747; Muntner P, 2008, AM J MED, V121, P341, DOI 10.1016/j.amjmed.2008.01.003; Nicholas SB, 2013, SEMIN NEPHROL, V33, P409, DOI 10.1016/j.semnephrol.2013.07.002; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Nwaneri C., 2013, BRIT J DIABETES VASC, V13, P192, DOI [10.1177/1474651413495703, DOI 10.1177/1474651413495703]; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Peralta CA, 2006, J AM SOC NEPHROL, V17, P2892, DOI 10.1681/ASN.2005101122; Peralta CA, 2013, J AM GERIATR SOC, V61, P90, DOI 10.1111/jgs.12040; Perez-Escamilla R, 2011, AM J CLIN NUTR, V93, p1163S, DOI 10.3945/ajcn.110.003467; Qamar A, 2018, JCPSP-J COLL PHYSICI, V28, P288, DOI 10.29271/jcpsp.2018.04.288; Reutens AT, 2013, NEPHROL DIAL TRANSPL, V28, P1820, DOI 10.1093/ndt/gfs561; Ruiz JM, 2013, AM J PUBLIC HEALTH, V103, pE52, DOI 10.2105/AJPH.2012.301103; Sabanayagam C, 2013, EUR J EPIDEMIOL, V28, P311, DOI 10.1007/s10654-013-9781-3; Sahakyan K, 2011, DIABETOLOGIA, V54, P1335, DOI 10.1007/s00125-011-2096-6; Sangeeta S, 2018, J CLIN DIAGN RES, V12, pBC30, DOI 10.7860/JCDR/2018/36698.12069; Schneiderman N, 2014, DIABETES CARE, V37, P2233, DOI 10.2337/dc13-2939; Shlipak MG, 2013, NEW ENGL J MED, V369, P932, DOI 10.1056/NEJMoa1214234; Shlipak MG, 2006, J AM SOC NEPHROL, V17, P254, DOI 10.1681/ASN.2005050545; Sonnega A, 2014, INT J EPIDEMIOL, V43, P576, DOI 10.1093/ije/dyu067; Tsalamandris S, 2019, EUR CARDIOL REV, V14, P50, DOI 10.15420/ecr.2018.33.1; Uruska A, 2014, CLIN BIOCHEM, V47, P1235, DOI 10.1016/j.clinbiochem.2014.06.014; Weir DR, 2016, VALIDATING MORTALITY; Xu GD, 2019, EUR J ENDOCRINOL, V180, P243, DOI 10.1530/EJE-18-0792; Ying X, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006289	56	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0270289	10.1371/journal.pone.0270289	http://dx.doi.org/10.1371/journal.pone.0270289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094936	gold, Green Published			2022-12-26	WOS:000892376500007
J	Netere, AK; Sendekie, AK				Netere, Adeladlew Kassie; Sendekie, Ashenafi Kibret			Time to doubling of serum creatinine in patients with diabetes in Ethiopian University Hospital: Retrospective follow-up study	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR OUTCOMES; RENAL-FAILURE; PROGRESSION; RISK; BENAZEPRIL; RAMIPRIL; DECLINE	Background Diabetic kidney disease is one of the long-term microvascular complications of diabetes. Doubling of serum creatinine is an important biomarker and predictor of diabetic kidney disease for patients with diabetes. This study aimed to determine the time in which the serum creatinine level is doubled measured from the baseline in patients with diabetes in Ethiopian University Hospital. Methods Analysis of the patients with diabetes medical records was employed retrospectively for five years from 2016 to 2020 in the University of Gondar Comprehensive Specialized Hospital. The Kaplan-Meier procedure was used to predict the time to which the serum creatinine level was doubled measured from the baseline value, while the Log-rank test and cox-proportional hazard regression models were employed to show significant serum creatinine (SCr) changes against the predictor variables. Results Among the total of 387 patients with diabetes, 54.5% were females with a mean age of 61.1 +/- 10.3 years. After 5-years of retrospective follow-up, 10.3% of patients with diabetes had doubled their serum creatinine level computed from the baseline values. The baseline and last SCr levels (measured in mg/dL) were 0.87 (+/- 0.23) and 1.0(+/- 0.37), respectively. This resulted in a mean SCr difference of 0.12 +/- 0.38 mg/dL. The SCr score was continuously increasing uninterruptedly for five years and measured as 0.94, 0.95, 0.94, 1 and 1.03 mg/dL, respectively. The average survival time taken for the serum creatinine to be doubled computed from baseline was 55.4 months (4.6 years). Patients treated with greater than or equal to 30 IU NPH were found 3.3 times more likely to have higher risks of doubling the serum creatinine level (DSC); with HR of 3.29 [(95%CI); 1.28-8.44: P = 0.013]. Conclusion Compared with the baseline level, a significant proportion of patients with diabetes were found to have doubling of serum creatinine DSC within less than five years around four and half years. A continuous increasing in the SCr level was noted when measured from the baseline scores. Therefore, to preserve the renal function of patients with diabetes, close SCr level monitoring and regular follow-up would be recommended in combined with effective therapeutic interventions.	[Netere, Adeladlew Kassie; Sendekie, Ashenafi Kibret] Univ Gondar, Sch Pharm, Dept Clin Pharm, Coll Med & Hlth Sci, Gondar, Ethiopia	University of Gondar	Netere, AK (corresponding author), Univ Gondar, Sch Pharm, Dept Clin Pharm, Coll Med & Hlth Sci, Gondar, Ethiopia.	kassieadeladlew21@gmail.com		Sendekie, Ashenafi Kibret/0000-0001-5982-853X				Alicic RZ, 2017, CLIN J AM SOC NEPHRO, V12, P2032, DOI 10.2215/CJN.11491116; American Diabetes Association, 2018, J CLIN APPL RES ED D, V41; Avinash S, 2015, J ASS PHYS INDIA, V63, P28; Badve SV, 2016, NEPHROL DIAL TRANSPL, V31, P1425, DOI 10.1093/ndt/gfv269; Bishu KGJ.C., 2019, OBESITY MED, V15, P100, DOI [10.1016/j.obmed.2019.100132, DOI 10.1016/J.OBMED.2019.100132]; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Chen Y, 2020, KIDNEY DIS-BASEL, V6, P215, DOI 10.1159/000506634; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Fasil A, 2019, DIABET METAB SYND OB, V12, P75, DOI 10.2147/DMSO.S185614; Federation I.D, 2017, INT DIABETES FEDERAT, VEighth; Gansevoort RT, 2011, KIDNEY INT, V80, P93, DOI 10.1038/ki.2010.531; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Johnson DW, 2012, MED J AUSTRALIA, V197, P222, DOI 10.5694/mja11.11329; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Knott L., 2020, DIABETIC KIDNEY DIS; Kuriyama S, 1997, NEPHRON, V77, P176, DOI 10.1159/000190270; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; M H.M.C., 2014, BIOMARKERS DIABETIC; Mann JFE, 2008, LANCET, V372, P547, DOI 10.1016/S0140-6736(08)61236-2; Marathe PH, 2017, J DIABETES, V9, P320, DOI 10.1111/1753-0407.12524; Maschio G, 1996, NEW ENGL J MED, V334, P939, DOI 10.1056/NEJM199604113341502; Moon JS, 2013, ENDOCRINOL METAB, V28, P207, DOI 10.3803/EnM.2013.28.3.207; Noble E, 2008, NEPHROL DIAL TRANSPL, V23, P3845, DOI 10.1093/ndt/gfn385; Pina AF, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00519; Ruggenenti P, 1997, LANCET, V349, P1857; Schneider C, 2016, CLIN EPIDEMIOL, V8, P177, DOI 10.2147/CLEP.S107060; SHAH BV, 1992, J AM SOC NEPHROL, V2, P1186; SHEMESH O, 1985, KIDNEY INT, V28, P830, DOI 10.1038/ki.1985.205; SKOTT P, 1989, DIABETOLOGIA, V32, P694; Sulaiman MK, 2019, DIABETOL METAB SYNDR, V11, DOI 10.1186/s13098-019-0403-4; The European Agency for the Evaluuation of Medicinal Products, 2002, NOTE GUIDANCE CLIN I; Tuttle KR, 2014, AM J KIDNEY DIS, V64, P510, DOI [10.1053/j.ajkd.2014.08.001, 10.2337/dc14-1296]; van der Velde MM.K., 2011, KIDNEY INT, V80, P93; WALSER M, 1988, KIDNEY INT, V34, P412, DOI 10.1038/ki.1988.196; White SL, 2010, AM J KIDNEY DIS, V55, P660, DOI 10.1053/j.ajkd.2009.12.011; World Health O, 2021, HOMENEWSROOMFACT SHE; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zhang XX, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/2315607	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0274495	10.1371/journal.pone.0274495	http://dx.doi.org/10.1371/journal.pone.0274495			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36095019	Green Published, gold			2022-12-26	WOS:000892376500049
J	Zhengi, JC; Shi, L; Jiang, TH				Zhengi, Jiancun; Shi, Lu; Jiang, Tianhong			What mechanism design helps to realize the innovation function of maker-spaces: A qualitative comparative analysis based on fuzzy sets	PLOS ONE			English	Article							FIRM PERFORMANCE; HIGH-TECH; MAKERSPACES; BUSINESS; ECOSYSTEM; MOVEMENT; PROJECTS; TIES	Most of the existing studies on maker-space focus on internal subjects (such as makers) or external factors (such as policy support, ecological environment, and more). There has been relatively little discussion on the design of a series of mechanisms of maker-space. This paper theorizes the operating mechanism for platform services, resource gathering, network connections and endogenous cultural protection for the maker-space. It uses the method of fuzzy set qualitative comparative analysis (fsQCA) to analyze data from 63 maker-spaces in Zhejiang Province. The study proposes a reasonable mechanism design scheme for maker-space. The results show that the innovativeness of a maker-space is the result of the synergistic effect of various operating mechanisms. Among them, the platform service function, the channel for gathering resources, the formal linkages, and the culture for sharing achievements are indispensable support mechanisms for maker-spaces. Two effective ways to promote innovation in maker-space are outlined: first, preventing interventions from external resource providers; second, building an inclusive culture of trial and error.	[Zhengi, Jiancun; Jiang, Tianhong] Wenzhou Univ Technol, Econ & Management Sch, Wenzhou, Peoples R China; [Shi, Lu] Wenzhou Vocat Coll Sci & Technol, Dept Business & Management, Wenzhou, Peoples R China		Zhengi, JC (corresponding author), Wenzhou Univ Technol, Econ & Management Sch, Wenzhou, Peoples R China.	zhengjiancun@139.com		Zheng, Jiancun/0000-0003-1923-1354				Ahmad AJ, 2014, INT J ENTREP BEHAV R, V20, P375, DOI 10.1108/IJEBR-11-2012-0133; Aldrich H., 1986, RES ORGAN BEHAV, V8, P165; Atanasov V A, 2006, SSRN ELECT J, V6, P1, DOI [10.2139/ssrn.905923, DOI 10.2139/SSRN.905923]; Bergner D, 2009, CH CRC DATA MIN KNOW, P19; Brax SA, 2009, INT J OPER PROD MAN, V29, P539, DOI 10.1108/01443570910953621; Browder RE, 2019, J BUS VENTURING, V34, P459, DOI 10.1016/j.jbusvent.2019.01.005; Cacciatori E, 2012, MANAGE LEARN, V43, P309, DOI 10.1177/1350507611426240; Caselli S, 2009, EUR FINANC MANAG, V15, P92, DOI 10.1111/j.1468-036X.2008.00445.x; Chen S, 2015, BUSINESS EC ADM, P35, DOI [10.14134/j.cnki.cn33-1336/f.2015.11.004, DOI 10.14134/J.CNKI.CN33-1336/F.2015.11.004]; Chen Z Z., 2020, EXPLORATION EC PROBL, P69; Cloodt M, 2006, RES POLICY, V35, P642, DOI 10.1016/j.respol.2006.02.007; Coduras A, 2016, J BUS RES, V69, P1265, DOI 10.1016/j.jbusres.2015.10.090; Dai X S., 2016, EC FORUM, P87; Du Y.Z., 2017, MANAGE WORLD WASTE, V6, P155, DOI DOI 10.19744/J.CNKI.11-1235/F.2017.06.012; Dul J, 2020, ORGAN RES METHODS, V23, P385, DOI 10.1177/1094428118795272; Dul J, 2016, ORGAN RES METHODS, V19, P10, DOI 10.1177/1094428115584005; Edmans A, 2014, ANNU REV FINANC ECON, V6, P23, DOI 10.1146/annurev-financial-110613-034455; Fernandez MTF, 2015, SERV IND J, V35, P783, DOI 10.1080/02642069.2015.1080243; Fiss PC, 2011, ACAD MANAGE J, V54, P393, DOI 10.5465/AMJ.2011.60263120; Han SY, 2017, TELEMAT INFORM, V34, P184, DOI 10.1016/j.tele.2017.02.003; He Z., 2018, J U ELECT SCI TECHNO, V20, P50, DOI [10.14071/j.1008-8105(2017)-1009, DOI 10.14071/J.1008-8105(2017)-1009]; Hopkins MM, 2019, RES POLICY, V48, P1113, DOI 10.1016/j.respol.2019.01.008; [黄钟仪 Huang Zhongyi], 2020, [科研管理, Science Research Management], V41, P21; Irie NR, 2019, TECHTRENDS, V63, P397, DOI 10.1007/s11528-018-0355-9; Isenberg D., 2011, PRESENT I INT EUR AF, V1, P1; Jacobides MG, 2018, STRATEGIC MANAGE J, V39, P2255, DOI 10.1002/smj.2904; Jensen MB, 2016, PROC CIRP, V54, P65, DOI 10.1016/j.procir.2016.05.069; Jia T M, 2017, SCI TECHNOLOGY MANAG, V37, P8; Kera D, 2012, JCOM-J SCI COMMUN, V11; Khan MR, 2013, WORLD J ENTREP MANAG, V9, P28, DOI 10.1108/20425961311315700; M'Chirgui Z, 2018, J TECHNOL TRANSFER, V43, P1142, DOI 10.1007/s10961-016-9535-y; Mortara L, 2016, INT J PROD RES, V54, P7158, DOI 10.1080/00207543.2016.1198505; Nambisan S, 2011, ACAD MANAGE PERSPECT, V25, P40, DOI 10.5465/AMP.2011.63886529; Oliver KM, 2016, TECHTRENDS, V60, P160, DOI 10.1007/s11528-016-0028-5; Peng MW, 2000, ACAD MANAGE J, V43, P486, DOI 10.2307/1556406; Prendeville S, 2017, INT J SUSTAIN ENG, V10, P272, DOI 10.1080/19397038.2017.1317876; Ragin C.C., 2008, REDESIGNING SOCIAL I, DOI DOI 10.7208/CHICAGO/9780226702797.001.0001; Reale F, 2019, TECHNOL SOC, V59, DOI 10.1016/j.techsoc.2019.101174; Ren LM., 2017, ACAD FORUM, V40, P136, DOI [10.16524/j.45-1002.2017.04.022, DOI 10.16524/J.45-1002.2017.04.022]; Schneider CQ, 2012, STRAT SOC INQ, P1; Shahzad Basit, 2018, Information Technology - New Generations. 15th International Conference on Information Technology. Advances in Intelligent Systems and Computing (AISC 738), P621, DOI 10.1007/978-3-319-77028-4_79; Sheng SB, 2011, J MARKETING, V75, P1, DOI 10.1509/jmkg.75.1.1; Spigel B, 2017, ENTREP THEORY PRACT, V41, P49, DOI 10.1111/etap.12167; Stinchcombe AL, 2000, ADV STRAT M, V 17, P229; Tian J., 2019, J JIANGSU U SCI TECH, V19, P82, DOI [10.16148/j.cnki.cn32-1743/c.2019.02.012, DOI 10.16148/J.CNKI.CN32-1743/C.2019.02.012]; Torch High-tech Industry Development Center of the Ministry of Science and Technology of China, 2019, CHINA TORCH STAT YB; Tsang E.W.K., 1998, ACAD MANAGEMENT EXEC, V12, P64, DOI [DOI 10.5465/AME.1998.650517, https://doi.org/10.5465/ame.1998.650517]; Van Holm EJ, 2015, WORLD CONFERENCE ON TECHNOLOGY, INNOVATION AND ENTREPRENEURSHIP, P24, DOI 10.1016/j.sbspro.2015.06.167; Wang L P, 2017, CHINA SCI TECHNOLOGY, P109, DOI [10.13580/j.cnki.fstc.2017.03.015, DOI 10.13580/J.CNKI.FSTC.2017.03.015]; Wang Y M, 2015, E ED RES, V36, P5, DOI [10.13811/j.cnki.eer.2015.11.001, DOI 10.13811/J.CNKI.EER.2015.11.001]; Wareham J, 2014, ORGAN SCI, V25, P1195, DOI 10.1287/orsc.2014.0895; [解学梅 Xie Xuemei], 2020, [科学学研究, Studies in Science of Science], V38, P912; [张玉利 Zhang Yuli], 2017, [科学学与科学技术管理, Science of Science and Management of S.& T.], V38, P22; Zhang Z., 2020, SCI TECHNOLOGY PROGR, V37, P10; Zheng J C., 2020, J CHANGCHUN NORMAL U, V39, P68; Zheng WW, 2020, TECHNICAL EC, V39	56	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2022	17	9							e0274307	10.1371/journal.pone.0274307	http://dx.doi.org/10.1371/journal.pone.0274307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6P6FY	36083971	gold, Green Published			2022-12-26	WOS:000891025700001
J	Pinto, L; Farghaly, M; Nunna, S; Ramachandrachar, BC; Chilukuri, SH; Natarajan, A				Pinto, Lionel; Farghaly, Mohamed; Nunna, Sasikiran; Ramachandrachar, Badarinath Chickballapur; Chilukuri, Sri Harshadeep; Natarajan, Ashok			Lipid lowering therapy patterns and the risk of cardiovascular events in the 1-year after acute myocardial infarction in United Arab Emirates	PLOS ONE			English	Article							MIDDLE-EASTERN PATIENTS; GULF REGISTRY; REAL-WORLD; DISEASE; MANAGEMENT; CHOLESTEROL; OUTCOMES; DYSLIPIDEMIA	Aim In United Arab Emirates, cardiovascular disease (CVD) is a leading cause of mortality and 22% of CVD deaths are attributable to acute myocardial infarction (MI). Adherence to guidelines for lipid management is incompletely described in the Middle East. This study aimed to characterize lipid lowering therapy (LLT) patterns and the risk of subsequent cardiovascular events (CVEs) in the first year after MI. Methods This was a retrospective cohort study using the Dubai Real-World Claims Database, including all patients discharged with MI between January 01, 2015 and December 31, 2018, followed-up until December 31, 2019. Results In the first year after MI, 8.42% of 4,595 patients included experienced at least one recurrent MI (rate 6.77 events/100 person-years [PYs]), 2.94% had one revascularization (cumulative rate 0.55 events/100 PYs) and 2.66% had one hospitalization due to unstable angina (cumulative rate 5.16 new events/100 PYs). The majority (60.40%) of the patients presented with LDL-C levels >= 70 mg/dL after MI. In the first year after MI, 93.45% of the patients received LLT, mainly high-intensity statin (67.79%); with a minority of patients receiving statin + ezetimibe (4.55%), PCSK9i (0.20%) or ezetimibe alone (0.07%). Conclusion Patients hospitalized with MI in Dubai present an increased risk of CVEs in their first-year post-discharge. Majority of the patients presented with LDL-C levels above 70 mg/dL, which indicates suboptimal lipid control with existing LLT, particularly in high-risk patients.	[Pinto, Lionel] Amgen Inc, 1 Amgen Dr, Thousand Oaks, CA USA; [Farghaly, Mohamed] Dubai Hlth Author, Dubai, U Arab Emirates; [Nunna, Sasikiran] IQVIA, Plymouth, PA USA; [Ramachandrachar, Badarinath Chickballapur; Chilukuri, Sri Harshadeep; Natarajan, Ashok] Dubai World Trade Ctr, IQVIA, Dubai, U Arab Emirates	Amgen; IQVIA	Ramachandrachar, BC (corresponding author), Dubai World Trade Ctr, IQVIA, Dubai, U Arab Emirates.	BCRamachandrachar@ae.imshealth.com		Natarajan, Ashok/0000-0001-9435-1300	Amgen Inc.	Amgen Inc.(Amgen)	The study was funded by Amgen Inc. and had substantial role in the study design, study methodology and decision to publish."No specific author received any grant for the work. No grant number was associated with the funding.	Akyea RK, 2019, HEART, V105, P975, DOI 10.1136/heartjnl-2018-314253; Al Rasadi K, 2016, ATHEROSCLEROSIS, V252, P182, DOI 10.1016/j.atherosclerosis.2016.07.925; Al Sayed N, 2016, INT J CARDIOL, V225, P268, DOI 10.1016/j.ijcard.2016.09.081; AlHabib KF, 2012, ANN SAUDI MED, V32, P9, DOI 10.5144/0256-4947.2012.9; Alsheikh-Ali AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102830; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Brown WV, 2001, CURR CONTR TRIALS C, V2, P12, DOI 10.1186/CVM-2-1-012; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Freedman DM, 2017, JAMA NEUROL, V74, P868, DOI 10.1001/jamaneurol.2017.0427; Grundy SM, 2019, J AM COLL CARDIOL, V73, P3168, DOI 10.1016/j.jacc.2018.11.002; Jernberg T, 2015, EUR HEART J, V36, P1163, DOI 10.1093/eurheartj/ehu505; Karalis DG, 2012, CHOLESTEROL, DOI 10.1155/2012/861924; Kauffman AB, 2010, J CLIN LIPIDOL, V4, P173, DOI 10.1016/j.jacl.2010.03.002; Kochar A, 2017, J AM COLL CARDIOL, V69, P183, DOI 10.1016/S0735-1097(17)33572-6; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Menzin J, 2017, J MANAG CARE SPEC PH, V23, P1270, DOI 10.18553/jmcp.2017.16414; Miao B, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014402; Ramahi TM, 2010, ASIA-PAC J PUBLIC HE, V22, p83S, DOI 10.1177/1010539510373034; Rapsomaniki E, 2016, EUR HEART J-QUAL CAR, V2, P172, DOI 10.1093/ehjqcco/qcw004; Razzak H., 2018, PREVALENCE RISK FACT, V11, P105; Tangri N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180010; Teramoto T, 2016, ATHEROSCLEROSIS, V251, P248, DOI 10.1016/j.atherosclerosis.2016.07.001; WHO, 2017, WHO CARDIOVASCULAR D; Yan AT, 2006, AM J MED, V119, P676, DOI 10.1016/j.amjmed.2005.11.015; Zubaid M, 2009, ACTA CARDIOL, V64, P439, DOI 10.2143/AC.64.4.2041607	25	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0268709	10.1371/journal.pone.0268709	http://dx.doi.org/10.1371/journal.pone.0268709			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054205	Green Published, gold			2022-12-26	WOS:000892641400004
J	Bretes, E; Wroblewski, J; Wyszczelska-Rokiel, M; Jakubowski, H				Bretes, Ewa; Wroblewski, Jacek; Wyszczelska-Rokiel, Monika; Jakubowski, Hieronim			Cystathionine beta-synthase gene inactivation dysregulates major urinary protein biogenesis and impairs sexual signaling in mice	FASEB JOURNAL			English	Article							N-HOMOCYSTEINYLATION; EXPRESSION; DEFICIENT; FOLATE; MODELS	Reproductive success in mice depends on sexually dimorphic major urinary proteins (Mup) that facilitate interactions between females and males. Deletion of cystathionine beta-synthase (Cbs) gene, a metabolic gene important for homeostasis of one-carbon metabolism, impairs reproduction by causing female infertility in mice. Here, we examined Mup biogenesis and sexual signaling in Cbs(-/-) versus Cbs(+/-) mice. We found significantly reduced levels of total urinary Mup protein in male and female Cbs(-/-) versus Cbs(+/-) mice. SDS-PAGE/Western blot, ESI-MS, and RT-qPCR analyses of the liver, plasma, and urinary proteins identified a male-specific Mup20 in Cbs(-/-), but not in Cbs(+/-) females. The 18 893 Da Mup20 became the most abundant in urine of Cbs(-/-) females and males. Effects of Cbs genotype on 18 645 Da, 18 693 Da, and 18 709 Da Mup species abundance were Mup- and sex-specific. Cbs genotype-dependent changes in hepatic Mups and Mup20 expression were similar at the protein and mRNA level. Changes in Mups, but not in Mup20, can be explained by downregulation of hepatic Zhx2 and Ghr receptors in Cbs(-/-) mice. Behavioral testing showed that Cbs(+/-) females ignored Cbs(-/-) male urine but were attracted to Cbs(+/-) male urine. Cbs(+/-) males ignored urine of Cbs(-/-) males but countermarked urine of other Cbs(+/-) males and were attracted to urines of Cbs(-/-) as well as Cbs(+/-) females. Cbs(-/-) males did not countermark urine of Cbs(+/-) males but were attracted to urines of Cbs(+/-) females. Taken together, these findings show that Cbs, a metabolic gene, interacts with the processes involved in Mup biogenesis that are essential for the maintenance of sexual dimorphism and signaling and suggest that dysregulation of these interactions impairs reproductive fitness in mice.	[Bretes, Ewa; Wroblewski, Jacek; Jakubowski, Hieronim] Poznan Univ Life Sci, Dept Biochem & Biotechnol, Poznan, Poland; [Wroblewski, Jacek] Inst Bioorgan Chem, Poznan, Poland; [Wyszczelska-Rokiel, Monika; Jakubowski, Hieronim] Rutgers State Univ, Dept Microbiol Biochem & Mol Genet, New Jersey Med Sch, Int Ctr Publ Hlth, Newark, NJ USA	Poznan University of Life Sciences; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wroblewski, J (corresponding author), Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Int Ctr Publ & Lealth, 225 Warren St, Newark, NJ 07103 USA.	jakubows@rutgers.edu	Bretes, Ewa/AAN-9419-2021	Bretes, Ewa/0000-0001-9218-385X	Narodowe Centrum Nauki (NCN) [2019/33/B/NZ4/01760, 2018/29/B/NZ4/00771, 2016/23/B/NZ5/00573, 2014/15/N/NZ5/01646]	Narodowe Centrum Nauki (NCN)(National Science Centre, Poland)	Narodowe Centrum Nauki (NCN), Grant/Award Number: 2019/33/B/NZ4/01760, 2018/29/B/NZ4/00771, 2016/23/B/NZ5/00573 and 2014/15/N/NZ5/01646	Blom HJ, 2006, NAT REV NEUROSCI, V7, P724, DOI 10.1038/nrn1986; Bossenmeyer-Pourie C, 2019, J PATHOL, V248, P291, DOI 10.1002/path.5254; Cavaggioni A, 2003, CHEM SENSES, V28, P791, DOI 10.1093/chemse/bjg073; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cheetham SA, 2009, PHYSIOL BEHAV, V96, P253, DOI 10.1016/j.physbeh.2008.10.005; Connerney J, 2017, ENDOCRINOLOGY, V158, P1386, DOI 10.1210/en.2017-00060; CONSTANTINE G, 1987, BRIT J OBSTET GYNAEC, V94, P803, DOI 10.1111/j.1471-0528.1987.tb03732.x; Forges T, 2007, HUM REPROD UPDATE, V13, P225, DOI 10.1093/humupd/dml063; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Guzman MA, 2006, HUM MOL GENET, V15, P3168, DOI 10.1093/hmg/ddl393; Jakubowski H, 2020, EXPERT REV PROTEOMIC, V17, P751, DOI 10.1080/14789450.2020.1865160; Jakubowski H, 2019, TRENDS CANCER, V5, P7, DOI 10.1016/j.trecan.2018.10.006; Jakubowski H, 2019, PHYSIOL REV, V99, P555, DOI 10.1152/physrev.00003.2018; Jiang JY, 2017, J BIOL CHEM, V292, P6765, DOI 10.1074/jbc.M116.768275; KNOPF JL, 1983, MOL CELL BIOL, V3, P2232, DOI 10.1128/MCB.3.12.2232; Lehmann ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069822; Liu K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15548; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maron BA, 2009, ANNU REV MED, V60, P39, DOI 10.1146/annurev.med.60.041807.123308; Martin-Sanchez A, 2015, HORM BEHAV, V68, P65, DOI 10.1016/j.yhbeh.2014.08.007; Mei XY, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201809469; MEJBAUMKATZENELLENBOGEN W, 1955, ACTA BIOCHIM POL, V2, P279; Nuno-Ayala M, 2012, PHYSIOL GENOMICS, V44, P702, DOI 10.1152/physiolgenomics.00189.2010; Penn DJ, 2022, FRONT PHYSIOL, V13, DOI 10.3389/fphys.2022.822073; Perla-Kajan J, 2016, FASEB J, V30, P3810, DOI 10.1096/fj.201600539; Qin WY, 2022, J CLIN LAB ANAL, V36, DOI 10.1002/jcla.24312; Roberts SA, 2012, SCIENCE, V338, P1462, DOI 10.1126/science.1225638; Roberts SA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-75; Smith AD, 2021, J INTERN MED, V290, P826, DOI 10.1111/joim.13279; Wang D, 2018, CELL REP, V25, P398, DOI 10.1016/j.celrep.2018.09.022; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Wu LL, 2002, CLIN CHIM ACTA, V322, P21, DOI 10.1016/S0009-8981(02)00174-2; Xu QH, 2022, BMC PREGNANCY CHILDB, V22, DOI 10.1186/s12884-022-04491-8	33	0	0	5	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2022	36	10							e22547	10.1096/fj.202200969R	http://dx.doi.org/10.1096/fj.202200969R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	4M9MT	36098436	Green Submitted			2022-12-26	WOS:000853643000001
J	Mighri, N; Mejri, N; Boujemaa, M; Berrazega, Y; Rachdi, H; El Benna, H; Labidi, S; Benna, F; Boubaker, S; Boussen, H; Abdelhak, S; Hamdi, Y				Mighri, Najah; Mejri, Nesrine; Boujemaa, Maroua; Berrazega, Yosra; Rachdi, Haifa; El Benna, Houda; Labidi, Soumaya; Benna, Farouk; Boubaker, Samir; Boussen, Hamouda; Abdelhak, Sonia; Hamdi, Yosr			Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast cancer patients	PLOS ONE			English	Article							YOUNG AGE; MOLECULAR SUBTYPES; WOMEN; MANAGEMENT; DIAGNOSIS; MARKER; IMPACT; COMORBIDITIES; CARCINOMA; COHORT	Breast cancer has different epidemio-clinical characteristics in Middle East and North-African populations compared to those reported in the Western countries. The aim of this study is to analyze the epidemiological and clinico-pathological features of breast cancer in Tunisia and to determine prognostic factors with special interest to family history, Ki-67 proliferation index and comorbidity. We retrospectively reviewed epidemiological and clinicopathological data from patients' medical records, treated in the Medical Oncology Department at Abderrahmane Mami Hospital, in the period 2011-2015. Data has been collected on 602 breast cancer patients and analyzed using SPSS software V.23.0. Our study showed high fractions of young breast cancer patients and cases with dense breasts. The most prevalent comorbidities observed in the studied cohort were cardiovascular diseases and diabetes. Familial breast cancer was found in 23.3% of cases and was associated with younger age at diagnosis (p<0.001) and advanced stage (p = 0.015). Ki-67 index >20% was significantly associated with early age at diagnosis, lymph node involvement (p = 0.002), advanced tumor grade (p<0.001) and high risk of relapse (p = 0.007). Ki-67 cut-off 30% predicted survival in luminal cases. Survival was worse in patients with triple negative breast cancer compared to non-triple negative breast cancer, inflammatory breast cancer compared to non-inflammatory breast cancer, moderately to poorly differentiated tumors compared to well-differentiated tumors and with positive lymph nodes compared to pN0 (p<0.05). Our study showed new insights into epidemiological and clinico-pathological characteristics of breast cancer that are not well explored in Tunisian population. Considering our findings along with the implementation of electronic health record system may improve patient health care quality and disease management.	[Mighri, Najah; Mejri, Nesrine; Boujemaa, Maroua; El Benna, Houda; Labidi, Soumaya; Boubaker, Samir; Boussen, Hamouda; Abdelhak, Sonia; Hamdi, Yosr] Univ Tunis El Manar, Inst Pasteur Tunis, LR20IPT05, Lab Biomed Genom & Oncogenet, Tunis, Tunisia; [Mejri, Nesrine; Berrazega, Yosra; Rachdi, Haifa; El Benna, Houda; Labidi, Soumaya; Boussen, Hamouda] Univ Tunis El Manar, Fac Med Tunis, Abderrahman Mami Hosp, Dept Med Oncol, Tunis, Tunisia; [Benna, Farouk] Univ Tunis, Dept Radiat Oncol, Tunis, Tunisia; [Boubaker, Samir; Hamdi, Yosr] Inst Pasteur Tunis, Lab Human & Expt Pathol, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Hopital Abderrahmene Mami; Universite de Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis	Hamdi, Y (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, LR20IPT05, Lab Biomed Genom & Oncogenet, Tunis, Tunisia.; Hamdi, Y (corresponding author), Inst Pasteur Tunis, Lab Human & Expt Pathol, Tunis, Tunisia.	yosr.hamdi@pasteur.tn		Hamdi, Yosr/0000-0002-2815-1834	Tunisian Ministry of Health [PEC-4-TUN]; Tunisian Ministry of Higher Education and Scientific Research [LR16IPT05, LR20IPT05]	Tunisian Ministry of Health; Tunisian Ministry of Higher Education and Scientific Research	This study was supported by the Tunisian Ministry of Health (PEC-4-TUN) and the Tunisian Ministry of Higher Education and Scientific Research (LR16IPT05 and LR20IPT05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Tamimi DM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-223; Alco G, 2015, ONCOL LETT, V9, P1046, DOI 10.3892/ol.2015.2852; Anders CK, 2008, J CLIN ONCOL, V26, P3324, DOI 10.1200/JCO.2007.14.2471; Belaid I, 2018, BREAST J, V24, P846, DOI 10.1111/tbj.13062; Ben Abdallah M, 2009, Tunis Med, V87, P417; Ben Abdelkrim S, 2015, PATHOL ONCOL RES, V21, P553, DOI 10.1007/s12253-015-9944-5; Ben Abdelkrim S, 2010, PATHOL RES PRACT, V206, P772, DOI 10.1016/j.prp.2010.07.012; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Bertucci Francois, 2008, J Biol, V7, P6, DOI 10.1186/jbiol67; Bhargava R, 2009, INT J CLIN EXP PATHO, V2, P444; Boussen H, 2010, CANCER-AM CANCER SOC, V116, P2730, DOI 10.1002/cncr.25175; Boussen H, 2008, SEMIN ONCOL, V35, P17, DOI 10.1053/j.seminoncol.2007.11.017; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Caldarella A, 2013, J CANCER RES CLIN, V139, P617, DOI 10.1007/s00432-012-1365-1; Cancer NCCf, 2013, FAM BREAST CANC CLAS; Chalabi N., 2008, Cancer Genomics & Proteomics, V5, P253; Cherbal Farid, 2015, Breast Dis, V35, P95, DOI 10.3233/BD-150398; Chouchane L, 2013, LANCET ONCOL, V14, pE417, DOI 10.1016/S1470-2045(13)70165-7; Corbex M, 2014, EUR J CANCER, V50, P1808, DOI 10.1016/j.ejca.2014.03.016; de Azambuja E, 2007, BRIT J CANCER, V96, P1504, DOI 10.1038/sj.bjc.6603756; Figueiredo JC, 2007, BREAST CANCER RES TR, V105, P69, DOI 10.1007/s10549-006-9433-3; Fourati A, 2014, ASIA-PAC J CLIN ONCO, V10, pE69, DOI 10.1111/ajco.12034; Fu MR, 2015, J PERS MED, V5, P229, DOI 10.3390/jpm5030229; Fukutomi Takashi, 2001, International Journal of Clinical Oncology, V6, P80, DOI 10.1007/PL00012087; Gavrilov I, 2002, J BUON, V7, P61; Hochlef M., 2013, PAN, V6, P19; Hong CC, 2015, ADV EXP MED BIOL, V862, P155, DOI 10.1007/978-3-319-16366-6_11; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Jiang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029459; Kallel M, 2015, REP PRACT ONCOL RADI, V20, P155, DOI 10.1016/j.rpor.2015.01.007; Khanfir A, 2006, Cancer Radiother, V10, P565, DOI 10.1016/j.canrad.2006.09.115; Khanfir A, 2013, REP PRACT ONCOL RADI, V18, P127, DOI 10.1016/j.rpor.2013.01.001; Kim J, 2015, ANN SURG ONCOL, V22, P3481, DOI 10.1245/s10434-015-4399-1; Kontzoglou K, 2013, ONCOLOGY-BASEL, V84, P219, DOI 10.1159/000346475; Labidi SI, 2008, ANN ONCOL, V19, P473, DOI 10.1093/annonc/mdm480; Lee AHS, 2005, BREAST, V14, P151, DOI 10.1016/j.breast.2004.07.002; Lee HB, 2014, J BREAST CANCER, V17, P301, DOI 10.4048/jbc.2014.17.4.301; Li FY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087264; Manai M, 2019, MOL CLIN ONCOL, V10, P223, DOI 10.3892/mco.2018.1773; Margolin S, 2006, FAM CANCER, V5, P309, DOI 10.1007/s10689-006-7851-3; Mejri N, 2015, Asian Pac J Cancer Prev, V16, P1277; Mejri N, 2015, THER ADV MED ONCOL, V7, P144, DOI 10.1177/1758834015576141; Molino A, 2004, BRIT J CANCER, V91, P96, DOI 10.1038/sj.bjc.6601905; Najjar H, 2010, INT J SURG, V8, P448, DOI 10.1016/j.ijsu.2010.05.012; Nielsen TO, 2021, JNCI-J NATL CANCER I, V113, P808, DOI 10.1093/jnci/djaa201; Nishimura R, 2010, EXP THER MED, V1, P747, DOI 10.3892/etm.2010.133; Pharoah PDP, 1997, INT J CANCER, V71, P800, DOI 10.1002/(SICI)1097-0215(19970529)71:5<800::AID-IJC18>3.3.CO;2-R; Rummel S, 2015, ECANCERMEDICALSCIENC, V9, DOI 10.3332/ecancer.2015.552; Salhia B, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-44; Shibuta K, 2011, BREAST CANCER-TOKYO, V18, P292, DOI 10.1007/s12282-010-0209-6; Soliman Amr S, 2011, Breast Dis, V33, P159, DOI 10.3233/BD-2012-000337; Soliman NA, 2016, CANCER BIOL MED, V13, P496, DOI 10.20892/j.issn.2095-3941.2016.0066; Syrine A, 2017, J BUON, V22, P377; TABBANE F, 1985, BREAST CANCER RES TR, V6, P137, DOI 10.1007/BF02235745; Tan PH, 2020, HISTOPATHOLOGY, V77, P181, DOI 10.1111/his.14091; Tashima R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119565; Tazzite A, 2013, ETHIOP J HEALTH SCI, V23, P150; Verkooijen HM, 2006, BRIT J CANCER, V94, P231, DOI 10.1038/sj.bjc.6602914; Zemni I, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-017-1272-7	59	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2022	17	9							e0269732	10.1371/journal.pone.0269732	http://dx.doi.org/10.1371/journal.pone.0269732			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R5XR	36094928	Green Published, gold			2022-12-26	WOS:000892376500006
J	Dyer, DW; Patrignani, A; Bremer, D				Dyer, Don Wesley; Patrignani, Andres; Bremer, Dale			Measuring turfgrass canopy interception and throughfall using co-located pluviometers	PLOS ONE			English	Article							RAINFALL INTERCEPTION; FOREST FLOOR; FOWLERS GAP; EVAPOTRANSPIRATION; VARIABILITY; EVENTS; MODEL	Turfgrass management relies on frequent watering events from natural precipitation or irrigation. However, most irrigation scheduling strategies in turfgrass ignore the magnitude of canopy interception. Interception is the process by which precipitation or irrigation water is intercepted by and evaporated from plant canopies or plant residue. The objective of this study was to quantify the magnitude of precipitation interception and throughfall in 'Meyer' zoysiagrass (Zoysia japonica L.) and '007' creeping bentgrass (Agrostis stolonifera L.). We used a new method consisting of co-located pluviometers with and without circular turfgrass patches to measure interception and throughfall. The resulting dataset includes 15 storms and 25 individual rainfall events ranging in precipitation totals from 0.3 mm to 42.4 mm throughout the research study. Throughfall amount resulted in a strong (r= 0.98) positive linear relationship with precipitation totals. On average, zoysiagrass and creeping bentgrass canopies intercepted a minimum of 4.4 mm before throughfall occurred. This indicates that, on average, no precipitation reaches the soil surface for precipitation events <4.4 mm. After the point of throughfall, 16% of each additional millimeter of precipitation or irrigation is lost due to interception. Nearly, 45% of the area of the contiguous U.S. could result in >50% of the annual precipitation being intercepted by canopies of zoysiagrass and bentgrass. This study provides detailed insights to understanding the interception dynamics in turfgrass and highlights the inefficient nature of small precipitation and irrigation events in turfgrass systems.	[Dyer, Don Wesley; Bremer, Dale] Kansas State Univ, Dept Hort & Nat Resources, Manhattan, KS USA; [Patrignani, Andres] Kansas State Univ, Dept Agron, Manhattan, KS USA	Kansas State University; Kansas State University	Bremer, D (corresponding author), Kansas State Univ, Dept Hort & Nat Resources, Manhattan, KS USA.; Patrignani, A (corresponding author), Kansas State Univ, Dept Agron, Manhattan, KS USA.	andrespatrignani@ksu.edu; bremer@ksu.edu			U.S. Golf Association (USGA) [2017-38-648]	U.S. Golf Association (USGA)	DJB and AP acknowledge support from the U.S. Golf Association (USGA) for grant 2017-38-648 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard JB., 2001, TURFAX, V9, P4; Beard JB., 2002, TURF MANAGEMENT GOLF, V2nd ed; Bremer DJ, 2001, AGRON J, V93, P338, DOI 10.2134/agronj2001.932338x; Bremer DJ, 1999, AGR FOREST METEOROL, V97, P43, DOI 10.1016/S0168-1923(99)00034-9; BURGY R. H., 1958, TRANS AMER GEOPHYS UNION, V39, P1095; Carlyle-Moses DE, 2004, J ARID ENVIRON, V58, P181, DOI 10.1016/S0140-1963(03)00125-3; Dunkerley D, 2000, HYDROL PROCESS, V14, P669, DOI 10.1002/(SICI)1099-1085(200003)14:4&lt;669::AID-HYP965&gt;3.0.CO;2-I; Dunkerley DL, 2008, HYDROL PROCESS, V22, P1985, DOI 10.1002/hyp.6783; Dunkerley D, 2015, HYDROL PROCESS, V29, P3294, DOI 10.1002/hyp.10454; Dunkerley D, 2013, J ARID ENVIRON, V96, P23, DOI 10.1016/j.jaridenv.2013.04.002; GASH JHC, 1979, Q J ROY METEOR SOC, V105, P43, DOI 10.1002/qj.49710544304; Gerrits AMJ, 2007, HYDROL EARTH SYST SC, V11, P695, DOI 10.5194/hess-11-695-2007; GILLIAM FS, 1987, SOUTHWEST NAT, V32, P267, DOI 10.2307/3671570; He ZB, 2014, AGR FOREST METEOROL, V188, P58, DOI 10.1016/j.agrformet.2013.12.008; Lee H, 2017, J GEOPHYS RES-ATMOS, V122, P7371, DOI 10.1002/2017JD026564; Morris KE, 2003, NATL TURFGRASS RES I; Mueller GD, 2009, J AM WATER RESOUR AS, V45, P1116, DOI 10.1111/j.1752-1688.2009.00347.x; Ochsner TE, 2022, RAIN SHINE INTRO SOI, P94, DOI [10.17605/OSF.IO/Z4RBT, DOI 10.17605/OSF.IO/Z4RBT]; Parker N, 2021, J HYDROMETEOROL, V22, P3275, DOI 10.1175/JHM-D-21-0168.1; Patrignani A, 2020, J ATMOS OCEAN TECH, V37, P2167, DOI 10.1175/JTECH-D-19-0214.1; Patton AJ, 2017, CROP SCI, V57, pS37, DOI 10.2135/cropsci2017.02.0074; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007; Reid LM, 2009, J HYDROL, V375, P459, DOI 10.1016/j.jhydrol.2009.06.048; Savenije HHG, 2004, HYDROL PROCESS, V18, P1507, DOI 10.1002/hyp.5563; Shachnovich Y, 2008, J HYDROL, V349, P168, DOI 10.1016/j.jhydrol.2007.10.051; Sheng HC, 2019, FORESTS, V10, DOI 10.3390/f10030248; TAYLOR DH, 1982, SOIL SCI SOC AM J, V46, P616, DOI 10.2136/sssaj1982.03615995004600030033x; Throssell CS., 2009, APPL TURFGRASS SCI, V6, P1, DOI DOI 10.1094/ATS-2009-0129-01-RS; Tsiko CT, 2012, PHYS CHEM EARTH, V47-48, P122, DOI 10.1016/j.pce.2011.06.009; Warnke S., 2003, TURFGRASS BIOL GENET, P175; Yimam YT, 2015, AGR WATER MANAGE, V155, P40, DOI 10.1016/j.agwat.2015.03.018; Zimmerman TL., 1973, EFFECT AMENDMENT COM; Zou CB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141422	33	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0271236	10.1371/journal.pone.0271236	http://dx.doi.org/10.1371/journal.pone.0271236			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054190	Green Published, gold			2022-12-26	WOS:000892641400007
J	Lee, H; Wintermantel, WM; Trumble, JT; Fowles, TM; Nansen, C				Lee, Hyoseok; Wintermantel, William M.; Trumble, John T.; Fowles, Trevor M.; Nansen, Christian			Modeling and validation of oviposition by a polyphagous insect pest as a function of temperature and host plant species	PLOS ONE			English	Article							DEPENDENT DEVELOPMENT; COLEOPTERA; CICADELLIDAE; LEPIDOPTERA; LEAFHOPPER; FECUNDITY; VECTOR; AGENT	Modeling oviposition as a function of female insect age, temperature, and host plant suitability may provide valuable insight into insect population growth of polyphagous insect pests at a landscape level. In this study, we quantified oviposition by beet leafhoppers, Circulifer (= Neoaliturus) tenellus (Baker) (Hemiptera: Cicadellidae), on four common non-agricultural host plant species [Erodium cicutarium (L.) L'Her. (Geraniaceae), Kochia scoparia (L.) Schrader (Amaranthaceae), Plantago ovata Forsskal (Plantaginaceae), and Salsola tragus L. (Amaranthaceae)] at two constant temperature conditions. Additionally, temperaturebased oviposition models for each host plant species were validated, under semi-field and greenhouse conditions. We found that K. scoparia was the most suitable host plant, and optimal temperature for oviposition was estimated to be 30.6 degrees C. Accordingly, beet leafhoppers appear to be well-adapted to high-temperature conditions, so increasing temperatures due to climate change may favor population growth in non-agricultural areas. Maximum total fecundity (R-m) was used as an indicator of relative suitability of host plants. S. tragus has been considered an important non-agricultural host plant, however, we found that S. tragus and E. cicutarium have lower R m compared to K. scoparia and P. ovata. The combination of detailed experimental oviposition bioassays, modeling, and model validation is considered widely relevant and applicable to host plant assessments and modeling of population dynamics of other polyphagous insect pests.	[Lee, Hyoseok; Fowles, Trevor M.; Nansen, Christian] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA; [Wintermantel, William M.] ARS, US Dept Agr, Salinas, CA USA; [Trumble, John T.] Univ Calif Riverside, Dept Entomol, Riverside, CA USA	University of California System; University of California Davis; University of California System; University of California Riverside	Lee, H (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.	hyslee@ucdavis.edu			U.S. Department of Agriculture's (USDA) Agricultural Marketing Service [190001-032-SF]	U.S. Department of Agriculture's (USDA) Agricultural Marketing Service	CN received a grant (Project No. 190001-032-SF) from the U.S. Department of Agriculture's (USDA) Agricultural Marketing Service (https://www.ams.usda.gov/) to perform this research.	BACKUS EA, 1988, J ECON ENTOMOL, V81, P1819, DOI 10.1093/jee/81.6.1819; Baek S, 2017, J ASIA-PAC ENTOMOL, V20, P367, DOI 10.1016/j.aspen.2017.02.009; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bennett CW., 1971, CURLY TOP DIS SUGARB; Chapter Creamer R., 2020, APPL PLANT VIROLOGY, P521; Choi KS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235910; Cook W.C., 1967, LIFE HIST HOST PLANT; Crosslin JM, 2012, AM J POTATO RES, V89, P82, DOI 10.1007/s12230-011-9223-2; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Gilbertson RL., 2021, ENCY VIROLOGY, VFourth Edition, P200, DOI [10.1016/B978-0-12-809633-8.21238-7, DOI 10.1016/B978-0-12-809633-8.21238-7]; HALLOCK HC, 1956, J ECON ENTOMOL, V49, P388, DOI 10.1093/jee/49.3.388; HARRIES FH, 1948, ECOL MONOGR, V18, P45, DOI 10.2307/1948628; Hayes EJ, 1999, PHYSIOL ENTOMOL, V24, P1, DOI 10.1046/j.1365-3032.1999.00104.x; HOWE RW, 1953, ANN APPL BIOL, V40, P134, DOI 10.1111/j.1744-7348.1953.tb02372.x; Kafi Mohammad, 2008, P177, DOI 10.1007/978-3-7643-8554-5_17; Kennedy GG, 2000, ANNU REV ENTOMOL, V45, P467, DOI 10.1146/annurev.ento.45.1.467; Kim DS, 2005, BIOCONTROL, V50, P881, DOI 10.1007/s10526-005-5380-x; Kim DS, 2003, ECOL MODEL, V162, P145, DOI 10.1016/S0304-3800(02)00402-7; Lam N, 2009, ARCH VIROL, V154, P429, DOI 10.1007/s00705-009-0320-1; Lawson FR., 1951, DISSEMINATION BEET L; Lee H, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-12618-2; Lee YS, 2018, J ASIA-PAC ENTOMOL, V21, P984, DOI 10.1016/j.aspen.2018.07.011; Lenth Russell V, 2020, CRAN; McBryde MC, 1936, AM J BOT, V23, P686, DOI 10.2307/2436351; McClay AS, 2007, BIOL CONTROL, V40, P405, DOI 10.1016/j.biocontrol.2006.12.011; McFarland A.R., 1987, MATH FDN POPULATION; Meikle WG, 1998, ENVIRON ENTOMOL, V27, P59, DOI 10.1093/ee/27.1.59; Meyers SC, 2008, INT J PLANT SCI, V169, P954, DOI 10.1086/589699; Panizzi AR, 1997, ANNU REV ENTOMOL, V42, P99, DOI 10.1146/annurev.ento.42.1.99; Park YG, 2020, J ASIA-PAC ENTOMOL, V23, P869, DOI 10.1016/j.aspen.2020.07.021; Promislow DEL, 2022, ANNU REV ENTOMOL, V67, P83, DOI 10.1146/annurev-ento-061621-064341; Romero B, 2022, ENVIRON ENTOMOL, V51, P460, DOI 10.1093/ee/nvab148; Romero B, 2020, J ECON ENTOMOL, V113, P2695, DOI 10.1093/jee/toaa243; Saeed R, 2010, CROP PROT, V29, P178, DOI 10.1016/j.cropro.2009.09.012; TAYLOR F, 1981, AM NAT, V117, P1, DOI 10.1086/283683; Team R. R, 2020, R LANG ENV STAT COMP; Tuan SJ, 2014, J ECON ENTOMOL, V107, P897, DOI 10.1603/EC13435; Weintraub PG, 2006, ANNU REV ENTOMOL, V51, P91, DOI 10.1146/annurev.ento.51.110104.151039; Wintermantel WM, 2003, 1 JOINT IIRB ASSBT C	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2022	17	9							e0274003	10.1371/journal.pone.0274003	http://dx.doi.org/10.1371/journal.pone.0274003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	6R9TT	36054184	Green Published, gold			2022-12-26	WOS:000892641400050
J	Wizrah, MSI; Chua, SMH; Luo, ZY; Manik, MK; Pan, MQ; Whyte, JML; Robertson, AAB; Kappler, U; Kobe, B; Fraser, JA				Wizrah, Maha S. I.; Chua, Sheena M. H.; Luo, Zhenyao; Manik, Mohammad K.; Pan, Mengqi; Whyte, Jessica M. L.; Robertson, Avril A. B.; Kappler, Ulrike; Kobe, Bostjan; Fraser, James A.			AICAR transformylase/IMP cyclohydrolase (ATIC) is essential for de novo purine biosynthesis and infection by Cryptococcus neoformans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMP CYCLOHYDROLASE; CRYSTAL-STRUCTURE; STRUCTURAL INSIGHTS; MYCOPHENOLIC-ACID; ENZYME; GENE; VIRULENCE; FEATURES; CRYSTALLIZATION; PURIFICATION	The fungal pathogen Cryptococcus neoformans is a leading cause of meningoencephalitis in the immunocompromised. As current antifungal treatments are toxic to the host, costly, limited in their efficacy, and associated with drug resistance, there is an urgent need to identify vulnerabilities in fungal physiology to accelerate antifungal discovery efforts. Rational drug design was pioneered in de novo purine biosynthesis as the end products of the pathway, ATP and GTP, are essential for replication, transcription, and energy metabolism, and the same rationale applies when considering the pathway as an antifungal target. Here, we describe the identification and characterization of C. neoformans 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR) transformylase/50-ino-sine monophosphate cyclohydrolase (ATIC), a bifunctional enzyme that catalyzes the final two enzymatic steps in the formation of the first purine base inosine monophosphate. We demonstrate that mutants lacking the ATIC-encoding ADE16 gene are adenine and histidine auxotrophs that are unable to establish an infection in a murine model of virulence. In addition, our assays employing recombinantly expressed and purified C. neoformans ATIC enzyme revealed Km values for its substrates AICAR and 5-formyl-AICAR are 8-fold and 20-fold higher, respectively, than in the human ortholog. Subsequently, we performed crystallographic studies that enabled the deter-mination of the first fungal ATIC protein structure, revealing a key serine-to-tyrosine substitution in the active site, which has the potential to assist the design of fungus-specific inhibitors. Overall, our results validate ATIC as a promising antifungal drug target.	[Wizrah, Maha S. I.; Chua, Sheena M. H.; Manik, Mohammad K.; Pan, Mengqi; Whyte, Jessica M. L.; Robertson, Avril A. B.; Kappler, Ulrike; Kobe, Bostjan; Fraser, James A.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Wizrah, Maha S. I.; Chua, Sheena M. H.; Luo, Zhenyao; Manik, Mohammad K.; Pan, Mengqi; Whyte, Jessica M. L.; Robertson, Avril A. B.; Kappler, Ulrike; Kobe, Bostjan; Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Luo, Zhenyao; Manik, Mohammad K.; Pan, Mengqi; Robertson, Avril A. B.; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Fraser, JA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.; Fraser, JA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	j.fraser1@uq.edu.au	Kobe, Bostjan/D-1292-2009	Kobe, Bostjan/0000-0001-9413-9166	National Health and Medical Research Council;  [APP1130192];  [FL180100109]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ; 	Funding and additional information-This research was supported by the National Health and Medical Research Council (http:// www.nhmrc.gov.au/; grant no.: APP1130192; to J. A. F.) . B. K. is Australian Research Council Laureate Fellow (grant no.: FL180100109) .	Arras SDM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163049; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; Asby DJ, 2015, CHEM BIOL, V22, P838, DOI 10.1016/j.chembiol.2015.06.008; Axelrod HL, 2008, PROTEINS, V71, P1042, DOI 10.1002/prot.21967; BAGGOTT JE, 1979, BIOCHEMISTRY-US, V18, P1036, DOI 10.1021/bi00573a016; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beardsley GP, 1998, ADV EXP MED BIOL, V431, P221; BLACK SL, 1978, ANAL BIOCHEM, V90, P397, DOI 10.1016/0003-2697(78)90042-8; Blundell RD, 2016, ACS INFECT DIS, V2, P651, DOI 10.1021/acsinfecdis.6b00121; Brown AM, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-63; Caicedo LD, 1999, MYCOPATHOLOGIA, V147, P121, DOI 10.1023/A:1007146700339; Cardinale D, 2010, CURR MED CHEM, V17, P826, DOI 10.2174/092986710790712156; Casadevall A, 1998, ANTIMICROB AGENTS CH, V42, P1437, DOI 10.1128/AAC.42.6.1437; Chapuis AG, 2000, NAT MED, V6, P762, DOI 10.1038/77489; Cheong CG, 2004, J BIOL CHEM, V279, P18034, DOI 10.1074/jbc.M313691200; Chitty JL, 2017, J BIOL CHEM, V292, P11829, DOI [10.1074/jbc.M117.787994, 10.1074/jbc.m117.787994]; Chua SMH, 2020, IMMUNOL CELL BIOL, V98, P819, DOI 10.1111/imcb.12389; Cowieson NP, 2015, J SYNCHROTRON RADIAT, V22, P187, DOI 10.1107/S1600577514021717; De Jesus M, 2010, VIRULENCE, V1, P500, DOI 10.4161/viru.1.6.13451; Efferth T, 2003, BIOCHEM PHARMACOL, V66, P613, DOI 10.1016/S0006-2952(03)00341-1; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Garber G, 2001, DRUGS, V61, P1, DOI 10.2165/00003495-200161001-00001; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; Greasley SE, 2001, NAT STRUCT BIOL, V8, P402, DOI 10.1038/87555; HARTMAN SC, 1959, ANNU REV BIOCHEM, V28, P365, DOI 10.1146/annurev.bi.28.070159.002053; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Hurlimann HC, 2011, J BIOL CHEM, V286, P30994, DOI 10.1074/jbc.M111.262659; Irokanulo EOA, 1997, J WILDLIFE DIS, V33, P343, DOI 10.7589/0090-3558-33.2.343; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Jenkins A, 2011, INFECT IMMUN, V79, P153, DOI 10.1128/IAI.00925-10; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kathiravan MK, 2012, BIOORGAN MED CHEM, V20, P5678, DOI 10.1016/j.bmc.2012.04.045; Le Nours J, 2011, J BIOL CHEM, V286, P40706, DOI 10.1074/jbc.M111.291138; LESCH M, 1964, AM J MED, V36, P561, DOI 10.1016/0002-9343(64)90104-4; LUKENS L, 1963, METHOD ENZYMOL, V6, P671, DOI 10.1016/0076-6879(63)06236-4; Malykh EA, 2018, MICROB CELL FACT, V17, DOI 10.1186/s12934-018-0890-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morrow CA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002957; Morrow CA, 2010, ACTA CRYSTALLOGR F, V66, P1104, DOI 10.1107/S1744309110031659; MUELLER WT, 1981, BIOCHEMISTRY-US, V20, P337, DOI 10.1021/bi00505a017; Pfaller MA, 2006, CLIN INFECT DIS, V43, pS3, DOI 10.1086/504490; RABINOWITZ JC, 1963, METHOD ENZYMOL, V6, P814, DOI 10.1016/0076-6879(63)06256-X; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/s1473-3099(17)30243-8, 10.1016/S1473-3099(17)30243-8]; Rayl EA, 1996, J BIOL CHEM, V271, P2225, DOI 10.1074/jbc.271.4.2225; Refojo N, 2009, MED MYCOL, V47, P177, DOI 10.1080/13693780802227290; Reyes VM, 2000, ACTA CRYSTALLOGR D, V56, P1051, DOI 10.1107/S0907444900007800; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Stevens DA, 2009, MED MYCOL, V47, pS1, DOI 10.1080/13693780802322232; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tibbetts AS, 2000, J BIOL CHEM, V275, P20920, DOI 10.1074/jbc.M909851199; Vazquez-Salazar A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196349; Verma P, 2017, FEBS J, V284, P4233, DOI 10.1111/febs.14303; WEBER G, 1983, CLIN BIOCHEM, V16, P57, DOI 10.1016/S0009-9120(83)94432-6; Wolan DW, 2004, BIOCHEMISTRY-US, V43, P1171, DOI 10.1021/bi030162i; Wolan DW, 2002, BIOCHEMISTRY-US, V41, P15505, DOI 10.1021/bi020505x	62	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	298	10							102453	10.1016/j.jbc.2022.102453	http://dx.doi.org/10.1016/j.jbc.2022.102453			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	5K6GU	36063996	Green Published, gold			2022-12-26	WOS:000869823800005
